<SEC-DOCUMENT>0000064803-21-000028.txt : 20210804
<SEC-HEADER>0000064803-21-000028.hdr.sgml : 20210804
<ACCEPTANCE-DATETIME>20210804063656
ACCESSION NUMBER:		0000064803-21-000028
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210804
DATE AS OF CHANGE:		20210804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		211142252

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cvs-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:efef91c4-b90c-4f53-8e18-716aea49f04e,g:46f154a9-1618-4e84-a3da-cd42ade064f2,d:da7fcde96ac345b2afc29fa84a520ed4--><html xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20210630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF8zLTEtMS0xLTA_92641017-db34-4b84-b044-c19c04802e9a">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF80LTEtMS0xLTA_8b63331c-e8ed-498c-aa27-6b0931431148">12/31</ix:nonNumeric><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF81LTEtMS0xLTA_242a2ad5-2e8f-431b-af32-175e18d1a05e">2021</ix:nonNumeric><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF82LTEtMS0xLTA_b4c14f70-944f-43e8-b375-4b36985e2707">Q2</ix:nonNumeric><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF83LTEtMS0xLTA_a461b6fb-a6c2-4139-b699-0f9343b5e8c0">false</ix:nonNumeric><ix:nonNumeric contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_25a5ce81-9390-445c-9d04-19bbb524680f">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_61ff17c9-97ed-4555-9af6-e3678e84c702">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_827ca4af-45d2-4722-b7e8-1ab1c7ebfae1">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_908a6944-01b3-44e3-9dc1-2018aba1d3c3">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="ibb4e231b6ed34804a0fac5206c9a3d5e_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMC0xLTEtNTUy_56466a58-8dbc-48ef-95d1-dc25d931058a">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0594fd101b564f96833fe922d849fd0c_I20210728"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie37da30b820144b09569aab8a05e7f28_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb62f039bb8842bc8ef8d95a854f9da4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d69c899161043de9c5695babe9a5226_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i919b19b29e644269b1afa564f760f9a9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e9b5e20d3e45f48dde1f569d67ed38_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if904a9513ecf4d9c83fa99b4032188d1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ecd6a626d1b42619b0531a785259c3d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a9847c4ef243cb940e602fdd9eb982_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ief51a7c21e12418191bfc6502162bc0b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f7761a4b9349978ab4d5316305bf43_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2849a2c586c46ca9f53db41bc644dce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69913db1407a480f8ffe4f65326387a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a68f85e6ae54b538e5f5597d97d1b7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic95472b2b89f4a878e888b2c6008da19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15d8aea22554cdbb76b87171c699449_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725e600ffd0e4474a684a511d91bf159_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i454f0a28269d4702bfc7afcb9aa5b5da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c46bc10f72646959e1ea5748cb11a97_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9bb9213ec2f4b83bf72ed648ff095bb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifef9fce1a4ab4fd2a6594fc95e1d677e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10bd9c2fefdf4b9b91c9e4c4c6e1c65d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba7043ec64d945079d428818e5fbaca9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9a72643612492c9389741defc77a60_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie383aef477f142c8a4ee9589eb871023_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9058898b3da04168adb83a7684c321ab_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc698fc867dc4bd5a40b8b39c3e3163b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb9d976268a44c29a6827a32bf43b47_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib40fe1673abe4a33b8ac7cd76c227e06_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1568266e931446589f92de497dd53eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0958e630b333456980651efb292c7c53_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e278d7295144ed994bb3fc2ee59a4c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d57ce235fd24cb692f4d0236f176f1c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286be063e99e48df99369d829e93c217_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5414e6cf48f414195513e58f1463f45_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf5fc475d1e49ff9053858c7255bf55_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i240be611ec6b458ab8544f6e424d4ab4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76b917a9650e493f8ed240df994cceff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9761a7d58dca45aba855e8b41e1dc1f3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c23afe3b82047c6929678c19cff2d07_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10016feda33d45238a3ea372b54a6eea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa87c9699e7d4b7ba3c7265c59239a90_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ade08e12deb4ce9b6e638145fd412fb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b5c733f51b48d3a973b7f1be17e3c0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c686e301544071b819b02df1403210_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb200c306c77462da3c260709207f142_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aabd0ef5b1048f4ac916396b08d7b25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31e862a1d4b443ea4f8845ae925852e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72d4f602c6ed4d0ebf494b7979f86f67_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a66d45936d84142bdd6e849ecbe7789_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e00411b2aaf43f8921414ab0ea39785_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie970b254b4ab4fd9949e74e9ab2d6b22_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb4e231b6ed34804a0fac5206c9a3d5e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98608eeed8d14d428759190c950b5465_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b30c2fa6a049fe966b44f48240fa3b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0da4d83180d243299812ac6a2eb3e7ab_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b9da8b49334c78a02939885c5ff91d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb6047b3685b46b296c06bf8cda6cf5e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed30a7f990b49dbbd6fc681ed4e164d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06487711e13e4c548dc075099d2dcf4e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d0d505da7c43e1ba4f399a5cb33457_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a885a54dd1743b0ad1cfc07e3045822_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9281f3b7011a4d5bba7f90551405ff6c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6087bf853b04c018d9664fc1da50a2a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7490b026d6d4a8d8ffe46672b4ef377_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib744df2f5180441d84b1f3233fef9a67_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01b81dca43f14167b65754c7fe593052_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc66c36f5a22420d886ff33223ea53c2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b6cfdbb5a84b37bb82d80f4997197b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d8629ee1c19401daa61e8d5a614d5df_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5049524449d410199f77b0d7237ac47_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib291fbdf9f5b46998ad02b3172e8ed1e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0934f4bb5efa44ef900ff2ef426e56c9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13fe73a518a24b02a40a1f3440e71f50_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a8adba1de1f4894a089eed1e7c97186_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25119c25c92b4f2db55b1b12c814d98f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id50e79715dae484d8bb0b80b30835854_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i022278e3d45b4b6e87ac5a6324a5b7fb_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f5fcae96f94664bcccd015f8aaef7e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223cec6898e447328115d33128bf3b5b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab4c8b62b63f480793c7a4aadd30e7d2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03db7eb72302412682bc5861ee38dfc3_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5037b7672ca64770b57ccbefe27214a1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="location"><xbrli:measure>cvs:location</xbrli:measure></xbrli:unit><xbrli:context id="ie162e65831a24d7ab6410600ff4e0eb5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:context id="id0838c3d504c4b0ba188c00aa78d7033_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i8f6a3d3df86b4fc6877832fc49952ae8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26532a4b62d467aa9a8517bc7419919_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e7456f591546feb889d8098d55bd2b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80f9e4113d044d07a6f887feda963f25_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i572b532a257b4eb29f5818e465112777_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e466ab07004cd0914feafe9a6bf57e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b2d360907ea45f0b08862db70c4d3d7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aa1afd1040f44cf8547b63d41dbe591_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3bca70c57704131aa24ce446c205802_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6c46eed192d41dc99861555299a540a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28be049ff18f43fbaf9cdd9ef79e8fa0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dcce512f8f4473389ed02f496c8b487_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e5bd3d12817424a83bdab3e1ef08149_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44034671f9c84fe8b2a64b71bb298348_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0ce4e1b8cd247a3afa48a6db26e4e70_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032e4e9b3eda4cb18d91840ce8d0e1dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5c7ea4581f40a28c6c335f145013dd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e2905eda41a471f8d885c44663f8134_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3a0d48a02bb422399156ace038008ad_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c50ebb9b454e83b240a67beba32866_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i496dec9258b04dcb9203d4d4c27ff56c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b9d1860aea74e00ad2c89291bc24962_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60ddfcc881984e29b4f64377dfc996c2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce75e54f582485ab1f2e764803ce78c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d12aed0d38d43b7913ac1ed40d9742d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3901d540d984bdbbe7954d01630c93e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib63e5fbf23624c13957ee808a92953b4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a382aa8220f4a0a8e22b91b4225625a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic571fcb252b9454580ca0b9a68a73d74_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i571c2782d55d4067ac07ad878ad2cda0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id584afc20f824cb5b10632de8cedc4e8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d48d9893b4e4e8fa0ae931e8905c5af_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5825e37024df49d08a5c01af8e8c0cbe_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86e6aad25c1b48e18ec4aedb16181989_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieabfd20c74d44f14b5f7309d49ff43fd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1150195ef084b308adc08d5b6fd6d37_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i277b57b4d1bb4be1b4eed74758be2d3a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c845f14e279418b852581196c54f9c8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i920cdf64d2fe4196a7c51badf2e4b2ee_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70267249c6134e0184dcdf8d3a4b67cf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820e7e5dad1e4cc99afe17c533670331_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6172f9453d340f39d59d5101635a85a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i411456f412ea4846a96be3b32e388bd5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fa3071f0b9a448599732f89a137d911_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79016db736f64c5bbe4e068ac2adcd98_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e4ac40a398f427cb77a2094a1e447e7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24a50869ac304742b49b405bf41bdc02_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600ff56b85734cbba43e0b25e8b6f595_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice379e0dacf9467da98333a95b5e13ff_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29c79146b5294d08add1c3efc10db8ce_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e8d73c14454d5aadcdd542013be434_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib920548c0b1a454d81f1407f3de6be03_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if479dca3854347d3be7f823a1683f8b5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364787c47e394a57938aa7f7999c533f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166554c720f64af9bcbc5fd85e9bcee6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fb5e05c3b6493da3da36f60554098b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f45cc0df9464d56aeaa2320aaed3b45_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i212fe2f3583e496088a7a5e86f5f1b17_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i759569ae7b9b48af8ea1770c353db400_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6889ed969d4544329ba1c263b5ac4e03_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f22972f46042c297c7c89259a121c6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bcd11287bf94b91819f67ab1137751f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11dcc6b36e054b7f83db5e8213b3e4a7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd33f24ebc4242b4a184fe50093ba8f1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f434ba89a2463491a53e466c45f175_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c500e6eec404740b845bbc6749d9816_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5560473d23f4f238af0827e871ebe16_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0190811d39f4835b7c199890587db0d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92367a9e55d345ae84f133238ad6f0c5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i140296fa522140e8b9fff9b2f366d8e1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5770294e42ea4e908f315f226b548613_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id320ea86e20d46c5b18c7cc290be409c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b3699d17ab4bc49abd7de1d430af9f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64696f2811204153b3a4db3e0624abce_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd9f5dd41194be8aa3c1c1db6ac93fd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c96c74db01f4ec1ba8c3b7ed9abcc0e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48dbcd0e840b41f0ad881ba4a5cb6ce5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i216530e358d54f83b2e18ae38bb5be13_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e8bbdf8e1364bb78dd9cb3211b8052e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91de92b5d1d44a68fa60bf2e45aa5d2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd2c902bbe145308ec3aa05c17b567c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ffc9a8dd41244b8acff67f5bde3ea2f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2efc32665c704f25894100c8ce4d0df7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95dd9befbed24089a9f86d2e656a2894_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee48290a6467466dbd923d0cdeae5c9e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3466d17106d4ff0ab52299c6a6ab8e9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f50e02b79ee45deb02a3ed6774b2cb0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i125594ebf3e84110a3111697a3b48e4e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0b811b19b1445fa845554f632a26d2d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i095ac5b05f56430b92c8170b133a7866_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if937cafeb43442a9aa8e67151c4d0301_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadff063171ac423d92c2da8077c58172_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8164c11b7854ff18ddfd168e0890d44_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i207199ecb13645e897faf29de46c250a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd1ce170b5c4a62b7556fdc2322c872_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39233506c97a4bffa7f4b9b02c27354d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64ced488010e4594a0781af33f4169d5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i587dd0796ad94946b28c9400be32b020_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i650d317e298a41ff8c04c7c3675c3c0e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286440c966274717b8d93a9e931b1209_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5672950bdb32444195bac533201af94b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96971f980314cc6824c828891c2a32b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i630fb69c6df2418b968902ada8401a5a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife997dbd130a4d2e9fd1499ba1bea839_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1703ae8e098b46b78e9927eaf75be8bd_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e954630bc78462e89281fe898f9064b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04b88e9ad43344949030a683b6a00df5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ed80d35553c4d40a468c52a12055be7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba7c706ce4764a0da3369af23605e185_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c07f5d814342089f6740d390c7572a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i432117100b93456f8cf6f278d0e673e9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:context id="i560d1a79f1ab4e93b2f826080d1e1e98_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i050986668b0745f78bd6639177dc57d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i785d26b7ae9b4b46858aaedd48a3f463_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cf6c37f26e849ed865434c8e9ca659c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67da0ed9c4d447b49163344869bcabfe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37114866aaba41cfb18a68f2cd2fde62_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d6f559cac05474bb144a75f235bcb09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb425d67a354590bedb80036ca60278_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3590ee0301174d61875cb4de2bb00cd8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50eced10560845d6a9cd175c5552eb84_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb104d269b9f4f0ead4974de98e0e425_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05fa8546b543495c817f8870574cf91c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie04051f399d14d09899ca54b68a00a7b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fc4d19ba499475caf61a593859df3d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id78f486649f54627bfd2a824897634ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74a11c9f2c994687b6022db81270ca31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46b3488cc73943e4acd89188f2b451fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbf240305fb945c386be358ec6c9c573_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a1de2913fe54b508792cc352b2f82bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80430002c1a3435e8f4abfa75c0919f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330716651f3445f2b16d92e604e21dce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="if91258c802ea4a78a5826616a1737d80_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0b8c6a6f20c461db287f9f793fbf9d7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb1943f336d24144a589379cf6e74715_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i486f1122037e48ebba56da0ba8464796_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b4441f7bf64f9db07dd58f12b394b5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1483e14fbc3a4929b38090e7dde2ad45_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7cdf1afe2da4dde8c7318e6ab1a8301_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91df7cc733e2416eae8bfe2970841365_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f598f62b58f44329684aa34ad736af0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i450c5941c7d942b0a54ddb1a32a20443_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4873ff3af0794784807c3e3ca3789caf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib600a4f1216f44378cf6f1b44d67d7ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaef7062893e5408eba53ca68b4edd0b0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48bd9aac481142a2b07aba094d9e81af_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1b8df1cc2643e8a0309a06abb7aca0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if924b5acfea142f0ab260a1dea210427_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007ade0d31a744fa85eece461d2ea04a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f755a38a33470f981cf406c956dd12_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic06ba18385514181b60ef5b38d07c7c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b2d1fbfab6345c08006daadfad4a310_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iceb56897df794c4191f6c4c04564d9c1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220a807050aa4c2ea3679d48640b0fc3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131e208f966e4264a055bb71305599da_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33523e15d5dc4123907ac3a0675f494e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia890bdfab1f54e6ca2e37c25ed5811f8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367b52fbb0a240aa82bd1a02d8a324f3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab34f008298435eb46af52c54f017d6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdb3058d4ed94963aaae1af4e53a426b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6ad7d715e9485e80a9f39a359e966e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic274db3d35ee4f3ebc05cc96aff41eb0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299180676e0a428090878a4e964ae3c3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie28ecf2d0aa0430b9c1cb966f93498b7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabefdd8927e1421d870bbc8356276157_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaffe79f8b7ea41698ffc230904de27f6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83f1ed1f5a7f4f3bb16d0358da0bb94f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449532a2d62a4951a3f3831a08a4fda3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9f2126c084443d9eda652a4acefb7f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e0a13ad4d0459196454862400790b9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c188280b0cd4569a3ce9e68984969a2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aff7e212dba4f1fbf45ee44721fbe81_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie247c0296a5e402b85463bc03fbab6c1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39dfb11efc44ccb81323ee1fcf29437_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54610f9931e549eca4055d422845c143_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if427cb3fea58401c8674f141a28396a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15d5490a569a400b8f3dcd7e8f5deeb7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d587f40c2be4fea92c1a51b110451cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b64b0dd3c184cf68f39f81eceb5b2a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i885cdcbd4dcd428eb8b3f2c4bf5ca941_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id753e4b7a848420eb1bf019e0dff3575_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie652cb275f004e0a8ec39116d03c51b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218aea3dada84f1fa06872e0f38b36c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d49cacf71ba442b8c626e29ceaba33b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6753c528bf954911905b7a442393bd2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3911cc7a050a463a9917d1b270dee929_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66926c144af6454b87ae1b8f6716f4b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3111a7bacfde42758aa324b189e45891_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3732b9eaa81d40fabbf3b7dcf14af188_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8412f07e8a547df9a2fcec0a4836635_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51b11270b11c465a83657fcd47ed4efa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2162ee28ee3f4ffdbcd637de827d5019_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie79e56a852074e97a192b8b7beff8f36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06bd1e75b881405f9702ac7ddbce9775_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f79cb2e161946d4929d70a5ba4b004e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad22fdfddeaf4656861bd7eeb9c94c0b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f663f5fccd4951aadd8900a4387256_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7007437bd44f4d68ad1ad8bd03e2f923_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica882fe4d91740f2b81b3646815ff854_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f0ffb4cb5747e5ae102f05f6be5426_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9fdbba4396e465aa67202f3d051bf09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie98081acc8c6408991f4c8cfefb17661_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaea822d1827147c99d73617628295d8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc598c056391483daf070cbea7830172_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0bfcd29b10f48ae92b73e7e61315ccd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i517df693ba094adcb6a72f956951017a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie42822d1eacc4a8eb4231d4dc693ea43_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3d1e2584e2e4ece9d9ce0724718c49e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i635b7d77a86447cbbde8755fc40a8123_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bdeac025f774c94829e3eb2edfc85ed_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d87419632b4611adab279ece7e7ab5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2b888f576f9425dbc1db1dd81427da5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc660620ba647f4b99c1bf75a1627fa_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16505c15a33845cc90e5567fa18ee168_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7b0bb4b38a45ffab552ab679c7ed71_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if766f5d0385a41e6b60c61a94201bd04_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f9c017860948b99f0fb8dea97d4d51_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib882de119eac484b9d951f61870fc5f9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0b4a3cd76c34e31b91ed92d1872d19c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c2fbf0383914cbeb84f216152e87705_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if510787ec69a47dab801c3bc8709accf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e17fbacae7443ed952ba5013f247779_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210cfc37361e470c839857aa7665fd2e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5756d6da663844dd8e3245d0308e243b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8122e2ed870645328446a41f8f459934_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4774aadb10b74dcd88e20d1880176f2b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d647a560d834ed7bec26a73aea83cce_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f256ca262f46f29af5968001b43da2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4937f0b48be141ada107552f5c969303_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec3859c325c4e37bdc207864784224c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcd344f786334eeba5b6b5f3e83b93d8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf06625a4a7e42ad8768a5601e932198_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if648025f3229424d9fb2cb50b21a4d8e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a83e5029cd544968b3f62662c6606dc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib243fd82757e4fa48ebb957b2b99c657_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i666e214c5a9044248a863407bd0eb6d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48d697cff45d428eb1ade196d28a9895_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c9463581a84b608a88153478abae38_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff11c38224d54e13923ab497bfa6a493_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0ee846d07ec4f5da014c0cbee5f6325_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaafc729b92494245ab81e716ce94cb2a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d54b47fd594fef8e068ff8c673c092_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1649f3335c0494e81c99fc59c8b29f5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if652301e5b5943129f8dabc5c8548671_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7bcca6c60a14999a5c77af4ebe5e5ae_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e6325064a1c495391cc89279cb2514f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf38374d2b44debb4cab8d016415de6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22d3dfbf8c9f4ac0bb704473ec643a62_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia08106700a614dff9824cb0fe4668155_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc2aabed88fc4d488c491b6a45904991_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i508570dbfe5849138bc3977ff2cb5ef7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72735f55bd18494cacc33cb8c99b64d9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f512df7d4da495d8f781fb880dc0284_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fb024b2608349f0b1205f18ce388c77_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia30edaab02914ed1a4fb09da02b3afef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43462d31172f47d98a4a3224e271ebd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic544aea1c1a74584aca18be496ce9788_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bd934620d014afeb56e178d35779aa7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibed7dee2937d4edda5a4f4eea940e0c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41c79aea9b744926b279baefd7888c7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc1767b92b5c4de5a2e23e7eb3179d2b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa429dd3d3443068ab973df732e3c5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5804356b138422d80717a1da9579a89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib901721cf1bc447e858860d4cb20ce74_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b4df452eaa45da9e4f334a54e4276b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7e5f228a57743f1b6ea83a254776653_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife856c95fabc422e946de71df9f85f7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd180ab75d5a4fecb68db3e8d283b9f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85785249c39f4629a053294868f4fcdf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19ff9770b3940188b1c9822a1c6d9b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a1418e8df34c6cb73572ce728f62ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f5a355792b49a293afec62f4455847_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2374f86f801462a83df1f2c38872a96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8cd73f6a957430db9ad4fba0bb5ee64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bd730a9a7384fcba46ad7b64d43e6d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09ff8669b4a54e3e90a5ab48256328b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d20c989c3b64c90ac3cd629c8bf4640_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04a0e0235a7c4490a5d9ce38d2dec0f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0dc3ba5e04941c187297fe40513dde5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3854b6138a7e4b6ba179f9daaf4bf706_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18930979d5f444fc9ce85d4aea31a3a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdb74a304f8a449c904b5ac5ed9a47d3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b89a5844183436683430ac9c92e2493_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff75c2db4cc4af1b847def76f22a529_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7c828dc2e7148ec8b99c9d153298510_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i492d50e843c848998eb35ba39503a0c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73382bef295f429781872fe2001fc529_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c677e6daec4e8780d801dfa6da3c94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e642c930d94a8d9996ce4bed724ae0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5b641cecaa495588a4e4dba1cafd61_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i118929ebf94a4e06be11a3ad3b27a03d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6584062de818418fac5ed71f5a372118_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34356136fef34ea68725d0b2dedc1d87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i854709c930d6449fb02d80ed81b53e55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c3a89719074423b8d52bc27096fff9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a115fbfb91c4616a824c7ad041c71b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2e12ab2ed44a1685c511613129c6ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb7d9bc6a274f09859f00ab5e174888_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5abce7dc4f744fb8be00645bffc65db_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad91cb1314994e379923841f48edf212_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffde036edf014ed291d1a23247cc772a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a2cc0aef0ef434ca7a520686e5a5a11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae628a7e9e9d4d70990367c3408854c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i076f74e1a0eb466192510067a9c8a7c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idac6c16e9b5b4dc8a02816d8c21aeafa_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8968fff252724607a7a65bdc9378629e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9e44f82810c440485338f4334976121_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdb59237beda4ebaacb4ab8eb6a97d0b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0244059f9628439f877b719efced6c7f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie43a8645a41a4ef2a7ef116fc6539527_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eaea3134fed4570a85d692327045a39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef4cf2bbf004e71ac5c7cca1cfd3a50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34b9eb3d66c14bc28cb0cc540b80fc4c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7857397f0c414fe58b62068caf0af267_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaebacd56446c4171843144f398469d81_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib77cba1c8ec74b5ea417e97bfc25f625_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01eb9253c97c4e5b9250d83998bcec06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44630855078a48b9908bbdadf53bc736_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c30b37500e14214ad5855fdc0950616_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic242a2b931a4468b8b353b6e0aef8bcd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22db164f3ee140ce9151bfbea89bff98_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09809fb393924acb85b3db48f54103ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f077ab3271f495385d381d572fbe9e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b390a8e65e1443bb33e8ab459655c77_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64ece45dfbc249c0a0e2afea4e637eba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30f3983821e94ff09717ee684cee383a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58bd0bd6852b45eea2c0896f18f97044_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17e39654116145cdb653f9ed90d33e64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8097a507fc364b0bad573079ff802eb0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba58e1397ac49f68fb7f5f0f5837ff0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d0846f2bdb423fad6dde41f494d94d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib452e1f428b347f39293769ac08d9478_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4101cecc5df744f5a0b26d331861ca9e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id118d34f2b5c4d3f8bef18af6def2414_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0152c20c97aa43078a0e9f51783dc116_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59c04e7fb5d44ae6997958c568ba3a08_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92993780db143b7b0e4a20bccee8f39_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdec0af0fd9f4f60ab69ce914af06e6a_I20161102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i112799dbf93348fca843c7d691faf8b1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i142f058b8bb74591a7b7633b6055fdb8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03a3ed387264a22b8a9acf639af05bf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic645e74bfbdd4334929938f94e38d35a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0fedee6ab64c609195f894c49bca7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb18023bf9b4744abf0271e233e621d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia293eeb507694d29b061f167f11864bd_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17321eb57374b8abc46c944d2885a9a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b04b502bb5c4952b90f134d823c69b7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79d9fd45dcf3482cacd29cdd9932e790_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3220f907b164c859ca1b0dc2c4f6b28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2abba1f0810f4477917b3b690bc38448_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bb9417d47fc43f1897e27292ba0ceeb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07261151d31f426a8232fcb0f14da1ae_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a9782f5451439dbac16821699f7854_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd049c214e14e6b8653d68bd8a3e2f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb4c36eb3df4620a92deefe268baac0_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5232fdd455f74d7da74de09d354498c3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75c8fc3eedf24bee8f01fff1c288efc4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i834cc5cc64384c53bbdae7fa265c9dc1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea949437ea7642b58259e785c86e9340_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1e3563999254ce18bebe63113318168_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica622595b996421496158a8950271496_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37226568eaa9431f82f538d433d5910d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb51c1fc52c417391c987b64935b747_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6cde7cf62354c9f90d8f5d1b6beed42_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0f1fa309d244561b4d4255b13e72185_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1728a5a6a3242af80ab519ee500c71c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aff438e903c4976a85160658a6e3ebc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44713b7441b84d789aa571d6a659979a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1631ebf77054c36aadaba422e742499_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ccd57de85dc4077979b39a24f44206e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3da72faaf2b4475f838efca9f0889b65_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2f056bb44964d78b883cc1b11fb04a6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70240851d9624b2b833aff8775606301_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e9af44465864c999326af45d83b0a2a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34955bacc9344a75bd20cc975c6d72dd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b0c7405c7a44354a5b01c38a42318c7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i699e98c5cf6e484bb4ad38af546870e1_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:context id="i70b16429cf7d4b5ebba7b368990673d2_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="i001dccf76afc4c24992b25b72dcb6e28_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia726d6239ffd4749b438a44af233681b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieddd6943d58948fca9da637d49a68e16_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i622f60133e0f447ba5a9b36b96bae65d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fb82e1b7ebd4c54be9d1622a6b266a3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13fec49e4db045d598a854e6be36041f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i468fcff0a66441fbad1b998c36682c15_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id11782f1722a4ab1a431f51a8b8bb767_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fba9e2c34f44e5ca1e106a2a73285b1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb80760bed64a4ea52ff1222cfcd13d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5662cc7cd70b4808b16a82e9bc2161b4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c0ccf7e987345a8a9c4f161c072bb04_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563c6cc59100449cb1b087e6d683b97b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d1e96563e740f186d85a4df1469291_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23673f3bf56a41a982c19211f550e038_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i259c3a6a85d34cad9bb1f18eb7f79a6a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdd42d2ed15e435daff26e80bcb970ea_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71be5af836584a6eac396f68bf46ee96_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc5e6d1bf7764728ba7479982f03642e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c7a1d3118640968e9a75f187d6b40b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93fdab396b0143ccba07019b56d386ec_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd6ea18260343fe8d826574d00c787b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c5177a6cd544aea90d592c291b5439_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7592f4455e574a298526d9bc23a5566b_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNC0xLTEtMA_7f316f1b-dc43-491a-8c8d-695b7e031c8c id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtNC0xLTEtMA_6bb3e726-1da8-4905-9248-e5ab6d18d2d2 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC00LTEtMS0w_d19de74a-a420-4773-878c-7708f957b4bf id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS00LTEtMS0w_0a84bc09-a75e-41f3-a855-f96d170c8ee1 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNC0xLTEtMA_eeafa215-8c4d-4f77-9a29-602cb5b96bbf" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNS0xLTEtNTUy_01170ae2-3cfd-4dbf-baf0-e5f84c37dee0 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMi0xLTEtNTUy_aaa59c91-2c8c-4bc6-9fae-f2004158076a id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNS0xLTEtNTUy_bc106cb1-4cc3-4ad4-961c-e50bd551252b id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMi0xLTEtNTUy_086fddac-c03b-4336-aee3-c5cf54003721 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtNS0xLTEtNTUy_c5d53360-3c2f-4371-a2b8-c5945515b120 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMi0xLTEtNTUy_9faadd55-3305-4b8c-86b0-635cdf0c51e7 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMi0xLTEtNTUy_2b695517-9fa0-4060-9712-c785e9a61767 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNS0xLTEtNTUy_5fe81db8-f08a-46f5-8dd9-5969e92e53e2 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMi0xLTEtNTUy_3c24294a-83fe-4fad-bd4f-da9998c2f8aa id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtNS0xLTEtNTUy_30e9e76b-eb8c-4b7b-9ec8-3f4acb011479" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktOC0xLTEtNTUy_f7f2d015-f1d8-4e9d-b50e-f9e070d54da8 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMTAtMS0xLTU1Mg_c65fc5fa-829e-4c89-ab40-651d938b254a id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktNi0xLTEtNTUy_57d164e0-790b-4848-a8a6-9e39366c9552" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS01LTEtMS0w_0e4e0e55-99e9-4e56-904b-60b9f137bedb id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtNS0xLTEtMA_5fa47889-de68-4757-999e-4d5000eeb54a id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNS0xLTEtMA_45a7ecfd-6122-49bf-af2f-c7a1b7b7e8dc id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNS0xLTEtMA_0e8aad1b-d954-41a3-87f6-7e7282581202 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMi0xLTEtMA_36db3ec1-bc73-4af3-afd1-819eacb01b4d id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0yLTEtMS0w_d6fc320c-70ac-458c-bb12-56729a35e2a1 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0yLTEtMS0w_9880108b-ee15-44bb-9f49-0d4a889dd2ae id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMi0xLTEtMA_bb169a23-a4f1-42d3-a193-eeba9fd4fd7f id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMi0xLTEtMA_cff07a43-78b1-48d4-8ad0-27781b033506 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS01LTEtMS0w_149e934d-1cee-4830-85d7-6f78c36e137e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNC0xLTEtNTUy_c7407ad0-d847-455f-a7af-7540f8ac4463 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItNC0xLTEtNTUy_bcbbc22c-8e07-4d02-b2a5-ba0f973d0626 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNC0xLTEtNTUy_6c173928-5673-4e72-ab3c-179342e32921 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktNC0xLTEtNTUy_f5c764c8-c4cd-4356-94a2-de618b57fe99 id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNC0xLTEtNTUy_656f23d1-9cb7-4002-9602-2f38a0e35d47" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_1"></div><div style="min-height:22.5pt;width:100%"><div style="padding-left:101.25pt;padding-right:101.25pt;text-align:center;text-indent:-184.5pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM184Nw_28ea11d4-7c2c-49cc-b244-dc2a7fe634a0">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMw_e20dcfc8-529a-47a8-8866-e85602138ab5">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMjU_5bb2623e-6225-48c9-b293-3d7a29932d73">June&#160;30, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMx_6b2bd942-f7c2-457f-b9be-b6de750abd04">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMy_5184afd9-1e73-413b-a53b-1a09d3bdd83e">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="cvs-20210630_g1.jpg" alt="cvs-20210630_g1.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:104px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMz_5ddf6288-837c-4fe2-bc96-a7eb02d771ee">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6OWM5NjQ0ZDE3ZDU1NGRhOGE5MDJkY2Y0NTQ4NzJiZTgvdGFibGVyYW5nZTo5Yzk2NDRkMTdkNTU0ZGE4YTkwMmRjZjQ1NDg3MmJlOF8wLTAtMS0xLTA_a86eabff-9319-4531-989c-9aab68f9b8aa">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6OWM5NjQ0ZDE3ZDU1NGRhOGE5MDJkY2Y0NTQ4NzJiZTgvdGFibGVyYW5nZTo5Yzk2NDRkMTdkNTU0ZGE4YTkwMmRjZjQ1NDg3MmJlOF8wLTItMS0xLTA_5dadbfb5-a24e-4303-ad1d-6f9364a7b440">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:4.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTEtMS0xLTA_f128c5d8-d589-490a-b7b1-64c64d4bf307">One CVS Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTItMS0xLTA_38afaedc-e8e1-4062-9e64-c6a6e2f60153">Woonsocket,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTMtMS0xLTA_05fedac6-761b-45d4-bf93-aa33306344db">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTUtMS0xLTA_4be05edd-c5be-46de-8d51-88f700015de1">02895</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Zip Code)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code: &#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8zLTUtMS0xLTA_a700d560-dfb2-4d5e-b03c-09fd398de743">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8zLTYtMS0xLTA_736246e5-a95c-42de-8822-ca7ed95e922e">765-1500</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Former name, former address and former fiscal year, if changed since last report:</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></div></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6YTRiYjQxZGI2YTQyNDdhYmE5ODAwNzc2YjM0MzI5MWYvdGFibGVyYW5nZTphNGJiNDFkYjZhNDI0N2FiYTk4MDA3NzZiMzQzMjkxZl8xLTAtMS0xLTA_ebb7b9e1-a45b-4871-a488-4ae9b81b2c6a">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6YTRiYjQxZGI2YTQyNDdhYmE5ODAwNzc2YjM0MzI5MWYvdGFibGVyYW5nZTphNGJiNDFkYjZhNDI0N2FiYTk4MDA3NzZiMzQzMjkxZl8xLTEtMS0xLTA_83d8ee1b-55a2-441f-a580-2be6bf960cf8">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6YTRiYjQxZGI2YTQyNDdhYmE5ODAwNzc2YjM0MzI5MWYvdGFibGVyYW5nZTphNGJiNDFkYjZhNDI0N2FiYTk4MDA3NzZiMzQzMjkxZl8xLTItMS0xLTA_cce83107-5e64-42bc-a64a-f2c5516496d3">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                            </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDM0_c85fe629-57d4-493c-a628-f32f85f9c6c3">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">                                                                                                               &#160;&#160;&#160;&#160;                  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDM1_caccf899-5720-458f-8e45-fe7ef04e621b">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.175%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6MzczZDc0NGRkYWFiNDc4MzhhOTI0MGNjZjBmMGIzYzEvdGFibGVyYW5nZTozNzNkNzQ0ZGRhYWI0NzgzOGE5MjQwY2NmMGYwYjNjMV8wLTAtMS0xLTA_3907c8ea-998a-4238-b9e5-391446eb9971">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer                     </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6MzczZDc0NGRkYWFiNDc4MzhhOTI0MGNjZjBmMGIzYzEvdGFibGVyYW5nZTozNzNkNzQ0ZGRhYWI0NzgzOGE5MjQwY2NmMGYwYjNjMV8xLTMtMS0xLTA_77343c62-2a5f-4bc3-8245-9042c061a237">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 97.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company    </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6MzczZDc0NGRkYWFiNDc4MzhhOTI0MGNjZjBmMGIzYzEvdGFibGVyYW5nZTozNzNkNzQ0ZGRhYWI0NzgzOGE5MjQwY2NmMGYwYjNjMV8yLTMtMS0xLTA_d52d339d-096f-4ceb-87a5-42641d51ed18">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDM2_0e41812f-66c1-4ab9-9f5a-851ae477ca09">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;28, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i0594fd101b564f96833fe922d849fd0c_I20210728" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18xOTgy_4e04f395-45ce-41b1-9d8e-17a2191cc6a4">1,319,574,744</ix:nonFraction> shares of common stock issued and outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Information</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_70">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_70">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_103">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_103">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_106">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_106">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_112">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_112">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_115">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_115">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_118">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_118">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_121">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_121">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_124">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_124">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_127">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_127">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_130">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_130">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_133">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_133">60</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8.25pt">Financial Information</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_13"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Financial Statements</span></div><div style="padding-left:27pt"><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Condensed Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Operations (Unaudited) for the three and six months ended June 30, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_19">2</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and six months ended June 30, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_22">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Balance Sheets (Unaudited) as of June 30, 2021 and December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_25">4</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended June 30, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_28">5</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Condensed Consolidated Statements of Shareholders&#8217; Equity (Unaudited) for the three months ended June 30, 2021 and 2020 and the three months ended March 31, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_31">7</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_34">9</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_67">35</a></span></div></td></tr></table></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_16"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie37da30b820144b09569aab8a05e7f28_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy0xLTEtMS0w_eb73dfb4-23e5-4c4f-a46c-d0caa0387377">50,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb62f039bb8842bc8ef8d95a854f9da4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy0zLTEtMS0w_ad4153ea-d571-466a-abd9-b993bbbc3304">46,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d69c899161043de9c5695babe9a5226_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy01LTEtMS0w_f1fb6b1a-8045-446b-a84d-58a955cabd45">97,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919b19b29e644269b1afa564f760f9a9_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy03LTEtMS0w_e8a86a66-2912-4074-9636-ebc556428a92">93,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC0xLTEtMS0w_cfb8bd6b-f705-4be0-a85f-11a6fd51c589">18,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC0zLTEtMS0w_67cc84cf-6a41-4174-a125-0eaca2b47daa">16,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC01LTEtMS0w_8a516843-24d9-4335-8707-ee4c04ace5a3">37,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC03LTEtMS0w_84f99832-0319-4d5f-b154-a6ea5bad2c16">34,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e9b5e20d3e45f48dde1f569d67ed38_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS0xLTEtMS0w_9e6cb09e-88b9-42ce-9eda-fc7a9a4d7eed">2,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if904a9513ecf4d9c83fa99b4032188d1_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS0zLTEtMS0w_54757c68-8a5c-4d5b-9b2f-d54aa63851a5">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ecd6a626d1b42619b0531a785259c3d_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS01LTEtMS0w_1062eba0-2061-4a32-91b9-6f2b856f8283">5,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89a9847c4ef243cb940e602fdd9eb982_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS03LTEtMS0w_12c4f6fa-148c-4f1c-966c-fa5f9d8e3549">3,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi0xLTEtMS0w_1ce09391-e484-4597-8ada-944f8921fe89">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi0zLTEtMS0w_4fb57558-5935-4984-a34c-0509e554a102">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi01LTEtMS0w_6e4aeb3b-ea29-4421-b0cb-2ff0c1eaecdb">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi03LTEtMS0w_452a6af6-cd43-40e7-a17d-a7324179d2d9">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy0xLTEtMS0w_ec0c0c58-83bb-4ac6-8cff-63e0f5acde86">72,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy0zLTEtMS0w_176d3182-8a1b-4bc2-b4cd-025eb82214be">65,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy01LTEtMS0w_f6b67506-96f1-4648-97c5-6796f79592d2">141,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy03LTEtMS0w_06c7b8ff-edc3-46fc-95ad-04ecbabdffd6">132,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_25a5ce81-9390-445c-9d04-19bbb524680f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_61ff17c9-97ed-4555-9af6-e3678e84c702"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_827ca4af-45d2-4722-b7e8-1ab1c7ebfae1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_908a6944-01b3-44e3-9dc1-2018aba1d3c3">Cost of products sold</span></span></span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0xLTEtMS0w_6ec2eb5e-4888-40bc-bc80-0f34cad8c5e0">43,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0zLTEtMS0w_e560577e-780c-437b-9273-0b4466b6c710">40,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS01LTEtMS0w_f2ead627-e23d-4ded-ab5f-96730ffc8ec7">84,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS03LTEtMS0w_e797a6c0-87e1-4b64-aa5e-9d26e8e64f22">80,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtMS0xLTEtMA_7757903c-e5ea-421c-ba88-b0c7e4d126f9">15,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtMy0xLTEtMA_2f2d5820-6a74-45b8-9370-9e70d1cb9e1b">11,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtNS0xLTEtMA_fd4718e9-c9a1-4d3f-a3aa-587708ea6195">31,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtNy0xLTEtMA_cbd5fb84-b397-4ab9-9547-2bef54d046bf">26,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtMS0xLTEtMA_183b510d-4da1-49c8-b2bf-87d7a500c66e">8,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtMy0xLTEtMA_0c963736-d792-4c72-8060-2910cf22b5b3">8,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtNS0xLTEtMA_461c7a96-f1d3-444e-9a82-77394b4e4414">17,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtNy0xLTEtMA_77fa99ad-8866-4df4-ab85-544887e99baa">17,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItMS0xLTEtMA_d9330e60-b8d7-47df-8b56-306e971ed36e">68,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItMy0xLTEtMA_9906ee7f-c1a0-4e6b-9314-cbcaa8a1d05a">60,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItNS0xLTEtMA_bacafb1f-c048-4be3-b98a-f5f42799a923">133,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItNy0xLTEtMA_92e5b453-01be-4413-92a4-a28cc36e9d7b">123,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtMS0xLTEtMA_b8764cba-728e-4bd6-a4aa-c1a55a7dd402">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtMy0xLTEtMA_2363ec44-2b60-4d1f-8e4a-b3f3157d42dd">4,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtNS0xLTEtMA_81c277bd-5c00-49f9-a6c1-39a7cd1a5385">7,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtNy0xLTEtMA_e42b8e3f-5048-4e6b-be00-93053e0e95bb">8,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtMS0xLTEtMA_3e866f1b-98a0-4151-a5ed-dbc814eda18f">636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtMy0xLTEtMA_fb7af746-8c01-4cf3-8611-27d71aa409f5">765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtNS0xLTEtMA_5948342f-053d-4eeb-983e-d58db3e1a72b">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtNy0xLTEtMA_b1069f22-ebb1-4e3b-8df4-5c9431e9b496">1,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtMS0xLTEtMA_fbc3e3fe-e601-4004-b1d1-9e890c8122c8">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtMy0xLTEtMA_fe83fad4-93bd-4879-b126-15d1cf6ca7da">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtNS0xLTEtMA_5e7996fb-dbba-454f-8c99-e9a0097c7b17">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtNy0xLTEtMA_0df0de4e-ffa3-4abd-972a-cb077835eb0e">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctMS0xLTEtMA_cd301440-59b3-49b5-8da2-e5a0ab3f3c6d">3,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctMy0xLTEtMA_37da4baa-d8e2-40fa-a7bd-b3c9b2a600d8">3,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctNS0xLTEtMA_e0297277-feb3-4aaf-bce1-4533f15b652b">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctNy0xLTEtMA_371866ee-95a4-4a31-affb-dcc1e3ec6405">6,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtMS0xLTEtMA_b655f688-94a5-456f-8463-e0dec08c797b">944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtMy0xLTEtMA_90d694cd-792f-4e9e-ba32-5faf7f9a2b32">974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtNS0xLTEtMA_1a18b61b-5ace-4460-9d89-3fe55bca87ac">1,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtNy0xLTEtMA_fe25b9d3-9720-4727-b465-5f95cc085cdf">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtMS0xLTEtMA_8fd15d73-8517-43e6-ae59-8b6c314de955">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtMy0xLTEtMA_5022c42e-5b01-44d3-b3a0-b2e5b908cb72">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtNS0xLTEtMA_0cd72c6c-0e0d-4c47-bb59-51902c94b7a3">5,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtNy0xLTEtMA_f7fd791b-e6ac-44cc-bae6-abdf6bf576eb">4,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItMS0xLTEtMA_c6fce611-9787-4ed9-9380-171685c77902">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItMy0xLTEtMA_fb3e4f81-9e7f-4250-875b-cc6405aee017">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItNS0xLTEtMA_1f93a451-7ee0-4dfd-b91c-0769208cb538">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItNy0xLTEtMA_1628e4a6-4a67-487f-9264-d5eef1028a92">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtMS0xLTEtMA_6cfc0e1f-aa9b-43b7-aa2f-32792d2be965">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtMy0xLTEtMA_7987637c-d5cd-4473-b6cf-40367492bd8a">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtNS0xLTEtMA_f8d202ca-8aad-4aa3-b191-6fe583801d88">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtNy0xLTEtMA_20c3f6e8-1cff-4bb4-ac89-3789d62c179f">4,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to CVS Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtMS0xLTEtMA_1bdb0071-8560-4f6c-8fd9-7dfb0a044c29">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtMy0xLTEtMA_ae811525-bf0d-41a5-9a1a-3da8868eff26">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtNS0xLTEtMA_33e1ca68-19e1-4fe5-9f18-c68cf06d0a1b">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtNy0xLTEtMA_51cac0fd-e52f-4695-933e-52659535956a">3.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctMS0xLTEtMA_4543860d-4df9-410c-a77e-026b30da0d9c">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctMy0xLTEtMA_a3972817-e5f3-4dd1-a740-f16a6d49d2cb">2.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctNS0xLTEtMA_a7f8da0d-7343-4211-8e16-a5af257c589a">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctNy0xLTEtMA_cfc726c5-88f7-47c7-881d-f2c1fe8fd7aa">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktMS0xLTEtMA_bc107ec3-c42b-4663-81b5-91ef64fe7ab2">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktMy0xLTEtMA_7d781cbe-27b0-41f9-8e1a-9c4247883a02">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktNS0xLTEtMA_2a638b23-079c-4989-9da1-ad726bdb2e28">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktNy0xLTEtMA_52eeca50-599a-4b94-ad18-ffbee93ae56c">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtMS0xLTEtMA_09c5700d-b163-4906-907b-6497c55a7a70">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtMy0xLTEtMA_585a11b9-388b-4398-b35c-a464fa5cbb29">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtNS0xLTEtMA_e79d023d-fce9-4b43-9f1d-4b6d71fc369e">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtNy0xLTEtMA_c5d36d97-4e4e-4d06-ba76-a061d994560e">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtMS0xLTEtMA_29d1e457-37b1-4bf9-9e78-0887462c5a29">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtMy0xLTEtMA_001c6edc-2566-429c-8ef4-a79a39c8a193">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtNS0xLTEtMA_33208732-c8ef-4022-a65b-1decf7419f42">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtNy0xLTEtMA_2916ee5d-aaca-476d-97ff-b3515425a9a7">1.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi0xLTEtMS0w_8fd15d73-8517-43e6-ae59-8b6c314de955">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi0zLTEtMS0w_5022c42e-5b01-44d3-b3a0-b2e5b908cb72">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi01LTEtMS0w_0cd72c6c-0e0d-4c47-bb59-51902c94b7a3">5,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi03LTEtMS0w_f7fd791b-e6ac-44cc-bae6-abdf6bf576eb">4,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC0xLTEtMS0w_9fb94dc9-506e-46f0-94f3-7324a29d9415">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC0zLTEtMS0w_e9e59e50-d422-48dd-a1e0-366c3c2747c1">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC01LTEtMS0w_89579f77-96e5-4fe2-bcca-c93827d8bf33">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC03LTEtMS0w_54b664e9-a261-4d0b-91cf-fd2d852a91c4">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS0xLTEtMS0w_e0bb609b-0311-4f2f-ab66-c58f08650fe9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS0zLTEtMS0w_187fe24a-7f3d-4d8b-ac7a-dba20dc0282d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS01LTEtMS0w_5273ff4e-1cb8-45af-a09a-369e615ec586">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS03LTEtMS0w_ac621634-1610-4281-9854-e69e1ffb5e28">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi0xLTEtMS0w_d0310ae6-9ae0-4786-90bc-ecceb20d2712">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi0zLTEtMS0w_6ee7153e-4191-4caf-af11-5ea2d4413638">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi01LTEtMS0w_6cd4da63-0fd5-49e6-aac3-9c3bae7405f1">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi03LTEtMS0w_aff79c9c-f8ab-4467-977c-8f888f5d42f1">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy0xLTEtMS0w_554a7521-1352-4738-883b-067de5b3b25f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy0zLTEtMS0w_5a73791a-c8be-423b-a06f-c20edcb7002a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy01LTEtMS0w_f58f1797-487f-4dc1-ad62-533ea926a84c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy03LTEtMS0w_5d391eb0-b015-4f88-bad5-e859cb81d21a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC0xLTEtMS0w_d3f75bd0-6474-4f3a-b514-dc73f409d98b">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC0zLTEtMS0w_afabbe6c-93a5-40e7-9f99-a60cf18ff3ce">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC01LTEtMS0w_4c3b0959-828b-498f-8fa7-0de655da5979">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC03LTEtMS0w_c27ea184-c2a6-466d-9653-87400e46dd02">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS0xLTEtMS0w_700312f8-ee16-4474-b5a9-e7b985d2550c">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS0zLTEtMS0w_09742255-51f8-4fa9-afc4-4f6aaae2003e">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS01LTEtMS0w_67599156-ec16-4e2c-bc66-1d51cbdba181">4,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS03LTEtMS0w_2374be49-31aa-4f15-b119-0bf8daa5ca62">5,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtMS0xLTEtMA_c6fce611-9787-4ed9-9380-171685c77902">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtMy0xLTEtMA_3d3ec9ce-66f6-431d-8438-f0cae11b4842">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtNS0xLTEtMA_1f93a451-7ee0-4dfd-b91c-0769208cb538">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtNy0xLTEtMA_1628e4a6-4a67-487f-9264-d5eef1028a92">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtMS0xLTEtMA_c0310de3-e934-48bb-89bb-6bbc42788a1a">2,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtMy0xLTEtMA_49bc1e2b-c057-49ce-b3e3-748da443979e">3,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtNS0xLTEtMA_f94c5bec-d6ee-4d02-81e5-4da9bad68e98">4,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtNy0xLTEtMA_e9f75e8d-0766-4420-9b36-2679fade893f">5,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMi0xLTEtMS0w_5d198605-6893-47a7-ace3-29c5729d84b0">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMi0zLTEtMS0w_55058523-9201-4431-a153-e6c87734b5e9">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMy0xLTEtMS0w_eef59d6e-ecb1-46bf-8b63-3c5148b07855">3,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMy0zLTEtMS0w_2c5a26fa-7eb8-45db-a96b-f773ba0fb0d1">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNC0xLTEtMS0w_0c2d0498-f446-46f7-b51b-0822a69da012">24,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNC0zLTEtMS0w_967389f4-c70e-43d5-be81-8ab4e1460d80">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNS0xLTEtMS0w_2ab3d28d-a629-4e8a-8dbb-66d1eac08b41">16,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNS0zLTEtMS0w_6ace5948-bea5-46f7-b8a7-52d9552afcd0">18,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNi0xLTEtMS0w_587588be-65f5-4d1b-b215-0d330897f6f2">5,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNi0zLTEtMS0w_60a15bf4-225c-40fa-ae7e-5a7ec5fd9272">5,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNy0xLTEtMS0w_ff610652-394d-431d-903f-de9512af4f02">56,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNy0zLTEtMS0w_d985ce8f-4eea-40b5-8bd9-c0f26ba59e41">56,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOC0xLTEtMS0w_bbc7766a-5d1d-4dd8-9755-505bc2eebcaf">22,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOC0zLTEtMS0w_6e702d34-ef08-43a8-a610-16f401c44118">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOS0xLTEtMS0w_9e0c430b-d448-47ee-93a2-21491c756aa8">12,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOS0zLTEtMS0w_82858dfd-7df9-43ea-9c15-0125636302af">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTAtMS0xLTEtMA_869a11e9-f767-43a5-8fa9-649f4f24b217">20,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTAtMy0xLTEtMA_5243c18b-e877-4d7d-920a-2915d933621d">20,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTEtMS0xLTEtMA_c50ea360-ef03-4234-8540-276ca16f7c5c">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTEtMy0xLTEtMA_6a66d14a-b60c-4145-abec-ec3e8f644d0e">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTItMS0xLTEtMA_1b13fd1b-1f7a-4f3d-819e-1a890fb1a3af">30,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTItMy0xLTEtMA_ca3635fd-138c-4257-a9fa-d1b2319bd431">31,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTMtMS0xLTEtMA_99976aca-bc72-4949-8036-58c3c5253226">4,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTMtMy0xLTEtMA_0023fdef-7392-4601-87d4-b03c9a00917a">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTQtMS0xLTEtMA_409b2b01-e132-473b-a00c-9e6bd9b54428">4,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTQtMy0xLTEtMA_3930573a-ceca-4242-bfaf-eb004d660a5e">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTUtMS0xLTEtMA_0a257d6e-0584-4482-adbb-f5cc7a92a799">231,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTUtMy0xLTEtMA_594392bf-e8a5-4ae2-9969-37be0c3492a0">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTgtMS0xLTEtMA_51d4b4de-d5b5-4e7b-90e9-d1e5b0cf1756">11,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTgtMy0xLTEtMA_13d44175-5ba4-49a7-ba2c-5b6ae1091f40">11,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTktMS0xLTEtMA_9bbbb4d8-4dda-4894-bcf5-6b3cea7277df">17,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTktMy0xLTEtMA_affe403a-6854-4940-978b-a0ab6b927d7d">15,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjAtMS0xLTEtMA_12493069-6993-4c42-9380-8595ce86a91e">8,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjAtMy0xLTEtMA_5eb5d702-c94e-43d0-b294-2227b95a8113">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjEtMS0xLTEtMA_e3eb3dcf-c0c6-4e8e-b975-f31e4c7b7e10">4,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherPolicyholderFunds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjEtMy0xLTEtMA_61075170-47be-414e-97a6-121f5dea5eca">4,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjItMS0xLTEtMA_b081d6fe-9261-4e61-afec-62afc195a323">14,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjItMy0xLTEtMA_f3669286-a15c-4e39-9df4-936b6b1724ab">14,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjMtMS0xLTEtMA_7a5fdb76-424a-4744-b72d-5e99b2b9be9e">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjMtMy0xLTEtMA_0a837ba0-cdc3-4be7-9ca7-79f5781973b4">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjQtMS0xLTEtMA_30b0b68f-639f-4fd0-83a8-03b72727b77d">1,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjQtMy0xLTEtMA_11ab8e86-3ead-4fa1-8651-b8a19409c2e7">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjYtMS0xLTEtMA_7f0ae4dc-0cc4-46f7-af60-24df23a8e7ae">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjYtMy0xLTEtMA_ff649e06-b25d-4961-aa76-ccd81a1b3b48">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjctMS0xLTEtMA_36b786d5-ad30-4cf2-91c8-a48470481bf6">59,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjctMy0xLTEtMA_420ad695-63de-46ae-8404-01bc3aa67fcd">62,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjgtMS0xLTEtMA_3120be78-5983-445d-8191-63fbacfbef51">18,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjgtMy0xLTEtMA_8142d927-061f-40cb-9bbc-ba932c043853">18,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjktMS0xLTEtMA_8c93a722-c11f-4b34-a1d3-8cc09d8bc94f">59,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjktMy0xLTEtMA_d2caf180-c21f-4a0a-8981-0927d3e3b549">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzAtMS0xLTEtMA_21a00600-1856-43fa-9e84-06033f5e602b">6,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzAtMy0xLTEtMA_81086409-7d73-4b69-9b7e-990141662d47">6,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzEtMS0xLTEtMA_7d5b8a9f-34bc-4ce9-904f-5adf222d6104">4,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountsLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzEtMy0xLTEtMA_df8cb65c-f1fe-4141-9127-7da6d0a7b9b4">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzItMS0xLTEtMA_91da1f97-707c-4963-976b-dc8aab2a8f19">6,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:OtherInsuranceLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzItMy0xLTEtMA_47f2994b-ade0-4938-b5a6-24bada3a3835">7,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzMtMS0xLTEtMA_5643e183-0911-49b1-b424-62645ec3e7d1">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzMtMy0xLTEtMA_acce22bf-8aec-4750-9e6e-bff8a22fa982">2,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzQtMS0xLTEtMA_c5561ba4-f602-4a5d-b5dd-ac849106e721">157,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzQtMy0xLTEtMA_e145fcc8-e026-450b-babf-2fffe199a332">161,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzMx_55029632-bdec-4f70-8523-5f684527b32d"><ix:nonFraction unitRef="usdPerShare" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzMx_b382bc04-4228-4538-8b2a-159859757807">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzM1_be83711b-b705-4d64-805f-51009047ca9a"><ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzM1_e5876e37-bdaa-4e6b-af9b-fb3bb59a1ee5">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_085a5d4c-dab7-4fe3-9637-0260d23d2a50"><ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_216b465d-8285-4fcb-829e-e8700f098f17"><ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_b228e685-01ad-4534-9420-49c186b40989"><ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_de0e1de7-ebcf-4f0c-a30e-ddbfa3cb5fc3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne issued or outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMS0xLTEtMA_e135dd40-b080-4176-b538-03f8370ec078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMy0xLTEtMA_ce41c85f-c528-4a8b-b2b0-31b7f8651ee2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzI4_037bbf6c-f5d3-4358-ae73-90ae3e6451ee"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzI4_42422701-991c-4cd6-a67d-8c38158360f3">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzMy_2dd71a9c-5501-4a4c-8237-0dd16c3619c0"><ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzMy_75b553e5-5eb0-4da8-bf8b-f2753c831122">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzU0_7bf2d098-a948-4f87-acf8-8da1dafd6c1d">1,742</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzc1_241d6b05-e591-4619-9162-99c69a5e5a54">1,318</ix:nonFraction> shares outstanding at June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzExOQ_722213d6-f890-42c0-a7d3-d5be2680a5f8">1,733</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzE0MA_bd7babf4-f8fb-4b0a-8239-b9deba0f7bea">1,310</ix:nonFraction> shares outstanding at December 31, 2020 and capital surplus</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMS0xLTEtMA_6f67ebe5-e1b3-4a74-b9d5-11b806f23df9">46,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMy0xLTEtMA_1b6a7d76-5341-498d-b1fb-4cb5e4c26cd4">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjNkYjZjZjJjMTZmZTRhOTU5MjhkNGQyYTkyNGU0NzIwXzI5_4349fe08-ccc1-4796-9d67-6dc01d428137">424</ix:nonFraction> shares at June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjNkYjZjZjJjMTZmZTRhOTU5MjhkNGQyYTkyNGU0NzIwXzYx_d2cd06ee-84b8-4d57-b254-061daf6fa4cd">423</ix:nonFraction> shares at December&#160;31,&#160;2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMS0xLTEtMA_1c198ce3-8b99-4c06-977e-d58474ee6e11">28,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMy0xLTEtMA_391a021c-7a64-4e6e-a2a6-e6540bbca989">28,178</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDAtMS0xLTEtMA_6f4ac8e5-43f7-4a53-aab3-2ad29b93f40b">53,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDAtMy0xLTEtMA_132dd228-0a08-43c1-a0b2-bafe5ce77a45">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDEtMS0xLTEtMA_b14df73d-3083-4728-b40d-21e50ef87622">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDEtMy0xLTEtMA_cb3a31f8-9a35-42dd-91a3-c2f28ec109a8">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDItMS0xLTEtMA_a1747fa7-14d3-4a7b-8eeb-66f6da416300">73,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDItMy0xLTEtMA_acb1d889-9128-4030-ac70-81b769e5b101">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDMtMS0xLTEtMA_63dec13f-c5c1-4f9c-9310-4a7af977ddd0">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDMtMy0xLTEtMA_9dd27d50-4914-484c-9566-55870eae3cb5">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDQtMS0xLTEtMA_916e61d3-1dd9-4c9e-a32d-731c9a6c3dae">73,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDQtMy0xLTEtMA_059a2963-46f2-40df-a766-316a1a63f742">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDUtMS0xLTEtMA_9e2701f4-4d1a-41db-a7f2-580811a601bc">231,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDUtMy0xLTEtMA_3875b474-41d1-4117-b183-2ac7be7ab3ac">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMy0xLTEtMS0w_6bb2d221-7a3e-48de-b470-1620d6561f25">136,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromCustomers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMy0zLTEtMS0w_da6a4875-57ce-4e1a-ba82-90e7756075d7">129,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNC0xLTEtMS0w_a51023f3-cac3-4024-8f91-fa3aefc537f5">79,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNC0zLTEtMS0w_2cdc90bf-e896-499e-8bc4-4ffc37350629">76,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNS0xLTEtMS0w_fa017faf-daa0-4cb8-a555-ca8cf0b400a5">31,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PaymentsforInsuranceBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNS0zLTEtMS0w_13cb2da4-85be-4ccb-acf4-1b9e77ec36f0">26,483</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNi0xLTEtMS0w_b491abfe-ddb9-4d03-aa00-dd6f66056335">14,900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliersAndEmployees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNi0zLTEtMS0w_84dcbbe1-2344-4131-9b7c-6b16faf2e675">14,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNy0xLTEtMS0w_54d22d5a-c4e3-4555-907e-3378f9c0cd71">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNy0zLTEtMS0w_ccd88de6-e07c-43e9-bd53-b2ecde320388">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOC0xLTEtMS0w_010fac45-c6f4-4b0b-96bf-7ee5f5bc63e2">1,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOC0zLTEtMS0w_f8ee1f27-48b1-40f6-8db6-bfac0f042364">1,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOS0xLTEtMS0w_56d69dbf-d478-49cb-8f3f-05f0a276ba86">1,552</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOS0zLTEtMS0w_8441d794-b606-4200-999e-fd0cadadc2f3">230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTAtMS0xLTEtMA_d10b53bf-349b-4b01-92a4-4b4309e38dcd">8,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTAtMy0xLTEtMA_15f158a7-d9e2-4340-91f1-1287c2ef1eed">10,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTMtMS0xLTEtMA_ea226add-e3e1-4c41-b7f6-a968b316d167">3,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTMtMy0xLTEtMA_327bf033-6931-4719-9650-e954cde1c405">2,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTQtMS0xLTEtMA_bbf09801-76ec-40e6-8f34-f5d3a8d12e21">5,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTQtMy0xLTEtMA_3ed13a0f-d1e6-4cf8-bb1a-b63d66ec05e9">3,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTUtMS0xLTEtMA_7d687b1d-6fcc-4173-81d3-cf03d95e84a8">1,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTUtMy0xLTEtMA_4d930b51-4235-4014-930f-92952739e357">1,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTYtMS0xLTEtMA_c791f982-bd9e-4597-bcde-f1c9dd2e0d6f">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTYtMy0xLTEtMA_609acf54-cf00-4d17-993d-021b236007c9">768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTgtMS0xLTEtMA_0fda6b7c-f139-4e22-b319-134de8788acf">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTgtMy0xLTEtMA_d16e4c2b-9cb3-40f6-b188-1b093d6c9196">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTktMS0xLTEtMA_94a71155-9159-4671-a239-488787640ac2">2,974</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTktMy0xLTEtMA_45c06633-a334-4e11-8ce3-94e2be93432b">2,930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjMtMS0xLTEtMA_d35d6e71-abf7-40f6-b54c-778d4ba09973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjMtMy0xLTEtMA_19de5d83-0336-41d3-b1c1-da541f494a32">3,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjQtMS0xLTEtMA_3b2ab592-2a01-4c66-bb8d-41f9f5ab5e29">5,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjQtMy0xLTEtMA_71f7b553-5ec8-429f-8be1-cb44a36a9187">1,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjYtMS0xLTEtMA_a02d34af-f83d-4368-8d57-9ab1d72e732c">1,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjYtMy0xLTEtMA_012f46f0-4d70-4ef1-8ddf-1552f52bd627">1,315</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjctMS0xLTEtMA_d179c85b-5778-4584-8c5c-e028273b9905">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjctMy0xLTEtMA_9c60dfbc-2647-4615-9833-098138652f1c">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjgtMS0xLTEtMA_fb5897e0-8266-4f66-867f-10bb77833cac">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjgtMy0xLTEtMA_1e05a81f-3168-4001-95fc-373a89dc2945">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjktMS0xLTEtMA_92ec7887-7d5d-4238-8f4a-f3b36f13e659">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjktMy0xLTEtMA_1cf986f4-73f5-4491-b815-4aa3f436dbb5">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzAtMS0xLTEtMA_e14268b8-cc58-4d01-abb4-06dc1c78d80d">6,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzAtMy0xLTEtMA_4b6f0433-bc7a-4753-a24e-ff92c23845d7">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzEtMS0xLTEtMA_a8d1dda9-36a2-42a5-89a7-0444a3604007">793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzEtMy0xLTEtMA_ad162956-8725-4bd0-a4da-7fea55ce90e1">9,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzItMS0xLTEtMA_ec049333-09c0-43d4-8206-4269dd0def8c">8,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzItMy0xLTEtMA_7835f33b-15e7-4b63-acfd-2c7a724c3c4b">5,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzMtMS0xLTEtMA_a8184a18-a228-440f-acb8-13b4ca5da8ab">7,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzMtMy0xLTEtMA_c41784e2-a3f7-44f9-9ffc-2c09987289c7">15,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMy0xLTEtMS0w_0cd72c6c-0e0d-4c47-bb59-51902c94b7a3">5,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMy0zLTEtMS0w_f7fd791b-e6ac-44cc-bae6-abdf6bf576eb">4,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNS0xLTEtMS0w_06cb4bef-425a-4eb0-8e13-dd425f402e19">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNS0zLTEtMS0w_4a8a5010-77c2-4d27-905f-b5bb051d3315">2,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNy0xLTEtMS0w_bc0935f2-af17-4090-afee-e492019e3b8e">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNy0zLTEtMS0w_038001a9-cbe1-4b4e-bb8d-9d285c48046a">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other noncash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTAtMS0xLTEtMA_acf0a901-daeb-478d-a70f-0b81b3569ba7">370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" name="cvs:Deferredincometaxesandothernoncashitems" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTAtMy0xLTEtMA_6a386e49-0bff-4f93-acee-50b559039efa">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTItMS0xLTEtMA_18943d72-feae-40cd-b85c-10b2761d02ec">2,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTItMy0xLTEtMA_eba7be0e-a131-4f63-843f-70427362aebb">2,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTMtMS0xLTEtMA_cf8b944d-a649-43b8-938c-dfcfdd28ae5c">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTMtMy0xLTEtMA_5b1a9416-32c6-41f8-b815-516a64b93b6f">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTQtMS0xLTEtMA_e7052a3b-679a-4439-8441-7cc49b5178b3">145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTQtMy0xLTEtMA_f493fab9-83f0-4c77-ba2a-896c55168a27">560</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTUtMS0xLTEtMA_6c48c16d-2edd-4dd5-b3e7-994a865bb590">1,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTUtMy0xLTEtMA_bad7f639-542d-43aa-bee8-eb8efc30c49b">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTYtMS0xLTEtMA_31e19a42-9b91-4c96-a77c-180afcd61403">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTYtMy0xLTEtMA_9ce743f3-4a47-43b0-965a-ad860701776a">415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTctMS0xLTEtMA_e53ef281-5831-41b8-b866-4e3795998bbd">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTctMy0xLTEtMA_0539f5f9-0ce5-4ae0-a5c7-fc6b7ad079bc">3,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTgtMS0xLTEtMA_38874729-bfd3-4f1d-b5bd-38d1d327cfda">8,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTgtMy0xLTEtMA_fe3feee0-58ae-4b59-a4aa-3e14fe59880d">10,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CVS Health Corporation </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie2849a2c586c46ca9f53db41bc644dce_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0xLTEtMS0w_4bd2e7ab-5a5e-4725-8447-d159c865dac8">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i69913db1407a480f8ffe4f65326387a5_I20201231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0yLTEtMS0w_d6fc320c-70ac-458c-bb12-56729a35e2a1">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a68f85e6ae54b538e5f5597d97d1b7a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS00LTEtMS0w_0a84bc09-a75e-41f3-a855-f96d170c8ee1">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69913db1407a480f8ffe4f65326387a5_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS01LTEtMS0w_0e4e0e55-99e9-4e56-904b-60b9f137bedb">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic95472b2b89f4a878e888b2c6008da19_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS02LTEtMS0w_3358903f-acd4-4545-b9df-75a1eb668d78">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15d8aea22554cdbb76b87171c699449_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS03LTEtMS0w_ec696316-2d4d-4159-b3fb-e76beb38cd30">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725e600ffd0e4474a684a511d91bf159_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS04LTEtMS0w_66c58be8-2295-4b12-a115-1a5e9382b11a">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i454f0a28269d4702bfc7afcb9aa5b5da_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS05LTEtMS0w_b41964d8-af1f-4d8f-87ea-26b26dc515e9">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0xMC0xLTEtMA_0671816c-a1df-406e-8cc7-ea460d938635">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c46bc10f72646959e1ea5748cb11a97_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi02LTEtMS0w_22dd4b1c-1f49-4fcd-8d91-23fc62d3821a">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi04LTEtMS0w_6663a3c1-7ada-4c35-a1b1-b01b7f17ee16">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bb9213ec2f4b83bf72ed648ff095bb_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi05LTEtMS0w_a3b194cf-18a2-47b7-b23d-3bab662e86f2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi0xMC0xLTEtMA_7e483037-4a77-45fc-ac6e-44a767e0d625">2,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifef9fce1a4ab4fd2a6594fc95e1d677e_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNy03LTEtMS0w_70e99d65-499f-4f89-b9fb-02768dfcb856">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNy04LTEtMS0w_fb6dcbdb-3db9-4db1-bc55-26d9e89df15c">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNy0xMC0xLTEtMA_58e2b5b7-5990-445d-9b15-12ede7ef8467">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10bd9c2fefdf4b9b91c9e4c4c6e1c65d_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC0xLTEtMS0w_638a7cb2-7131-416b-97d8-4ad2255f642e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7043ec64d945079d428818e5fbaca9_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC00LTEtMS0w_d19de74a-a420-4773-878c-7708f957b4bf">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC04LTEtMS0w_796a9b6e-2d7b-496a-99b5-d6c3c32bf859">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC0xMC0xLTEtMA_67465ea4-a0d8-4965-bb1b-8fb0e843ac54">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad9a72643612492c9389741defc77a60_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0yLTEtMS0w_9880108b-ee15-44bb-9f49-0d4a889dd2ae">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad9a72643612492c9389741defc77a60_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS01LTEtMS0w_149e934d-1cee-4830-85d7-6f78c36e137e">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS04LTEtMS0w_60158616-8c30-4410-893c-739c9e7269f5">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0xMC0xLTEtMA_01cb7145-a734-4353-88c2-3d0d8d084bf0">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c46bc10f72646959e1ea5748cb11a97_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTAtNi0xLTEtMA_ea9d7e3b-8549-4e63-b9ff-dbb7721c9e63">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTAtOC0xLTEtMA_0bb90b90-fa84-496b-aa62-84f54ea6eb8b">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTAtMTAtMS0xLTA_88a276fa-ffd8-4166-924d-a7f5273e84f9">660</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bb9213ec2f4b83bf72ed648ff095bb_D20210101-20210331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTEtOS0xLTEtMA_f5cd0d9c-9f74-418a-99a8-5cf66de2821f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTEtMTAtMS0xLTA_59d7c1a3-c5c2-4576-b2ad-c4c80d087318">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie383aef477f142c8a4ee9589eb871023_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMS0xLTEtMA_5c4dfcca-d995-4ba9-b4b9-3c1a5eb4b940">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9058898b3da04168adb83a7684c321ab_I20210331" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMi0xLTEtMA_36db3ec1-bc73-4af3-afd1-819eacb01b4d">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc698fc867dc4bd5a40b8b39c3e3163b_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNC0xLTEtMA_7f316f1b-dc43-491a-8c8d-695b7e031c8c">46,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9058898b3da04168adb83a7684c321ab_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNS0xLTEtMA_45a7ecfd-6122-49bf-af2f-c7a1b7b7e8dc">28,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb9d976268a44c29a6827a32bf43b47_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNi0xLTEtMA_4aa8c7d9-a28d-4739-bb92-b5044b10290d">51,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib40fe1673abe4a33b8ac7cd76c227e06_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNy0xLTEtMA_e83d1cff-27fb-452d-bd6d-0db022f1d86d">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1568266e931446589f92de497dd53eb_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItOC0xLTEtMA_f91577c3-0492-40c7-aca7-ef07d31164e3">70,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0958e630b333456980651efb292c7c53_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItOS0xLTEtMA_9314d8cd-06c2-4187-a556-60a027891aa7">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMTAtMS0xLTA_ce73730e-5d0d-4613-872d-92f0c8c9d24b">71,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d57ce235fd24cb692f4d0236f176f1c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtNi0xLTEtMA_8e12dd01-d510-4217-a10a-26eb5998f898">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtOC0xLTEtMA_224aeea5-9f1c-4cb6-ba0c-e997ee06a6bb">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286be063e99e48df99369d829e93c217_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtOS0xLTEtMA_7fb2391e-741b-4e0b-8a93-2bd35cae9e8d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtMTAtMS0xLTA_13a57390-c1f4-4dd8-b500-9a6319bfac5f">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5414e6cf48f414195513e58f1463f45_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTQtNy0xLTEtMA_e602c6bd-1689-4110-9185-9ef741b13b51">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTQtOC0xLTEtMA_a540e61d-757f-4650-bb89-2292c5fd8f51">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTQtMTAtMS0xLTA_d01e70cd-d1e6-453b-94e4-b284e5007f01">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaf5fc475d1e49ff9053858c7255bf55_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtMS0xLTEtMA_cb9e9599-a9b3-44d8-9a5b-00ddb566082b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i240be611ec6b458ab8544f6e424d4ab4_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtNC0xLTEtMA_6bb3e726-1da8-4905-9248-e5ab6d18d2d2">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtOC0xLTEtMA_e1a62478-51b1-4ebd-a444-809b50843865">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtMTAtMS0xLTA_315e81e6-9cfa-46d3-92a2-ef3676c1a49d">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i76b917a9650e493f8ed240df994cceff_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMi0xLTEtMA_bb169a23-a4f1-42d3-a193-eeba9fd4fd7f">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76b917a9650e493f8ed240df994cceff_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtNS0xLTEtMA_5fa47889-de68-4757-999e-4d5000eeb54a">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtOC0xLTEtMA_865155f8-a2cd-4b1e-b7ec-508444b7ac3d">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMTAtMS0xLTA_6799f244-aafc-487b-94b9-10e0bd3a0f83">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d57ce235fd24cb692f4d0236f176f1c_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTctNi0xLTEtMA_74f9acb4-3013-43e8-b8a2-1212def9d55b">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTctOC0xLTEtMA_9bbef948-e15d-4664-a16c-0ec030808591">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTctMTAtMS0xLTA_76f4f4e6-2977-4ace-a706-39fc1873090b">655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i286be063e99e48df99369d829e93c217_D20210401-20210630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTgtOS0xLTEtMA_74cf09d6-6d8b-4e51-8147-a41cf9597281">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTgtMTAtMS0xLTA_52dbe585-a8af-404b-8a0b-ab4ce7648f0a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9761a7d58dca45aba855e8b41e1dc1f3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMS0xLTEtMA_6a3c9efa-5ff3-48ec-9373-edf74af8e9f6">1,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9c23afe3b82047c6929678c19cff2d07_I20210630" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMi0xLTEtMA_cff07a43-78b1-48d4-8ad0-27781b033506">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10016feda33d45238a3ea372b54a6eea_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNC0xLTEtMA_eeafa215-8c4d-4f77-9a29-602cb5b96bbf">46,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c23afe3b82047c6929678c19cff2d07_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNS0xLTEtMA_0e8aad1b-d954-41a3-87f6-7e7282581202">28,252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa87c9699e7d4b7ba3c7265c59239a90_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNi0xLTEtMA_ea666da2-4f48-41af-91bf-75375d18ab73">53,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ade08e12deb4ce9b6e638145fd412fb_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNy0xLTEtMA_d1907957-064c-4aed-83b5-40607f0f104f">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b5c733f51b48d3a973b7f1be17e3c0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktOC0xLTEtMA_bb71edff-0285-4c49-98b1-5aa676ffd77b">73,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c686e301544071b819b02df1403210_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktOS0xLTEtMA_5009c319-e36b-4708-8ddc-46f428c73d02">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMTAtMS0xLTA_d2539223-f14a-4b9b-8b20-3a2b4d79264a">73,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTcy_44f68e91-8309-4843-997d-77c151cf2a98"><ix:nonFraction unitRef="shares" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTcy_452fd7fb-8628-4bb4-945d-d066295290a2"><ix:nonFraction unitRef="shares" contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTcy_f7a5e22a-af07-4661-bfc6-5e9046449491">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMjI0_0bc9386b-6b67-4ae0-9064-1541208ba582"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMjI0_8c28e16f-7513-4686-8fd0-be0787b5d688"><ix:nonFraction unitRef="usd" contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMjI0_ae3993bf-7e29-4d1d-9e43-622d1d5888db">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020. </ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMzk3_036a4cff-9c5c-49ff-8d4b-244214962e75"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMzk3_59a880d1-512f-47aa-9371-499cb4a0b94b"><ix:nonFraction unitRef="usd" contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMzk3_91689046-50b3-42fc-b4e2-a7fcae6e30b8">17</ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</ix:footnote></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total <br/>CVS Health<br/>Shareholders&#8217;<br/>&#160;Equity</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb200c306c77462da3c260709207f142_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMS0xLTEtNTUy_1a3a273c-82dc-4868-a858-30755776ad9d">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6aabd0ef5b1048f4ac916396b08d7b25_I20191231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMi0xLTEtNTUy_3c24294a-83fe-4fad-bd4f-da9998c2f8aa">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31e862a1d4b443ea4f8845ae925852e_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNC0xLTEtNTUy_6c173928-5673-4e72-ab3c-179342e32921">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aabd0ef5b1048f4ac916396b08d7b25_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNS0xLTEtNTUy_01170ae2-3cfd-4dbf-baf0-e5f84c37dee0">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d4f602c6ed4d0ebf494b7979f86f67_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNi0xLTEtNTUy_870281b5-5191-4fb1-9c7a-3ff5d93ce4b8">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a66d45936d84142bdd6e849ecbe7789_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNy0xLTEtNTUy_6cb7edbd-a851-4b84-bbc6-6a532886c9e0">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e00411b2aaf43f8921414ab0ea39785_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtOC0xLTEtNTUy_767509c1-32ac-4d1f-a37c-0e167cbb67bd">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie970b254b4ab4fd9949e74e9ab2d6b22_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtOS0xLTEtNTUy_398b5124-3516-406b-9c68-ca6b2a76f167">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMTAtMS0xLTU1Mg_c3f728ce-8d77-4a43-94c7-376194fce336">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMC0xLTEtNTUy_56466a58-8dbc-48ef-95d1-dc25d931058a"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98608eeed8d14d428759190c950b5465_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktNi0xLTEtNTUy_57d164e0-790b-4848-a8a6-9e39366c9552">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76b30c2fa6a049fe966b44f48240fa3b_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktOC0xLTEtNTUy_f7f2d015-f1d8-4e9d-b50e-f9e070d54da8">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0da4d83180d243299812ac6a2eb3e7ab_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMTAtMS0xLTU1Mg_c65fc5fa-829e-4c89-ab40-651d938b254a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98b9da8b49334c78a02939885c5ff91d_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtNi0xLTEtNTUy_300709f8-ac8d-4853-adf0-2fddc1ecd634">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtOC0xLTEtNTUy_d1b3a702-5df4-4d71-beab-b6ccde7ffc0a">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6047b3685b46b296c06bf8cda6cf5e_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtOS0xLTEtNTUy_64ee8d50-8945-49ae-a068-0ffa606fee3b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtMTAtMS0xLTU1Mg_b87af7f5-8577-46c9-a414-48feab26d872">2,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ed30a7f990b49dbbd6fc681ed4e164d_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzEtNy0xLTEtNTUy_e26c5300-fc21-4748-82da-35959d5876a5">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzEtOC0xLTEtNTUy_43540278-d482-49be-bf0f-853f4f6e5c87">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzEtMTAtMS0xLTU1Mg_4d0e5ce0-e147-4828-a30a-3d81d6b5da5e">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06487711e13e4c548dc075099d2dcf4e_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItMS0xLTEtNTUy_9ad9db8d-df2e-44ec-9780-6a585891e57f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d0d505da7c43e1ba4f399a5cb33457_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItNC0xLTEtNTUy_bcbbc22c-8e07-4d02-b2a5-ba0f973d0626">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItOC0xLTEtNTUy_678b4596-010c-47fc-8a5b-8e6d0cfe443b">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItMTAtMS0xLTU1Mg_e688ef7a-d36c-4d24-b8bf-23857f67feea">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a885a54dd1743b0ad1cfc07e3045822_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMi0xLTEtNTUy_086fddac-c03b-4336-aee3-c5cf54003721">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a885a54dd1743b0ad1cfc07e3045822_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtNS0xLTEtNTUy_c5d53360-3c2f-4371-a2b8-c5945515b120">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtOC0xLTEtNTUy_7565c5af-b593-4e44-a25c-9f6d62ad6754">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMTAtMS0xLTU1Mg_7e88a179-777f-46a7-beee-056ccfc11686">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98b9da8b49334c78a02939885c5ff91d_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzQtNi0xLTEtNTUy_0fd2aba3-0e4a-464f-b1c0-2ec580b5e1a4">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzQtOC0xLTEtNTUy_248ec406-666d-4c91-aa1e-eda036cb3f3a">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzQtMTAtMS0xLTU1Mg_1d18768d-0cb9-41cc-a8e1-2542e311b9df">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6047b3685b46b296c06bf8cda6cf5e_D20200101-20200331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzUtOS0xLTEtNTUy_8a247b5a-e324-4485-9686-177ebf159099">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzUtMTAtMS0xLTU1Mg_650cb146-2fae-4a81-bbf4-22aa39a3f359">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9281f3b7011a4d5bba7f90551405ff6c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMS0xLTEtNTUy_207c27d8-37f0-439e-917f-162379ad0837">1,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic6087bf853b04c018d9664fc1da50a2a_I20200331" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMi0xLTEtNTUy_9faadd55-3305-4b8c-86b0-635cdf0c51e7">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7490b026d6d4a8d8ffe46672b4ef377_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNC0xLTEtNTUy_c7407ad0-d847-455f-a7af-7540f8ac4463">46,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6087bf853b04c018d9664fc1da50a2a_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNS0xLTEtNTUy_bc106cb1-4cc3-4ad4-961c-e50bd551252b">28,182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib744df2f5180441d84b1f3233fef9a67_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNi0xLTEtNTUy_771f6f93-a993-4314-8c9f-cc694f0e479f">46,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01b81dca43f14167b65754c7fe593052_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNy0xLTEtNTUy_7f31a9b3-e8c6-4c55-a95e-756c79b9e9b9">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc66c36f5a22420d886ff33223ea53c2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtOC0xLTEtNTUy_0a522a56-409a-435d-ac0c-477f3432fee9">65,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b6cfdbb5a84b37bb82d80f4997197b_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtOS0xLTEtNTUy_3f07ac95-7043-4ebd-874b-a8b14622654a">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMTAtMS0xLTU1Mg_8b6e7683-f546-48a7-adf8-fa486e20a066">65,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d8629ee1c19401daa61e8d5a614d5df_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctNi0xLTEtNTUy_22f3a5dc-97c2-4f09-a611-f1c7a2219fc2">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctOC0xLTEtNTUy_f57ec0c8-d9b6-4b8d-b9d1-80a67eba02a2">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5049524449d410199f77b0d7237ac47_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctOS0xLTEtNTUy_c4353624-6144-470d-8864-fbd148f3f582">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctMTAtMS0xLTU1Mg_99c76105-1c4e-4cc3-90db-99066f258bd7">2,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib291fbdf9f5b46998ad02b3172e8ed1e_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzgtNy0xLTEtNTUy_c8667aee-602a-44e0-8b0d-dda28153da26">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzgtOC0xLTEtNTUy_4c8d6336-ef74-43c4-9aaa-0e60948eef5f">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzgtMTAtMS0xLTU1Mg_d405953f-dda5-47bf-a6e1-e281a74f0105">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0934f4bb5efa44ef900ff2ef426e56c9_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktMS0xLTEtNTUy_0f3b451b-a4fb-41c6-b2ba-2fa2cf5422bc">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fe73a518a24b02a40a1f3440e71f50_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktNC0xLTEtNTUy_f5c764c8-c4cd-4356-94a2-de618b57fe99">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktOC0xLTEtNTUy_d3b3fdad-df7f-4164-ba47-9da494676533">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktMTAtMS0xLTU1Mg_87374c1d-914d-420e-b4f8-1758a896050c">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0a8adba1de1f4894a089eed1e7c97186_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMi0xLTEtNTUy_2b695517-9fa0-4060-9712-c785e9a61767">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a8adba1de1f4894a089eed1e7c97186_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtNS0xLTEtNTUy_30e9e76b-eb8c-4b7b-9ec8-3f4acb011479">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtOC0xLTEtNTUy_fc19a57e-4ca5-492a-a435-6e0d7c45bf6e">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMTAtMS0xLTU1Mg_75f60ed6-afaa-4297-b437-acab066a66d0">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d8629ee1c19401daa61e8d5a614d5df_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDEtNi0xLTEtNTUy_59d1b8a1-0b1f-48f7-9ef2-a6c7f9a7858d">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDEtOC0xLTEtNTUy_25c722bc-4a3d-44e8-813a-82b5886dcb1e">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDEtMTAtMS0xLTU1Mg_283293cb-7169-419f-97c7-68a99c68de54">662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5049524449d410199f77b0d7237ac47_D20200401-20200630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDItOS0xLTEtNTUy_4bb25f28-311b-454e-bfc5-2f8b6704ed34">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDItMTAtMS0xLTU1Mg_8a1abb19-5878-4d75-bd3e-34f6d1ef8779">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i25119c25c92b4f2db55b1b12c814d98f_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMS0xLTEtNTUy_fe13cb16-f499-4bba-9290-c7c4bb16fd64">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id50e79715dae484d8bb0b80b30835854_I20200630" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMi0xLTEtNTUy_aaa59c91-2c8c-4bc6-9fae-f2004158076a">425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i022278e3d45b4b6e87ac5a6324a5b7fb_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNC0xLTEtNTUy_656f23d1-9cb7-4002-9602-2f38a0e35d47">46,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id50e79715dae484d8bb0b80b30835854_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNS0xLTEtNTUy_5fe81db8-f08a-46f5-8dd9-5969e92e53e2">28,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f5fcae96f94664bcccd015f8aaef7e_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNi0xLTEtNTUy_3359f0be-b6bc-42ca-be92-652ba94fd473">48,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223cec6898e447328115d33128bf3b5b_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNy0xLTEtNTUy_c3cb2f10-4ef7-42a8-a0ce-3a84453c96b6">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab4c8b62b63f480793c7a4aadd30e7d2_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtOC0xLTEtNTUy_07a32566-10d3-4dd9-a2dc-889e1275923a">68,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03db7eb72302412682bc5861ee38dfc3_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtOS0xLTEtNTUy_3db5a065-475a-4ba5-9a54-76718c7242db">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMTAtMS0xLTU1Mg_e40a30cc-b8e0-4c45-9bb3-9d712b29be96">68,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTM5Ng_657374ad-d418-4299-9820-f7195dfd8459"><ix:nonFraction unitRef="shares" contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTM5Ng_b6bebc31-94c7-40ad-9c67-bff166a4f5e4"><ix:nonFraction unitRef="shares" contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockSharesHeldinTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTM5Ng_cfcd3733-20b3-4034-9270-e72f90492c83">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust and treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwMQ_01f253aa-3f2a-4049-a399-b57055d0d3b7"><ix:nonFraction unitRef="usd" contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwMQ_ad54758e-2a91-4939-bd7b-bc51ba4ac68c"><ix:nonFraction unitRef="usd" contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:TreasuryStockValueSharesHeldInTrust" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwMQ_e9efecf0-a170-4da6-8695-3591c6642c26">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust as of June 30, 2020, March 31, 2020 and December 31, 2019. </ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwNg_ac689499-776d-4818-83e0-92fc971b1154"><ix:nonFraction unitRef="usd" contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwNg_b9bab6d3-c2cf-4e48-98e3-e9c205832577"><ix:nonFraction unitRef="usd" contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwNg_fb1fb150-085c-4b6f-aefe-bf4437d3e6c4">17</ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of  June 30, 2020, March 31, 2020 and December 31, 2019.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326), which resulted in a decrease to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i5037b7672ca64770b57ccbefe27214a1_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTY0OTI2NzQ0NTMxNw_a7bf8cff-3835-4030-b805-19a24d06b8e0">3</ix:nonFraction>&#160;million during the three months ended March 31, 2020.</span></ix:footnote></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements (unaudited).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_37"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMjI_f046ba7f-6589-48b2-b951-682f6e170f38" continuedAt="iab0fef274ef44651b722d5a18c9fd5b8" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iab0fef274ef44651b722d5a18c9fd5b8" continuedAt="ice589a396f14471bb574aa65c47f0617"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="location" contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTgx_e2e95c81-f2a1-4de5-8dd4-753ebda17b2d">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630" decimals="-2" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMjE2_5a591ce3-7013-4832-9698-da14a86ead36">1,100</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with approximately <ix:nonFraction unitRef="people" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:NumberofPharmacyPlanMembers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMjk5_4db4984c-7921-4c0d-82a9-b52c130253c4">108</ix:nonFraction> million plan members, a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt-sec:numwordsen" name="cvs:NumberofPatientsServedperYear" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMzc2_90b05a3e-7788-4f65-9a75-059e46d27280">one million</ix:nonFraction> patients per year and expanding specialty pharmacy services. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="id0838c3d504c4b0ba188c00aa78d7033_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:NumberOfPeopleServed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfNDc3_5d611163-0872-434f-b976-8e1d42d0b532">34</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMzE_dc5e7961-6cc3-4640-a4a2-16b7d2cf73af" continuedAt="i1bcc9476580243908961fc8aa0ae5a1d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI2Nw_a7ca484d-a531-4d8d-9146-591479855774">four</ix:nonFraction> reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2021, the Retail/LTC segment operated more than <ix:nonFraction unitRef="location" contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfNDQ5OQ_e2e95c81-f2a1-4de5-8dd4-753ebda17b2d">9,900</ix:nonFraction> retail locations, approximately <ix:nonFraction unitRef="clinic" contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630" decimals="-2" format="ixt:numdotdecimal" name="cvs:NumberofWalkInMedicalClinics" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfNDUzNA_5a591ce3-7013-4832-9698-da14a86ead36">1,100</ix:nonFraction> MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ice589a396f14471bb574aa65c47f0617" continuedAt="icc944c8ee6d74809a83ef16a20d5e298"><ix:continuation id="i1bcc9476580243908961fc8aa0ae5a1d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNTE_d0205140-c561-46aa-bb49-ce74c2db0e87" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTM_adc69d42-f9aa-43f9-953d-51e36dc42523" escape="true"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTM_b0d3aba1-0108-4f41-8423-ee0d1c73d3e4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icc944c8ee6d74809a83ef16a20d5e298" continuedAt="iae8bd4e5e41e4ae0843111c69a81e17a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNTQ_20784d10-a93d-4b82-a327-1174154e39ac" continuedAt="i35b99e524509460cabb27498577e53d1" escape="true">Restricted Cash</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i35b99e524509460cabb27498577e53d1">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNDA_4a650027-cb4d-443c-893f-6f8fd108bc05" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMS0xLTEtMS0w_5d198605-6893-47a7-ace3-29c5729d84b0">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMS0zLTEtMS0w_55058523-9201-4431-a153-e6c87734b5e9">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMi0xLTEtMS0w_2ab6556b-e0b3-48c0-88e3-cf8be2505204">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMi0zLTEtMS0w_0c9db9c1-f0a6-471c-a038-02eb0c0c86bd">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMy0xLTEtMS0w_4d3df0cc-cabc-4dd3-b5f0-5ee33e2fdab0">7,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMy0zLTEtMS0w_bdc36cce-0980-4755-a587-a9d6ef80d40a">8,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzE_f8394151-53e1-40dc-aac8-52985bf687e9" continuedAt="i439236eb5f1c40aea7ee0322d9a7370a" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i439236eb5f1c40aea7ee0322d9a7370a">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</ix:continuation>. <ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzI_3576c45b-b70e-4269-b78e-2ec42d6cf815" continuedAt="i0804eee6b328498085e18924ff5a4493" escape="true">Accounts receivable, net is composed of the following:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><ix:continuation id="i0804eee6b328498085e18924ff5a4493"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMS0xLTEtMS0w_b1a9ff26-fe1e-487c-809a-286a7f84e756">8,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMS0zLTEtMS0w_fef1266f-e8a0-48aa-99b6-0623bfe612ae">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMi0xLTEtMS0w_af98423c-790a-43e0-8369-aeb3eb61b7b6">10,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:VendorandManufacturerReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMi0zLTEtMS0w_b9e81a63-adb2-44e9-ab8c-5a15a2a6b0ea">9,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMy0xLTEtMS0w_4b284baa-57df-45a3-b947-582926106a4f">2,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PremiumsReceivableAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMy0zLTEtMS0w_0c870b05-4729-4879-b2a5-55c18cb36b8e">2,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNC0xLTEtMS0w_16d232e9-d548-47b1-ad93-b4beaeea926f">2,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNC0zLTEtMS0w_2ca706c8-c720-4776-9752-456ced36979c">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNS0xLTEtMS0w_ac82a758-26bf-498b-a0f8-4ba24d272d42">24,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNS0zLTEtMS0w_ab6e2a2f-d0b2-4a06-af11-a016726f72ef">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfODg5Mg_7bd3d1fc-4b58-43c6-bf60-65bb2a38f35d">367</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfODg5OQ_ee51f7fc-41f3-4ae6-b7b3-1be0e4174fa9">358</ix:nonFraction> million as of June&#160;30, 2021 and December&#160;31,<br/>2020, respectively. <ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTk_b760022d-ffcf-4738-8fa1-fa35bae4135b" escape="true">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iae8bd4e5e41e4ae0843111c69a81e17a" continuedAt="ic23cdb73f6ce4dc2974e6cfa7c5070c1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTQ_ba18aa11-40c0-48c7-945d-a2918a268774" continuedAt="i99c23f308fb146e0819f5f63a2200333" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and six months ended June 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f6a3d3df86b4fc6877832fc49952ae8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy0xLTEtMS0w_00c50e62-3158-4ab4-a8ba-3425b0560dda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic26532a4b62d467aa9a8517bc7419919_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy0zLTEtMS0w_42ab88b6-d585-4a1e-8d2f-2e1293f1ac86">38,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e7456f591546feb889d8098d55bd2b_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy01LTEtMS0w_fd58916b-5d17-4e55-9d52-f21ad2c32404">18,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f9e4113d044d07a6f887feda963f25_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy03LTEtMS0w_fe6ef5b1-b985-456e-a516-96a4de0fd683">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i572b532a257b4eb29f5818e465112777_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy05LTEtMS0w_43fa97ae-52ac-4d03-afd0-f6db3280f48c">11,094</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e466ab07004cd0914feafe9a6bf57e_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy0xMS0xLTEtMA_ed5b21c7-b1e8-4caf-a1a4-a1cb871b6b6c">45,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2d360907ea45f0b08862db70c4d3d7_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC0xLTEtMS0w_13014151-28e1-4b74-b5f5-4793828bad9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa1afd1040f44cf8547b63d41dbe591_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC0zLTEtMS0w_654b7d3c-0a6b-450e-b54d-d88ec2076607">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3bca70c57704131aa24ce446c205802_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC01LTEtMS0w_6b24d742-57e6-498b-a3d7-55774ca790cc">5,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c46eed192d41dc99861555299a540a_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC03LTEtMS0w_ed282d4e-48d8-4348-afeb-d8bbacbc8257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28be049ff18f43fbaf9cdd9ef79e8fa0_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC05LTEtMS0w_26cd3a56-aa75-4df7-82b6-d720b36e3081">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dcce512f8f4473389ed02f496c8b487_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC0xMS0xLTEtMA_590c4903-2c39-455b-9334-8af42771d3f2">5,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e5bd3d12817424a83bdab3e1ef08149_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS0xLTEtMS0w_e9015b32-ba70-461a-8dec-cf48a76802e8">18,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44034671f9c84fe8b2a64b71bb298348_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS0zLTEtMS0w_871042d0-0787-45e8-bc51-07cc267db661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ce4e1b8cd247a3afa48a6db26e4e70_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS01LTEtMS0w_4e40103f-6e3c-4b49-a922-d5f66649a243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032e4e9b3eda4cb18d91840ce8d0e1dc_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS03LTEtMS0w_6da35108-2433-41ec-9120-dde48e73af7c">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e5c7ea4581f40a28c6c335f145013dd_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS05LTEtMS0w_8a35e44d-2285-4a69-91ee-ec8b8fd4d7b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e2905eda41a471f8d885c44663f8134_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS0xMS0xLTEtMA_db5fb826-201a-4443-8597-71f8cc0539f3">18,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi0xLTEtMS0w_5ac72232-33cc-4c53-9197-c421d0ff76c3">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi0zLTEtMS0w_7edff7b7-ae5c-414e-93af-06f62bae570e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi01LTEtMS0w_e879954a-98fc-4052-96f5-b9da631118fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi03LTEtMS0w_b169da7b-18c5-45a9-8fa9-1e018e0ff63d">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi05LTEtMS0w_12960994-319d-4283-9d40-5e871df73978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi0xMS0xLTEtMA_b043e3c6-cec2-432b-83c0-04fd2159c3ad">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a0d48a02bb422399156ace038008ad_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy0xLTEtMS0w_3495d18f-e797-43fc-8cd7-f2a4df0be94f">1,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c50ebb9b454e83b240a67beba32866_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy0zLTEtMS0w_0ac2fe43-c209-40ff-abb5-993caa0e91b4">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i496dec9258b04dcb9203d4d4c27ff56c_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy01LTEtMS0w_6e536851-bbed-44c6-9917-ed1683f8ea09">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9d1860aea74e00ad2c89291bc24962_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy03LTEtMS0w_da6cbe03-66eb-409a-9bfe-f3e74e20cea9">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ddfcc881984e29b4f64377dfc996c2_D20210401-20210630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy05LTEtMS0w_df01abf1-e2e6-4a7c-9ce2-65efc99eafef">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ce75e54f582485ab1f2e764803ce78c_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy0xMS0xLTEtMA_b8857115-6daf-4fd9-9fef-618579f8de2b">2,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC0xLTEtMS0w_275ef5d8-b8f7-4fd2-97b7-b594dd9dedfa">20,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC0zLTEtMS0w_76ca90d6-3f43-40f1-b8f4-a13a0a7033cd">38,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC01LTEtMS0w_95e52917-dee5-4b75-8c67-e3daecbe4bdd">24,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC03LTEtMS0w_84c58998-3852-4e5c-8723-085a569d850c">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC05LTEtMS0w_827e179d-9403-43b8-8ad2-008493033f28">11,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC0xMS0xLTEtMA_9744f6e3-8384-4a89-8baf-8e3de2dbc7b5">72,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d12aed0d38d43b7913ac1ed40d9742d_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTEtMy0xLTEtMA_ae04c450-be87-483a-9d91-6561ddc2993c">22,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3901d540d984bdbbe7954d01630c93e_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTItMy0xLTEtMA_d93e7852-c260-4fab-97b2-c6657fa45eb4">15,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib63e5fbf23624c13957ee808a92953b4_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTMtMy0xLTEtMA_92d87c1b-47a4-47a0-bdc0-323d43779ea8">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTQtMy0xLTEtMA_37fa1391-dd92-469d-b6c8-977b079ec4a5">38,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a382aa8220f4a0a8e22b91b4225625a_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtMS0xLTEtMA_f9e90cbf-c6ca-44b8-a433-5fae97445dfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic571fcb252b9454580ca0b9a68a73d74_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtMy0xLTEtMA_66d5a354-ed2b-423e-9d6d-0a578f0e0585">34,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571c2782d55d4067ac07ad878ad2cda0_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtNS0xLTEtMA_7f4e1499-cecb-4463-affc-0ef9f7082912">16,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id584afc20f824cb5b10632de8cedc4e8_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtNy0xLTEtMA_674b3c63-295d-4a98-8b58-c631080b0ea2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d48d9893b4e4e8fa0ae931e8905c5af_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtOS0xLTEtMA_126a9b58-7fda-4cc4-9db7-16cb83cf9ff9">9,741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5825e37024df49d08a5c01af8e8c0cbe_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtMTEtMS0xLTA_71a51895-3938-42e5-abc3-7b5da7589129">41,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e6aad25c1b48e18ec4aedb16181989_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktMS0xLTEtMA_ed2f1837-5435-4337-8218-cf662dab0364">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabfd20c74d44f14b5f7309d49ff43fd_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktMy0xLTEtMA_95336477-3621-4263-916b-a012cb49cea0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1150195ef084b308adc08d5b6fd6d37_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktNS0xLTEtMA_402341d4-4661-4af6-b2f8-dfc9e3d5bfe1">4,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i277b57b4d1bb4be1b4eed74758be2d3a_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktNy0xLTEtMA_35101d00-7704-484a-b0d7-b773d550b293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c845f14e279418b852581196c54f9c8_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktOS0xLTEtMA_674b02c1-71d1-49b7-b0b7-a4e2c3c85a0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920cdf64d2fe4196a7c51badf2e4b2ee_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktMTEtMS0xLTA_e9124463-4d75-4f8a-97a9-62aa0e665e92">4,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70267249c6134e0184dcdf8d3a4b67cf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtMS0xLTEtMA_7fbd1efa-69f8-437a-b693-f2001a855768">16,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820e7e5dad1e4cc99afe17c533670331_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtMy0xLTEtMA_21ade81e-7d74-4444-a194-5fd1a3efb387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6172f9453d340f39d59d5101635a85a_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtNS0xLTEtMA_04e12d94-f58c-4c2f-9767-dc77d9d1e4f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411456f412ea4846a96be3b32e388bd5_D20200401-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtNy0xLTEtMA_af8694c9-a951-4c0e-9cd4-79a9eb06600c">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa3071f0b9a448599732f89a137d911_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtOS0xLTEtMA_9502af82-7faa-43e1-b25e-b103637fc2f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79016db736f64c5bbe4e068ac2adcd98_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtMTEtMS0xLTA_c527022e-18eb-4aa3-ab03-08b05207f1f9">16,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtMS0xLTEtMA_547cd718-c728-4528-828d-1bd5f42e47ee">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtMy0xLTEtMA_26b6cc8d-bab6-418b-8838-59e8f586f37a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtNS0xLTEtMA_46f4dbef-bee7-4164-a86a-5d7f36d69788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtNy0xLTEtMA_5386f1e1-05a7-4a43-91dc-7e0a45565945">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtOS0xLTEtMA_7f91bfa3-29b0-438e-93fc-34c667541e59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtMTEtMS0xLTA_217f5069-6398-4b16-a9ab-be284d944510">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4ac40a398f427cb77a2094a1e447e7_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItMS0xLTEtMA_18ec7dfd-9c94-4b95-9a0d-764f09832df0">1,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24a50869ac304742b49b405bf41bdc02_D20200401-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItMy0xLTEtMA_0cd4d139-5449-4ece-ae71-553e01233746">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600ff56b85734cbba43e0b25e8b6f595_D20200401-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItNS0xLTEtMA_8c094ed7-8cf6-4341-9c5b-30df1152c2fc">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice379e0dacf9467da98333a95b5e13ff_D20200401-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItNy0xLTEtMA_49315b85-2e86-4da7-99e3-89c3305a5bd4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29c79146b5294d08add1c3efc10db8ce_D20200401-20200630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItOS0xLTEtMA_630457b1-09b3-48b8-b552-c832512a7fc6">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54e8d73c14454d5aadcdd542013be434_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItMTEtMS0xLTA_64eed779-09a2-445b-a100-e741fee0cb12">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtMS0xLTEtMA_831c508c-be05-49e6-9f66-3f0659930350">18,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtMy0xLTEtMA_3c312594-9386-4e5f-90a3-20df1959b6d1">34,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtNS0xLTEtMA_5c116a43-39e4-4ff0-938c-4e3329d1af4d">21,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtNy0xLTEtMA_038f0d5b-df43-4ae9-a15d-def3d9c75039">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtOS0xLTEtMA_34d4a4b2-07c6-40db-8e08-5abcb7924f23">9,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtMTEtMS0xLTA_94eba419-4ea2-4f1a-bd7d-b5988b9adebd">65,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib920548c0b1a454d81f1407f3de6be03_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjYtMy0xLTEtMA_be49a97b-3202-4f7a-9f15-8799e72e6e87">20,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if479dca3854347d3be7f823a1683f8b5_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjctMy0xLTEtMA_96a16e7d-33c1-417f-ab88-0d9d9eb36598">14,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364787c47e394a57938aa7f7999c533f_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjgtMy0xLTEtMA_6a019acc-713e-43b1-b0bf-836700bfacc9">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjktMy0xLTEtMA_f70a20aa-ed91-499b-afd3-6ffc0a99c3bc">34,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic23cdb73f6ce4dc2974e6cfa7c5070c1" continuedAt="i6f09c09d6e6642b6a4d235f043f162e1"><ix:continuation id="i99c23f308fb146e0819f5f63a2200333"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i166554c720f64af9bcbc5fd85e9bcee6_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy0xLTEtMS0xNzI_79a5143a-5151-4d32-83a9-00123b58ecac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fb5e05c3b6493da3da36f60554098b_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy0zLTEtMS0xNzc_4a426c86-1d62-4bd1-aabd-fcf1f31510d6">74,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f45cc0df9464d56aeaa2320aaed3b45_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy01LTEtMS0xNzc_ee5f839c-8e90-479a-b25a-c1ba21e33cac">36,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i212fe2f3583e496088a7a5e86f5f1b17_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy03LTEtMS0xODI_d1675663-d973-4107-8d43-2d7f8985a73c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i759569ae7b9b48af8ea1770c353db400_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy05LTEtMS0xODI_8a799d7c-17d8-44d5-b59e-2478295b251f">22,168</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6889ed969d4544329ba1c263b5ac4e03_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy0xMS0xLTEtMTgy_82839d18-ced1-4b5d-b005-b806b92db4bf">88,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f22972f46042c297c7c89259a121c6_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC0xLTEtMS0xNzI_3702daf2-27a7-471c-a564-ca0e7fda4630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bcd11287bf94b91819f67ab1137751f_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC0zLTEtMS0xNzc_bea8ddb2-09bb-42f7-8c49-94958576f601">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11dcc6b36e054b7f83db5e8213b3e4a7_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC01LTEtMS0xNzc_fa97bd6d-75ed-4b79-91c2-569236ee482b">9,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd33f24ebc4242b4a184fe50093ba8f1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC03LTEtMS0xODI_655ba69d-7ec6-47c3-aae8-4174838d1fb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f434ba89a2463491a53e466c45f175_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC05LTEtMS0xODI_09142c04-efda-4773-bce6-19a1d02972e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c500e6eec404740b845bbc6749d9816_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC0xMS0xLTEtMTgy_29999cf4-d665-4a85-8845-0cd9e9b09942">9,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5560473d23f4f238af0827e871ebe16_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS0xLTEtMS0xNzI_d5c262f6-0432-42ec-8239-6dc991f5f79f">37,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0190811d39f4835b7c199890587db0d_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS0zLTEtMS0xNzc_cc51940e-c945-48ba-8570-21bc7ca7fe1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92367a9e55d345ae84f133238ad6f0c5_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS01LTEtMS0xNzc_c2605cd2-c31a-41a9-96d4-1adf05ad96d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140296fa522140e8b9fff9b2f366d8e1_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS03LTEtMS0xODI_91b7b4a4-a39f-4da7-bc1e-6a393ff33ef7">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5770294e42ea4e908f315f226b548613_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS05LTEtMS0xODI_6dad172f-314b-4974-90df-51806e0d80f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id320ea86e20d46c5b18c7cc290be409c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS0xMS0xLTEtMTgy_867b8b95-4dcc-4033-a7b1-66d93bf623f0">37,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi0xLTEtMS0xNzI_d8f4ed47-cdd6-471e-b276-a2f8174875ff">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi0zLTEtMS0xNzc_2471cc58-b1ad-461c-ae43-dd210af699b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi01LTEtMS0xNzc_ed5e3f3f-05d7-4415-b8c2-cae3741cbbdf">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi03LTEtMS0xODI_0e1aef48-5ee1-45c9-afb3-ae7a08393535">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi05LTEtMS0xODI_b5a5415a-07ce-42c6-9f29-1ad2a03f3af6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi0xMS0xLTEtMTgy_8e34341f-0389-4a58-822f-663c3d6df52c">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b3699d17ab4bc49abd7de1d430af9f_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy0xLTEtMS0xNzI_97d3cc65-6ee8-4058-96b2-8b304fba5afe">2,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64696f2811204153b3a4db3e0624abce_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy0zLTEtMS0xNzc_1259b4bc-a4ad-43b6-8df4-52ed7506af4b">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd9f5dd41194be8aa3c1c1db6ac93fd_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy01LTEtMS0xNzc_95069437-7c1e-4a78-84bb-85590d40c1f2">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c96c74db01f4ec1ba8c3b7ed9abcc0e_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy03LTEtMS0xODI_85fa414f-dd32-483c-a484-b18a7c5016a0">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48dbcd0e840b41f0ad881ba4a5cb6ce5_D20210101-20210630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy05LTEtMS0xODI_5447ae25-ae62-4a27-ad98-d5d6c64456be">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216530e358d54f83b2e18ae38bb5be13_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy0xMS0xLTEtMTgy_dbe0369e-8462-43f3-81c6-2d2738041d3b">4,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC0xLTEtMS0xNzI_b9faa472-2316-48d5-aaf6-0a4ec35815a6">41,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC0zLTEtMS0xNzc_0b31019d-342e-45ba-8421-8b35f85e1b48">74,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC01LTEtMS0xNzc_565a6fbb-742c-4b4b-b851-67a561c51da6">48,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC03LTEtMS0xODI_9deb4473-ea26-4d91-8d4e-a11420519de0">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC05LTEtMS0xODI_9269b204-00cc-4fdb-804a-7b76b166ba0b">22,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC0xMS0xLTEtMTgy_d1a64bc1-9f95-45f3-a635-b66e8d3dd485">141,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8bbdf8e1364bb78dd9cb3211b8052e_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTEtMy0xLTEtMTkz_aaf88d9f-dde3-4147-a7c3-263a6012ed60">44,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91de92b5d1d44a68fa60bf2e45aa5d2_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTItMy0xLTEtMTg2_6f9b6997-6896-469e-9a95-90b286d96626">29,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadd2c902bbe145308ec3aa05c17b567c_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTMtMy0xLTEtMTg2_6cb48087-21b7-4490-a6d6-52de37bcd04f">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTQtMy0xLTEtMTg2_15511087-a903-4bba-847f-9926888abec9">74,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ffc9a8dd41244b8acff67f5bde3ea2f_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtMS0xLTEtMTk3_6b7bc59f-4f79-4a0e-a109-65493137dca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2efc32665c704f25894100c8ce4d0df7_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtMy0xLTEtMjAy_f932a521-59af-476d-828b-9df2c3fdc2b9">69,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95dd9befbed24089a9f86d2e656a2894_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtNS0xLTEtMjAy_318f74ae-a150-4d4e-a8b9-8c03a8cd09d2">34,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee48290a6467466dbd923d0cdeae5c9e_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtNy0xLTEtMjA3_dcf3b82b-6ad6-406b-a97e-5f5cf7ade114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3466d17106d4ff0ab52299c6a6ab8e9_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtOS0xLTEtMjA3_1f26e85a-5fad-47d3-baa4-a970b69bde8f">19,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f50e02b79ee45deb02a3ed6774b2cb0_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtMTEtMS0xLTIwNw_a89666a3-68ea-49e4-b7eb-d66eb042f358">83,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125594ebf3e84110a3111697a3b48e4e_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktMS0xLTEtMTk3_c8734538-d685-4083-9c2e-40035ba1b050">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b811b19b1445fa845554f632a26d2d_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktMy0xLTEtMjAy_397955c9-528b-48cc-b573-5a6bd96eb908">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i095ac5b05f56430b92c8170b133a7866_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktNS0xLTEtMjAy_7fea76a6-3e33-4987-8925-6749f3308ada">9,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if937cafeb43442a9aa8e67151c4d0301_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktNy0xLTEtMjA3_34c546ba-8899-423a-a8e2-f176ac72e9a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadff063171ac423d92c2da8077c58172_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktOS0xLTEtMjA3_da1c5d8a-d361-4c31-903e-0635e56eb122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8164c11b7854ff18ddfd168e0890d44_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktMTEtMS0xLTIwNw_81e437aa-fdec-4a66-b327-78a50c38f1f8">9,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207199ecb13645e897faf29de46c250a_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtMS0xLTEtMTk3_eeb7c124-172a-4041-bfff-dc82c9bf2ee2">34,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd1ce170b5c4a62b7556fdc2322c872_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtMy0xLTEtMjAy_62fe6a8a-c0d4-418c-98b4-d0a0464abace">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39233506c97a4bffa7f4b9b02c27354d_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtNS0xLTEtMjAy_c1194841-efd0-4e9f-8944-9679fcf11e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64ced488010e4594a0781af33f4169d5_D20200101-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtNy0xLTEtMjA3_9aeea1ec-12f1-4b93-82b4-b28351937ef2">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i587dd0796ad94946b28c9400be32b020_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtOS0xLTEtMjA3_1efa7fcf-7e17-421f-90fa-30965224ca86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i650d317e298a41ff8c04c7c3675c3c0e_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtMTEtMS0xLTIwNw_0fd646ec-176b-4648-860b-2cdbc1be5d30">34,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtMS0xLTEtMTk3_32502457-6183-45ad-96d6-e711813ccc73">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtMy0xLTEtMjAy_2bed7200-9676-4059-9537-ce5f94e6a4bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtNS0xLTEtMjAy_bd314a35-bff4-42b6-acb9-8dd3f5d280e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtNy0xLTEtMjA3_dfdfff80-3e21-4d02-b947-e032b6b65f5a">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtOS0xLTEtMjA3_29828dbd-4697-4df0-9453-c688cf53fb16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtMTEtMS0xLTIwNw_412593af-9af5-4a50-8930-676bac74a820">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630fb69c6df2418b968902ada8401a5a_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItMS0xLTEtMTk3_92fd48dc-750e-4cde-98e4-d6f95b586139">2,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife997dbd130a4d2e9fd1499ba1bea839_D20200101-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItMy0xLTEtMjAy_73caa1c1-0d16-45b6-ad9d-7ed5dff9c5da">453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1703ae8e098b46b78e9927eaf75be8bd_D20200101-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItNS0xLTEtMjAy_9ff7ec41-09f3-4a49-8ad5-dab386861074">325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e954630bc78462e89281fe898f9064b_D20200101-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItNy0xLTEtMjA3_62190ff8-d9e7-46f7-b6a4-48d200032a53">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04b88e9ad43344949030a683b6a00df5_D20200101-20200630" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItOS0xLTEtMjA3_d2e8cf8b-c58a-4550-989e-c150a988adf7">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed80d35553c4d40a468c52a12055be7_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItMTEtMS0xLTIwNw_7d6cf7ac-6680-4386-8ac6-8e069c49ab00">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtMS0xLTEtMTk3_d5288e7d-2a07-48b4-bdd8-321b7624c4d4">37,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtMy0xLTEtMjAy_64db5680-a4af-45a7-b233-20f92348afe2">69,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtNS0xLTEtMjAy_78721e17-80fb-4367-b763-0eb29e8d6d9e">44,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtNy0xLTEtMjA3_ecbd9b77-2e35-4e14-ab4c-914a897fe1f9">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtOS0xLTEtMjA3_110f5ddb-7d94-4d44-abb9-cd3652c423b5">20,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtMTEtMS0xLTIwNw_8493b24e-5048-48a7-9a31-3a59dda0ec13">132,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba7c706ce4764a0da3369af23605e185_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjYtMy0xLTEtMjEx_46a7b160-f9bc-4b64-96da-aecb8b81409d">41,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c07f5d814342089f6740d390c7572a_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjctMy0xLTEtMjEx_9d2f88f7-02b1-4e31-8301-a9cfbd0d8213">27,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i432117100b93456f8cf6f278d0e673e9_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjgtMy0xLTEtMjEx_9ae8fcdd-217f-43e3-b3fc-8e9112f9b044">453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjktMy0xLTEtMjEx_33d229ea-2cd8-498f-af72-e37b05318211">69,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNjE_feeed2ca-d6a8-4ad8-9d44-586f7f26ca17" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTA_b023d27c-7ffc-40cb-bf1a-e72103e4fd59" continuedAt="i7401e40759c44b1894b0afd623e90919" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMS0xLTEtMS0w_b1a9ff26-fe1e-487c-809a-286a7f84e756">8,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMS0zLTEtMS0w_9e66ec0c-ca1b-470b-9cf6-c2c7b91d808b">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMi0xLTEtMS0w_7fb8dd6e-ee4b-487d-8ef9-69fbd175fab1">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMi0zLTEtMS0w_6de237a9-b50a-47dc-b799-4f5d0350175f">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6f09c09d6e6642b6a4d235f043f162e1" continuedAt="id70ef615b9954cc18caaa19dafe6d710"><ix:continuation id="i7401e40759c44b1894b0afd623e90919"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMi0xLTEtMS0w_6de237a9-b50a-47dc-b799-4f5d0350175f">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMi0zLTEtMS0w_892451d8-6683-419c-831a-747bd7ae28e4">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMy0xLTEtMS0w_3e4d9277-f2e3-4f19-9ef4-1e4911a945a5">183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMy0zLTEtMS0w_9e1fa3c8-5825-4e82-923b-1c3aad3b40c6">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNC0xLTEtMS0w_e9c75305-16ea-441c-a784-bd8ca3ce3d4d">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="cvs:ContractwithCustomerLiabilityRedemptionandBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNC0zLTEtMS0w_14b1c0af-8578-4b45-bfeb-e13cee81b4ce">174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNS0xLTEtMS0w_7fb8dd6e-ee4b-487d-8ef9-69fbd175fab1">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNS0zLTEtMS0w_e07b3cd7-96ea-41c1-bf26-7e3cccc23937">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:HealthCareEntitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMjg_5e9a3843-4a97-4f2c-b52f-588c5b8c89ba" continuedAt="i4ef9c9e4780e45e4a7d3604d610955ce" escape="true">Health Insurer Fee</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ef9c9e4780e45e4a7d3604d610955ce">Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes.</ix:continuation> In December 2019, the HIF was repealed for calendar years after 2020, therefore there was <ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="cvs:HealthInsurerFee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTE3NTU_23c3826a-5055-418d-b015-150f5f620184"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="cvs:HealthInsurerFee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTE3NTU_383bf6e7-d8bb-4f10-ad66-292b26e6bbaf">no</ix:nonFraction></ix:nonFraction> expense related to the HIF in the three and six months ended June&#160;30, 2021. In the three and six months ended June&#160;30, 2020, operating expenses included $<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDM0MA_84dd4b70-d069-4e80-9c8e-54d63ec237b1">248</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="cvs:HealthInsurerFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDMxMw_e0c7b85a-cf6a-4759-b9fd-3674bec24f1a">519</ix:nonFraction> million, respectively, related to the Company&#8217;s estimated share of the 2020 HIF.</span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzM_2582b4f8-2eca-4133-b6bb-90ff697b3425" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTIyODQ_48f9dbb9-6c31-4ceb-a9c9-88e141df01dc">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTIyOTE_bcd92fe5-f3b6-47ff-94c2-587a9dc2adf0">3</ix:nonFraction> million in the three months ended June&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDA1OQ_dc682475-b1f0-47d9-975a-8cf1f5a5ee10">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDA2Nw_22d1ecc1-c0be-4086-b837-30543d7df19d">23</ix:nonFraction> million in the six months ended June&#160;30, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i560d1a79f1ab4e93b2f826080d1e1e98_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI1OTk_2d10d5fe-6e7c-44f5-93e0-7151f4a84d98">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI2Mzc_7fffb382-0ed0-4630-9abc-ad2bef5c9356">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI2NDQ_cc146cd4-9efd-470d-af46-9eaa2a8999a0">22</ix:nonFraction> million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDI1OA_6482aa57-e36b-4a0b-8c52-92e75f635c8c">37</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDI2OA_fc2ba890-5ca5-47ad-aa3b-835f8473d694">43</ix:nonFraction> million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzc_00248a85-baf7-4edd-a3e9-343aa145fd13" continuedAt="i66da31fbd6424686b0d0ae967ce22992" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id70ef615b9954cc18caaa19dafe6d710"><ix:continuation id="i66da31fbd6424686b0d0ae967ce22992">comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.</ix:continuation></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_40"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY4NQ_2855b321-1ae3-440f-959f-70a6bd278b01" continuedAt="ie223ec8ef6584314af9cfb6cfc14b8a1" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ie223ec8ef6584314af9cfb6cfc14b8a1" continuedAt="i1d25bf6eab3d45f8bca7e650a71572ca"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDU5MA_fc24731f-1cdd-4968-91fc-b26bb4a578e2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050986668b0745f78bd6639177dc57d1_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi0xLTEtMS0w_2536d597-b77d-4204-b546-f0a48f49a0ef">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050986668b0745f78bd6639177dc57d1_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi0zLTEtMS0w_5c250af8-e017-4c15-9782-7569bcc070dc">19,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i050986668b0745f78bd6639177dc57d1_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi01LTEtMS0w_10e02153-41fd-4850-a69f-4fd32239b4a1">22,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785d26b7ae9b4b46858aaedd48a3f463_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi03LTEtMS0w_eac82a70-2887-4d60-9a14-e0ffe0835876">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785d26b7ae9b4b46858aaedd48a3f463_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi05LTEtMS0w_2acfd3e7-507d-46bd-a57c-e53501e0f299">18,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785d26b7ae9b4b46858aaedd48a3f463_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi0xMS0xLTEtMA_17cda792-fc13-46c8-9064-8e0a8c6b1d40">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf6c37f26e849ed865434c8e9ca659c_I20210630" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy0xLTEtMS0w_976395c2-e425-4dbe-a5f0-ce65e976771a">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf6c37f26e849ed865434c8e9ca659c_I20210630" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy0zLTEtMS0w_de8baa75-a61c-433e-9d5f-c97c407bf791">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cf6c37f26e849ed865434c8e9ca659c_I20210630" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy01LTEtMS0w_607c4775-7c98-458b-adac-2221a2b74e1c">976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67da0ed9c4d447b49163344869bcabfe_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy03LTEtMS0w_c88f57e1-628a-4d82-8cae-1e7e2d305256">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67da0ed9c4d447b49163344869bcabfe_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy05LTEtMS0w_e6423201-d954-4283-b09e-3cc4d72772d6">821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67da0ed9c4d447b49163344869bcabfe_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy0xMS0xLTEtMA_0c4c20aa-8575-465e-9de1-df6f26c712cb">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37114866aaba41cfb18a68f2cd2fde62_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC0xLTEtMS0w_a9fe1842-1dcc-4614-93ed-d51683c34885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37114866aaba41cfb18a68f2cd2fde62_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC0zLTEtMS0w_ce847d8f-e2e9-4a50-b977-03a9e9ec37d5">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37114866aaba41cfb18a68f2cd2fde62_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC01LTEtMS0w_8138e2e5-3fd2-465b-9f68-c802a65021d5">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6f559cac05474bb144a75f235bcb09_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC03LTEtMS0w_ba15342e-4b15-48cc-a14c-6e29035b83e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6f559cac05474bb144a75f235bcb09_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC05LTEtMS0w_21c30eb9-3c84-4726-beee-c5cb85409a5b">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d6f559cac05474bb144a75f235bcb09_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC0xMS0xLTEtMA_b9a17fc2-4a15-450c-b34a-92bff0b3d1f3">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS0xLTEtMS0w_fb634c54-7bad-41a7-bd0a-e58df5da6ac4">3,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS0zLTEtMS0w_349b610a-78d3-4f73-80e1-a464a10c781f">22,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS01LTEtMS0w_7a0859db-f0a4-4560-9a4f-0ba92ad1bcb3">25,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS03LTEtMS0w_c66f7df1-99e8-4ef3-a20d-d18603c43107">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS05LTEtMS0w_9cfa4a75-7808-4440-b852-c69f29c6e6bb">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS0xMS0xLTEtMA_bcdedccf-d751-45e7-a0d0-509f184aacd7">23,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY3OQ_c6ee7b29-b50a-4819-bd10-6435b106708b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy01LTEtMS0w_d3e978ec-893e-4d10-ac43-9bb8cf9a4daf">2,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy03LTEtMS0w_9c99acc0-3592-4516-8147-44f176f0e502">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy05LTEtMS0w_6d0ea7d9-507a-4dff-bca1-f9a52d96a3dc">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy0xMS0xLTEtMA_1ac5c9b9-46f5-4965-b910-6678e3d80a73">2,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC01LTEtMS0w_e52ff4a7-3fdc-4a5b-8476-49d6e550f36a">2,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC03LTEtMS0w_30fe7c44-a66a-4646-b73a-bf1da42e991c">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC05LTEtMS0w_0349546d-e60f-4ee3-af53-f6c3a5f4eaf9">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC0xMS0xLTEtMA_b99ed923-852f-4e8c-b187-e3265940da9e">3,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS01LTEtMS0w_fef3a909-be01-4f23-816a-714a4acf127a">8,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS03LTEtMS0w_52c7c540-2dde-466e-8c76-38c1ce7a730c">822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS05LTEtMS0w_dcba0316-0992-4189-8066-567aed55b093">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS0xMS0xLTEtMA_8860b199-82e8-4db8-afb2-75df4dbf9be1">9,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi01LTEtMS0w_8d24bb22-fb6f-4345-8206-baeae82fb1e2">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi03LTEtMS0w_cddf27bf-d3f6-411f-a7c5-a6be2563fa9a">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi05LTEtMS0w_70e1be83-60ab-452d-bd63-9d0c5315c7b3">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi0xMS0xLTEtMA_dce3815e-123f-4ec0-8dfd-086868231ec2">2,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy01LTEtMS0w_1c8d5f52-7afb-4d92-bcea-d21be5930968">812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy03LTEtMS0w_d4b7f6c7-152d-4f68-8c42-e757362e08ab">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy05LTEtMS0w_6a283f41-2722-4b32-aef2-8d9a414ba2d8">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy0xMS0xLTEtMA_72f2bc47-e35c-42d1-a14b-cf247a70e978">829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC01LTEtMS0w_fac3f636-1300-493e-adf4-32010987f90b">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC03LTEtMS0w_aa1cb2da-d107-4a29-832e-aa0c6f00cbd1">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC05LTEtMS0w_4ec8435d-840a-435c-8877-615747179e49">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC0xMS0xLTEtMA_5d253003-1af3-4203-a27e-2ed3bc697ad2">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS01LTEtMS0w_aeefd16f-f0f7-4b28-a85b-c7594fe87054">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS03LTEtMS0w_bfe14c58-150d-4299-a30c-11e6b91f7e5a">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS05LTEtMS0w_10acdb47-96ef-46ee-9230-d76884e257f9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS0xMS0xLTEtMA_5434fc7b-1d26-4167-b85f-bef8fc3a0f16">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtNS0xLTEtMA_a26f9fd2-f207-4aa1-9bf0-45d41a4ed87d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtNy0xLTEtMA_44b9376a-21e8-417e-8e01-16f2daa5a104">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtOS0xLTEtMA_da43fc02-e882-4e90-a745-171e52be7dc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtMTEtMS0xLTA_c462de47-a2f3-401d-854e-2143afdf634e">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtNS0xLTEtMA_019fa7e5-6bf8-4286-9a39-e566aa481067">20,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtNy0xLTEtMA_dc156960-4f28-4a6e-9b25-6afb7b02b0ea">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtOS0xLTEtMA_cfa8b953-3176-4b2f-964a-33e9bd544286">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtMTEtMS0xLTA_206baff4-cc50-4ec7-8120-2cbeb17dc04a">22,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtNS0xLTEtMA_92c7cd18-53ed-4107-a71b-2299089a91b6">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtNy0xLTEtMA_835d8b2a-b658-4b09-b80b-4f7fab69a326">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtOS0xLTEtMA_50bd0f8f-d521-4c10-a865-765e591d424a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtMTEtMS0xLTA_38676f62-be3c-4465-b5bf-fd2cc6fa23ae">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtNS0xLTEtMA_92f080a4-4f6b-47d3-90e2-205190de92a6">2,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtNy0xLTEtMA_ed120e42-45c2-4004-941b-49b935ce1904">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtOS0xLTEtMA_7940cdf8-f205-401d-afea-6d770037f97f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtMTEtMS0xLTA_c644ca03-1163-4095-8e08-3df6b9fcc835">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctNS0xLTEtMA_816c4ba1-5c26-458b-829c-1fc0b191c3f2">7,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctNy0xLTEtMA_cff11a80-6866-4216-ad6e-b819f4a8b77e">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctOS0xLTEtMA_60b56157-0016-45fc-b95e-3c531d4f9621">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctMTEtMS0xLTA_a57f2459-b244-4094-bc87-f770cc8297a2">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtNS0xLTEtMA_772a3bbd-0373-44dc-b855-35ad7bb366ee">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtNy0xLTEtMA_2a640c56-9b0c-49ef-bbe0-8fa768b4c32e">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtOS0xLTEtMA_b435077f-8a19-4a52-bc8c-0f9a39466602">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtMTEtMS0xLTA_6630d2d3-61c3-4778-9a9f-092ce50afb33">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktNS0xLTEtMA_30cced57-e069-43b9-b34e-c23f41a9a97a">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktNy0xLTEtMA_d0c910e0-9246-4952-9211-94f0053aa410">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktOS0xLTEtMA_5128247d-f39b-4cc2-b170-2e134184ae63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktMTEtMS0xLTA_51ff6481-9414-4462-b783-10b8e538ed21">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtNS0xLTEtMA_419253cf-542b-4a5a-a79f-9dd0f7f7cdb8">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtNy0xLTEtMA_b3b03bb9-6a42-4c24-a639-10060cf8d7c3">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtOS0xLTEtMA_5550c63d-9504-4868-b45a-bee048d55650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtMTEtMS0xLTA_a47bc45d-348e-4f4b-a053-14b174079b66">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtNS0xLTEtMA_250bc6ad-bafd-423a-a0f6-0c70e4e0b280">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtNy0xLTEtMA_76af4880-1474-4d33-86b4-bc8b25a96d65">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtOS0xLTEtMA_0454bdb7-e512-41c9-9da1-3e769ea02cac">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtMTEtMS0xLTA_aa6229ba-ee2f-4f2a-907c-cb365b31f095">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItNS0xLTEtMA_b0524751-e49e-403d-b3a9-6f4398dc1483">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItNy0xLTEtMA_e8525773-87ee-4cfa-9fab-ff3da3741a1b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItOS0xLTEtMA_b26b6a1a-ea51-4139-8687-87f434c19f38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItMTEtMS0xLTA_84e2e808-f998-4b9e-8741-49fa947e2afc">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtNS0xLTEtMA_005552f3-0405-4172-9f10-c4ec4e6245d1">19,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtNy0xLTEtMA_bb3c3a11-ea55-4ef6-98ae-cae70f5e9277">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtOS0xLTEtMA_78bcedad-6f5c-4ade-8524-3e39852ab38b">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtMTEtMS0xLTA_b5d86149-9155-41cf-8857-c706624b7907">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was <ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMjEy_8ac49336-8a2f-421e-95f2-fa2d417b9132"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMjEy_c4119d31-e0a5-4997-83c9-5eaf2b9c6a83">no</ix:nonFraction></ix:nonFraction> allowance for expected credit losses recorded on available-for-sale debt securities at June&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At June&#160;30, 2021, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDkw_bc43b09a-6942-49ed-9fef-7e7b1ddcf300">886</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNTI4_060880bc-470c-40bc-b171-3345104a8dfe">110</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNTcw_83caa04d-0cca-4bde-a772-59d9e379ab50">1</ix:nonFraction> million and at December&#160;31, 2020, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i330716651f3445f2b16d92e604e21dce_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNjIx_b58b701b-c636-4fd3-a6ea-427d7c5ffda8">919</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i330716651f3445f2b16d92e604e21dce_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNjU5_786e6a05-9da1-44b6-9d77-641c5cd3db68">135</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i330716651f3445f2b16d92e604e21dce_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNjY2_768393c4-46aa-421d-a349-a00381bde943">no</ix:nonFraction> gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i1d25bf6eab3d45f8bca7e650a71572ca" continuedAt="i8105ef80b98d405c82ed5c0fd5159937"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY0MQ_860cfb53-a420-4bff-8a9d-f8b952e1c6a1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at June&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.690%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMi0xLTEtMS0w_f9bc87a1-645d-4ee4-a734-4c2256dacc5c">1,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMi0zLTEtMS0w_4efa7bee-e73c-44c1-8c9a-7e152ea6166d">1,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMy0xLTEtMS0w_7740239d-e8b3-4433-808c-9431c8748819">7,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMy0zLTEtMS0w_969bcd5f-a334-4a75-a2e7-7b98b4931b7c">7,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNC0xLTEtMS0w_7c981ddb-db25-4a61-94f4-76162ce28653">4,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNC0zLTEtMS0w_0703d3e5-bf1c-4975-8ff9-09ef0dc58452">4,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNS0xLTEtMS0w_23b5e8dc-ed00-401e-8713-44b50ed28c3d">4,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNS0zLTEtMS0w_530a04de-a117-4e68-b883-67a50e83e71c">4,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNi0xLTEtMS0w_2fb0ab27-fafa-420e-9770-aad04d2a7630">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNi0zLTEtMS0w_26083012-a195-47fc-8fb9-c9e84731431d">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNy0xLTEtMS0w_e5235870-c483-4a2c-a347-8751a015fb9f">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNy0zLTEtMS0w_07c9b93e-b317-4b3c-a25d-a1ff8b31f7f7">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOC0xLTEtMS0w_386e1924-4157-45a9-bcc8-c4a06a61c139">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOC0zLTEtMS0w_0f70705d-2209-4dfd-abd7-51e57e5a4bac">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOS0xLTEtMS0w_817c4802-96f4-4396-b263-c67c75a69094">20,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOS0zLTEtMS0w_fd7fbaa5-a270-466b-acc3-2ef3be2e039b">22,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8105ef80b98d405c82ed5c0fd5159937" continuedAt="i0589fa6f274845bbad71da58494525a8"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY3NQ_6e06dc28-0352-4557-ac47-e4e1525674ec" continuedAt="i874e71561f8a4c0591ba4447a367e712" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at June&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xLTEtMS0w_28e83e50-48d5-4aa9-af60-c74715e95f20">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0zLTEtMS0w_456514be-9cdc-4c92-93bb-d8adf80dccc3">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC01LTEtMS0w_f3064748-6818-4fa8-ae66-2e269b8c099e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC03LTEtMS0w_af39309b-467d-4448-9b65-cb21ce7b61f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC05LTEtMS0w_1a7c9be2-42f8-4739-afb3-83c0e2dae9f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xMS0xLTEtMA_ba9cdc91-f10c-49bb-8873-6c7c0b2c0055">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xMy0xLTEtMA_6f773ad4-35d6-4e13-bf02-4ef39d9a7f68">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xNS0xLTEtMA_5da1a629-f192-4d5b-a05c-b8a27558509b">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb425d67a354590bedb80036ca60278_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xNy0xLTEtMA_bec0ff47-353d-4e77-97f7-be46fe781045">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xLTEtMS0w_072ab027-4fa6-4c0f-8575-9dd67a7fc94e">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0zLTEtMS0w_904d0949-c877-4ad7-a889-317da1af0bb0">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS01LTEtMS0w_aa3127f1-e289-4597-84a5-64da6e0eade8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS03LTEtMS0w_59d21b48-ce1d-4649-b71e-6ea500989f26">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS05LTEtMS0w_f4185ee6-36ac-4b69-95ea-d9eb2089b930">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xMS0xLTEtMA_00c3da10-09b6-4bf5-b772-1377397fcb5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xMy0xLTEtMA_e9ac4a4a-5df1-4ffb-b00f-08849d3fae2f">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xNS0xLTEtMA_6c35abf3-ae1c-4cf9-b0c0-9d35cbcf8255">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xNy0xLTEtMA_51e0d5d7-85fb-4119-b6ed-a7cc1d66e200">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xLTEtMS0w_87da415d-46da-46b1-a66a-ec1d22040660">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0zLTEtMS0w_bce85d61-7601-40bd-bdf8-ad922e7a016e">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi01LTEtMS0w_e1212ee5-8826-4edc-bd96-9a6a9d649e8e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi03LTEtMS0w_814fb532-39c0-48df-ba8b-7f267de0ce4b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi05LTEtMS0w_9fe41ec1-c419-44df-9f79-c201fb20de67">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xMS0xLTEtMA_ea082899-0bca-4f39-b41e-476c09206f82">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xMy0xLTEtMA_7a99d155-fa59-472a-b84e-1005f691b28e">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xNS0xLTEtMA_fb6c3428-d95a-4ccd-af68-7da68e82a44d">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xNy0xLTEtMA_e6a9f377-b686-484a-a1b9-b2b4699b586a">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xLTEtMS0w_d4532cd1-32f8-49c7-aa89-b46f68670629">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0zLTEtMS0w_1a4dd5ae-1d24-4608-911e-c6a11cb3cc9b">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy01LTEtMS0w_97725285-5eb2-4e24-b68b-8fcd823ad4a2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy03LTEtMS0w_4d0bc10d-ca55-4a81-89dd-e4fdd412ca59">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy05LTEtMS0w_29742af4-96a2-45af-8dcd-47a8355c2ed6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xMS0xLTEtMA_fafdb56b-7642-4897-b2b9-be765c9c2bf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xMy0xLTEtMA_c6fbf838-7bc5-4fbc-9227-f20089d2b30b">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xNS0xLTEtMA_be521c02-6bf6-49b2-8188-93e6b6ab420e">376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xNy0xLTEtMA_f6b10d67-98db-4361-be52-475e5500508a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xLTEtMS0w_6f0a522a-b418-4ea4-8986-5f23f80192cb">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0zLTEtMS0w_c6a99f38-50d4-405c-940d-b16a85348af1">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC01LTEtMS0w_5acf1c37-7e40-40fa-a53e-346db8a78175">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC03LTEtMS0w_f3f29058-04e2-4a0b-8325-81e9ee6505f2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC05LTEtMS0w_8f47db31-d9c2-491b-b099-96b47096361f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xMS0xLTEtMA_07cba379-8d8a-4a80-bbef-91faf1fd627b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xMy0xLTEtMA_3bb1551a-0857-4790-a37d-8e83e38f35c8">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xNS0xLTEtMA_cec011c7-4288-4735-a341-c651ea17ce19">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xNy0xLTEtMA_3da5bf3e-860f-489c-9fce-74fd3dc27739">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xLTEtMS0w_1ad5af41-9949-4220-a952-31c85b7710ce">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0zLTEtMS0w_68574ce4-2e7d-48a6-a6ec-4de30b8f8880">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS01LTEtMS0w_a3fb7d8d-ebb3-4a93-ae79-f7d2b8eef943">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS03LTEtMS0w_7023fc5a-1fe5-4586-b984-47c21af44d16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS05LTEtMS0w_bcd553e7-5a13-40be-8f59-b2d8d777595a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xMS0xLTEtMA_d99f18cc-1114-45b3-a14b-4f0f4ad86699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xMy0xLTEtMA_16a87549-b29c-4a5d-9406-90bec17536b9">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xNS0xLTEtMA_798a444c-9a2e-4af1-ba45-db1a99f0b916">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xNy0xLTEtMA_de99ff16-098a-4aa4-9089-94d427bf6f6e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMS0xLTEtMA_1141edb7-644a-455f-a6ea-ea889bee41f7">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMy0xLTEtMA_e1fb8da7-6589-4e51-b1a0-8f6c39805ba2">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtNS0xLTEtMA_c0a7745c-2ca2-4e7e-9682-2d9b384b445f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtNy0xLTEtMA_a2f621fc-e3ab-4f05-9195-f397272b90de">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtOS0xLTEtMA_a5f9f6f5-ab07-499b-baab-cf82c72fb9b0">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTEtMS0xLTA_ccd0e2c1-100d-4604-b6c3-7d164d3490aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTMtMS0xLTA_382c1cd1-e7c2-4e88-b508-58a56bd77984">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTUtMS0xLTA_e2693501-f169-49d9-ab85-0c5192468e2b">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTctMS0xLTA_6e091ff5-dfc1-445a-97bb-ee3aaa62e2b8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMS0xLTEtMA_78c73628-cb42-493d-8ff6-9a137dff7332">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMy0xLTEtMA_4dbc8b5e-017e-441c-a3b8-f2f00c21a72d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtNS0xLTEtMA_7c53aaef-fac5-4864-8a45-32a929a06825">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtNy0xLTEtMA_175818fb-58f7-4440-a230-67f7a97d423f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtOS0xLTEtMA_8188992f-0da0-4d1f-a7f7-bf3b932d0af1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTEtMS0xLTA_a3060a6b-4be0-4277-8964-6f18c086a573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTMtMS0xLTA_35dc1984-f41d-4ebe-93c5-f085636f7b59">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTUtMS0xLTA_f2bc44b8-7de8-463a-8557-0b918eef6ef3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTctMS0xLTA_19b1df3d-cf51-4a68-880b-f040318ff7b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMS0xLTEtMA_e66be686-6ebc-43f0-b13a-e250810c63e6">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMy0xLTEtMA_4cebae23-9c61-4094-873e-f908d0e565fe">3,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItNS0xLTEtMA_b57bda26-f37e-442c-955a-eb35fc7d598b">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItNy0xLTEtMA_4afe4d55-333c-4e39-acfd-a2aacf576209">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItOS0xLTEtMA_671b7767-6e55-4a90-b369-39e6bfc0d45e">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTEtMS0xLTA_4b7c4d49-7ae9-44b8-945c-6837642bb389">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTMtMS0xLTA_201aa61e-d33a-444b-9c8d-8b153a96fec8">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTUtMS0xLTA_3796c21f-beb5-4140-b836-759a57914d99">3,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTctMS0xLTA_cc61725d-f2fa-4e7c-aeb6-c51ea85e36d8">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMS0xLTEtMA_13035943-d626-4a0a-ab43-68bcc293ae14">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMy0xLTEtMA_928e5d5e-7a0f-4219-9b68-81c401b2c8a8">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtNS0xLTEtMA_d6b0c91a-e906-421d-8d42-5b2144b2e1c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtNy0xLTEtMA_25308e99-c701-4797-8f75-407850adb52d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtOS0xLTEtMA_454b71c3-ad5f-45ec-afae-4578665ce869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTEtMS0xLTA_93c9a90d-c849-42c4-86de-97d475b42b6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTMtMS0xLTA_d1036ef0-a0f5-4f4a-89da-314cf8e4c899">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTUtMS0xLTA_ff8c009e-1cde-43ad-ba2c-b74695b78dd6">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTctMS0xLTA_3bd6b983-db0f-4aa5-8558-167ad5d4723a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMS0xLTEtMA_8b5702ba-499d-41a5-9517-1189489b8c2b">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMy0xLTEtMA_a01349b3-64d1-4517-9af3-243e0a132c47">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctNS0xLTEtMA_a10f44a0-34ee-494a-b26c-e859a21f52f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctNy0xLTEtMA_4123855d-698d-450e-9b48-37c8012f0d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctOS0xLTEtMA_425d974c-14b5-4fae-842d-96b86dfd7ff2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTEtMS0xLTA_e03c653e-677d-461c-b804-e391e5210a5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTMtMS0xLTA_2b48a482-b442-424e-8969-c8daf3d97738">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTUtMS0xLTA_5c41f0b1-769f-484a-93b7-4cbaf3cdc544">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78f486649f54627bfd2a824897634ce_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTctMS0xLTA_fd86f9af-ebc9-4510-99db-7659ae852f9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMS0xLTEtMA_e1bea36b-bc85-4b26-b1f0-85baa300cf5e">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMy0xLTEtMA_2cd2f841-94f4-4ab6-8551-3645df62330e">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtNS0xLTEtMA_322faf0a-5c33-47b8-bb1e-69a7efdac4be">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtNy0xLTEtMA_6c6f50bf-94f9-4f0c-ab4d-eccd53f073b2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtOS0xLTEtMA_25219227-f665-4ef1-88b0-0eba8cb5dc4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTEtMS0xLTA_eef3c5c0-97f6-4bc8-9709-f95da3d0d025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTMtMS0xLTA_8c28ff04-6e5a-4467-9e49-dd620e2c6928">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTUtMS0xLTA_9f119257-bcd3-4617-9584-7d92bec06623">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTctMS0xLTA_286a4332-26c5-428d-ba11-8e3dde802c7d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMS0xLTEtMA_6fb89211-f88b-4c22-82e8-8cd0e34d7222">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMy0xLTEtMA_c752c99f-f466-4f2b-9d24-6845d7fd5f8d">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktNS0xLTEtMA_6d3af79a-a1fc-45cd-b2c8-9c7f26105a0c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktNy0xLTEtMA_9cba98fe-98c5-4210-a957-704cf94c0a45">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktOS0xLTEtMA_a30b858a-862e-4786-8d1a-5c1efedbbee9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTEtMS0xLTA_9d98dd19-c766-47bc-96e6-4804d80b822c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTMtMS0xLTA_fac2c98f-1468-4a23-8088-a6085a9f917a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTUtMS0xLTA_5fbca630-a538-4251-ad7d-68bc59575ba8">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTctMS0xLTA_f7d4241a-62b8-43dc-9ee7-dcae510e7919">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMS0xLTEtMA_c42dc793-59b9-47d7-a423-6cec2ab1f7fe">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMy0xLTEtMA_daf7d112-bf38-4c35-904e-6c1cbabca74b">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtNS0xLTEtMA_e063d124-15f5-41d2-a1c1-8f0daf6e9c92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtNy0xLTEtMA_cb077216-6fe9-42ee-a121-fe7839c4c820">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtOS0xLTEtMA_7f78b561-79ce-44c8-b93f-da3d08784837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTEtMS0xLTA_815d9ddc-f7b4-4e14-b138-2b76c8938406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTMtMS0xLTA_4ab84aa5-0ab1-421b-82f7-af8663d3fc8e">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTUtMS0xLTA_89c1f27a-4ba1-49f1-b263-fa79b8809f22">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTctMS0xLTA_bda0275b-3a01-48ba-9dcc-2aa602ae8f97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMS0xLTEtMA_ec81fa85-c92f-4982-b0d6-5e32b0b28ad3">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMy0xLTEtMA_3a930293-80af-49e0-a2de-8cd6db29d429">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtNS0xLTEtMA_d65849fe-5604-4afd-b652-77a5b85dbe72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtNy0xLTEtMA_caadaa57-313b-4190-85ed-4a0779b48656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtOS0xLTEtMA_26974a32-3b9c-4f80-a6af-db31484203f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTEtMS0xLTA_6df4355c-1417-41e9-be7a-a372da4b570f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTMtMS0xLTA_7dfcd098-aded-4d0d-a89c-527e67ecbf53">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTUtMS0xLTA_2fe25986-9faf-496c-8c40-6e188c0bf0fa">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTctMS0xLTA_2d2b2084-6065-4e3e-aa2a-6c3b10d4c7a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMS0xLTEtMA_d60d7bb7-4565-40df-9985-5566e1ffbec7">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMy0xLTEtMA_cc01eb2a-7758-43f8-8dcb-9b05e0f5cb4e">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItNS0xLTEtMA_ec0ca9e5-36d8-4398-a8cc-d778dfaeb006">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItNy0xLTEtMA_ab74e085-4497-4de7-836e-7941a15ebb7e">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItOS0xLTEtMA_413a89e3-b41f-42f7-beb9-a424f1a24876">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTEtMS0xLTA_bc9968b0-6e88-43e9-b81d-7fc50657e040">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTMtMS0xLTA_a72a4a83-57b3-49ad-99a5-42935ba34ea7">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTUtMS0xLTA_260474bd-f478-4d00-b2cb-7214824baedb">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTctMS0xLTA_abc446ef-6144-45ce-ad03-384fbd424207">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMS0xLTEtMA_c8058696-ea67-47a1-bad0-bdf20ad271ad">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMy0xLTEtMA_1bf196a0-e7e9-4d10-9d00-54a45ba1a44e">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtNS0xLTEtMA_06ee281b-b810-40bd-84af-ea194dab8bea">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtNy0xLTEtMA_dfce3826-4d85-4d65-93b1-00238c891ec0">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtOS0xLTEtMA_0ec96b59-0499-4ef8-b152-942cb24fdff8">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTEtMS0xLTA_4b11e2fb-1941-4ace-a08b-42d864a5eaa7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTMtMS0xLTA_ea5d384d-1bfa-4cc6-a165-bc94e55002cf">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTUtMS0xLTA_fc5682cc-8d82-4fbd-a5b8-bac065595462">915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTctMS0xLTA_4db34271-2916-410f-9a87-6665720c0990">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at June&#160;30, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of June&#160;30, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0589fa6f274845bbad71da58494525a8" continuedAt="ia4fe645b25884dd480f874093b0cbe6c"><ix:continuation id="i874e71561f8a4c0591ba4447a367e712"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.948%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy0xLTEtMS0w_90817b3a-e1d2-4873-a44e-2c6192a0cc2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy0zLTEtMS0w_7e238a5c-3cee-40d3-b5ae-39b6e834f14a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy01LTEtMS0w_e37df885-35b2-47d7-afe5-62e1eb1c34a7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy03LTEtMS0w_b0475915-a239-4102-8555-a5023e78c738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy05LTEtMS0w_a86ae277-bd11-4338-906a-ae6ca9f16434">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy0xMS0xLTEtMA_b42b0c90-bee4-4373-b92e-779876b59a09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC0xLTEtMS0w_9aca6d4d-2ae7-44de-8b2e-51117dfd0462">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC0zLTEtMS0w_bd5a2960-d003-4156-89f1-3669aa830212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC01LTEtMS0w_348fdcb7-2ac6-48b4-8c7c-791e4ce1b7e2">1,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC03LTEtMS0w_f4203f45-5fd7-4868-be0e-800f86062421">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC05LTEtMS0w_36c53fcb-3949-4dd8-8a83-44e6840b3a3a">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC0xMS0xLTEtMA_8b5066bb-57cb-4974-82ae-cc8594be112f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS0xLTEtMS0w_64d20fec-85a2-49a5-85ee-177ef81f8598">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS0zLTEtMS0w_36297f87-7959-4df2-9b95-8bb62b108159">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS01LTEtMS0w_b70c2799-c2fe-4b4e-929a-0e46a8cff275">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS03LTEtMS0w_f2bb7152-7b63-4f61-ab90-7a67229fe791">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS05LTEtMS0w_48dfe0c6-c8b0-42f0-b3dc-8569f8f82521">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS0xMS0xLTEtMA_f8112dd2-d562-4a3b-a668-9bbf4bb6b6a8">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi0xLTEtMS0w_1db3c0b7-b3b5-4a99-ae9c-cfb9e2417f72">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi0zLTEtMS0w_4feec7b6-7748-47be-a69e-2fff1d60ffd8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi01LTEtMS0w_920bdffd-030e-4e6f-bb4f-32a07242b10e">236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi03LTEtMS0w_0421d090-1f04-400f-9c6f-185435aa1dc1">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi05LTEtMS0w_0cfe45a2-1a00-47ad-a122-faa65a73fe46">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi0xMS0xLTEtMA_ccc0241f-a064-4062-b313-f0abb76acf22">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b8c6a6f20c461db287f9f793fbf9d7_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy0xLTEtMS0w_9b4bc622-26a5-460d-a3a1-74f961028c26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0b8c6a6f20c461db287f9f793fbf9d7_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy0zLTEtMS0w_ab2e1805-03a6-4be6-9eeb-c2649b67a5bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1943f336d24144a589379cf6e74715_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy01LTEtMS0w_0cc31e6c-efc4-4d59-8c4f-9c889f492f5e">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb1943f336d24144a589379cf6e74715_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy03LTEtMS0w_0cd84e92-fef3-42b9-887e-14073956261d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy05LTEtMS0w_0b6cdf34-1510-4ead-aa72-c09a010bbd91">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy0xMS0xLTEtMA_85751c44-bb74-4406-a360-aac89a60853f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486f1122037e48ebba56da0ba8464796_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC0xLTEtMS0w_6abb6c50-2a37-4b33-86c5-7cf9e250180e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i486f1122037e48ebba56da0ba8464796_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC0zLTEtMS0w_06b3fdd5-f488-43ed-bff5-7869a6521956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b4441f7bf64f9db07dd58f12b394b5_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC01LTEtMS0w_a4e23aa1-fcb9-42e9-8270-230bee137315">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b4441f7bf64f9db07dd58f12b394b5_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC03LTEtMS0w_84923724-c5b9-4d63-8abe-d4e4a3a6d022">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC05LTEtMS0w_91e47e56-28a3-4493-bfea-3b484992d63a">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fa8546b543495c817f8870574cf91c_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC0xMS0xLTEtMA_49bc05e9-30b1-4828-b73d-bae8180da928">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1483e14fbc3a4929b38090e7dde2ad45_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS0xLTEtMS0w_7459f206-8ea0-4ff6-a8c1-7ed092832ba0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1483e14fbc3a4929b38090e7dde2ad45_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS0zLTEtMS0w_a554d1b4-470f-4d89-b41d-33f9f73eda5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cdf1afe2da4dde8c7318e6ab1a8301_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS01LTEtMS0w_2bbb1171-3d67-4327-815a-723301158da3">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7cdf1afe2da4dde8c7318e6ab1a8301_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS03LTEtMS0w_cc6b5e8a-5ead-416f-bd53-2fa73dcc9077">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS05LTEtMS0w_350dccd7-72b5-45d9-b6db-246e97c3c28f">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS0xMS0xLTEtMA_4408845f-6ec5-441a-9a7f-dc4a2a19a597">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtMS0xLTEtMA_a39213c4-2af8-425a-beec-8e84cda1cd4e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtMy0xLTEtMA_94be47c6-2f6b-4a0d-8e8b-c66744a1f09d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtNS0xLTEtMA_8d77b840-f36b-490b-a528-18f91b00aa2b">3,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if91258c802ea4a78a5826616a1737d80_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtNy0xLTEtMA_173ec53f-0151-4f71-96a0-a264a15de297">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtOS0xLTEtMA_d841ceb3-80e6-476e-9e26-5a58c244f334">3,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtMTEtMS0xLTA_f29e8cb0-dae8-4b0c-bc3b-60a7086489f9">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;<ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY3Nw_824758b6-4d24-4187-85e3-374bfa2a2244" continuedAt="i3aa8c431142745eabc43c81492274616" escape="true">During the three and six months ended June&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i3aa8c431142745eabc43c81492274616"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.285%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi0xLTEtMS0w_7632170c-6041-4313-bd18-f053a2552a3e">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi0zLTEtMS0w_e6ff0dba-59bc-4b4e-8267-f322398312ff">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi01LTEtMS0w_0f17a318-62a3-4fef-8bb8-db1d00d4ef38">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi03LTEtMS0w_9d484790-9029-4199-a8a2-195c5052d28f">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy0xLTEtMS0w_6674711f-0f21-4deb-8424-0814ce7575d2">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy0zLTEtMS0w_59a30599-fd80-422e-9b42-1723ca271504">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy01LTEtMS0w_3c8419be-be3c-4acd-b5ec-de2d0e616e02">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy03LTEtMS0w_8b6a629b-c725-421e-84b2-b77a2a5a72a8">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC0xLTEtMS0w_8ba4303b-4b6e-4bd1-8184-65ed321a07c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC0zLTEtMS0w_78beda06-ea0e-4ab1-890c-acf4459041af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC01LTEtMS0w_4b0b9490-775f-467d-8c08-88e1c455c7c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstateForeclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC03LTEtMS0w_e33fe1db-9e5a-4fda-8c65-b6f05be963b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia4fe645b25884dd480f874093b0cbe6c"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDcxNw_a893452c-3176-455b-b021-fe5f604519a6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at June&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91df7cc733e2416eae8bfe2970841365_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0xLTEtMS0w_0c1143f8-7d39-450e-9b99-f735698f8c9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f598f62b58f44329684aa34ad736af0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0zLTEtMS0w_239100c0-d0bb-413f-b8f0-3dc3105dbc4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450c5941c7d942b0a54ddb1a32a20443_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy01LTEtMS0w_d4b085ee-9a29-4c25-8550-932b269894ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4873ff3af0794784807c3e3ca3789caf_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy03LTEtMS0w_7b0ac067-ee42-4540-8ebb-73795d7e8540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib600a4f1216f44378cf6f1b44d67d7ea_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy05LTEtMS0w_327b9901-936c-462d-9683-9933009cf08c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef7062893e5408eba53ca68b4edd0b0_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0xMS0xLTEtMA_b0145336-8785-4d66-b1f9-a9050ab5b064">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48bd9aac481142a2b07aba094d9e81af_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0xMy0xLTEtMA_7746507a-1b1b-4a1a-9df1-ee6d7a40b342">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1b8df1cc2643e8a0309a06abb7aca0_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0xLTEtMS0w_1d9d4cb0-1961-4f49-9fb3-0db61ae702b3">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if924b5acfea142f0ab260a1dea210427_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0zLTEtMS0w_df5eb2c2-cd81-46cb-827b-c1bd2db444f0">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007ade0d31a744fa85eece461d2ea04a_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC01LTEtMS0w_1aa9197a-85d5-42dc-af70-a13761c3bff9">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f755a38a33470f981cf406c956dd12_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC03LTEtMS0w_20c42a4c-6bae-479e-871a-b77b059183ef">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic06ba18385514181b60ef5b38d07c7c8_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC05LTEtMS0w_43c4bbfe-a798-4f8e-a285-7fcfc4c58d77">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b2d1fbfab6345c08006daadfad4a310_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0xMS0xLTEtMA_1e9d5c77-0a27-4d1a-aea8-e796d63ed5c9">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iceb56897df794c4191f6c4c04564d9c1_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0xMy0xLTEtMA_e9557de3-e351-4448-b04e-22bf5bdce05a">897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220a807050aa4c2ea3679d48640b0fc3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0xLTEtMS0w_005eb5c7-3c41-41de-bbf2-949b8ed603b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131e208f966e4264a055bb71305599da_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0zLTEtMS0w_da3a14cc-2a4f-4119-bd17-a55ea370a09e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33523e15d5dc4123907ac3a0675f494e_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS01LTEtMS0w_236325b8-0463-49cc-86fe-5ecb4a065b0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia890bdfab1f54e6ca2e37c25ed5811f8_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS03LTEtMS0w_6028a058-4472-4a44-89cd-c7d02e28205d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367b52fbb0a240aa82bd1a02d8a324f3_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS05LTEtMS0w_7eb503b1-9cb0-4f8b-9651-cd5f487ebee8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab34f008298435eb46af52c54f017d6_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0xMS0xLTEtMA_d49fbd5a-48e2-4c36-9a4a-668546ba35fa">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdb3058d4ed94963aaae1af4e53a426b_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0xMy0xLTEtMA_e5ad7051-d15a-4988-86ca-2d9d3f30425f">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d6ad7d715e9485e80a9f39a359e966e_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0xLTEtMS0w_cfc25f8e-f31e-4dab-86f5-54aaeb8df28e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic274db3d35ee4f3ebc05cc96aff41eb0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0zLTEtMS0w_f6a0eb86-708f-406b-96ad-d5e4903a8b85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299180676e0a428090878a4e964ae3c3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi01LTEtMS0w_704217c1-93dc-4197-91db-3665fca5f720">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28ecf2d0aa0430b9c1cb966f93498b7_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi03LTEtMS0w_53533fe4-96a6-4bab-ae53-2e785858a430">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabefdd8927e1421d870bbc8356276157_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi05LTEtMS0w_28dacc4e-686e-4984-90dc-861bd2ed02d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaffe79f8b7ea41698ffc230904de27f6_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0xMS0xLTEtMA_0da5024d-e2aa-44a6-abec-8639f565fbbf">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83f1ed1f5a7f4f3bb16d0358da0bb94f_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0xMy0xLTEtMA_86915167-de26-4da7-a280-a8d5d2f15e57">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i449532a2d62a4951a3f3831a08a4fda3_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0xLTEtMS0w_e4e1af2a-a002-4d2e-a484-325aeb130436">118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9f2126c084443d9eda652a4acefb7f_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0zLTEtMS0w_50d4a0b9-bbc3-444d-bf3f-831c544c5f0b">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e0a13ad4d0459196454862400790b9_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy01LTEtMS0w_8b314e29-8313-4d17-a825-fc1267352ae5">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c188280b0cd4569a3ce9e68984969a2_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy03LTEtMS0w_2d6bbfd2-2421-4143-8539-cffbcdf954d7">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aff7e212dba4f1fbf45ee44721fbe81_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy05LTEtMS0w_3cec3bee-3870-46ab-a570-d9559f17f783">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie247c0296a5e402b85463bc03fbab6c1_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0xMS0xLTEtMA_5787580b-969f-439f-b2cc-fb6927bc20c1">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39dfb11efc44ccb81323ee1fcf29437_I20210630" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0xMy0xLTEtMA_b161c6ee-cbdc-4b7c-b319-149840ad7d6d">976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54610f9931e549eca4055d422845c143_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtMy0xLTEtMA_870f29de-2c65-4bb2-8429-02953ea5548e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if427cb3fea58401c8674f141a28396a0_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtNS0xLTEtMA_92b421bb-bf94-43c8-8783-3669f3d2b31e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15d5490a569a400b8f3dcd7e8f5deeb7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtNy0xLTEtMA_30a1fe28-5dee-4f9e-b037-41316b5782f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d587f40c2be4fea92c1a51b110451cd_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtOS0xLTEtMA_7e0800c7-870b-4651-9e5c-43751b309a48">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b64b0dd3c184cf68f39f81eceb5b2a1_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtMTEtMS0xLTA_f5fb6ad2-82e2-4909-841e-fc49e47166f6">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i885cdcbd4dcd428eb8b3f2c4bf5ca941_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtMTMtMS0xLTA_f9ec58f4-223c-4c2f-b753-d2f09df63737">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id753e4b7a848420eb1bf019e0dff3575_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtMy0xLTEtMA_f2a2a0af-9cbb-4bff-9751-6a31eec55eb0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie652cb275f004e0a8ec39116d03c51b8_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtNS0xLTEtMA_ce06258d-4633-4cc5-9270-2f401de9fd1f">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i218aea3dada84f1fa06872e0f38b36c1_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtNy0xLTEtMA_4da2a42d-bf42-4496-8afe-98e3becfd3b6">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d49cacf71ba442b8c626e29ceaba33b_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtOS0xLTEtMA_793e350f-9db1-43dc-a5ba-15a52d4b97f0">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6753c528bf954911905b7a442393bd2b_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtMTEtMS0xLTA_efd8493a-0f5d-4278-8b46-fc309da88edb">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3911cc7a050a463a9917d1b270dee929_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtMTMtMS0xLTA_9be58ae8-8b69-44b1-8c2e-a7ed50affc88">952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66926c144af6454b87ae1b8f6716f4b0_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItMy0xLTEtMA_2f6ac8cb-3b89-4fe0-9f89-1c5b5c3d58eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3111a7bacfde42758aa324b189e45891_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItNS0xLTEtMA_03a89f8b-0b5e-40c1-be69-26e01b5d5be8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3732b9eaa81d40fabbf3b7dcf14af188_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItNy0xLTEtMA_4bfd1056-11c4-4f58-a3b3-31a1ca0ae751">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8412f07e8a547df9a2fcec0a4836635_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItOS0xLTEtMA_f6a34143-3d3b-4785-92a1-240b61e16a41">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b11270b11c465a83657fcd47ed4efa_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItMTEtMS0xLTA_b47ec557-75a6-4d22-beb3-1e16ccfcd953">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2162ee28ee3f4ffdbcd637de827d5019_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItMTMtMS0xLTA_5b8006e8-d219-4171-aad9-c435da5a0e6d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie79e56a852074e97a192b8b7beff8f36_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtMy0xLTEtMA_9d0b441c-c7fe-4015-899e-281cb6f1f9ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06bd1e75b881405f9702ac7ddbce9775_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtNS0xLTEtMA_f679e0bb-1112-47a8-b70a-b52bb217dc3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f79cb2e161946d4929d70a5ba4b004e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtNy0xLTEtMA_b79318e7-d7a1-4faf-8389-5c16aa5e584d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad22fdfddeaf4656861bd7eeb9c94c0b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtOS0xLTEtMA_6de9b60a-8b84-4b33-abf1-655b5112ec54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f663f5fccd4951aadd8900a4387256_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtMTEtMS0xLTA_0d8c1d1e-7919-49a0-9e3d-09d719a48036">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7007437bd44f4d68ad1ad8bd03e2f923_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtMTMtMS0xLTA_bf6a6e09-6457-4f34-a1e0-c5a892dbdea9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica882fe4d91740f2b81b3646815ff854_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtMy0xLTEtMA_cc1afc7d-00a8-4944-8df1-7e7ce37cd695">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f0ffb4cb5747e5ae102f05f6be5426_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtNS0xLTEtMA_9cd868fa-abca-4ab2-8b52-5a189bfa8751">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9fdbba4396e465aa67202f3d051bf09_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtNy0xLTEtMA_e61789d2-7655-45fc-9b34-ed35d96b4e37">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98081acc8c6408991f4c8cfefb17661_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtOS0xLTEtMA_3a5c3da3-c85f-4564-82a4-cebe316931e8">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea822d1827147c99d73617628295d8e_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtMTEtMS0xLTA_36c19b68-3a4e-4059-8719-f69c01f501ae">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc598c056391483daf070cbea7830172_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtMTMtMS0xLTA_3e93e13c-9c84-4573-afcc-9d2a0de32cf4">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY2NQ_ecdcc8e5-d489-4dc4-bb43-0c169dda366e" continuedAt="if7e296d570a244208fb05aff90da0663" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and six months ended June&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0bfcd29b10f48ae92b73e7e61315ccd_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi0xLTEtMS0w_50c7563f-87db-41d9-a845-581fe1ca8578">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i517df693ba094adcb6a72f956951017a_D20200401-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi0zLTEtMS0w_06d45133-379c-4213-97cb-ee9f51572f8f">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie42822d1eacc4a8eb4231d4dc693ea43_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi01LTEtMS0w_c7047c09-e163-42b1-a05c-3a6a795b0e00">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3d1e2584e2e4ece9d9ce0724718c49e_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi03LTEtMS0w_ac506c91-3f3d-4a24-a098-f495ccfd4044">290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635b7d77a86447cbbde8755fc40a8123_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy0xLTEtMS0w_6e3b03eb-13f2-4f9c-bf65-8689de1b9ded">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bdeac025f774c94829e3eb2edfc85ed_D20200401-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy0zLTEtMS0w_91fd9e5a-cd27-4b40-af5a-0a0db6615058">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d87419632b4611adab279ece7e7ab5_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy01LTEtMS0w_e4c26fcf-eaff-45b0-8a22-9b44cdc5dd3a">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2b888f576f9425dbc1db1dd81427da5_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy03LTEtMS0w_7d6123a8-80c5-4834-bf1a-c8ca3388c2c0">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc660620ba647f4b99c1bf75a1627fa_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC0xLTEtMS0w_17853b0c-6e18-48b8-a4e5-642e4b2061ce">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16505c15a33845cc90e5567fa18ee168_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC0zLTEtMS0w_249b8348-3d94-4ee6-8098-2d9fe3645a77">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7b0bb4b38a45ffab552ab679c7ed71_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC01LTEtMS0w_fdf269a0-e942-4121-bc30-3484ad7f861d">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if766f5d0385a41e6b60c61a94201bd04_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC03LTEtMS0w_322d28be-7a19-4770-aa58-2b7367f5304e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS0xLTEtMS0w_fdf978c0-2dd9-4ea3-8732-4fb6681dd8ea">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS0zLTEtMS0w_edded50a-a059-49c5-b206-ff6b5cfff2ec">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS01LTEtMS0w_e34bc244-41fa-499b-8965-ae02f95e2d20">543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS03LTEtMS0w_423fdc9a-17ce-44a3-b82b-6eecbfcbbe09">347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi0xLTEtMS0w_ed9e89e7-11f3-47a3-8011-8a3f04d2c205">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi0zLTEtMS0w_70ff5235-0eda-4f57-8a00-d5a239b21327">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi01LTEtMS0w_55aea1f8-d740-4ee0-82c7-2a81920556cc">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi03LTEtMS0w_bb9c5616-7ac5-4745-b6f5-af10d7e20157">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy0xLTEtMS0w_a4a64064-dd09-4f23-b9d0-b786ce632484">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy0zLTEtMS0w_2db9b7c5-f42a-4c41-b733-7ec7e3fb50dd">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy01LTEtMS0w_40bd1453-7121-4b12-b7a0-633650aca209">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy03LTEtMS0w_2a0aea7d-d98e-4f47-a9f9-1d7d2211718b">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC0xLTEtMS0w_22b1f4dc-ea31-4f39-8bd8-54f6a9a405ca">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC0zLTEtMS0w_119b751e-8b0a-462b-a564-051ec56c3277">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC01LTEtMS0w_8fccd884-380b-47ba-a455-b7ced0b76eea">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC03LTEtMS0w_77ddff0e-9657-4e7d-be6e-c650197f622c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS0xLTEtMS0w_f39eed11-2bb4-43f2-8229-da8bb7a494a5">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS0zLTEtMS0w_0af00daf-af1f-4a87-8603-f69f0e865f1b">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS01LTEtMS0w_886ddfee-5774-4e2e-9a66-64421b4eb668">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS03LTEtMS0w_5b1bbfc2-96f4-4b2d-92cc-ff611ee6a076">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTY0OTI2NzQ0NzU3Nw_93d7b726-990e-4c50-858e-d887090e642b">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTY0OTI2NzQ0NzU5Nw_d8b89ef1-03fb-46d8-b7fd-f055c6af75ee">32</ix:nonFraction> million, respectively, in the three and six months ended June&#160;30, 2021. There were <ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt-sec:numwordsen" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMzk5Mw_3151d900-cf66-4e20-97be-9848ec974e8b"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMzk5Mw_66ef4b47-3b28-4cec-9c97-f7c26f0271e4">no</ix:nonFraction></ix:nonFraction> credit-related losses on debt securities in the three and six months ended June&#160;30, 2021. Net realized capital gains include the reversal of previously recorded credit-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU1MA_91d43a04-eaca-4174-97cd-53d358f91a75">42</ix:nonFraction> million and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU2MQ_9eebb045-0729-4d03-bfaa-3f8595b834af">1</ix:nonFraction> million in the three months ended June&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU3Ng_3efc4f4b-b51f-4ea2-a5dc-b9d22f1bcfcf">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU5Mw_d49ae27c-a938-4aab-bf3b-6ea3dd94fb40">42</ix:nonFraction> million, respectively, in the six months ended June&#160;30, 2020. </span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="if7e296d570a244208fb05aff90da0663" continuedAt="i3a48e513e1ad47609fb597ef5ad89713">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i3a48e513e1ad47609fb597ef5ad89713">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="i42f9c017860948b99f0fb8dea97d4d51_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDI2Mg_4a3e498b-6c28-449f-aed5-b658b33a164b">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib882de119eac484b9d951f61870fc5f9_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzUwMg_b09af680-49fb-4fed-ae31-eabfa2628528">19</ix:nonFraction> million for the three and six months ended June&#160;30, 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="ie0b4a3cd76c34e31b91ed92d1872d19c_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzA1OQ_caead480-b88b-4fb0-bac1-94977191431a">10</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4c2fbf0383914cbeb84f216152e87705_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzUxNQ_d6822f5e-5b1f-4d28-8950-4c1ceb8f92db">21</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively, related to investments supporting experience-rated products.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDcwOA_5a77e31c-c9ec-468f-a8f0-fce37b7c8b87" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi0xLTEtMS0w_0bd8899d-5da3-45a5-af72-9bdd3ccc4cad">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi0zLTEtMS0w_ac490c6b-45c4-4d4a-89ba-b328f5b6ee4a">1,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi01LTEtMS0w_92912490-a160-4956-a552-486cb06589c3">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi03LTEtMS0w_46c58691-b0f4-4bbf-8916-852b4fd6692c">2,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy0xLTEtMS0w_1eb976de-82ef-43ba-be88-3fb3019ef878">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy0zLTEtMS0w_5fdc9451-0c41-418c-94c8-19b6b39a370a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy01LTEtMS0w_a0da39d5-78c1-4b0d-abd2-b28b2b7458b4">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy03LTEtMS0w_39442850-bef5-41b6-afaf-7a0953fe535f">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC0xLTEtMS0w_56241730-1a35-4855-b80b-2bd13b1c1265">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC0zLTEtMS0w_ac22d89b-0609-4b53-92f0-9dbf4e665d64">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC01LTEtMS0w_1f0313a5-2159-40e9-8788-027fc8d51162">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC03LTEtMS0w_74108199-a266-4782-adde-ddcfaec96d0e">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc3OA_ebcc000f-4d60-44f5-bc30-5c867f7786ab" continuedAt="ia324d12e5df04ad999e93bbe604a3743" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia324d12e5df04ad999e93bbe604a3743" continuedAt="i5a6d88853b2a43ec9268aa6a0ce49c6e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2020 Form 10-K.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5a6d88853b2a43ec9268aa6a0ce49c6e" continuedAt="i4fac02128b61457a8279a58386a7cd36"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="if510787ec69a47dab801c3bc8709accf_I20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMTQzNQ_4ed50a6d-5fbf-496c-82ad-0f834b524704"><ix:nonFraction unitRef="usd" contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMTQzNQ_c052477f-a846-4cd6-959b-40a3e1c3e592">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 or December&#160;31, 2020. <ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc3Mw_b4b2575f-7db0-425b-ba61-996c77b59f39" continuedAt="i2e74bcaf814640c9baf84219ad11eb0c" escape="true">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i2e74bcaf814640c9baf84219ad11eb0c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi0xLTEtMS0w_dfc4dc53-ad31-40b9-b7a1-317361fc1433">3,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi0zLTEtMS0w_114eb078-a340-415b-98f1-70879981c687">3,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi01LTEtMS0w_6e4541ea-c082-4ede-b528-68537c2b4a15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi03LTEtMS0w_ada422f4-a2dd-4561-9938-40e21b0da252">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i210cfc37361e470c839857aa7665fd2e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC0xLTEtMS0w_4e38008a-4053-483a-8fff-98c65dfd1f3b">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5756d6da663844dd8e3245d0308e243b_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC0zLTEtMS0w_aa69485e-5825-46ed-a0ec-13c897922d4d">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8122e2ed870645328446a41f8f459934_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC01LTEtMS0w_a61e9282-d969-498d-bc11-0edc9f80d2ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4774aadb10b74dcd88e20d1880176f2b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC03LTEtMS0w_52b6153b-490c-4fbd-90ee-c3eb010f4663">2,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d647a560d834ed7bec26a73aea83cce_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS0xLTEtMS0w_7860bc51-0fd3-411f-b625-1d2945eb2eba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51f256ca262f46f29af5968001b43da2_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS0zLTEtMS0w_f44f1f78-97c3-4862-b6e3-7b02eee5074e">3,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4937f0b48be141ada107552f5c969303_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS01LTEtMS0w_686fefa2-010a-4a0f-a8ca-ad5df66c2144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec3859c325c4e37bdc207864784224c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS03LTEtMS0w_b8bf0c46-446c-4f33-ae62-7b75b4f3c829">3,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcd344f786334eeba5b6b5f3e83b93d8_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi0xLTEtMS0w_703b9923-a10b-438f-81a6-1bfe40ccdd2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf06625a4a7e42ad8768a5601e932198_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi0zLTEtMS0w_6e4917ae-ee82-4fff-9f8f-c816b45b0b0a">9,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if648025f3229424d9fb2cb50b21a4d8e_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi01LTEtMS0w_0ebd28d7-e42c-4234-a958-e1a29722ca66">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a83e5029cd544968b3f62662c6606dc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi03LTEtMS0w_ecb4463f-a571-4c23-987b-f453cffd65d4">9,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib243fd82757e4fa48ebb957b2b99c657_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy0xLTEtMS0w_de744a88-e8aa-4917-90d6-fba8992dbd5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i666e214c5a9044248a863407bd0eb6d1_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy0zLTEtMS0w_154a7ed2-ee4e-4042-bce2-6dff6a5d7a4d">2,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d697cff45d428eb1ade196d28a9895_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy01LTEtMS0w_c8ffcc49-89d0-4afa-aa0c-10fc65ff05fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c9463581a84b608a88153478abae38_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy03LTEtMS0w_a02dedcc-5386-4f33-a4bf-46453a26a8cc">2,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff11c38224d54e13923ab497bfa6a493_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC0xLTEtMS0w_f321afb7-cc53-4564-bb49-a806ecaf3696">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0ee846d07ec4f5da014c0cbee5f6325_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC0zLTEtMS0w_37a328ca-e2ad-4936-852a-5b1b43ab8466">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaafc729b92494245ab81e716ce94cb2a_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC01LTEtMS0w_c0677985-7b14-4833-ad3e-3746cb2ce18b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d54b47fd594fef8e068ff8c673c092_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC03LTEtMS0w_b37f9e40-54cb-4231-a031-c25334827ba1">829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1649f3335c0494e81c99fc59c8b29f5_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS0xLTEtMS0w_a33a3bda-9fdd-4fba-87e4-2d88e47d2f8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if652301e5b5943129f8dabc5c8548671_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS0zLTEtMS0w_5d147929-5487-4aea-89e5-7c2be4b734ac">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bcca6c60a14999a5c77af4ebe5e5ae_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS01LTEtMS0w_9b9e58d5-e6dd-4d7f-954b-946181c66913">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e6325064a1c495391cc89279cb2514f_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS03LTEtMS0w_90e4ec82-871e-4972-9959-2f9b4b51111e">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf38374d2b44debb4cab8d016415de6_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtMS0xLTEtMA_750239ca-353c-4595-8ced-8b71743ac22e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d3dfbf8c9f4ac0bb704473ec643a62_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtMy0xLTEtMA_893df882-3dc3-4fbd-acea-6845f0fdd04d">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia08106700a614dff9824cb0fe4668155_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtNS0xLTEtMA_66d9ee83-54af-467f-8204-28df2b60245f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc2aabed88fc4d488c491b6a45904991_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtNy0xLTEtMA_42da68f8-da34-435f-b885-f531b4ddca72">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508570dbfe5849138bc3977ff2cb5ef7_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtMS0xLTEtMA_21169b74-965d-4a36-bb94-86bb86f8c741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72735f55bd18494cacc33cb8c99b64d9_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtMy0xLTEtMA_0c08524b-6c0f-4bae-90fd-a85b31ba21d4">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f512df7d4da495d8f781fb880dc0284_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtNS0xLTEtMA_5342d038-3a05-4023-8e68-f89262317365">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fb024b2608349f0b1205f18ce388c77_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtNy0xLTEtMA_66375450-55e9-4109-9f2b-2b10d565c5e5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItMS0xLTEtMA_f9fdbb4f-01ba-4af0-85e8-c8694c217996">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItMy0xLTEtMA_eecdc705-acb1-4fd4-82d0-fb2553c2681e">19,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItNS0xLTEtMA_f393a08f-94b1-4292-b943-d6bbddd4f3cf">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItNy0xLTEtMA_31cbd248-4d92-4444-9a1f-1a66c6591a04">22,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtMS0xLTEtMA_58d0f368-f24f-478c-9b6c-3a5be360ce13">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtMy0xLTEtMA_c163817e-f568-46d7-abe6-8032e254f14c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtNS0xLTEtMA_b751a10c-1cd9-406d-b25a-d0c7488ab524">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtNy0xLTEtMA_ca647514-97fa-4b1c-9673-ea9ebb374906">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtMS0xLTEtMA_6a8aa2d4-e576-456a-8d67-9fa5a799c981">5,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtMy0xLTEtMA_6ed6381a-600c-402c-93bb-a215c14aa367">23,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtNS0xLTEtMA_a16be233-f809-454e-bc9f-38504c7f32c0">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtNy0xLTEtMA_46231c24-30f0-476c-a535-a349353e76bc">29,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctMS0xLTEtMA_ac8746f2-036c-4fb9-a457-eb9aa3174385">3,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctMy0xLTEtMA_2139c224-2c07-4fac-8961-5ee5ce50045a">3,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctNS0xLTEtMA_f81f032c-dbf3-460e-a742-72216f8cd151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if510787ec69a47dab801c3bc8709accf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctNy0xLTEtMA_15599f12-0856-4ab5-a63f-aaa4d630ec9d">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd934620d014afeb56e178d35779aa7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktMS0xLTEtMA_ce568b64-ec91-490f-ba0b-ae637e4fd2fa">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibed7dee2937d4edda5a4f4eea940e0c1_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktMy0xLTEtMA_d0406885-ed86-4d2f-ac01-077238664010">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41c79aea9b744926b279baefd7888c7f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktNS0xLTEtMA_580a3634-b0e8-47fe-ad78-b0270761666b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc1767b92b5c4de5a2e23e7eb3179d2b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktNy0xLTEtMA_8c1dca98-0e41-4d96-932b-aaf2098047f5">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa429dd3d3443068ab973df732e3c5c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtMS0xLTEtMA_866caf15-6fb4-4c7f-8f41-14f4f55e3b60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5804356b138422d80717a1da9579a89_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtMy0xLTEtMA_4f62517b-ff4d-4d30-bcfa-14c44a8303e2">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib901721cf1bc447e858860d4cb20ce74_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtNS0xLTEtMA_e6ee5b32-8615-437c-bd58-a17e502e55a4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63b4df452eaa45da9e4f334a54e4276b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtNy0xLTEtMA_c17cb5a1-b169-41d0-9359-2d036f33879e">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7e5f228a57743f1b6ea83a254776653_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtMS0xLTEtMA_b3e724b7-09fa-493d-a668-76b7078643d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife856c95fabc422e946de71df9f85f7f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtMy0xLTEtMA_4dc475d4-08a7-44d2-9262-fcc21dab9036">8,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd180ab75d5a4fecb68db3e8d283b9f7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtNS0xLTEtMA_f24b5f8c-0d1d-4420-ba38-26218bc4ebd2">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85785249c39f4629a053294868f4fcdf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtNy0xLTEtMA_81e302bc-d2c8-4093-88d9-941e57138c67">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19ff9770b3940188b1c9822a1c6d9b3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItMS0xLTEtMA_e5c45b30-71a2-466f-a664-b5fc2309a9cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a1418e8df34c6cb73572ce728f62ac_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItMy0xLTEtMA_a29f49da-62f5-4e5e-8ab5-460c2ebddede">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f5a355792b49a293afec62f4455847_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItNS0xLTEtMA_ee3f6d5a-ea28-4716-9d17-bbf84cdbe41c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2374f86f801462a83df1f2c38872a96_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItNy0xLTEtMA_a704d1e5-0367-49d6-92ac-476e15a37dd2">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8cd73f6a957430db9ad4fba0bb5ee64_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtMS0xLTEtMA_c11979f8-df48-443e-8f93-f165907ded73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd730a9a7384fcba46ad7b64d43e6d7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtMy0xLTEtMA_770209e8-5077-4e5c-add3-55a2d774c377">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09ff8669b4a54e3e90a5ab48256328b4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtNS0xLTEtMA_6120cf46-47f4-43ca-a944-33233cd1674f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d20c989c3b64c90ac3cd629c8bf4640_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtNy0xLTEtMA_6c32963f-2d65-4316-8581-49b327fa3941">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a0e0235a7c4490a5d9ce38d2dec0f7_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtMS0xLTEtMA_4bbf75b8-72c4-4a84-b653-7dc23bddb96d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0dc3ba5e04941c187297fe40513dde5_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtMy0xLTEtMA_1c263bd5-0478-4440-84fd-7200bfd78243">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3854b6138a7e4b6ba179f9daaf4bf706_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtNS0xLTEtMA_b6196785-3dac-42db-bdd4-daf08f767c33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18930979d5f444fc9ce85d4aea31a3a7_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtNy0xLTEtMA_493651ae-b630-4740-b41b-948b1f3df6cd">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdb74a304f8a449c904b5ac5ed9a47d3_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtMS0xLTEtMA_3d508e67-a5a1-428d-953e-b2ae9b815481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b89a5844183436683430ac9c92e2493_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtMy0xLTEtMA_0072fb20-1b2f-45b1-be81-3f31b7909611">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff75c2db4cc4af1b847def76f22a529_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtNS0xLTEtMA_da49f2f1-5c8b-4dea-b920-e39234e313e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c828dc2e7148ec8b99c9d153298510_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtNy0xLTEtMA_42776f02-b8c1-41d3-a476-e830126a7a30">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i492d50e843c848998eb35ba39503a0c9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtMS0xLTEtMA_3f53b15a-828e-4aee-b778-f8ccb55584ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73382bef295f429781872fe2001fc529_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtMy0xLTEtMA_428472bb-d935-41ff-9ad2-4ae2d432dba2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c677e6daec4e8780d801dfa6da3c94_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtNS0xLTEtMA_4d99216e-b91a-47aa-aae9-f8a5c2559c5f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e642c930d94a8d9996ce4bed724ae0_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtNy0xLTEtMA_19179859-5162-437a-ada7-12446531fe4d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctMS0xLTEtMA_c88ebc07-dea6-4664-80d4-83813f0078c7">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctMy0xLTEtMA_fd37b3e4-16e5-45be-8892-ebd9c6c76e4d">18,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctNS0xLTEtMA_f8d23451-53a6-4407-b498-b586df7cbd5e">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if510787ec69a47dab801c3bc8709accf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctNy0xLTEtMA_4a692ff7-c038-4761-8d0b-d76aa663cf1b">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtMS0xLTEtMA_2ff0ba00-b0f9-4773-a512-a1cb8b0e6112">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtMy0xLTEtMA_eb93612a-ffaa-4d61-af7b-0082a3baeeb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtNS0xLTEtMA_05993d4c-00f6-45d8-9f95-a248b903298c">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if510787ec69a47dab801c3bc8709accf_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtNy0xLTEtMA_22f77d13-7cdd-4015-99e8-70490e682610">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktMS0xLTEtMA_7af287c7-dc33-43ae-9faa-21a31fa41684">6,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktMy0xLTEtMA_6f7aa5be-2671-4428-8243-4df609d867d6">22,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktNS0xLTEtMA_43f96429-3562-4e16-b662-19de8ce31a0d">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if510787ec69a47dab801c3bc8709accf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktNy0xLTEtMA_998292e2-58bc-48f7-8a2b-6c65781db106">29,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021 and 2020, there were no transfers into or out of Level 3.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4fac02128b61457a8279a58386a7cd36"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc0NA_c0ff04c0-9c1f-4a9d-aba0-3b738ed31488" continuedAt="icecd7994cf4e4dab96d8076c8f981768" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC0xLTEtMS0w_17aa2dfe-682d-4b0e-8e72-0f6fac37f63c">976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC0zLTEtMS0w_069c09af-8b9a-4dc5-a746-98db2600b046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC01LTEtMS0w_9453a097-b6d8-4182-9c9d-ba18dde9182c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6584062de818418fac5ed71f5a372118_I20210630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC03LTEtMS0w_a884a017-1544-415d-bc3d-26a3cc3d25a6">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC05LTEtMS0w_80d43ea4-c10f-460e-a84b-10f8ff0f5565">992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNS0xLTEtMS0w_45507a62-4e35-4c2a-9396-b97e9afa883b">129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC0xLTEtMS0w_237b6f47-cbbd-492e-af62-59d96badce4e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC0zLTEtMS0w_e0142c99-010d-4b52-871c-5204a03e2d28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC01LTEtMS0w_6e9bb0ca-58f8-448c-831a-33463b24dc7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6584062de818418fac5ed71f5a372118_I20210630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC03LTEtMS0w_3a61acab-5bd3-48dc-b301-dd4ffcb57595">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC05LTEtMS0w_8b28ff6b-dc1f-4db1-927e-1c7d0794e706">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS0xLTEtMS0w_d0e8e23d-c4d7-46fd-ae07-68625b81ce48">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS0zLTEtMS0w_3511c2e8-c8ba-4de3-ab29-61f304dc8c02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS01LTEtMS0w_0730c2f8-b53b-49ef-a713-d50e9c96019b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6584062de818418fac5ed71f5a372118_I20210630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS03LTEtMS0w_c60e74e6-39a3-4e6e-886b-f36b331c6572">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS05LTEtMS0w_cbce04be-2758-4e5b-9c17-6a9e4a100d95">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtMS0xLTEtMA_a70d6abc-4d14-4bd0-a5d0-b5a2da7ea752">59,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtMy0xLTEtMA_2e8901fe-34d5-4b77-9b40-8e24f8a47e1b">68,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtNS0xLTEtMA_b53d2668-0e4a-4899-9768-8b759b149f8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6584062de818418fac5ed71f5a372118_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtNy0xLTEtMA_a01f9f8c-8d4f-4ce4-9384-13755139bb1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtOS0xLTEtMA_6c0bb4e8-e428-4e1b-9d91-9cf21a583a3c">68,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtMS0xLTEtMA_7af3579d-6650-4fb3-a8fa-01e78d66b9df">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtMy0xLTEtMA_25e32571-0549-4466-acf4-3e33e5baf20c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtNS0xLTEtMA_6d2beb2f-f34a-466f-8a3c-5de7cd728592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtNy0xLTEtMA_612a2321-c86e-4a53-ac76-6cb7ee14a308">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtOS0xLTEtMA_06476a5d-a072-462f-95d4-c93fc23b3eb6">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTUtMS0xLTEtMA_c835f498-2e60-4df0-84c2-5aaa7e351bd9">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtMS0xLTEtMA_a6cf2cc3-59c9-46e4-87a6-660cb6b902a9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtMy0xLTEtMA_16acb3c7-4baa-477c-b67f-e92dce04ba45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtNS0xLTEtMA_6a60bbc1-ddaf-49a4-be38-ba80a1f96e68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtNy0xLTEtMA_c544a25d-ded3-4f72-9560-d55ae685a924">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtOS0xLTEtMA_ddbe2615-7c5c-4814-814a-061e078b624b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktMS0xLTEtMA_6c5d960a-b828-4381-9277-27c0aa657282">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktMy0xLTEtMA_89bbb8f2-00ee-4ec8-a63c-7653cb22a39c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231" decimals="-6" format="ixt:zerodash" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktNS0xLTEtMA_5ceebcec-af38-4f2c-9193-3cab54c668ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktNy0xLTEtMA_46db4b5c-9c77-4f47-85a5-1a09cdef9b71">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktOS0xLTEtMA_306ac22e-acf1-4bb8-89f4-58f627bb9744">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtMS0xLTEtMA_8af3da3f-a761-4421-98f3-00a282fe45a7">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtMy0xLTEtMA_34ef4419-7e7c-4503-8db0-fb8d630fb565">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtNS0xLTEtMA_e1a07ae0-d381-4e68-b555-09d2f92c8a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtNy0xLTEtMA_b7ff4fc9-92bf-45f8-b009-941284e6ef1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtOS0xLTEtMA_0f82fe1b-b4be-4dfd-81d7-c44b735b2c38">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="icecd7994cf4e4dab96d8076c8f981768" continuedAt="i2fd4943c586a46d9ad1ed872e8883d07">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i2fd4943c586a46d9ad1ed872e8883d07">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;<ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc0MA_052e5c1b-a1ac-4fd6-942f-994a7068926b" continuedAt="i204f28a671d4475d97f1fafe790ba852" escape="true">Separate Accounts financial assets as of June&#160;30, 2021 and December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><ix:continuation id="i204f28a671d4475d97f1fafe790ba852"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.243%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c2e12ab2ed44a1685c511613129c6ea_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0yLTEtMS0w_cb224976-c707-44c8-bde9-d65ded01dd21">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb7d9bc6a274f09859f00ab5e174888_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi00LTEtMS0w_7e73d287-6571-45df-8a9d-e0ec7852183d">227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5abce7dc4f744fb8be00645bffc65db_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi02LTEtMS0w_322eafc5-7511-400e-aa10-304c254af51c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad91cb1314994e379923841f48edf212_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi04LTEtMS0w_00a0221d-ad5b-41f8-b733-253dda93f4e2">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffde036edf014ed291d1a23247cc772a_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xMC0xLTEtMA_7da2cc01-4a81-41bc-a3b9-f195117bd6d2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2cc0aef0ef434ca7a520686e5a5a11_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xMi0xLTEtMA_8ea42416-6e2c-4717-99e7-2164a6e1cf63">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae628a7e9e9d4d70990367c3408854c4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xNC0xLTEtMA_e59d388b-16b9-4eb1-ba37-d64e174a923b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i076f74e1a0eb466192510067a9c8a7c3_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xNi0xLTEtMA_b2b82b64-6254-4467-96d9-b48314286b9d">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac6c16e9b5b4dc8a02816d8c21aeafa_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0yLTEtMS0w_640af503-c70c-4d79-b683-e1a9f954a977">1,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8968fff252724607a7a65bdc9378629e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy00LTEtMS0w_54bc3a75-4954-4bff-94d9-08f19574db37">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e44f82810c440485338f4334976121_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy02LTEtMS0w_2e189bda-71de-4424-bc39-86ce1f8aaff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdb59237beda4ebaacb4ab8eb6a97d0b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy04LTEtMS0w_b6956cff-137d-49f3-aa5b-41c3501498d1">4,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0244059f9628439f877b719efced6c7f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xMC0xLTEtMA_fefaa545-9d96-4acc-a05d-7af6f837fcda">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie43a8645a41a4ef2a7ef116fc6539527_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xMi0xLTEtMA_e40c31d1-827b-4997-9db0-e83dbef02784">2,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eaea3134fed4570a85d692327045a39_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xNC0xLTEtMA_6096b189-c411-4f05-8ae8-98a18bc21bb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef4cf2bbf004e71ac5c7cca1cfd3a50_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xNi0xLTEtMA_fb5778e3-1d40-43e5-a9b9-4708705ea525">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b9eb3d66c14bc28cb0cc540b80fc4c_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0yLTEtMS0w_8bd9ea4f-ee4c-4f1d-95de-523e63a9e911">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7857397f0c414fe58b62068caf0af267_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC00LTEtMS0w_c5756d84-418f-4692-ae2f-e47baea28a5f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaebacd56446c4171843144f398469d81_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC02LTEtMS0w_3007bb3b-92ce-419f-a169-9530662bd4f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77cba1c8ec74b5ea417e97bfc25f625_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC04LTEtMS0w_478275e5-1213-49f2-84b8-81862bd831c4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01eb9253c97c4e5b9250d83998bcec06_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xMC0xLTEtMA_49ae9566-90e7-45f2-94c0-e1591e3df533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44630855078a48b9908bbdadf53bc736_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xMi0xLTEtMA_87c07934-64a1-4841-9845-424eb2ba595c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c30b37500e14214ad5855fdc0950616_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xNC0xLTEtMA_5eca8d11-dfc9-4460-840a-623c25db2aaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic242a2b931a4468b8b353b6e0aef8bcd_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xNi0xLTEtMA_edde119a-a735-43ab-b7d5-0b349d9b1410">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22db164f3ee140ce9151bfbea89bff98_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0yLTEtMS0w_8ead8efb-81c0-4d52-bff1-f30ddc6f5436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09809fb393924acb85b3db48f54103ea_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS00LTEtMS0w_09296b68-65ca-4372-9028-e1598545c03e">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f077ab3271f495385d381d572fbe9e7_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS02LTEtMS0w_52e14dc7-6ce4-4c85-bd98-e90a7eeb57ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b390a8e65e1443bb33e8ab459655c77_I20210630" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS04LTEtMS0w_62cc67d4-4594-4006-9ec1-d729fee9e1b3">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64ece45dfbc249c0a0e2afea4e637eba_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xMC0xLTEtMA_56f216d6-c8bd-420b-814f-091f5909654a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30f3983821e94ff09717ee684cee383a_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xMi0xLTEtMA_2829e7e8-896b-4a76-abd0-1792b437c5a4">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bd0bd6852b45eea2c0896f18f97044_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xNC0xLTEtMA_933469ec-3ae6-4d89-8608-9d21016fcaf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17e39654116145cdb653f9ed90d33e64_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xNi0xLTEtMA_40604561-7805-43cc-9914-01a88cb9357d">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0yLTEtMS0w_b619e184-6f13-4781-952b-cdf1f467e6fd">1,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi00LTEtMS0w_f9f24459-af29-45b4-a893-aeef9b6820c3">3,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi02LTEtMS0w_a68ea0fc-3856-43db-95c3-ff8b492c5aeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi04LTEtMS0w_2c7166f0-bafc-4635-8023-aa7cea25e601">4,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xMC0xLTEtMA_ccc437b1-d185-4a1f-9518-398693efb676">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xMi0xLTEtMA_0ecbd7bb-c6b0-4ee0-9211-f6f636709347">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xNC0xLTEtMA_278ecca0-4229-4d8a-99c7-f71714082f2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if510787ec69a47dab801c3bc8709accf_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xNi0xLTEtMA_55dbc728-80a0-4983-85a0-46cdcb4b6358">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="i8097a507fc364b0bad573079ff802eb0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjY4Mg_5b85102a-7da8-4f57-a914-9c50c2889553">100</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaba58e1397ac49f68fb7f5f0f5837ff0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjY4OQ_7384548d-897c-47ae-ab3c-c9d1627e7855">29</ix:nonFraction> million of other receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMTgxMA_b1675fb1-743f-42bb-9e0d-63c1d6ffa037" continuedAt="i5b0cec9c593c479a850430e31c411342" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5b0cec9c593c479a850430e31c411342"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMTgxNA_4b3f3d27-cf2f-4a4c-888d-daf86216e484" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d0846f2bdb423fad6dde41f494d94d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMi0xLTEtMS0w_b67a574d-a386-4dd7-88b6-a06d3d933758">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib452e1f428b347f39293769ac08d9478_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMi0zLTEtMS0w_1cd7eb08-a267-478d-9a15-bf6d90fa145d">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d0846f2bdb423fad6dde41f494d94d_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMy0xLTEtMS0w_c18d33c2-8d0f-4d2c-bf0d-93bf4c2f5567">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib452e1f428b347f39293769ac08d9478_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMy0zLTEtMS0w_9c04f52f-466c-4722-9071-c59835bc07fc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d0846f2bdb423fad6dde41f494d94d_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNC0xLTEtMS0w_461095bf-7bd7-4d83-8869-0f1e111027ee">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib452e1f428b347f39293769ac08d9478_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNC0zLTEtMS0w_d4bf5852-5fe7-4e97-8eb6-c64be67aebd1">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNS0xLTEtMS0w_317169f7-3207-4645-bca3-9f200da0c4b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNS0zLTEtMS0w_49ccc86e-f8ba-4cc8-8a3a-6bd7c3214d42">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNy0xLTEtMS0w_5ab33f34-738a-4949-be48-1692bba97b40">32,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNy0zLTEtMS0w_f50a2760-558f-4af9-a05e-32631a3fc4ad">26,390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOC0xLTEtMS0w_27d0f292-f9b9-43a0-996a-c25b7ec34aad">709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOC0zLTEtMS0w_c115010a-f605-465a-b839-a927d47c1927">420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOS0xLTEtMS0w_b36e0ca9-ec09-41df-ae30-5fb529183431">31,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOS0zLTEtMS0w_8b670a9d-1ff1-44db-886c-fdf16f53df01">25,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTEtMS0xLTEtMA_f1430385-d2b7-4609-a29d-37f3b4bef06c">24,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTEtMy0xLTEtMA_a35e024f-79f0-450c-be91-3587684f7f3f">20,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTItMS0xLTEtMA_76201872-bb07-401f-a2c6-e8af68083687">6,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTItMy0xLTEtMA_6cb759a6-f97b-41bc-aa40-469ab03b19de">5,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTMtMS0xLTEtMA_048459ea-1e87-4e70-aef3-64109f332751">31,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTMtMy0xLTEtMA_4c22341d-53b8-4e5b-b2ed-1d2a21c621d8">25,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTQtMS0xLTEtMA_e27744d0-fe4f-48eb-ac92-d10f66198bfe">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTQtMy0xLTEtMA_7f047c95-6e1c-44c2-a9ee-0c36788b34fc">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTUtMS0xLTEtMA_3a8c9c8b-0ce9-4fdd-a14f-6332c5583e45">8,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTUtMy0xLTEtMA_47e63926-3150-4b7c-9c74-11dcb57e3aef">7,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTYtMS0xLTEtMA_d1c0b055-ec20-48c8-99b4-7872ef20f6b0">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTYtMy0xLTEtMA_946dba87-ef27-444f-b38c-bc5dcfcd049b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTctMS0xLTEtMA_d0279d83-bd36-4d0e-9569-9e31de2c5a65">8,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTctMy0xLTEtMA_e223c75e-120c-4728-b2a3-99017fcb5268">7,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the six months ended June&#160;30, 2021 and 2020 in the table above exclude (i) $<ix:nonFraction unitRef="usd" contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMjc3_e27744d0-fe4f-48eb-ac92-d10f66198bfe">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMjg0_7f047c95-6e1c-44c2-a9ee-0c36788b34fc">29</ix:nonFraction> million, respectively, related to a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $<ix:nonFraction unitRef="usd" contextRef="icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMzkx_59db69e7-8134-46fe-b8ff-c61658e89570">27</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0152c20c97aa43078a0e9f51783dc116_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMzk4_fda18601-ff7f-45cc-a826-1706c9c10c28">20</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $<ix:nonFraction unitRef="usd" contextRef="i59c04e7fb5d44ae6997958c568ba3a08_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfNjAy_e402c8f2-e035-4dba-a16e-ae33a4478f1b">99</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie92993780db143b7b0e4a20bccee8f39_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfNjA5_8ab52d7e-cd96-43ba-a204-5870d4d1fc99">119</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfODc5_27d0f292-f9b9-43a0-996a-c25b7ec34aad">709</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfODg2_c115010a-f605-465a-b839-a927d47c1927">420</ix:nonFraction> million, respectively, in the six months ended June&#160;30, 2021 and 2020, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMTY1OQ_cf2d7e1e-d4f4-4eed-836e-a4296a4a8ece">6.4</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at June&#160;30, 2021 related to the current year.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_49"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTIxOA_9aa916cc-cd5a-4ace-8d9d-635c12690577" continuedAt="i7ed1cbc21b61421088a29d821567aa49" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7ed1cbc21b61421088a29d821567aa49" continuedAt="i8c5e8e52dc9c4973b3d3e562d75c0385"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2016, CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized the 2016 share repurchase program (&#8220;2016 Repurchase Program&#8221;) for up to&#160;$<ix:nonFraction unitRef="usd" contextRef="ifdec0af0fd9f4f60ab69ce914af06e6a_I20161102" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTk3_bd407786-3911-486e-96d1-0ee17d5ef23f">15.0</ix:nonFraction> billion of the Company&#8217;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021 and 2020, the Company did <ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfNjI4_00d3a8bc-2c4c-494f-b544-faf7475f8363"><ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfNjI4_1a574d54-afa0-46ea-82fe-797d1f426d5f">no</ix:nonFraction></ix:nonFraction>t repurchase any shares of its common stock. At June&#160;30, 2021, the Company had remaining authorization to repurchase an aggregate of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i112799dbf93348fca843c7d691faf8b1_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfNzcy_047b88b1-5ed7-41a1-9241-391f07e45fde">13.9</ix:nonFraction> billion of its common shares under the 2016 Repurchase Program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8c5e8e52dc9c4973b3d3e562d75c0385">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfODk4_05ef578d-880f-43e1-b88a-070820450a49"><ix:nonFraction unitRef="usdPerShare" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfODk4_7e6cfdec-cdab-46ce-9005-e845f82074a7">0.50</ix:nonFraction></ix:nonFraction> per share in each of the three-month periods ended June&#160;30, 2021 and 2020. Cash dividends declared by the Board were $<ix:nonFraction unitRef="usdPerShare" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTA5OTUxMTYyOTIwMQ_e3d874af-3c02-4540-af11-5ecc592f4fb2"><ix:nonFraction unitRef="usdPerShare" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTA5OTUxMTYyOTIwMQ_e4642bd1-e06d-446b-b9ec-460622fbe1a6">1.00</ix:nonFraction></ix:nonFraction> per share in each of the six-month periods ended June&#160;30, 2021 and 2020. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_52"></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RleHRyZWdpb246NjA1ZDJjY2U1ODUzNGRlMDg5MzM2MTg0Y2NmNzUxN2RfNzky_e56c1220-885e-496e-b2a2-88009ce8fef7" continuedAt="i07bf4228c9434001aa7070d226386812" escape="true">Other Comprehensive Income</ix:nonNumeric></span></div><ix:continuation id="i07bf4228c9434001aa7070d226386812" continuedAt="i93899f2a975545b792f19c147f59267b"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RleHRyZWdpb246NjA1ZDJjY2U1ODUzNGRlMDg5MzM2MTg0Y2NmNzUxN2RfNzg0_08fea43d-a357-422f-acb8-7e99beadfc38" continuedAt="i916374ecb67f40ea9beea8553c29ac14" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142f058b8bb74591a7b7633b6055fdb8_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy0xLTEtMS0w_c0643f49-b26e-4761-bda9-61e1456184e0">828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if03a3ed387264a22b8a9acf639af05bf_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy0zLTEtMS0w_981c15c6-7a9d-4b2d-a30c-0cc2615f6aa1">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic645e74bfbdd4334929938f94e38d35a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy01LTEtMS0w_7b90d944-895e-412d-adc2-2f0a5b4b6ea2">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0fedee6ab64c609195f894c49bca7c_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy03LTEtMS0w_a20e3849-aa74-4754-b4bd-d922e59fc5e1">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfMTA5OTUxMTYyNzg4Mg_e3512258-ff05-451f-abf7-a9836cd6bfc2">214</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfNjI_737b158d-cc95-46fc-98b4-723c30989172">681</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfMTA5OTUxMTYyNzg5MA_28cf9740-b36b-4c2a-a185-e1395cc7cb39">273</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfMTA5OTUxMTYyNzg3MQ_5fd2716c-f045-4804-9c35-231edacbcb5d">195</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0xLTEtMS0w_51b99813-2d9e-4a18-a231-b7ed70b8594b">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0zLTEtMS0w_14025d21-0bef-4ebc-8aba-8ff2edf0354f">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC01LTEtMS0w_70edddb1-96cb-43f6-84c0-a55fb76e1c14">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC03LTEtMS0w_d709e55f-0596-49dc-b050-a2a3b2537e71">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfMTA5OTUxMTYyNzg5MQ_9e2a1cdd-abad-4aa9-8af0-d8cd348439a1">18</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfNzc_00802def-649f-4d03-9673-facd4d74cb93">44</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfMTA5OTUxMTYyNzg5Nw_bbf6f922-fb6d-4c84-9826-2e054876f751">1</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfMTA5OTUxMTYyNzg4MQ_42931fc7-fbc2-47cc-bb82-cd20927d58d0">57</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0xLTEtMS0w_af424131-b686-437f-8e9f-3959ac0238cd">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0zLTEtMS0w_bc9ac57a-cf98-4e70-b05c-a6041712982e">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS01LTEtMS0w_750e087f-5f9d-4fc4-8f72-7f0984bcb0e8">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS03LTEtMS0w_f02fa15e-f665-4253-830a-e2703654bdd6">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi0xLTEtMS0w_b5dc0a1e-46b8-4c57-a55b-d478fbc7d2c4">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi0zLTEtMS0w_85a3411c-4f15-42e0-ac20-8519f82e3b2a">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi01LTEtMS0w_fde6bd16-a330-48ee-a556-807a90396713">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi03LTEtMS0w_e10eec23-5838-4136-84ae-27fb3bb3f194">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb18023bf9b4744abf0271e233e621d_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy0xLTEtMS0w_9df26990-d64b-4201-a45d-203074508ecf">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293eeb507694d29b061f167f11864bd_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy0zLTEtMS0w_7dcfdc6f-6912-4a43-aac8-06ba6a2d9cd4">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb18023bf9b4744abf0271e233e621d_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy01LTEtMS0w_b41ce29f-5848-4aa1-a8ca-bc5a45cd2ba1">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia293eeb507694d29b061f167f11864bd_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy03LTEtMS0w_64df47f7-e3cf-445d-985f-9e3313eddda9">987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17321eb57374b8abc46c944d2885a9a_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtMS0xLTEtMA_50b64272-343b-4d4f-b1b4-fd0b7b987ef2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b04b502bb5c4952b90f134d823c69b7_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtMy0xLTEtMA_d0f140d3-c90d-47e1-b9a7-8b72c3212384">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d9fd45dcf3482cacd29cdd9932e790_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtNS0xLTEtMA_c46db3f5-87a0-404a-beb7-4966960df17d">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3220f907b164c859ca1b0dc2c4f6b28_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtNy0xLTEtMA_ea4d7e66-abfb-46cd-be2f-50a7fc93ef87">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abba1f0810f4477917b3b690bc38448_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtMS0xLTEtMA_218b206d-95d0-4bdf-97d1-32019a301e38">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb9417d47fc43f1897e27292ba0ceeb_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtMy0xLTEtMA_f46a2921-3d53-4faf-9c6f-1fe2658b4a24">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07261151d31f426a8232fcb0f14da1ae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtNS0xLTEtMA_e6b3a164-cf95-4054-8ef4-3ea2772caa77">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49a9782f5451439dbac16821699f7854_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtNy0xLTEtMA_cc9aecf3-77d1-4a65-b281-1508ee7839bf">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2abba1f0810f4477917b3b690bc38448_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtMS0xLTEtMA_7ea27047-da15-4981-94e2-33c561601d46">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bb9417d47fc43f1897e27292ba0ceeb_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtMy0xLTEtMA_e99b4016-3efa-4cb9-a3d0-7872a2fc3178">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07261151d31f426a8232fcb0f14da1ae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtNS0xLTEtMA_7ace9e02-ad5c-46b2-9d43-6f74583ec33b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49a9782f5451439dbac16821699f7854_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtNy0xLTEtMA_e6f1a5f4-65ca-42e9-9b49-e10dd49865fe">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd049c214e14e6b8653d68bd8a3e2f0_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtMS0xLTEtMA_7a1623aa-25e3-41c0-b790-4706620a7f87">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bb4c36eb3df4620a92deefe268baac0_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtMy0xLTEtMA_19fc4fa6-2ce7-48e3-adc0-221714cb458c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bd049c214e14e6b8653d68bd8a3e2f0_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtNS0xLTEtMA_cabcf0a7-7324-4c47-a872-66bd23a702ce">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bb4c36eb3df4620a92deefe268baac0_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtNy0xLTEtMA_432e66dd-81e0-4721-a5c7-a83811dad3ea">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5232fdd455f74d7da74de09d354498c3_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctMS0xLTEtMA_cdd14e4b-292a-48f9-9865-7f846ab72bbd">244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75c8fc3eedf24bee8f01fff1c288efc4_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctMy0xLTEtMA_8469129e-62c1-49e8-a501-ad2db1b41a6c">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i834cc5cc64384c53bbdae7fa265c9dc1_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctNS0xLTEtMA_2d1d758d-0434-4d0e-a499-09ca57074db9">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea949437ea7642b58259e785c86e9340_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctNy0xLTEtMA_2a70b0c2-4e82-487b-938b-2b1e7a024013">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4NzQ_244e5e89-0b4b-4188-9584-4c286c1ac667">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ica622595b996421496158a8950271496_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4ODA_068df5b7-4b1f-42a8-a345-50e3b332604e">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4ODY_28dfee99-a196-4e09-93fc-f288d7a01818">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4NjM_bfd059ba-d23d-41ab-9a33-44d07e85edfe">7</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMS0xLTEtMA_117bc586-f2ff-4be3-a7c6-388c1e5dea96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica622595b996421496158a8950271496_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMy0xLTEtMA_8610a336-fd2f-4cee-a0fe-64a24423bbeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtNS0xLTEtMA_b25ca85c-7232-4d38-a6c5-8c6c5fa94e5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtNy0xLTEtMA_d2c4c3b8-efce-4907-9ce4-ff5384e05b88">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzEwOTk1MTE2Mjc4OTE_42616257-ae64-4e0d-9228-84a9d000f269">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="ica622595b996421496158a8950271496_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzc3_ca8c4078-ee36-4e10-b863-103ef7e8ad2c">4</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzEwOTk1MTE2Mjc4OTc_676232c2-2a4b-46eb-baac-864f1aa98d35">9</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzEwOTk1MTE2Mjc4Nzk_3b068e3d-a307-457a-826f-3be6fa8208d4">10</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMS0xLTEtMA_bcca14c7-cb08-4001-b905-6d16e45f1770">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica622595b996421496158a8950271496_D20200401-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMy0xLTEtMA_e4e5029f-14bb-4695-a0b2-ddb1ecd882c3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktNS0xLTEtMA_d2eede0f-329a-401b-abe6-a719cefb2f70">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktNy0xLTEtMA_5ce24f70-eb8f-4a86-b866-173328853927">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtMS0xLTEtMA_55ee5e2c-3312-4b3d-a8db-6fc78601f82b">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica622595b996421496158a8950271496_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtMy0xLTEtMA_f3a6f12d-fc0e-4cc1-a3be-c05fd5cded03">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtNS0xLTEtMA_23f0083e-7528-4898-950c-ab330a3380b1">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtNy0xLTEtMA_c0455cf7-5059-4442-a371-9b6c672e060d">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtMS0xLTEtMA_269a8531-cb0c-4a1a-a959-1c30afd1b052">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb51c1fc52c417391c987b64935b747_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtMy0xLTEtMA_a39ffa55-be9d-4818-a23f-39bc57d91a41">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtNS0xLTEtMA_24ed7ce9-bfe1-420e-b369-75efe78dafcd">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb51c1fc52c417391c987b64935b747_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtNy0xLTEtMA_13f9f3b2-d382-4ab6-8f3e-acb54af66929">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6cde7cf62354c9f90d8f5d1b6beed42_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtMS0xLTEtMA_51eed524-c23c-4f03-898f-a1035bb82d79">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0f1fa309d244561b4d4255b13e72185_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtMy0xLTEtMA_c468aeea-1dca-440e-bf65-8a01c9d85110">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1728a5a6a3242af80ab519ee500c71c_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtNS0xLTEtMA_672eb289-33a6-4cf4-897e-69bb1a9f004e">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7aff438e903c4976a85160658a6e3ebc_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtNy0xLTEtMA_2b320d63-70bc-4f65-b534-e235df5ea1ea">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc5MDg_a33c1bc5-f729-4f07-9373-8460b2c67bdd">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc4NjQ_8db42a90-3c4b-4a5d-b289-9e455e57df47">8</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc5MTQ_b253405a-7da3-4c80-bc15-c98d9c58b156">0</ix:nonFraction>, and $(<ix:nonFraction unitRef="usd" contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc4OTg_b46b4339-34c9-4e0e-a79e-453ad0e50dbf">8</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMS0xLTEtMA_3296ae1a-ec60-444c-8a4c-1b82b87b58c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMy0xLTEtMA_82b92aa6-6d63-471b-82d8-681d43e6bece">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtNS0xLTEtMA_6c5f6ced-b0cf-4259-98f3-e031ce311c97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtNy0xLTEtMA_e6c066b9-414b-4f3e-898b-da2d49410320">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4ODc_c4ef82df-62cb-4e0d-b628-d1693a1bef75">1</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4Njg_1afee91a-01de-44c6-b3a2-861e118de17a">7</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4OTM_98d09799-0e14-422a-a331-6b908384fe12">1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4Nzk_1f9e2d52-9b08-4350-b615-f1d0b2fed432">7</ix:nonFraction> pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMS0xLTEtMA_ab084e46-e38a-4897-8068-02e6a1d4a0a5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMy0xLTEtMA_860a9f25-cd53-477c-a623-84a241e96ee8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtNS0xLTEtMA_7fc53059-4e09-42dd-92da-b5fef211686c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtNy0xLTEtMA_7d367583-2b9c-4108-b6a6-2d1a9e353bf0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctMS0xLTEtMA_2505ab65-3ba5-4c7e-b3aa-49b5030f4510">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctMy0xLTEtMA_d6434aed-6da3-4e43-8d68-19a0b7f518f6">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctNS0xLTEtMA_de7b6a05-5271-4722-b154-debedc6c7575">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctNy0xLTEtMA_667f00a5-9f79-4771-9992-26206246187d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ccd57de85dc4077979b39a24f44206e_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtMS0xLTEtMA_bd5071f4-b69b-46f3-b3c9-87769aa59050">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da72faaf2b4475f838efca9f0889b65_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtMy0xLTEtMA_9a6c0415-104d-454d-85b9-7f9431ffef8e">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ccd57de85dc4077979b39a24f44206e_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtNS0xLTEtMA_a043388c-5b8d-4012-940a-89f8682b8b92">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3da72faaf2b4475f838efca9f0889b65_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtNy0xLTEtMA_b470ba02-17b4-4dce-a221-8d2d57e50879">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2f056bb44964d78b883cc1b11fb04a6_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtMS0xLTEtMA_dd097b97-ce17-42c7-a116-5f0bacb96afc">1,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70240851d9624b2b833aff8775606301_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtMy0xLTEtMA_e4a709b4-189c-4c0c-9786-0d04cea9e483">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e9af44465864c999326af45d83b0a2a_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtNS0xLTEtMA_0ce796aa-2d68-4055-a776-7ef0c977e0ad">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34955bacc9344a75bd20cc975c6d72dd_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtNy0xLTEtMA_8f831e01-67ba-4a6a-ae47-310ef8ccca71">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtMS0xLTEtMA_e2177e77-fb97-45b4-a490-149d1a656960">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtMy0xLTEtMA_24cb9152-6336-4207-86e3-3121489e6c3a">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtNS0xLTEtMA_b5336e3f-93b3-4bb9-a74a-8b5e0444fccd">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtNy0xLTEtMA_6cf57901-c0f0-4b39-9e36-79e0ecc0bd16">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b0c7405c7a44354a5b01c38a42318c7_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItMS0xLTEtMA_5686015d-e962-4c4b-8261-40ab26dd9378">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699e98c5cf6e484bb4ad38af546870e1_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItMy0xLTEtMA_059f2c3d-aa6d-4a4f-9236-cc770cde969f">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b0c7405c7a44354a5b01c38a42318c7_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItNS0xLTEtMA_4a73a9ab-545f-4c3d-b5af-b2f48f138b60">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i699e98c5cf6e484bb4ad38af546870e1_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItNy0xLTEtMA_f86d0e92-d18e-46bf-96a2-7315f16e8333">1,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RleHRyZWdpb246NjA1ZDJjY2U1ODUzNGRlMDg5MzM2MTg0Y2NmNzUxN2RfNjcw_11e82751-7fe9-43e8-b9b6-4b14bfede10b">13</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i93899f2a975545b792f19c147f59267b" continuedAt="id27800a502b34667aef373fd6a2917f6"><ix:continuation id="i916374ecb67f40ea9beea8553c29ac14" continuedAt="id481434b26e049e185a5605237751f02">(3)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="id27800a502b34667aef373fd6a2917f6"><ix:continuation id="id481434b26e049e185a5605237751f02">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</ix:continuation></ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfNTQy_9b718e52-ed5a-46d7-9793-fb9290a4c4ff" continuedAt="if230f6f398f749c5ba8f3d909c5903e7" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if230f6f398f749c5ba8f3d909c5903e7"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase <ix:nonFraction unitRef="shares" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMTM1_29badf54-10d6-4b7c-ade3-e7c500fad82f">8</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMjE5OTAyMzI1NjQwNA_697819d6-1387-498f-899c-76f193b0b99e">9</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2021, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.  For the same reason, stock appreciation rights and options to purchase <ix:nonFraction unitRef="shares" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMjE5OTAyMzI1NjM5Mg_4211ac69-c41e-4ee1-b0fe-bc26f0aabdad">17</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMjE5OTAyMzI1NjM5OQ_e35a65d8-e981-4acd-a2cb-31764f387595">15</ix:nonFraction> million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2020, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfNTg2_70cbec49-2bc1-4b85-b287-cda1d6843741" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi0xLTEtMS0w_15fb29ed-d04b-4ce7-b541-108c482b72a8">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi0zLTEtMS0w_9e4778e5-9df7-4db0-a7cb-c8d32faa0ef5">2,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi01LTEtMS0w_bed357d9-1e4d-4535-abed-8931bdb7bdec">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi03LTEtMS0w_68018c52-4a64-4e7d-83c9-fdcadb6ef96d">4,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS0xLTEtMS0w_bc107ec3-c42b-4663-81b5-91ef64fe7ab2">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS0zLTEtMS0w_7d781cbe-27b0-41f9-8e1a-9c4247883a02">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS01LTEtMS0w_2a638b23-079c-4989-9da1-ad726bdb2e28">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS03LTEtMS0w_52eeca50-599a-4b94-ad18-ffbee93ae56c">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtMS0xLTEtMA_c4cd104d-6f7a-44b0-9376-20e382edf358">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtMy0xLTEtMA_e68f5c7a-8478-4486-8d17-2e7acb07a643">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtNS0xLTEtMA_fd26252d-d56f-496b-88d1-8b714c3a37fe">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtNy0xLTEtMA_7e4a877d-0e5e-465e-9c27-f21721e6b316">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtMS0xLTEtMA_09c5700d-b163-4906-907b-6497c55a7a70">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtMy0xLTEtMA_585a11b9-388b-4398-b35c-a464fa5cbb29">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtNS0xLTEtMA_e79d023d-fce9-4b43-9f1d-4b6d71fc369e">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtNy0xLTEtMA_c5d36d97-4e4e-4d06-ba76-a061d994560e">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtMS0xLTEtMA_60a0b7ee-9b59-4680-969e-bd7afa65cdc4">2.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtMy0xLTEtMA_31acf0b4-604b-48f2-a9b5-34591996a3dc">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtNS0xLTEtMA_1bb54b1b-7d87-4760-8b27-82b44659586b">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtNy0xLTEtMA_763b0e1c-35d4-48f0-9908-93924808af1b">3.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtMS0xLTEtMA_52d20699-b6a3-4505-824f-4cc07433d232">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtMy0xLTEtMA_2be2c368-8ca6-4d08-9d7a-784a83c5b7c4">2.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtNS0xLTEtMA_e8347739-4d33-4dc1-818d-c635e6c68968">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtNy0xLTEtMA_029899c6-15cb-46b1-a9c7-71b2a97acd2e">3.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_58"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMjc4MzU_3fe9f8c3-8336-46cf-8e58-686fa8e7b8e1" continuedAt="i111b9af8b4ba45d7b45e955da10c590f" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i111b9af8b4ba45d7b45e955da10c590f" continuedAt="i1a517494e177446f8b7ac9ac96023ee7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of June&#160;30, 2021, the Company guaranteed <ix:nonFraction unitRef="store" contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630" decimals="INF" name="cvs:GuarantorObligationsNumberofLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMjAxNA_a0e2c0a0-afc9-42da-8a93-887564b70ce9">73</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1a517494e177446f8b7ac9ac96023ee7" continuedAt="i277e119583b6412e9242075763f4bf88"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), state insurance and health and welfare departments, state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i277e119583b6412e9242075763f4bf88" continuedAt="i08fbb4399397428b97f8a3a45f8cb551"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In June 2021, prior to the start of the New York State Court bellwether trial, the Company reached a settlement with Nassau and Suffolk Counties for an immaterial amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the U.S. Department of Justice (the &#8220;DOJ&#8221;) served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been providing documents and information in response to this subpoena.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i08fbb4399397428b97f8a3a45f8cb551" continuedAt="i50077d3a159842179bf93ee3f1726ba3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;HHS-OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately <ix:nonFraction unitRef="member" contextRef="i70b16429cf7d4b5ebba7b368990673d2_D20120101-20121231" decimals="-2" name="cvs:LossContingencyAuditMethodologySampleSize" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMTc5Njc_59090da9-f4b3-4121-a6f7-ce7cb1a5f2d2">200</ix:nonFraction> members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i50077d3a159842179bf93ee3f1726ba3" continuedAt="ifea582f58850418ab5e67b530204d503"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involved, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. In June 2021, the government withdrew this CID and indicated that no further action is required from the Company with respect to the April 2020 CID. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), was dismissed with prejudice in February 2021. Plaintiffs filed a notice of appeal with the First Circuit after their motion for reconsideration was denied. The Company has moved to dismiss the other federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). In March 2021, the New York Supreme Court, Appellate Division (First Department) dismissed the consolidated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Labourers&#8217; Pension Fund of Central &amp; Eastern Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> case; plaintiffs&#8217; motion for reargument was denied and this matter is now concluded. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, <ix:nonFraction unitRef="claim" contextRef="i001dccf76afc4c24992b25b72dcb6e28_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMjIwNTg_7d801cec-84af-4bb6-bc2d-62dc236092ef">two</ix:nonFraction> ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#8220;Aetna&#8221;), and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifea582f58850418ab5e67b530204d503"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div></ix:continuation><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_61"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMjMyNA_7ec0dcd0-03b9-4c0b-8e93-88db5b6fa7ed" continuedAt="ie34c49459c94422daa632135f2fb44b0" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie34c49459c94422daa632135f2fb44b0" continuedAt="i9e4b5ab632ef4384a6999749abc3438c">The Company has <ix:nonFraction unitRef="segment" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfNDE_48dc462e-90d0-4cf7-8c6f-800508b28663">three</ix:nonFraction> operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. </ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9e4b5ab632ef4384a6999749abc3438c" continuedAt="ic2b981fd84cd4400ba7cad68d68dfb1b"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMjMyMA_e1c5054d-881b-4f9d-8416-f4d155416c4b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy0xLTEtMS0w_8d55df3d-384c-439c-b700-a29dc9be84a9">20,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy0zLTEtMS0w_356950f2-129f-46b5-800e-111f2f5c33ab">35,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy01LTEtMS0w_5709286b-393f-44c5-a604-3dd23e065b55">16,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy03LTEtMS0w_5fbf6c6c-135b-4535-aefa-407dff485004">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy0xMS0xLTEtMA_699b5a44-a30a-4608-8866-0397ec150f01">72,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia726d6239ffd4749b438a44af233681b_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC0xLTEtMS0w_af2ff859-2589-4128-a16e-139ea24dc3c9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieddd6943d58948fca9da637d49a68e16_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC0zLTEtMS0w_d6f6ba59-0545-44fb-8b8a-9b71a791bed2">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i622f60133e0f447ba5a9b36b96bae65d_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC01LTEtMS0w_018de17c-b7a3-4fb4-86c7-317a0ee53616">8,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC05LTEtMS0w_3b7c281b-eb9d-440d-9b07-d85d24ec3b4e">11,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS0xLTEtMS0w_5ac72232-33cc-4c53-9197-c421d0ff76c3">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS0zLTEtMS0w_7edff7b7-ae5c-414e-93af-06f62bae570e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS01LTEtMS0w_e879954a-98fc-4052-96f5-b9da631118fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS03LTEtMS0w_b169da7b-18c5-45a9-8fa9-1e018e0ff63d">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS05LTEtMS0w_12960994-319d-4283-9d40-5e871df73978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS0xMS0xLTEtMA_b043e3c6-cec2-432b-83c0-04fd2159c3ad">289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb82e1b7ebd4c54be9d1622a6b266a3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi0xLTEtMS0w_f046f747-4b0e-43f0-bb82-3f431bc2e944">20,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13fec49e4db045d598a854e6be36041f_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi0zLTEtMS0w_2761e61a-3668-493f-b0f2-e56d3485bf11">38,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i468fcff0a66441fbad1b998c36682c15_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi01LTEtMS0w_dcc4118a-daf5-423a-a1ba-88f161c6686e">24,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi03LTEtMS0w_680b9151-720a-40ba-99b4-37c525083c37">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi05LTEtMS0w_38749f12-5f60-441f-8434-328706d7e648">11,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi0xMS0xLTEtMA_933d8347-e2b6-411b-bee1-ba858cda901f">72,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy0xLTEtMS0w_f87d48dc-28b3-4ee9-901f-1fb01a3380d5">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy0zLTEtMS0w_4f06035d-5740-432b-949d-8484c54ab9cc">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy01LTEtMS0w_ebb86a5b-b841-4070-a39d-37594c51ca5d">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy03LTEtMS0w_826c6f24-1709-4612-8e21-aafcf5342350">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy05LTEtMS0w_5c55ca79-c04e-4946-84ac-34971cd2815d">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy0xMS0xLTEtMA_d4275774-6391-4271-948d-da09c6e4b747">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtMS0xLTEtMA_823039f6-9eb2-4062-bd70-c2c387a15eee">18,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtMy0xLTEtMA_c2bf793e-c77c-4da3-a9e8-0438c60b99f9">32,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtNS0xLTEtMA_06c56568-4b37-411f-8698-eba9a1adb7e4">14,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtNy0xLTEtMA_32e5d994-cade-448d-9f24-a919f04937cb">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtMTEtMS0xLTA_e65c662e-aec0-40dd-abbf-f1cc7b4be835">65,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11782f1722a4ab1a431f51a8b8bb767_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtMS0xLTEtMA_24cca750-6919-43aa-a666-af618ba235e7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fba9e2c34f44e5ca1e106a2a73285b1_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtMy0xLTEtMA_8d73a186-832f-465b-9035-8e990b028eaf">2,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb80760bed64a4ea52ff1222cfcd13d_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtNS0xLTEtMA_8a31c35d-f171-4570-8d12-58542187b588">7,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtOS0xLTEtMA_f744c8cc-2344-48b2-82ea-553f4d166ee5">9,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItMS0xLTEtMA_547cd718-c728-4528-828d-1bd5f42e47ee">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItMy0xLTEtMA_26b6cc8d-bab6-418b-8838-59e8f586f37a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItNS0xLTEtMA_46f4dbef-bee7-4164-a86a-5d7f36d69788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItNy0xLTEtMA_5386f1e1-05a7-4a43-91dc-7e0a45565945">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItOS0xLTEtMA_7f91bfa3-29b0-438e-93fc-34c667541e59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItMTEtMS0xLTA_4fb57558-5935-4984-a34c-0509e554a102">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5662cc7cd70b4808b16a82e9bc2161b4_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtMS0xLTEtMA_1d575487-a4c9-497b-a313-7bddd3571d63">18,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0ccf7e987345a8a9c4f161c072bb04_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtMy0xLTEtMA_c11199ff-5b77-4a67-91f5-e9cce64c4d5b">34,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563c6cc59100449cb1b087e6d683b97b_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtNS0xLTEtMA_d24ec04c-307c-4d1a-9440-cddea3e5017e">21,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtNy0xLTEtMA_90ea9821-f384-476c-965d-ec65c1fc82a2">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtOS0xLTEtMA_5ba9213e-cf44-4217-8327-729b437185c4">9,764</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtMTEtMS0xLTA_68b4486f-4e9c-4f27-b2d6-5237125546dd">65,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtMS0xLTEtMA_8e1f145d-c9ef-48f7-af9e-eea65d0f83f1">3,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtMy0xLTEtMA_8b4dfcd5-29f9-4140-a83f-7b948f87773d">1,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtNS0xLTEtMA_10bf30d0-2553-468c-afb7-be5785372bcd">1,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtNy0xLTEtMA_eafa5f7a-3784-4a94-8bba-8a57a5b8df30">343</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtOS0xLTEtMA_2ac6c5bf-4a35-466d-b67c-e1f4fc7cf1cc">177</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtMTEtMS0xLTA_e28719cd-ac52-4bdc-8bf4-a9c5643a0369">5,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtMS0xLTEtMjMx_92d379fa-29bf-4636-8fc9-83ea80623334">40,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtMy0xLTEtMA_c64db17e-bcdb-4809-a34b-31a291314218">69,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtNS0xLTEtMA_3de4ba85-d15f-42a2-83b7-070b302365db">31,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtNy0xLTEtMA_b6ac51eb-5b43-45fe-b2bc-208a3475ebc2">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtMTEtMS0xLTA_b7471d73-9e27-4bab-acc9-e4532a61eae4">141,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d1e96563e740f186d85a4df1469291_D20210101-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktMS0xLTEtMjMx_556f2c12-fce4-40ba-a779-117c8b144f13">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23673f3bf56a41a982c19211f550e038_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktMy0xLTEtMA_1177a827-bebd-4214-addb-e3c00d47abe0">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i259c3a6a85d34cad9bb1f18eb7f79a6a_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktNS0xLTEtMA_140ddf7a-3ee9-4359-b342-0dc9d5c1e4f0">16,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktOS0xLTEtMA_65a4ed58-9dd4-4525-9ebb-5da852df450f">22,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtMS0xLTEtMjMx_a603abd1-0ac7-49cd-9181-c53409257817">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtMy0xLTEtMA_2471cc58-b1ad-461c-ae43-dd210af699b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtNS0xLTEtMA_ed5e3f3f-05d7-4415-b8c2-cae3741cbbdf">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtNy0xLTEtMA_0e1aef48-5ee1-45c9-afb3-ae7a08393535">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtOS0xLTEtMA_b5a5415a-07ce-42c6-9f29-1ad2a03f3af6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtMTEtMS0xLTA_6e4aeb3b-ea29-4421-b0cb-2ff0c1eaecdb">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtMS0xLTEtMjMx_4e28a24f-0340-476f-817c-e4998516c3d5">41,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdd42d2ed15e435daff26e80bcb970ea_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtMy0xLTEtMA_0c73819e-006d-4048-bdf5-7fbb6e82cd84">74,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71be5af836584a6eac396f68bf46ee96_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtNS0xLTEtMA_2a6e78ad-dea6-49be-b365-5b2085700904">48,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtNy0xLTEtMA_b534c25e-ba53-4d65-9027-d45225211978">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtOS0xLTEtMA_6790c7d3-71dc-4146-ad4a-b1fc564967b8">22,249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtMTEtMS0xLTA_ef07fdb9-a264-47c5-9567-e6c93de81e7a">141,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItMS0xLTEtMjM1_6715d797-af3c-4f32-8dad-dcc73aab1040">3,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItMy0xLTEtMA_9cfa4a13-23de-4f98-8611-2735db4045c0">3,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItNS0xLTEtMA_7dea62b2-29e3-4ca6-984c-88cf8b9e54b3">3,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItNy0xLTEtMA_27d02a2c-c705-4724-b4db-73df03d82857">672</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItOS0xLTEtMA_0382d243-5ece-4753-aa42-be4b7447700b">337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItMTEtMS0xLTA_3e01635b-0050-45b6-8d37-b25078a9d326">9,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtMS0xLTEtMjM5_e4aa2fbd-7a46-4fcb-9c50-285bec643c36">37,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtMy0xLTEtMA_5e669bc2-1b64-49b7-9a85-a81b9939e4ba">64,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtNS0xLTEtMA_257f58b6-4cad-40c0-be58-407c919a5bcf">29,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtNy0xLTEtMA_d604b63b-d0b0-42a2-acf2-63561f4b0785">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtMTEtMS0xLTA_1e212907-0e89-4d0e-b43c-9301bffcb1f2">131,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5e6d1bf7764728ba7479982f03642e_D20200101-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtMS0xLTEtMjM5_63638045-3f0c-46ff-a5f2-46e0e9de9b02">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63c7a1d3118640968e9a75f187d6b40b_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtMy0xLTEtMA_e66123c1-f78b-4236-a00b-9eada1beb372">5,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93fdab396b0143ccba07019b56d386ec_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtNS0xLTEtMA_fee5ef9f-b95c-4c60-aa21-a698b339ee5d">14,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtOS0xLTEtMA_cb5659d7-b564-4086-bbae-9e928bef4dea">20,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctMS0xLTEtMjM5_f9751291-8c76-4be1-973e-6cc173e849a6">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctMy0xLTEtMA_2bed7200-9676-4059-9537-ce5f94e6a4bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctNS0xLTEtMA_bd314a35-bff4-42b6-acb9-8dd3f5d280e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctNy0xLTEtMA_dfdfff80-3e21-4d02-b947-e032b6b65f5a">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctOS0xLTEtMA_29828dbd-4697-4df0-9453-c688cf53fb16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctMTEtMS0xLTA_452a6af6-cd43-40e7-a17d-a7324179d2d9">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0152c20c97aa43078a0e9f51783dc116_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtMS0xLTEtMjM5_dcb423fa-de9e-407b-8953-2940c5820e31">37,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd6ea18260343fe8d826574d00c787b_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtMy0xLTEtMA_f8e32635-5f02-420e-91c9-ff46bcda90fe">69,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c5177a6cd544aea90d592c291b5439_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtNS0xLTEtMA_b4a4153d-3222-4940-a43b-33e1fd8ffaf2">44,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtNy0xLTEtMA_9e511070-b7db-4196-b2d9-85b2ca26c9bc">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtOS0xLTEtMA_d36b49ee-03b5-493c-976f-e0260af9047e">20,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtMTEtMS0xLTA_f9939836-62a4-4acd-abf1-e46141784cdc">132,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktMS0xLTEtMjM5_a4130830-4014-496c-bac4-5d6b152159eb">4,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktMy0xLTEtMA_3f363d83-df56-439a-8015-e531bbac249e">2,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktNS0xLTEtMA_6577d2e6-6c03-431e-a0d9-5151bbfcc660">2,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktNy0xLTEtMA_9097db10-0b11-4e92-9cc6-93f8fc44162c">628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktOS0xLTEtMA_22bbd158-0cf0-4791-904e-b3831669cb7f">353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktMTEtMS0xLTA_2a3ba67c-a3b6-44c6-b9e5-b046ac51dc3f">9,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTczOQ_f59b8881-0589-4576-8453-e97cc911f026">2.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTA5OTUxMTYzMDI1Mg_d305e4c8-80b2-4fd0-857d-20387fdedc16">2.6</ix:nonFraction> billion of retail co-payments for the three months ended  June&#160;30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTA5OTUxMTYzMDI3NQ_3253c095-1096-46f8-bd3f-9d44d1f080ad">6.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630" decimals="-8" format="ixt:numdotdecimal" name="cvs:NetRevenuesRetailCoPayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTA5OTUxMTYzMDI2Nw_13b0ab02-f5cb-4145-88c6-148e987799b3">6.0</ix:nonFraction> billion of retail co-payments for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic2b981fd84cd4400ba7cad68d68dfb1b" continuedAt="ieb2c20f84ae64a9585ea0e26fd7d7b22"><ix:nonNumeric contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMjMxNQ_6986c1d4-69ac-4c9c-80c7-45a7662bfbbf" continuedAt="i8149acc569f7411980c7064b1c5f639d" escape="true"><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi0xLTEtMS0w_b8764cba-728e-4bd6-a4aa-c1a55a7dd402">4,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi0zLTEtMS0w_2363ec44-2b60-4d1f-8e4a-b3f3157d42dd">4,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi01LTEtMS0w_81c277bd-5c00-49f9-a6c1-39a7cd1a5385">7,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi03LTEtMS0w_e42b8e3f-5048-4e6b-be00-93053e0e95bb">8,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy0xLTEtMS0w_219e1703-fbc3-4333-8169-813481d1fa81">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy0zLTEtMS0w_65afdb7f-e4ec-4fe0-9709-0b837e766c60">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy01LTEtMS0w_a68cc518-2d07-4d9f-9e72-aa25e120e88b">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy03LTEtMS0w_f3049a17-933b-4591-b74e-9e24be59b0c8">1,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC0xLTEtMS0w_b6507a39-aba5-4ea2-bf9e-245cb7965df2">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC0zLTEtMS0w_6654a1d3-fb10-4d2c-9ccd-2834749c20b5">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC01LTEtMS0w_462fb5ef-8e71-4f47-8667-f5344546344f">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC03LTEtMS0w_eb392d1f-845c-422e-895e-c635c4fe52f2">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS0xLTEtMS0w_a1cabf1d-b415-4858-a773-b281f3c93a62">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS0zLTEtMS0w_77d98143-3c8a-4eb5-81b6-96b6fbdb98c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS01LTEtMS0w_e8b5de3b-e6a9-42f3-9c0a-429d1482c10f">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS03LTEtMS0w_ea76b8a1-509d-430d-a6a5-50bcf2775961">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy0xLTEtMS0w_d4275774-6391-4271-948d-da09c6e4b747">4,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy0zLTEtMS0w_e28719cd-ac52-4bdc-8bf4-a9c5643a0369">5,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy01LTEtMS0w_3e01635b-0050-45b6-8d37-b25078a9d326">9,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy03LTEtMS0w_2a3ba67c-a3b6-44c6-b9e5-b046ac51dc3f">9,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ieb2c20f84ae64a9585ea0e26fd7d7b22" continuedAt="ieff5402e96e44b96b1cc4a0593fb4705"><ix:continuation id="i8149acc569f7411980c7064b1c5f639d" continuedAt="i14e0b18acd4e47a6a28e096554277a5f">(3)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ieff5402e96e44b96b1cc4a0593fb4705"><ix:continuation id="i14e0b18acd4e47a6a28e096554277a5f">In June 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="i7592f4455e574a298526d9bc23a5566b_D20210601-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTY0OTI2NzQ0NTc5MQ_83ccec36-9b41-4c40-b5cb-9c75cc7b2096">61</ix:nonFraction>&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</ix:continuation></ix:continuation> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_13">Index to Condensed Consolidated Financial Statements</a></span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Review of Interim Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed the accompanying condensed consolidated balance sheet of CVS Health Corporation (the Company) as of June&#160;30, 2021, the related condensed consolidated statements of operations and comprehensive income for the three-month and six-month periods ended June&#160;30, 2021 and 2020, the related condensed consolidated statements of shareholders&#8217; equity for the three-month periods ended March&#160;31, 2021 and 2020 and June&#160;30, 2021 and 2020, the related condensed consolidated statements of cash flows for the six-month periods ended June&#160;30, 2021 and 2020, and the related notes (collectively referred to as the &#8220;condensed consolidated interim financial statements&#8221;). Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December&#160;31, 2020,  the related consolidated statements of operations, comprehensive income (loss), shareholders&#8217; equity and cash flows for the year then ended, and the related notes (not presented herein); and in our report dated February 16, 2021, we expressed an unqualified audit opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December&#160;31, 2020, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Review Results</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These financial statements are the responsibility of the Company&#8217;s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the SEC and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;4, 2021</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;)</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a diversified health services company united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 108 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services, and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Overview of the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and Covered Entities. The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, coronavirus disease 2019 (&#8220;COVID-19&#8221;) and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Current Trends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face trends and uncertainties specific to our reportable segments, certain of which are summarized below and also discussed in the review of our segment results. For the remainder of the year, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic continues to impact the economies of the U.S. and other countries around the world. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic, as well as the pandemic&#8217;s impact on the U.S. and global economies, consumer behavior and health care utilization patterns. In addition, as described in the &#8220;Government Regulation&#8221; section of the 2020 Form 10-K, federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 may not effectively combat the severity and/or duration of the COVID-19 pandemic, and have resulted in a myriad of impacts on our businesses. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. Specific COVID-19 related impacts on the Company during the three and six months ended June 30, 2021 and 2020 are further described below. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to experience lower Medicare risk adjustment revenue and modestly elevated medical costs for the remainder of the year, with non-COVID-19 related utilization returning towards baseline levels and continued COVID-19 related costs, largely related to treatment, testing and the administration of the vaccine. The Company also expects to incur higher operating expenses during the fourth quarter related to investments to support future growth and readiness for the start of the 2022 plan year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment is expected to continue to benefit from our ability to drive improvements in purchasing economics and growth in specialty pharmacy, albeit at a slower pace than experienced in the first half of the year, partially offset by continued price compression. We expect year-over-year growth to moderate in the remainder of the year due to operating results in the second half of 2020 reflecting the benefit of the launch of our group purchasing organization entity  and specialty generic launches. The Company also expects to incur higher operating expenses during the fourth quarter related to investments to enhance operations, digital and clinical trials capabilities and readiness for the start of the 2022 plan year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment is expected to continue to benefit from increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure. While COVID-19 diagnostic testing and vaccinations are expected to continue for the remainder of 2021, we expect vaccinations to slow in the second half of the year. The extent of COVID-19 vaccinations and diagnostic testing will be dependent upon various factors including vaccine hesitancy, the emergence of new variants and the availability and administration of pediatric and booster vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to continue to benefit from its cost savings initiatives, including ongoing digitalization and technology improvements, a reduction in non-retail real estate associated with workforce management changes and initiatives to increase productivity and operational efficiency. The Company also expects incremental investments in wages, including an increase in the minimum wage for store, warehouse and call center colleagues in support of its initiatives to retain and attract talent for its community health destinations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Results</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion explains the material changes in the Company&#8217;s operating results for the three and six months ended June&#160;30, 2021 and 2020, and the significant developments affecting the Company&#8217;s financial condition since December&#160;31, 2020. We strongly recommend that you read our audited consolidated financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, which are included in the 2020 Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">46,355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">97,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">93,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">18,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">16,927&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">34,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,272&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,341&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">132,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,617&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">40,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">80,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">11,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">31,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">26,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">133,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">123,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,138&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(225)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">27.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,975&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $7.3 billion, or 11.1%, in the three months ended June&#160;30, 2021 compared to the prior year driven by growth across all segments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $201 million, or 2.3%, in the three months ended June&#160;30, 2021 compared to the prior year. The increase in operating expenses was primarily due to incremental costs associated with growth in the business, including costs associated with COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment. The increase was partially offset by the repeal of the HIF for 2021, the favorable impact of company-wide cost savings initiatives in 2021 and a $137&#160;million gain from an anti-trust legal settlement, of which $125&#160;million was included in the Retail/LTC segment and $12&#160;million was included in the Pharmacy Services segment in the three months ended June&#160;30, 2021. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues were 12.2% in the three months ended June&#160;30, 2021, a decrease of 110 basis points compared to the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $354 million, or 7.6%, in the three months ended June&#160;30, 2021 compared to the prior year primarily due to the return of more normalized utilization levels in the Health Care Benefits segment following a significant decrease in utilization during the three months ended June&#160;30, 2020 due to the COVID-19 pandemic. The decrease in operating income in the three months ended June&#160;30, 2021 was partially offset by increased prescription and front store volume, COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment as well as improved purchasing economics and increased pharmacy claims volume in the Pharmacy Services segment during the three months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $129 million, or 16.9%, in the three months ended June&#160;30, 2021 compared to the prior year due to lower debt in the three months ended June&#160;30, 2021. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate was 25.3% for the three months ended June&#160;30, 2021 compared to 24.6% for the three months ended June&#160;30, 2020. The increase in the effective income tax rate in the three months ended June&#160;30, 2021 was primarily due to the absence of the favorable impact associated with the resolution of several state and local income tax matters in the three months ended June&#160;30, 2020, partially offset by the repeal of the non-deductible HIF for 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $9.6 billion, or 7.3%, in the six months ended June&#160;30, 2021 compared to the prior year driven by growth across all segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the revenues of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $560 million, or 3.2%, in the six months ended June&#160;30, 2021 compared to the prior year. The increase in operating expenses was primarily due to incremental costs associated with growth in the business, including costs associated with COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment. The increase was partially offset by the repeal of the HIF for 2021 and the favorable impact of company-wide cost savings initiatives in 2021. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues were 12.6% in the six months ended June&#160;30, 2021, a decrease of 40 basis points compared to the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues described above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $235 million, or 2.9%, in the six months ended June&#160;30, 2021 compared to the prior year. The decrease in operating income was primarily driven by the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the six months ended June&#160;30, 2020 in the Health Care Benefits segment. The decrease was partially offset by improved purchasing economics in the Pharmacy Services segment and COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment in the six months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this report for additional information about the operating results of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $205 million, or 13.7%, in the six months ended June&#160;30, 2021 compared to the prior year due to lower debt in the six months ended June&#160;30, 2021. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate was 25.2% for the six months ended June&#160;30, 2021 compared to 25.8% for the six months ended June&#160;30, 2020. The decrease in the effective income tax rate in the six months ended June&#160;30, 2021 was primarily due to the repeal of the non-deductible HIF for 2021, partially offset by the absence of the favorable impact associated with the resolution of several state and local income tax matters in the six months ended June&#160;30, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 9 &#8216;&#8216;Segment Reporting&#8217;&#8217; to the unaudited condensed consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.6 billion of retail co-payments for the three months ended  June&#160;30, 2021 and 2020, respectively, and $6.2 billion and $6.0 billion of retail co-payments for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income, as well as reconciliations of segment GAAP operating income to segment adjusted operating income:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="margin-bottom:0.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.163%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss) </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span><br/></span></div><div style="margin-bottom:0.3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:31.792%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.325%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,161&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June&#160;30, 2021 and 2020, acquisition-related integration costs relate to the Company&#8217;s acquisition (the &#8220;Aetna Acquisition&#8221;) of Aetna Inc. (&#8220;Aetna&#8221;). The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.949%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,968</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,913</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,910</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,534</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,468</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,666</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,954</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,884</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,711</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,400</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,380</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,644</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,105</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,161</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,793)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,508)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,850)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,559)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,897</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,976</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,445</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,071</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,937</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,096</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,089</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Health Care Benefits segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2021 vs. 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $2.1 billion, or 11.1%, to $20.5 billion in the three months ended June&#160;30, 2021 compared to the prior year primarily driven by growth in the Government Services business, partially offset by the unfavorable impact of the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR increased from 70.3% to 84.1% in the three months ended June&#160;30, 2021 compared to the prior year primarily driven by the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the three months ended June&#160;30, 2020 and the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $220 million, or 6.3%, in the three months ended June&#160;30, 2021 compared to the prior year. The decrease in operating expenses was primarily due to the repeal of the HIF for 2021, the impact of cost savings initiatives in the three months ended June&#160;30, 2021 and the receipt of a $61&#160;million purchase price working capital adjustment subsequent to the acquisition accounting measurement period related to an acquisition completed during the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">first quarter of 2020, which was recorded as a reduction in operating expenses in the three months ended June&#160;30, 2021. These decreases were partially offset by incremental operating expenses to support the growth in the Government Services business described above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 16.1% in the three months ended June&#160;30, 2021 compared to 19.0% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $1.9 billion, or 53.4% in the three months ended June&#160;30, 2021 compared to the prior year. The decrease in adjusted operating income was primarily driven by the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the three months ended June&#160;30, 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June 30, 2021 vs. 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.3 billion, or 8.9%, to $41.0 billion in the six months ended  June&#160;30, 2021 compared to the prior year primarily driven by growth in the Government Services business, partially offset by the unfavorable impact of the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR increased from 76.4% to 83.6% in the six months ended June&#160;30, 2021 compared to the prior year primarily driven by the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the six months ended June&#160;30, 2020 and the repeal of the HIF for 2021. These increases were partially offset by higher favorable development of prior-years&#8217; health care cost estimates in the six months ended June&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $461 million, or 6.5%, in the six months ended June&#160;30, 2021 compared to the prior year. The decrease in operating expenses was primarily due to the repeal of the HIF for 2021 and the impact of cost savings initiatives in the six months ended June&#160;30, 2021, partially offset by incremental operating expenses to support the growth in the Government Services business described above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 16.2% in the six months ended June&#160;30, 2021 compared to 18.9% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily due to the repeal of the HIF for 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $1.6 billion, or 31.5% in the six months ended June&#160;30, 2021 compared to the prior year. The decrease in adjusted operating income was primarily driven by the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during the six months ended June&#160;30, 2020, partially offset by improved performance in the Government Services business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">16,902&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">3,298&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">17,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,504&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">13,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,510&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">9,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,412&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">14,765&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">23,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Supplemental membership information: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">5,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of June&#160;30, 2021 of 23.5 million decreased 116,000 members compared with March&#160;31, 2021, primarily reflecting declines in Medicaid and Commercial products, partially offset by an increase in Medicare products. The decline in Medicaid membership reflects the loss of a large ASC customer during the three months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of June&#160;30, 2021 of 23.5 million decreased 76,000 members compared with June&#160;30, 2020 primarily reflecting a decline in Commercial products, partially offset by increases in Medicare and Medicaid products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 15, 2021, the U.S. Centers for Medicare &amp; Medicaid Services issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates (the &#8220;Final Notice&#8221;). Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy Services segment&#8217;s performance for the respective periods:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,010</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,595</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,077</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,341</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,425&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,763&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,266</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,271</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,789</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,774</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,157</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,385</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel): </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,536</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,636</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,235</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,109</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,483</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,783</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Pharmacy Services segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.4 billion, or 9.8%, to $38.3 billion in the three months ended June&#160;30, 2021 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued price compression.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy Services segment include selling, general and administrative expenses; depreciation and amortization expense; and expenses related to specialty retail pharmacies, which include store and administrative payroll, employee benefits and occupancy costs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 0.9% and 1.0% in the three-month periods ended June&#160;30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $428 million, or 32.3% in the three months ended June&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics that reflected products and services of our group purchasing organization that was launched in the second quarter of 2020 and specialty pharmacy (including pharmacy and/or administrative services for providers and Covered Entities), as well as increased pharmacy claims volume. These increases were partially offset by continued price compression.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates, fees and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates, fees and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total pharmacy claims processed represents the number of prescription claims processed through our pharmacy benefits manager and dispensed by either our retail network pharmacies or our own mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 12.7% to 479.3 million claims in the three months ended June&#160;30, 2021 compared to 425.1 million claims in the prior year primarily driven by net new business, COVID-19 vaccinations and increased new therapy prescriptions, which were adversely impacted by the COVID-19 pandemic during the three months ended June&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 3.2% to 82.9 million claims in the three months ended June&#160;30, 2021 compared to 80.3 million claims in the prior year primarily driven by net new business and the continued adoption of Maintenance Choice offerings.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 8.4% on a 30-day equivalent basis for the three months ended June&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy Services segment&#8217;s generic drug prescriptions processed or filled by its total prescriptions processed or filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Pharmacy Services segment&#8217;s total generic dispensing rate decreased to 86.7% in the three months ended June&#160;30, 2021 compared to 88.7% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the three months ended June&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.0% in the three months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $4.8 billion, or 6.8%, to $74.6 billion in the six months ended June&#160;30, 2021 compared to the prior year primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued price compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 0.9% and 1.0% in the six-month periods ended June&#160;30, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $754 million, or 30.1% in the six months ended June&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by improved purchasing economics that reflected products and services of our group purchasing organization that was launched in the second quarter of 2020 and specialty pharmacy (including pharmacy and/or administrative services for providers and Covered Entities), partially offset by continued price compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 5.5% to 934.7 million claims in the six months ended June&#160;30, 2021 compared to 886.2 million claims in the prior year primarily driven by net new business and COVID-19 vaccinations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 1.7% to 163.4 million claims in the six months ended June&#160;30, 2021 compared to 160.6 million claims in the prior year primarily driven by net new business and the continued adoption of Maintenance Choice offerings.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 3.0% on a 30-day equivalent basis for the six months ended June&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Pharmacy Services segment&#8217;s total generic dispensing rate decreased to 87.4% in the six months ended June&#160;30, 2021 compared to 88.8% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the six months ended June&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.0% in the six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Retail/LTC segment&#8217;s performance for the respective periods:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,609</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,476</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,998</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,119</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,662</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,411</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,952</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,220</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,994</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,798</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,857</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,509</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,824</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,900</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,919</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,873</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,870</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,758</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,861</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">720.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase (decrease): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Retail/LTC segment operating income (GAAP measure) to adjusted operating income, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues from MinuteClinic, revenues and prescriptions from LTC operations. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful&#160;in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.1 billion, or 14.2%, to $24.7 billion in the three months ended June&#160;30, 2021 compared to the prior year primarily driven by increased prescription volume, COVID-19 vaccinations and diagnostic testing and higher front store revenues. These increases were partially offset by continued pharmacy reimbursement pressure. COVID-19 vaccinations and diagnostic testing contributed nearly a third of the increase in the segment&#8217;s revenues for the three months </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended June&#160;30, 2021 compared to the prior year, as the prior year included an immaterial impact from diagnostic testing and no COVID-19 vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 12.4% in the three months ended June&#160;30, 2021 compared to the prior year. The increase was primarily driven by the 14.8% increase in pharmacy same store prescription volume on a 30-day equivalent basis and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Front store same store sales increased 12.0% in the three months ended June&#160;30, 2021 compared to the prior year. The increase was primarily due to reduced customer traffic in the segment&#8217;s retail pharmacies due to shelter-in-place orders in response to the COVID-19 pandemic in the three months ended June&#160;30, 2020 as well as strength across all product categories in the three months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues increased $462 million in the three months ended June&#160;30, 2021 compared to the prior year. The increase was primarily due to increased COVID-19 diagnostic testing in the three months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Retail/LTC segment include store payroll, store employee benefits, store occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $348 million, or 7.7%, in the three months ended June&#160;30, 2021 compared to the prior year. The increase was primarily due to incremental costs associated with increased volume including COVID-19 vaccinations and diagnostic testing, partially offset by a $125&#160;million gain from an anti-trust legal settlement recorded in the three months ended June&#160;30, 2021 and the absence of incremental expenses associated with the Company&#8217;s initial COVID-19 pandemic mitigation efforts incurred in the three months ended June&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues decreased to 19.6% in the three months ended June&#160;30, 2021 compared to 20.8% in the prior year. The decrease in operating expenses as a percentage of total revenues was primarily driven by the increases in total revenues described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $992 million, or 93.9% in the three months ended June&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by the increased prescription and front store volume described above, COVID-19 vaccinations and diagnostic testing and a $125&#160;million gain from an anti-trust legal settlement recorded in the three months ended June&#160;30, 2021. These increases were partially offset by continued pharmacy reimbursement pressure. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Retail/LTC segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income has been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Retail/LTC segment. If the pharmacy reimbursement pressure accelerates, the segment may not be able grow revenues, and its adjusted operating income could be adversely affected.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand to generic drug conversions.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income benefited from the administration of COVID-19 vaccinations and diagnostic testing, which contributed approximately half of the increase in adjusted operating income for the three months ended June&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Retail/LTC segment&#8217;s pharmacies. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Prescriptions filled increased 14.2% on a 30-day equivalent basis in the three months ended June&#160;30, 2021 compared to the prior year primarily driven by COVID-19 vaccinations, as well as the continued adoption of patient care programs and increased new therapy prescriptions, both of which were adversely impacted by the COVID-19 pandemic during the three months ended June&#160;30, 2020. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 9.3% on a 30-day equivalent basis for the three months ended June&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Retail/LTC segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Retail/LTC segment&#8217;s generic dispensing rate decreased to 85.7% in the three months ended June&#160;30, 2021 compared to 89.1% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the three months ended June&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.5% in the three months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $3.6 billion, or 8.1%, to $48.0 billion in the six months ended June&#160;30, 2021 compared to the prior year primarily driven by COVID-19 vaccinations and diagnostic testing, increased prescription volume and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. COVID-19 vaccinations and diagnostic testing contributed nearly half of the increase in the segment&#8217;s revenues for the six months ended June&#160;30, 2021, as the prior year included an immaterial impact from diagnostic testing and no COVID-19 vaccinations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 8.2% in the six months ended June&#160;30, 2021 compared to the prior year. The increase was primarily driven by the 7.6% increase in pharmacy same store prescription volume on a 30-day equivalent basis and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Front store same store sales decreased 0.4% in the six months ended June&#160;30, 2021 compared to the prior year. The decrease was primarily due to a weak cough, cold and flu season in the first quarter of 2021, partially offset by increased consumer health and beauty care sales in the six months ended June&#160;30, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues increased $977 million in the six months ended June&#160;30, 2021 compared to the prior year. The increase was primarily due to increased COVID-19 diagnostic testing in the six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $924 million, or 10.4%, in the six months ended June&#160;30, 2021 compared to the prior year. The increase was primarily due to incremental costs associated with increased volume including COVID-19 vaccinations and diagnostic testing, partially offset by the absence of incremental expenses associated with the Company&#8217;s initial COVID-19 pandemic mitigation efforts incurred in the six months ended June&#160;30, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues increased to 20.5% in the six months ended June&#160;30, 2021 compared to 20.0% in the prior year. The increase in operating expenses as a percentage of total revenues was primarily driven by the increases in operating expenses described above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $484 million, or 16.4% in the six months ended June&#160;30, 2021 compared to the prior year. The increase in adjusted operating income was primarily driven by COVID-19 vaccinations and diagnostic testing, increased prescription volume and improved generic drug purchasing. These increases were partially offset by continued pharmacy reimbursement pressure. COVID-19 vaccinations and diagnostic testing contributed approximately 20% of the segment&#8217;s adjusted operating income for the six months ended June&#160;30, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Prescriptions filled increased 6.8% on a 30-day equivalent basis in the six months ended June&#160;30, 2021 compared to the prior year primarily driven by COVID-19 vaccinations and the continued adoption of patient care programs. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 3.2% on a 30-day equivalent basis for the six months ended June&#160;30, 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">The Retail/LTC segment&#8217;s generic dispensing rate decreased to 86.5% in the six months ended June&#160;30, 2021 compared to 89.2% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in the six months ended June&#160;30, 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.6% in the six months ended June&#160;30, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,<br/>2021 vs 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,<br/>2021 vs 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(409)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this report for a reconciliation of Corporate/Other segment operating loss (GAAP measure) to adjusted operating loss, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Three Months Ended June&#160;30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $96 million, or 111.6% to $182 million in the three months ended June&#160;30, 2021 compared to the prior year primarily driven by higher net investment income, primarily related to private equity investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $26 million in the three months ended June&#160;30, 2021 compared to the prior year. The increase was primarily driven by higher employee benefit costs and incremental operating expenses associated with Company&#8217;s investments in transformation, partially offset by the increase in net investment income in the three months ended June&#160;30, 2021 described above.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - Six Months Ended June 30, 2021 vs. 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $141 million, or 80.1% to $317 million in the six months ended June&#160;30, 2021 compared to the prior year primarily driven by higher net investment income, primarily related to private equity investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $44 million in the six months ended June&#160;30, 2021 compared to the prior year. The increase was primarily driven by higher employee benefit costs and incremental operating expenses associated with Company&#8217;s investments in transformation, partially offset by the increase in net investment income in the six months ended June&#160;30, 2021 described above.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, sale-leaseback program, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of June&#160;30, 2021, the Company had approximately $7.1 billion in cash and cash equivalents, $1.9 billion of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash during the six months ended June&#160;30, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,930)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,558)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(486.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(793)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,984)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $1.7 billion in the six months ended June&#160;30, 2021 compared to the prior year. The decrease was primarily due to items that favorably impacted operating cash flows in the six months ended June&#160;30, 2020 that did not recur during the current year including: the deferral of quarterly estimated federal and state income tax payments normally due during the second quarter of 2020 until the third quarter of 2020, reduced benefit costs during the second quarter of 2020 due to the deferral of elective procedures and other discretionary utilization in the Health Care Benefits segment as a result of the COVID-19 pandemic and the timing of payments and pricing actions during 2020 designed to recover the HIF, which was paid in the third quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $44 million in the six months ended June&#160;30, 2021 compared to the prior year primarily due to increased net purchases of investments and property and equipment, largely offset by a decrease in cash used for acquisitions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $6.6 billion in the six months ended June&#160;30, 2021 compared to net cash provided by financing activities of $1.7 billion in the prior year. The decrease in cash provided by financing activities primarily related to increased repayments of long-term debt in the six months ended June&#160;30, 2021 compared to the prior year and the absence of proceeds from the issuance of $4.0 billion of senior notes in the six months ended June&#160;30, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of June&#160;30, 2021. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May&#160;16, 2024, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of June&#160;30, 2021, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the Federal Home Loan Bank of Boston (the &#8220;FHLBB&#8221;). As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">borrowing capacity available from the FHLBB as of June&#160;30, 2021 was approximately $985 million. As of June&#160;30, 2021, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities and unsecured senior notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of June&#160;30, 2021, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investor Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by Moody&#8217;s. In June 2021, S&amp;P changed the outlook on the Company&#8217;s long-term debt from &#8220;Stable&#8221; to &#8220;Positive.&#8221; In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021 and 2020, the Company did not repurchase any shares of common stock. See Note 5 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; to the unaudited condensed consolidated financial statements for additional information on the Company&#8217;s share repurchase program.</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the unaudited condensed consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the unaudited condensed consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recoverability of Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 6% and 12%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the reporting units is estimated using a combination of a discounted cash flow method and a market multiple method. The determination of the fair value of the reporting units requires the Company to make significant assumptions and estimates. These assumptions and estimates primarily include the selection of appropriate peer group companies; control premiums and valuation multiples appropriate for acquisitions in the industries in which the Company competes; discount rates; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization, income taxes, capital expenditures and future working capital requirements. When determining these assumptions and preparing these estimates, the Company considers each reporting unit&#8217;s historical results and current operating trends; consolidated revenues, profitability and cash flow results and forecasts; and industry trends. The Company&#8217;s estimates can be affected by a number of factors, including general economic and regulatory conditions; the risk-free interest rate environment; the Company&#8217;s market capitalization; efforts of customers and payers to reduce costs, including their prescription drug costs, and/or increase member co-payments; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the continued efforts of competitors to gain market share, consumer spending patterns and the Company&#8217;s ability to achieve its revenue growth projections and execute on its cost reduction initiatives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LTC reporting unit has continued to face challenges that affect the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed and may continue to do so. These challenges include lower net bed additions and the prolonged adverse impact of the COVID-19 pandemic, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. Some of the key assumptions included in the Company&#8217;s financial projections to determine the estimated fair value of the LTC reporting unit include client retention rates; occupancy rates in skilled nursing facilities; the financial health of skilled nursing facility customers; facility reimbursement pressures; the Company&#8217;s ability to extract cost savings from labor productivity and other initiatives; the geographies impacted and the severity and duration of COVID-19; COVID-19&#8217;s impact on health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to COVID-19. The fair value of the LTC reporting unit also is dependent on market multiples of peer group companies and the risk-free interest rate environment, which impacts the discount rate used in the discounted cash flow valuation method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. If the LTC reporting unit does not achieve its forecasts, it is reasonably possible in the near term that the goodwill of the LTC reporting unit could be deemed to be impaired by a material amount. As of June&#160;30, 2021, the goodwill balance in the LTC reporting unit was $431 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a full description of the Company&#8217;s other critical accounting policies, see &#8220;Critical Accounting Policies&#8221; in Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; of the 2020 Form 10-K.</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Statement Concerning Forward-Looking Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We want to take advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this Quarterly Report on Form 10-Q (this &#8220;report&#8221;) is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to the forward-looking information in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) included in Part I, Item 2 of this report. In addition, throughout this report and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the projected impact of COVID-19 on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, integration synergies, net synergies, integration costs, enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_7">Form 10-Q Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. Certain of these risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this report, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_103"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has not experienced any material changes in exposures to market risk since December 31, 2020. See the information contained in Part II, Item 7A &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 for a discussion of the Company&#8217;s exposures to market risk. </span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_106"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Securities Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) as of June&#160;30, 2021, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective and designed to provide reasonable assurance that material information relating to the Company and its subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that occurred in the three months ended&#160;June&#160;30, 2021 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_109"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:40.36pt">Other Information</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_112"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 8 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein. </span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_115"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:34.8pt">Risk Factors</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the &#8220;Risk Factors&#8221; disclosed in Part I, Item 1A of the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020. Those risk factors could adversely affect the Company&#8217;s businesses, operating results, cash flows and/or financial condition as well as the market price of the Company&#8217;s common shares. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_7">Form 10-Q Table of Contents</a></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:42.02pt">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Stock Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total number of shares purchased in the three months ended June&#160;30, 2021, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase program authorized by CVS Health Corporation&#8217;s Board of Directors on November 2, 2016. See Note 5 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; contained in &#8220;Notes to Condensed Consolidated Financial Statements (Unaudited)&#8221; in Part I, Item 1 of this Quarterly Report on Form&#160;10-Q for additional information.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Fiscal&#160;Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of&#160;Shares<br/>Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid&#160;per<br/>Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of&#160;Shares<br/>Purchased&#160;as&#160;Part&#160;of<br/>Publicly&#160;Announced<br/>Plans&#160;or&#160;Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Approximate&#160;Dollar<br/>Value&#160;of&#160;Shares&#160;that<br/>May&#160;Yet&#160;Be<br/>Purchased&#160;Under&#160;the<br/>Plans&#160;or&#160;Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2021 through April 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2021 through May 31, 2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2021 through June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,869,392,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div><span><br/></span></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_7">Form 10-Q Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in this Item 6 are filed as part of this Quarterly Report on Form 10-Q. Exhibits marked with an asterisk (*) are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Contracts</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm">The Registrant</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm">&#8217;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm">s Severan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm">ce P</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm">lan for Non-Store Employees amended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm">as of January 1,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex101.htm"> 2021.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">Five Year Credit Agreement dated as of May </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">11</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">, 2021, by and among the Registrant, the lenders party thereto</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">Barclays Bank PLC and JPMorgan Chase Bank, N.A., as Co-Syndication Agents, Goldman Sachs Bank USA and Wells Fargo Bank, National Association, as Co-Documentation Agents, and Bank of America, N.A.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="a06302021ex102.htm">as Administrative Agent.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a06302021ex103.htm">Separation</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a06302021ex103.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="a06302021ex103.htm">Agreement dated June 9, 2021 between CVS Pharmacy, Inc. and Eva C. Boratto.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex104.htm">Letter Agreement dated May 16, 2021 between the Registrant and Shawn Guertin.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex105.htm">Restrictive Covenant Agreement dated May 16, 2021 between CVS Pharmacy, Inc. and Shawn Guertin. </a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex106.htm">Change in Control Agreement dated May 16, 2021 between the Registrant and Shawn Guertin. </a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Letter re: unaudited interim financial information</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex151.htm">Letter from Ernst &amp; Young LLP acknowledging awareness of the use of a report dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex151.htm">August</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex151.htm"> 4, 2021 related to their reviews of interim financial information.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex311.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex312.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex321.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a06302021ex322.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Quarterly Report on Form 10-Q for the three and six months ended June 30, 2021 formatted in Inline XBRL: (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, (v) the Condensed Consolidated Statements of Shareholders&#8217; Equity and (vi) the related Notes to Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021, formatted in Inline XBRL (included as Exhibit 101).</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ida7fcde96ac345b2afc29fa84a520ed4_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ida7fcde96ac345b2afc29fa84a520ed4_7">Form 10-Q Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.854%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a06302021ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idc0e834f233f492d8e15b6470b51bb21_1"></div><div style="min-height:74pt;width:100%"><div style="margin-bottom:0.1pt;padding-left:360pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:360pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Exhibit 10.1</font></div></div><div style="margin-top:0.5pt;text-align:center"><font><br></font></div><div style="margin-top:120pt;padding-left:91.75pt;padding-right:91.75pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:14pt;font-weight:700;line-height:120%">CVS HEALTH SEVERANCE PLAN FOR</font></div><div style="margin-bottom:0.1pt;padding-left:46.75pt;padding-right:46.75pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:14pt;font-weight:700;line-height:133%">NON-STORE EMPLOYEES </font></div><div style="margin-top:1.7pt;padding-left:76pt;padding-right:76pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:14pt;font-weight:700;line-height:120%">(Amended and Restated as of January 1, 2021)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:48.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt;padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary</font></div></div></div><div id="idc0e834f233f492d8e15b6470b51bb21_4"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4pt;padding-left:106.95pt;padding-right:106.95pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH SEVERANCE PLAN </font></div><div style="margin-top:4pt;padding-left:106.95pt;padding-right:106.95pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:120%">FOR NON-STORE EMPLOYEES</font></div><div style="padding-left:133.65pt;padding-right:133.65pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:112%">(Amended and Restated as of January 1, 2021)</font></div><div style="margin-top:0.45pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:2.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">WHEREAS, CVS Health Corporation (the &#8220;Company&#8221;) has established the CVS Health                  Severance Plan for Non-Store Employees (the &#8220;Plan&#8221;) to provide financial assistance to employees in non-store positions who are involuntarily terminated and are eligible within the terms and conditions of the Plan&#59;</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:2.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, it is intended that the Plan constitute an employee welfare benefit plan within the scope of Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), that the Plan constitute a separation pay plan within the scope of Department of Labor (&#8220;DOL&#8221;) Regulation Section 2510.3-     2(b), and that all payments made under the Plan be deductible by the Company under Section 162(a) of the      Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)&#59;</font></div><div style="margin-top:0.95pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">WHEREAS, the benefits provided under the Plan are intended to constitute separation pay within              the meaning of Treasury Regulation Section 1.409A-1(b)(9)(iii)&#59;</font></div><div style="margin-top:0.9pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, this document is the official plan document&#59; and</font></div><div style="margin-bottom:0.1pt;padding-left:41pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:36pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:133%">  WHEREAS, the Company wishes to make certain amendments to the Plan, effective as of</font></div><div style="margin-bottom:0.1pt;padding-left:4.5pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">January 1, 2021 (the &#8220;Effective Date&#8221;)&#59;</font></div><div style="margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">NOW, THEREFORE, as of the Effective Date, the Company does hereby amend the Plan to             provide as follows&#58;</font></div><div style="margin-top:6pt;padding-left:7.2pt;padding-right:7.2pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 1</font></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:110%;text-decoration:underline">DEFINITIONS</font></div><div style="margin-top:0.7pt;text-align:justify"><font><br></font></div><div style="margin-top:1.95pt;padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:116%">For purposes of the Plan, the following terms, when used with an initial capital letter, shall have the    meaning set forth below unless a different meaning is plainly required by the context.</font></div><div style="margin-top:0.25pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:116%">1.1&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:116%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:116%">&#8221; shall mean (a) any corporation which is required to be aggregated with the Company under Code Section 414(b), (c), (m), or (o) and (b) any other entity in which the Company has an  ownership     interest and which the Company designates as an Affiliate for purposes of the Plan.</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:0.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.2&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall  refer to a termination of an Eligible Employee&#8217;s employment because of the      Eligible Employee&#8217;s (a) failure to satisfactorily perform under a performance improvement plan of the Employer&#59;     (b) acts of unethical business activity, including but not limited to fraud, misappropriation, embezzlement,    dishonesty, harassment, discrimination in violation of Employer policies, or willful or negligent destruction of  property of an Employer or an Affiliate&#59; (c) misconduct that could cause damage (monetary, reputational or  otherwise) to the Employer, an Affiliate, or any personnel thereof&#59; (d) conviction of or a plea of guilty or nolo contendere to any felony, whether or not any right to appeal has been or may be exercised&#59;  (e) negligence of duty&#59;    (f) insubordination&#59; or (g) a violation of the Employer&#8217;s policy, procedure, or practice.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:41.05pt;padding-right:-0.7pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">1.3&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="padding-left:41.05pt;padding-right:-0.7pt;text-align:justify"><font><br></font></div><div style="margin-top:4pt;padding-left:5pt;padding-right:2.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.4&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an individual who is employed  by the Employer on a regular      basis in a non-store position and has been employed by the Employer in any position for  a minimum of             ninety (90) days prior to the individual&#8217;s separation of employment.  For purposes of the Plan, distribution   warehouse employees, field managers and employees employed by CVS ProCare, Inc. working at Company headquarters, shall be treated as working in a non-store location and therefore not subject to exclusion from  eligibility.  For purposes of the Plan, individuals in the following categories will not be considered Eligible  Employees&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;padding-right:3.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:103%">(a)&#160;&#160;&#160;&#160;individuals who are covered by a collective bargaining agreement, provided welfare      benefits were the subject of bargaining, unless the terms of the collective bargaining agreement provide        for participation in the Plan&#59;</font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             2</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:41.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;individuals who are seasonal employees, leased employees, independent contractors, temporary employees, or consultants&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:2.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;individuals who work for the Employer or an Affiliate in a store location of the Company  or an Affiliate, or whose compensation is paid through or according to a  store payroll, including but          not limited to&#58; pharmacists, store managers, assistant store managers, crew, and pharmacy staff&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(d)&#160;&#160;&#160;&#160;individuals employed by MinuteClinic, L.L.C. or  by any practitioner-owned entity    managed by MinuteClinic, L.L.C.&#59;</font></div><div style="margin-top:0.75pt;text-align:justify"><font><br></font></div><div style="padding-left:41.05pt;padding-right:28.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:232%">(e)&#160;&#160;&#160;&#160;the President and CEO of CVS Health Corporation&#59; </font></div><div style="padding-left:77pt;padding-right:139.4pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:232%">(f)&#160;&#160;&#160;&#160;individuals employed in Puerto Rico&#59; and</font></div><div style="padding-left:77pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:111%">(g)&#160;&#160;&#160;&#160;individuals employed outside the United States of America.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:2.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">The decision of whether an individual falls into one of these categories and whether an individual is employed          by an Employer on a regular basis in a non-store position for a minimum of ninety (90) days shall be made by         the Employer in its sole discretion.  Any individual who is excluded from being considered an Eligible Employee under the Plan shall be excluded from the Plan regardless of the individual&#8217;s reclassification by a government    agency, including a reclassification by the Internal Revenue Service for tax withholding purposes.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.5&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Employer</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean CVS Pharmacy, Inc., Caremark Rx, L.L.C. and Aetna Inc. and                     any current or future Affiliate thereof that does not maintain its own severance plan for employees of           that Affiliate.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.6&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:2.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.7&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exempt Employee</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an Eligible Employee who is paid on a salaried basis for payroll purposes and classified in the sole discretion of the Employer under its normal classification procedures as an   exempt employee under the Fair Labor Standards Act.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.8&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Involuntary Termination</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an Eligible Employee&#8217;s termination of employment with     the Employer due to the unilateral action of the Employer, including but not limited to a termination as a result        of the elimination of an Eligible Employee&#8217;s position due to a reorganization or changes in responsibilities, a reduction in force, or a closing of the business unit in which the Eligible Employee works&#59; provided, however,       that such Involuntary Termination constitutes a separation from service under Treasury Regulation Section 1.409A-1(h).  Notwithstanding the foregoing, an Eligible Employee will not have an Involuntary Termination            if the Eligible Employee&#58; (a) is terminated for Cause, as determined by the Employer in its sole                     discretion&#59; (b) voluntarily terminates his or her employment at any time or resigns prior to  an                     Involuntary Termination&#59; (c) takes a leave of absence&#59; (d) is administratively terminated for failure to return          from a leave of absence upon expiration of his or her leave&#59; (e) terminates employment due  to his or  her            death or disability&#59; (f) transfers to an Affiliate&#59; (g) transfers to a new employer in connection with the sale of an Employer facility&#59; or (h) fails to accept an offer for a job with the Employer that is comparable to the job that           he or she is performing for the Employer at the time of the offer.  For purposes of Subsection (h) of this          Section 1.8, whether a job is considered &#8220;comparable&#8221; shall be determined in the sole discretion of the Employer, taking into account whether the new job is located 50 or fewer miles from the Eligible Employee&#8217;s job at the          time of the offer, whether the compensation offered is materially less than the Eligible Employee&#8217;s compensation      at the time of the offer, and whether the new job will result in a substantial change of duties from the Eligible Employee&#8217;s job at the time of the offer.  The determination of whether an Eligible Employee&#8217;s termination of employment is an Involuntary Termination shall be made in the sole discretion of the Employer.  If an          Employer deems an Eligible Employee&#8217;s termination of employment to be an Involuntary Termination and, Employer later learns of facts and circumstances that, had the Employer known such facts and                circumstances at the time of termination, would have resulted in a termination of employment for Cause, the    Eligible Employee&#8217;s termination shall be deemed as of the date of termination to not have been an             Involuntary Termination.</font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             3</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:3.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">1.9&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Non-exempt Employee</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">&#8221; shall mean an Eligible Employee who is paid on an hourly basis             for time worked and classified in the sole discretion of the Employer under its normal classification             procedures as a non-exempt employee under the Fair Labor Standards Act.</font></div><div style="margin-top:0.9pt;text-align:justify"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">1.10&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Plan Administrator</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">&#8221; shall mean the Senior Vice President of Human Resources of CVS     Pharmacy, Inc., or such other person, designated by the Chief Human Resources Officer of the Company to act       as the Plan Administrator. </font></div><div style="margin-top:0.35pt;padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">1.11&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Rehire Date</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">&#8221; shall mean the date an Eligible Employee accepts reemployment with any     Employer.</font></div><div style="margin-top:0.35pt;padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">1.12&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">&#8221; shall mean the pay an Eligible Employee is eligible to receive under           Subsection (b) of Section 2.1 of the Plan upon his or her Involuntary Termination.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.13&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Period</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the period of time during which an Eligible Employee is           eligible to receive Severance Pay.</font></div><div style="padding-left:5pt;padding-right:3.2pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt;padding-right:3.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.14&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Weekly Rate</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean, (a) with respect to an Eligible Employee paid on a salaried basis,              an Eligible Employee&#8217;s annual base salary (as determined by the Employer), as of the date of the Eligible     Employee&#8217;s Involuntary Termination, expressed on a weekly basis (as determined in the sole discretion of the Employer), and (b) with respect to an Eligible Employee paid on an hourly basis, the hourly wage rate of the     Eligible Employee as of the date of the Eligible Employee&#8217;s Involuntary Termination multiplied by the             Eligible Employee&#8217;s regularly scheduled number of hours of service per week (as determined by the Employer),      not in excess of 40 hours.  Weekly Rate shall exclude any overtime, incentive, and bonus payments,                      unless otherwise required by law.</font></div><div style="margin-top:0.9pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">1.15&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Year of Service</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">&#8221; shall mean each full year of service performed by the Eligible Employee             for an Employer as reflected in the records of the Employer and as determined as of the Eligible Employee&#8217;s         date of termination of employment, based on the Employer&#8217;s policies and procedures for determining periods          of service, and the applicable law.</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-top:1.95pt;padding-left:200.92pt;padding-right:200.92pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%"> ARTICLE 2</font></div><div style="padding-left:47.5pt;padding-right:47.5pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:110%;text-decoration:underline">SEVERANCE PAY AND ELIGIBLE EMPLOYEE BENEFITS</font></div><div style="margin-top:0.8pt;text-align:justify"><font><br></font></div><div style="margin-top:1.5pt;padding-left:22pt;padding-right:3pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">2.1&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">. Upon his or her Involuntary Termination, an Eligible Employee may, in the   discretion of the Plan Administrator, be granted Severance Pay and benefits provided under Subsections (b),     (c), and (d) of this Section 2.1, provided the conditions of Section 2.2 are satisfied. The determination of    whether Severance Pay is payable under the Plan, and the form and amount of such pay, shall be made in the   sole discretion of the Plan Administrator.</font></div><div style="margin-top:0.75pt;text-align:justify"><font><br></font></div><div style="padding-left:22pt;padding-right:3.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The Severance Pay payable to an Eligible Employee in the event of      Involuntary Termination shall be determined by the Plan Administrator in its, his or her sole discretion,         using the guidelines set forth in Appendix A for the applicable Eligible Employee&#8217;s grade, as determined by       the Employer.  Notwithstanding such referenced guidelines, the Plan Administrator may increase or decrease (including, to zero) the amount of Severance Pay with respect to any Eligible Employee for reasons it, he or      she deems appropriate in its sole discretion at any time, whether before or after payments of Severance Pay     have commenced (including, but not limited to, a decrease to take into account any debts owed to an       Employer or a decrease if an Eligible Employee fails to satisfactorily perform his or her duties and is not            on or has not completed a performance improvement plan at the time of termination of employment), at          any time, whether before or after payments of Severance Pay have commenced.</font></div><div style="margin-bottom:0.1pt;padding-right:3.25pt;text-align:justify"><font><br></font></div><div style="padding-left:22pt;padding-right:3.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA Assistance</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event an Eligible Employee who has an Involuntary Termination    (i) is eligible to elect continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of     1985 as amended (&#8220;COBRA&#8221;) in accordance with the terms of the medical and prescription drug plan and&#47;or dental  plan of the  Employer  and  (ii)  properly  and  timely  elects such  continuation  coverage,  the  Employer </font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             4</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:22pt;padding-right:3.25pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">may pay for a portion of the cost of COBRA coverage equivalent to the contribution which the Employer    makes on behalf of similarly situated active employees under such plan for the appropriate tier of coverage selected and in place immediately prior to the date of the Eligible Employee&#8217;s Involuntary Termination            (</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">, employee-only, family coverage), for a period determined in the sole discretion of the Plan        Administrator, which generally shall be the Severance Period but in any event no longer than eighteen (18)  months from the date of the Involuntary Termination.  Any COBRA assistance provided under this      Subsection (c) shall be paid by the Employer directly to the insurance carrier, if applicable.  The portion              of the COBRA premium not covered by the COBRA assistance specified in this Subsection (c) must be          paid by the Eligible Employee directly to the insurance carrier or service provider that administers COBRA,        as applicable, based on the standard rules under the respective plan for payment of COBRA premiums. This Subsection (c) does not provide COBRA assistance in the event the Eligible Employee fails to properly and   timely elect COBRA continuation coverage, regardless of whether his or her covered dependents elect      COBRA continuation coverage.</font></div><div style="margin-top:0.9pt;text-align:justify"><font><br></font></div><div style="padding-left:22pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Outplacement Services</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.     Upon an Involuntary Termination, the outplacement services provided to an Eligible Employee shall be provided in the sole discretion of the Plan Administrator based          on the guidelines contained in this Subsection (d).</font></div><div style="padding-left:58pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:58pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(i)&#160;&#160;&#160;&#160;If an Eligible Employee so desires, he or she may be eligible for                   outplacement services for assistance in obtaining new employment, provided through a vendor       selected by the Employer, with the Employer directly providing payment to such vendor. The     provision of outplacement services is contingent upon the Eligible Employee&#8217;s cooperation with          the outplacement service vendor, upon the active efforts of the Eligible Employee to locate a              new position, and upon the Eligible Employee initiating outplacement services during the Severance Period.</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:58pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(ii)&#160;&#160;&#160;&#160;Subject to the requirements of Paragraph (i) of this Subsection (d), outplacement services shall be offered for a period of time determined in the sole discretion of the Plan    Administrator, based on the guidelines set forth in Appendix A for the applicable Eligible        Employee&#8217;s grade, as determined by the Employer, provided that in no event shall such services      extend beyond twelve (12) months following the Involuntary Termination of the Eligible Employee.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:22pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Form and Timing of Payment</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. In the event an Eligible Employee is awarded                 Severance Pay under the terms of Subsection (a) of this Section 2.1, such Severance Pay shall be paid       following an Eligible Employee&#8217;s Involuntary Termination (except as provided in Section 2.3, below), as     follows&#58;  No Severance Pay shall commence (with respect to salary continuation payments) or be paid (with respect to a lump sum) (i) prior to the expiration of the later of a period that is identified in a severance  agreement with the Eligible Employee during which he or she may consider the execution of the release of   claims form (the &#8220;Consideration Period&#8221;) or a period ending at least seven (7) days following the execution         of the release of claims form (the &#8220;Revocation Period&#8221;), or (ii) later than sixty (60) days following the date           of Eligible Employee&#8217;s Involuntary Termination. Severance Pay that is paid in the form of salary         continuation shall commence as soon as feasible following expiration of the later of the Consideration Period     or the Revocation Period, which generally shall be the first regularly scheduled payroll date following the expiration of the Consideration Period or the Revocation Period, as the case may be, and shall thereafter be     paid in substantially equal installments in accordance with the Employer&#8217;s regular payroll practice, except as provided in Section 2.3 of the Plan, except that the first installment paid after the expiration of the later of         the Consideration Period or the Revocation Period shall include, on a retroactive basis, all installments that    would have been paid had they started as soon as administratively feasible after the date of the Eligible Employee&#8217;s Involuntary Termination. It is the intent of the Plan that the Severance Period in all cases be measured from the date of the Eligible Employee&#8217;s Involuntary Termination. Further, in the Plan   Administrator&#8217;s sole discretion, Severance Pay may be paid to any Eligible Employees in a single lump             sum, in which event Severance Pay shall be paid within the period that satisfies the 409A requirements               for short-term deferrals under Section 409A of the Code.</font></div><div style="margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="padding-left:22.3pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  Any payment of Severance Pay to an Eligible Employee shall be subject               to normal withholding for state and federal income taxes and Social Security taxes.</font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             5</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:22.3pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the death of the Eligible Employee who had an Involuntary                 Termination and who has not received all Severance Pay payable under the Plan, the Severance Pay otherwise payable under Section 2.1(b) of the Plan shall be paid in the form of a lump sum to the Eligible Employee&#8217;s surviving legal spouse or, if there is no surviving legal spouse, to the Eligible Employee&#8217;s estate as soon as practicable, but in no event later than 60 days following death.  Any other severance benefits provided           under this Section 2.1 (COBRA assistance and outplacement services) shall cease upon the Eligible       Employee&#8217;s death.</font></div><div style="padding-left:22.3pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt;padding-right:3.2pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Conditions on Payment of Severance Pay and Benefits</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  Payment of the Severance Pay and     benefits provided in Section 2.1 of the Plan shall be subject to and conditioned upon the following&#58;</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:3.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(a)&#160;&#160;&#160;&#160;to the extent an Eligible Employee receives notice of a date selected by the             Employer (in its sole discretion) on which the Eligible Employee&#8217;s Involuntary Termination shall occur         (a &#8220;Designated Termination Date&#8221;), the Eligible Employee must continue to work in a satisfactory       manner until his or her Designated Termination Date&#59;</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:3.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;the Eligible Employee must cooperate in transitioning all of the Eligible Employee&#8217;s      work in consultation with the Eligible Employee&#8217;s supervisor or other designated employee&#59;</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;the Eligible Employee must execute and deliver a severance agreement that includes             a release of claims, which agreement shall be in a form specified by the Employer from time to time,      which may include restrictive covenants and a waiver as described in Subsection (d) of this Section             2.2) within the time period specified under the terms of the applicable severance offer.  Further, in              no event will Severance Pay be paid with respect to an Eligible Employee in the event the release of       claims form is revoked during the Revocation Period (described in Section 2.1(e) of the Plan)&#59; and</font></div><div style="margin-top:0.75pt;text-align:justify"><font><br></font></div><div style="padding-left:41pt;padding-right:3.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the Eligible Employee must waive the right to receive any other severance payment      relating to salary continuation or salary replacement the Eligible Employee may otherwise be eligible to receive upon termination of employment under any employment agreement, severance plan, practice,     policy or program of the Employer or an Affiliate.</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Maximum Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding any other provisions to the contrary, benefits             paid hereunder (a) shall not exceed two times the lesser of (i) the Eligible Employee&#8217;s Compensation (as defined        in this Section 2.3) during the calendar year immediately preceding the Eligible Employee&#8217;s Involuntary       Termination or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to      Section 401(a)(17) of the Code for the calendar year in which the Eligible Employee&#8217;s Involuntary Termination  occurs and (b) shall be paid in full within twenty-four (24) months after the date the Eligible Employee&#8217;s     Involuntary Termination occurs.  In the event that any Severance Pay payable to an Eligible Employee                 would exceed the twenty-four (24) month period provided in the foregoing sentence if the Severance Pay       continued to be paid in accordance with the Employer&#8217;s regular payroll practice, any Severance Pay that would otherwise exceed the twenty-four (24) month time period will be paid to the Eligible Employee in a lump               sum on the last regular payroll date within the twenty-four (24) month period.  For purposes of this Section 2.3, &#8220;Compensation&#8221; shall mean the Eligible Employee&#8217;s total annualized compensation, based upon the annual rate       of pay for services provided to the Employer for the calendar year preceding the calendar year in which the      Eligible Employee&#8217;s Involuntary Termination occurs, adjusted for any increase in such preceding calendar               year that was expected to continue indefinitely if the Eligible Employee had not had an Involuntary          Termination.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cessation of Severance Pay Upon Reemployment</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  If an Eligible Employee who had an    Involuntary Termination and who is receiving Severance Pay thereafter accepts reemployment with any         Employer during the Severance Period, such Employee&#8217;s Severance Pay shall cease on the Rehire Date and              any remaining Severance Pay shall be forfeited.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cessation of Severance Pay After Commencement of Payments</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  If an Eligible Employee is    deemed to have an Involuntary Termination and begins to receive Severance Pay under the Plan and the        Employer or the Plan Administrator becomes aware of facts and circumstances that, had the Employer              known same at the time of the Eligible Employee&#8217;s termination of employment, would have affected the     </font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             6</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">Employer&#8217;s determination as to whether such Employee&#8217;s termination was an Involuntary Termination, the Plan Administrator may suspend any future Severance Pay payments to the Eligible Employee while the Employer investigates the facts and circumstances and finalizes such investigation, and, if the Employer determines that          the Eligible Employee should have been terminated for Cause, such Eligible Employee&#8217;s Severance Pay shall         cease as of the suspension date, any remaining Severance Pay shall be forfeited and any Severance Pay that has      been paid shall be subject to repayment by the Eligible Employee.</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Impact of Debt on Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event an Eligible Employee is indebted to the       Company or Employer (determined in the sole discretion of the Company or Employer, as applicable), the Plan Administrator reserves the right to reduce, offset, withhold, and&#47;or forfeit the Severance Pay otherwise payable   under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  As of the date of an Eligible Employee&#8217;s Involuntary Termination, the     Eligible Employee&#8217;s active participation in any benefit plan, program, or policy sponsored or subsidized by              the Employer shall cease, unless otherwise continued pursuant to the terms of such plan, program or policy.</font></div><div style="margin-top:0.75pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Awards</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Any award or grant made to the Eligible Employee under any stock option, stock   purchase, or stock appreciation rights plan of the Company or Employer shall be administered and              interpreted in accordance with the terms of the applicable plan documents.</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-left:5.05pt;padding-right:3.6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Paid Time Off</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Any pay for accrued paid time off shall be determined under the terms of             the Employer&#8217;s applicable policies.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bonuses</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Whether any bonuses or other incentive payments are payable to an Eligible         Employee shall be determined based on the terms of any applicable bonus or incentive program, plan, or policy.</font></div><div style="margin-top:0.85pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Benefits Not Vested</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  No one under any circumstance is automatically entitled to Severance           Pay or benefits described in Section 2.1 of the Plan.  Notwithstanding anything in the Plan to the contrary, the      Plan Administrator reserves the right, at its, his or her sole discretion, to increase, decrease, or eliminate        Severance Pay and benefits under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:10.8pt;padding-right:10.8pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">ARTICLE 3</font></div><div style="padding-left:10.8pt;padding-right:10.8pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:underline">ADMINISTRATION OF THE PLAN</font></div><div style="margin-top:0.4pt;text-align:justify"><font><br></font></div><div style="margin-top:1.95pt;padding-left:5pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Control and Administration</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;Notwithstanding any other provision in the Plan, and to the full          extent permitted under ERISA and the Internal Revenue Code, the Plan Administrator shall have the              exclusive right, power and final authority, in its, his or her sole and absolute discretion, to administer, apply,     construe and interpret the terms of the Plan and all related plan documents and all facts surrounding                   claims for benefits under the Plan and shall determine all questions arising in the administration, interpretation       and application of the Plan, including, but not limited to, those concerning eligibility for benefits.  Accordingly, benefits under the Plan shall be paid only if the Plan Administrator decides in its, his or her sole discretion that         an Eligible Employee is entitled to benefits, and the Plan Administrator shall decide all questions regarding              the form, amount and duration of benefits.  The Plan Administrator may consult with attorneys, consultants and  other persons for advice, counsel and reports to make determinations under the Plan, and the Plan Administrator  may delegate its administrative duties and responsibilities to persons or entities of its choice, in all cases who                 may be employees of the Company. All determinations of the Plan Administrator shall be conclusive and          binding on all parties.  The Plan Administrator shall be the named fiduciary of the Plan for purposes of            ERISA.</font></div><div style="padding-left:5pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">3.2  </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Claim Procedures</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Procedure for Granting or Denying Claims</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  An Eligible Employee, or his or her duly           authorized representative, may file a claim for payment of benefits under the Plan within 30 days after termination      of employment.  Such a claim must be made in writing and be delivered to the Plan Administrator, in person or          by mail, postage paid.  Within 90 days after receipt of such claim, the Plan Administrator shall notify the            claimant of the granting or denying, in whole or in part, of such claim, unless special circumstances require an extension of time for processing the claim.  In no event may the extension exceed 90 days from the end of the       </font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             7</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-right:3pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">initial 90-day period.  If such extension is necessary, the claimant will be given a written notice to this effect             prior to the expiration of the initial 90-day period.  The Plan Administrator shall have full discretion to deny or       grant a claim in whole or in part.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Requirement for Notice of Claim Denial</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  The Plan Administrator shall provide to every          claimant who is denied a claim for benefits a written or electronic notice setting forth in a manner calculated to          be understood by the claimant&#58;</font></div><div style="margin-top:0.95pt;text-align:justify"><font><br></font></div><div style="padding-left:113pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;The specific reason or reasons for the denial&#59;</font></div><div style="margin-top:0.4pt;padding-left:113.05pt;padding-right:2.9pt;text-align:justify"><font><br></font></div><div style="margin-top:0.4pt;padding-left:113.05pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Specific reference to pertinent Plan provisions on which the denial is based&#59; </font></div><div style="margin-top:0.4pt;padding-left:113.05pt;padding-right:2.9pt;text-align:justify"><font><br></font></div><div style="margin-top:0.4pt;padding-left:113.05pt;padding-right:2.9pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;A description of any additional material or information necessary for the      claimant to perfect the claim and an explanation of why such material is necessary&#59;           and</font></div><div style="margin-top:0.55pt;text-align:justify"><font><br></font></div><div style="padding-left:113pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;An explanation of the Plan&#8217;s claim review procedures and the time limits     applicable to such procedures, including a statement of the claimant&#8217;s right to bring               a civil action under Section 502(a) of ERISA following an adverse determination on      review.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-right:3.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Right to Appeal on Claim Denial</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  Within 60 days after receipt by the claimant of written or   electronic notification of the denial (in whole or in part) of his or her claim, the claimant or his or her duly       authorized representative may make a written application to the Plan Administrator, in person or by certified mail, postage prepaid, to be afforded a full and fair review of such denial.  The claimant or his or her duly authorized representative may submit written comments, documents, records, and other information relating to the claim           for benefits.  Moreover, the claimant or his or her duly authorized representative shall be provided, upon request       and free of charge, reasonable access to, and copies of, all documents, records, and other information                relevant to the claimant&#8217;s claim for benefits.</font></div><div style="margin-top:0.3pt;text-align:justify"><font><br></font></div><div style="padding-right:3.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disposition of Disputed Claims</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon receipt of a request for review, the Plan Administrator       shall make a decision on the claim.  The review shall take into account all comments, documents, records, and         other information submitted by the claimant relating to the claim, without regard to whether such information         was submitted or considered in the initial benefit determination.  The decision on review shall be made not later      than 60 days after the Plan Administrator's receipt of a request for a review, unless special circumstances require         an extension of time for processing, in which case a decision shall be rendered not later than 120 days after receipt     of the request for review.  If an extension is necessary, the claimant shall be given written notice of the extension   prior to the expiration of the initial 60-day period.</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan Administrator shall provide the claimant or his or her duly authorized representative with        written or electronic notification of the Plan Administrator&#8217;s determination on review.  In the case of an adverse determination, the notification shall set forth, in a manner calculated to be understood by the claimant, the specific reason or reasons for the decision as well as specific references to the Plan provisions on which the decision was  based.  The decision shall also include a statement that the claimant is entitled to receive, upon request and free          of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the    claimant&#8217;s claim for benefits.  Moreover, the decision shall contain a statement of the claimant&#8217;s right to bring an   action under Section 502(a) of ERISA.</font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Legal Action.</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">  No legal action may be commenced or maintained against the         Plan, the Company or any Employer prior to the claimant&#8217;s exhaustion of the claims procedures set forth in      Section 3.2 of the Plan.  In addition, no legal action may be commenced against the Plan more than ninety (90)      days after the Plan Administrator&#8217;s final claim determination on review pursuant to Section 3.2(d) of the               Plan. Any legal action must be conducted in the United States District Court for Rhode Island.</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.4</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Named Fiduciary</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  The Plan Administrator of the Plan shall be the Named Fiduciary of the          Plan for purposes of ERISA Section 402(a)(1).</font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             8</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.1pt;padding-left:3.6pt;padding-right:3.6pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:133%">ARTICLE 4</font></div><div style="padding-left:7.2pt;padding-right:7.2pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:110%;text-decoration:underline">MISCELLANEOUS</font></div><div style="margin-top:0.7pt;text-align:justify"><font><br></font></div><div style="margin-top:1.95pt;padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment or Termination</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  The Plan may be amended, terminated, withdrawn or suspended        at any time in writing by the Management Planning and Development Committee of the Company or any      individual designated by such Committee to take such actions.</font></div><div style="margin-top:0.85pt;text-align:justify"><font><br></font></div><div style="padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%"> 4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  The validity, interpretation, construction and performance of the obligations     created under the Plan shall be governed by ERISA, and to the extent not preempted by federal law, the laws of        the State of Rhode Island without regard to its conflicts of law principles.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:116%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:116%;text-decoration:underline">Validity</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:116%">.  The invalidity or unenforceability of any provision of the Plan shall not affect the       validity or enforceability of any other provision of the Plan, which shall remain in full force and effect.</font></div><div style="margin-top:0.8pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Plan Exclusive Source of Rights</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  The Plan contains all of the terms and conditions with          respect to the benefits provided hereunder, and no employee or former employee of the Company or any      Employer may rely on any other communication or representation, whether oral or written, of the                 Company or any Employer or any of its subsidiaries, or any officer or employee thereof, as creating                         any right or obligation not expressly provided by the Plan.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Nonassignability</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.     No benefit which shall be payable under the Plan to any Eligible           Employee shall be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge,      encumbrance, or charge (except as required by law), and any attempt to anticipate, alienate, sell, transfer,             assign, pledge, encumber, or charge a benefit shall be null and void.  No benefit shall in any manner be liable           for, or subject to, the debts, contracts, liabilities, engagements, or torts of any Eligible Employee.  No benefit        shall be subject to legal attachment or legal process for, or against, the Eligible Employee and the same shall not       be recognized under the Plan.  Notwithstanding the preceding sentence, the Employer retains the discretion, in accordance with federal and&#47;or state laws, to reduce the amount of benefits payable under the Plan to any        Eligible Employee to recover any amounts that the Eligible Employee owes to the Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">No Employment Rights</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  The Plan shall not give any Eligible Employee any right or claim         except to the extent that the right is specifically provided under the terms of the Plan.  The establishment of            the Plan shall not be construed (a) to give any Eligible Employee a right to continue in the employ of the        Employer or (b) to interfere with the right of the Employer to terminate the employment of any Eligible        Employee at any time.</font></div><div style="margin-top:0.75pt;text-align:justify"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Headings.</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">  Article and section headings are for convenience only and the language of the             Plan itself will be controlling.</font></div><div style="margin-top:0.9pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%;text-decoration:underline">Gender and Numbers</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">.  Masculine pronouns include the feminine as well as the neuter            genders, and the singular shall include the plural, unless indicated otherwise by the context.</font></div><div style="padding-left:5pt;padding-right:3.15pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt;padding-right:2.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  The benefits provided under the terms of the Plan are intended to fall       within the short-term deferral exception, the separation pay exception or another exception to the application of Section 409A of the Code and the applicable guidance issued thereunder.  In furtherance of this intent, the Plan    shall be interpreted, operated and administered in a manner consistent with this intention.  To the extent the    benefits provided under the Plan become subject to Code Section 409A and applicable guidance issued       thereunder, the Plan shall be construed, and benefits paid hereunder, as necessary to comply with Section             409A of the Code and such guidance.  Further, to the extent that an Eligible Employee becomes entitled to       receive Severance Pay under the terms of the Plan, and, at the time of the Eligible Employee&#8217;s Involuntary Termination, he or she is a &#8220;specified employee&#8221; within the meaning of Treasury Regulation Section 1.409A-         1(i), any portion of Severance Pay payable to such Eligible Employee that is subject to Code Section 409A              and applicable guidance thereunder shall be delayed until the date that is the earlier of (i) the Eligible            Employee&#8217;s death or (ii) six months following the date of the Eligible Employee&#8217;s Involuntary Termination, at       which time the payments that were delayed for such six month period shall be paid in a lump sum on the date of      the next occurring regular payroll date of the Employer, and any remaining payments shall be paid                 according to the  original  schedule  provided  herein.   In addition,  each payment of  a  salary continuation stream of </font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             9</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:2.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">installment payments hereunder shall be a separate payment for purposes of Section 409A of the Code.</font></div><div style="margin-top:0.35pt;text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Funding</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  The Plan is not funded, and Severance Pay and benefits under the Plan are paid            from the general assets of the Employer.</font></div><div style="margin-top:0.45pt;text-align:justify"><font><br></font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year.</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">  The Plan&#8217;s records shall be maintained on the basis of the calendar year.</font></div><div style="padding-left:5.05pt;padding-right:2.9pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-top:0.25pt;text-align:justify"><font><br></font></div><div style="margin-top:1.95pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Management Planning and Development Committee of the Company, or                   its duly authorized delegate, has amended the Plan as of the Effective Date pursuant to the execution hereof on           its behalf by a duly authorized officer on January 8, 2021 .</font></div><div style="margin-top:1.95pt;padding-right:-1pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-right:-1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.988%"><tr><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:700;line-height:133%">CVS Health Corporation</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:133%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:133%">&#47;s&#47; Lisa G. Bisaccia</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:133%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:133%">EVP and CHRO</font></td></tr></table></div><div style="margin-bottom:0.1pt;padding-right:-1pt"><font><br></font></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             10</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:120%">Appendix A</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:120%">Amount of Severance Pay and Outplacement Services</font></div><div style="padding-left:25.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:25.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">Severance Pay is the Weekly Rate payable for the number of weeks listed below, determined by Grade and Years of Service (YOS)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Tier 1</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Tier 2</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Tier 3</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Tier 4</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Executive Tier 1</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Executive Tier 2</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grades 101, 102, 103, 104, 105, 106, 550, 551, 552, 652, 752</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grades 107, 108, 201, 202, 203, 301, 302, 405, 406, 407, 408, 553, 554, 653, 753, 654, 754</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grades 109, 110, 111, 204, 205, 303, 304, 409, 410, 411, 555, 556, 557, 558, 655, 656, 657, 658, 755, 756, 757, 758</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grades 112, 206, 305, 412, 559, 560, 659, 759</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grades 36 A-Z, 70G</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Grades 38 A-Z, 39 A-Z , 71G, 72G</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Full <br>YOS</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of Weeks</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of <br>Weeks</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of Weeks</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of Weeks</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of Weeks</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Number of Weeks</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">0</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">6</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">*52 or 78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">2</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">6</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">8</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">3</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">8</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">10</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">4</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">10</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">12</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">5</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">12</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">14</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">14</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">6</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">16</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">16</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">7</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">18</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">18</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">8</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">9</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">10</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">11</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">21</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">12</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">22</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">23</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">14</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">24</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">15</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">25</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">28</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">16</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">29</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">17</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">30</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">18</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">31</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">19</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">32</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">33</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">21</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">34</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">22</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">35</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">23</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">36</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">24</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">37</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">25</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">38</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">39</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">27+</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">13</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">20</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">26</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">39</font></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">52</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:0.25pt solid #000000;padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:133%">78</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6-Week Virtual Outplacement</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3-Month Virtual Outplacement</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3-Month Professional Outplacement</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:133%">3-Month Professional Outplacement</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6-Month Executive Outplacement</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:133%">6-Month Executive Outplacement</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:-58pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">* </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Under 18 months of service receives 52 weeks</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:33.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:3.97pt;padding-right:3.97pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:113%">             11</font></div><div style="padding-left:5pt;padding-right:2.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:113%">Proprietary&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a06302021ex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie8a48033cb224a6a91c10db64280cc10_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Deal CUSIP&#58; 23242UAV5</font></div><div style="padding-left:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facility CUSIP&#58; 23242UAW3</font></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">by and among</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE LENDERS PARTY HERETO,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC and JPMORGAN CHASE BANK, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Syndication Agents,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Co-Documentation Agents,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Administrative Agent</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dated as of May 11, 2021</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">______________________________</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BOFA SECURITIES, INC.,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC, GOLDMAN SACHS BANK USA,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">and</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO SECURITIES, LLC,</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">as Joint Lead Arrangers and Joint Bookrunners</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:48pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><div id="ie8a48033cb224a6a91c10db64280cc10_4"></div><hr style="page-break-after:always"><div style="min-height:57.06pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">TABLE OF CONTENTS</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEFINITIONS AND PRINCIPLES OF CONSTRUCTION...............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.12pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Definitions.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Principles of Construction.........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AMOUNT AND TERMS OF LOANS.................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revolving Credit Loans............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Swing Line Loans.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notice of Borrowing Revolving Credit Loans and Swing Line Loans.....................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Competitive Bid Loans and Procedure.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Use of Proceeds.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Termination, Reduction or Increase of Commitments..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prepayments of Loans...............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">30</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Letter of Credit Sub-facility......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">31</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Letter of Credit Participation....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">32</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Absolute Obligation with respect to Letter of Credit Payments...............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">33</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notes..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">34</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Extension of Commitment Termination Date...........................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">34</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Defaulting Lenders....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">35</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AND FEES.............................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">37</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Disbursement of the Proceeds of the Loans..............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">37</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Payments...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">38</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Conversions&#59; Other Matters......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">39</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Interest Rates and Payment Dates.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">40</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indemnification for Loss...........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">42</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reimbursement for Costs, Etc..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">42</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Illegality of Funding.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">43</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Option to Fund&#59; Substituted Interest Rate.................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">44</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certificates of Payment and Reimbursement............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">48</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Taxes&#59; Net Payments................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">48</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facility Fees..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">51</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Letter of Credit Participation Fee..............................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">52</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Replacement of Lender.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">52</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REPRESENTATIONS AND WARRANTIES.....................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">53</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Existence and Power.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">53</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Authority&#59; Affected Financial Institution..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">53</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Binding Agreement...................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">53</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Litigation...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No Conflicting Agreements......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Governmental Regulations........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Federal Reserve Regulations&#59; Use of Proceeds.........................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">54</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No Misrepresentation................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;..................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial Statements.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.06pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anti-Corruption Laws and Sanctions........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">55</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDITIONS TO EFFECTIVENESS................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Corporate Action.......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Opinion of Counsel to the Borrower.........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Termination of Existing 2017 Credit Agreement.....................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No Default and Representations and Warranties......................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">56</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fees...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">57</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Due Diligence&#59; &#8220;Know Your Customer&#8221;..................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">57</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT..................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">57</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Compliance...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">57</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Requests....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">57</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AFFIRMATIVE COVENANTS..........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Legal Existence.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Taxes.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Observance of Legal Requirements..........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">58</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Financial Statements and Other Information............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">59</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Records.....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">60</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NEGATIVE COVENANTS.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">60</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">60</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Liens..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">60</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dispositions...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">61</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Merger or Consolidation, Etc....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">61</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">62</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">62</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Limitation on Upstream Dividends by Subsidiaries..................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">62</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Reserved&#93;.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">62</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ratio of Consolidated Indebtedness to Total Capitalization.....................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">62</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">DEFAULT............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">63</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Events of Default......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">63</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Remedies...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">65</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">AGENT.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Appointment and Authority......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rights as a Lender.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exculpatory Provisions.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">66</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Reliance by Administrative Agent............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">67</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Delegation of Duties.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">68</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Resignation of Administrative Agent.......................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">68</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-Reliance on Administrative Agent and Other Credit Parties............................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">69</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No Other Duties, Etc.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">69</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Recovery of Erroneous Payments.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">69</font></div></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.06pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:31.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:366.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OTHER PROVISIONS.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">70</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Amendments, Waivers, Etc.......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">70</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">71</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Waiver&#59; Cumulative Remedies................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">74</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Survival of Representations and Warranties..................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">74</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Payment of Expenses&#59; Indemnified Liabilities..............................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">74</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lending Offices........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">75</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Successors and Assigns..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">75</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Counterparts&#59; Electronic Execution...............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">81</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Set-off and Sharing of Payments..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">82</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indemnity           .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">83</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Governing Law  .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">85</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Severability        .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">85</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Integration          .......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">85</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Treatment of Certain Information.............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">85</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Acknowledgments.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">86</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consent to Jurisdiction..............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">86</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Service of Process.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">87</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No Limitation on Service or Suit..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">87</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.19</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WAIVER OF TRIAL BY JURY..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">87</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Patriot Act Notice.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">87</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No Fiduciary Duty....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">88</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.22</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Acknowledgement and Consent to Bail-In of Affected Financial</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Institutions     .............................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">88</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.23</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Certain ERISA Matters..............................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">88</font></td></tr></table></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:57.06pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXHIBITS</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:344.25pt"><tr><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:279.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">List of Commitments</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit B</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Note</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Borrowing Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit D-1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Opinion of Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit D-2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Opinion of Special Counsel to the Borrower</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit E</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Assignment and Assumption</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit F</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Competitive Bid Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit G</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Invitation to Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit H</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Competitive Bid</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit I</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Competitive Bid Accept&#47;Reject Letter</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit J</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Letter of Credit Request</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit K</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Form of Commitment Increase Supplement</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:61.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><div id="ie8a48033cb224a6a91c10db64280cc10_7"></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIVE YEAR CREDIT AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, dated as of May 11, 2021, by and among </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a Delaware corporation (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), the lenders party hereto from time to time (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BARCLAYS BANK PLC </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as co-syndication agents (in such capacity, each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">GS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as codocumentation agents (in such capacity, each a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and, collectively, the</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Co-Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as administrative agent for the Lenders (in  such capacity, together with its successors and assigns, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;DEFINITIONS AND PRINCIPLES OF CONSTRUCTION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Definitions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">When used in any Loan Document (as defined below), each of the following terms shall have the meaning ascribed thereto unless the context otherwise specifically requires&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ABR Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans (or any portions thereof) at such time as they (or such portions) are made or are being maintained at a rate of interest based upon the Alternate Base Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Acquisition Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  any Indebtedness incurred by the Borrower or any of its Subsidiaries for the purpose of financing, in whole or in part, a Material Acquisition and any related transactions or series of related transactions (including for the purpose of refinancing or replacing all or a portion of any pre-existing Indebtedness of the Person(s) or assets to be acquired), which Indebtedness is redeemable or prepayable if such Material Acquisition is not consummated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Accumulated Funding Deficiency&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in Section 304 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Administrative Agent&#8217;s Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Administrative Agent&#8217;s address and, as appropriate, account  as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or such other address or account as the Administrative Agent may from time to time notify to the Borrower and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Administrative Questionnaire&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Advances&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABR Advances or Eurodollar Advances.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Affected Advance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Affected Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any EEA Financial Institution or (b) any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person at any time and from time to time, any other Person (other than a wholly-owned subsidiary of such Person) which, at such time (a) controls such Person, (b) is controlled by such Person or (c) is under common control with such Person. The term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as used     in this definition with respect to any Person, means the power, whether direct or indirect through one or more intermediaries, to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by contract or otherwise.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agent Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of the Commitment Amounts of the Lenders at such time under this Agreement. The Aggregate Commitment Amount on the Effective Date is $2,000,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, the sum of (a) the aggregate Committed Credit  Exposure of the Lenders at such time and (b) the aggregate outstanding principal balance of all Competitive Bid Loans at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Aggregate Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">at any time, the sum of the Letter of Credit Commitments of the Issuers at such time. The Aggregate Letter of Credit Commitment on the Effective  Date is $250,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Five Year Credit Agreement, as the same may be amended, amended and restated, supplemented or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Alternate Base Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; for any day, a fluctuating rate per annum equal to the highest of (a) the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 1&#47;2 of 1%, (b) the rate of interest in effect for such day as publicly announced from time to time by BofA as its &#8220;prime rate&#8221;, and (c) the One Month LIBOR Rate in effect on such day plus 1.00%.  The &#8220;prime rate&#8221; is a rate set by BofA based upon various factors including BofA&#8217;s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate.  Any change in such prime rate announced by BofA shall take effect at the opening of business on the day specified in the public announcement of such change. If the Alternate Base Rate is being used as an alternate rate of interest pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereof, then the Alternate Base Rate shall be the greater of clauses (a) and (b) above and shall be determined without reference to clause (c) above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Anti-Corruption Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, and regulations of any jurisdiction applicable to the Borrower or the Subsidiaries from time to time concerning or relating to bribery or corruption.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Applicable Margin&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) with respect to the unpaid principal balance of ABR Advances, the applicable percentage set forth below in the column entitled &#8220;ABR Advances&#8221;, (ii)&#160;with respect to the  unpaid principal balance of Eurodollar Advances and Swing Line Loans bearing interest at the LIBOR  Daily Floating Rate, the applicable percentage set forth below in the column entitled &#8220;Eurodollar   Advances&#47;Swing Line Loans&#8221;, (iii) with respect to the Facility Fee, the applicable percentage set forth  below in the column entitled &#8220;Facility Fee&#8221;, (iv) with respect to the Letter of Credit Participation Fee payable in respect of standby Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee - Standby&#8221;, and (v) with respect to the Letter of Credit Participation Fee payable in respect of commercial Letters of Credit, the applicable percentage set forth below in the column entitled &#8220;Participation Fee-Commercial&#8221;, in each case opposite the applicable Pricing Level&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pricing Level</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ABR Advances</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Eurodollar Advances&#47; Swing Line Loans</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Facility Fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participation Fee - Standby</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participation Fee &#8211; Commercial</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Level I</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.685%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.065%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.685%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.3425%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Level II</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.795%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.080%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.795%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.3975%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Level III</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.000%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.910%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.090%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.910%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.4550%</font></td></tr></table></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Level IV</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.015%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.015%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.110%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.015%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.5075%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Level V</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.125%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.5625%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pricing Level VI</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.225%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.275%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">0.6375%</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Decreases in the Applicable Margin resulting from a change in Pricing Level shall become effective upon the delivery by the Borrower to the Administrative Agent of notice upon the Borrower becoming aware of any change in the applicability of a Pricing Level.  Increases in the Applicable Margin resulting from a change in Pricing Level shall become effective on the effective date of any downgrade or withdrawal in the rating by Moody&#8217;s or S&#38;P of the senior unsecured long term debt rating of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Approved Fund&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Assignment and Assumption&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an assignment and assumption entered into by a Lender and an assignee (with the consent of any party whose consent is required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and accepted by the Administrative Agent, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit&#160;E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Authorized Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; (a) the chief executive officer, president, chief financial officer, treasurer, assistant treasurer or controller of the Borrower, (b) solely for purposes of the delivery of incumbency certificates pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the secretary or any assistant secretary of the Borrower, and (c) solely  for purposes of notices given pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any other officer or employee of the  Borrower so designated by any of the foregoing officers in a notice to the Administrative Agent. Any document delivered hereunder that is signed by an Authorized Officer shall be conclusively presumed to have been authorized by all necessary corporate and&#47;or other action on the part of the Borrower and such Authorized Officer shall be conclusively presumed to have acted on behalf of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Action&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the exercise of any Write-Down and Conversion Powers by the applicable Resolution Authority in respect of any liability of an Affected Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Bail-In Legislation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law, rule, regulation or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or  rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Barclays&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BAS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA Securities, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  31 C.F.R. &#167; 1010.230.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;BofA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; means Bank of America, N.A. and its successors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrower Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) in respect of Revolving Credit Loans, any Domestic Business Day or Eurodollar Business Day, as the case may be, on which the Lenders shall make Revolving Credit Loans pursuant to a Borrowing Request or pursuant to a Mandatory Borrowing, (ii) in respect of Competitive Bid Loans, any Domestic Business Day on which a Lender shall make a Competitive Bid Loan pursuant to a Competitive Bid Request, (iii) in respect of Swing Line Loans, any Domestic Business Day on which the Swing Line Lender shall make a Swing Line Loan pursuant to a Borrowing Request and (iv) in respect of Letters of Credit, any Domestic Business Day on which an Issuer shall issue a Letter of Credit pursuant to    a Letter of Credit Request.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Borrowing Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request for Revolving Credit Loans or Swing Line Loans substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or such other form as may be approved by the Administrative Agent, including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent, appropriately completed and signed by an Authorized Officer of the Borrower.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Change of Control&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Person or group (as such term is used in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended), (a) shall have or acquire beneficial ownership of securities having 35% or more of the ordinary voting power of the Borrower or (b) shall possess, directly or indirectly, the power to direct or cause the direction of the management and policies of the Borrower, whether through the ownership of voting securities, by contract or otherwise&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Continuing Directors shall cease for any reason to constitute a majority of the board of directors of the Borrower then in office.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Documentation Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agent&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Co-Syndication Agents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue commercial Letters of Credit in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Commercial Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or,  if not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Commercial Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (b) 7.5% of the Aggregate Commitment Amount as in effect at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commercial Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time in respect of any Issuer, an amount equal to such Issuer&#8217;s Letter of Credit Exposure in respect of commercial Letters of Credit.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Lender, such Lender&#8217;s undertaking to make Revolving Credit Loans, subject to the terms and conditions hereof, in an aggregate outstanding principal amount not to exceed the Commitment Amount of such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, the amount set forth adjacent to such Lender&#8217;s name under the heading </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, in the event that such Lender is not listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> which such Lender shall have assumed from another Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may    be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Increase Supplement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Commitment Increase Supplement substantially in the  form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Percentage&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and with respect to any Lender, a fraction (expressed as a percentage carried out to the ninth decimal place) the numerator of which is such Lender&#8217;s Commitment Amount at such time, and the denominator of which is the Aggregate Commitment Amount at such time&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event the Commitments shall have expired or otherwise terminated or been terminated, then Commitment Percentage shall be determined immediately prior thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period commencing on the Effective Date and ending on the Commitment Termination Date or on such earlier date as all of the Commitments shall have been terminated in accordance with the terms hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the earlier of (i) May 11, 2026 (subject to extension as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and (ii) the date on which the Loans shall become due and payable in accordance with the terms hereof, whether by acceleration, notice of intention to prepay or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Committed Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum at such time of (a) the outstanding principal balance of such Lender&#8217;s Revolving Credit Loans, (b) the Swing Line Exposure   of such Lender and (c) the Letter of Credit Exposure of such Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Communication&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an offer by a Lender, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to make one or more Competitive Bid Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Accept&#47;Reject Letter&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a notification made by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid made by a Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the fixed rate of interest (which shall be expressed in the form of a decimal to no more than four decimal places) offered by such Lender with respect thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request by the Borrower, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for Competitive Bids.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Competitive Bid Loan, the period commencing on the   date of such Competitive Bid Loan and ending on the date requested in the Competitive Bid Request with respect thereto, which shall not be earlier than 3 days after the date of such Competitive Bid Loan or later than 180 days after the date of such Competitive Bid Loan&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that if any Competitive Interest Period would end on a day other than a Domestic Business Day, such Competitive Interest Period shall be extended to the next succeeding Domestic Business Day, unless such next succeeding Domestic Business Day would be a date on or after the Commitment Termination Date, in which case such Competitive Interest Period shall end on the next preceding Domestic Business Day. Interest shall accrue from and including the first  day of a Competitive Interest Period to but excluding the last day of such Competitive Interest Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Consolidated&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Borrower and the Subsidiaries on a consolidated basis in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Contingent Obligation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">secondary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), any obligation of such secondary obligor (a) guaranteeing or in effect guaranteeing any return on any investment made by another Person, or (b) guaranteeing or in effect guaranteeing any Indebtedness, lease, dividend or other obligation (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of any other Person (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in any manner, whether directly or indirectly, including any obligation of such secondary obligor, whether or not contingent, (i) to purchase  any such primary obligation or any Property constituting direct or indirect security therefor, (ii) to advance or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (iii) to purchase Property, securities or services primarily for the purpose of assuring the beneficiary of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation, (iv) otherwise to assure or hold harmless the beneficiary of such primary obligation against loss in respect thereof, and (v) in respect of the Indebtedness of any partnership in which such secondary obligor is a general partner, except to the extent that such Indebtedness of such partnership is nonrecourse to such secondary obligor and its separate Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the term </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not include the indorsement of instruments for deposit or collection in the ordinary course of business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Continuing Director&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any member of the board of directors of the Borrower (i) who is a member of that board of directors on the Effective Date, (ii) who was nominated for election by the board of directors a majority of whom were directors on the Effective Date, or (iii) whose election or nomination for election was approved by one or more of such directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Convert&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Conversion&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Converted&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; each, a reference to a conversion pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of one Type of Revolving Credit Loan into the other Type of Revolving Credit Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Lender at any time, the sum of (a) the Committed Credit Exposure of such Lender at such time and (b) the outstanding principal balance of all Competitive Bid  Loans of such Lender at such time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Credit Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Administrative Agent, the Swing Line Lender, the Issuers and the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, whether or not any requirement for the giving of notice, the lapse of time, or both, or any other condition, has been satisfied.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender, as reasonably determined by the Administrative Agent, that has (a) failed to fund any portion of its Loans or participations in Letters of Credit or Swing Line Loans within two Domestic Business Days of the date required to be funded by it hereunder, unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the result of such Lender&#8217;s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, (b) notified the Borrower or any Credit Party in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its funding obligations under this Agreement or generally under other agreements in which   it commits to extend credit, unless such writing or public statement relates to such Lender&#8217;s obligation to fund a Loan hereunder and states that such position is based on such Lender&#8217;s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied, (c) failed, two Domestic Business Days after written request by the Administrative Agent (based on the reasonable belief that it may not fulfill its funding obligation), to confirm that it will comply with the terms of this Agreement relating to its  obligations to fund prospective Loans and participations in then outstanding Letters of Credit and Swing Line Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Lender shall cease to be a Defaulting Lender under this clause (c) upon receipt by the Administrative Agent of such confirmation, (d) otherwise failed to pay over to the Administrative Agent or any other Lender any other amount required to be paid by it hereunder within two Domestic Business Days of the date when due, unless the subject of a good faith dispute, or (e) (i) becomes or is insolvent or has a parent company that has become or is insolvent, (ii) becomes the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or has a parent company that has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, interim receiver, receiver and manager, administrator, liquidator, conservator, trustee or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment, or (iii) becomes, or has a parent company that becomes, the subject of a Bail-in Action&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that a Lender shall not qualify as a Defaulting Lender solely as a result of the acquisition or maintenance of an ownership interest in such Lender or its parent company, or of the exercise of control over such Lender or any Person controlling such Lender, by a Governmental Authority or instrumentality thereof so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States of America or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any agreements made by such Lender.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Disposition&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Person, any sale, assignment, transfer or other disposition by  such Person by any means, of&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the stock of, or other equity interests of, any other Person,</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any business, operating entity, division or segment thereof, or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any other Property of such Person, other than (i) the sale of inventory (other than    in connection with bulk transfers), (ii) the disposition of equipment and (iii) the sale of cash investments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; those Persons that are (a) competitors of the Borrower or its Subsidiaries, identified in writing by the Borrower to the Administrative Agent and the Lenders from time  to time (by posting such notice to the Platform) not less than one (1) Domestic Business Day prior to the date of determination (it being understood that, notwithstanding anything herein to the contrary, in no event </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">shall a supplement apply retroactively to disqualify any Person that has previously acquired an assignment  or participation interest hereunder that is otherwise an Eligible Assignee, but upon the effectiveness of such designation, any such Person may not acquire any additional Commitments, Advances or participations),   (b) such other Persons identified in writing by the Borrower to the Administrative Agent prior to the Effective Date and (c) Affiliates of the Persons identified pursuant to clause (a) or (b) that are either clearly identifiable by name or identified in writing by the Borrower to the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that &#8220;Disqualified Institutions&#8221; shall exclude any Person that the Borrower has designated as no longer being a &#8220;Disqualified Institution&#8221; by written notice delivered to the Administrative Agent and the Lenders from  time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dollar&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;$&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; lawful currency of the United States of America.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Domestic Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any day other than a Saturday, Sunday or a day which in New York  City is a legal holiday or a day on which banking institutions are authorized or required by law or other governmental action to close.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Financial Institution&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of  an institution described in clause (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Member Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EEA Resolution Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Copy&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Record&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Electronic Signature&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Eligible Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Person that is a permitted assignee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that has received the consent of each party whose consent is required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  For the avoidance of doubt, any Disqualified Institution is subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Employee Benefit Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an employee benefit plan, within the meaning of Section&#160;3(3) of ERISA, maintained, sponsored or contributed to by the Borrower, any Subsidiary or any ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Laws&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all laws, rules, regulations, codes, ordinances, orders, decrees, judgments, injunctions, notices or binding agreements issued, promulgated or entered into by any Governmental Authority, relating in any way to the environment, preservation or reclamation of natural resources, the </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">management, release or threatened release of any Hazardous Material or, as such relate to exposure to Hazardous Materials, to health and safety matters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Environmental Liability&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person, any statutory, common law or equitable liability, contingent or otherwise (including any liability for damages, costs of environmental investigation, sampling or remediation, fines, penalties or indemnities), of such Person directly or indirectly resulting from or based upon (i) violation of any Environmental Law, (ii) the generation, use, handling, transportation, storage, treatment, discharge or disposal of any Hazardous Materials, (iii) exposure to any Hazardous Materials, (iv) the release or threatened release of any Hazardous Materials into the environment or (v) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect  to any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; shares of capital stock, partnership interests, membership interests, beneficial interests or other ownership interests, whether voting or nonvoting, in, or interests in the income or profits of, a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire    any of the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Employee Retirement Income Security Act of 1974, as amended from time to time,  or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ERISA Affiliate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to an Employee Benefit Plan, ERISA, the PBGC or a provision of the Internal Revenue Code pertaining to employee benefit plans, any Person that is a member  of any group of organizations within the meaning of Sections 414(b) or (c) of the Internal Revenue Code   or, solely with respect to the applicable provisions of the Internal Revenue Code, Section 414(m) or (o) of the Internal Revenue Code, of which the Borrower or any Subsidiary is a member.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">ERISA Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) any &#8220;reportable event&#8221;, as defined in Section&#160;4043 of ERISA with respect to     a Pension Plan (other than an event for which the 30-day notice period is waived)&#59; (b) the determination   that any Pension Plan is considered an at-risk plan or a plan in endangered or critical status within the meaning of Sections&#160;430, 431 or 432 of the Internal Revenue Code or Sections&#160;303, 304 or 305 of ERISA&#59; (c) the filing pursuant to the Internal Revenue Code or ERISA of an application for a waiver of the minimum funding standard with respect to any Pension Plan&#59; (d) the incurrence by the Borrower, any Subsidiary or   an ERISA Affiliate of any liability under Title IV of ERISA with respect to the termination of any Pension Plan, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Borrower, any Subsidiary or an ERISA Affiliate&#59; (e) the receipt by the Borrower, any Subsidiary or an ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Pension Plan or to appoint a trustee to administer any Pension Plan&#59; (f) the incurrence by the Borrower, any Subsidiary or an ERISA Affiliate of any liability with respect to the withdrawal or partial withdrawal from any Pension Plan or Multiemployer Plan&#59; (g) any limits under Section 436 of the Internal Revenue Code become applicable&#59; or (h) any failure to make any payment required by Section 430(j) of the Internal Revenue Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;EU Bail-In Legislation Schedule&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Eurodollar Advance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a portion of the Revolving Credit Loans selected by the Borrower to bear interest during a Eurodollar Interest Period selected by the Borrower at a rate per annum based upon a Eurodollar Rate determined with reference to such Eurodollar Interest Period, all pursuant to and in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Eurodollar Business Day&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Domestic Business Day, other than a Domestic Business Day on which banks are not open for dealings in Dollar deposits in the interbank Eurodollar market.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Eurodollar Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period commencing on any Eurodollar Business Day selected    by the Borrower in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and ending one, two, three or six months thereafter, as selected by the Borrower in accordance with either such Sections, subject to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:31.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if any Eurodollar Interest Period would otherwise end on a day which is not a Eurodollar Business Day, such Eurodollar Interest Period shall be extended to the immediately succeeding Eurodollar Business Day, unless the result of such extension would be to carry the end   of such Eurodollar Interest Period into another calendar month, in which event such Eurodollar Interest Period shall end on the Eurodollar Business Day immediately preceding such day&#59; and</font></div><div style="margin-bottom:12pt;padding-left:31.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if any Eurodollar Interest Period shall begin on the last Eurodollar Business Day       of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Eurodollar Interest Period), such Eurodollar Interest Period shall end on   the last Eurodollar Business Day of such latter calendar month.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Eurodollar Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Eurodollar Advance for any Eurodollar Interest Period, (a) the LIBO Rate for such Eurodollar Interest Period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">multiplied</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by (b) the Statutory Reserve Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any of the events specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any requirement for  the giving of notice, the lapse of time, or both, or any other condition has been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Excluded Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, (a)&#160;Taxes imposed on or measured by its net income (however denominated) or overall gross receipts, and franchise Taxes, in each case, (i) imposed on it by the jurisdiction (or any political subdivision thereof) under the laws of which it is organized or in which its principal office is located or, in the case of any Lender, in which its applicable lending office is located, or (ii) that are Other Connection Taxes, (b)&#160;any branch profits Taxes imposed by the United States of America or that are Other Connection Taxes, (c)&#160;in the case of a Lender (other than an assignee pursuant to a request by the Borrower under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), any withholding Tax that  is imposed on amounts payable to such Lender at the time such Lender becomes a party hereto (or designates a new lending office), except to the extent that such Lender  (or its assignor, if any) was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to such withholding Tax pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (d) any Tax attributable to such recipient&#8217;s failure or inability (other than as a result of a Regulatory Change, except for a Regulatory Change relating to the implementation of FATCA) to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (e) any Taxes imposed under FATCA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing Commitment Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2017 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 18, 2017,    by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                co-syndication agents, BofA and Wells Fargo, as co-documentation agents, and The Bank of New York Mellon, as administrative agent, as amended by Amendment No. 1 to Five Year Credit Agreement, dated    as of December 15, 2017, Amendment No. 2 to Five Year Credit Agreement, dated as of May 17, 2018, Amendment No. 3 to Five Year Credit Agreement, dated as of May 16, 2019, and as the same may be further amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2018 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 17, 2018,    by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                co-syndication agents, BofA, GS and Wells Fargo, as co-documentation agents, and The Bank of New York Mellon, as administrative agent, as amended by Amendment No. 1 to Five Year Credit Agreement, dated    as of May 16, 2019, and as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 2019 Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Five Year Credit Agreement, dated as of May 16, 2019,    by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as                co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent, as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Existing 364-Day Credit Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the 364-Day Credit Agreement, dated as of May 13, 2020, by and among the Borrower, the lenders party thereto from time to time, Barclays and JPMC, as co-syndication agents, GS and Wells Fargo, as co-documentation agents, and BofA, as administrative agent,    as the same may be amended, amended and restated, supplemented, replaced or otherwise modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Expiration Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the first date, occurring on or after the date the Commitments shall have terminated or been terminated in accordance herewith, upon which there shall be no Loans, Reimbursement Obligations or Letters of Credit outstanding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Extension Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;FATCA&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Internal Revenue Code, any applicable intergovernmental agreements with respect thereto, and any treaty, law, regulations, or other official guidance enacted in any other jurisdiction relating to such intergovernmental agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Federal Funds Effective Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  for any day, the rate per annum calculated by the Federal Reserve Bank of New York based on such day&#8217;s federal funds transactions by depository institutions (as determined in such manner as the Federal Reserve Bank of New York shall set forth on its public website from time to time) and published on the next succeeding Domestic Business Day by the Federal Reserve Bank of New York as the federal funds effective rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Federal Funds Effective Rate as so determined would be less than zero, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be deemed to be zero for purposes of   this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Foreign Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any Lender or any Issuer that is not a United States person within the meaning of Section 7701(a)(30) of the Internal Revenue Code.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GAAP&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the accounting profession, which are applicable to the circumstances as of the date of determination, consistently applied.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Governmental Authority&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any foreign, federal, state, municipal or other government, or any department, commission, board, bureau, agency, public authority or instrumentality thereof, or any court, arbitrator, regulatory body or central bank (including any supra-national bodies such as the European Union or the European Central Bank).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;GS&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Hazardous Materials&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all ignitable, explosive, reactive, corrosive or radioactive substances or wastes and all hazardous or toxic materials, substances, chemicals, wastes or other pollutants, including but not limited to petroleum or petroleum distillates, asbestos or asbestos containing materials, polychlorinated biphenyls, radon gas, toxic mold, infectious or medical wastes, hazardous biological agents, hazardous pharmaceutical substances and all other materials, substances, chemicals, wastes, contaminants or   pollutants of any nature that are now or hereafter regulated pursuant to any Environmental Law, or are now or hereafter defined, listed or classified as a hazardous or toxic material, substance, chemical, waste, contaminant or pollutant in any Environmental Law.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Highest Lawful Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Lender, the maximum rate of interest, if any, which at any time  or from time to time may be contracted for, taken, charged or received on the Loans or the Notes or which may be owing to such Lender pursuant to this Agreement under the laws applicable to such Lender and this Agreement and the other Loan Documents. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Increasing Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price of Property (other than trade payables and accrued expenses incurred in the ordinary course of business), (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) indebtedness with respect to any conditional sale or other title retention agreement, (d) indebtedness arising under acceptance facilities and the amount available to be drawn under all letters of credit (excluding, for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, letters   of credit obtained in the ordinary course of business by the Borrower or any Subsidiary) issued for the account of such Person and, without duplication, all drafts drawn thereunder to the extent such Person shall not have reimbursed the issuer thereof in respect of such issuer&#8217;s payment of such drafts, (e) that portion of any obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on     a balance sheet of such Person, (f) all indebtedness described in clauses (a) through (e) above secured by  any Lien on any Property owned by such Person even though such Person shall not have assumed or otherwise become liable for the payment thereof (other than carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, repairmen&#8217;s or other like non-consensual Liens arising in the ordinary course of business), and (g) Contingent Obligations in respect of any indebtedness described in clauses (a) through (f) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indebtedness for Borrowed Money&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as to any Person at a particular time, all items of such Person which constitute, without duplication, (a) indebtedness for borrowed money or the deferred purchase price  of Property (other than trade payables and accrued expenses incurred in the ordinary course of business),   (b) indebtedness evidenced by notes, bonds, debentures or similar instruments, (c) that portion of any </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">obligation of such Person, as lessee, which in accordance with GAAP is required to be capitalized on a balance sheet of such Person, and (d) Contingent Obligations in respect of any indebtedness described in clauses (a) through (c) above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, for purposes of this definition, Indebtedness for Borrowed Money shall not include Intercompany Debt and obligations in respect of interest rate caps, collars, exchanges, swaps or other, similar agreements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Taxes other than Excluded Taxes and Other Taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Insurance Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any Subsidiary subject to regulation by the commissioner of insurance,  the commissioner of health or any equivalent Governmental Authority in any applicable jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the value, as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior to such date, prepared in accordance with GAAP, of&#58; (i) all trade names, trademarks, licenses, patents, copyrights, service marks, goodwill and other like intangibles, (ii) organizational and development costs, (iii) deferred charges (other than prepaid items, such as insurance, taxes, interest, commissions, rents, pensions, compensation and similar items and tangible assets being amortized), and (iv) unamortized debt discount and expense, less unamortized premium.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Intercompany Debt&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) Indebtedness of the Borrower to one or more of the Subsidiaries of the Borrower and (ii) Indebtedness of one or more of the Subsidiaries of the Borrower to the Borrower or any one or more of the other Subsidiaries of the Borrower.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Payment Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) as to any ABR Advance, the last day of each March, June, September and December, commencing on the first of such days to occur after such ABR Advance is made or any Eurodollar Advance is converted to an ABR Advance, (ii) as to any Swing Line Loan, the day on which    the outstanding principal balance of such Swing Line Loan shall become due and payable in accordance  with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) as to any Eurodollar Advance in respect of which the Borrower has selected a Eurodollar Interest Period of one, two or three months, the last day of such Eurodollar Interest Period, (iv)  as to any Competitive Bid Loan in respect of which the Borrower has selected a Competitive Interest Period of 90 days or less, the last day of such Competitive Interest Period and (v) as to any Eurodollar Advance or Competitive Bid Loan in respect of which the Borrower has selected an Interest Period greater than three months or 90 days, as the case may be, the last day of the third month or the 90th day, as the case may be,   of such Interest Period and the last day of such Interest Period.  </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Interest Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Eurodollar Interest Period or a Competitive Interest Period, as the case may   be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Internal Revenue Code&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the rules and regulations issued thereunder, as from time to time in effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;ISDA Definitions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any successor definitional booklet for interest rate derivatives published from time to time by the International Swaps and Derivatives Association, Inc. or such successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issue&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;issuance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; when used with respect to a Letter of Credit, shall be deemed to include    any increase in the amount of such Letter of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Barclays, BofA, GS, JPMC and Wells Fargo&#59; each an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Issuer&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Joint Lead Arrangers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BAS, Barclays, GS, JPMC and WFS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;JPMC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble&#59; such term to also include the Swing Line Lender and each Issuer where the context hereof requires or permits such inclusion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lender Party&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Application&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an application and agreement for the issuance or amendment of a Letter of Credit in the form from time to time in use by the applicable Issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time with respect to any Issuer, the commitment of such Issuer to issue Letters of Credit (which, for the avoidance of doubt, shall include all standby letters of credit and all commercial letters of credit issued by such Issuer) in accordance with the terms hereof in an aggregate outstanding face amount not exceeding the lesser of (a) the amount set forth adjacent to such Issuer&#8217;s name under the heading &#8220;Letter of Credit Commitment&#8221; in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at such time or, if not listed  on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the &#8220;Letter of Credit Commitment&#8221; which such Issuer shall have assumed from another Issuer in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on or prior to such time, as the same may be adjusted from time to time pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) the amount equal to the Aggregate Commitment Amount as in effect at such time multiplied by a percentage equal to a fraction, the numerator of which is one and  the denominator of which is five.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) in respect of all Lenders, the sum, without duplication, of (i) the maximum aggregate amount which may be drawn under all unexpired Letters of Credit at such time (whether or not the conditions for drawing thereunder have or may be satisfied), (ii) the aggregate amount, at such time, of all unpaid drafts (which have not been dishonored) drawn under all Letters of Credit, and (iii) the aggregate unpaid principal amount of the Reimbursement Obligations at such time, (b)  in respect of any Lender, an amount equal to such Lender&#8217;s Commitment Percentage at such time multiplied by the amount determined under clause (a) of this definition, and (c) in respect of any Issuer, the amount determined under clause (a) of this definition in respect of a Letter of Credit issued by such Issuer.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Request&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a request substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;LIBO Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  for any Eurodollar Interest Period with respect to a Eurodollar Rate Loan, the rate per annum equal to the London Interbank Offered Rate as administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate for Dollars for a period equal in length   to such Interest Period) (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">from time to time) at approximately 11&#58;00 a.m., London time, two Eurodollar Business Days prior to the commencement of such Eurodollar Interest Period, for Dollar deposits (for delivery on the first day of such Eurodollar Interest Period) with a term equivalent to such Eurodollar Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the LIBO Rate shall be less than zero, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBO Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall be deemed to be zero for the purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;LIBO Screen Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the LIBOR quote on the applicable screen page the Administrative Agent designates to determine LIBOR (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; as defined in the definition of LIBO Rate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Daily Floating Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;  a fluctuating rate of interest, which can change on each Domestic Business Day, equal to LIBOR, or a comparable or successor rate which rate is approved by the Administrative Agent, as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Swing Line Lender from time to time) at or about 11&#58;00 a.m., London time, two Eurodollar Business Days prior to the date in question, for Dollar deposits with a term equivalent to a one month term beginning on that date, as adjusted from time     to time in the Swing Line Lender&#8217;s sole discretion for reserve requirements, deposit insurance assessment rates and other regulatory costs&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (i) to the extent a comparable or successor rate is approved  by the Swing Line Lender in connection herewith, the approved rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that to the extent such market practice is not administratively  feasible for the Swing Line Lender, such approved rate shall be applied in a manner as otherwise reasonably determined by the Swing Line Lender, (ii) if the LIBOR Daily Floating Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement and (iii) if such rate is not available at such time for any reason, then the rate will be determined by such alternate method as reasonably selected by the Swing Line Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Successor Rate Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lien&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any mortgage, pledge, hypothecation, assignment, lien, deposit arrangement, charge, encumbrance or other security arrangement or security interest of any kind, or the interest of a vendor or lessor under any conditional sale agreement, capital lease or other title retention agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that   in no event shall an operating lease or license of Intangible Assets be deemed to constitute a Lien.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Revolving Credit Loan, a Competitive Bid Loan or a Swing Line Loan, as the case may be.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loan Documents&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; this Agreement and, upon the execution and delivery thereof, the Notes, if  any, and the Reimbursement Agreements, if any.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Revolving Credit Loans, the Competitive Bid Loans and the Swing Line Loans.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Margin Stock&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">margin stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as said term is defined in Regulation U of the Board of Governors of the Federal Reserve System, as the same may be amended or supplemented from time to time.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; any acquisition of (a) Equity Interests in any Person if, after giving effect thereto, such Person will become a Subsidiary or (b) assets comprising all or substantially all the assets of (or all or substantially all the assets constituting a business unit, division, product line or line of business   of) any Person&#59; provided that the aggregate consideration therefor (including Indebtedness assumed in connection therewith, all obligations in respect of the deferred purchase price therefor (including   obligations under any purchase price adjustment but excluding earn-out or similar payments) and all other consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) equals or exceeds $500,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Material Adverse&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any change or effect, a material adverse change in, or effect   on, as the case may be, (i) the financial condition, operations, business, or Property of the Borrower and the Subsidiaries taken as a whole, (ii) the ability of the Borrower to perform its obligations under the Loan Documents, or (iii) the ability of the Administrative Agent, any Issuer or any Lender to enforce the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Material Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; a Subsidiary of the Borrower with respect to which (i) the Borrower&#8217;s and  its other Subsidiaries&#8217;  investments in, and advances to, such Subsidiary exceed ten percent (10%) of the total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, (ii) the Borrower&#8217;s and its other Subsidiaries&#8217; proportionate share of the total assets (after intercompany eliminations) of such Subsidiary exceeds 10 percent (10%) of the total assets of the Borrower and its Consolidated Subsidiaries as of the end of the most recently completed fiscal year, or (iii) the Borrower&#8217;s and its other Subsidiaries&#8217; equity in the income from continuing operations before income taxes of such Subsidiary exclusive of amounts attributable to any non-controlling interests exceeds ten percent (10%) of such income of the Borrower and its Consolidated Subsidiaries for the most recently completed fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Moody&#8217;s&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Moody&#8217;s Investors Service, Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Multiemployer Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a Pension Plan which is a multiemployer plan as defined in Section 4001(a)(3) of ERISA.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Negotiated Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; with respect to each Swing Line Loan, the rate per annum agreed to in writing by the Borrower and the Swing Line Lender as the interest rate which such Swing Line Loan shall bear.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Net Tangible Assets&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the total assets as shown on the most recent Consolidated balance sheet of the Borrower and the Subsidiaries as at the end of the fiscal quarter ending not more than 135 days prior to such date, prepared in accordance with GAAP, less, without duplication (i) all current liabilities (due within one year) as shown on such balance sheet and (ii) Intangible Assets and liabilities relating thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;New Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Note&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to each Lender that has requested one in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a promissory note evidencing such Lender&#8217;s Loans payable to such Lender (or, if required by such Lender,    to such Lender and its registered assigns), substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;One Month LIBOR Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  for any interest calculation with respect to an ABR Advance on any date, the rate per annum equal to LIBOR, at or about 11&#58;00 a.m., London time determined two Eurodollar Business Days prior to such date for Dollar deposits with a term of one month commencing that day, </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in the event that the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month LIBOR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> would otherwise be less than zero, such  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">One Month LIBOR Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to be zero for purposes of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Other Connection Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to the Administrative Agent, any Lender, any Issuer or  any other recipient of any payment to be made by or on account of any obligation of the Borrower hereunder or any other Loan Document, Taxes imposed as a result of a present or former connection between such recipient and the jurisdiction imposing such Tax (other than connections arising from such recipient having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to, enforced any Loan Document, or sold or assigned an interest in any Loan or Loan Document).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Other Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future stamp, court or documentary Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made hereunder or under any other   Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document, except any such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Participant Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PBGC&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV  of ERISA, or any Governmental Authority succeeding to the functions thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pension Plan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, any Employee Benefit Plan (including a Multiemployer Plan) subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, the funding requirements of which are, or at any time within the six years immediately preceding the time in question were, in whole or in part, the responsibility of the Borrower, any Subsidiary or an ERISA Affiliate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any individual, firm, partnership, limited liability company, joint venture, corporation, association, business trust, joint stock company, unincorporated association, trust, Governmental Authority or any other entity, whether acting in an individual, fiduciary, or other capacity, and for the purpose of the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, a trade or business.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Plan of Reorganization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.7(h)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pre-Adjustment Successor Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV, Pricing   Level V or Pricing Level VI, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level I&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when the senior unsecured long term debt rating of the Borrower by   (x) S&#38;P is A or higher or (y) Moody&#8217;s is A2 or higher.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level II&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower   by (x) S&#38;P is A- or higher or (y) Moody&#8217;s is A3 or higher and (ii) Pricing Level I does not apply.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level III&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&#38;P is BBB+ or higher or (y) Moody&#8217;s is Baa1 or higher and (ii) neither Pricing Level I nor Pricing Level II applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level IV&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower by (x) S&#38;P is BBB or higher or (y) Moody&#8217;s is Baa2 or higher and (ii) none of Pricing Level I, Pricing  Level II or Pricing Level III applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level V&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when (i) the senior unsecured long term debt rating of the Borrower   by (x) S&#38;P is BBB- or higher or (y) Moody&#8217;s is Baa3 or higher and (ii) none of Pricing Level I, Pricing Level II, Pricing Level III or Pricing Level IV applies.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Pricing Level VI&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any time when none of Pricing Level I, Pricing Level II, Pricing Level III, Pricing Level IV or Pricing Level V applies.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding each definition of Pricing Level set forth above, if at any time the senior unsecured long term debt ratings of the Borrower by S&#38;P and Moody&#8217;s differ by more than one equivalent rating level,  then the applicable Pricing Level shall be determined based upon the lower such rating adjusted upwards    to the next higher rating level.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Prohibited Transaction&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a transaction that is prohibited under Section 4975 of the Internal Revenue Code or Section 406 of ERISA and not exempt under Section 4975 of the Internal Revenue Code, Section 408 of ERISA or any applicable administrative exemptions.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Property&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in respect of any Person, all types of real, personal or mixed property and all types of tangible or intangible property owned or leased by such Person.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;PTE&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Regulatory Change&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the occurrence, after the date hereof, of any of the following&#58; (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation    or treaty or in the administration, implementation, interpretation or application thereof by any   Governmental Authority or (c) the making or issuance of any request, guideline or directive (whether or    not having the force of law) by any Governmental Authority&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding anything  herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (ii) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case, pursuant to Basel III, in the case of each of clauses (i) and (ii), shall be deemed to be a &#8220;Regulatory Change&#8221;, regardless of the date enacted, adopted or issued, but only if any such requirements are generally applicable to (and for which reimbursement is generally being sought by the Lenders in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing a provision similar to this definition), as determined  by the Lenders in their respective reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, as the context requires, shall include the Letter of Credit Application related to the applicable Letter of Credit.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Obligations&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all obligations and liabilities of the Borrower due and to become due (a) under the Reimbursement Agreements and (b) hereunder in respect of Letters of Credit.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Related Adjustment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; in determining any LIBOR Successor Rate, the first relevant available alternative set forth in the order below that can be determined by the Administrative Agent applicable to such LIBOR Successor Rate&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the spread adjustment, or method for calculating or determining such spread adjustment, that has been selected or recommended by the Relevant Governmental Body for the relevant Pre-Adjustment Successor Rate (taking into account the interest period, interest payment date or payment period for interest calculated and&#47;or tenor thereto) and which adjustment or method (x) is published on an information service as selected by the Administrative Agent from time to  time in its reasonable discretion or (y) solely with respect to Term SOFR, if not currently published, which was previously so recommended for Term SOFR and published on an information service acceptable to the Administrative Agent&#59; or </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the spread adjustment that would apply (or has previously been applied) to the fallback rate for a derivative transaction referencing the ISDA Definitions (taking into account the interest period, interest payment date or payment period for interest calculated and&#47;or tenor thereto).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Related Parties&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Relevant Governmental Body</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and&#47;or the Federal Reserve Bank of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replaced Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replacement Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Required Lenders&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) at any time prior to the Commitment Termination Date or such earlier   date as all of the Commitments shall have terminated or been terminated in accordance herewith, Lenders   having Commitment Amounts greater than 50% of the Aggregate Commitment Amount, and (b) at all other times, Lenders having Credit Exposure greater than 50% of the Aggregate Credit Exposure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Rescindable Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;S&#38;P&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Standard &#38; Poor&#8217;s Financial Services LLC, a subsidiary of S&#38;P Global Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Country&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, a country or territory which is the subject or target of any Sanctions.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctioned Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State, (b) any Person operating, organized or resident in a Sanctioned Country or (c)   any Person controlled by any such Person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Sanctions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; economic or financial sanctions or trade embargoes imposed, administered or  enforced from time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(ii).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SEC Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the Borrower&#8217;s 2020 Annual Report on Form 10-K, the Borrower&#8217;s quarterly   report on Form 10-Q for the quarterly period ending March 31, 2021, and any 8-K filings made by the Borrower subsequent to March 31, 2021 and prior to the Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with respect to any Eurodollar Business Day, the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark  (or a successor administrator) on the Federal Reserve Bank of New York&#8217;s website (or any successor  source) at approximately 8&#58;00 a.m. (New York City time) on the immediately succeeding Eurodollar Business Day and, in each case, that has been selected or recommended by the Relevant Governmental Body.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Special Counsel&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; such counsel as the Administrative Agent may engage from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Statutory Reserve Rate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; a fraction (expressed as a decimal), the numerator of which is the  number one and the denominator of which is the number one minus the aggregate of the maximum reserve percentages (including any marginal, special, emergency or supplemental reserves) expressed as a decimal established by the Board of Governors of the Federal Reserve System to which the Administrative Agent     is subject for eurocurrency funding (currently referred to as &#8220;Eurocurrency liabilities&#8221; in Regulation D of  the Board of Governors of the Federal Reserve System, as amended). Such reserve percentages shall include those imposed pursuant to said Regulation D.  Eurodollar Loans shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements without benefit of, or credit for, proration, exemptions or offsets that may be available from time to time to any Lender under said Regulation D or   any comparable regulation. The Statutory Reserve Rate shall be adjusted automatically on and as of the effective date of any change in any reserve percentage.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time and from time to time, any corporation, partnership, limited liability company, joint venture or other business entity of which the Borrower and&#47;or any Subsidiary of the Borrower, directly or indirectly at such time, either (a) in respect of a corporation, owns or controls more than 50% of the outstanding stock having ordinary voting power to elect a majority of the board of directors or similar managing body, irrespective of whether a class or classes shall or might have voting power by reason of the happening of any contingency, or (b) in respect of a partnership, limited liability company, joint venture or other business entity, is entitled to share in more than 50% of the profits and losses, however determined.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the commitment of the Swing Line Lender to make Swing Line Loans in accordance with the terms hereof in an aggregate outstanding principal amount not exceeding $100,000,000 (or, if less, the Aggregate Commitment Amount) at any time, as the same may be reduced pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Commitment Period&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the period from the Effective Date to, but excluding, the Swing Line Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Exposure&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any time, in respect of any Lender, an amount equal to the aggregate principal balance of such Lender&#8217;s Swing Line Participation Amount.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; BofA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Termination Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the date which is 7 Domestic Business Days prior to the Commitment Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Taxes&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges in the nature of a tax imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; the forward-looking term rate for any period that is approximately (as determined  by the Administrative Agent) as long as any of the Eurodollar Interest Period options set forth in the definition of &#8220;Eurodollar Interest Period&#8221; and that is based on SOFR and that has been selected or recommended by the Relevant Governmental Body, in each case, as published on an information service    as selected by the Administrative Agent from time to time in its reasonable discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Termination Event&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Pension Plan, (a) an ERISA Event, (b) the termination   of a Pension Plan under Section 4041(c) of ERISA, or the filing of a notice of intent to terminate a Pension Plan under Section 4041(c) of ERISA, or the treatment of a Pension Plan amendment as a termination under Section 4041(e) of ERISA (except an amendment made after such Pension Plan satisfies the requirement   for a standard termination under Section 4041(b) of ERISA), (c) the institution of proceedings by the PBGC to terminate a Pension Plan under Section 4042 of ERISA, or (d) the appointment of a trustee to administer any Pension Plan under Section 4042 of ERISA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Threshold Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; $300,000,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Total Capitalization&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; at any date, the sum of the Borrower&#8217;s Consolidated Indebtedness and shareholders&#8217; equity on such date, determined in accordance with GAAP.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Trade Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Type&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; with respect to any Revolving Credit Loan, the characteristic of such Loan as an ABR Advance or a Eurodollar Advance, each of which constitutes a Type of Revolving Credit Loan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person subject to IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">UK Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10(f)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Wells Fargo&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; as defined in the preamble.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">WFS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#58; Wells Fargo Securities, LLC.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Write-Down and Conversion Powers&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule, and (b) with respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change   the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised  under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Principles of Construction</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All capitalized terms defined in this Agreement shall have the meanings given to such capitalized terms herein when used in the other Loan Documents or in any certificate, opinion or other document made or delivered pursuant hereto or thereto, unless otherwise expressly  provided therein.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Unless otherwise expressly provided herein, the word </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;fiscal&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> when used herein shall refer to the relevant fiscal period of the Borrower. As used in the Loan Documents and in any certificate, opinion or other document made or delivered pursuant thereto, accounting terms not defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and accounting terms partly defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the extent not defined, shall have the respective meanings given to them under GAAP as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change occurring after the date hereof in GAAP or in the application thereof on the operation of such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to   any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision&#160;shall be interpreted    on the basis of, and any accounting term related thereto shall have the respective meaning given to  it under, GAAP as in effect and applied immediately before such change shall have become  effective until such notice shall have been withdrawn or such provision amended in accordance herewith.  Any lease that is characterized as an operating lease in accordance with GAAP after the Borrower&#8217;s adoption of ASC 842 (regardless of the date on which such lease has been entered into) shall not be a capital or finance lease, and any such lease shall be, for all purposes of this Agreement, treated as though it were reflected on the Borrower&#8217;s consolidated financial statements </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the same manner as an operating lease would have been reflected prior to Borrower&#8217;s adoption   of ASC 842.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereof&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;herein&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereto&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;hereunder&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and similar words   when used in each Loan Document shall refer to such Loan Document as a whole and not to any particular provision of such Loan Document, and Section, schedule and exhibit references   contained therein shall refer to Sections thereof or schedules or exhibits thereto unless otherwise expressly provided therein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;All references herein to a time of day shall mean the then-applicable time in New York, New York, unless otherwise expressly provided herein.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Section headings have been inserted in the Loan Documents for convenience only and shall not be construed to be a part thereof. Unless the context otherwise requires, words in the singular number include the plural, and words in the plural include the singular.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Whenever in any Loan Document or in any certificate or other document made or delivered pursuant thereto, the terms thereof require that a Person sign or execute the same or refer to the same as having been so signed or executed, such terms shall mean that the same shall be, or was, duly signed or executed by (i) in respect of any Person that is a corporation, any duly authorized officer thereof, and (ii) in respect of any other Person (other than an individual), any analogous counterpart thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;The words </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;include&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;including&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, when used in each Loan Document, shall mean that the same shall be included </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;without limitation&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, unless otherwise specifically provided.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;All references to &#8220;knowledge&#8221; or &#8220;awareness&#8221; of the Borrower or any Subsidiary means the actual knowledge of an Authorized Officer of the Borrower or such Subsidiary.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;AMOUNT AND TERMS OF LOANS</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Revolving Credit Loans</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to the terms and conditions hereof, each Lender severally (and not jointly) agrees to make loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively with each other Revolving Credit Loan of such Lender and&#47;or with each Revolving Credit Loan of each other Lender, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Revolving Credit Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to  time during the Commitment Period, during which period the Borrower may borrow, prepay and reborrow in accordance with the provisions hereof. Immediately after making each Revolving  Credit Loan and after giving effect to all Swing Line Loans and Competitive Bid Loans repaid and all Reimbursement Obligations paid on the same date, the Aggregate Credit Exposure will not exceed the Aggregate Commitment Amount. With respect to each Lender, at the time of the making of any Revolving Credit Loan, the sum of (I) the principal amount of such Lender&#8217;s Revolving Credit Loan constituting a part of the Revolving Credit Loans to be made, (II) the aggregate principal balance of all other Revolving Credit Loans (exclusive of Revolving Credit Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding from such Lender and (III) the product of (A) such Lender&#8217;s Commitment Percentage and (B) the sum of (1) the aggregate principal balance of all Swing Line Loans (exclusive of Swing Line Loans which are repaid with the proceeds of, and simultaneously with the incurrence of, the Revolving Credit Loans to be made) then outstanding and (2) the Letter of Credit Exposure of all Lenders, will not exceed the Commitment of such Lender at such time.    </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At the option of the Borrower, indicated in a Borrowing Request, Revolving Credit Loans may be made as ABR Advances or Eurodollar Advances.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The aggregate outstanding principal balance of all Revolving Credit Loans shall    be due and payable on the Commitment Termination Date or on such earlier date upon which all     of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Swing Line Loans</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to the terms and conditions hereof and in reliance upon the agreements of the other Lenders set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Swing Line Lender agrees to make loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Loans&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the Borrower from time to time during the Swing Line Commitment Period. Swing Line Loans (i) may be repaid and reborrowed in accordance with the provisions hereof, (ii) shall not, immediately after giving effect thereto, result in the Aggregate Credit Exposure exceeding the Aggregate Commitment Amount, and (iii) shall not, immediately after giving effect thereto, result  in the aggregate outstanding principal balance of all Swing Line Loans exceeding the Swing Line Commitment. The Swing Line Lender shall not be obligated to make any Swing Line Loan at a   time when any Lender is a Defaulting Lender unless the Swing Line Lender has entered into arrangements satisfactory to it and the Borrower to eliminate the Swing Line Lender&#8217;s risk with respect to such Defaulting Lender&#8217;s participation in such Swing Line Loan. The Swing Line Lender will not make a Swing Line Loan if the Administrative Agent or any Lender, by notice to the Swing Line Lender and the Borrower no later than one Domestic Business Day prior to the Borrowing  Date with respect to such Swing Line Loan, shall have determined that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived and such conditions remain unsatisfied as of the requested time of the making of such Loan. Each Swing Line Loan shall be due and payable on the day (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Maturity Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) being the earliest of the tenth Domestic Business Day after such Swing Line Loan is made, the date on which the Swing Line Commitment shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the date on which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise. Each Swing Line Loan shall bear interest at the Negotiated Rate (or, if the Negotiated Rate is not available, the LIBOR Daily Floating Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin). The Swing Line Lender shall disburse    the proceeds of Swing Line Loans at its office designated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting such proceeds to an account of the Borrower maintained with the Swing Line Lender.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;On any Domestic Business Day, the Swing Line Lender may, in its sole discretion, give notice to the Lenders and the Borrower that such outstanding Swing Line Loan shall be funded with a borrowing of Revolving Credit Loans (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such notice shall be deemed to have been automatically given upon the occurrence of a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), in which case a borrowing of Revolving Credit Loans made as ABR Advances (each such borrowing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Mandatory Borrowing&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by all Lenders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> based on each such Lender&#8217;s Commitment Percentage on the Domestic Business Day immediately  succeeding the giving of such notice. The proceeds of each Mandatory Borrowing shall be remitted directly to the Swing Line Lender to repay such outstanding Swing Line Loan. Each Lender irrevocably agrees to make a Revolving Credit Loan pursuant to each Mandatory Borrowing in the amount and in the manner specified in the preceding sentence and on the date specified in writing  by the Swing Line Lender notwithstanding&#58; (i) whether the amount of such Mandatory Borrowing complies with the minimum amount for Loans otherwise required hereunder, (ii) whether any condition specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> is then unsatisfied, (iii) whether a Default then exists, (iv) the Borrowing Date of such Mandatory Borrowing, (v) the aggregate principal amount of all Loans   </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then outstanding, (vi) the Aggregate Credit Exposure at such time and (vii) the amount of the Commitments at such time.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Upon each receipt by a Lender of a notice from the Administrative Agent, such Lender shall purchase unconditionally, irrevocably, and severally (and not jointly) from the Swing Line Lender a participation in the outstanding Swing Line Loans (including accrued interest  thereon) in an amount equal to the product of its Commitment Percentage and the outstanding balance of the Swing Line Loans (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Swing Line Participation Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Each Lender shall also be liable for an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard    to the occurrence of any Default or the compliance by the Borrower with any of its obligations  under the Loan Documents.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In furtherance of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each receipt by a Lender of a notice from    the Administrative Agent, such Lender shall promptly (and, in any event, no later than the Domestic Business Day immediately succeeding the giving of such notice) make available to the Administrative Agent for the account of the Swing Line Lender its Swing Line Participation  Amount at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in Dollars and in immediately available funds. The Administrative Agent shall deliver the payments made by each Lender pursuant to the immediately preceding sentence to the Swing Line Lender promptly upon receipt thereof in like funds as received. Each Lender hereby indemnifies and agrees to hold harmless the Administrative Agent and the Swing Line Lender from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and   expenses resulting from any failure on the part of such Lender to pay, or from any delay in paying, the Administrative Agent any amount such Lender is required by notice from the Administrative Agent to pay in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or the Swing Line Lender, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or the Swing Line Lender, as the case may be), and such Lender shall pay interest to the Administrative Agent   for the account of the Swing Line Lender from the date such amount was due until paid in full, on the unpaid portion thereof, at a rate of interest per annum, whether before or after judgment, equal  to (i) from the date such amount was due until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, payable upon demand by the Swing Line Lender. The Administrative Agent shall distribute such interest payments to the Swing Line Lender upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Whenever the Administrative Agent is reimbursed by the Borrower for the account of the Swing Line Lender for any payment in connection with Swing Line Loans and such payment relates to an amount previously paid by a Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent will promptly remit such payment to such Lender.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notice of Borrowing Revolving Credit Loans and Swing Line Loans</font></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to notify the Administrative Agent (and with respect to a Swing Line Loan,  the Swing Line Lender), which notification shall be irrevocable, no later than (a) 2&#58;00 P.M., on the proposed Borrowing Date in the case of Swing Line Loans, (b) 12&#58;00 Noon on the proposed Borrowing Date in the case of Revolving Credit Loans to consist of ABR Advances and (c) 12&#58;00 Noon at least three Eurodollar Business Days prior to the proposed Borrowing Date in the case of Revolving Credit Loans to consist of Eurodollar Advances. Each such notice shall specify (i) the aggregate amount requested to be borrowed under the Commitments or the Swing Line Commitment, (ii) the proposed Borrowing Date, (iii) whether a </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">borrowing of Revolving Credit Loans is to be made as an ABR Advance, one or more Eurodollar Advances, or both, and the amount of each thereof, (iv) the Eurodollar Interest Period for each such Eurodollar Advance and (v) the amount of each Swing Line Loan. Each such notice shall be promptly confirmed by delivery to the Administrative Agent (and, with respect to a Swing Line Loan, the Swing Line Lender) of     a Borrowing Request. Each Eurodollar Advance to be made on a Borrowing Date, when aggregated with    all amounts to be Converted to Eurodollar Advances on such date and having the same Interest Period as such Eurodollar Advance, shall equal no less than $10,000,000, or an integral multiple of $1,000,000 in excess thereof. Each ABR Advance made on each Borrowing Date shall equal no less than $5,000,000 or   an integral multiple of $500,000 in excess thereof. Each Swing Line Loan made on each Borrowing Date shall equal no less than $1,000,000 or an integral multiple of $500,000 in excess thereof. The  Administrative Agent shall promptly notify each Lender (by telephone or otherwise, such notification to be confirmed by fax, email or other writing) of each such Borrowing Request. Subject to its receipt of each  such notice from the Administrative Agent and subject to the terms and conditions hereof, (A) each Lender shall make immediately available funds available to the Administrative Agent at the address therefor set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on each Borrowing Date in an amount equal to such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans requested by the Borrower on such Borrowing Date and&#47;or (B) the Swing Line Lender shall make immediately available funds available to the Borrower on  such Borrowing Date in an amount equal to the Swing Line Loan requested by the Borrower.</font></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Competitive Bid Loans and Procedure</font></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to the terms and conditions hereof, the Borrower may request competitive bid loans in Dollars under this Agreement (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Competitive Bid Loan&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the  Commitment Period. In order to request Competitive Bids, the Borrower shall deliver by hand, fax or email to the Administrative Agent a duly completed and executed Competitive Bid Request not later than 12&#58;00 Noon, one Domestic Business Day before the proposed Borrowing Date therefor.   A Competitive Bid Request that does not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent in the Administrative Agent&#8217;s reasonable discretion, and the Administrative Agent shall promptly notify the Borrower of such rejection by fax or email and by telephone. Each Competitive Bid Request shall specify (x) the proposed Borrowing Date for the Competitive Bid Loans then being requested (which shall be a Domestic Business Day) and the aggregate principal amount thereof and (y) the Competitive Interest Period or Competitive Interest Periods (which shall not exceed ten different Interest Periods in a single Competitive Bid Request), with respect thereto (which may not end after the Domestic Business Day immediately preceding  the Commitment Termination Date). Promptly after its receipt of each Competitive Bid Request   that is not rejected as aforesaid, the Administrative Agent shall invite by fax or email (substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Lenders (other than any Defaulting Lender) to bid, on the terms and conditions of this Agreement, to make Competitive Bid Loans pursuant to such Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Lender (other than any Defaulting Lender), in its sole and absolute discretion, may make one or more Competitive Bids to the Borrower responsive to a Competitive Bid Request. Each Competitive Bid by a Lender must be received by the Administrative Agent not later than 10&#58;00 A.M. on the proposed Borrowing Date for the relevant Competitive Bid Loan. Multiple bids will be accepted by the Administrative Agent. Bids to make Competitive Bid Loans that, in the reasonable judgment of the Administrative Agent, do not conform to the Competitive Bids solicited by the related Competitive Bid Request shall be rejected by the Administrative Agent. Competitive Bids that do not conform substantially to the format of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may be rejected by the Administrative Agent after conferring with, and upon the instruction of, the Borrower, and the Administrative Agent shall notify the Lender making such nonconforming bid of such rejection as soon as practicable. Each Competitive Bid shall be irrevocable and shall specify (x) the principal </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">amount (which (1) shall be in a minimum principal amount of $10,000,000 or an integral multiple  of $1,000,000 in excess thereof, and (2) may equal the entire principal amount requested by the Borrower) of the Competitive Bid Loan or Competitive Bid Loans that the Lender is willing to  make to the Borrower, (y) the Competitive Bid Rate or Competitive Bid Rates at which the Lender  is prepared to make such Competitive Bid Loan or Competitive Bid Loans, and (z) the Competitive Interest Period with respect to each such Competitive Bid Loan and the last day thereof. If any Lender shall elect not to make a Competitive Bid, such Lender shall so notify the Administrative Agent by fax or email not later than 10&#58;00 A.M. on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the failure by any Lender to give any such notice shall not obligate such Lender to make any Competitive Bid Loan in connection with the relevant Competitive Bid Request.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;With respect to each Competitive Bid Request, the Administrative Agent shall (i) notify the Borrower by fax or email by 11&#58;00 A.M. on the proposed Borrowing Date with respect thereto of each Competitive Bid made, the Competitive Bid Rate applicable thereto and the identity of the Lender that made such Competitive Bid, and (ii) send a list of all Competitive Bids to the Borrower for its records as soon as practicable after completion of the bidding process. Each notice and list sent by the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall list the Competitive Bids in ascending yield order.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Borrower may, in its sole and absolute discretion, subject only to the  provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, accept or reject any Competitive Bid made in accordance with the procedures set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall notify the Administrative Agent by telephone, confirmed by fax or email in the form of a duly completed and executed Competitive   Bid Accept&#47;Reject Letter, whether and to what extent it has decided to accept or reject any or all of such Competitive Bids not later than 12&#58;00 Noon on the proposed Borrowing Date therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure by the Borrower to give such notice shall be deemed to be a rejection of    all such Competitive Bids. In connection with each acceptance of one or more Competitive Bids    by the Borrower&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the Borrower shall not accept a Competitive Bid of a given tenor made at    a particular Competitive Bid Rate if the Borrower has decided to reject a Competitive Bid having the same tenor made at a lower Competitive Bid Rate unless the acceptance of such Competitive Bid made at a lower Competitive Bid Rate would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents, in which case the Borrower may reject such Competitive Bid made    at a lower Competitive Bid Rate,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the aggregate amount of the Competitive Bids accepted by the Borrower shall not exceed the principal amount specified in the Competitive Bid Request therefor,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;if the Borrower shall desire to accept a Competitive Bid made at a  particular Competitive Bid Rate, it must accept all other Competitive Bids at such Competitive Bid Rate, except for any such Competitive Bid the acceptance of which would subject the Borrower to any requirement to withhold any taxes or deduct any amount from any amounts payable under the Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the acceptance of all   such other Competitive Bids would cause the aggregate amount of all such accepted Competitive Bids to exceed the amount requested, then such acceptance shall be made pro rata in accordance with the amount of each such Competitive Bid at such Competitive Bid Rate,</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;except pursuant to clause (3) above, no Competitive Bid shall be accepted unless the Competitive Bid Loan with respect thereto shall be in a minimum principal amount of $10,000,000 or an integral multiple of $1,000,000 in excess thereof, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;no Competitive Bid shall be accepted and no Competitive Bid Loan shall  be made, if immediately after giving effect thereto, the Aggregate Credit Exposure would exceed the Aggregate Commitment Amount.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Administrative Agent shall promptly fax or email to each bidding Lender   (with a copy to the Borrower) a Competitive Bid Accept&#47;Reject Letter advising such Lender  whether its Competitive Bid has been accepted (and if accepted, in what amount and at what Competitive Bid Rate), and each successful bidder so notified will thereupon become bound,  subject to the applicable conditions hereof, to make the Competitive Bid Loan in respect of which each of its Competitive Bids has been accepted by making immediately available funds available    to the Administrative Agent at its address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> not later than 1&#58;00 P.M. on the Borrowing Date for such Competitive Bid Loan in the amount thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Anything herein to the contrary notwithstanding, if the Administrative Agent shall elect to submit a Competitive Bid in its capacity as a Lender, it shall submit such bid directly to the Borrower not later than 9&#58;30 A.M. on the relevant proposed Borrowing Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;All notices required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be given in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Each Competitive Bid Loan shall be due and payable on the last day of the Competitive Interest Period applicable thereto or on such earlier date upon which the Loans shall become due and payable pursuant to the provisions hereof, whether by acceleration or otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that the proceeds of the Loans and Letters of Credit shall be used solely for    its general corporate purposes, but not inconsistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or any other provision of this Agreement, including, without limitation, the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and not in contravention of any applicable law, rule or regulation.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Termination, Reduction or Increase of Commitments</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination on Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless previously terminated, the Commitments and the Letter of Credit Commitment shall terminate on the Commitment  Termination Date and the Swing Line Commitment shall terminate on the Swing Line Termination Date.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary Termination or Reductions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. At the Borrower&#8217;s option in its sole and absolute discretion and upon at least one Domestic Business Day&#8217;s prior irrevocable notice to the Administrative Agent, the Borrower may (i) terminate the Commitments, the Swing Line Commitment and the Letter of Credit Commitment, at any time, or (ii) permanently reduce the Aggregate Commitment Amount, the Swing Line Commitment or the Letter of Credit   Commitment, in part at any time and from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (1) each such partial reduction shall be in an amount equal to at least $5,000,000 or an integral multiple of $1,000,000 in excess thereof and (2) immediately after giving effect to each such reduction, (A) the Aggregate Commitment Amount shall equal or exceed the Aggregate Credit Exposure, (B) the Swing Line </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commitment shall equal or exceed the aggregate outstanding principal balance of all Swing Line Loans and (C) the Letter of Credit Commitment shall equal or exceed the Letter of Credit Exposure of all Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, (x) notwithstanding the foregoing, a notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment delivered by the Borrower may state that such notice is conditioned upon the effectiveness of other credit facilities or transactions (such notice to specify the proposed effective date), in which case such notice may be revoked by the Borrower (by notice to the Administrative Agent on or prior to such specified effective date) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable and (y) the Administrative Agent and the Lenders who are a party to the Existing 364-Day Credit Agreement hereby (i) acknowledge and agree that the Existing 364-Day Credit Agreement shall be terminated and have no further force   and effect on and as of the Effective Date (other than those provisions which by their terms expressly survive the termination thereof), (ii) acknowledge and agree that the &#34;Expiration Date&#34;</font><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (as</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">defined in the Existing 364-Day Credit Agreement) shall be deemed to have occurred on the Effective Date, (iii) acknowledge and agree that no Loans or other amounts are outstanding under the Existing 364-Day Existing Credit Agreement, and (iv) waive any notice requirement pursuant   to Section 2.6 of the Existing 364-Day Credit Agreement.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each reduction of the Aggregate Commitment Amount shall be made  by reducing each Lender&#8217;s Commitment Amount by an amount equal to the product of such Lender&#8217;s Commitment Percentage and the amount of such reduction.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Increase in Aggregate Commitment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower may at any time and from time to time prior to the 90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day prior to the then-applicable Commitment Termination Date,  at its sole cost and expense, request any one or more of the Lenders having a Commitment to increase its Commitment Amount (the decision to increase the Commitment Amount of a Lender    to be within the sole and absolute discretion of such Lender), or any Eligible Assignee to provide     a new Commitment, by submitting to the Administrative Agent a Commitment Increase  Supplement, duly executed and delivered by the Borrower and each such Lender increasing its Commitment Amount or Eligible Assignee providing a new Commitment, as the case may be.   Upon receipt of any such Commitment Increase Supplement, the Administrative Agent, the Swing Line Lender and each Issuer shall promptly execute and deliver such Commitment Increase Supplement and the Administrative Agent shall deliver a copy thereof to the Borrower and each such Lender or Eligible Assignee, as the case may be. Upon execution and delivery of such Commitment Increase Supplement by the Administrative Agent, the Swing Line Lender and each Issuer, (i) in the case of each such Lender increasing its Commitment Amount (an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Increasing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), its Commitment Amount shall be increased to the amount set forth in such Commitment Increase Supplement, and (ii) in the case of each such Eligible Assignee providing a new Commitment (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">New Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), such New Lender shall become a party hereto and have the rights and obligations of a Lender under the Loan Documents and its Commitment shall be as set forth in such Commitment Increase Supplement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;immediately after giving effect thereto, the sum of all increases in the Aggregate Commitment Amount made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not exceed $500,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;each such increase of the Aggregate Commitment Amount shall be in an amount not less than $25,000,000 or such amount plus an integral multiple of $5,000,000&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that an increase may be in a lesser amount if such increase is an increase of the entire remaining amount available under clause (1) above&#59;</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;no Default shall have occurred or be continuing on the effective date of    the increase&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;the representations and warranties contained in this Agreement shall be   true and correct in all material respects with the same effect as though such representations and warranties had been made on the effective date of such increase (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein)    in all respects on such effective date), except those which are expressly specified to be  made as of an earlier date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;in the case of each New Lender, the Commitment Amount assumed by  such New Lender shall not be less than $25,000,000&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;if Revolving Credit Loans would be outstanding immediately after giving effect to any such increase, then simultaneously with such increase (A) each such  Increasing Lender, each such New Lender and each other Lender shall be deemed to have entered into a master assignment and assumption, in form and substance substantially similar to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pursuant to which each such other Lender shall have assigned to each such Increasing Lender and each such New Lender a portion of its Revolving Credit Loans necessary to reflect proportionately the Commitments as increased in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (B) in connection with such assignment, each such Increasing Lender and each such New Lender shall pay to the Administrative Agent, for the account of each such other Lender, such amount as shall be necessary to reflect the assignment to it of such Revolving Credit Loans, and in connection with such master assignment each such other Lender may treat the assignment of Eurodollar Advances as a prepayment of such Eurodollar Advances for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;each such New Lender shall have delivered to the Administrative Agent    an Administrative Questionnaire and to the Administrative Agent and the Borrower all forms, if any, that are required to be delivered by such New Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;at least five Domestic Business Days prior to the effectiveness of such increase, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered, to each Lender that so requests, a Beneficial Ownership Certification&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;the Administrative Agent shall have received such other customary certificates, resolutions and opinions as the Administrative Agent shall have reasonably requested.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Prepayments of Loans</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary Prepayments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, prepay Revolving Credit Loans, Competitive Bid Loans or Swing Line Loans, in whole or in part, without premium or penalty, but subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, at any time and from time to time, by notifying the Administrative Agent (which notice shall be in a form reasonably acceptable to the Administrative Agent) at least two Eurodollar Business Days, in the case of a prepayment of Eurodollar Advances, two Domestic Business Days, in the case of a prepayment of Competitive   Bid Loans, or one Domestic Business Day, in the case of a prepayment of Swing Line Loans or </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABR Advances, prior to the proposed prepayment date specifying (i) the Loans to be prepaid, (ii)  the amount to be prepaid, and (iii) the date of prepayment. Upon receipt of each such notice, the Administrative Agent shall promptly notify each Lender thereof. Each such notice given by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be irrevocable, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if a notice of prepayment  is given in connection with a conditional notice of termination of the Commitments, the Swing Line Commitment and the Letter of Credit Commitment as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such   notice of prepayment may be revoked if such notice of termination is revoked in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. Each partial prepayment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be (A) in the case of Eurodollar Advances, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Eurodollar Advances, (B) in the case of ABR Advances,  in a minimum amount of $1,000,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of ABR Advances, (C) in the case of Swing Line Loans, in a minimum amount of $500,000 or an integral multiple of $100,000 in excess thereof or the entire remaining amount of Swing Line Loans, and (D) in the case of Competitive Bid Loans, in a minimum amount of $5,000,000 or an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of Competitive Bid Loans.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Simultaneously with each prepayment hereunder, the Borrower shall prepay all accrued and unpaid interest on the amount prepaid through the date of prepayment and indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Letter of Credit Sub-facility</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Subject to the terms and conditions hereof and the payment by the Borrower to  each Issuer of such fees as the Borrower and such Issuer shall have agreed in writing, each Issuer severally (and not jointly) agrees, in reliance on the agreement of the other Lenders set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to issue standby or commercial letters of credit (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letters of Credit&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the Commitment Period for the account of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance of each Letter of Credit (i) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, (ii)   the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount, (iii) the   Letter of Credit Exposure of such Issuer shall not exceed the Letter of Credit Commitment of such Issuer, and (iv) the Commercial Letter of Credit Exposure of such Issuer shall not exceed the Commercial Letter of Credit Commitment of such Issuer. Each Letter of Credit shall have an expiration date which shall be not later than, in the case of standby Letters of Credit, the earlier to occur of one year from the date of issuance thereof or 5 days prior to the Commitment Termination Date and, in the case of commercial Letters of Credit, the earlier to occur of 180 days from the date of issuance thereof or 5 days prior to the Commitment Termination Date. No Letter of Credit shall be issued if the Administrative Agent, or any Lender by notice to the Administrative Agent, and    the proposed Issuer shall have determined, no later than 3&#58;00 P.M. one Domestic Business Day  prior to the requested date of issuance of such Letter of Credit, that the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have not been satisfied or waived.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Letter of Credit shall be issued at the request of the Borrower in support of    an obligation of the Borrower or any Subsidiary in favor of a beneficiary who has requested the issuance of such Letter of Credit. The Borrower shall give the Administrative Agent a Letter of Credit Request for the issuance of each Letter of Credit by 12&#58;00 Noon at least two Domestic Business Days prior to the requested date of issuance. Such Letter of Credit Request shall specify   (i) whether such Letter of Credit is a standby or commercial Letter of Credit, (ii) the beneficiary of such Letter of Credit and the obligations of the Borrower or the Subsidiary in respect of which such </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Letter of Credit is to be issued, (iii) the Borrower&#8217;s proposal as to the conditions under which a drawing may be made under such Letter of Credit and the documentation to be required in respect thereof, (iv) the maximum amount to be available under such Letter of Credit, (v) the requested   date of issuance, and (vi) the name of the proposed Issuer thereof. Upon receipt of such Letter of Credit Request from the Borrower, the Administrative Agent shall promptly notify the applicable Issuer and each Lender thereof. Such Issuer shall, on the proposed date of issuance and subject to  the terms and conditions of this Agreement, issue the requested Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that in   the event such Issuer fails to issue such Letter of Credit or is a Defaulting Lender, any other Issuer may (in its sole and absolute discretion, and notwithstanding that its Letter of Credit Exposure may exceed its Letter of Credit Commitment, but with (x) the consent of the Borrower and (y) notice to the Administrative Agent) issue such Letter of Credit otherwise in accordance with the terms  hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that immediately after the issuance thereof (A) the Letter of Credit Exposure of all Lenders shall not exceed the Aggregate Letter of Credit Commitment, and (B) the Aggregate Credit Exposure shall not exceed the Aggregate Commitment Amount. Each Letter of Credit shall be in form and substance reasonably satisfactory to the Issuer thereof, with such provisions with respect to the conditions under which a drawing may be made thereunder and the documentation required in respect of such drawing as such Issuer shall reasonably require. Each Letter of Credit shall be used solely for the purposes described therein. Each Letter of Credit Request and each Letter of Credit shall be subject to the standard terms and conditions for letters    of credit of the Issuer thereof (each as amended, supplemented or replaced from time to time, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Reimbursement Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) executed by the Borrower and delivered to such Issuer.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Each payment by an Issuer of a drawing under a Letter of Credit issued thereby shall give rise to the obligation of the Borrower to promptly (and in any event within one Domestic Business Day) reimburse such Issuer for the amount thereof (together with any interest). Such  Issuer shall promptly notify the Borrower of such payment by such Issuer of a drawing under a Letter of Credit. In lieu of such notice, if the Borrower has not made reimbursement prior to the   end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing, the Borrower hereby authorizes such Issuer to deduct the amount of any such reimbursement from such account(s) as the Borrower may from time to time designate in writing    to such Issuer, upon which such Issuer shall apply the amount of such deduction to such reimbursement. If all or any portion of any Reimbursement Obligation in respect of a Letter of Credit shall not be paid on the date that the Issuer thereof shall have made payment of a drawing under such Letter of Credit, the amount of such Reimbursement Obligation shall bear interest, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR Advances, from the date such Issuer made such payment of such drawing until the end of the Domestic Business Day following the day during which such Issuer made such payment of such drawing (whether at the stated maturity thereof, by acceleration or otherwise), and from and after such Domestic Business Day (whether at the stated maturity thereof, by acceleration or otherwise), such Reimbursement Obligation shall bear interest, payable upon demand, at a rate per annum equal to the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin applicable to ABR Advances </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, from such due date until paid in full (whether before or after the entry of a judgment thereon).</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;In the event of any conflict between the terms hereof and the terms of any Reimbursement Agreement or Letter of Credit Application, the terms hereof shall control.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Letter of Credit Participation</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Lender hereby unconditionally and irrevocably, severally (and not jointly) takes an undivided participating interest in the obligations of each Issuer under and in connection with each Letter of Credit issued thereby in an amount equal to such Lender&#8217;s Commitment </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Percentage (as in effect from time to time) of the amount of such Letter of Credit. Each Lender   shall be liable to each Issuer for its Commitment Percentage of the unreimbursed amount of any drawing honored under each Letter of Credit issued thereby. Each Lender shall also be liable for    an amount equal to the product of its Commitment Percentage and any amounts paid by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that are subsequently rescinded or avoided, or must otherwise be restored or returned. Such liabilities shall be unconditional and without regard to the occurrence of any Default or the compliance by the Borrower with any of its obligations under the Loan Documents.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Each Issuer shall promptly notify the Administrative Agent, and the   Administrative Agent shall promptly notify each Lender (which notice shall be promptly confirmed in writing), of the date and the amount of each drawing paid under each Letter of Credit issued by such Issuer with respect to which full reimbursement payment shall not have been made by the Borrower as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and forthwith upon receipt of such notice, such Lender   shall promptly make available to the Administrative Agent for the account of such Issuer its Commitment Percentage of the amount of such unreimbursed drawing at the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in Dollars and in immediately available funds. The Administrative Agent shall distribute the payments made by each Lender pursuant to the immediately preceding sentence to such Issuer promptly upon receipt thereof in like funds as received. Each Lender shall indemnify and hold harmless the Administrative Agent and each Issuer from and against any and all losses, liabilities (including liabilities for penalties), actions, suits, judgments, demands, costs and expenses (including, without limitation, reasonable attorneys&#8217; fees and expenses) resulting from any failure on the part of such Lender to provide, or from any delay    in providing, the Administrative Agent with such Lender&#8217;s Commitment Percentage of the amount of any payment made by such Issuer under a Letter of Credit issued by such Issuer in accordance with this clause (b) (except in respect of losses, liabilities or other obligations suffered by the Administrative Agent or such Issuer, as the case may be, resulting from the gross negligence or willful misconduct of the Administrative Agent or such Issuer, as the case may be). If a Lender   does not make available to the Administrative Agent when due an amount equal to such Lender&#8217;s Commitment Percentage of any unreimbursed payment made by an Issuer under a Letter of Credit issued thereby, such Lender shall be required to pay interest to the Administrative Agent for the account of such Issuer on the unpaid portion of such amount at a rate of interest per annum equal    to (i) from the date such Lender should have made such amount available until the third day therefrom, the Federal Funds Effective Rate, and (ii) thereafter, the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%, in each case payable upon demand by such Issuer. The Administrative Agent shall distribute such interest payments to such Issuer upon receipt thereof in like funds as received.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Whenever the Administrative Agent is reimbursed by the Borrower, for the   account of an Issuer, for any payment under a Letter of Credit issued thereby and such payment relates to an amount previously paid by a Lender in respect of its Commitment Percentage of the amount of such payment under such Letter of Credit, the Administrative Agent (or such Issuer, if such payment by a Lender was paid by the Administrative Agent to such Issuer) will promptly pay over such payment to such Lender.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Absolute Obligation with respect to Letter of Credit Payments</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower&#8217;s obligation to reimburse the Administrative Agent for the account of an Issuer for each payment under or in respect of each Letter of Credit issued thereby shall be absolute and unconditional under any and all circumstances and irrespective of any set-off, counterclaim or defense to payment which the Borrower may have or have had against the beneficiary of such Letter of Credit, the Administrative Agent, such Issuer, the Swing Line Lender, any Lender or any other Person, including, without limitation, </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any defense based on the failure of any drawing to conform to the terms of such Letter of Credit, any drawing document proving to be forged, fraudulent or invalid, or the legality, validity, regularity or enforceability of such Letter of Credit&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, with respect to any Letter of Credit, the foregoing  shall not relieve the Issuer thereof of any liability it may have to the Borrower for any actual damages sustained by the Borrower arising from a wrongful payment (or failure to pay) under such Letter of Credit made as a result of such Issuer&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Lender may request that the Loans made by it be evidenced by a Note. In such event, the Borrower shall prepare, execute and deliver to such Lender a Note payable to such Person or, if requested  by such Person, such Person and its registered assigns.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Extension of Commitment Termination Date</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Request for Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower may, in its sole and absolute discretion, by notice to the Administrative Agent (which shall promptly notify the Lenders) not more than 90    days and not less than 30 days prior to each of the first, second, third, fourth and fifth anniversary   of the Effective Date (each such anniversary date, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), request (each, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Extension Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the Lenders extend the Commitment Termination Date then in effect  (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Existing Commitment Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) for an additional one-year period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrower may only effect one such extension of the Commitment Termination Date. Each Lender, acting in its sole discretion, shall, by notice to the Borrower and the Administrative Agent given not later than the 20th day (or such later day as shall be acceptable to the Borrower) following the date of the Borrower&#8217;s notice, advise the Borrower and the Administrative Agent whether or   not such Lender agrees to such extension&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Lender (which includes each Issuer   and the Swing Line Lender) that does not so advise the Borrower and the Administrative Agent  shall be deemed to have rejected such Extension Request. The election of any Lender to agree to such extension shall not obligate any other Lender to so agree.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement of Non-Extending Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall have the right at any time on or prior to the relevant Extension Date to replace any Lender which has not consented to   the Extension Request (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Non-Extending Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Agreement to the contrary, the extension of the Existing Commitment Termination Date on any Extension Date shall not be effective unless, immediately before and after giving effect to such extension on such Extension Date&#58; (i) no Default shall have occurred and be continuing on such Extension Date and the representations and warranties contained in this Agreement shall be true   and correct in all material respects with the same effect as though such representations and warranties had been made on such Extension Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such Extension Date), except   those which are expressly specified to be made as of an earlier date, and the Administrative Agent shall have received a certificate, in form and substance reasonably satisfactory to the   Administrative Agent, to such effect from an Authorized Officer of the Borrower (or such other financial officer reasonably acceptable to the Administrative Agent), and (ii) the Administrative Agent shall have received such other customary certificates, resolutions and opinions as the Administrative Agent may reasonably request.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effectiveness of Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If (and only if) the conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall have been satisfied or waived with respect to the extension of the Existing  Commitment Termination Date on the applicable Extension Date, then, effective as of such Extension Date, the Commitment Termination Date, with respect to the Commitment of each  Lender that has agreed to so extend its Commitment and of each Replacement Lender that has assumed a Commitment of a Non-Extending Lender in connection with such Extension Request, shall be extended to the date falling one year after the Existing Commitment Termination Date (or,  if such date is not a Domestic Business Day, the immediately preceding Domestic Business Day), and each such Replacement Lender shall thereupon become a &#8220;Lender&#8221; for all purposes of this Agreement. Notwithstanding anything herein to the contrary, (i) with respect to any portion of the Commitment of any Non-Extending Lender that has not been fully assumed by one or more Replacement Lenders, the Commitment Termination Date for such Lender with respect to such   non-assumed portion of its Commitment shall remain unchanged, and (ii) with respect to any Loans of such Lender that have not been purchased by one or more Replacement Lenders, the applicable maturity date with respect to such non-purchased Loans shall remain unchanged and shall be repayable by the Borrower on such applicable maturity date without there being any requirement that any such repayment be shared with other Lenders. In addition, on the Extension Date, the Borrower agrees to pay all accrued and unpaid interest, fees and other amounts then due under this Agreement from the Borrower to each Lender consenting to the Extension Request, each            Non-Extending Lender and each Replacement Lender. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Non-Extending Lender of any Eurodollar Advance prior to the last day of the Interest Period applicable thereto in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to constitute a prepayment by the Borrower of such Eurodollar Advance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Defaulting Lenders</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Facility Fees shall cease to accrue, and shall not be payable, on the unfunded  portion of the Commitment of such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Commitment and Credit Exposure of such Defaulting Lender shall not be included in determining whether all Lenders or the Required Lenders have taken or may take any action hereunder (including any consent to any amendment or waiver pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, any waiver, amendment or modification with respect to the following shall require the consent of such Defaulting Lender&#58; (i) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender which affects such Defaulting Lender in a manner that is materially adverse in comparison to the other affected Lenders, (ii) any waiver, amendment or modification increasing the Commitment of such  Defaulting Lender, (iii) any waiver, amendment or modification extending the Commitment Period with respect to such Defaulting Lender, (iv) any waiver, amendment or modification reducing the principal amount owed under the Loan Documents to such Defaulting Lender (other than by payment thereof), or (v) any waiver, amendment or modification extending the final maturity of sums owed to such Defaulting Lender, or (vi) a modification of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;if any Swing Line Exposure or Letter of Credit Exposure exists at the time a Lender becomes a Defaulting Lender then&#58;</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;all or any part of such Defaulting Lender&#8217;s Swing Line Exposure and   Letter of Credit Exposure shall be reallocated among the non-Defaulting Lenders in accordance with their respective Commitment Percentages but only to the extent that (A)  the sum of all non-Defaulting Lenders&#8217; Committed Credit Exposures </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lenders, does not exceed the total of   all non-Defaulting Lenders&#8217; Commitments and (B) with respect to each non-Defaulting Lender, the sum of such non-Defaulting Lender&#8217;s Committed Credit Exposure </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,   without duplication, the amount of such Defaulting Lender&#8217;s Swing Line Exposure and Letter of Credit Exposure reallocated to such non-Defaulting Lender, does not exceed such           non-Defaulting Lender&#8217;s Commitment&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;if the reallocation described in clause (1) above cannot, or can only partially, be effected, the Borrower shall within one Domestic Business Day following notice by the Administrative Agent (A) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, prepay such Swing Line Exposure and (B) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, cash collateralize such Defaulting Lender&#8217;s Letter of Credit Exposure (after giving effect to any partial reallocation pursuant to clause (1) above) in a manner reasonably satisfactory to the Administrative Agent and the Issuers of the Letters of Credit of which shall be outstanding at such time for so long as such Letter of Credit Exposure is outstanding&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s Letter of Credit Exposure pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to pay any Letter of Credit Participation Fees to such Defaulting Lender pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to such Defaulting Lender&#8217;s Letter of Credit Exposure during the period such Defaulting Lender&#8217;s Letter of Credit Exposure is cash collateralized&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;if the Swing Line Exposure or Letter of Credit Exposure of such   Defaulting Lender is reallocated pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the fees payable to  the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> Section 3.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be adjusted to give effect to  such reallocation, and the Administrative Agent shall promptly notify the Lenders of any reallocation described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;so long as any Lender is a Defaulting Lender, the Swing Line Lender shall not be required to fund any Swing Line Loan and no Issuer shall be required to issue, amend, extend or increase any Letter of Credit, unless it is satisfied that the related exposure will be 100% covered   by the Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and participating interests in any such newly issued, amended, extended or increased Letter of Credit or newly funded Swing Line Loan shall be allocated among non-Defaulting Lenders in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and Defaulting Lenders shall not participate therein)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;any amount payable to such Defaulting Lender hereunder (whether on account of principal, interest, fees or otherwise and including any amount that would otherwise be payable to such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> but excluding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and other than any amount constituting Facilities Fees or Letter of Credit Participation Fees which are not payable to such Defaulting Lender in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 2.13(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">2.13(c)(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall, in lieu of being distributed to such Defaulting Lender, be retained by the Administrative Agent in a segregated account and, subject to any applicable requirements of law, be applied at such time or times as may be determined by the Administrative Agent (i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder, (ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata, to the payment of </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any amounts owing by such Defaulting Lender to the Issuers and the Swing Line Lender hereunder, (iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower or if requested by any Issuer or the Swing Line Lender, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any existing or future participating interest in any Swing Line Loan or Letter of Credit, (iv) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the funding of any Revolving Credit Loan (including any Mandatory Borrowing) in respect of which such Defaulting Lender has failed to   fund its portion thereof as required by this Agreement, as determined by the Administrative Agent, (v) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if so determined by the Administrative Agent and the Borrower, held in such account as cash collateral for future funding obligations of the Defaulting Lender in respect of any Revolving Credit Loans (including any Mandatory Borrowings) under this Agreement, (vi) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Lenders, the Issuers or the Swing Line Lender as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by any Lender, any Issuer or the Swing Line Lender against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, (vii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">seventh</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of any amounts owing to the Borrower as a result of any final and non-appealable judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender&#8217;s breach of its obligations under this Agreement, and (viii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">eighth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such payment is (x) a prepayment of the principal amount of any Revolving Credit Loan (including any Mandatory Borrowing) or Reimbursement Obligations in respect of drawings under Letters of Credit paid by an Issuer with respect to which a Defaulting Lender has funded its participation obligations and (y) made at a time when the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are satisfied or waived, such payment shall be applied solely to prepay the Revolving Credit Loans (including Mandatory Borrowings) of, and Reimbursement Obligations owed to, all non-Defaulting Lenders pro rata prior to being applied to the prepayment of any Loans, or Reimbursement Obligations owed to, any Defaulting Lender&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;the Borrower shall have the right at any time during which a Lender is a Defaulting Lender to replace such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, no reallocation pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.13(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall   constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender arising from a Lender having become a Defaulting Lender, including any claim of a non-Defaulting Lender as a result of such non-Defaulting Lender&#8217;s increased exposure following such reallocation.</font></div><div style="margin-bottom:8pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;PROCEEDS, PAYMENTS, CONVERSIONS, INTEREST, YIELD PROTECTION AND FEES</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Disbursement of the Proceeds of the Loans</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall disburse the proceeds of the Loans (other than the Swing Line Loans) at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by crediting to the Borrower&#8217;s general deposit account with    the Administrative Agent the funds received from each Lender. Unless the Administrative Agent shall have received prior notice from a Lender (by telephone or otherwise, such notice to be confirmed by fax, email   or other writing) that such Lender will not make available to the Administrative Agent such Lender&#8217;s Commitment Percentage of the Revolving Credit Loans, or the amount of any Competitive Bid Loan, to be made by it on a Borrowing Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such Borrowing Date in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, in the case of a Revolving Credit Loan, such Lender received notice thereof from the Administrative Agent in accordance with the terms hereof, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower on such Borrowing Date a corresponding amount.    </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If and to the extent that such Lender shall not have so made such amount available to the Administrative Agent, such Lender and the Borrower severally agree to pay to the Administrative Agent, forthwith on demand, such corresponding amount (to the extent not previously paid by the other), together with interest thereon for each day from the date such amount is made available to the Borrower until the date such  amount is paid to the Administrative Agent, at a rate per annum equal to, in the case of the Borrower, the applicable interest rate set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in the case of such Lender, the Federal Funds Effective Rate from the date such payment is due until the third day after such date and, thereafter, at the Federal Funds Effective Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2%. Any such payment by the Borrower shall be without prejudice to its rights against such Lender. If such Lender shall pay to the Administrative Agent such corresponding  amount, such amount so paid shall constitute such Lender&#8217;s Loan as part of such Loans for purposes of this Agreement, which Loan shall be deemed to have been made by such Lender on the Borrowing Date applicable to such Loans.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Payments</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each payment, including each prepayment, of principal and interest on the Loans and of the Facility Fee and the Letter of Credit Participation Fee (collectively, together with all of the other fees to be paid to the Administrative Agent, the Lenders, the Issuers and the Swing Line Lender in connection with, and pursuant to the terms of, the Loan Documents, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Fees&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and of all of the other amounts to be paid to the Administrative Agent and the Lenders in connection with, and pursuant to the terms of, the Loan Documents (other than amounts payable to a Lender under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be made by the Borrower to the Administrative Agent at its office specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without condition, recoupment, defense, setoff, deduction or counterclaim in funds immediately available in New   York by 3&#58;00 P.M. on the due date for such payment. The failure of the Borrower to make any such payment by such time shall not constitute a default hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such payment is made on such due date, but any such payment made after 3&#58;00 P.M. on such due date shall be deemed to have been made on the next Domestic Business Day or Eurodollar Business Day, as the case may be, for the purpose of calculating interest on amounts outstanding on the Loans. If the Borrower    has not made any such payment prior to 3&#58;00 P.M., the Borrower hereby authorizes the Administrative Agent to deduct the amount of any such payment from such account(s) as the Borrower may from time to time designate in writing to the Administrative Agent, upon which the Administrative Agent shall apply the amount of such deduction to such payment. Promptly upon receipt thereof by the Administrative Agent, each payment of principal and interest on the&#58; (i) Revolving Credit Loans shall be remitted by the Administrative Agent in like funds as received to each Lender (a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of interest which is then due and payable to the Lenders, and (b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, pro rata according to the amount of principal which is then due and payable to the Lenders, (ii) Competitive Bid Loans shall be remitted by the Administrative Agent   in like funds as received to each applicable Lender and (iii) Swing Line Loans shall be remitted by the Administrative Agent in like funds as received to the Swing Line Lender. Each payment of the Facility Fee and the Letter of Credit Participation Fee payable to the Lenders shall be promptly transmitted by the Administrative Agent in like funds as received to each Lender pro rata according to such Lender&#8217;s Commitment Amount or, if the Commitments shall have terminated or been terminated, according to the outstanding principal amount of such Lender&#8217;s Revolving Credit  Loans.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If any payment hereunder or under the Loans shall be due and payable on a day which is not a Domestic Business Day or a Eurodollar Business Day, as the case may be, the due date thereof (except as otherwise provided in the definition of Eurodollar Interest Period or Competitive Interest Period) shall be extended to the next Domestic Business Day or Eurodollar Business Day, as the case may be, and (except with respect to payments in respect of the Facility  </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fee and the Letter of Credit Participation Fee) interest shall be payable at the applicable rate specified herein during such extension.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Unless the Administrative Agent shall have received notice from the Borrower  prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders or any of the Issuers hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the applicable  Lenders or the applicable Issuers, as the case may be, the amount due.  With respect to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any payment that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Administrative Agent makes for the account of the Lenders or any of the Issuers hereunder as to which the Administrative Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Rescindable Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) &#58; (1) the Borrower has not in fact made such payment&#59; (2) the Administrative Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed)&#59; or   (3) the Administrative Agent has for any reason otherwise erroneously made such payment&#59; then each of the Lenders or the applicable Issuers, as the case may be, severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount so distributed to such Lender  or such Issuer, in immediately available funds with interest thereon, for each day from and  including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Conversions&#59; Other Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Borrower may elect at any time and from time to time to Convert one or more Eurodollar Advances to an ABR Advance by giving the Administrative Agent at least one Domestic Business Day&#8217;s prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted. In addition, the Borrower may elect at any time and from time to time to Convert an ABR Advance to any one or more new Eurodollar Advances or to Convert any one or more existing Eurodollar Advances to any one or more new Eurodollar Advances by giving the Administrative Agent no later than 10&#58;00 A.M. at least two Eurodollar Business Days&#8217; prior irrevocable notice of such election (in the form of a Borrowing Request), specifying the amount to be so Converted and the initial Interest Period relating thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any Conversion of an ABR Advance to an Eurodollar Advance shall only be made on a Eurodollar Business Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, notwithstanding the foregoing, a Borrowing Request for a Conversion delivered by the Borrower may state that such Borrowing Request is conditioned upon the effectiveness of other credit facilities or transactions (such Borrowing   Request to specify the proposed effective date), in which case such Borrowing Request may be revoked by the Borrower (by notice to the Administrative Agent prior to the day specified for such Conversion in such Borrowing Request) if such condition is not satisfied and the Borrower shall indemnify the Lenders in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, if applicable. The Administrative Agent  shall promptly provide the Lenders with notice of each such election. Each Conversion of Loans shall be made pro rata according to the outstanding principal amount of the Loans of each Lender. ABR Advances and Eurodollar Advances may be Converted pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in whole  or in part&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the amount to be Converted to each Eurodollar Advance, when aggregated with any Eurodollar Advance to be made on such date in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and having  the same Interest Period as such first Eurodollar Advance, shall equal no less than $10,000,000 or  an integral multiple of $1,000,000 in excess thereof or the entire remaining amount of the  Eurodollar Advances.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding anything in this Agreement to the contrary, the Borrower shall    not have the right to elect to Convert any existing ABR Advance to a Eurodollar Advance or to Convert any existing Eurodollar Advance to a new Eurodollar Advance if (i) a Default or an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall then exist, or (ii) any other Event of Default shall then exist and the Administrative Agent shall  have notified the Borrower at the request of the Required Lenders that no ABR Advance or Eurodollar Advance may be Converted to a new Eurodollar Advance. In such event, such ABR Advance shall be automatically continued as an ABR Advance or such Eurodollar Advance shall   be automatically Converted to an ABR Advance on the last day of the Interest Period applicable to such Eurodollar Advance. The foregoing shall not affect any other rights or remedies that the Administrative Agent or any Lender may have under this Agreement or any other Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Each Conversion shall be effected by each Lender by applying the proceeds of   each new ABR Advance or Eurodollar Advance, as the case may be, to the existing ABR Advance or Eurodollar Advance (or portion thereof) being Converted (it being understood that such Conversion shall not constitute a borrowing for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Notwithstanding any other provision of any Loan Document&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;if the Borrower shall have failed to elect a Eurodollar Advance under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in connection with any borrowing of  new Revolving Credit Loans or expiration of an Interest Period with respect to any existing Eurodollar Advance, the amount of the Revolving Credit Loans subject to such borrowing  or such existing Eurodollar Advance shall thereafter be an ABR Advance until such time,   if any, as the Borrower shall elect a new Eurodollar Advance pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the Borrower shall not be permitted to select a Eurodollar Advance the Interest Period in respect of which ends later than the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the Borrower shall not be permitted to have more than (x) 15 Eurodollar Advances and (y) 15 Competitive Bid Loans outstanding at any one time&#59; it being understood and agreed that each borrowing of Eurodollar Advances or Competitive Bid Loans pursuant to a single Borrowing Request or Competitive Bid Request, as the case   may be, shall constitute the making of one Eurodollar Advance or Competitive Bid Loan  for the purpose of calculating such limitation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Rates and Payment Dates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Prior to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Except as otherwise provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.4(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Loans shall bear interest on the unpaid principal balance thereof at the applicable interest rate or rates per annum set forth below&#58;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.719%"><tr><td style="width:1.0%"></td><td style="width:36.458%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LOANS</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RATE</font></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revolving Credit Loans constituting ABR Advances</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin.</font></div></td></tr></table></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.875%"><tr><td style="width:1.0%"></td><td style="width:36.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:61.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Revolving Credit Loans constituting Eurodollar Advances</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Eurodollar Rate applicable thereto </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin.</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Competitive Bid Loans</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Fixed rate of interest applicable thereto accepted by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.4(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Swing Line Loans</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Negotiated Rate applicable thereto as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (or if not available, the LIBOR Daily Floating Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin).</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Late Payment Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any payment of principal or interest on the Loans, Fees or  other amounts payable by the Borrower under the Loan Documents not paid on the date when due and payable shall, after the occurrence and during the continuance of an Event of Default pursuant  to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, bear interest, in the case of principal or interest on    a Loan, at the applicable interest rate on such Loan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum and, in the case of any Fees or other amounts, at the Alternate Base Rate </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2% per annum, in  each case from the due date thereof until the date such payment is made (whether before or after   the entry of any judgment thereon).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Highest Lawful Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything to the contrary contained in this Agreement, at no time shall the interest rate payable to any Lender on any of its Loans, together  with the Fees and all other amounts payable hereunder to such Lender to the extent the same constitute or are deemed to constitute interest, exceed the Highest Lawful Rate. If, in respect of any period during the term of this Agreement, any amount paid to any Lender hereunder, to the extent the same shall (but for the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) constitute or be deemed to constitute interest, would exceed the maximum amount of interest permitted by the Highest Lawful Rate during such period (such amount being hereinafter referred to as an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Unqualified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), then (i) such Unqualified Amount shall be applied or shall be deemed to have been applied as a prepayment of the Loans of such Lender, and (ii) if, in any subsequent period during the term of   this Agreement, all amounts payable hereunder to such Lender in respect of such period which constitute or shall be deemed to constitute interest shall be less than the maximum amount of  interest permitted by the Highest Lawful Rate during such period, then the Borrower shall pay to such Lender in respect of such period an amount (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Compensatory Interest Payment&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) equal to the lesser of (x) a sum which, when added to all such amounts, would equal the maximum amount of interest permitted by the Highest Lawful Rate during such period, and (y) an amount equal to    the aggregate sum of all Unqualified Amounts </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> all other Compensatory Interest Payments.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Interest shall be payable in arrears on each Interest Payment Date, on the Commitment Termination Date, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, upon each prepayment of the Loans and, to the extent provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.12(d), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on the Extension Date. Any change in the interest rate on the Loans resulting from an increase or a decrease in the Alternate Base Rate or any reserve requirement shall become effective as of the opening of business on the day on which such change shall become effective.  Each determination by the Administrative Agent of the Alternate Base Rate, the Eurodollar Rate and the Competitive Bid Rate pursuant to this Agreement shall be conclusive and binding on the Borrower absent manifest error. The Borrower acknowledges that to the extent interest payable on the Loans is based on the Alternate Base Rate, such rate is only one   of the bases for computing interest on loans made by the Lenders, and by basing interest payable   on ABR Advances on the Alternate Base Rate, the Lenders have not committed to charge, and the Borrower has not in any way bargained for, interest based on a lower or the lowest rate at which    the Lenders may now or in the future make extensions of credit to other Persons. All interest (other </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">than interest calculated with reference to the Alternate Base Rate) shall be calculated on the basis   of a 360-day year for the actual number of days elapsed, and all interest determined with reference      to the Alternate Base Rate shall be calculated on the basis of a 365&#47;366-day year for the actual number of days elapsed.</font></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Warranty</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Administrative Agent does not warrant or accept responsibility for, and shall not have any liability with respect to, the administration, submission or any other matter related to the rates in the definition of &#8220;LIBO Rate&#8221;, &#8220;Eurodollar Rate&#8221;, &#8220;One Month LIBOR Rate&#8221;, &#8220;LIBOR Successor Rate&#8221; and &#8220;LIBOR Successor Rate Conforming Changes&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to any liability arising out of the bad faith, willful misconduct or gross negligence of the Administrative Agent.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnification for Loss</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything contained herein to the contrary, if&#58; (i) the Borrower shall fail to borrow   a Eurodollar Advance or if the Borrower shall fail to Convert all or any portion of any Revolving Credit Loan constituting an ABR Advance to a Eurodollar Advance after it shall have given notice to do so in which it shall have requested a Eurodollar Advance pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, (ii) the Borrower shall fail to borrow a Competitive Bid Loan after it shall have accepted any offer with respect thereto in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) a Eurodollar Advance or Competitive Bid Loan shall    be terminated for any reason prior to the last day of the Interest Period applicable thereto, (iv) any repayment or prepayment of the principal amount of a Eurodollar Advance or Competitive Bid Loan is made for any reason on a date which is prior to the last day of the Interest Period applicable thereto, (v) the Borrower  shall have revoked a notice of prepayment or notice of termination of the Commitments and the Letter of Credit Commitment that was conditioned upon the effectiveness of other credit facilities or transactions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (vi) a Eurodollar Advance is assigned other than on the last day    of the Interest Period applicable thereto as a result of an increase in the Aggregate Commitment Amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a replacement of a Lender pursuant to clause (x) or (z) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then  the Borrower agrees to indemnify each Lender against, and to pay on demand directly to such Lender the amount (calculated by such Lender using any method chosen by such Lender which is customarily used by such Lender for such purpose for borrowers similar to the Borrower) equal to any loss or expense suffered by such Lender as a result of such failure to borrow or Convert, or such termination, repayment, prepayment or revocation, including any loss, cost or expense suffered by such Lender in liquidating or employing deposits acquired to fund or maintain the funding of such Eurodollar Advance or Competitive Bid Loan, as the case may be, or redeploying funds prepaid or repaid, in amounts which correspond to such Eurodollar Advance or Competitive Bid Loan, as the case may be, and any reasonable internal processing charge customarily charged by such Lender in connection therewith for borrowers similar to the Borrower.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Reimbursement for Costs, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If at any time or from time to time there shall occur a Regulatory Change and any Issuer or any Lender shall have reasonably determined that such Regulatory Change (i) shall have had or will thereafter have the effect of reducing (A) the rate of return on such Issuer&#8217;s or such Lender&#8217;s capital or liquidity or    the capital or liquidity of any Person directly or indirectly owning or controlling such Issuer or such Lender (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Control Person&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (B) the asset value (for capital or liquidity purposes) to such Issuer, such Lender or such Control Person, as applicable, of the Reimbursement Obligations, or any participation therein, or the Loans, or any participation therein, in any case to a level below that which such Issuer, such Lender or such Control Person could have achieved or would thereafter be able to achieve but for such Regulatory Change (after taking into account such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s policies regarding capital or liquidity), (ii) will impose, modify or deem applicable any reserve, asset, special deposit or special assessment requirements on deposits obtained in the interbank Eurodollar market in connection </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with the Loan Documents (excluding, with respect to any Eurodollar Advance, any such requirement which is included in the determination of the rate applicable thereto), or (iii) will subject such Issuer, such Lender or such Control Person, as applicable, to any tax (documentary, stamp or otherwise) with respect to this Agreement, any Note, any Reimbursement Agreement or any other Loan Document (except, in the case of clause (iii) above, for any Indemnified Taxes, Excluded Taxes or Other Taxes), then, in each such case, within ten days after demand by such Issuer or such Lender, as applicable, the Borrower shall pay directly  to such Issuer, such Lender or such Control Person, as the case may be, such additional amount or amounts as shall be sufficient to compensate such Issuer, such Lender or such Control Person, as the case may be,   for any such reduction, reserve or other requirement, tax, loss, cost or expense (excluding general administrative and overhead costs) (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Costs&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) attributable to such Issuer&#8217;s, such Lender&#8217;s or such Control Person&#8217;s compliance during the term hereof with such Regulatory Change, but only if such Costs are generally applicable to (and for which reimbursement is generally being sought by such Issuer, such Lender or such Control Person, as applicable, in respect of) credit transactions similar to this transaction from similarly situated borrowers (which are parties to credit or loan documentation containing   a provision similar to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), as determined by such Issuer or such Lender, as applicable, in its reasonable discretion. Each Issuer and each Lender may make multiple requests for compensation under   this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Borrower will not be required to compensate any Issuer or any Lender for any Costs under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> arising prior to 45 days preceding the date of demand, unless  the applicable Regulatory Change giving rise to such Costs is imposed retroactively in which case the 45-day period referred to above shall be extended to include the period of retroactive effect thereof. In the case of retroactivity, such notice shall be provided to the Borrower not later than 45 days from the date that such Issuer or such Lender learned of such Regulatory Change. The Borrower&#8217;s obligation to compensate such Issuer or such Lender shall be contingent upon the provision of such timely notice (but any failure by such Issuer or such Lender to provide such timely notice shall not affect the Borrower&#8217;s obligations with respect to (i) Costs incurred from the date as of which such Regulatory Change became effective to the date that is 45 days after the date such Issuer or such Lender reasonably should have learned of such Regulatory Change and (ii) Costs incurred following the provision of such notice).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Illegality of Funding</font></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding any other provision hereof, if any Lender shall reasonably determine that any law, regulation, treaty or directive, or any change therein or in the interpretation or application thereof, shall  make it unlawful for such Lender to make or maintain any Eurodollar Advance as contemplated by this Agreement or to determine or charge interest rates based upon LIBOR, such Lender shall promptly notify the Borrower and the Administrative Agent thereof, and (a) the commitment of such Lender to make such Eurodollar Advances or Convert ABR Advances to such Eurodollar Advances shall forthwith be suspended, (b) such Lender shall fund its portion of each requested Eurodollar Advance as an ABR Advance, (c) such Lender&#8217;s Loans then outstanding as such Eurodollar Advances, if any, shall be Converted automatically to an ABR Advance on the last day of the then-current Interest Period applicable thereto or at such earlier   time as may be required and (d) if such notice asserts the illegality of such Lender making or maintaining ABR Advances the interest rate on which is determined by reference to One Month LIBOR Rate, the interest rate on which ABR Advances of such Lender shall, if necessary to avoid such illegality, be determined by the Administrative Agent without reference to the One Month LIBOR Rate component of the Alternate  Base Rate.  If the commitment of any Lender with respect to Eurodollar Advances is suspended pursuant    to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and such Lender shall have obtained actual knowledge that it is once again legal for such Lender to make or maintain Eurodollar Advances, such Lender shall promptly notify the Administrative Agent and the Borrower thereof and, upon delivery of such notice to each of the Administrative Agent and the Borrower, such Lender&#8217;s commitment to make or maintain Eurodollar Advances shall be reinstated. If </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the commitment of any Lender with respect to Eurodollar Advances is suspended pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, such suspension shall not otherwise affect such Lender&#8217;s Commitment.</font></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Option to Fund&#59; Substituted Interest Rate</font></div><div style="margin-bottom:7pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Lender has indicated that, if the Borrower requests a Eurodollar Advance or    a Competitive Bid Loan, such Lender may wish to purchase one or more deposits in order to fund  or maintain its funding of its Commitment Percentage of such Eurodollar Advance or Competitive Bid Loan during the Interest Period with respect thereto&#59; it being understood that the provisions of this Agreement relating to such funding are included only for the purpose of determining the rate    of interest to be paid in respect of such Eurodollar Advance or Competitive Bid Loan and any amounts owing under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Each Lender shall be entitled to fund and maintain its funding of all or any part of each Eurodollar Advance and Competitive Bid Loan in   any manner it sees fit, but all such determinations hereunder shall be made as if such Lender had actually funded and maintained its Commitment Percentage of each Eurodollar Advance or Competitive Bid Loan, as the case may be, during the applicable Interest Period through the purchase of deposits in an amount equal to the amount of its Commitment Percentage of such Eurodollar Advance or Competitive Bid Loan, as the case may be, and having a maturity corresponding to such Interest Period. Each Lender may fund its Loans from or for the account of any branch or office of such Lender as such Lender may choose from time to time, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event that (i) the Administrative Agent shall have determined in good faith (which determination shall be conclusive and binding upon the Borrower) that (A) Dollar deposits are not being offered to banks in the London interbank Eurodollar market for the applicable amount and Interest Period or (B)(1) if by reason of circumstances affecting the interbank Eurodollar  market adequate and reasonable means do not exist for ascertaining the Eurodollar Rate with  respect to a proposed Eurodollar Advance and (2) the circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> do not apply, or (ii) the Required Lenders shall have notified the Administrative Agent that they have in good faith determined (which determination shall be conclusive and binding on the Borrower) that the applicable Eurodollar Rate will not adequately and fairly reflect the cost to such Lenders of maintaining or funding loans bearing interest based on such Eurodollar Rate with   respect to any portion of the Revolving Credit Loans that the Borrower has requested be made as Eurodollar Advances or any Eurodollar Advance that will result from the requested Conversion of any portion of the Revolving Credit Loans into Eurodollar Advances (each, an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Affected Advance&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), the Administrative Agent shall promptly notify the Borrower and the Lenders (by telephone or otherwise, to be promptly confirmed in writing) of such determination on or, to the extent practicable, prior to the requested Borrowing Date or Conversion date for such Affected Advances. If the Administrative Agent shall give such notice, (A) any Affected Advances shall be made as ABR Advances, (B) the Revolving Credit Loans (or any portion thereof) that were to have been Converted to Affected Advances shall be Converted to or continued as ABR Advances, and  (C) any outstanding Affected Advances shall be Converted, on the last day of the then-current Interest Period with respect thereto, to ABR Advances. Until any notice under clauses (i) or (ii), as the case may be, of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has been withdrawn by the Administrative Agent (by notice to the Borrower) promptly upon either (x) the Administrative Agent having determined that such circumstances affecting the relevant market no longer exist and that adequate and reasonable means do exist for determining the Eurodollar Rate with respect to a proposed Eurodollar Advance, or (y) the Administrative Agent having been notified by the Required Lenders that circumstances no longer render the Loans (or any portion thereof) Affected Advances, no further Eurodollar  Advances shall be required to be made by the Lenders nor shall the Borrower have the right to Convert all or any portion of the Revolving Credit Loans to Eurodollar Advances.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event that the Administrative Agent shall have determined in good faith (which determination shall be conclusive and binding upon the Borrower absent manifest error)  that, by reason of circumstances affecting the interbank Eurodollar market, adequate and reasonable means do not exist for ascertaining the One Month LIBOR Rate and the circumstances described    in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> do not apply, the Administrative Agent shall promptly notify the Borrower and the Lenders (by telephone or otherwise, to be promptly confirmed in writing) of such determination. If the Administrative Agent shall give such notice, the Alternate Base Rate shall be determined without giving effect to clause (c) thereof until such time, if any, as such notice shall have been withdrawn by the Administrative Agent (by notice to the Borrower) promptly upon the Administrative Agent having determined that such circumstances affecting the relevant market no longer exist and that adequate and reasonable means do exist for determining the One Month  LIBOR Rate.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, but without limiting </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 3.8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> above, if the Administrative Agent and the Borrower determine that&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;adequate and reasonable means do not exist for ascertaining LIBOR for   any requested Eurodollar Interest Period and such circumstances are unlikely to be temporary, including, without limitation, because the LIBO Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary&#59; or</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the administrator of the LIBO Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent or such administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has made a public statement identifying a specific date after which LIBOR or the LIBO Screen Rate shall no longer be made available, or used for determining the interest rate of loans in the U.S. syndicated loan market denominated in Dollars&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, at the time of such  statement, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide LIBOR after such specific date (such specific date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Scheduled Unavailability Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; or</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the administrator of the LIBO Screen Rate or a Governmental Authority having jurisdiction over such administrator has made a public statement announcing that    all Eurodollar Interest Periods and other tenors of LIBOR are no longer representative&#59; or</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;syndicated loans currently being executed, or that include language similar to that contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, are generally being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR,</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">then, in the case of clauses (i)-(iii) above, on a date and time determined by the Administrative Agent and the Borrower (any such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Replacement Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which date shall be at the end of a Eurodollar Interest Period or on the relevant interest payment date, as applicable, for interest calculated and shall occur reasonably promptly upon the occurrence of any  of the events or circumstances under clause (i), (ii) or (iii) above and, solely with respect to clause (ii) above, no later than the Scheduled Unavailability Date, LIBOR will be replaced hereunder and under any other Loan Document with, subject to the proviso below, the first available alternative   set forth in the order below for any payment period for interest calculated that can be determined   by the Administrative Agent, in each case, without any amendment to, or further action or consent  of any other party to, this Agreement or any other Loan Document (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;&#59; and any such rate before giving effect to the Related Adjustment, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Pre-Adjustment Successor Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(x)&#160;&#160;&#160;&#160;Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Related Adjustment&#59; and</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(y) &#160;&#160;&#160;&#160;SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Related Adjustment&#59; </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and in the case of clause (iv) above, the Borrower and Administrative Agent may amend  this Agreement solely for the purpose of replacing LIBOR under this Agreement and under any other Loan Document in accordance with the definition of &#8220;LIBOR Successor Rate&#8221; and such amendment will become effective at 5&#58;00 p.m., on the fifth Domestic Business Day after the Administrative Agent shall have notified all Lenders and the Borrower of the occurrence of the circumstances described in clause (iv) above unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to the implementation of a LIBOR Successor Rate pursuant to such clause&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, if the Administrative Agent and the Borrower determine that Term SOFR   has become available, is administratively feasible for the Administrative Agent and would have        been identified as the Pre-Adjustment Successor Rate in accordance with the foregoing if it had  been so available at the time that the LIBOR Successor Rate then in effect was so identified, and   the Administrative Agent notifies each Lender of such availability, then from and after the  beginning of the Eurodollar Interest Period, relevant interest payment date or payment period for interest calculated, in each case, commencing no less than thirty (30) days after the date of such notice, the Pre-Adjustment Successor Rate shall be Term SOFR and the LIBOR Successor Rate shall be Term SOFR </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the relevant Related Adjustment.  </font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent will promptly (in one or more notices) notify the Borrower and each Lender of (x) any occurrence of any of the events, periods or circumstances under clauses (i) through (iii) above, (y) a LIBOR Replacement Date and (z) the LIBOR Successor Rate.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Any LIBOR Successor Rate shall be applied in a manner consistent with market practice&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that to the extent such market practice is not administratively feasible for the Administrative Agent, such LIBOR Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding anything else herein, if at any time any LIBOR Successor Rate as so determined would otherwise be less than zero, the LIBOR Successor Rate will be deemed to be   zero for the purposes of this Agreement and the other Loan Documents.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the implementation of a LIBOR Successor Rate, the Administrative Agent will have the right to make LIBOR Successor Rate Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such LIBOR Successor Rate Conforming Changes in the discretion of the Administrative Agent and in consultation with the Borrower will become effective without any further action or consent of any other party to this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, with respect to any such amendment effected, the Administrative Agent shall post each such amendment implementing such LIBOR Successor Rate Conforming Changes to the Borrower and the Lenders reasonably promptly after such amendment becomes effective.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">LIBOR Successor Rate Conforming Changes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, with respect to any proposed LIBOR Successor Rate, any conforming changes to the definitions of Alternate Base Rate, Eurodollar Interest Period and One Month LIBOR Rate, timing and frequency of determining rates and making payments of interest  and other technical, administrative or operational matters as may be appropriate, in the discretion    of the Administrative Agent in consultation with the Borrower, to reflect the adoption of such LIBOR Successor Rate and to permit the administration thereof by the Administrative Agent in a </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">manner substantially consistent with market practice (or, if the Administrative Agent determines  that adoption of any portion of such market practice is not administratively feasible or that no  market practice for the administration of such LIBOR Successor Rate exists, in such other manner  of administration as the Administrative Agent determines is reasonably necessary in connection  with the administration of this Agreement).</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the events or circumstances of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have occurred with respect to the LIBOR Successor Rate then in effect, then the successor rate thereto shall be determined in accordance with the definition of &#8220;LIBOR Successor Rate.&#8221;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein, (i) after any such determination   by the Administrative Agent and the Borrower described under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as  applicable, if the Administrative Agent and the Borrower determine that none of the LIBOR Successor Rates is available on or prior to the LIBOR Replacement Date, (ii) if the events or circumstances described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have occurred but none of the LIBOR Successor  Rates is available, or (iii) if the events or circumstances of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> - </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> have occurred with respect to the LIBOR Successor Rate then in effect and the Administrative Agent and the Borrower determine that none of the LIBOR Successor Rates is available, then in each case, the Administrative Agent and the Borrower may amend this Agreement solely for the purpose of replacing LIBOR or any then current LIBOR Successor Rate in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> at the end of any Eurodollar Interest Period, relevant interest payment date or payment period for interest calculated, as applicable, with another alternate benchmark rate giving due consideration to any evolving or then-existing convention for similar Dollar denominated  syndicated credit facilities for such alternative benchmarks and, in each case, including any Related Adjustments and any other mathematical or other adjustments to such benchmark giving due consideration to any evolving or then-existing convention for similar Dollar denominated  syndicated credit facilities for such benchmarks, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated. For the avoidance   of doubt, any such proposed rate and adjustments shall constitute a LIBOR Successor Rate. Any such amendment shall become effective at 5&#58;00 p.m. on the fifth Domestic Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders object to such amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;If, at the end of any Eurodollar Interest Period, relevant interest payment date or payment period for interest calculated, no LIBOR Successor Rate has</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">been determined in accordance with clauses (d) or (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the circumstances under clauses (d)(i) or (d)(iii) above exist or the Scheduled Unavailability Date has occurred (as applicable), the Administrative Agent will promptly so notify the Borrower and each Lender. Thereafter, (x) the obligation of the Lenders to make or maintain Eurodollar Advances shall be suspended, (to the extent of the affected Eurodollar Advances, Eurodollar Interest Periods, interest payment dates or payment periods), and (y) the One Month LIBOR Rate component shall no longer be utilized in determining the Alternate Base Rate, until the LIBOR Successor Rate has been determined in accordance with clauses (d) or (e). Upon receipt of such notice, the Borrower may revoke any pending request for a borrowing of, Conversion to or continuation of Eurodollar Advances (to the extent of the affected Eurodollar Advances, Eurodollar Interest Periods, interest payment dates or payment periods) or, failing that, will be deemed to have Converted such request into a request for   a borrowing of ABR Advances (subject to the foregoing clause (y)) in the amount specified therein.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Certificates of Payment and Reimbursement</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Issuer and each Lender agrees, in connection with any request by it for payment or reimbursement pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to provide the Borrower with a certificate, signed by an officer of such Issuer or such Lender, as the case may be, setting forth a description in reasonable detail of any such payment or reimbursement and the applicable Section of this Agreement pursuant to and in accordance with which such request is made. Each determination by such Issuer and such Lender of such payment or reimbursement shall be conclusive absent manifest error.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Taxes&#59; Net Payments</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payments Free of Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any and all payments by or on account of any obligation of the Borrower hereunder or under any other Loan Document shall be made free and clear of, and without reduction or withholding for, any Indemnified Taxes or Other Taxes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower shall be required by applicable law to deduct any Indemnified Taxes (including any Other Taxes) from such payments, then (i)&#160;the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) the Administrative Agent, the applicable Lender or the applicable Issuer, as the case may be, receives an amount equal to the sum it would have received had no such deductions  for Indemnified Taxes or Other Taxes been made, (ii)&#160;the Borrower shall make such deductions    and (iii)&#160;the Borrower shall timely pay the full amount deducted to the relevant Governmental Authority in accordance with applicable law. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the term &#8220;Lender&#8221; includes the Swing Line Lender and each Issuer.&#8221;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Other Taxes by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Without limiting the provisions of paragraph (a) above, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification by the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall indemnify the   Administrative Agent, each Lender and each Issuer, within 30 days after demand therefor, for the full amount of any Indemnified Taxes imposed on or with respect to, any payment made by, or on account of, any obligation of the Borrower under any Loan Document or Other Taxes (including Indemnified Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) paid by the Administrative Agent, such Lender or such Issuer, as the case may   be, and, without duplication, any penalties, interest and reasonable and documented out-of-pocket expenses arising therefrom or with respect thereto (other than any penalties that result from the  gross negligence, bad faith or willful misconduct of the Administrative Agent, such Lender or such Issuer, as applicable, as determined by a final and non-appealable judgment of a court of competent jurisdiction)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower reasonably believes that such Taxes were not correctly  or legally asserted, the Administrative Agent, such Lender or such Issuer, as applicable, will cooperate with the Borrower to obtain a refund of such Taxes so long as such efforts would not result in any additional costs or expenses not reimbursed by the Borrower and such cooperation would not, in the judgment of such Lender or such Issuer, as applicable, be materially disadvantageous to it.  A certificate as to the amount of such payment or liability that complies with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and is delivered to the Borrower by such Lender or such Issuer (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of such Lender or such Issuer, shall be conclusive absent manifest error. After any Lender or any Issuer (as the case may be) learns of the imposition of any Indemnified Taxes or Other Taxes, such Lender    or such Issuer (as the case may be) will as soon as reasonably practicable notify the Borrower thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to provide the Borrower with such notice shall not release the Borrower from its indemnification obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything   </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall not be required to indemnify the Administrative Agent or any Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for any additional costs, such as penalties or interest, to the extent that such costs resulted from a failure of the Administrative Agent or such Lender or Issuer to notify the Borrower of such possible indemnification claim within 180 days after the Administrative Agent or such Lender or Issuer receives notice from the applicable taxing authority of the tax giving rise to such indemnification claim.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Evidence of Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. As soon as practicable after any payment of Indemnified Taxes or Other Taxes by the Borrower to a Governmental Authority, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Indemnification by the Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Lender shall severally indemnify the Administrative Agent, within 10 days after demand therefor, for (i) any Indemnified Taxes attributable to such Lender (but only to the extent that the Borrower has not already indemnified   the Administrative Agent for such Indemnified Taxes and without limiting the obligation of the Borrower to do so), (ii) any Taxes attributable to such Lender&#8217;s failure to comply with the  provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> relating to the maintenance of a Participant Register, and (iii) any Excluded Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment    or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this paragraph (e).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Status of Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender that is entitled to an exemption from, or reduction  of, withholding Tax under the law of the jurisdiction in which the Borrower is resident for Tax purposes, or any treaty to which such jurisdiction is a party, with respect to payments hereunder or under any other Loan Document shall deliver to the Borrower (with a copy to the Administrative Agent), at the time or times prescribed by applicable law or reasonably requested by the Borrower  or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate    of withholding. In addition, any Lender, if requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the foregoing, any Foreign Lender shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter (i) if such Foreign Lender shall determine that any applicable form or certification has expired or will then expire or has or will then become obsolete or incorrect or that an event has occurred that requires or will then require a change in the most recent form or certification previously delivered by it to the Borrower and the Administrative Agent </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and (ii) upon the request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;duly completed copies of Internal Revenue Service Form W-8BEN or  Form W-8BEN-E claiming eligibility for benefits of an income Tax treaty to which the United States of America is a party,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;duly completed copies of Internal Revenue Service Form W-8ECI,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Internal Revenue Code, (x) a certificate (a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;United States Tax Compliance Certificate&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to the effect that such Foreign Lender is not (A) a &#8220;bank&#8221; within the meaning of Section 881(c)(3)(A) of the Internal Revenue Code,   (B) a &#8220;10 percent shareholder&#8221; of the Borrower within the meaning of Section 881(c)(3)(B) of the Internal Revenue Code, (C) a &#8220;controlled foreign corporation&#8221; described in Section 881(c)(3)(C) of the Internal Revenue Code nor (D) engaged in the conduct of a trade or business within the United States to which the interest payment is effectively connected   and (y) duly completed copies of Internal Revenue Service Form W-8BEN or Form W- 8BEN-E,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;to the extent a Foreign Lender is not the beneficial owner (for example, where the Foreign Lender is a partnership or participating Lender granting a typical participation), a complete and executed Internal Revenue Service Form W-8IMY, accompanied by a Form W-8ECI, Form W-8BEN, Form W-8BEN-E, a United States Tax Compliance Certificate, Internal Revenue Service Form W-9 and&#47;or other certification documents from each beneficial owner, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, if the Foreign Lender  is a partnership (and not a participating Lender) and one or more partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender shall provide a United States Tax Compliance Certificate, on behalf of such beneficial owner(s) in lieu of requiring each beneficial owner to provide its own certificate, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in United States Federal withholding Tax duly completed together with such supplementary documentation as may be prescribed by applicable law   to permit the Borrower to determine the withholding or deduction required to be made.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal Revenue Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by  applicable law (including as prescribed by Section 1471(b)(3)(C) of the Internal Revenue Code)   and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this clause, &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the foregoing, upon request of the Administrative Agent or the Borrower, each Lender and each Issuer that is a &#8220;United States person&#8221; within the meaning of Section 7701(a)(30) of the Internal Revenue Code that lends to the Borrower (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;U.S. Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall deliver to the Administrative Agent and the Borrower two duly signed, properly completed copies  of Internal Revenue Service Form W-9 on or prior to the Effective Date (or on or prior to the date    it becomes a party to this Agreement), certifying that such U.S. Lender is entitled to an exemption from United States backup withholding, or any successor form.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Treatment of Certain Refunds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If the Administrative Agent, a Lender or an Issuer determines, in its sole discretion exercised in good faith, that it has received a refund of any Taxes  or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it shall promptly pay to the Borrower an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Taxes or Other Taxes giving rise to such refund), net of all reasonable and documented out-of-pocket expenses of the Administrative Agent, such Lender or such Issuer, as the case may be, and without interest  (other than any interest paid by the relevant Governmental Authority with respect to such refund), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Borrower, upon the written request of the Administrative Agent, such Lender or such Issuer, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent, such Lender or such Issuer in the event that the Administrative Agent, such Lender or such Issuer is required to repay such refund or Tax credit to such Governmental Authority. This paragraph shall not be construed to require the Administrative Agent, any Lender or any Issuer to make available   its Tax returns (or any other information relating to its Taxes that it deems confidential) to the Borrower or any other Person.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Designation of a Different Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any Lender requests compensation under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or requires the Borrower to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then such Lender shall use reasonable efforts to promptly designate a different lending office for funding or booking its Loans hereunder or to assign its rights and obligations hereunder to another of its  offices, branches or affiliates, if such designation or assignment (i)&#160;would eliminate or reduce amounts payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as the case may be, in the future and (ii)&#160;in the judgment of such Lender, would not subject such Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to such Lender. The Borrower hereby agrees to pay all reasonable and documented out-of-pocket costs and expenses incurred by any Lender in connection with any such designation or assignment.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each party&#8217;s obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Facility Fees</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Facility Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) during the period commencing on the Effective Date and ending on the Expiration Date, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter during which the Facility Fee shall commence to accrue, and on the Expiration Date, at a rate per annum equal to the Applicable Margin of (a) prior to the Commitment Termination Date or such earlier date upon which all of the Commitments shall have been </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">terminated in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount of such Lender (whether used or unused), and (b) thereafter, the sum of (i) the outstanding principal balance of all Revolving Credit Loans   of such Lender, (ii) such Lender&#8217;s Swing Line Exposure and (iii) such Lender&#8217;s Letter of Credit Exposure. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, on and after the Commitment Termination Date, the Facility Fee shall be payable upon demand. In addition, upon each reduction of the Aggregate Commitment Amount, the Borrower shall pay the Facility Fee accrued on the amount of such reduction through the date of such reduction. The Facility Fee shall be computed on the basis of a 360-day year for the actual number of days elapsed.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Letter of Credit Participation Fee</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees to pay to the Administrative Agent for the pro rata account of each Lender a fee (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Letter of Credit Participation Fee&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with respect to the Letters of Credit during the period commencing on the Effective Date and ending on the Commitment Termination Date or, if later, the date when the Letter of Credit Exposure of all Lenders is $0, payable quarterly in arrears on the last day of each March, June, September and December of each year, commencing on the last day of the calendar quarter     in which the Effective Date shall have occurred, and on the last date of such period, at a rate per annum equal to (i) in the case of standby Letters of Credit, the Applicable Margin of the actual daily amount which may be drawn under all standby Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage, and    (ii) in the case of commercial Letters of Credit, the Applicable Margin of the actual daily amount which  may be drawn under all commercial Letters of Credit during such period (whether or not the conditions for drawing thereunder have or may be satisfied) multiplied by such Lender&#8217;s Commitment Percentage. The Letter of Credit Participation Fee shall be computed on the basis of a 360-day year for the actual number     of days elapsed.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Replacement of Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If (x) the Borrower is obligated to pay to any Lender any amount under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower shall have the right within 90 days thereafter, (y) any Lender shall be a Defaulting Lender,    the Borrower shall have the right at any time during which such Lender shall remain a Defaulting Lender,   or (z) any Lender shall have not consented to an Extension Request, the Borrower shall have the right at   any time on the relevant Extension Date, in each case in accordance with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and only if no Default shall exist, to replace such Lender (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replaced Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) with one or more Eligible Assignees (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Replacement Lender&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) at the time of any replacement pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall enter into one or more Assignment and Assumptions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with the processing and recordation fee referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> payable pursuant to said </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to be paid by the Replacement Lender) pursuant to which the Replacement Lender shall acquire the Commitment, the outstanding Loans, the Swing Line Exposure and the Letter of Credit Exposure of the Replaced Lender and, in connection therewith, shall pay the following&#58; (a) to the Replaced Lender, an amount equal to the sum of (A) an amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans and Swing Line Participation Amounts of the Replaced Lender, (B) an amount equal to all drawings on all Letters of Credit that have been funded by (and not reimbursed to) such Replaced Lender, together with all then unpaid interest with respect thereto at such time, and (C) an amount equal to all accrued, but unpaid, fees owing to the Replaced Lender, (b) to each Issuer, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of all drawings on Letters of Credit issued by such Issuer (which at such time remain unpaid drawings) to the extent such amount was not funded by such Replaced Lender, (c) to the Swing Line Lender, an amount equal to such Replaced Lender&#8217;s Commitment Percentage of any Mandatory Borrowing to the extent such amount was not funded by such Replaced Lender, and (d) to the Administrative Agent an amount equal to all amounts owed by  such Replaced Lender to the Administrative Agent under this Agreement, including, without limitation, an </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">amount equal to the principal of, and all accrued and unpaid interest on, all outstanding Loans of the Replaced Lender, a corresponding amount of which was made available by the Administrative Agent to the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and which has not been repaid to the Administrative Agent by such Replaced Lender or the Borrower, and (ii) all obligations of the Borrower owing to the Replaced Lender (other than those specifically described in clause (i) above in respect of which the assignment purchase   price has been, or is concurrently being, paid) shall be paid in full to such Replaced Lender concurrently with such replacement. Upon the execution and delivery of the respective Assignment and Assumptions   and the payment of amounts referred to in clauses (i) and (ii) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Replacement Lender shall become a Lender hereunder and the Replaced Lender shall cease to constitute a Lender hereunder, except with respect to indemnification provisions under this Agreement that are intended to survive the termination of the Commitments and the repayment of the Loans which may be applicable to any such Replaced Lender prior to the date of its replacement. Solely for the purpose of calculating break funding payments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the assignment by any Replaced Lender of any Eurodollar Advance prior to   the last day of the Interest Period applicable thereto pursuant to clause (x) or (z) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall   be deemed to constitute a prepayment by the Borrower of such Eurodollar Advance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In order to induce the Administrative Agent, the Lenders and the Issuers to enter into this Agreement, the Lenders to make the Loans and the Issuers to issue Letters of Credit, the Borrower hereby makes the following representations and warranties to the Administrative Agent, the Lenders and the  Issuers&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Existence and Power</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation, has all requisite corporate power and authority to own its Property and to carry on its business as now conducted, and is qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which it owns or leases real Property or in which the nature of its business requires it to be so qualified (except those jurisdictions where the failure to be so qualified or to    be in good standing could not reasonably be expected to have a Material Adverse effect).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Authority&#59; Affected Financial Institution</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has full corporate power and authority to enter into, execute, deliver and perform the terms of the Loan Documents, all of which have been duly authorized by all proper and necessary corporate action and are not in contravention of&#58; (i) except as could not reasonably be expected to have a Material Adverse effect, any applicable law or (ii) the terms of its Certificate of Incorporation and By-Laws. No consent or approval of, or other action by, shareholders of the Borrower, any Governmental Authority, or any other Person (which has not already been obtained) is required to authorize in respect of the Borrower, or is required in connection with, the execution, delivery and performance by the Borrower of the Loan Documents or is required as a condition to the enforceability of the Loan Documents against the Borrower. The Borrower is not an Affected Financial Institution.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Binding Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents constitute the valid and legally binding obligations of the Borrower, enforceable against the Borrower in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting the enforcement of creditors&#8217; rights generally and by equitable principles relating to the availability of specific performance as a remedy.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Litigation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the Effective Date, there are no actions, suits, arbitration proceedings or claims (whether purportedly on behalf of the Borrower, any Material Subsidiary or otherwise) pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary or any of their respective Properties, or maintained by the Borrower or any Material Subsidiary, at law or in equity, before any Governmental Authority which have not been disclosed in the SEC Reports that could reasonably be expected to have a Material Adverse effect. There are no proceedings pending or, to the knowledge of the Borrower, threatened against the Borrower or any Material Subsidiary (a) which call into question the validity or enforceability of any Loan Document, or otherwise seek to invalidate, any Loan Document, or  (b) which might, individually or in the aggregate, materially and adversely affect any of the transactions contemplated by any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Conflicting Agreements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#91;Reserved&#93;.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;No provision of any existing material mortgage, material indenture, material contract or material agreement or of any existing statute, rule, regulation, judgment, decree or order binding on the Borrower or affecting the Property of the Borrower (i) conflicts with any Loan Document, (ii) requires any consent which has not already been obtained with respect to any Loan Document, or (iii) would in any way prevent the execution, delivery or performance by the Borrower of the terms of any Loan Document, except in the case of provisions of any existing material mortgage, material indenture, material contract or material agreement, as could not reasonably be expected to have a Material Adverse effect. Neither the execution and delivery, nor the performance, by the Borrower of the terms of each Loan Document will constitute a default under, or result in the creation or imposition of, or obligation to create, any Lien upon the Property of the Borrower pursuant to the terms of any such mortgage, indenture, contract or agreement.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Governmental Regulations</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not required to be registered as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Federal Reserve Regulations&#59; Use of Proceeds</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any Margin Stock. No part of the proceeds of the Loans or the Letters of Credit has been or will be used, directly or indirectly, and whether immediately, incidentally or ultimately, for a purpose which violates the provisions of Regulation T, U or X of the Board of Governors of the Federal Reserve System, as amended. Anything in this Agreement to the contrary notwithstanding, neither any Issuer nor any Lender shall be obligated to extend credit to, or on behalf of,   the Borrower in violation of any limitation or prohibition provided by any applicable law, regulation or statute, including said Regulation U. Following application of the proceeds of each Loan and the issuance   of each Letter of Credit, not more than 25% (or such greater or lesser percentage as is provided in the exclusions from the definition of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indirectly Secured</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> contained in said Regulation U as in effect at the  </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">time of the making of such Loan or issuance of such Letter of Credit) of the value of the assets of the Borrower and the Subsidiaries on a Consolidated basis that are subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> will be Margin Stock. </font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Misrepresentation</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No representation or warranty contained in any Loan Document and no certificate or written report furnished by the Borrower to the Administrative Agent or any Lender pursuant to any Loan Document contains, as of its date, a misstatement of a material fact, or omits to state, as of its date, a material fact required to be stated in order to make the statements therein contained, when taken as a whole, not  materially misleading (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation, warranty, statement or written report that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such date) in the light of the circumstances under which made (after giving effect to all supplements and updates with respect thereto) (it being understood that the Borrower makes no representation or warranty hereunder with respect to any projections, other forward looking information, industry information or general economic information).  As of the Effective Date, the information included in any Beneficial Ownership Certification of the Borrower, if applicable, is true and correct in all respects.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Statements</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has heretofore delivered to the Lenders through the Administrative Agent copies of the audited Consolidated Balance Sheet of the Borrower and its Subsidiaries as of December 31, 2020, and the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for the fiscal year then-ended. The financial statements referred to immediately above, including all related notes and schedules, are herein referred to collectively as the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Financial Statements&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Financial Statements fairly present, in all material respects, the Consolidated financial condition and results of the operations of the Borrower and the Subsidiaries as of the dates and for the periods indicated therein and, except as noted therein, have been prepared in conformity with GAAP as then in effect. Neither the Borrower nor any of the Subsidiaries has any material obligation or liability of any kind (whether fixed, accrued, contingent, unmatured or otherwise) which, in accordance with GAAP as then in effect, should have been disclosed in the Financial Statements and was not. During the period from January 1, 2021 to   and including the Effective Date, there was no Material Adverse change, including as a result of any change in law, in the Consolidated financial condition, operations, business or Property of the Borrower and the Subsidiaries taken as a whole that was not disclosed in the SEC Reports.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Anti-Corruption Laws and Sanctions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, the Subsidiaries and their  respective officers and employees and, to the knowledge of the Borrower, its directors are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower or such Subsidiary, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person. No Loan or Letter of Credit, use of proceeds or other transaction contemplated by this Agreement will violate Anti-Corruption Laws or applicable Sanctions.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;CONDITIONS TO EFFECTIVENESS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement shall become effective on and as of the date (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Effective Date&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) that the following conditions shall have been satisfied or waived in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Agreement</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received counterparts of this Agreement executed by the Borrower, the Administrative Agent, each Issuer, the Swing Line Lender and each Lender.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a Note, executed and delivered by the Borrower, for each Lender that shall have given at least three Domestic Business Days&#8217; prior written notice of its request for a Note.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate Action</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the  Secretary or an Assistant Secretary of the Borrower (i) attaching a true and complete copy of the resolutions of its Board of Directors and of all documents evidencing all other necessary corporate action taken by the Borrower to authorize this Agreement, the other Loan Documents and the transactions contemplated hereby and thereby, (ii) attaching a true and complete copy of its Certificate of Incorporation and By-Laws, (iii) setting forth the incumbency of the officer or officers of the Borrower who may sign this Agreement and   the other Loan Documents, and any other certificates, requests, notices or other documents required hereunder or thereunder, and (iv) attaching a certificate of good standing of the Secretary of State of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Opinion of Counsel to the Borrower</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received (a) an opinion of Thomas Moffatt, assistant general counsel of the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit D-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and (b) an opinion of Shearman &#38; Sterling LLP, special counsel to the Borrower, dated the Effective Date, in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">D-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Termination of Existing 2017 Credit Agreement </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">After giving effect to the application of the proceeds of the Loans on the Effective Date, the Indebtedness under the Existing 2017 Credit Agreement shall have been fully repaid, the commitments under the Existing 2017 Credit Agreement shall have been canceled or terminated, and the Administrative Agent shall have received reasonably satisfactory evidence thereof.  In order to facilitate the termination of the commitments under the Existing 2017 Credit Agreement, the Borrower hereby gives notice that the Borrower wishes to terminate the commitments under the Existing 2017 Credit Agreement, effective as of the Effective Date.  Each Lender that is a party to the Existing 2017 Credit Agreement, by its execution hereof, waives any requirement of prior notice set forth therein as a condition to the right of the Borrower   to terminate the commitments thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Default and Representations and Warranties</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received a certificate, dated the Effective Date, of the Senior Vice President and Treasurer of the Borrower certifying that there exists no Default and that the </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">representations and warranties contained in this Agreement are true and correct in all material respects (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on the Effective Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Fees</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have received all fees and other amounts due and payable to it on the Effective Date in respect of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Due Diligence&#59; &#8220;Know Your Customer&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) Each Lender shall have received such documents and information as it may have requested in order to comply with &#8220;know-your-customer&#8221; and other applicable Sanctions, anti-terrorism, anti-money laundering and similar rules and regulations and related policies, to the extent the Borrower shall have received written requests therefor at least ten (10) Domestic Business Days prior to the Effective Date, and (b) at least five Domestic Business Days prior to the Effective Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation, it shall have delivered to each Lender that so requests a Beneficial Ownership Certification.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limiting the generality of the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, for purposes of determining compliance with the conditions specified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Effective Date specifying its objection thereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;CONDITIONS OF LENDING - ALL LOANS AND LETTERS OF CREDIT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The obligation of each Lender on any Borrowing Date to make each Revolving Credit Loan (other than a Revolving Credit Loan constituting a Mandatory Borrowing), the Swing Line Lender to make each Swing Line Loan, each Issuer to issue each Letter of Credit and each Lender to make a Competitive Bid Loan are subject to the fulfillment (or waiver in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of the following conditions precedent&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Compliance</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On each Borrowing Date, and after giving effect to the Loans to be made or the Letters of Credit     to be issued on such Borrowing Date, (a) there shall exist no Default, and (b) the representations and warranties contained in this Agreement shall be true and correct in all material respects with the same effect as though such representations and warranties had been made on such Borrowing Date (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse&#8221; or similar language  shall be true and correct (after giving effect to any qualification therein) in all respects on such Borrowing Date), except those which are expressly specified to be made as of an earlier date.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Requests</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall have timely received from the Borrower on or before such Borrowing Date, as applicable, a duly executed Borrowing Request (together with, in the case of a request for a Swing Line Loan that will bear interest at the Negotiated Rate, a duly executed agreement as to the Negotiated Rate with respect to such Swing Line Loan), Letter of Credit Request (together with a duly </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">executed Reimbursement Agreement with respect to the Letter(s) of Credit requested thereby) and&#47;or Competitive Bid Request (together with a duly executed Competitive Bid Accept&#47;Reject Letter).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;AFFIRMATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Legal Existence</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except as may otherwise be permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, maintain, and cause each Material Subsidiary to maintain, its corporate existence in good standing in the jurisdiction of its incorporation or formation and in each other jurisdiction in which the failure so to do could reasonably be expected to have a Material Adverse effect, except that the corporate existence of Material Subsidiaries   may be terminated if (i) such Material Subsidiaries operate closing or discontinued operations or (ii) if the Borrower determines in good faith that such termination is in the best interests of the Borrower and is not materially disadvantageous to the Lenders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Taxes</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pay and discharge when due, and cause each Material Subsidiary so to do, all taxes, assessments, governmental charges, license fees and levies upon or with respect to the Borrower and such Material Subsidiary, and upon the income, profits and Property thereof unless, and only to the extent, that either  (i)(a) such taxes, assessments, governmental charges, license fees and levies shall be contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary, and (b) such reserve or other appropriate provision as shall be required by GAAP shall have been made therefor,    or (ii) the failure to pay or discharge such taxes, assessments, governmental charges, license fees and levies could not reasonably be expected to have a Material Adverse effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Observance of Legal Requirements</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Observe and comply in all material respects, and cause each Material Subsidiary    so to do, with all laws, ordinances, orders, judgments, rules, regulations, certifications, franchises, permits, licenses, directions and requirements of all Governmental Authorities, which now or at   any time hereafter may be applicable to it or to such Material Subsidiary, except (i) where a violation of which could not reasonably be expected to have a Material Adverse effect, or (ii) to    the extent that such noncompliance is being  contested in good faith and by appropriate proceedings diligently conducted by the Borrower or such Material Subsidiary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, the Subsidiaries and their respective directors, officers, employees   and agents with Anti-Corruption Laws and applicable Sanctions.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Financial Statements and Other Information</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Maintain, and cause each Subsidiary to maintain, a standard system of accounting in accordance with GAAP, and furnish to the Administrative Agent for distribution to the Lenders&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;As soon as available and, in any event, within 90 days after the close of each fiscal year, a copy of (x) the Borrower&#8217;s 10-K in respect of such fiscal year, and (y) (i) the Borrower&#8217;s Consolidated Balance Sheet as of the end of such fiscal year, and (ii) the related Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows, as of and through the end of such fiscal year, setting forth in each case in comparative form the corresponding figures in respect of the previous fiscal year, all in reasonable detail, and accompanied by a report   of the Borrower&#8217;s auditors, which report shall state that (A) such auditors audited such financial statements, (B) such audit was made in accordance with generally accepted auditing standards in effect at the time and provides a reasonable basis for such opinion, and (C) said financial statements have been prepared in accordance with GAAP&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;As soon as available, and in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal year, a copy of (x) the Borrower&#8217;s 10-Q in respect of such fiscal quarter, and (y) (i) the Borrower&#8217;s condensed Consolidated Balance Sheet as of the end of such quarter and (ii) the related condensed Consolidated Statements of Income, Comprehensive Income, Shareholders&#8217; Equity and Cash Flows for (A) such quarter and (B) the period from the beginning of the then-current fiscal year to the end of such quarter, in each case in comparable form with the prior fiscal year, all in reasonable detail and prepared in accordance with GAAP (without footnotes and subject to year-end adjustments)&#59;</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Simultaneously with the delivery of the financial statements required by clauses    (a) and (b) above, a certificate of the Chief Financial Officer or the Senior Vice President and Treasurer of the Borrower certifying that no Default shall have occurred or be continuing or, if so, specifying in such certificate all such Defaults, and setting forth computations in reasonable detail demonstrating compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:11pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;As soon as practicable after becoming available, copies of all regular or periodic reports (including current reports on Form 8-K) which the Borrower or any Subsidiary may now or hereafter be required to file with or deliver to the U.S. Securities and Exchange Commission, or   any other Governmental Authority succeeding to the functions thereof&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Prompt written notice of the occurrence of (i) each Default and (ii) each Event of Default&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;From time to time, such other information regarding the financial position or business of the Borrower and the Subsidiaries as the Administrative Agent, at the reasonable   request of any Lender, may reasonably request&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Prompt written notice of such other information with documentation required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering  </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">laws, rules and regulations (including, without limitation, the Patriot Act and the Beneficial Ownership Regulation), as from time to time may be reasonably requested by the Administrative Agent or by any Issuer or any Lender (through the Administrative Agent).</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Information required to be delivered pursuant to (x) this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed to have been delivered if such information shall have been posted by the Administrative Agent on a Debtdomain, IntraLinks, Syndtrak or similar electronic system (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Platform&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) to which each Lender and each Issuer  has been granted access and (y) clauses (a), (b) and (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be deemed delivered to the Administrative Agent, the Issuers and the Lenders when available on the Borrower&#8217;s website at             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.cvshealth.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or the website of the U.S. Securities and Exchange Commission at                </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">http&#58;&#47;&#47;www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Information delivered pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may also be delivered by electronic communications pursuant to procedures approved by the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower hereby acknowledges that the Administrative Agent and&#47;or the Joint Lead Arrangers will make available to the Lenders materials and&#47;or information provided by or on behalf of the Borrower hereunder (collectively, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Borrower Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) by posting the Borrower Materials on the Platform.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Records</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon reasonable notice and during normal business hours after an Event of Default has occurred  and is continuing, permit representatives of the Administrative Agent and each Lender to visit the offices           of the Borrower and each Material Subsidiary, to examine the books and records (other than tax returns and work papers related to tax returns) thereof and auditors&#8217; reports relating thereto, to discuss the affairs of the Borrower and each Material Subsidiary with the respective officers thereof, and to meet and discuss the affairs of the Borrower and each Material Subsidiary with the Borrower&#8217;s auditors, except for information covered by an attorney-client or other legal privilege or to the extent the inspection would reasonably be expected to result in a violation or other breach of any third party confidentiality agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;NEGATIVE COVENANTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower covenants and agrees that on and after the Effective Date and until the later to occur of (a) the Commitment Termination Date and (b) the payment in full of the Loans, the Reimbursement Obligations, the Fees and all other sums payable under the Loan Documents (other than contingent obligations for which no claim has been made), the Borrower will not&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Liens</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Create, incur, assume or suffer to exist any Lien against or on any Property now owned or hereafter acquired by the Borrower or any of the Subsidiaries, or permit any of the Subsidiaries so to do, except any one or more of the following types of Liens&#58; (a) Liens in connection with workers&#8217; compensation, unemployment insurance or other social security obligations (which phrase shall not be construed to refer   to ERISA or the minimum funding obligations under Section 412 of the Internal Revenue Code), (b) Liens to secure the performance of bids, tenders, letters of credit, contracts (other than contracts for the payment  of Indebtedness), leases, statutory obligations, surety, customs, appeal, performance and payment bonds   and other obligations of like nature, or to qualify to do business, maintain insurance or obtain other benefits, in each such case arising in the ordinary course of business, (c) mechanics&#8217;, workmen&#8217;s, carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, landlords&#8217; or other like Liens arising in the ordinary course of business with respect to obligations which are not due or which are being contested in good faith and by appropriate proceedings diligently conducted, (d) Liens for taxes, assessments, fees or governmental charges the </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">payment of which is not required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (e) easements, rights of way, restrictions, leases of Property to others, easements for installations of public utilities, title imperfections and restrictions, zoning ordinances and other similar encumbrances affecting Property which in the aggregate do not materially impair its use for the operation of the business of the Borrower or such Subsidiary, (f) Liens on Property of the Subsidiaries under capital leases and Liens on Property (including on the capital stock or other equity interests) of the Subsidiaries acquired (whether as a result of purchase, capital lease, merger or other acquisition) and either existing on such Property when acquired, or created contemporaneously with or within 12 months of such acquisition to secure the payment or financing of the purchase price of such Property (including the construction, development, substantial repair, alteration or improvement thereof), and any renewals thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Liens attach only to the Property so purchased or acquired (including any such construction, development, substantial repair, alteration or improvement thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indebtedness secured by such Liens is not otherwise prohibited hereunder, (g) statutory Liens in favor of lessors arising in connection with Property leased to the Borrower or any of the Subsidiaries, (h) Liens of attachments, judgments or awards against the Borrower or any of the Subsidiaries with respect to which an appeal or proceeding for review shall be pending or a stay of execution or bond shall have been obtained, or which are otherwise being contested in good faith and by appropriate proceedings diligently conducted, and in respect of which adequate reserves shall have been established in accordance with GAAP on the books of the Borrower or such Subsidiary, (i) Liens securing Indebtedness   of a Subsidiary to the Borrower or another Subsidiary, (j) Liens (other than Liens permitted by any of the foregoing clauses) arising in the ordinary course of its business which do not secure Indebtedness and do not, in the aggregate, materially detract from the value of the business of the Borrower and its Subsidiaries, taken as a whole, (k) Liens in favor of the United States of America, or any state thereof, to secure partial, progress, advance or other payments pursuant to any contract or provisions of any statute, and (l) additional Liens securing Indebtedness of the Borrower and the Subsidiaries in an aggregate outstanding Consolidated principal amount not exceeding 15% of Net Tangible Assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Dispositions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Make any Disposition (including by way of limited liability company division), or permit any of    its Subsidiaries so to do, of all or substantially all of the assets of the Borrower and the Subsidiaries on a Consolidated basis&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (a) any Subsidiary may make Dispositions to the Borrower, and (b) so  long as no Default or Event of Default exists immediately prior to or immediately after giving effect thereto, (i) the Borrower may dispose of all or substantially all of its assets to a wholly-owned domestic Subsidiary that assumes all of the obligations of the Borrower under this Agreement and (ii) any Subsidiary may dispose of all or substantially all of its assets to another Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such Subsidiary is a wholly-owned Subsidiary, the transferee shall be a wholly-owned Subsidiary.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Merger or Consolidation, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Consolidate with, be acquired by, or merge into or with any Person unless (x) immediately after giving effect thereto, no Default shall or would exist and (y) either (i) the Borrower or (ii) a corporation organized and existing under the laws of one of the States of the United States of America or the District     of Columbia shall be the survivor of such consolidation or merger&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Borrower is not the survivor, the corporation which is the survivor shall expressly assume, pursuant to an instrument executed and delivered to the Administrative Agent, and in form and substance reasonably satisfactory to the Administrative Agent, all obligations of the Borrower under the Loan Documents and the Administrative Agent shall have received such documents, opinions and certificates as it shall have reasonably requested     in connection therewith.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Limitation on Upstream Dividends by Subsidiaries</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit or cause any of the Subsidiaries (other than any Insurance Subsidiary) to enter into or agree, or otherwise be or become subject, to any agreement, contract or other arrangement (other than this Agreement and the other Loan Documents) with any Person (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Restrictive Agreement&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) pursuant to the terms of which (a) such Subsidiary is or would be prohibited from declaring or paying any cash dividends on any class of its stock owned directly or indirectly by the Borrower or any of the other Subsidiaries or from making any other distribution on account of any class of any such stock (herein referred to as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Upstream Dividends&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), or (b) the declaration or payment of Upstream Dividends by a Subsidiary to the Borrower or another Subsidiary, on an annual or cumulative basis, is or would be otherwise limited or restricted (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Dividend Restrictions&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). Notwithstanding the foregoing, nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall prohibit&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Dividend Restrictions set forth in any Restrictive Agreement in effect on the date hereof and any extensions, refinancings, renewals or replacements thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Dividend Restrictions existing with respect to any Person acquired by the   Borrower or any Subsidiary and existing at the time of such acquisition, which Dividend Restrictions are not applicable to any Person or the property or assets of any Person other than such Person or its property or assets acquired, and any extensions, refinancings, renewals or  replacements of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Dividend Restrictions in any such extensions, refinancings, renewals or replacements are no less favorable in any material respect to the Lenders than those Dividend Restrictions that are then in effect and that are being extended, refinanced, renewed or replaced&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Dividend Restrictions consisting of customary net worth, leverage and other financial covenants, customary covenants regarding the merger of or sale of stock or assets of a Subsidiary, customary restrictions on transactions with affiliates, and customary subordination provisions governing Indebtedness owed to the Borrower or any Subsidiary, in each case contained in, or required by, any agreement governing Indebtedness incurred by a Subsidiary in accordance with the terms of this Agreement&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Dividend Restrictions contained in any other credit agreement so long as such Dividend Restrictions are no more restrictive than those contained in this Agreement (including Dividend Restrictions contained in the Existing 2018 Credit Agreement and the Existing 2019  Credit Agreement).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">&#91;Reserved&#93;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Ratio of Consolidated Indebtedness to Total Capitalization</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Permit its ratio of Consolidated Indebtedness to Total Capitalization at the end of any fiscal quarter to exceed 0.60&#58;1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i) upon the consummation of any Material Acquisition and the written election of the Borrower to the Administrative Agent no later than thirty days following the consummation </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of such Material Acquisition, the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be increased by 0.05&#58;1.00 above the otherwise-applicable maximum permitted ratio of Consolidated Indebtedness to Total Capitalization with respect to the last day of the fiscal quarter during which such Material Acquisition shall have been consummated and the last day of each of the immediately following three consecutive fiscal quarters, and (ii) between the signing of the definitive agreement (or   offer documentation, as applicable) for a Material Acquisition and the earlier of (x) the closing of such Material Acquisition and (y) thirty days following the termination of such definitive agreement (or offer documentation, as applicable) for such Material Acquisition, any Acquisition Debt incurred to finance such Material Acquisition shall be excluded for purposes of calculation the ratio of Consolidated Indebtedness    to Total Capitalization hereunder.  The Borrower shall only be permitted to make an election pursuant to   the proviso of the preceding sentence twice during the term of this Agreement, and there shall be at least  two consecutive fiscal quarters between such elections during which time no increase to the maximum permitted ratio of Consolidated Indebtedness to Total Capitalization shall be in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;DEFAULT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Events of Default</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following shall each constitute an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Event of Default&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereunder&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The failure of the Borrower to make any payment of principal on any Loan or any reimbursement payment in respect of any Letter of Credit when due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The failure of the Borrower to make any payment of interest on any Loan or of any Fee on any date when due and payable and such default shall continue unremedied for a period of    5 Domestic Business Days after the same shall be due and payable&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The failure of the Borrower to observe or perform any covenant or agreement contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (with respect to the Borrower only), or in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The failure of the Borrower to observe or perform any other covenant or agreement contained in this Agreement, and such failure shall have continued unremedied for a period of 30 days after the Borrower shall have become aware of such failure&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#91;Reserved&#93;&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Any representation or warranty of the Borrower (or of any of its officers on its behalf) made in any Loan Document, or made in any certificate or report or other document (other than an opinion of counsel) delivered on or after the date hereof in connection with any such Loan Document shall in any such case prove to have been incorrect or misleading (whether because of misstatement or omission) in any material respect when made&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;(i) Obligations in an aggregate Consolidated amount in excess of the Threshold Amount of the Borrower (other than its obligations hereunder and under the Notes) and the Material Subsidiaries, whether as principal, guarantor, surety or other obligor, for the payment of any Indebtedness for Borrowed Money or any net liability under interest rate swap, collar, exchange or cap agreements, (A) shall become or shall be declared to be due and payable prior to the expressed maturity thereof, or (B) shall not be paid when due or within any grace period for the payment thereof, or (ii) any holder of any such obligations shall have the right to declare the Indebtedness   for Borrowed Money evidenced thereby due and payable prior to its stated maturity&#59; or</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;An involuntary proceeding shall be commenced or an involuntary petition shall be filed seeking (i) liquidation, reorganization or other relief in respect of the Borrower or any Material Subsidiary or its debts, or of a substantial part of its assets, under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii) the  appointment of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or any Material Subsidiary or for a substantial part of its assets, and, in any such case, such proceeding or petition shall continue undismissed for 60 days or an order or decree approving or ordering any of the foregoing shall be entered&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;The Borrower or any Material Subsidiary shall (i) voluntarily commence any proceeding or file any petition seeking liquidation, reorganization or other relief under any federal, state or foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (ii) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding   or petition described in clause (h) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (iii) apply for or consent to the appointment   of a receiver, trustee, custodian, sequestrator, conservator or similar official for the Borrower or   any Material Subsidiary or for a substantial part of its assets, (iv) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (v) make a general assignment for the benefit of creditors or (vi) take any action for the purpose of effecting any of the foregoing&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;The Borrower or any Material Subsidiary shall (i) generally not be paying its debts as such debts become due or (ii) admit in writing its inability to pay its debts as they become due&#59;   or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Judgments or decrees in an aggregate Consolidated amount in excess of the Threshold Amount (to the extent not covered by independent third-party insurance or captive insurance as to which the insurer does not dispute coverage) against the Borrower and the Material Subsidiaries shall remain unpaid, unstayed on appeal, undischarged, unbonded or undismissed for    a period of 60 days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of the Borrower or any Material Subsidiary to enforce any such judgment&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;After the Effective Date a Change of Control shall occur&#59; or</font></div><div style="margin-bottom:7.3pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)&#160;&#160;&#160;&#160;Solely to the extent as would have a Material Adverse effect&#58;  (i) any Termination Event shall occur (x) with respect to any Pension Plan (other than a Multiemployer Plan) or (y)   with respect to any other retirement plan subject to Section 302 of ERISA or Section 412 of the Internal Revenue Code, which plan, during the five year period prior to such Termination Event,  was the responsibility in whole or in part of the Borrower, any Material Subsidiary or any ERISA Affiliate&#59; (ii) the failure to satisfy the minimum funding standards under Section 302 of ERISA or Section 412 of the Internal Revenue Code shall exist with respect to any Pension Plan for which    the Borrower has responsibility (other than that portion of a Multiemployer Plan&#8217;s Accumulated Funding Deficiency to the extent such Accumulated Funding Deficiency is attributable to  employers other than the Borrower)&#59; (iii) any Person shall engage in a Prohibited Transaction involving any Employee Benefit Plan in respect of which it is reasonably likely that liability will    be imposed upon the Borrower&#59; (iv) the Borrower shall fail to pay when due an amount which is payable by it to the PBGC or to a Pension Plan (including a Multiemployer Plan) under Title IV of ERISA&#59; (v) the imposition on the Borrower of any tax under Section 4980(B)(a) of the Internal Revenue Code&#59; or (vi) the assessment of a civil penalty on the Borrower with respect to any Employee Benefit Plan under Section 502(c) of ERISA.  In determining the Consolidated amount for any purpose pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the liabilities, funding amounts, taxes and penalties </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:7.3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">referenced in the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall include those of the Material Subsidiaries and ERISA Affiliates of the Borrower to the extent the Borrower is obligated to pay  any such liabilities, funding amounts, taxes and penalties.</font></div><div style="margin-bottom:7.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Remedies</font></div><div style="margin-bottom:7.3pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Upon the occurrence of an Event of Default or at any time thereafter during the continuance of an Event of Default, the Administrative Agent, at the written request of the Required Lenders, shall notify the Borrower that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment have been terminated and&#47;or that all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other  amounts owing under the Loan Documents have been declared immediately due and payable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that upon the occurrence of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h), (i) or (j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to the Borrower, the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall automatically terminate and all of the Loans, the Notes and the Reimbursement Obligations and all accrued and unpaid interest on any thereof and all other amounts owing under the Loan Documents shall become immediately due and payable without declaration or notice to   the Borrower. To the fullest extent not prohibited by law, except for the notice provided for in the preceding sentence, the Borrower expressly waives any presentment, demand, protest, notice of protest or other notice of any kind in connection with the Loan Documents and its obligations thereunder. To the fullest extent not prohibited by law, the Borrower further expressly waives and covenants not to assert any appraisement, valuation, stay, extension, redemption or similar law,   now or at any time hereafter in force which might delay, prevent or otherwise impede the performance or enforcement of the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In the event that the Commitments, the Swing Line Commitment and the Letter of Credit Commitment shall have been terminated or all of the Loans, the Notes and the Reimbursement Obligations shall have become or been declared to be due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (i) the Borrower shall forthwith deposit an amount equal to the Letter of Credit Exposure in a cash collateral account with and under the exclusive control of the Administrative Agent, and (ii) the Administrative Agent, the Issuers and the Lenders agree, among themselves, that any funds received from or on behalf of the Borrower under any Loan Document  by any Issuer or any Lender (except funds received by any Issuer or any Lender as a result of a purchase from such Issuer or such Lender, as the case may be, pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) shall be remitted to the Administrative Agent, and shall be applied by the Administrative Agent in payment of the Loans, the Reimbursement Obligations and the other obligations of the Borrower under the Loan Documents in the following manner and order&#58; (1) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment   or reimbursement of the Administrative Agent, the Issuers and the Lenders, in that order, for any fees, expenses or amounts (other than the principal of and interest on the Reimbursement Obligations) due from the Borrower pursuant to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the Reimbursement Agreements, (2) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of the Fees, (3) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment of  any other fees, expenses or amounts (other than the principal of and interest on the Loans and the Notes and the Reimbursement Obligations) payable by the Borrower to the Administrative Agent, any Issuer or any of the Lenders under the Loan Documents, (4) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the outstanding principal balance of the Loans and the Letter of Credit Exposure of each Lender, of interest due on the Loans and the Reimbursement Obligations, (5) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the payment, pro rata according to the sum of (A) the aggregate outstanding principal balance of the Loans of each Lender </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (B) the aggregate outstanding balance of the Reimbursement Obligations of each Lender, of the aggregate outstanding principal balance of the Loans and the aggregate outstanding balance of the Reimbursement Obligations, and (6) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">sixth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, any remaining funds shall be paid to whosoever shall be entitled thereto or as a court of competent jurisdiction shall direct.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;In the event that the Loans and the Notes and the Reimbursement Obligations shall have been declared due and payable pursuant to the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Administrative Agent, upon the written request of the Required Lenders, shall proceed to enforce  the Reimbursement Obligations and the rights of the holders of the Loans and the Notes by suit in equity, action at law and&#47;or other appropriate proceedings, whether for payment or the specific performance of any covenant or agreement contained in the Loan Documents. In the event that the Administrative Agent shall fail or refuse so to proceed, each Issuer and each Lender shall be entitled to take such action as the Required Lenders shall deem appropriate to enforce its rights under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;AGENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Appointment and Authority</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party hereby irrevocably appoints BofA to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such  actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (other than </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) are solely for the benefit of the Administrative Agent and the Credit Parties and the Borrower shall have no rights as a third party beneficiary or otherwise of any of such provisions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Rights as a Lender</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Person serving as the Administrative Agent hereunder shall have the same rights and powers    in its capacity as a Lender (which includes Issuer) as any other Lender and may exercise the same as though it were not the Administrative Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money   to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with, the Borrower, any of its Subsidiaries or any other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exculpatory Provisions</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, the Administrative Agent&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;shall not be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated  hereby or by the other Loan Documents that the Administrative Agent is required to  exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law&#59; and</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose,    any information relating to the Borrower, any of its Subsidiaries or any Affiliate thereof   that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Administrative Agent shall not be liable for any action taken or not taken by     it (i)&#160;with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) or (ii)&#160;in the absence of its own gross negligence or willful misconduct. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until written notice describing such Default is given to the Administrative Agent by the Borrower, a Lender or an Issuer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set  forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">    or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Administrative Agent shall not be responsible or have any liability for, or have any duty to ascertain, inquire into, monitor or enforce, compliance with the provisions of this Agreement relating to Disqualified Institutions.  Without limiting the generality of the foregoing,  the Administrative Agent shall not (x) be obligated to ascertain, monitor or inquire as to whether  any Lender or prospective Lender is a Disqualified Institution or (y)&#160;have any liability with respect to or arising out of any assignment of Loans, or disclosure of confidential information, to any Disqualified Institution.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Reliance by Administrative Agent</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, internet or intranet website posting or other distribution) believed by it to be  genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan or the issuance of a Letter of Credit that by its terms must be fulfilled to the satisfaction of a Lender or an Issuer, the Administrative Agent may presume that such condition is satisfactory to such Lender or such Issuer unless the Administrative Agent shall have received notice to the contrary from such Lender or such Issuer prior to the making of such Loan or the issuance of such Letter of Credit. The Administrative Agent may consult with legal counsel (who may be counsel for the Borrower), independent public accounting firms and other experts selected by it and shall  not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accounting firm or experts.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Delegation of Duties</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply to any such sub-agent and to the Related Parties of the Administrative Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as the Administrative Agent.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Resignation of Administrative Agent</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Administrative Agent may at any time give notice of its resignation to the Credit Parties and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent    of the Borrower (such consent not to be unreasonably withheld or delayed), to appoint a successor, which shall be a bank with an office in New York, New York, or an Affiliate of any such bank with an office in New York, New York. If no such successor shall have been so appointed by the Required Lenders and shall have accepted such appointment within 30&#160;days after the retiring Administrative Agent gives notice of its resignation, then the retiring Administrative Agent may    on behalf of the Credit Parties, appoint a successor Administrative Agent meeting the qualifications set forth above, subject to, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the consent of the Borrower (such consent not to be unreasonably withheld or delayed)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if the Administrative Agent shall notify the Borrower and the Credit Parties that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents and all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Credit Party directly, until such time as the Required Lenders appoint a  successor Administrative Agent as provided for above in this Section. Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent, and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed in writing between the Borrower and such successor. After the retiring Administrative Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall continue in effect for the benefit of such retiring Administrative Agent, its         sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any resignation by BofA as Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall also constitute its resignation as an Issuer and Swing Line Lender.  If BofA resigns as an Issuer, it shall, pending the issuance of letters of credit in substitution of the outstanding Letters of Credit in accordance with clause (iii) of the last sentence of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the return and cancellation of such outstanding Letters of Credit, retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit outstanding as of the effective date of its </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">resignation as an Issuer and all Reimbursement Obligations with respect thereto, including the right to require the Lenders to make ABR Advances or fund risk participations pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.   If BofA resigns as Swing Line Lender, it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment by the Borrower of a successor Issuer or Swing Line Lender hereunder (which successor shall in all cases be a Lender other than a Defaulting Lender), (i) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as applicable, (ii) the retiring Issuer and Swing Line Lender shall be discharged from all of their respective duties and obligations hereunder or under the other Loan Documents (other than with respect to outstanding Swing Line Loans made by it and outstanding Letters of Credit issued by it), and (iii) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to BofA and the Borrower to effectively assume the obligations of BofA with respect to such Letters of Credit.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Non-Reliance on Administrative Agent and Other Credit Parties</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Credit Party acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Credit Party also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Credit Party or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related  agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Other Duties, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Anything herein to the contrary notwithstanding, none of the Joint Lead Arrangers, the Co-Documentation Agents or the Co-Syndication Agents listed on the cover page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity,  as applicable, as the Administrative Agent, a Lender or an Issuer.</font></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Recovery of Erroneous Payments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation of any other provision in this Agreement, if at any time the Administrative Agent makes a payment hereunder in error to any Lender or any Issuer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), whether or not in respect of an obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Lender Party receiving a Rescindable Amount severally agrees to repay to the Administrative Agent forthwith on demand the Rescindable Amount received by such Lender Party in immediately available funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to  the Administrative Agent, at the greater of the Federal Funds Effective Rate and a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.  Each Lender Party irrevocably waives any and all defenses, including any &#8220;discharge for value&#8221; (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount.&#160; The Administrative Agent shall inform each Lender Party promptly upon determining that any payment made to such Lender Party comprised, in whole or in part, a Rescindable Amount.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;OTHER PROVISIONS</font></div><div style="margin-bottom:5.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Amendments, Waivers, Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With the written consent of the Required Lenders, the Administrative Agent and the Borrower may, from time to time, enter into written amendments, supplements or modifications of the Loan Documents (which, for the avoidance of doubt, shall require the prior written consent of the Borrower) and, with the written consent of the Required Lenders and the Borrower, the Administrative Agent on behalf of the Lenders may execute and deliver to any such parties a written instrument waiving or consenting to the departure from, on such terms and conditions as the Administrative Agent may specify in such instrument (which terms and conditions shall have been agreed to by the Borrower), any of the requirements of the  Loan Documents or any Default or any Event of Default and its consequences, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such amendment, supplement, modification, waiver or consent shall (i) increase the Commitment Amount of    any Lender without the consent of such Lender (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that no waiver of a Default or Event of Default shall be deemed to constitute such an increase), (ii) extend the Commitment Period without the consent of each Lender directly affected thereby, (iii) reduce the amount, or extend the time of payment, of the Fees without the consent of each Lender directly affected thereby, (iv) reduce the rate, or extend the time of payment of, interest on any Revolving Credit Loan, any Note or any Reimbursement Obligation (other than the applicability of any post-default increase in such rate of interest) without the consent of each Lender directly affected thereby, (v) reduce the amount of, or extend the time of payment of, any payment of any Reimbursement Obligation or principal on any Revolving Credit Loan or any Note without the consent of each Lender directly affected thereby, (vi) decrease or forgive the principal amount of any Revolving Credit Loan, any Note or any Reimbursement Obligation without the consent of each Lender directly affected thereby, (vii) consent to any assignment or delegation by the Borrower of any of its rights or obligations under any Loan Document without the consent of each Lender, (viii) change the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of each Lender, (ix) change the definition of Required Lenders without the consent of each Lender, (x) change the several nature of the obligations of the Lenders without the consent of each Lender, (xi) change the sharing provisions among Lenders without the consent of each Lender directly affected thereby, or (xii) extend the expiration date of a Letter of Credit beyond the Commitment Termination Date without the consent of each Lender. Notwithstanding the foregoing, in addition to the receipt of the prior written consents of the Borrower and the Required Lenders, no such amendment, supplement, modification, waiver or consent shall (A) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or otherwise change any of the rights or obligations of the Administrative Agent, any Issuer or the Swing Line Lender under any Loan Document without the written consent of the Administrative Agent, such  Issuer or the Swing Line Lender, as the case may be, (B) change the Letter of Credit Commitment, change the amount or the time of payment of any Letter of Credit or any commission or fee payable to the Issuer thereof in connection therewith, or change any other term or provision which relates to the Letter of Credit Commitment of such Issuer or the Letters of Credit issued thereby without the written consent of such Issuer, (C) change the Swing Line Commitment, change the amount or the time of payment of the Swing Line Loans or interest thereon or change any other term or provision which relates to the Swing Line Commitment or the Swing Line Loans without the written consent of the Swing Line Lender or (D) change the amount or the time of payment of any Competitive Bid Loan or interest thereon without the written consent of the Lender holding such Competitive Bid Loan. Any such amendment, supplement,  modification, waiver or consent shall apply equally to each of the Lenders and shall be binding upon the parties to the applicable Loan Document, the Lenders, the Issuers, the Administrative Agent and all future holders of the Loans, the Notes and the Reimbursement Obligations. In the case of any waiver, the Borrower, the Lenders, the Issuers and the Administrative Agent shall be restored to their former position and rights under the Loan Documents, but any Default or Event of Default waived shall not extend to any subsequent or other Default or Event of Default, or impair any right consequent thereon. Notwithstanding anything to the contrary in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (1) the Administrative Agent and the Borrower may make amendments contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.8(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> without the consent of any other Person party hereto and (2)    </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">if the Administrative Agent and the Borrower shall have jointly identified an obvious error, ambiguity,   defect, inconsistency, omission or any error or omission of a technical nature, in each case, in any provision of the Loan Documents, then the Administrative Agent and the Borrower shall be permitted to amend such provision, and, in each case, such amendment shall become effective without any further action or consent  of any party to any Loan Document (other than the Administrative Agent and the Borrower) if the same (x) does not adversely affect the rights of any Lender or (y) is not objected to in writing by the Required Lenders Administrative Agent within five Domestic Business Days following receipt of notice thereof. Any amendment, waiver or consent effected in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall be binding upon each Person that is at the time thereof a Lender and each Person that subsequently becomes a Lender.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Notices</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Notices Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Except in the case of notices and other communications expressly permitted to be given by telephone, all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by facsimile or email, as follows&#58;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MC2340</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Carol A. DeNale</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Vice President and Treasurer</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 770-5768</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-4407</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;carol.denale&#64;cvshealth.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy, in the case of a notice of Default or Event of Default, to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CVS Health Corporation</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 CVS Drive</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Woonsocket, Rhode Island 02895</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Tom Moffatt</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Assistant Secretary and Assistant General Counsel &#8211; Corporate Services</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(401) 216-3758</font></div><div style="padding-left:72pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(401) 770-5409</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;thomas.moffatt&#64;cvshealth.com</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">with a copy (in the case of a notice of Default or Event of Default and which shall not constitute notice under this Agreement or any other Loan Document for any purpose) to&#58;</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shearman &#38; Sterling LLP</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">599 Lexington Avenue</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, New York 10022</font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160;&#160;&#160;&#160;Gus M. Atiyah</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58;&#160;&#160;&#160;&#160;(646) 848-5227</font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Telephone&#58;&#160;&#160;&#160;&#160;(212) 848-5227</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;gus.atiyah&#64;shearman.com</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to the Administrative Agent, BofA as an Issuer or the Swing Line Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Borrowing Request, each notice of prepayment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, each Letter    of Credit Request, each Competitive Bid Request, each Competitive Bid, and each Competitive    Bid Accept&#47;Reject Letter&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-03</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;&#160; Donna Barron</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 980-387-3426</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 704-804-5235    </font></div><div style="margin-bottom:8pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; donna.h.barron&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions- US Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A. </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA# 026009593</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account No.&#58;  1366072250600</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account Name&#58; Wire Clearing Acct for Syn Loans-LIQ</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58;  CVS HEALTH CORPORATION </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the case of each Letter of Credit Request&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1 Fleet Way</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Mail Code&#58; PA6-580-02-30</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scranton, Pa. 18507</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Trade Operations</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 570-496-9619</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 800-755-8740</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; tradeclientserviceteamus&#64;bofa.com</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Remittance Instructions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">New York, NY</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ABA #&#58; 026-009-593 </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Account #&#58; 04535-883980</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Scranton Standby&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58; CVS HEALTH CORPORATION </font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and in all other cases&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bank of America, N.A., as Administrative Agent</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">900 W. Trade St., 6th Floor </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NC1-026-06-03</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Charlotte, NC 28255</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attention&#58;  Kyle Harding</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Tel&#58; 980-275-6132</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facsimile&#58; 704-719-5215</font></div><div style="margin-bottom:8pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Email&#58; kyle.d.harding&#64;bofa.com</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">If to any Lender or any other Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; to it at its address (or facsimile number or email address) set forth in its Administrative Questionnaire.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notices and other communications to the Credit  Parties hereunder may be delivered or furnished by electronic communication (including email, FpML messaging and internet or intranet websites) pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the foregoing shall not apply to notices to any Credit Party pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if such Credit Party has notified the Administrative Agent that  it is incapable of receiving notices under such Sections by electronic communication. The Administrative Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Unless the Administrative Agent otherwise prescribes, (i)&#160;notices and other  communications sent to an email address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; or &#8220;read requested&#8221; function, as available, return email or other written acknowledgement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next Domestic Business Day for the recipient, and (ii)&#160;notices or communications posted to an internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its email address as described in the foregoing clause&#160;(i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Change of Address.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any party hereto may change its address, facsimile number or email address for notices and other communications hereunder by notice to the other parties hereto (or, in the case of any Lender or any Issuer, by notice to the Administrative Agent and the Borrower). Subject to the second paragraph of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, all notices and other communications given to any party hereto in accordance with the provisions of this Agreement   shall be deemed to have been given on the date of receipt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such notice or communication that is not received on a Domestic Business Day during the normal business hours  of the recipient shall be deemed received at the opening of business on the next Domestic Business Day.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">The Platform.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">THE PLATFORM IS PROVIDED &#8220;AS IS&#8221; AND &#8220;AS AVAILABLE.&#8221;  THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR   ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS.  NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT  OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS,  IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER  MATERIALS OR THE PLATFORM.  In no event shall the Administrative Agent or any of its Related Parties (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Agent Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) have any liability to the Borrower, any Lender, any Issuer or any other Person for losses, claims, damages, liabilities or expenses of any kind </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(whether in tort, contract or otherwise) arising out of the Borrower&#8217;s or the Administrative Agent&#8217;s transmission of Borrower Materials or notices through the Platform, any other electronic platform  or electronic messaging service, or through the Internet.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Waiver&#59; Cumulative Remedies</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No failure to exercise and no delay in exercising, on the part of the Administrative Agent, any Lender or any Issuer, any right, remedy, power or privilege under any Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power or privilege under any Loan Document preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges under the Loan Documents are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Survival of Representations and Warranties</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All representations and warranties made in the Loan Documents and in any document, certificate    or statement delivered pursuant thereto or in connection therewith shall survive the execution and delivery  of the Loan Documents.</font></div><div style="margin-bottom:8.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Payment of Expenses&#59; Indemnified Liabilities</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Borrower agrees, as soon as practicable following presentation of a statement  or invoice therefor setting forth in reasonable detail the items thereof, and whether any Loan is  made or Letter of Credit is issued, (a) to pay or reimburse the Administrative Agent and its  Affiliates for all their reasonable and documented out-of-pocket costs and expenses actually  incurred in connection with the development, syndication, preparation and execution of, and any amendment, waiver, consent, supplement or modification to, the Loan Documents, any documents prepared in connection therewith and the consummation of the transactions contemplated thereby, whether such Loan Documents or any such amendment, waiver, consent, supplement or modification to the Loan Documents or any documents prepared in connection therewith are executed and whether the transactions contemplated thereby are consummated, including the reasonable and documented out-of-pocket fees and disbursements of Special Counsel, (b) to pay, indemnify, and hold the Administrative Agent, the Lenders and the Issuers harmless from any and all recording and filing fees and any and all liabilities and penalties with respect to, or resulting  from any delay (other than penalties to the extent attributable to the negligence of the  Administrative Agent, the Lenders or the Issuers, as the case may be, in failing to pay such fees, liabilities or penalties when due) which may be payable or determined to be payable in connection with the execution and delivery of, or consummation of any of the transactions contemplated by,    or any amendment, supplement or modification of, or any waiver or consent under or in respect of, the Loan Documents or any documents prepared in connection therewith, and (c) to pay, reimburse, indemnify and hold each Indemnified Person harmless from and against any and all other liabilities, obligations, claims, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements of any kind or nature whatsoever (including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person affected by such conflict notifies the Borrower of the existence of such conflict and thereafter  retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty),    for each such affected Indemnified Person))) actually incurred with respect to the enforcement, performance of, and preservation of rights under, the Loan Documents (all the foregoing, collectively, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Liabilities&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) and, if and to the extent that the foregoing indemnity may be unenforceable for any reason, the Borrower agrees to make the maximum payment  permitted under applicable law. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing payment, indemnification and reimbursement obligations will not, as to any Person identified in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud or bad faith of such Person, (B) from a material breach of the obligations hereunder of such Person, (C) out of  or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by any such Person against any such other Person (other than the Administrative Agent, Joint Lead Arranger, Issuer or Swing Line Lender, in each case, in its capacity as such), in each case under clauses (A) and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction. The agreements in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Lending Offices</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender shall have the right at any time and from time to time to transfer any Loan to a different office of such Lender, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Successors and Assigns</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Successors and Assigns Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and  assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of paragraph (b) of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, (ii) by way of participation in accordance with the provisions of paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or (iii) by way of pledge or assignment of a security interest subject to the restrictions of paragraph (f) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, the Participants to the extent provided in paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and,   to the extent expressly contemplated hereby, the Related Parties of each Credit Party) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignments by Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">portion of its Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that any such assignment shall be subject to the following conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Minimum Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;in the case of an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitment Amount or Swing Line Commitment and the Loans and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;in any case not described in paragraph (b)(1)(A) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Commitment Amount or Swing Line Commitment (which for this   purpose includes the Loans of the assigning Lender outstanding thereunder and obligations in respect of its Letter of Credit Exposure and Swing Line Exposure at the time owing to it thereunder) or, if the Commitment or Swing Line Commitment of the assigning Lender is not then in effect, the principal outstanding balance of  the Loans and the Letter of Credit Exposure and Swing Line Exposure of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if a &#8220;Trade Date&#8221; is specified in the Assignment and Assumption, as of such &#8220;Trade Date&#8221;) shall not be less than $5,000,000, unless  each of the Administrative Agent and, so long as no Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed).</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Proportionate Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement with respect to the Loans, Letter of Credit Exposure and Swing Line Exposure or the Commitment assigned, except that this clause (2) shall not prohibit any Lender from assigning all or a portion of its rights and obligations in respect of Competitive Bid Loans on a non-pro rata basis.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Required Consents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No consent shall be required for any assignment   except to the extent required by paragraph (b)(1)(B) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and, in addition&#58;</font></div><div style="margin-bottom:9pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;the consent of the Borrower (such consent not to be unreasonably withheld or delayed) shall be required unless (x) an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(h),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> has occurred and is continuing at the time of such assignment or (y) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund (it being understood that it shall not be deemed unreasonable for the Borrower to withhold consent to any assignment if it reasonably believes that such assignment would result in the Borrower incurring increased costs pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;the consent of the Administrative Agent (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for assignments   in respect of an unfunded or revolving facility hereunder if such assignment is to     </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a Person that is not a Lender with a Commitment in respect of such facility, an Affiliate of such Lender or an Approved Fund with respect to such Lender&#59; and</font></div><div style="margin-bottom:9pt;padding-left:108pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the consent of each Issuer (such consent not to be unreasonably withheld, conditioned or delayed) shall be required for any assignment that increases the obligation of the assignee to participate in exposure under one or   more Letters of Credit (whether or not then outstanding) and the Swing Line  Lender (such consent not to be unreasonably withheld or delayed) shall be required for any assignment in respect of the revolving facility hereunder.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $4,500 ($7,500 in the case of an assignment by a Defaulting Lender) (which fee shall be paid by the assignor or the assignee and may be waived or reduced in the sole discretion of the Administrative Agent), and the assignee, if   it is not a Lender, shall deliver to the Administrative Agent an Administrative     Questionnaire.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Assignment to Certain Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to  (A) the Borrower, any of its Subsidiaries or any of their respective Affiliates or (B) any Defaulting Lender or any of its Subsidiaries or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this clause (B).</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Assignment to Natural Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No such assignment shall be made to    a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person).</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Additional Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to   the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be  outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the Borrower and the Administrative Agent, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, any Issuer or any Lender   hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full pro rata share of all Loans and participations in Letters of Credit and Swing Line Loans in accordance with its Commitment Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable law without compliance with the provisions of this  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs.</font></div><div style="margin-bottom:5.8pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to acceptance and recording thereof by the Administrative Agent pursuant to paragraph (c) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, from and after the effective date specified in each Assignment  and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of    the interest assigned by such Assignment and Assumption, have the rights and obligations of a     Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.8pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> with respect to facts and circumstances occurring prior to the effective date of such assignment. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this paragraph shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (d) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5.8pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrative Agent, acting solely for this purpose as an agent of  the Borrower, shall maintain at one of its offices in the United States of America a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of  the Loans owing to, each Lender pursuant to the terms hereof from time to time (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Register&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent, the Issuers and the Lenders shall treat each Person whose name is recorded  in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection   by the Borrower, any Issuer and any Lender (but only, in the case of an Issuer or a Lender, at the Administrative Agent&#8217;s Office and with respect to any entry relating to such Lender&#8217;s  Commitments, Advances and other obligations pursuant to the terms hereof or such Issuer&#8217;s Letter of Credit Commitments and other obligations pursuant to the terms hereof, as applicable) at any reasonable time and from time to time upon reasonable prior notice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Participations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Any Lender may at any time, without the consent of, or notice to,  the Borrower or the Administrative Agent, sell participations to any Person (other than a natural person (or a holding company, investment vehicle or trust for, or owned and operated by or for the primary benefit of a natural person), the Borrower, any of its Subsidiaries or any of their respective Affiliates) (each, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) in all or a portion of such Lender&#8217;s rights and&#47;or obligations  under this Agreement (including all or a portion of its Commitment, Letter of Credit Exposure, Swing Line Exposure and&#47;or the Loans, Letter of Credit Exposure or Swing Line Exposure owing   to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that (i)&#160;all of such Lender&#8217;s obligations under this Agreement and the other Loan Documents shall remain in all respects unchanged, (ii)&#160;such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrower, the Administrative Agent and each Credit Party shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that  such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver which requires the consent of all Lenders or all affected Lenders that directly affects such Participant. Subject to paragraph (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to the same extent as if it were a Lender and had acquired its interest  by assignment pursuant to paragraph (b) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such Participant agrees to be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;11.9(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as though it were a Lender. Each Lender that sells a participation with respect to a Commitment or Loan shall, solely for the purposes of complying with the rules regarding registered form in the Internal Revenue Code, act   as a non-fiduciary agent of the Borrower, maintaining a register on which it enters the name and </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">address of each Participant and the principal amounts (and stated interest amounts) of each Participant&#8217;s interest in the Commitment and&#47;or Loan (each a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), and the entries in such Participant Register shall be conclusive, absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. No Lender shall be required to disclose the existence of, or any of the information contained in, any Participant Register maintained by it to the Borrower or any other Person unless requested in  writing by the Borrower, and only to the Internal Revenue Service to the extent such disclosure is required in order to comply with the rules requiring registered form pursuant to the Internal  Revenue Code.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations upon Participant Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Participant shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent. A Participant shall not be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of the Borrower, to comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;3.10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as though it were a Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Pledges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any Lender may at any time pledge or assign a security interest    in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central bank having jurisdiction over such Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Resignation as Issuer or Swing Line Lender after Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary contained herein, if at any time any Issuer or the Swing Line Lender assigns all of its Commitment and Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> above, such Issuer or Swing Line Lender may, (i) upon 30 days&#8217; notice to the Administrative Agent, the Borrower and the Lenders, resign     as an Issuer and&#47;or (ii) upon 30 days&#8217; notice to the Borrower, resign as Swing Line Lender.  In the event of any such resignation as an Issuer or Swing Line Lender, the Borrower shall be entitled to appoint from among the Lenders a successor Issuer or Swing Line Lender hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that no failure by the Borrower to appoint any such successor shall affect the resignation  of the applicable Issuer or Swing Line Lender as an Issuer or Swing Line Lender, as the case may be.  If the applicable Issuer resigns as an Issuer, it shall retain all the rights, powers, privileges and duties of an Issuer hereunder with respect to all Letters of Credit issued by it and outstanding as of the effective date of its resignation as an Issuer and all Reimbursement Obligations with respect thereto (including the right to require the Lenders to make ABR Advances or fund risk  participations in pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">).  If the Swing Line Lender resigns as Swing Line Lender,  it shall retain all the rights of the Swing Line Lender provided for hereunder with respect to Swing Line Loans made by it and outstanding as of the effective date of such resignation, including the right to require the Lenders to make ABR Advances or fund risk participations in outstanding  Swing Line Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Upon the appointment of a successor Issuer and&#47;or Swing Line Lender, (x) such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Issuer or Swing Line Lender, as the case may be, and  (y) the successor Issuer shall issue letters of credit in substitution for the Letters of Credit, if any, outstanding at the time of such succession or make other arrangements satisfactory to the applicable retiring Issuer and the Borrower to effectively assume the obligations of the applicable retiring Issuer with respect to such Letters of Credit.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.8pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Disqualified Institutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  (i)  No assignment shall be made to any Person that was   a Disqualified Institution as of the date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Trade Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) on which the applicable Lender entered into a binding agreement to sell and assign all or a portion of its rights and obligations under this Agreement to such Person (unless the Borrower has consented to  such assignment in writing as otherwise contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in which case such Person will not be considered a Disqualified Institution for the purpose of such assignment).  For the avoidance of doubt, with respect to any assignee that becomes a Disqualified Institution after the applicable Trade Date (including as a result of the delivery of a notice pursuant to, and&#47;or the expiration of the notice period referred to in, the  definition of &#8220;Disqualified Institution&#8221;), (x) such assignee shall not retroactively be disqualified from becoming a Lender and (y) the execution and delivery by the Borrower   of an Assignment and Assumption with respect to such assignee will not by itself result in such assignee no longer being considered a Disqualified Institution.  Any assignment in violation of this clause (h)(i) shall not be void, but the other provisions of this clause (h) shall apply.</font></div><div style="margin-bottom:5.8pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;If any assignment is made to any Disqualified Institution without the Borrower&#8217;s prior consent in violation of clause (i) above, or if any Person becomes a Disqualified Institution after the applicable Trade Date,  the Borrower may, at its sole expense and effort, upon notice to the applicable Disqualified Institution and the Administrative Agent, (A) terminate any Commitment of such Disqualified Institution and repay all obligations of the Borrower owing to such Disqualified Institution in connection with such Commitment, and&#47;or (B) require such Disqualified Institution to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), all of its interest, rights and obligations under this Agreement and the other Loan Documents to an Eligible Assignee that shall assume such obligations at the lesser of (x) the principal amount thereof and (y) the amount that such Disqualified Institution paid to acquire such interests, rights and obligations, in each case plus accrued interest, accrued fees and all other amounts (other than principal amounts) payable to it hereunder and other the other Loan Documents.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary contained in this Agreement, Disqualified Institutions (A) will not (x) have the right to receive information, reports or other materials provided to Lenders by the Borrower, the Administrative Agent or any   other Lender, (y) attend or participate in meetings attended by the Lenders and the Administrative Agent, or (z) access any electronic site established for the Lenders or confidential communications from counsel to or financial advisors of the Administrative Agent or the Lenders and (B) (x) for purposes of any consent to any amendment, waiver     or modification of, or any action under, and for the purpose of any direction to the Administrative Agent or any Lender to undertake any action (or refrain from taking any action) under this Agreement or any other Loan Document, each Disqualified Institution will be deemed to have consented in the same proportion as the Lenders that are not Disqualified Institutions consented to such matter, and (y) for purposes of voting on any plan of reorganization or plan of liquidation pursuant to any bankruptcy or insolvency laws (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan of Reorganization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each Disqualified Institution party hereto hereby agrees (1) not to vote on such Plan of Reorganization, (2) if such Disqualified Institution does vote on  such Plan of Reorganization notwithstanding the restriction in the foregoing clause (1),   such vote will be deemed not to be in good faith and shall be &#8220;designated&#8221; pursuant to Section 1126(e) of the United States Bankruptcy Code (or any similar provision in any  other bankruptcy or insolvency laws), and such vote shall not be counted in determining whether the applicable class has accepted or rejected such Plan of Reorganization in </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">accordance with Section 1126(c) of the United States Bankruptcy Code (or any similar provision in any other bankruptcy or insolvency laws) and (3) not to contest any request    by any party for a determination by the bankruptcy court (or other applicable court of competent jurisdiction) effectuating the foregoing clause (2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Counterparts&#59; Electronic Execution </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the Loan Documents (other than the Notes) may be executed on any number of separate counterparts and all of said counterparts taken together shall be deemed to constitute one and the same agreement.  It shall not be necessary in making proof of any Loan Document to produce or account for more than one counterpart signed by the party to be charged.   A set of the copies of this Agreement signed by all of the parties hereto shall be lodged with each    of the Borrower and the Administrative Agent.  Delivery of an executed counterpart of a signature page of any Loan Document by fax or other electronic means (e.g., &#8220;.pdf&#8221; or &#8220;.tif&#8221;) shall be effective as delivery of a manually executed counterpart of such Loan Document.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and any document, amendment, approval, assignment, consent, information, notice, certificate, request, statement, disclosure or authorization related to this Agreement (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Communication</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), including Communications required to be in writing, may be in the form of an Electronic Record and may be executed using Electronic Signatures. Each party hereto hereby agrees that any Electronic Signature on, or associated with,  any Communication shall be valid and binding on such party to the same extent as a manual,  original signature, and that any Communication entered into by Electronic Signature, will constitute the legal, valid and binding obligation of such party enforceable against such party in accordance with the terms thereof to the same extent as if a manually executed original signature was delivered.   Any Communication may be executed in as many counterparts as necessary or convenient,  including both paper and electronic counterparts, but all such counterparts are one and the same Communication.  For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by each party hereto of a manually signed paper Communication which has been converted into electronic form (such as scanned into PDF format), or an electronically signed Communication converted into another format, for transmission,   delivery and&#47;or retention. Each party hereto may, at its option, create one or more copies of any Communication in the form of an imaged Electronic Record (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Copy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document.  All Communications in the form of an Electronic Record, including an Electronic Copy, shall be considered an original for all purposes, and shall have the same legal effect, validity and enforceability as a paper record. Notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to accept an Electronic Signature in any form or in    any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it (it being acknowledged that the Administrative Agent will accept &#8220;.pdf&#8221; signatures).  Without limiting the foregoing sentence, (a) to the extent the Administrative Agent has agreed to accept   such Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to   rely on any such Electronic Signature purportedly given by or on behalf of the Borrower without further verification, and (b) upon the request of the Administrative Agent or any Lender hereto, any Electronic Signature shall be promptly (to the extent reasonably practicable at such time as reasonably determined by the Borrower) followed by such manually executed counterpart.  For purposes hereof, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Record</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall have the meanings   assigned to them, respectively, by 15 USC &#167;7006, as it may be amended from time to time.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Set-off and Sharing of Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;In addition to any rights and remedies of the Lenders and the Issuers provided by law, after the occurrence and during the continuance of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">     or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or upon the acceleration of the Loans, each Lender and each Issuer shall have the right, without prior notice to the Borrower, any such notice being expressly waived by the  Borrower, to set-off and apply against any indebtedness or other liability, whether matured or unmatured, of the Borrower to such Lender or such Issuer arising under the Loan Documents, any amount owing from such Lender or such Issuer to the Borrower. To the extent permitted by applicable law, the aforesaid right of set-off may be exercised by such Lender or such Issuer against the Borrower or against any trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receiver, or execution, judgment or attachment creditor of the Borrower, or against anyone else claiming through or against the Borrower or such trustee in bankruptcy, custodian, debtor in possession, assignee for the benefit of creditors, receivers, or execution, judgment or attachment creditor, notwithstanding the fact that such right of set-off shall not have been exercised by such Lender or such Issuer prior to the making, filing or issuance of, service   upon such Lender or such Issuer of, or notice to such Lender or such Issuer of, any petition, assignment for the benefit of creditors, appointment or application for the appointment of a   receiver, or issuance of execution, subpoena, order or warrant. Each Lender and each Issuer agree promptly to notify the Borrower and the Administrative Agent after each such set-off and application made by such Lender or such Issuer, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the failure to give such notice shall not affect the validity of such set-off and application.</font></div><div style="margin-bottom:8.3pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;If any Lender or any Issuer shall obtain any payment (whether voluntary, involuntary, through the exercise of any right of setoff, or otherwise) on account of its Loans or  its Notes or the Reimbursement Obligations in excess of its pro rata share (in accordance with the outstanding principal balance of all Loans or the Reimbursement Obligations) of payments then   due and payable on account of the Loans and Notes received by all the Lenders or the Reimbursement Obligations received by all Issuers, such Lender or such Issuer, as the case may    be, shall forthwith purchase, without recourse, for cash, from the other Lenders or Issuers, as the case may be, such participations in their Loans and Notes or the Reimbursement Obligations as  shall be necessary to cause such purchasing Lender or Issuer to share the excess payment with each of them according to their pro rata share (in accordance with the outstanding principal balance of   all Loans and the Reimbursement Obligations)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that if all or any portion of such excess payment is thereafter recovered from such purchasing Lender or Issuer, such purchase from each Lender or Issuer shall be rescinded and each such Lender and Issuer shall repay to the purchasing Lender or Issuer the purchase price to the extent of such recovery, together with an amount equal    to such Lender&#8217;s or Issuer&#8217;s pro rata share (according to the proportion of (i) the amount of such Lender&#8217;s or Issuer&#8217;s required repayment to (ii) the total amount so recovered from the purchasing Lender or Issuer) of any interest or other amount paid or payable by the purchasing Lender or Issuer in respect of the total amount so recovered. The Borrower agrees, to the fullest extent permitted by law, that any Lender or Issuer so purchasing a participation from another Lender or Issuer pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> may exercise such rights to payment (including the right of set-off) with respect to such participation as fully as if such Lender or Issuer were the direct creditor of the Borrower in the amount of such participation.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be construed to  apply to (A) any payment made by or on behalf of the Borrower pursuant to, and in accordance  with, the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender or Disqualified Institution), (y) the application of cash collateral   as provided herein, or (z) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans or subparticipations in Reimbursement Obligations or </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8.3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Swing Line Loans to any assignee or participant, other than an assignment to the Borrower or any Subsidiary thereof (as to which the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall apply).</font></div><div style="margin-bottom:8.3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Indemnity</font></div><div style="margin-bottom:8.3pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Borrower shall indemnify each Credit Party and each Related Party thereof (each such Person being called an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Indemnified Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) against, and hold each Indemnified Person harmless from, any and all losses, claims, damages, liabilities and related expenses,  including the reasonable and documented out-of-pocket fees and disbursements of one counsel (but excluding the allocated cost of internal counsel) representing all of the Indemnified Persons, taken  as a whole, and, if reasonably necessary, of a single local counsel for each applicable jurisdiction (which may include a single counsel acting in multiple jurisdictions) (and, if reasonably necessary, one specialty counsel for each applicable specialty), representing all of the Indemnified Persons, taken as a whole (and, in the case of any actual or perceived conflict of interest where the Indemnified Person affected by such conflict notifies the Borrower of the existence of such conflict and thereafter retains its own counsel, of another firm of counsel (and, if reasonably necessary, a single local counsel for each applicable jurisdiction (and, if reasonably necessary, one specialty counsel for each applicable specialty), for each such affected Indemnified Person)), actually  incurred by any Indemnified Person arising out of, in connection with, or as a result of (i) the execution or delivery of any Loan Document or any agreement or instrument contemplated thereby, the performance by the parties to the Loan Documents of their respective obligations thereunder or the consummation of the transactions contemplated hereby or any other transactions contemplated thereby, (ii) any Loan or Letter of Credit or the use of the proceeds thereof, (iii) any actual or  alleged presence or release of Hazardous Materials in, on, under or from any property owned or operated by the Borrower or any of the Subsidiaries, or any Environmental Liability related in any way to the Borrower or any of the Subsidiaries or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on statute, contract, tort or any other theory and regardless of whether any Indemnified Person is a party thereto. Notwithstanding anything to the contrary contained in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the foregoing  indemnity will not, as to any Indemnified Person, apply to any losses, claims, damages, liabilities and related expenses to the extent arising (A) from the willful misconduct, gross negligence, fraud  or bad faith of such Indemnified Person, (B) from a material breach of the obligations hereunder of such Indemnified Person, (C) out of or in connection with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, or (D) out of or in connection with any claim, litigation, investigation or proceeding that does not involve an act or omission of the Borrower or any of its Affiliates and that is brought by an Indemnified Person against any other Indemnified Person (other than the Administrative Agent, a Joint Lead Arranger, Issuer or Swing Line Lender, in each case in its capacity as such), in each case under clauses (A)  and (B), to the extent determined by a final and non-appealable judgment of a court of competent jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To the extent that the Borrower fails to pay as soon as practicable any amount required to be paid by it to the Administrative Agent under subsection (a) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Indemnified Amount&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), each Lender severally agrees to pay to the Administrative Agent an amount equal to the product of such unpaid amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">multiplied by</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (i) at any time when no Loans    are outstanding, its Commitment Percentage, and (ii) at any time when Loans are outstanding (x)     if the Commitments then exist, its Commitment Percentage or (y) if the Commitments have been terminated or otherwise no longer exist, the percentage equal to the fraction, (A) the numerator of which is the sum of such Lender&#8217;s Credit Exposure and (B) the denominator of which is the sum    of the Aggregate Credit Exposure (in each case determined as of the time that the applicable Indemnified Amount is sought)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that the Indemnified Amount was payable to the Administrative Agent in its capacity as such.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5.8pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The obligations of the Borrower and the Lenders under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall survive the termination of the Commitments and the payment of the Loans and the Notes and all other amounts payable under the Loan Documents.</font></div><div style="margin-bottom:5.9pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;If any settlement of any investigation, litigation or proceeding to which the indemnity in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> applies (any of the foregoing, a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Proceeding&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is instituted or threatened against any Indemnified Person (or its Related Parties) in respect of which indemnity  may be sought hereunder, unless an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.1(a),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">9.1(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> exists, the Borrower shall be entitled to assume the defense thereof with counsel selected by the Borrower (which counsel shall be reasonably satisfactory to such Indemnified Person) and after notice from the Borrower to such Indemnified Person of the Borrower&#8217;s election so to assume the defense thereof, the Borrower will not be liable to such Indemnified Person hereunder for any legal or other expenses subsequently incurred by such Indemnified Person in connection with the defense thereof, other than reasonable and documented out-of-pocket costs of investigation and such other reasonable and documented out-of-pocket expenses as have been approved in advance&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that (i) if counsel for such Indemnified Person determines in good faith that there is a conflict that requires separate representation for the Borrower and such Indemnified Person or that there may    be legal defenses available to such Indemnified Person which are different from, or in addition to, those available to the Borrower or (ii) the Borrower fails to assume or proceed in a timely and reasonable manner with the defense of such action or fails to employ counsel reasonably  satisfactory to such Indemnified Person in any such action, then in either such event, (A) such Indemnified Person shall be entitled to one primary counsel and, if necessary, one local counsel to represent such Indemnified Person and all other Indemnified Persons similarly situated (such counsels selected by the Administrative Agent), (B) the Borrower shall not, or shall not any longer, be entitled to assume the defense thereof on behalf of such Indemnified Person, and (C) such Indemnified Person shall be entitled to indemnification for the expenses (including fees and expenses of such counsel) to the extent provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, the Borrower shall not be liable for any settlement, compromise or consent to the entry  of any judgment in any action or Proceeding effected without the Borrower&#8217;s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed, it being understood and agreed that the withholding, conditioning or delaying of the Borrower&#8217;s consent in connection with  a settlement, compromise or consent to the entry of any judgment in any action or proceeding which does not include an unconditional release of the Borrower and the Subsidiaries from all liability or claims that are the subject matter of such Proceeding or which includes a statement as to any admission of fault by or on behalf of the Borrower or any Subsidiary shall not be deemed unreasonable), but if settled with the Borrower&#8217;s prior written consent or if there is a final judgment for the plaintiff in any such Proceeding, the Borrower agrees to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and expenses  by reason of such settlement, compromise or consent to the entry of any judgment in any action or Proceeding in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower shall not, without the prior written consent of an Indemnified Person, effect any settlement of any pending or threatened Proceeding against such Indemnified Person in respect of which indemnity could have been sought hereunder  by such Indemnified Person unless such settlement (x) includes an unconditional release of such Indemnified Person from all liability or claims that are the subject matter of such Proceeding, (y) does not include any statement as to any admission of fault by or on behalf of such Indemnified Person, and (z) contains customary confidentiality provisions with respect to the terms of such settlement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Notwithstanding any provision in this Agreement to the contrary, none of the Borrower, the Administrative Agent, the Lenders or any Affiliate of any of the foregoing will be responsible or liable to any Person or entity, on any theory of liability, for any indirect, special, </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">punitive or consequential damages that may be alleged as a result of the transactions contemplated hereby or by the other Loan Documents or any use or intended use of the proceeds of the Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that nothing in this clause (e) shall limit the Borrower&#8217;s indemnity obligations set forth in this Agreement with respect to any indirect, punitive or consequential damages included in any   third party claim in connection with which an Indemnified Person is entitled to indemnification hereunder. In addition to, and without limiting the immediately foregoing sentence, and to the  extent permitted by applicable law, the Borrower shall not assert, and hereby waives, any claim against any Indemnified Person, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct and actual damages) arising out of, in connection with, or    as a result of, any Loan Document or any agreement, instrument or other document contemplated thereby, the transactions contemplated hereby or any Loan or any Letter of Credit or the use of the proceeds thereof.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Notwithstanding the above, the Borrower shall have no liability under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> to indemnify or hold harmless any Indemnified Person for any losses, claims, damages, liabilities and related expenses relating to income or withholding Taxes or any Tax in lieu of such Taxes. Notwithstanding the foregoing, any amounts claimed by an Indemnified Person under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be available to be claimed by such Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, it being understood and agreed that the rights of an Indemnified Person under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> shall not be duplicative.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Governing Law</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Loan Documents and the rights and obligations of the parties thereto shall be governed by, and construed and interpreted in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Severability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Every provision of the Loan Documents is intended to be severable, and if any term or provision thereof shall be invalid, illegal or unenforceable for any reason, the validity, legality and enforceability of the remaining provisions thereof shall not be affected or impaired thereby, and any invalidity, illegality or unenforceability in any jurisdiction shall not affect the validity, legality or enforceability of any such term   or provision in any other jurisdiction.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Integration</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All exhibits to the Loan Documents shall be deemed to be a part thereof. Each Loan Document embodies the entire agreement and understanding between or among the parties thereto with respect to the subject matter thereof and supersedes all prior agreements and understandings between or among the parties thereto with respect to the subject matter thereof.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Treatment of Certain Information</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Credit Party agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (i) to its Affiliates and to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, advisors and other representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that each Credit Party shall be responsible for its controlled Affiliates&#8217; compliance in keeping Information confidential, (ii) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as    </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the National Association of Insurance Commissioners) (in which case such Person agrees (except     with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to use commercially   reasonable efforts to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iii) to the extent required by applicable laws or regulations or by any subpoena or similar legal process (in which case such Person agrees to (except with respect to any audit or examination conducted by bank accountants or any governmental regulatory authority exercising examination or regulatory authority) to inform the Borrower promptly thereof prior to such disclosure to the extent practicable and not prohibited by law), (iv) to any other party hereto, (v) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (vi) subject to an agreement containing provisions substantially the same as those of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to (A) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or (B) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (vii) to Gold Sheets and other similar bank trade publications, such information to consist of deal terms and other information customarily found in such publications, (viii) with the prior written consent of the Borrower, (ix) to the extent such Information (1)&#160;becomes publicly available other than as a result of a breach of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or a breach of any other confidentiality obligation owing by such Credit Party to the Borrower or (2)&#160;becomes available to the Administrative Agent, any Credit Party or any of their respective Affiliates on a nonconfidential basis from a source other than the Borrower not known to such Credit Party to be prohibited from disclosing such Information, and (x) on a confidential basis to   (1) any rating agency in connection with rating the Borrower or its Subsidiaries or the credit facilities provided hereunder or (2) the CUSIP Service Bureau or any similar agency in connection with the application, issuance, publishing and monitoring of CUSIP numbers of other market identifiers with respect to the credit facilities provided hereunder.  In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry and service providers to the Administrative Agent and the Lenders in connection with the administration of this Agreement, the other Loan Documents, and the Commitments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Information&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> means all information received from the Borrower or any of its Subsidiaries relating to the Borrower or any of its Subsidiaries or any of their respective businesses, other than any such information that is available to the Administrative Agent or any other Credit Party on a non-confidential basis prior to disclosure by   the Borrower or any of its Subsidiaries.</font></div><div style="margin-bottom:11pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Acknowledgments</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower acknowledges that (a) it has been advised by counsel in the negotiation, execution  and delivery of the Loan Documents, (b) by virtue of the Loan Documents, the relationship among the Administrative Agent, the Issuers and the Lenders, on the one hand, and the Borrower, on the other hand,    is solely that of debtor and creditor, and (c) by virtue of the Loan Documents, no joint venture exists among the Lenders or among the Borrower and the Lenders.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Consent to Jurisdiction</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto irrevocably submits to the exclusive jurisdiction of any New York State  or Federal Court sitting in the City of New York, Borough of Manhattan, over any suit, action, claim, counterclaim or proceeding arising out of or relating to the Loan Documents. EACH OF THE PARTIES </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION, CLAIM, COUNTERCLAIM OR PROCEEDING BROUGHT IN SUCH A COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.  Each of the parties hereto agrees that a final judgment in any such suit, action, claim, counterclaim or proceeding brought in such a court, after all appropriate appeals, shall be conclusive and binding upon it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Service of Process</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each of the parties hereto agrees that process may be served against it in any suit, action or proceeding referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> by sending the same by first class mail, return receipt requested or  by overnight courier service, with receipt acknowledged, to the address of such party set forth or referred    to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the parties hereto agrees that any such service (i) shall be deemed in every  respect effective service of process upon it in any such suit, action, or proceeding, and (ii) shall to the fullest extent enforceable by law, be taken and held to be valid personal service upon and personal delivery to it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Limitation on Service or Suit</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Nothing in the Loan Documents or any modification, waiver, or amendment thereto shall affect the right of the Administrative Agent, any Issuer or any Lender to serve process in any manner permitted by   law or limit the right of the Administrative Agent, any Issuer or any Lender to bring proceedings against          the Borrower in the courts of any jurisdiction or jurisdictions.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.19&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">WAIVER OF TRIAL BY JURY</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EACH OF THE CREDIT PARTIES AND THE BORROWER KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY. FURTHER, THE BORROWER HEREBY CERTIFIES THAT NO REPRESENTATIVE OR AGENT OF ANY OF THE CREDIT PARTIES, OR COUNSEL TO ANY OF THE CREDIT PARTIES, HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT ANY OF THE CREDIT PARTIES WOULD NOT, IN THE EVENT OF SUCH LITIGATION, SEEK TO ENFORCE THIS WAIVER OF RIGHT TO JURY TRIAL PROVISION. THE BORROWER ACKNOWLEDGES THAT THE CREDIT PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">INTER ALIA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, THE PROVISIONS OF THIS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">SECTION 11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.20&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Patriot Act Notice</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each Lender and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001), as amended from time to time) (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Patriot Act&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">), it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the Patriot Act.</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">No Fiduciary Duty</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Borrower agrees that in connection with all aspects of the transactions contemplated hereby   and any communications in connection therewith, the Borrower and its Subsidiaries, on the one hand, and the Credit Parties, the Joint Lead Arrangers named on the cover page hereof, and their respective Affiliates, on the other hand, will have a business relationship that does not create, by implication or otherwise, any fiduciary duty on the part of the Credit Parties or such</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Joint Lead Arrangers, or their respective Affiliates, and no such duty will be deemed to have arisen in connection with any such transactions or  communications.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.22&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Acknowledgement and Consent to Bail-In of Affected Financial Institutions</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the application of any Write-Down and Conversion Powers by the applicable Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender that is an Affected Financial Institution&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent entity, or a   bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect    to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the variation of the terms of such liability in connection with the exercise   of the Write-Down and Conversion Powers of the applicable Resolution Authority.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.23&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Certain ERISA Matters</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that at least one of the following is and will be true&#58;</font></div><div style="margin-bottom:11pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;such Lender is not using &#8220;plan assets&#8221; (within the meaning of   Section&#160;3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans,   the Letters of Credit, the Commitments or this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the transaction exemption set forth in one or more PTEs, such as PTE 84- 14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions </font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:70.56pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96- 23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in,   administration of and performance of the Loans, the Letters of Credit, the Commitments  and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection  (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender further (x) represents and warrants, as of the date such Person became a Lender party hereto, to,   and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Agents and the Joint Lead Arrangers and not, for the avoidance of doubt, to or for the benefit of the Borrower, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the following defined terms when used herein have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in Section 4975 of the Internal Revenue Code or (c) any Person whose assets include (for purposes of ERISA Section  3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Internal Revenue Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-bottom:60pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Balance of this Page is Intentionally Blank&#93;</font></div><div style="height:66.1pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CHAR1&#92;1787260v5</font></div></div></div><div id="ie8a48033cb224a6a91c10db64280cc10_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">   AS EVIDENCE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of the agreement by the parties hereto to the terms and conditions herein contained, each such party has caused this Agreement to be executed on its behalf.</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Carol A. DeNale&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;&#160;&#160;&#160;&#160;Carol A. DeNale</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160;&#160;&#160;Senior Vice President and Treasurer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as the Administrative Agent</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Kyle D Harding&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Kyle D Harding</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;  Vice President </font></div><div style="padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer, the          Swing Line Lender and a Lender</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Joseph L. Corah&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Joseph L. Corah</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      Director</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a         Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Christopher M. Aitkin&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">      Name&#58;    Christopher M. Aitkin</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">      Title&#58;     Vice President</font></div><div style="margin-bottom:60pt;padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer          and a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Jacob Elder&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Jacob Elder</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;  Authorized Signatory</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an             Issuer and a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Stacey Zoland&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Stacey Zoland</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as an Issuer and a Lender </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Jordan Harris&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Jordan Harris</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Managing Director</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:27pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CITIBANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Eugene Yermash&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Eugene Yermash</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MIZUHO BANK, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Tracy Rahn&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Tracy Rahn</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Executive Director</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MUFG BANK, LTD.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Henry Schwarz&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Henry Schwarz</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROYAL BANK OF CANADA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Gordon MacArthur &#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Gordon MacArthur</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TRUST BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; James W. Ford&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   James W. Ford</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Managing Director</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">U.S. BANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as              a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Joyce P. Dorsett&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Joyce P. Dorsett</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Senior Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CREDIT SUISSE AG, NEW YORK            BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Vipul Dhadda&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Vipul Dhadda</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Brady Bingham&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Brady Bingham</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Authorized Signatory</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FIFTH THIRD BANK, NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Todd S. Robinson&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Todd S. Robinson</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Senior Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PNC BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">               </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Michael Richards&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Michael Richards</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      SVP &#38; Managing Director</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SANTANDER BANK</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Pablo Urgoiti &#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Pablo Urgoiti</font></div><div style="margin-bottom:21pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      Managing Director</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Andres Barbosa&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;    Andres Barbosa</font></div><div style="margin-bottom:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;      Managing Director</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING  CORPORATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Rosa Pritsch&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Rosa Pritsch</font></div><div style="margin-bottom:21pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Director</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">BANK OF CHINA, NEW YORK BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">             </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Raymond Qiao&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Raymond Qiao</font></div><div style="margin-bottom:21pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDUSTRIAL AND COMMERCIAL BANK         OF CHINA LIMITED, NEW YORK            BRANCH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Haiyao Su&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Haiyao Su</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Executive Director</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Xiaoxing Huang&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Xiaoxing Huang</font></div><div style="margin-bottom:21pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    AVP</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KEYBANK NATIONAL ASSOCIATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as              a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Marianne T. Meil&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Marianne T. Meil</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Sr. Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TD BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, as a Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Steve Levi&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Steve Levi</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Senior Vice President</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">THE BANK OF NEW YORK MELLON, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as a      Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:9pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">  &#47;s&#47; Clifford A. Mull&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;   Clifford A. Mull</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;     Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FIVE YEAR CREDIT AGREEMENT </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>a06302021ex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie5ac115d1f9442f0adc004d5b441a169_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:324pt;text-indent:36pt"><font><br></font></div><div style="padding-left:324pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SEPARATION AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Separation Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) between Eva C. Boratto (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and CVS Pharmacy, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CVS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be effective as of June 9, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Employee has been employed by CVS or one of its subsidiaries&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Employee and CVS desire to enter into an agreement setting forth the terms  of Employee&#8217;s mutual agreement to separate from the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Employee and CVS are already bound to the obligations set forth in the Restrictive Covenant Agreement dated December 1, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which is attached as Exhibit C, all of which survive this separation of employment&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Employee has thoroughly reviewed this Agreement, has entered into it voluntarily, and has had the opportunity to consult with legal counsel of Employee&#8217;s choice before signing this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the covenants below, including but not limited to the General Release of Claims, and for other good and valuable consideration as set forth in this Agreement, Employee and the Company agree as follows&#58;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">SEPARATION FROM EMPLOYMENT&#59; OTHER SERVICE.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As of May 28, 2021, Employee has resigned as an officer of CVS Health Corporation and CVS Pharmacy, Inc., and from all other offices or directorships held as of that date, and shall continue to be employed in a special senior advisory capacity until December 1, 2021.  The parties agree that Employee may terminate her employment as a special senior advisor prior to December 1, 2021.  For purposes of this Agreement, &#8220;Separation Date&#8221; shall mean December 1, 2021 or, if earlier, the date on which Employee terminates her employment with the Company.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">CONSIDERATION. </font></div><div style="padding-left:36pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In order to receive the payments and benefits set forth in this Agreement, Employee must&#58; (a) sign this Agreement&#59;&#160;(b) sign the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">General Release of Claims</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> within 21 days after the Separation Date and allow the attendant Revocation Period to expire and the General Release of Claims to become effective&#59; and (c)&#160;materially comply with all of her obligations to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary in this Agreement, Employee shall receive the payments and benefits set forth in this Agreement if her employment is involuntarily terminated (x) by CVS other than due to Employee&#8217;s gross misconduct (subject to Employee&#8217;s execution of the General Release of Claims), or (y) due to Employee&#8217;s death prior to the Separation Date.</font></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">SEVERANCE.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">During the twenty-four (24) month period immediately following the Separation Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Employee shall continue to receive her base salary (as in effect immediately prior to the Separation Date) paid in accordance with the Company&#8217;s ordinary payroll practices during such period.  The parties agree that the Severance Period shall be reduced for the period, if any, of Employee&#8217;s continued employment with the Company between October 1, 2021 through December 1, 2021, but in no event shall the Severance Period be less than twenty-two (22) months. Subject to a valid COBRA election, Employee shall participate in the Company&#8217;s medical and other health benefit plans and programs  that Employee participated in immediately prior to the Separation Date at Company-subsidized rates for up to eighteen (18) months following the Separation Date, subject to the terms and conditions of each such plan or program.  Employee understands and agrees that CVS may modify its premium structure, employer subsidy, the terms of its plans, and the coverage of the plans at any time subject only to applicable law. The parties agree that notwithstanding anything in the CVS Health Severance Plan to the contrary, any cash payments made to Employee under paragraph 3 of this Agreement shall&#58; (a) not be subject to mitigation&#59; and (b) in the event of Employee&#8217;s death, be paid to Employee&#8217;s estate in the form of a lump sum as soon as practicable, but in no event later than 60 days following death.   </font></div><div><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">EXECUTIVE OUTPLACEMENT&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As part of its separation benefits to Employee, CVS will provide Employee with outplacement assistance as set forth on Exhibit A.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">ANNUAL BONUS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee shall receive a pro-rated cash bonus for Plan Year 2021, which shall be no less than Employee&#8217;s target bonus percentage times Employee&#8217;s eligible earnings through the Separation Date, times the funding percentage determined by the Company&#8217;s Management Planning and Development Committee for the 2021 Management Incentive Plan performance period, which shall be paid at the time that annual bonuses in respect of calendar year 2021 are otherwise paid to active executives of the Company.   </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">STOCK OPTIONS&#59; RESTRICTED STOCK UNITS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee&#8217;s previously-granted CVS Health stock options, as set forth in Section 1 of Exhibit B, shall continue to vest during the three-year period following the Separation Date and shall be exercisable through the last day of such three-year period (unless previously expired by their terms). Employee&#8217;s previously-granted CVS Health restricted stock unit award as set forth in Section 2 of Exhibit B, shall vest in the amount and on the date set forth in Section 2 of Exhibit B and shall be settled in accordance with its terms. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">PERFORMANCE STOCK UNITS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee&#8217;s outstanding performance stock unit awards (as set forth in Section 3 of Exhibit B) shall vest on a pro-rated basis through the Separation Date and shall be settled on their original vesting dates, in each case, as set forth in Section 3 of Exhibit B.  The parties agree that the post-termination holding periods applicable to the 2020 and 2021 performance stock unit awards will be satisfied upon the settlement of the awards.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">DEFERRED COMPENSATION.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee has been a participant in the Company&#8217;s Deferred Compensation and Deferred Stock programs.  Employee&#8217;s deferred cash balance shall be paid pursuant to the terms thereof consistent with the elections on file as of the Separation Date, including the withholding of applicable taxes.  Pursuant to the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), such amounts, subject to applicable withholding, shall be distributed commencing in the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) month following the Separation Date. </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">NO OTHER PAY OR BENEFITS&#59; SUFFICIENCY OF CONSIDERATION.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Any amounts of accrued but unused Paid Time Off (&#8220;PTO&#8221;) will be paid out in accordance with Company policy. Except as otherwise specifically set forth in this Agreement, Employee shall be entitled to no other wages, salary, vacation pay, myTime, PTO, bonuses, incentive awards, commissions, benefits, or any other compensation of any kind, except as required by law.  Employee acknowledges that the promises described in this Agreement are in excess of any earned wages and any other amounts due and owing to Employee, and are good and valuable consideration for the general release of claims and the other covenants and terms in this Agreement.  Employee understands and agrees that Employee is not eligible for or entitled to any other payments except as provided in this Agreement.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">GENERAL RELEASE OF CLAIMS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Within twenty-one (21) days following the Separation Date, Employee shall sign and deliver the General Release of Claims in the form set forth at the end of this Agreement.  </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">NO PENDING ACTIONS&#59; COVENANT NOT TO SUE.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided in this Agreement, Employee agrees not to initiate or file, or cause to be initiated or filed, any action, lawsuit, complaint, arbitration proceeding, or other proceeding asserting any of the Released Claims against any of the Released Parties.  Employee further agrees not to be a member of any class or collective action in any court  or in any arbitration proceeding seeking relief against the Released Parties based on claims released by this Agreement, and that even if a court or arbitrator rules that Employee may not waive a claim released by this Agreement, Employee shall not accept any money damages or other relief. Employee agrees to promptly reimburse the Company for any legal fees that the Company incurs as a result of any breach of this paragraph by Employee.  These provisions are subject to the Limitation on Restrictions provisions set forth in paragraph 8 of the parties&#8217; Restrictive Covenant Agreement, which are incorporated by reference herein.  Employee shall not, however, be entitled to receive any relief, recovery or monies in connection with any claim or action filed with and&#47;or pursued by any federal, state or local government agency, or any Released Claim brought against any of the Released Parties, regardless of who filed or initiated any such complaint, charge or proceeding.  Notwithstanding the above, nothing in this Agreement limits Employee&#8217;s right to receive an award for information provided to the SEC.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the limitations set forth above, Employee represents that as of the date Employee signs this Agreement, Employee has not filed or initiated, or caused to be filed or initiated, any complaint, claim, action or lawsuit of any kind against any of the Released Parties in any federal, state, or local court or agency or other forum, and Employee agrees not to </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">initiate or file, or cause to be initiated or filed, any action, lawsuit, complaint or proceeding in any federal, state, or local court or in any administrative tribunal or other forum with authority to adjudicate disputes asserting any of the Released Claims against any of the Released Parties.  Employee agrees to promptly reimburse the Company for any legal fees that the Company incurs as a result of any breach of this section by Employee.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">NO FMLA OR FLSA CLAIMS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee acknowledges that the Company has provided Employee with any leave to which Employee may be or may have been entitled under the Family and Medical Leave Act.  Employee represents that Employee is not aware of any facts that would support a claim by Employee against any of the Released Parties for any violation of the Family and Medical Leave Act.  Employee further acknowledges that Employee has been properly  paid for all time worked and is unaware of any facts that would support a claim by Employee against any of the Released Parties for any claim of unpaid overtime or any other violation of the Fair Labor Standards Act or comparable state law.      </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">RESTRICTIVE COVENANT AGREEMENT</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee and CVS acknowledge and agree that the Restrictive Covenant Agreement attached hereto as Exhibit C shall be modified as set forth in Addendum I hereto and shall otherwise remain in full force and effect in accordance with its terms.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">NON-DISCLOSURE OF CONFIDENTIAL INFORMATION.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee remains obligated to the terms of the Non-Disclosure of Confidential Information provisions set forth in paragraphs 4a and 4b of the parties&#8217; Restrictive Covenant Agreement, which are incorporated by reference herein.  As set forth in paragraph 8 of the parties&#8217; Restrictive Covenant Agreement, expressly incorporated into paragraph 11 above, nothing in this paragraph is intended to or shall interfere with Employee&#8217;s right to file a charge or complaint or participate or cooperate in an investigation or proceeding with the NLRB, SEC, EEOC or comparable state or local agencies.  Employee shall not, however, receive any individual benefit, including without limitation receipt of any monetary benefit, from any such action, charge, or complaint for any Released Claim brought against any of the Released Parties, regardless of who filed or initiated any such complaint, charge or proceeding.  Notwithstanding the above, nothing in this Agreement limits Employee&#8217;s right to receive an award for information provided to  the SEC.  Moreover, pursuant to 18 USC &#167; 1833(b), an individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of  a trade secret that is made in confidence to a Federal, State, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law.  An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal&#59; and does not disclose the trade secret, except pursuant to court order.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">RETURN OF COMPANY PROPERTY.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee acknowledges and represents that she remains bound by her obligations under the Ownership and Return of the Company&#8217;s Property provisions set forth in paragraph 5  of the parties&#8217; Restrictive Covenant Agreement, which are incorporated by reference herein. Notwithstanding anything to the contrary in this Agreement or the Restrictive Covenant Agreement, the Employee may retain the mobile device, phone number and iPad provided to Employee during her employment with the Company&#59; provided, however, that Employee reasonably cooperates with the Company in transferring and&#47;or removing any and all Confidential Information (as defined in the Restrictive Covenant Agreement). </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">UNDERSTANDING OF AGREEMENT&#59; ADVICE OF COUNSEL.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee acknowledges and confirms that Employee has entered into this Agreement of Employee&#8217;s own free will, without duress or coercion.  Employee acknowledges that Employee has read and fully understands the meaning and intent of this Agreement and is competent to execute it.  The Company hereby advises Employee to seek the advice of legal counsel before signing this Agreement, and Employee represents that Employee has had the opportunity to do so prior to signing this Agreement.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">REVIEW AND REVOCATION OF GENERAL RELEASE.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the Older Workers Benefit Protection Act, Employee has twenty-one (21) days from the date of receipt of this Agreement or, in the case of the General Release of Claims, from the Separation Date (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consideration Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to consider whether to enter into this Agreement and the General Release of Claims.  Employee shall send the entire original signed Agreement to Laurie Havanec, EVP and Chief People Officer, One CVS Drive, Woonsocket, RI 02895.  If Employee chooses not to consider this Agreement for the full twenty-one (21) days, Employee acknowledges that Employee does so knowingly, voluntarily, and with full understanding that Employee is waiving Employee&#8217;s statutory right to consider this Agreement for the full twenty-one (21) days.  Any modifications to this Agreement, whether material or immaterial, shall not restart the Consideration Periods.  Following the Separation Date, Employee shall send the signed General Release of Claims in the form attached hereto to Laurie Havanec, EVP and Chief People Officer, One CVS Drive, Woonsocket, RI 02895.  If Employee chooses not to consider the General Release  of Claims for the full twenty-one (21) days, Employee acknowledges that Employee does so knowingly, voluntarily, and with full understanding that Employee is waiving Employee&#8217;s statutory right to consider the General Release of Claims for the full twenty-one (21) days.  Any modifications to the General Release of Claims, whether material or immaterial, shall not restart the Consideration Periods.  CVS hereby advises Employee to consult with an attorney prior to executing this Agreement and the General Release of Claims, and that Employee may rescind this Agreement within seven (7) calendar days of its execution or revoke the General Release of Claims within seven (7) days of execution (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Revocation Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  To revoke this Agreement or the General Release of Claims, Employee must send written notice by mail stating&#58; &#8220;I revoke my acceptance of  the Separation Agreement,&#8221; or &#8220;I revoke my acceptance of the General Release of Claims&#8221; or words to that effect to Laurie Havanec, EVP and Chief People Officer, before the end   of the applicable Revocation Period.  Any such rescission must be delivered by hand or mail within the seven (7) day period.  If delivered by mail, the rescission must be&#58; (a) postmarked within the seven (7) day period&#59; (b) addressed to Laurie Havanec, EVP and </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Chief People Officer, One CVS Drive, Woonsocket, RI 02895&#59; and, (c) sent by certified mail, return receipt requested.  Employee acknowledges and agrees that this Agreement  and the General Release of Claims do not become fully enforceable and effective until the applicable Revocation Period has expired.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">EMPLOYEE COVENANTS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee acknowledges and agrees that the Restrictive Covenant Agreement attached hereto as Exhibit C is a valid agreement supported by adequate consideration.  Employee further acknowledges that the consideration provided by the Company in this Agreement   is contingent on Employee&#8217;s compliance with her obligations under the Restrictive Covenant Agreement as amended herein and in Addendum I, which Employee has acknowledged shall survive the separation of her employment, as set forth in the Survival of Employee&#8217;s Obligations provisions in paragraph 17 of the parties&#8217; Restrictive Covenant Agreement&#59; provided, however, that Employee and the Company agree to execute an Amendment to the Restrictive Covenant Agreement in the form attached hereto as Addendum I to this Agreement.  Employee further certifies that, during the term of her employment with the Company, Employee has complied with all applicable laws and regulations and that, as of the date Employee signs below, Employee has notified the Company of any actual or potential violations of applicable laws or regulations about which Employee has information.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">NON-DISPARAGEMENT.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee shall not make any statements that disparage the business or reputation of the Company, and&#47;or any officer, director or employee of the Company.  Notwithstanding the foregoing, nothing in this Agreement shall prohibit Employee from&#58; (a) making truthful statements or disclosures that are required by applicable law, regulation or legal process&#59; (b) requesting or receiving confidential legal advice&#59; or (c) cooperating, participating, or filing charges with any federal, state or local government agency enforcing discrimination laws, including the EEOC.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">COOPERATION.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee remains obligated to the Cooperation provisions set forth in paragraphs 7a and 7b of the parties&#8217; Restrictive Covenant Agreement, which are incorporated by reference herein&#59; provided, however, nothing herein shall require Employee to cooperate with the Company in an action Employee files, or participates in furthering, against the Company, with any federal, state or local government agency enforcing discrimination laws, including the NLRB, EEOC, SEC, EEOC or other federal, state or local agencies. Further, the Company shall&#58; (a) reimburse the Employee for reasonable expenses incurred in  connection with this cooperation&#59; and (b) in its request for cooperation, take into consideration Employee&#8217;s personal and business commitments and the amount of notice provided to Employee.    </font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">BREACH OF EMPLOYEE COVENANTS AND INJUNCTIVE RELIEF.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Without limiting the remedies available to CVS, Employee acknowledges that a breach by Employee of any of the covenants in this Agreement shall result in irreparable injury to some or all of the Company for which there is no adequate remedy at law, that monetary relief shall be inadequate, and that, in the event of such a material breach or threat thereof, </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CVS shall be entitled to obtain, in addition to any other relief that may be available, a temporary restraining order and&#47;or a preliminary or permanent injunction, restraining Employee from engaging in activities prohibited by any of the sections of this Agreement identified in this paragraph, as well as such other relief as may be required specifically to enforce any of the sections of this Agreement identified in this paragraph, without the payment of any bond.  In the event a dispute arises in connection with this paragraph 21 and a court of competent jurisdiction issues a ruling in favor of one of the parties, the breaching party agrees to promptly reimburse the prevailing party for all reasonable attorneys&#8217; fees incurred by the prevailing party in connection with obtaining such equitable relief or damages. However, nothing in this Agreement shall prohibit Employee from participating, cooperating, or filing charges with any federal, state or local government agency enforcing discrimination laws, including the NLRB, SEC or EEOC, and thus such action shall not constitute a breach of this Agreement.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">NONADMISSION OF WRONGDOING.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee and CVS agree that neither this Agreement nor the furnishing of consideration hereunder shall be deemed or construed at any time for any purpose as an admission by either party of any liability, wrongdoing or unlawful conduct, and Employee and CVS expressly deny any such liability, wrongdoing or unlawful conduct.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">GOVERNING LAW&#59; VENUE&#59; HEADINGS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be governed by and conformed in accordance with the laws of the state of Rhode Island without regard to its conflict of law provisions.  The exclusive venue for any legal action to enforce or allege breach of this Agreement shall be a court located  in the State of Rhode Island.  Employee consents to the Rhode Island courts&#8217; personal jurisdiction over her and waives her right to object to a Rhode Island court&#8217;s jurisdiction.  Section headings in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">COUNTERPARTS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement may be executed in counterparts and using electronic means of signature such as Docusign and each counterpart shall be deemed an original.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">SEVERABILITY.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any of the provisions of this Agreement, including but not limited to the Employee Covenants, are deemed unenforceable by a court of competent jurisdiction because they  are overly broad, then the court shall have the ability to modify the offending provision in order to make it enforceable.  Should any term or provision of this Agreement be declared illegal, invalid or unenforceable by any court of competent jurisdiction and if such provision cannot be modified to be enforceable, such provision shall immediately become null and void, leaving the remainder of this Agreement in full force and effect.  The language of all parts of this Agreement shall in all cases be construed as a whole, according to its fair meaning, and not strictly for or against either of the parties.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">SECTION 409A AND RESPONSIBILITY FOR TAXES.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each payment made under this Agreement shall be deemed and treated as a separate payment for purposes of Section 409A.  Further, to the extent that the Employee becomes </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">entitled to receive payments under this Agreement and, at the time of the Separation Date, Employee is a &#8220;specified employee&#8221; within the meaning of Treasury Regulation Section 1.409A-1(i), any portion of the payments under this Agreement payable to the Employee that is subject to Section 409A and applicable guidance thereunder shall be delayed until the date that is the earlier of&#58; (i) Employee&#8217;s death&#59; or (ii) six (6) months following Employee&#8217;s Separation Date, at which time the payments that were delayed for such six  (6) month period shall be paid in a lump sum on the date of the next occurring regular payroll date of the Company, and any remaining payments shall be paid according to the original schedule provided herein.  In no event shall any separation payment hereunder be made unless and until Employee has experienced a separation from service, as defined under Treasury Regulation Section 1.409A-1(h).  All payments set forth in this Agreement are subject to applicable withholdings and deductions.  Employee acknowledges and agrees that Employee is solely responsible for all taxes on the payments and benefits described in this Agreement, including income and excise taxes. The parties intend for payments and benefits provided under the terms of this Agreement to be exempt from or compliant with Section 409A, as applicable, and this Agreement shall be interpreted in a manner consistent with such intent.  If any provision of this Agreement (or award of any compensation due   to Employee under this Agreement) would cause Employee to incur any additional tax or interest under Section 409A of the Code or any regulations promulgated thereunder, the Company shall use reasonable efforts to correct any documentary or operational failures that would cause Employee to incur such additional tax or interest. CVS makes no representations or guarantees with respect to the tax status of any of the payments or benefits set forth herein, including taxation pursuant to Section 409A, and Employee acknowledges that Employee is solely responsible and shall hold the Company harmless  for same.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">SUCCESSORS.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall inure to the benefit of, and shall be binding upon, the parties, their heirs, executors, administrators, agents, assigns, and estates. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#010000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">28.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">ENTIRE AGREEMENT.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The expressed terms of this Agreement (including the Exhibits and Addendum I), the General Release of Claims, the Restrictive Covenant Agreement as modified herein and in Addendum I, and any applicable compensation, equity or benefit plan or agreement referred to herein set forth the entire agreement between the parties hereto.  Employee acknowledges and represents that Employee has not relied on any representations,  promises or agreements of any kind made to Employee in connection with Employee&#8217;s decision to accept the terms of this Agreement, except for the representations, promises  and agreements herein.  Any modification to this Agreement must be in a writing signed  by Employee and CVS&#8217;s Chief People Officer or her authorized representative.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the parties knowingly and voluntarily executed this Separation Agreement as of the dates set forth below.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.924%"><tr><td style="width:1.0%"></td><td style="width:3.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EVA C. BORATTO</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CVS PHARMACY, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Eva C. Boratto</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:12pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Eva C. Boratto</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Laurie Havanec<br>Executive Vice President, Chief</font></div><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">People Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">June 9, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">June 9, 2021</font></td></tr></table></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>a06302021ex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2007f6b3563d4290acff01d011e83eb2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div></div><div style="padding-left:4.5pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:22px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"></div><div style="padding-left:4.5pt"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="margin-top:2.8pt;padding-left:7pt;padding-right:369.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">May 16, 2021</font></div><div style="margin-top:2.8pt;padding-left:7pt;padding-right:369.1pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:338.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Mr. Shawn Guertin</font></div><div style="padding-left:4.5pt;padding-right:338.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#000000;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXXXXXXXXX</font></div><div style="padding-left:4.5pt;padding-right:338.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="background-color:#000000;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">XXXXXXXXXXXXXXXX</font></div><div style="padding-right:338.4pt"><font><br></font></div><div style="margin-top:2.8pt;padding-left:7pt;padding-right:369.1pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:232%">Dear Shawn,</font></div><div style="padding-left:7pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On behalf of CVS Health, I am pleased to offer you the position of Executive Vice President, Chief Financial Officer at CVS Health reporting to the President and Chief Executive Officer of CVS Health. If you accept this offer, your first day of employment will be May 28, 2021 (&#8220;Start Date&#8221;).  You will be based in Woonsocket with travel as needed.  We are excited to have you join the CVS Health team and trust you  will attain a high level of professional achievement and satisfaction as you contribute to the growth and success of our business.</font></div><div style="padding-right:6.6pt;text-align:justify"><font><br></font></div><div style="padding-left:7pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This letter highlights the basic components of your employment offer and sets forth the conditions to your acceptance of this offer. It is not intended to be a comprehensive description of all benefits available to you or to provide the details of the plans that govern the administration of compensation or benefits programs as our offerings change periodically. As an employee, you will be able to access information about your benefits at any time through our employee portal. In the meantime, if you have questions about your compensation or benefit offerings, please contact me.</font></div><div style="padding-right:6.75pt;text-align:justify"><font><br></font></div><div style="padding-left:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Compensation Components</font></div><div style="margin-top:6pt;padding-left:7pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Upon successful completion of the requirements described below and commencement of your employment, you will be eligible for the following&#58;</font></div><div style="padding-right:6.75pt;text-align:justify"><font><br></font></div><div style="padding-left:25pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Salary&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Your initial  annualized  base salary  will be $1,250,000,  payable  consistent with the company&#8217;s    bi-monthly payroll schedule.</font></div><div><font><br></font></div><div style="padding-left:25pt;padding-right:6.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Annual Cash Incentive&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will be eligible to participate in the CVS Health Management Incentive Plan, our annual cash bonus program, beginning with the 2021 plan year. Your target award is 175%   of your annual eligible earnings (salary paid during the plan year) (&#8220;Target Award&#8221;). Actual awards are based on your individual performance and CVS Health&#8217;s performance during the performance year. The actual award amount is determined in accordance with the plan. Awards are generally paid in March following the plan year.  For the 2021 plan year, your Target Award will be pro-rated based on your Start Date. </font></div><div id="i2007f6b3563d4290acff01d011e83eb2_4"></div><div><font><br></font></div><div style="margin-top:2.8pt;padding-left:25pt;padding-right:6.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Annual Equity Awards Program&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will be eligible to participate in CVS Health&#8217;s Annual Equity Awards program beginning with the target award to be granted in 2021 on the next normally scheduled quarterly grant date following your Start Date. The target value of your annual equity award is $7,000,000. Equity award components, weightings, vesting provisions, holding periods and ownership requirements are determined each year by the Management Planning and Development Committee of the Board of Directors. Individual eligibility and target opportunity levels are reviewed </font></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:120%">One CVS Drive </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:8pt;font-weight:400;line-height:120%"> Woonsocket, RI 02895</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:2.8pt;padding-left:25pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on an annual basis and actual awards are based both on your performance and that of CVS Health during the performance year. The grant date for the Annual Equity Awards program typically occurs    in April. As an officer of CVS Health, you are required to own CVS Health common stock and eligible equivalents with a value equal to four (4) times your base salary within five years of your date of hire and maintain that ownership level throughout your employment.  Equity awards are subject to the terms of the applicable plan, currently the 2017 Incentive Compensation Plan (the &#8220;2017 ICP&#8221;), and  the underlying award agreements.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:25pt;padding-right:6.55pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Sign-On Cash Bonus&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will receive a $1,000,000 sign-on cash bonus to be paid within the first 60 days of employment, less applicable withholdings and deductions. If you voluntarily terminate your employment, or if your employment is terminated by CVS Health for Cause, prior to the two-year anniversary of your Start Date, you must repay the sign-on bonus promptly upon termination of your employment. For purposes of this offer letter, &#8220;Cause&#8221; shall mean that you have (a) materially violated the terms of the enclosed Restrictive Covenant Agreement&#59; (b) willfully violated the CVS Health Code of Conduct or any of CVS Health&#8217;s other reasonable policies&#59; (c) engaged in dishonest or fraudulent conduct&#59; or (d) willfully engaged in conduct that is materially detrimental to CVS Health&#8217;s reputation.   If your employment is terminated by CVS Health without Cause, you will not be required to repay the sign-on bonus.</font></div><div><font><br></font></div><div style="padding-left:25pt;padding-right:6.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Sign-On RSU Award&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> On the quarterly grant date following your first day of employment, you will receive a restricted stock unit award with a grant date value of $3,000,000 (&#8220;Sign-On RSU Award&#8221;).  The Sign-On RSU Award will vest in full on the third anniversary of the grant date, subject to the terms of the 2017 ICP and the underlying award agreement.  The Sign-On RSU Award will provide for full vesting, with settlement on the original vesting date, in the event your employment is involuntarily terminated by CVS Health other than for Cause.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If you voluntarily terminate your employment, or if your employment is terminated by CVS Health for Cause, prior to the vesting date of the Sign-On RSU Award, the Sign-On RSU Award will be forfeited upon termination of your employment.</font></div><div style="padding-left:25pt;padding-right:6.6pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:25pt;padding-right:6.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:122%;padding-left:12.53pt">Benefits&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">CVS Health offers a wide range of benefits to our employees, including medical and dental,    a 401(k) plan, employee stock purchase plan, and many other benefits as set forth in the benefits summary provided to you. You are also eligible to participate in the CVS Health Severance Plan for Non-Store Employees. These benefits will also include all benefits and perquisites provided to other executive vice president officers from time to time, including home security. Please note that certain benefits require minimum tenure before you are eligible to participate and that our benefit offerings are subject to change. </font></div><div style="padding-left:25pt;padding-right:6.65pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:25pt;padding-right:6.65pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:122%;padding-left:12.53pt">Change in Control Agreement&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:122%"> You will be entitled to enter into the customary CVS Health  Corporation Change in Control Agreement applicable to other executive vice president officers, effective as of your Start Date.</font></div><div><font><br></font></div><div style="padding-left:25pt;padding-right:6.6pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Deferred Compensation Program&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Beginning in 2021, you will be eligible to enroll in the CVS Health Deferred Compensation Plan (for the 2022 plan year), which allows you to defer certain forms of compensation on a pre-tax basis, in accordance with its terms.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:25pt;padding-right:6.5pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Paid Time Off&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will be eligible to accrue up to 29 days of paid time off per calendar year, pro- rated for any partial years of employment, in accordance with our paid time off policy as well as applicable corporate holidays.</font></div><div><font><br></font></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:396pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:80%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:80%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:80%"> of 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Conditions of Offer</font></div><div style="margin-top:5.9pt;padding-left:7pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We will ask you to undergo our traditional pre-hire requirements, including a drug-screening test as well  as a criminal background check. Additional instructions for what you need to do to schedule a drug testing appointment, which must be completed within 48 hours of receiving your offer package, will be sent to you separately. </font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:2.85pt;padding-left:7pt;padding-right:6.8pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, as a condition of this offer and your employment, you are required to sign the enclosed Restrictive Covenant Agreement prior to beginning your employment. You will also be required to complete a Director and Officer Questionnaire so that we can evaluate </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any potential conflicts or other disclosable transactions.  </font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:7pt;padding-right:6.55pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">It is important that you understand that CVS Health does not want you to violate any agreements that you may have with other entities by accepting employment with CVS Health. Further, we also want to ensure that you understand CVS Health does not want you to use confidential or proprietary information from other employers in your employment with CVS Health and in fact prohibits such conduct.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:7pt;padding-right:6.6pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By accepting the terms of this offer letter, you are confirming that your employment with CVS Health in the position offered to you will not violate the terms of any agreement you may have with any other entity and that you will not provide CVS Health with any trade secrets or any other confidential information from any prior employer. If you have not done so already, you must provide us with a copy of any non- competition, non-solicitation, and&#47;or non-disclosure agreements that may still apply to you.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:7pt;padding-right:6.7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">While we anticipate that you will have a long, successful and rewarding career with CVS Health, this offer  is for &#8220;at will&#8221; employment, and either you or CVS Health may terminate the employment relationship at any time and for any reason.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:7pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Please indicate your acceptance of this offer by countersigning this letter and returning it and the signed Restrictive Covenant Agreement to me, along with the requested new hire paperwork in this package. Please remember to make copies for yourself. We look forward to working with you. If you have any questions regarding your offer, feel free to contact me.</font></div><div><font><br></font></div><div style="padding-left:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Laurie P. Havanec</font></div><div style="padding-left:7pt;text-align:justify"><font><br></font></div><div style="padding-left:7pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Laurie Havanec</font></div><div style="padding-left:7pt;padding-right:203.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:232%">Executive Vice President, Chief People Officer</font></div><div style="padding-left:7pt;padding-right:293.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Attachments</font></div><div style="padding-left:7pt;padding-right:293.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restrictive Covenant Agreement</font></div><div style="padding-left:7pt;padding-right:293.35pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Change in Control Agreement</font></div><div><font><br></font></div><div style="margin-top:2.85pt;padding-left:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accepted and agreed to on the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">16th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day of May, 2021.</font></div><div><font><br></font></div><div style="padding-left:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> &#47;s&#47; Shawn M. Guertin</font></div><div style="padding-left:7pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:118%">Signature</font></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:396pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:80%">Page </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:80%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:80%"> of 3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>a06302021ex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i73a4174a8d2d41caa49c915c80cc03ec_1"></div><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 10.5</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS Pharmacy, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restrictive Covenant Agreement</font></div><div style="text-align:justify"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, Shawn Guertin, enter into this Restrictive Covenant Agreement (&#8220;Agreement&#8221;) with CVS Pharmacy, Inc., on its own behalf and on behalf of its subsidiaries and affiliates (&#8220;CVS&#8221;), which is effective as of the date I sign the Agreement (&#8220;Effective Date&#8221;).  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Consideration for Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In connection with my duties and responsibilities at CVS Health Corporation or one of its subsidiaries or affiliates, including Aetna Inc. (collectively, the &#8220;Corporation&#8221;), the Corporation will provide me with Confidential Information and&#47;or access to the Corporation&#8217;s customers and clients and the opportunity to develop and maintain relationships and goodwill with them.  In consideration of the foregoing and the mutual promises in this Agreement and other good and valuable consideration, I hereby agree with CVS to comply with the terms of this Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  During my employment by the Corporation and during the Non-Competition Period following the termination of my employment for any reason, I will not directly or indirectly engage in Competition or provide Consulting or Audit Services within the Restricted Area.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Engaging in &#8220;Competition&#8221; means (whether as an employee, contractor, consultant, principal, agent, partner, officer, or director) (i) working on, developing, producing, marketing, selling, servicing, or managing (or assisting in developing, producing, marketing, selling, servicing, or managing) any product or service that is competitive with any existing or planned products or services of the Corporation that I managed, or with which I was involved, at any time during the last twenty-four (24) months of my employment with the Corporation&#59; or (ii)&#160;accepting any position or engaging in any activity that will likely result in the disclosure of Confidential Information to a Competitor or the use of Confidential Information on behalf of a Competitor.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Competitor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  A &#8220;Competitor&#8221; for purposes of this Agreement shall mean any person, corporation or other entity that competes with one or more of the business offerings of the Corporation  As of the Effective Date, the Corporation&#8217;s business offerings include&#58; (i) pharmacy benefits management (&#8220;PBM&#8221;), including&#58;  (a) the administration of pharmacy benefits for businesses, government agencies and health plans&#59; (b) mail order pharmacy&#59; (c) specialty pharmacy&#59; and (d) the procurement of prescription drugs at a negotiated rate for dispensing&#59; (ii) retail, which includes the sale of prescription drugs, over-the-counter medications, beauty products and cosmetics, digital and traditional photo finishing services, digital and other online offerings, seasonal and other general merchandise, greeting cards, convenience foods and other product lines and services which are sold by the Corporation&#8217;s retail division (&#8220;Retail&#8221;)&#59; (iii) retail health clinics (&#8220;MinuteClinic&#8221;)&#59; (iv) the provision of pharmaceutical products and ancillary services, including specialty pharmaceutical products and support services and the provision of related pharmacy consulting, data management services and medical supplies to long-term care facilities, other healthcare service providers and recipients of services from such facilities (&#8220;Long-Term Care&#8221;)&#59; (v) the provision of prescription infusion drugs and related services (&#8220;Infusion&#8221;)&#59; (vi) the provision of kidney care services, including but not limited to caring for patients with end stage renal disease (&#8220;Kidney Care&#8221;)&#59; (vii) services relating to or supporting clinical trials (&#8220;Clinical Trials&#8221;)&#59; (viii) the provision of insurance (&#8220;Insurance&#8221;) including&#58; (a) health insurance products and services&#59; (b) managed health care products and services&#59; (c) dental, vision, and employee assistance program products and services&#59; (d) wellness products and services to employers, government agencies,  health plans, other businesses or third party payers&#59; (e) Medicare Part&#160;D services&#59; and (f)&#160;other voluntary products that are excepted benefits under HIPAA&#59; (ix) the creation and provision of population health management products and services (&#8220;Health Management&#8221;)&#59; (x) services supporting or related to the administration of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 1</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the business offerings in (i) &#8211; (ix) (&#8220;Administration&#8221;)&#59; and (xi) any other business in which Corporation is engaged or imminently will be engaged. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For the purpose of assessing whether I am engaging in &#8220;Competition&#8221; under section 2(a)(i) above, a person, corporation or other entity shall not be considered a Retail Competitor if such entity derives annual gross revenues from its business in an amount which is less than 2% of the Corporation&#8217;s gross revenues from Retail, during its most recently completed fiscal year. For avoidance of doubt, this exclusion does not apply to a determination of whether I am engaging in &#8220;Competition&#8221; as set forth in section 2(a)(ii) above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I and the Corporation acknowledge that both the Corporation&#8217;s products and services and the entities which compete with the Corporation&#8217;s products and services evolve over time, and that an entity will be considered a Competitor if it provides products or services competitive with the products and services provided by the Corporation within the last two years of my employment with the Corporation.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I agree that the provisions of Section 2 of this Agreement are reasonable to protect and preserve the Corporation&#8217;s legitimate business interests, including the protection of the Company&#8217;s Confidential Information and the Company&#8217;s substantial investment made to develop and retain its Confidential Information, clients, other business relationships, and related goodwill.         </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Consulting or</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Audit Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  &#8220;Consulting or Audit Services&#8221; shall mean any activity that involves providing audit review or other consulting or advisory services with respect to any relationship or prospective relationship between the Corporation and any third party that is likely to result in the use or disclosure of Confidential Information.     </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Non-Competition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The &#8220;Non-Competition Period&#8221; shall be the period of 18&#160;months following the termination of my employment with the Corporation for any reason.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Area</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  &#8220;Restricted Area&#8221; refers to those states within the United States in which the Corporation conducts its business, as well as the District of Columbia and Puerto Rico.  To the extent I worked on international matters involving the Corporation&#8217;s business in Asia, Europe, or other international locations where the Corporation may conduct business, the Restricted Area includes those countries and those countries where the Corporation is actively planning to conduct business. I understand and agree that the Corporation&#8217;s business is global in nature and that its clients are located throughout the world&#59; therefore, the Restricted Territory definition is reasonable and necessary to allow the Corporation to adequately protect its legitimate business interests, and the absence of a more restricted limitation would not be reasonable under these circumstances.  Nevertheless, the restrictions on my work during the Non-Competition Period shall only extend to those locations within the Restricted Area where such work constitutes engaging in Competition.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  During the Non-Solicitation Period, which shall be during my employment by the Corporation and for 18 months following the termination of my employment with the Corporation for any reason, I will not, unless a duly authorized officer of the Corporation gives me written authorization to do so&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">interfere with the Corporation&#8217;s relationship with its Business Partners by soliciting or communicating (regardless of who initiates the communication) with a Business Partner to&#58; (i) induce or encourage the Business Partner to stop doing business or reduce its business with the Corporation, or (ii)&#160;buy a product or service that competes with a product or service offered by the Corporation&#8217;s business.  &#8220;Business Partner&#8221; means&#58; a customer (person or entity), prospective customer (person or entity), healthcare provider, supplier, manufacturer, agency, broker, hospital, hospital system, long-term </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">care facility, Insurance client&#47;customer, and&#47;or pharmaceutical manufacturer with whom the Corporation has a business relationship and with which I had business-related contact or dealings, or about which I received Confidential Information, in the two years prior to the termination of my employment with the Corporation.  A Business Partner does not include a customer, supplier, manufacturer, broker, hospital, hospital system, long-term care facility and&#47;or pharmaceutical manufacturer which has fully and finally ceased doing any business with the Corporation independent of any conduct or communications by me or breach of this Agreement and such full cessation of business has been in effect for at least 1 year prior to my separation from employment with the Corporation.  Nothing in this Section&#160;3(a) shall prevent me from working as a staff pharmacist or in another retail position wherein I would be providing or selling prescriptions or other products directly to consumers.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt">work on a Corporation account on behalf of a Business Partner or serve as the representative of a Business Partner for the Corporation. </font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.37pt">interfere with the Corporation&#8217;s relationship with any employee or contractor of the Corporation by&#58;  (i) soliciting or communicating with the employee or contractor to induce or encourage him or her to leave the Corporation&#8217;s employ or engagement (regardless of who first initiates the communication)&#59; (ii) helping another person or entity evaluate such employee or contractor as an employment or contractor candidate&#59; or (iii)&#160;otherwise helping any person or entity hire an employee or contractor away from the Corporation.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Non-Disclosure of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Subject to Sections 7 and 8 below, I will not at any time, whether during or after the termination of my employment, disclose to any person or entity any of the Corporation&#8217;s Confidential Information, except as may be appropriately required in the ordinary course of performing my duties as an employee of the Corporation.  The Corporation&#8217;s Confidential Information includes but is not limited to the following non-public information&#58; trade secrets&#59; computer code generated or developed by the Corporation&#59; software or programs and related documentation&#59; strategic compilations and analysis&#59; strategic processes&#59; business or financial methods, practices and plans&#59; non-public costs and prices&#59; operating margins&#59; marketing, merchandising and selling techniques and information&#59; customer lists&#59; provider lists&#59; details of customer or provider agreements&#59; pricing arrangements with pharmaceutical manufacturers, distributors or suppliers including but not limited to any discounts and&#47;or rebates&#59; pricing arrangements with insurance clients and customers&#59; pharmacy reimbursement rates&#59; premium information&#59; payment rates&#59; contractual forms&#59; expansion strategies&#59; real estate strategies&#59; operating strategies&#59; sources of supply&#59; patient records&#59; business plans&#59; other financial, commercial, business or technical information related to the Corporation, and confidential information of third parties which is given to the Corporation  pursuant to an obligation or agreement to keep such information confidential (collectively, &#8220;Confidential Information&#8221;).  I shall not use or attempt to use any Confidential Information on behalf of any person or entity other than the Corporation, or in any manner which may injure or cause loss or may be calculated to injure or cause loss, whether directly or indirectly, to the Corporation. </font><font style="color:#1f497d;font-family:'Georgia',serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, at any time over the last two years of my employment at CVS, my position included access to Confidential Information, as described above, specifically related to the Corporation&#8217;s procurement of prescription drugs, I understand and agree my employment with a pharmaceutical manufacturer, distributor or supplier (&#8220;Pharmaceutical Entity&#8221;) would place a substantial risk of use and&#47;or disclosure of Confidential Information with which I have been or will be entrusted during my employment with the Corporation.&#160; In light of this risk of disclosure, I acknowledge and agree that the Corporation will be entitled to immediate injunctive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">relief to prevent me from disclosing any such Confidential Information in the course of my employment with any such Pharmaceutical Entity.  I agree that the disclosure of such Confidential Information to the Corporation&#8217;s PBM Competitors with which one may negotiate in the course of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">employment with such Pharmaceutical Entity, would cause immediate and irreparable harm to the Corporation.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;During my employment, I shall not make, use, or permit to be used, any materials of any nature relating to any matter within the scope of the business of the Corporation or concerning any of its dealings or affairs other than for the benefit of the Corporation.  I shall not, after the termination of my employment, use or permit to be used any such materials and shall return same in accordance with Section 5 below.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c. &#160;&#160;&#160;&#160;NOTICE OF IMMUNITY FROM LIABILITY FOR CONFIDENTIAL DISCLOSURE OF A TRADE SECRET TO THE GOVERNMENT OR IN A COURT FILING.  Pursuant to the United States Defend Trade Secrets Act of 2016 (the &#34;DTSA&#34;), the Company hereby provides the following notice to Employee&#58; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;IMMUNITY&#58;  An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made&#58; (1) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney&#59; and (2)&#160;solely for the purpose of reporting or investigating a suspected violation of law&#59; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;USE OF TRADE SECRET INFORMATION IN ANTI-RETALIATION LAWSUIT&#58;   An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret in the court proceeding, if the individual&#58; (A) files any document containing the trade secret under seal&#59; and (B) does not disclose the trade secret, except pursuant to court order.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Ownership and Return of the Corporation&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On or before my final date of employment with the Corporation, I shall return to the Corporation all property of the Corporation in my possession, custody or control, including but not limited to the originals and copies of any information provided to or acquired by me in connection with the performance of my duties for the Corporation, such as files, correspondence, communications, memoranda, e-mails, slides, records, and all other documents, no matter how produced or reproduced, all computer equipment, communication devices (including but not limited to any mobile phone or other portable digital assistant or device), computer programs and&#47;or files, and all office keys and access cards.  I agree that all the items described in this Section are the sole property of the Corporation.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Rights to Inventions, Works</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Assignment of Inventions.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All inventions, original works of authorship, developments, concepts, improvements, designs, discoveries, ideas, trademarks or trade secrets, whether patentable or otherwise protectable under similar law, made, conceived or developed by me, whether alone or jointly with others, from the date of my initial employment by the Corporation and continuing until the end of any period during which I am employed by the Corporation, relating or pertaining in any way to my employment with or the business of the Corporation (collectively referred to as &#8220;Inventions&#8221;) shall be promptly disclosed in writing to the Corporation.  I hereby assign to the Corporation, or its designee, all of my rights, title and interest to such Inventions.  All original works of authorship which are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Corporation and which are protectable by copyright are &#8220;works made for hire,&#8221; as that term is defined in the United States Copyright Act and as such are the sole property of the Corporation. The decision whether to commercialize or market any Invention developed by me solely or jointly with others is within </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Corporation&#8217;s sole discretion and for the Corporation&#8217;s sole benefit and no royalty will be due to me as a result of the Corporation&#8217;s efforts to commercialize or market any such Invention.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Inventions Retained and Licensed.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I have attached hereto as Exhibit A, a list specifically describing all inventions, original works of authorship, developments, improvements, and trade secrets that were made by me prior to my employment with the Corporation (&#8220;Prior Inventions&#8221;), which belong to me and are not assigned to the Corporation hereunder.  If no such list is attached, I represent that there are no such Prior Inventions. I will not incorporate, or permit to be incorporated, any Prior Invention owned by me or in which I have an interest into a Corporation product, process or machine without the Corporation&#8217;s prior written consent.  Notwithstanding the foregoing sentence, if, in the course of my employment with the Corporation, I incorporate into a Corporation product, process or machine a Prior Invention owned by me or in which I have an interest, the Corporation is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or machine. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Patent and Copyright Registrations.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I will assist the Corporation, or its designee, at the Corporation&#8217;s expense, in every proper way to secure the Corporation&#8217;s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto, including, but not limited to, the disclosure to the Corporation of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Corporation shall deem necessary in order to apply for and obtain such rights and in order to assign and convey to the Corporation, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto.  My obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after my employment ends for any reason and&#47;or after the termination of this Agreement.  If the Corporation is unable because of my mental or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Corporation as above, then I hereby irrevocably designate and appoint the Corporation and its duly authorized officers and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute and file any such applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by me. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exception to Assignments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  I understand that if I am an employee in Illinois, Kansas, North Carolina, Utah or Minnesota, I should refer to Exhibit B (incorporated herein for all purposes) for important limitations on the scope of the provisions of this Agreement concerning assignment of Inventions.  I will advise the Corporation promptly in writing of any inventions that I believe meet the criteria in Exhibit B and that are not otherwise disclosed on Exhibit A.</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;In the event  I receive a subpoena, deposition notice, interview request, or other process or order to testify or produce Confidential Information or any other information or property of the Corporation, I shall promptly&#58; (i) notify the Corporation of the item, document, or information sought by such subpoena, deposition notice, interview request, or other process or order&#59; (ii) furnish the Corporation with a copy of said subpoena, deposition notice, interview request, or other process or order&#59; and (iii)&#160;provide reasonable cooperation with respect to any procedure that the Corporation may initiate to protect Confidential Information or other interests.  If the Corporation objects to the subpoena, deposition notice, interview request, process, or order, I shall cooperate to ensure that there shall be no disclosure </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 5</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">until the court or other applicable entity has ruled upon the objection, and then only in accordance with the ruling so made.  If no such objection is made despite a reasonable opportunity to do so, I shall be entitled to comply with the subpoena, deposition, notice, interview request, or other process or order, provided that I have fulfilled the above obligations.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;I will cooperate fully with the Corporation, its affiliates, and their legal counsel in connection with any action, proceeding, or dispute arising out of matters with which I was directly or indirectly involved while serving as an employee of the Corporation, its predecessors, subsidiaries or affiliates.  This cooperation shall include, but shall not be limited to, meeting with, and providing information to, the Corporation and its legal counsel, maintaining the confidentiality of any past or future privileged communications with the Corporation&#8217;s legal counsel (outside and in-house), and making myself available to testify truthfully by affidavit, in depositions, or in any other forum on behalf of the Corporation.  The Corporation agrees to reimburse me for any reasonable and necessary out-of-pocket costs associated with my cooperation.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Notice of New Employment.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> If a representative of the Corporation, during or following my employment, requests that I identify the company or business to which I will be or am providing services, or with which I will be or am employed, and requests that I provide information about the services that I am or will be providing to such entity, I shall provide the Corporation with a written statement that identifies the entity and describes the nature of the services that I am or will be providing to such entity with sufficient detail to allow the Corporation to independently assess whether I am or will be in violation of this Agreement.  Such statement shall be delivered to the Corporation&#8217;s Chief People Officer or his or her authorized delegate via personal delivery or overnight delivery within five calendar days of my receipt of such request.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Limitation on Restrictions.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  Nothing in this Agreement is intended to or shall interfere with my right to file charges or participate in a proceeding with any appropriate federal, state or local government agency, including the Occupational Safety and Health Administration (&#8220;OSHA&#8221;), National Labor Relations Board (&#8220;NLRB&#8221;) or the Securities and Exchange Commission (&#8220;SEC&#8221;)&#59; to exercise rights under Section 7 of the National Labor Relations Act (&#8220;NLRA&#8221;)&#59; or to file a charge or complaint with or participate or cooperate in an investigation or proceeding with the US Equal Employment Opportunity Commission (&#8220;EEOC&#8221;) or comparable state or local agencies. Such agencies have authority to carry out their statutory duties by investigating a charge, issuing a determination, filing a lawsuit, or taking any other action authorized by law.  I retain the right to participate in any such action&#160;and retain the right to communicate with the NLRB, SEC, EEOC, OSHA and comparable state or local agencies and such communication shall not be limited by any provision in this Agreement. Nothing in this Agreement limits my right to receive an award for information provided to a government agency such as the SEC and OSHA.  In addition, nothing in this Agreement is intended to interfere with or restrain the immunity provided under 18 U.S.C. &#167; 1833(b) for confidential disclosures of trade secrets to government officials or lawyers, solely for the purpose of reporting or investigating a suspected violation of law, or in a sealed filing in court or other proceeding.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">Eligibility for Severance Pay</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If my employment with the Corporation terminates under circumstances in which I am eligible for severance under the applicable severance plan (the &#8220;Severance Plan&#8221;), the Corporation will offer me severance in accordance with the Severance Plan and the length of the Non-Competition Period will match the length of the severance period.  I acknowledge that the Severance Plan sets forth pre-requisites I must meet in order to receive severance, including but not limited to execution of the Corporation&#8217;s standard separation agreement and release of claims.  In the event that the Corporation fails to comply with its obligations to offer me severance according to the Severance Plan, then Section 2 of this Agreement shall be of no further effect.  I agree that if I decline the Corporation&#8217;s offer of severance, I shall continue to be subject to the restrictions in Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 6</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Injunctive Relief and Other Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any breach of this Agreement by me will cause irreparable damage to the Corporation and, in the event of such breach, the Corporation shall have, in addition to any and all remedies of law, the right to an injunction, specific performance or other equitable relief to prevent the violation of my obligations hereunder, and without providing a bond to the extent permitted by the applicable rules of civil procedure. Nothing contained in this Agreement shall be construed to prohibit the Corporation from pursuing any other remedy available to the Corporation at law or in equity, the parties having agreed that all remedies are cumulative.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">No Right of Continued Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement does not create an obligation on the Corporation or any other person or entity to continue my employment.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">No Conflicting Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  I represent that the performance of my job duties with the Corporation and my compliance with all of the terms of this Agreement does not and will not breach or conflict with any other agreement, covenant, obligation or restriction to which I am bound including but not limited to any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Corporation.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Entire Agreement&#47;No Reliance&#47;No Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement and any compensation, benefit or equity plan or agreement referred to herein or under which equity was granted, to the extent those other agreements apply to me, set forth the entire agreement between the parties hereto and fully supersede any and all prior and&#47;or supplemental understandings, whether written or oral, between the parties concerning the subject matter of this Agreement.  This agreement shall not have any effect on any prior existing agreements between Corporation and me regarding the arbitration of workplace legal disputes and any such agreements remain in full force and effect.  I agree and acknowledge that I have not relied on any representations, promises or agreements of any kind in connection with my decision to accept the terms of this Agreement, except for the representations, promises and agreements herein.  Any modification to this Agreement must be made in writing and signed by me and the Corporation&#8217;s Chief People Officer or his or her authorized representative.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">No Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any waiver by the Corporation of a breach of any provision of this Agreement, or of any other similar agreement with any other current or former employee of the Corporation, shall not operate or be construed as a waiver of any subsequent breach of such provision or any other provision hereof.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The parties hereby agree that each provision herein shall be treated as a separate and independent clause, and the unenforceability of any one clause shall in no way impair the enforceability of any of the other clauses herein.  Moreover, if one or more of the provisions of this Agreement are for any reason held to be excessively broad as to scope, activity, duration, subject or otherwise so as to be unenforceable at law, the parties consent to such provision or provisions being modified in any way necessary or limited by the appropriate judicial body (where allowed by applicable law), so as to be enforceable to the maximum extent compatible with the applicable law.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Survival of Employee&#8217;s Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  My obligations under this Agreement shall survive the termination of my employment regardless of the manner of such termination and shall be binding upon my heirs, personal representatives, executors, administrators and legal representatives.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Corporation&#8217;s Right to Assign Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Corporation has the right to assign this Agreement to its successors and assigns without the need for further agreement or consent by me, and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or assigns.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 7</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  I shall not assign my rights and obligations under this Agreement, in whole or in part, whether by operation of law or otherwise, without the prior written consent of the Corporation, and any such assignment contrary to the terms hereof shall be null and void and of no force or effect.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be governed by and construed in accordance with the laws of the state of Rhode Island excluding its choice of law rules or principles that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Personal Jurisdiction and Venue.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> I agree that any State or Federal court located within the State of Rhode Island shall have personal jurisdiction over me with regard to any claim or dispute arising out of or related to this Agreement or the subject matter of this Agreement. I agree that unless otherwise prohibited by applicable law, any claim or dispute arising out of or related to this Agreement or the subject matter of this Agreement shall be exclusively brought and resolved in a State or Federal court located within the state of Rhode Island. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Headings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The headings of the sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning or construction of any provision of this Agreement.&#160; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any party to this Agreement breaches any terms of this Agreement, then that party shall pay to the non-breaching party all of the non-breaching party&#8217;s costs and expenses, including attorneys&#8217; fees, incurred by that party in enforcing the terms of this Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Tolling.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In the event I violate one of the time-limited restrictions in Sections 2 and&#47;or 3 of this Agreement, I agree that the time period for such violated restriction shall be extended by one day for each day I have violated the restriction, up to a maximum extension equal to the length of the original period of the restricted covenant.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the undersigned has executed this Agreement as a sealed instrument as of the date set forth below.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:5.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#47;s&#47; Shawn M. Guertin</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Laurie Havanec</font></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Chief People Officer</font></td><td colspan="3" style="padding:0 1pt 0 3.77pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">CVS Pharmacy, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Employee ID</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Date&#58;</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">16 May 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Page &#124; 8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:133%">EVP SVP April 2021</font></td></tr></table></div><div style="padding-left:216pt;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proprietary</font><font style="color:#494949;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>7
<FILENAME>a06302021ex106.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4f88032e798c468a840dbd261abdf764_1"></div><div style="min-height:95.49pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.6</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:232%">CVS HEALTH CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:22pt;font-weight:400;line-height:232%">Change in Control Agreement for</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:232%">Shawn Guertin</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.775%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">CONFIDENTIAL</td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revised 2020</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div></div><div id="i4f88032e798c468a840dbd261abdf764_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-right:-27pt;text-align:center;text-indent:54pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:6.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:391.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Page</font></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definitions..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term of Agreement............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Entitlement of Severance Benefit......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Confidentiality&#59; Cooperation with Regard to Litigation&#59; Non-disparagement.....................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-solicitation...................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remedies..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of Agreement on Other Benefits..............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not an Employment Agreement........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resolution of Disputes......................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assignability&#59; Binding Nature.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Representation..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amendment or Waiver&#59; Section 409A...............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Severability........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Survivorship.......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beneficiaries&#47;References..................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governing Law&#47;Jurisdiction................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices..............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headings...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Counterparts.......................................................................................................................</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4f88032e798c468a840dbd261abdf764_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Change in Control Agreement (&#34;Agreement&#34;) is made and entered into as of May 16,  2021, between CVS Pharmacy, Inc., a wholly owned subsidiary of CVS Health Corporation and Shawn Guertin (the &#34;Executive&#34;).</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Board of Directors (the &#34;Board&#34;) of CVS Health Corporation (&#34;CVS&#34; or the &#8220;Company&#8221;) believes it is necessary and desirable for the Company to be able to rely upon Executive to continue serving in Executive&#8217;s position with the Company in the event of a pending or actual change in control of CVS&#59;</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Executive is employed by CVS Pharmacy, Inc., a Subsidiary of CVS, and this Agreement shall not alter Executive's status as an employee at will&#59;</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the promises and mutual covenants contained    herein and for other good and valuable consideration, the receipt of which is mutually acknowledged,     CVS and the Executive (individually a &#34;Party&#34; and together the &#34;Parties&#8221;) agree as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Base Salary&#34; shall mean Executive's annual rate of base salary at the time of     Executive&#8217;s termination of employment or, if greater, as in effect immediately prior to a Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Cause&#34; shall exist if&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">Executive willfully and materially breaches Sections 4 or 5 of this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">Executive is convicted of a felony involving moral turpitude&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Executive engages in conduct that constitutes willful gross neglect or willful gross misconduct in carrying out Executive&#8217;s duties under this Agreement, resulting, in either case, in material harm to the financial condition or reputation of the Company.</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Agreement, an act or failure to act on Executive's part shall   be considered &#34;willful&#34; if it was done or omitted to be done by Executive not in  good faith, and shall not include any act or failure to act resulting from any incapacity of Executive. A termination for Cause shall not take effect absent compliance with the provisions of this paragraph. Executive shall be given written notice by the Company of its intention to terminate Executive&#8217;s employment for Cause, such notice (A) to state in detail the particular act or acts or failure or      failures to act that constitute the grounds on which the proposed termination for Cause is based and (B) to be given within 90 days of the Company's learning of    such act or acts or failure or failures to act. Executive shall have 20 days after the date that such written notice has been given to Executive in which to cure such conduct, to extent such cure is possible. If Executive fails to cure such conduct, Executive shall then be entitled to a hearing before the Committee, or an officer    or officers designated by the Committee, at which Executive is entitled to appear. Such hearing shall be held within 25 days of such notice to Executive, provided Executive requests such hearing within 10 days of the written notice from the Company of the intention to terminate Executive for Cause. If, within five days following such hearing, Executive is furnished written notice by the Committee confirming that, in its judgment, grounds for Cause on the basis of the original notice exist, Executive shall thereupon be terminated for Cause. Executive's right to cure in accordance with this provision applies only in the event of a Change in </font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Control as defined in Section 1(c) below and does not alter Executive's &#34;at will&#34; employment status.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">A &#8220;Change in Control&#8221; shall be deemed to have occurred if&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;any Person (other than (a) the Company, (b) any trustee or other    fiduciary holding securities under any employee benefit plan of the Company, (c) any company owned, directly or indirectly, by the stockholders of the Company immediately after the occurrence with respect to which the evaluation is being made in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such occurrence or (d) any surviving or resulting   entity from a merger or consolidation referred to in clause (iii)  below that does not constitute a Change of Control under clause (iii) below)   becomes the Beneficial Owner (except that a Person shall be deemed to be the Beneficial Owner of all shares that any such Person has the right   to acquire pursuant to any agreement or arrangement or upon exercise     of conversion rights, warrants or options or otherwise, without regard to  the sixty day period referred to in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company or of any subsidiary owning directly or indirectly all or substantially all of the consolidated assets of the Company (a &#34;Significant Subsidiary&#34;), representing 30% or more of the combined voting power of the Company's or such Significant Subsidiary's then outstanding securities&#59;</font></div><div style="padding-left:144pt;padding-right:6.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">during any period of twelve (12) consecutive months, individuals who at the beginning of such period constitute the Board, and any new director whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least a majority of the directors then still in office who either were directors at the beginning of the twelve (12) month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board&#59;</font></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="padding-left:144pt;padding-right:6.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;the consummation of a merger or consolidation of the Company or any Significant Subsidiary with any other entity, other than a merger or consolidation which would result in the voting securities of the Company or a Significant Subsidiary outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or resulting entity) more than 50% of the combined voting power of the surviving or resulting entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="padding-left:144pt;padding-right:6.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;the consummation of a transaction (or series of transactions within a 12 month period) which constitutes the sale or disposition of all or substantially all of the consolidated assets of the Company but in no event assets having a gross fair market value of less than 40% of the total gross fair market value of all of the consolidated assets of the Company (other than such a sale or disposition immediately after which such assets will be owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the common stock of the Company immediately prior to such sale or disposition).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:6.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this definition&#58;</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="padding-left:180pt;padding-right:6.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;The term &#34;Beneficial Owner&#34; shall have the meaning ascribed to such term in Rule 13d-3 under the Exchange Act (including any successor to such Rule).</font></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="padding-left:180pt;padding-right:6.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;The term &#34;Exchange Act&#34; means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.</font></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="padding-left:180pt;padding-right:6.45pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;The term &#34;Person&#34; shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including &#34;group&#34; as defined in Section 13(d) thereof.</font></div><div style="padding-right:6.45pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Committee&#34; shall mean the Management Planning and Development Committee of the Board, or the corresponding committee of the board of directors of a successor to CVS.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Company&#34; shall mean, collectively, CVS and any Subsidiary or affiliate of CVS.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt">&#34;Confidential Information&#34; shall have the meaning set forth in Section 4 below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Constructive Termination Without Cause&#34; shall mean a termination of the Executive's employment at Executive&#8217;s initiative following the occurrence, without the Executive's written consent, of one or more of the following events (except as a result of a prior termination)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">an assignment of any duties to Executive that is materially inconsistent with Executive&#8217;s status as a member of the senior management of CVS&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">a material decrease in Executive's annual base salary or target annual incentive award opportunity&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">any failure to secure the agreement of any successor to CVS to fully assume the Company&#8217;s material obligations under this Agreement&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">a relocation of Executive's principal place of employment more than 35 miles    from Executive&#8217;s place of employment before such relocation.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In all cases, no Constructive Termination Without Cause shall be deemed to have   occurred unless (a) the Executive provides written notice to the Company that an event described in subsections i. through iv. has occurred, and such notice identifies such     event and is provided within 30 days of the initial occurrence of such event, (b) a cure period of 45 days following the Company&#8217;s receipt of such notice expires and the   Company has not cured such event within such cure period and (c) the Executive actually terminates his&#47;her employment within 30 days of the expiration of the cure period.     </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Disability&#34; shall mean disability as that term is defined in the Company's Long-Term Disability Plan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">&#34;Effective Date&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">&#34;Original Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">&#34;Renewal Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">&#34;Severance Period&#34; shall mean the period of 18 months following the termination of Executive's employment with the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">&#34;Subsidiary&#34; shall have the meaning set forth in Section 4 below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Term&#34; shall have the meaning set forth in Section 2 below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#8220;termination of employment&#8221;, &#8220;employment is terminated&#8221; and other similar words shall mean with respect to Executive</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;for any plan or arrangement that is subject to the rules of Section 409A of the Internal Revenue Code (the &#8220;Code&#8221;) a &#8220;Separation from Service&#8221; as such term is defined   in the Income Tax Regulations under Section 409A (the &#8220;409A Regulations&#8221;) of the Code  as modified by the rules described below&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;except in the case where Executive is on a bona fide leave of absence pursuant to the Company&#8217;s policies as provided below, Executive is deemed to have incurred a Separation from Service on a date if the company and Executive reasonably anticipate that the level of services to be performed by Executive after such date would be permanently reduced to 20% or less of the average services rendered by Executive during the immediately preceding 36-month period (or the total period of employment, if less than 36 months), disregarding periods during which Executive was on a bona fide leave of absence&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;if Executive is absent from work due to military leave, sick leave, or other bona fide leave of absence pursuant to the Company&#8217;s policies, Executive shall incur a Separation from Service on the first date that the rules of (A), above, are satisfied following the later of (i) the six-month anniversary of the commencement of the leave or (ii) the expiration of Executive&#8217;s right,   if any, to reemployment under statute, contract or Company policy&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;Executive shall be considered to continue employment and to not have a Separation from Service while on a bona fide leave of absence pursuant   to the Company&#8217;s policies if the leave does not exceed 6 consecutive months (12) months for a disability leave of absence) or, if longer, so long as the Executive retains a right to reemployment with the Company or an Affiliate under an applicable statute, contract or Company policy.  For this purpose, a &#8220;disability leave of absence&#8221; is an absence due to any medically determinable physical or mental impairment of Executive that can be expected to result in death or can be expected to last for a continuous period of not less than 6 months, where such impairment causes  Executive to be unable to perform the duties of Executive&#8217;s job or a substantially similar job&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;for purposes of determining whether another organization is an Affiliate of the Company, common ownership of at least 50% shall be determinative&#59;</font></div><div style="padding-left:144pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;the Company specifically reserves the right to determine whether a sale   or other disposition of substantial assets to an unrelated party constitutes  a Separation from Service with respect to Executive providing services to the seller immediately prior to the transaction and providing services to   the buyer after the transaction.  Such determination shall be made in accordance with the requirements of Section 409A of the Code&#59; or </font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;for any plan or arrangement that is not subject to the rules of Section 409A of the Code, the complete cessation of providing service to the Company or any     Affiliate as an employee.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Term of Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of this Agreement shall commence on the date of this Agreement (the &#34;Effective Date&#34;) and end on the third anniversary of such date (the &#34;Original Term&#34;).  The Original Term shall be automatically renewed for successive one-year terms (the &#34;Renewal Terms&#34;) unless at least 180 days prior to the expiration of the Original Term or any Renewal Term, either Party notifies the   other Party in writing that he&#47;she or it is electing to terminate this Agreement at the expiration of   the then current Term. &#34;Term&#34; shall mean the Original Term and all Renewal Terms.  If a Change    in Control shall have occurred during the Term, notwithstanding any other provision of this     Section 2, the Term shall not expire earlier than two years after such Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Entitlement to Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event Executive's employment with the Company is    Terminated Without Cause, other than due to death, or Disability, or in the event there is     a Constructive Termination Without Cause, in each case within two years following a Change in Control, Executive shall be entitled to receive&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">Base Salary through the date of termination of Executive's employment, which  shall be paid in a cash lump sum not later than 15 days following Executive's termination of employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">An amount equal to 1.5 times Executive's Base Salary in effect on the date of termination of Executive's employment (or in the event a reduction in Base Salary is a basis for a Constructive Termination Without Cause, then the Base Salary in effect immediately prior to such reduction), payable in a cash lump sum following Executive's termination of employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">An amount equal to the most recently established target annual cash incentive bonus amount, prorated based on the portion of the performance year that Executive has worked as of the date of Executive&#8217;s termination. Such payment of   a pro rata annual cash incentive bonus will be payable in a cash lump sum following Executive's termination of employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">An amount equal to 1.5 times the most recently established target annual   incentive cash bonus amount, payable in a cash lump sum following the Executive's termination of employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">Elimination of all restrictions on any restricted stock or restricted stock unit    awards outstanding at the time of termination of employment (other than awards under the Company's Partnership Equity Program, which shall be governed by    the terms of such awards)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Immediate vesting of all outstanding stock options and the right to exercise such stock options for the remainder of the full term of such option (other than awards under the Company's Partnership Equity Program, which shall be governed by    the terms of such awards)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.79pt">The balance of any incentive awards earned as of December 31 of the prior year but not yet paid, which shall be paid in a single lump sum not later than 15 days following Executive's termination of employment&#59;</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Settlement of all deferred compensation arrangements in accordance with any  then applicable deferred compensation plan or election form&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ix.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Continued participation in all medical, health and life insurance plans at the same benefit level at which Executive was participating on the date of termination of Executive&#8217;s employment until the earlier of&#58;</font></div><div style="margin-bottom:12pt;padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">the end of the Severance Period&#59; or</font></div><div style="margin-bottom:12pt;padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">the date, or dates, Executive receives equivalent coverage and benefits under the plans and programs of a subsequent employer (such coverage and benefits to be determined on a coverage-by-coverage, or benefit-by-benefit, basis)&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided that (1) if Executive is precluded from continuing Executive&#8217;s   participation in any employee benefit plan or program as provided in this clause  (ix) of this Section 3.a, Executive shall receive cash payments equal on an after- tax basis to the cost to Executive of obtaining the benefits provided under the    plan or program in which Executive is unable to participate for the period    specified in this clause (ix) of this Section 3.a, (2) such cost shall be deemed to    be the lowest reasonable cost that would be incurred by Executive in obtaining such benefit on an individual basis, and (3) payment of such amounts shall be made quarterly in advance&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">other or additional benefits then due or earned in accordance with applicable   plans and programs of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Change in Control Best Payments Determination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event the Severance Benefits described in Section 3(a) are payable to Executive in connection with a Change in     Control and, if paid, could subject Executive to an excise tax under Section 4999 of the Internal Revenue Code (the &#8220;Excise Tax&#8221;), then notwithstanding the provisions of Section 3(a) the Company shall reduce the Severance Benefits (the &#8220;Benefit Reduction&#8221;) under Section 3(a) by the amount necessary to result in the Executive not being subject to the Excise Tax, if such reduction would result in the Executive&#8217;s &#8220;Net After-Tax Amount&#8221; attributable to the Severance Benefits described in Section 3(a) being greater than it   would be if no Benefit Reduction was effected.  For this purpose &#8220;Net After-Tax Amount&#8221; shall mean the net amount of Severance Benefits Executive is entitled to receive under   this Agreement after giving effect to all Federal, state and local taxes which would be applicable to such payments, including, but not limited to, the Excise Tax.  The determination of whether any such Benefit Reduction shall be effected shall be made by     a nationally recognized public accounting firm selected by the Company (the &#8220;Accounting Firm&#8221;) prior to the occurrence of the Change in Control and such determination shall be binding on both Executive and the Company.  In the event it is determined that a Benefit Reduction is required, such reduction of items described in Section 3(a) above shall be done first by reducing cash severance determined in accordance with Section 3(a)(ii), 3(a)(iii) and 3(a)(iv)&#59; to the extent a further Benefit Reduction is necessary, then   Severance Benefits will be reduced from the amounts determined in accordance with Section 3(a)(v) and 3(a)(vi), all as determined by the Accounting Firm.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt;text-decoration:underline">No Mitigation&#59; No Offset</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event of any termination of employment under this   Section 3, Executive shall be under no obligation to seek other employment, and the amounts due Executive under this Agreement shall not be offset by any remuneration attributable to any subsequent employment that Executive may obtain.</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Nature of Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any amounts due under this Section 3 are in the nature of   severance payments considered to be reasonable by the Company and are not in the nature of a penalty.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Exclusivity of Severance Benefit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Upon termination of Executive's employment during the Term, Executive shall not be entitled to any severance payments or severance benefits from the Company, or any other payments by the Company, other than the Severance Benefit provided in this Section 3, except as required by law.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt;text-decoration:underline">General Release of Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive agrees, as a condition of payment of the   Severance Benefit provided for in this Section 3, that Executive will execute within 60    days of Executive&#8217;s termination of employment a separation agreement, in a form reasonably satisfactory to the Company, that includes a general release of any and all claims arising out of Executive's employment or termination of employment with the Company, other than claims for (i) enforcement of this Agreement, (ii) enforcement of Executive's rights under any of the Company's incentive compensation, equity and&#47;or employee benefit plans and programs to which Executive is entitled under this    Agreement, and (iii) any tort for personal injury not arising out of or related to Executive&#8217;s employment or termination of employment.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Subject to the provisions of Section 12(b), all payments to be made pursuant to this  Section 3 upon the termination of employment of Executive shall be made or commence, as the case may be, within 75 days after the Executive&#8217;s termination of employment provided, however, that if such termination of employment is after October 15 of a year,   the payout or first payment, as the case may be, shall be made at the end of such 75 day period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Confidentiality&#59; Cooperation with Regard to Litigation&#59; Non-disparagement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">During the Term and thereafter, Executive shall not, without the prior written consent of    the Company, disclose to anyone (except in good faith in the ordinary course of business  to a person who will be advised by Executive to keep such information confidential) or make use of any confidential information except in the performance of Executive&#8217;s duties hereunder or when required to do so by legal process, by any governmental agency  having supervisory authority over the business of the Company or by any administrative    or legislative body (including a committee thereof) that requires Executive to divulge, disclose or make accessible such information. In the event that Executive is so ordered, Executive shall give prompt written notice to the Company in order to allow the Company the opportunity to object to or otherwise resist such order.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">During the Term and thereafter, Executive shall not disclose the existence or contents of this Agreement beyond what is disclosed in the proxy statement or documents filed with  the government unless and to the extent such disclosure is required by law, by a governmental agency, or in a document required by law to be filed with a governmental agency or in connection with enforcement of Executive&#8217;s rights under this Agreement. In  the event that disclosure is so required, Executive shall give prompt written notice to the Company in order to allow the Company the opportunity to object to or otherwise resist such requirement. This restriction shall not apply to such disclosure by Executive to members of Executive&#8217;s immediate family, Executive&#8217;s tax, legal or financial advisors, any lender, or tax authorities, or to potential future employers to the extent necessary, each of whom shall be advised not to disclose such information.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">Confidential Information&#34; shall mean all information concerning the business of the Company or any Subsidiary relating to any of their products, product development, trade secrets, customers, suppliers, finances, and business plans and strategies. Excluded     from the definition of Confidential Information is information (i) that is or becomes part of  </font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the public domain, other than through the breach of this Agreement by Executive or (ii) regarding the Company's business or industry properly acquired by Executive in the  course of Executive&#8217;s career as an Executive in the Company's industry and independent  of Executive's employment by the Company. For this purpose, information known or available generally within the trade or industry of the Company or any Subsidiary shall be deemed to be known or available to the public.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">&#34;Subsidiary&#34; shall mean any corporation or other business entity owned or controlled directly or indirectly by CVS.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Executive agrees to cooperate with the Company, during the Term and thereafter  (including following Executive's termination of employment for any reason), by being reasonably available to testify on behalf of the Company or any Subsidiary in any action, suit, or proceeding, whether civil, criminal, administrative, or investigative, and to assist   the Company, or any Subsidiary, in any such action, suit, or proceeding, by providing information and meeting and consulting with the Board or its representatives or counsel,   or representatives or counsel to the Company, or any Subsidiary as requested&#59; provided, however that the same does not materially interfere with Executive&#8217;s then current professional activities. The Company agrees to reimburse Executive on an after tax     basis, for all reasonable expenses actually incurred in connection with Executive&#8217;s  provision of testimony or assistance.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:30.46pt">Executive agrees that, during the Term and thereafter (including following Executive's termination of employment for any reason) Executive will not make statements or representations, or otherwise communicate, directly or indirectly, in writing, orally, or otherwise, or take any action which may, directly or indirectly, disparage or be damaging   to the Company or any Subsidiary or their respective officers, directors, employees, advisors, businesses or reputations. Notwithstanding the foregoing, nothing in this Agreement shall preclude Executive from making truthful statements or disclosures that  are required by applicable law, regulation or legal process.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Non-solicitation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period beginning with the Effective Date and ending 18 months following the   termination of Executive's employment with the Company, Executive, whether acting on  Executive&#8217;s own behalf or by, through or on behalf of any third party, shall not (a) hire any employees of the Company or any Subsidiary, or recruit or solicit any such employees or  encourage them to terminate their employment with the Company or any Subsidiary&#59; (b) accept business from any customers of the Company or any Subsidiary, or solicit or encourage any customers, joint venture partners or investors of the Company or any Subsidiary to terminate or diminish their relationship with the Company or any Subsidiary or to violate any agreement with   the Company or any Subsidiary. For purposes of subsection 5(a), an employee of the Company    or any Subsidiary means any person who was employed by the Company or any Subsidiary    within 180 days of such hiring, recruitment, solicitation or encouragement. Executive agrees to make any employer with whom Executive becomes employed during the 18-month period   following Executive's termination with the Company aware of this non-solicitation obligation upon commencing employment with such subsequent entity.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to whatever other rights and remedies the Company may have at equity or in law, the Company (a) shall have the right to immediately terminate all payments and benefits due under  this Agreement if Executive breaches any of the provisions contained in Sections 4 or 5 above,   and (b) shall have the right to seek injunctive relief in any court of competent jurisdiction if Executive breaches or threatens to breach any of the provisions contained in Sections 4 or 5 above. Executive acknowledges that such a breach would cause irreparable injury and that    </font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">money damages would not provide an adequate remedy for the Company&#59; provided, however,      the foregoing shall not prevent Executive from contesting the issuance of any such injunction on   the ground that no violation or threatened violation of Sections 4 or 5 has occurred.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Effect of Agreement on Other Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as specifically provided in this Agreement, the existence of this Agreement shall not be interpreted to preclude, prohibit or restrict the Executive's participation in any other employee benefit or other plans or programs in which he &#47;she currently participates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Not an Employment Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement is not, and nothing herein shall be deemed to create, a contract of employment between Executive and the Company. The Company may terminate the employment of Executive at any time and for any reason, subject to the terms of any employment agreement between the Company and Executive that may then be in effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Resolution of Disputes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any controversy or claim arising out of or relating to this Agreement or any breach or asserted breach hereof or questioning the validity and binding effect hereof arising under or in connection with this Agreement, other than seeking injunctive relief under Sections 4 or 5, shall be resolved   by binding arbitration, to be held at an office closest to the Company&#8217;s principal offices in accordance with the rules and procedures of the American Arbitration Association.  Judgment   upon the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof.  Pending the resolution of any arbitration or court proceeding, the company shall continue payment of all amounts and benefits due Executive under this Agreement.  All reasonable costs  and expenses of any arbitration or court proceeding (including fees and disbursements of    counsel) shall be paid on behalf of or reimbursed to Executive promptly by the Company&#59;   provided, however, that no reimbursement shall be made of such expenses if and to the extent    the arbitrator(s) determine(s) that any of Executive&#8217;s litigation assertions or defenses were in bad faith or frivolous.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Assignability&#59; Binding Nature</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors, heirs (in the case of Executive) and permitted assigns. No rights or obligations of the Company under this Agreement may be assigned or transferred by the Company except that    such rights or obligations may be assigned or transferred in connection with the sale or transfer of all or substantially all of the assets of the Company, provided that the assignee or transferee is    the successor to all or substantially all of the assets of the Company and such assignee or transferee assumes the liabilities, obligations and duties of the Company, as contained in this agreement, either contractually or as a matter of law. The Company further agrees that, in the  event of a sale or transfer of assets as described in the preceding sentence, it shall take whatever action it legally can in order to cause such assignee or transferee to expressly assume the liabilities, obligations and duties of the Company hereunder. No rights or obligations of Executive under this Agreement may be assigned or transferred by Executive other than Executive&#8217;s rights    to compensation and benefits, which may be transferred only by will or operation of law, except     as provided in Section 15 below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Representation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company represents and warrants that it is fully authorized and empowered to enter into this Agreement and that the performance of its obligations under this Agreement will not violate any agreement between it and any other person, firm or organization.</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Amendment or Waiver&#59; Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;No provision in this Agreement may be amended unless such amendment is agreed to in writing and signed by Executive and an authorized officer of the Company. No waiver by either Party of any breach by the other Party of any condition or provision contained in    this Agreement to be performed by such other Party shall be deemed a waiver of a     similar or dissimilar condition or provision at the same or any prior or subsequent time.   Any waiver must be in writing and signed by Executive or an authorized officer of the Company, as the case may be.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Executive and Company agree that it is the intent of the Parties that this Agreement not violate any applicable provision of, or result in any additional tax or penalty under,     Section 409A of the Code, as amended, and that to the extent any provisions of this Agreement do not comply with such Code Section 409A the Parties will make such changes as are mutually agreed upon in order to comply with Code Section 409A.  In all events, to the extent required to avoid a violation of the applicable rules under all Section 409A by reason of Code Section 409A(a)(2)(B)(i), payment of any amounts subject to  Code Section 409A shall be delayed until the relevant date of payment that will result in compliance with the rules of Code Section 409A(a)(2)(B)(i).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole or in part, the remaining provisions of this Agreement     shall be unaffected thereby and shall remain in full force and effect to the fullest extent permitted   by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Survivorship</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The respective rights and obligations of the Parties hereunder shall survive any termination of Executive's employment to the extent necessary to the intended preservation of such rights and obligations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Beneficiaries&#47;References</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive shall be entitled, to the extent permitted under any applicable law, to select and change  a beneficiary or beneficiaries to receive any compensation or benefit payable hereunder following Executive's death by giving the Company written notice thereof. In the event of Executive's death  or a judicial determination of Executive&#8217;s incompetence, references in this Agreement to    Executive shall be deemed, where appropriate, to refer to Executive&#8217;s beneficiary, estate or other legal representative.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law&#47;Jurisdiction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be governed by and construed and interpreted in accordance with the laws   of Rhode Island without reference to principles of conflict of laws. Subject to Section 6, the Company and Executive hereby consent to the jurisdiction of any or all of the following courts for purposes of resolving any dispute under this Agreement&#58; (i) the United States District Court for Rhode Island or (ii) any of the courts of the State of Rhode Island. The Company and Executive further agree that any service of process or notice requirements in such proceeding shall be satisfied if the rules of such court relating thereto have been substantially satisfied. The Company and Executive hereby waive, to the fullest extent permitted by applicable law, any objection which   it or he&#47;she may now or hereafter have to such jurisdiction and any defense of inconvenient    forum.</font></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:-5.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice given to a Party shall be in writing and shall be deemed to have been given when delivered personally or sent by certified or registered mail, postage prepaid, return receipt  requested, duly addressed to the Party concerned at the address indicated below or to such  changed address as such Party may subsequently give written notice of&#58;</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to CVS&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Pharmacy, Inc.<br>One CVS Drive<br>Woonsocket, RI 02895<br>Attention&#58; Corporate Secretary</font></div><div style="margin-bottom:12pt;text-indent:54pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If to Executive&#58;</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shawn Guertin</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XXXXXXXXXXXXX</font></div><div style="padding-left:72pt;text-indent:36pt"><font style="background-color:#000000;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XXXXXXXXXXXXX</font></div><div style="padding-left:108pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The headings of the sections contained in this Agreement are for convenience only and shall not  be deemed to control or affect the meaning or construction of any provision of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement may be executed in two or more counterparts.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first   written above.</font></div><div style="padding-left:180pt;text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:260.25pt"><tr><td style="width:1.0pt"></td><td style="width:31.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Pharmacy, Inc.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laurie Havanec</font></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief People Officer</font></td></tr></table></div><div style="padding-left:180pt;text-indent:36pt"><font><br></font></div><div style="padding-left:180pt"><font><br></font></div><div style="padding-left:180pt;text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:265.50pt"><tr><td style="width:1.0pt"></td><td style="width:37.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:183.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive </font></td></tr><tr style="height:14pt"><td colspan="9" style="border-bottom:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Shawn M. Guertin</font></td></tr><tr style="height:14pt"><td colspan="9" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shawn Guertin</font></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief Finance Officer</font></td></tr></table></div><div style="height:52.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>8
<FILENAME>a06302021ex151.htm
<DESCRIPTION>EX-15.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id5c532b317544af7ae974c0587b73477_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 15.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Letter re&#58; Unaudited Interim Financial Information</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">August&#160;4, 2021 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated August&#160;4, 2021, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended June&#160;30, 2021.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, Massachusetts</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>a06302021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6c0af29473844b6493ad5df50eb4b22f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:8pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>a06302021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i96d1814d740d410a90ca131d945d7c11_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>a06302021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i032396f6bb994e0c957257ef1474ad2e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2021 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>a06302021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6ec6b294673d454c9c9e00465789bb9c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Quarterly Report of CVS Health Corporation (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2021 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>cvs-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efef91c4-b90c-4f53-8e18-716aea49f04e,g:46f154a9-1618-4e84-a3da-cd42ade064f2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnauditedParenthetical" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical">
        <link:definition>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityUnaudited" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquityParentheticals" roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails">
        <link:definition>2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>2110102 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>2311302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTotalInvestmentScheduleDetails" roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails">
        <link:definition>2412407 - Disclosure - Investments - Total Investment Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>2413408 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>2414409 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>2415410 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>2416411 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>2417412 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>2418413 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>2419414 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>2420415 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>2121103 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>2322303 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails">
        <link:definition>2423416 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>2424417 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>2425418 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>2126104 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>2327304 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
        <link:definition>2428419 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>2429420 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>2130105 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails">
        <link:definition>2431421 - Disclosure - Shareholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncome" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome">
        <link:definition>2132106 - Disclosure - Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>2333305 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails">
        <link:definition>2434422 - Disclosure - Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>2135107 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>2336306 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>2437423 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>2138108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2439424 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>2140109 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>2341307 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>2442425 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>2443426 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>2444427 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" abstract="false" name="PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" abstract="true" name="AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" abstract="true" name="ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_ChangeinContractwithCustomerLiabilityRollForward" abstract="true" name="ChangeinContractwithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_Deferredincometaxesandothernoncashitems" abstract="false" name="Deferredincometaxesandothernoncashitems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LossContingencyAuditMethodologySampleSize" abstract="false" name="LossContingencyAuditMethodologySampleSize" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_PaymentsforInsuranceBenefits" abstract="false" name="PaymentsforInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollinginterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofWalkInMedicalClinics" abstract="false" name="NumberofWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberofLeases" abstract="false" name="GuarantorObligationsNumberofLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" abstract="true" name="ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherReceivablesMember" abstract="true" name="OtherReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PharmacyServicesSegmentMember" abstract="true" name="PharmacyServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_CorporateOtherMember" abstract="true" name="CorporateOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthInsurerFee" abstract="false" name="HealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" abstract="true" name="RadcliffeAndFlaimVAetnaIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ContractwithCustomerLiabilityRedemptionandBreakage" abstract="false" name="ContractwithCustomerLiabilityRedemptionandBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" abstract="true" name="MortgageLoansOnRealEstateCreditQualityIndicatorDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PharmacyClaimsandDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsandDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberofPatientsServedperYear" abstract="false" name="NumberofPatientsServedperYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsorLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsorLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberofPharmacyPlanMembers" abstract="false" name="NumberofPharmacyPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_A2016RepurchaseProgramMember" abstract="true" name="A2016RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" abstract="true" name="HealthCareandOtherInsuranceLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>cvs-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efef91c4-b90c-4f53-8e18-716aea49f04e,g:46f154a9-1618-4e84-a3da-cd42ade064f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_56110977-e156-4d6f-9740-83f3daef60a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_6a352917-32f3-47cc-ace5-7eebdcb61941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_56110977-e156-4d6f-9740-83f3daef60a0" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_6a352917-32f3-47cc-ace5-7eebdcb61941" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a4d1f53-87c6-4acc-84bb-2b2af4d8acae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_56110977-e156-4d6f-9740-83f3daef60a0" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_0a4d1f53-87c6-4acc-84bb-2b2af4d8acae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a69b9161-a52d-481d-9399-9ddadc4c48c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_56110977-e156-4d6f-9740-83f3daef60a0" xlink:to="loc_us-gaap_OperatingExpenses_a69b9161-a52d-481d-9399-9ddadc4c48c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4a41ff42-314b-429a-850f-6519d15bedee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_facc0773-5afd-4b5f-a2cc-8ef0388e3820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_4a41ff42-314b-429a-850f-6519d15bedee" xlink:to="loc_us-gaap_NetInvestmentIncome_facc0773-5afd-4b5f-a2cc-8ef0388e3820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_d1f2960d-c20c-494d-9da6-08672731fc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_4a41ff42-314b-429a-850f-6519d15bedee" xlink:to="loc_us-gaap_PremiumsEarnedNet_d1f2960d-c20c-494d-9da6-08672731fc9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf750e75-213b-4361-9d8c-4d1ca975d442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_4a41ff42-314b-429a-850f-6519d15bedee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf750e75-213b-4361-9d8c-4d1ca975d442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_086185fd-a80f-4d5d-b139-142f4fb9395d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fff309c7-fdae-46d4-ac66-0141cc97ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_086185fd-a80f-4d5d-b139-142f4fb9395d" xlink:to="loc_us-gaap_ProfitLoss_fff309c7-fdae-46d4-ac66-0141cc97ad94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4fd4add-1ef4-4b79-bc86-aa7547a857eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_086185fd-a80f-4d5d-b139-142f4fb9395d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f4fd4add-1ef4-4b79-bc86-aa7547a857eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_877e7fff-37d9-41f3-9077-c9c95f9e9e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d7d8d963-3c32-4869-8f88-de83e1c2c6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_877e7fff-37d9-41f3-9077-c9c95f9e9e22" xlink:to="loc_us-gaap_InterestExpense_d7d8d963-3c32-4869-8f88-de83e1c2c6d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_98d45183-037b-4a09-9985-79af47a3bf75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_877e7fff-37d9-41f3-9077-c9c95f9e9e22" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_98d45183-037b-4a09-9985-79af47a3bf75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0f45384b-9139-439d-ac1e-a68d077f70bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_877e7fff-37d9-41f3-9077-c9c95f9e9e22" xlink:to="loc_us-gaap_OperatingIncomeLoss_0f45384b-9139-439d-ac1e-a68d077f70bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_151100d2-1aa7-4a18-909a-4ca5e7a87392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a93a20bc-5b8b-4637-8113-97b275949da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_151100d2-1aa7-4a18-909a-4ca5e7a87392" xlink:to="loc_us-gaap_CostsAndExpenses_a93a20bc-5b8b-4637-8113-97b275949da0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_13bcfaab-10f7-4aa3-83bf-9692fcdea5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_151100d2-1aa7-4a18-909a-4ca5e7a87392" xlink:to="loc_us-gaap_Revenues_13bcfaab-10f7-4aa3-83bf-9692fcdea5bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d5f24305-b85c-401a-b6ad-5cd107549589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6ed708d8-684e-4235-83ec-70c7f50dc058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d5f24305-b85c-401a-b6ad-5cd107549589" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6ed708d8-684e-4235-83ec-70c7f50dc058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0762997c-a4f5-454d-bbfe-b6e7e62d6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d5f24305-b85c-401a-b6ad-5cd107549589" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0762997c-a4f5-454d-bbfe-b6e7e62d6b34" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9bc2f0f-05bb-4fe9-97eb-93d3cfa515ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d3ce6e91-57e5-4ce8-af48-6ea2a5afc957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9bc2f0f-05bb-4fe9-97eb-93d3cfa515ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d3ce6e91-57e5-4ce8-af48-6ea2a5afc957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fad27ffc-b54f-4f57-8890-25617e7174d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9bc2f0f-05bb-4fe9-97eb-93d3cfa515ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_fad27ffc-b54f-4f57-8890-25617e7174d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3b2882b0-faf2-4d22-9985-6c90cfe925d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9bc2f0f-05bb-4fe9-97eb-93d3cfa515ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3b2882b0-faf2-4d22-9985-6c90cfe925d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_44731f59-a734-4edb-85da-cbdd3dd95a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c9bc2f0f-05bb-4fe9-97eb-93d3cfa515ea" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_44731f59-a734-4edb-85da-cbdd3dd95a38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_dde0ba19-a7c7-485e-8efb-eaf5ce9234b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_193f6868-8338-4a37-aac6-f687d9980866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_dde0ba19-a7c7-485e-8efb-eaf5ce9234b4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_193f6868-8338-4a37-aac6-f687d9980866" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9f3ce5e0-976f-4cac-9da5-c90873fc3ca3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_dde0ba19-a7c7-485e-8efb-eaf5ce9234b4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9f3ce5e0-976f-4cac-9da5-c90873fc3ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b41d7b1f-8b00-4b77-a996-ddbf56fc6e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_19b2fe68-efa3-4ed0-8f05-f6cbef629874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b41d7b1f-8b00-4b77-a996-ddbf56fc6e05" xlink:to="loc_us-gaap_ProfitLoss_19b2fe68-efa3-4ed0-8f05-f6cbef629874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_224f996f-e117-4544-9b4c-199c2170caf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b41d7b1f-8b00-4b77-a996-ddbf56fc6e05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_224f996f-e117-4544-9b4c-199c2170caf8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_95447005-3cd6-4b82-a5e0-b05f7cbffc03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_df7e8f92-51da-4ef8-878c-ad8a6a8e20d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_95447005-3cd6-4b82-a5e0-b05f7cbffc03" xlink:to="loc_us-gaap_PreferredStockValue_df7e8f92-51da-4ef8-878c-ad8a6a8e20d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_be927d06-9142-4863-8917-a8ab6217d7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_95447005-3cd6-4b82-a5e0-b05f7cbffc03" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_be927d06-9142-4863-8917-a8ab6217d7e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_03a8f922-72de-4bec-b3aa-0f772b929e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_95447005-3cd6-4b82-a5e0-b05f7cbffc03" xlink:to="loc_us-gaap_TreasuryStockValue_03a8f922-72de-4bec-b3aa-0f772b929e34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_22d98b9a-034d-4446-9984-7f4cbfb0ed7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_95447005-3cd6-4b82-a5e0-b05f7cbffc03" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_22d98b9a-034d-4446-9984-7f4cbfb0ed7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6b8c85d-5da7-419a-9654-b59e30b9bb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_95447005-3cd6-4b82-a5e0-b05f7cbffc03" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e6b8c85d-5da7-419a-9654-b59e30b9bb8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_5db5a91f-abd7-4c2b-87ee-16b9c981c318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_LongTermInvestments_5db5a91f-abd7-4c2b-87ee-16b9c981c318" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c3c5ad8e-73e9-4d05-ae8c-4be61d52dc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c3c5ad8e-73e9-4d05-ae8c-4be61d52dc0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_64bd1d41-e0ac-44c5-a703-152492874b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_64bd1d41-e0ac-44c5-a703-152492874b4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3e7ca95b-215d-4ccd-a463-c557a67b172c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_Goodwill_3e7ca95b-215d-4ccd-a463-c557a67b172c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_38899b93-d8f4-4098-8f6b-4e36bc97aab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_38899b93-d8f4-4098-8f6b-4e36bc97aab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_44020cad-89e7-4139-9c77-29a64cc35f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_SeparateAccountAssets_44020cad-89e7-4139-9c77-29a64cc35f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b6eb72d2-5bc1-44a6-9e23-5de2948df543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b6eb72d2-5bc1-44a6-9e23-5de2948df543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_55dd328f-c258-4a00-b6de-2125a4e7fa81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_92e49f38-168c-4d95-80df-0ae8ee388502" xlink:to="loc_us-gaap_AssetsCurrent_55dd328f-c258-4a00-b6de-2125a4e7fa81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_51aa4e4b-2814-470e-93a3-7472a9f758fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_952a3733-c823-43d9-ae97-7d7a71cbe0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51aa4e4b-2814-470e-93a3-7472a9f758fa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_952a3733-c823-43d9-ae97-7d7a71cbe0c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_39618425-c086-4d20-857e-1ea8a817621c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51aa4e4b-2814-470e-93a3-7472a9f758fa" xlink:to="loc_us-gaap_ShortTermInvestments_39618425-c086-4d20-857e-1ea8a817621c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cd5be227-dea7-4acb-a709-c413c46d67be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51aa4e4b-2814-470e-93a3-7472a9f758fa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_cd5be227-dea7-4acb-a709-c413c46d67be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dcbe28ab-6649-430d-8bf9-7c080761de15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51aa4e4b-2814-470e-93a3-7472a9f758fa" xlink:to="loc_us-gaap_InventoryNet_dcbe28ab-6649-430d-8bf9-7c080761de15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_3fb8a9f3-55f3-49a3-b030-f93495a9af12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_51aa4e4b-2814-470e-93a3-7472a9f758fa" xlink:to="loc_us-gaap_OtherAssetsCurrent_3fb8a9f3-55f3-49a3-b030-f93495a9af12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_38357e61-2322-43ea-a923-cd7879f943e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eb7b34f1-ce40-46a3-bb12-ccf77463902f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_38357e61-2322-43ea-a923-cd7879f943e0" xlink:to="loc_us-gaap_StockholdersEquity_eb7b34f1-ce40-46a3-bb12-ccf77463902f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_512747b7-36ff-4d9e-91ed-3eafeb61042c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_38357e61-2322-43ea-a923-cd7879f943e0" xlink:to="loc_us-gaap_MinorityInterest_512747b7-36ff-4d9e-91ed-3eafeb61042c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_edabf0a8-00ae-46b0-b0d2-a6816819629e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3bc2cba2-9351-4dd9-957a-4a6ff87e367c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_edabf0a8-00ae-46b0-b0d2-a6816819629e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3bc2cba2-9351-4dd9-957a-4a6ff87e367c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_854fa1c1-b623-4e2e-b080-74a680591f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_edabf0a8-00ae-46b0-b0d2-a6816819629e" xlink:to="loc_us-gaap_Liabilities_854fa1c1-b623-4e2e-b080-74a680591f58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_303a534f-f4b2-4086-95a3-9b3f1fdae6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_us-gaap_LiabilitiesCurrent_303a534f-f4b2-4086-95a3-9b3f1fdae6c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b719a422-7f58-4c9e-9727-d7f2e62d7816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_b719a422-7f58-4c9e-9727-d7f2e62d7816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6605121a-3e58-4ae2-b0a1-db9c47476bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6605121a-3e58-4ae2-b0a1-db9c47476bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_687ea2d4-0720-4c03-94c7-44f75f798036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_687ea2d4-0720-4c03-94c7-44f75f798036" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_ecb6f08f-51e5-4e18-96e5-a40ded0ca4ac" xlink:href="cvs-20210630.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_ecb6f08f-51e5-4e18-96e5-a40ded0ca4ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_44c69e84-0944-4289-b7fd-77c64ed3392e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_44c69e84-0944-4289-b7fd-77c64ed3392e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_3ff5679e-aa1a-4297-a2f4-a19ffea26e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3d9e5b52-4268-45f5-86fd-c3e36f202647" xlink:to="loc_us-gaap_SeparateAccountsLiability_3ff5679e-aa1a-4297-a2f4-a19ffea26e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_af0fb0a6-47ca-48af-9c28-fad9f4a1d2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_af0fb0a6-47ca-48af-9c28-fad9f4a1d2da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3e7f5bcc-9dfc-4ef3-b44f-ec9347ccfc35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3e7f5bcc-9dfc-4ef3-b44f-ec9347ccfc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_38f6d34d-5822-4e3c-91e0-93308dd78053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_38f6d34d-5822-4e3c-91e0-93308dd78053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_62cc20a8-efe5-4cd4-81a7-66b2ccf4f0f7" xlink:href="cvs-20210630.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_62cc20a8-efe5-4cd4-81a7-66b2ccf4f0f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_fab50a41-eace-4b2f-87db-773fb47c7f59" xlink:href="cvs-20210630.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_fab50a41-eace-4b2f-87db-773fb47c7f59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_0a126669-931b-43a3-8f0e-eba6502f1dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_0a126669-931b-43a3-8f0e-eba6502f1dd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_6fc046b5-1933-4815-8b8f-89830a725654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_us-gaap_OtherPolicyholderFunds_6fc046b5-1933-4815-8b8f-89830a725654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ecf6d0c8-4b61-4c0a-acfc-9ec8f0bbba75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a6950946-a8c9-4f9c-84cc-0b86668b77ee" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ecf6d0c8-4b61-4c0a-acfc-9ec8f0bbba75" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67dd44be-594b-4769-b52f-d6f72c559664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd87dbf7-80f1-46f9-9289-169dae875e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67dd44be-594b-4769-b52f-d6f72c559664" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd87dbf7-80f1-46f9-9289-169dae875e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_71d3756a-1a77-48f9-909e-76098f6bff68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67dd44be-594b-4769-b52f-d6f72c559664" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_71d3756a-1a77-48f9-909e-76098f6bff68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_999691ca-5cda-4fce-b74d-2ae42031956a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67dd44be-594b-4769-b52f-d6f72c559664" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_999691ca-5cda-4fce-b74d-2ae42031956a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d37fa22b-5070-4431-9f48-eb721d7cf363" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b5fdeb7e-459c-4329-9678-cbcfa6d21dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d37fa22b-5070-4431-9f48-eb721d7cf363" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b5fdeb7e-459c-4329-9678-cbcfa6d21dc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3044261a-3a74-49d0-beac-b9fbc406a8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d37fa22b-5070-4431-9f48-eb721d7cf363" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3044261a-3a74-49d0-beac-b9fbc406a8bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f267dd8f-94f5-4240-9e21-b4cba967d631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d37fa22b-5070-4431-9f48-eb721d7cf363" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f267dd8f-94f5-4240-9e21-b4cba967d631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_885ca51d-c9a6-4046-97ec-4dbb352b556b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d37fa22b-5070-4431-9f48-eb721d7cf363" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_885ca51d-c9a6-4046-97ec-4dbb352b556b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1171c506-0cae-4998-bab7-29b64b83c658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d37fa22b-5070-4431-9f48-eb721d7cf363" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_1171c506-0cae-4998-bab7-29b64b83c658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6e1bf968-f4e1-4cd1-a758-0284ad86147f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6e1bf968-f4e1-4cd1-a758-0284ad86147f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_6f685bc0-8b40-4d3e-98ac-78b608db4c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:to="loc_us-gaap_PaymentsOfDividends_6f685bc0-8b40-4d3e-98ac-78b608db4c76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_945b9168-0b03-4c49-9cca-65ba50ff9c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_945b9168-0b03-4c49-9cca-65ba50ff9c21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a21bc534-fede-4876-8385-bf7bd6f87fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a21bc534-fede-4876-8385-bf7bd6f87fb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9149fd0e-d64e-4baa-ba0d-739f28d77206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9149fd0e-d64e-4baa-ba0d-739f28d77206" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ce948c72-2abf-44d7-8d54-3873c5da03a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57148ca5-a5b1-43e6-b9ec-3a60fe361bf1" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ce948c72-2abf-44d7-8d54-3873c5da03a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_21018a0f-520d-4557-9b78-3d63b0337fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_us-gaap_InterestPaidNet_21018a0f-520d-4557-9b78-3d63b0337fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_a3593ce5-2415-4e94-91bb-e601419cff93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_a3593ce5-2415-4e94-91bb-e601419cff93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_bcb20c29-988d-45a8-91d4-33b1871508ec" xlink:href="cvs-20210630.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_bcb20c29-988d-45a8-91d4-33b1871508ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_4b0a6d8e-38ef-4d6e-b454-f2dcbd72abb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_us-gaap_ProceedsFromCustomers_4b0a6d8e-38ef-4d6e-b454-f2dcbd72abb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_e89ea129-fe6a-4830-b6ea-296eca990b97" xlink:href="cvs-20210630.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_e89ea129-fe6a-4830-b6ea-296eca990b97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_d408b688-cc2c-406c-8b60-f76de61dc75a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_d408b688-cc2c-406c-8b60-f76de61dc75a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_46cda76c-deb2-4070-8971-2cf6569dada8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7a371bce-e86d-4ad9-ab65-36ad92f933aa" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_46cda76c-deb2-4070-8971-2cf6569dada8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82c218bc-26e5-4c1e-9acf-742272e661ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d59764e-d363-4884-868e-58657de81cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82c218bc-26e5-4c1e-9acf-742272e661ca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9d59764e-d363-4884-868e-58657de81cb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_272e7a4d-f57a-4988-9655-d4962775ccfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82c218bc-26e5-4c1e-9acf-742272e661ca" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_272e7a4d-f57a-4988-9655-d4962775ccfa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ffe5764a-bad3-4e2b-85c2-7f62e4dcbeac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_57a8b950-eab4-4fe5-93bd-570d4cd8e613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_ffe5764a-bad3-4e2b-85c2-7f62e4dcbeac" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_57a8b950-eab4-4fe5-93bd-570d4cd8e613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_98a37572-297e-4630-884e-81dcf9b9ba6d" xlink:href="cvs-20210630.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_ffe5764a-bad3-4e2b-85c2-7f62e4dcbeac" xlink:to="loc_cvs_VendorandManufacturerReceivables_98a37572-297e-4630-884e-81dcf9b9ba6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_6dbd1c49-0cba-4395-ad2e-c51faa31ae8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_ffe5764a-bad3-4e2b-85c2-7f62e4dcbeac" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_6dbd1c49-0cba-4395-ad2e-c51faa31ae8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_d788c5aa-a2fd-4c0a-9ace-b81561c9f61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_ffe5764a-bad3-4e2b-85c2-7f62e4dcbeac" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_d788c5aa-a2fd-4c0a-9ace-b81561c9f61c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_c15a9e4b-9fc4-4510-ae03-5ace756525bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_eaf119b9-3d75-4d73-88f2-27fdaa832833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_c15a9e4b-9fc4-4510-ae03-5ace756525bd" xlink:to="loc_us-gaap_ShortTermInvestments_eaf119b9-3d75-4d73-88f2-27fdaa832833" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_4a020d96-bcf6-4a24-8b7e-71622173b521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_c15a9e4b-9fc4-4510-ae03-5ace756525bd" xlink:to="loc_us-gaap_LongTermInvestments_4a020d96-bcf6-4a24-8b7e-71622173b521" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_9d8d51b0-e2fa-4c44-a0b1-0794281d3baf" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c2490cff-33b2-4a3f-b67d-1ba3c5b3d25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_9d8d51b0-e2fa-4c44-a0b1-0794281d3baf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c2490cff-33b2-4a3f-b67d-1ba3c5b3d25d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_73532278-31d2-4944-bcdb-ed92de23d066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_9d8d51b0-e2fa-4c44-a0b1-0794281d3baf" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_73532278-31d2-4944-bcdb-ed92de23d066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_03f1b8c9-8a3c-4662-a686-30fb6cbcdfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_9d8d51b0-e2fa-4c44-a0b1-0794281d3baf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_03f1b8c9-8a3c-4662-a686-30fb6cbcdfbb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_abad6992-de82-4ac6-9a6c-bb343c0978ae" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_a0853da3-192f-4a7e-bea4-2c1b94d74314" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_abad6992-de82-4ac6-9a6c-bb343c0978ae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_a0853da3-192f-4a7e-bea4-2c1b94d74314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_9712f626-07e3-40b4-abdd-a110fe23a793" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_abad6992-de82-4ac6-9a6c-bb343c0978ae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_9712f626-07e3-40b4-abdd-a110fe23a793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_9989ff41-744c-4ec9-a975-5a31569df47d" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_abad6992-de82-4ac6-9a6c-bb343c0978ae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_9989ff41-744c-4ec9-a975-5a31569df47d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_3b027db5-d767-4902-8d43-7ed85c5ead42" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_abad6992-de82-4ac6-9a6c-bb343c0978ae" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_3b027db5-d767-4902-8d43-7ed85c5ead42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_174e0962-f0c9-45a6-a87e-bab5f1b5cc5e" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_abad6992-de82-4ac6-9a6c-bb343c0978ae" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_174e0962-f0c9-45a6-a87e-bab5f1b5cc5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38e08296-2c65-4afc-8b00-6038ad68e3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_cdcf038c-331b-4256-8e98-f24ad169a1b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38e08296-2c65-4afc-8b00-6038ad68e3a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_cdcf038c-331b-4256-8e98-f24ad169a1b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_01cd9bcb-7190-4458-ae61-4cf80d261b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38e08296-2c65-4afc-8b00-6038ad68e3a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_01cd9bcb-7190-4458-ae61-4cf80d261b4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_2a17cdbe-0283-49db-a748-50c0a7a549d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38e08296-2c65-4afc-8b00-6038ad68e3a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_2a17cdbe-0283-49db-a748-50c0a7a549d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e12cfc8a-cd7f-4f01-80c5-ff294b6d387b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38e08296-2c65-4afc-8b00-6038ad68e3a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_e12cfc8a-cd7f-4f01-80c5-ff294b6d387b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_01fdcfcf-976b-489f-87fc-0e35ab972edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38e08296-2c65-4afc-8b00-6038ad68e3a0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_01fdcfcf-976b-489f-87fc-0e35ab972edd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_5438f0a5-66e8-48a8-9530-b28bd328cacf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_5dac3ae4-f2db-46e4-9e5c-3d731147299b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_5438f0a5-66e8-48a8-9530-b28bd328cacf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_5dac3ae4-f2db-46e4-9e5c-3d731147299b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_2a6acb1d-b85d-42ba-97c2-894dc4f82257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_5438f0a5-66e8-48a8-9530-b28bd328cacf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_2a6acb1d-b85d-42ba-97c2-894dc4f82257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82a636f0-1626-48b3-a7a7-85616593a781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e4730ef4-2d2a-409a-bdf2-e06c5f1d511b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82a636f0-1626-48b3-a7a7-85616593a781" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e4730ef4-2d2a-409a-bdf2-e06c5f1d511b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_11d33490-dd43-4577-be5e-bb7db7669702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_82a636f0-1626-48b3-a7a7-85616593a781" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_11d33490-dd43-4577-be5e-bb7db7669702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_67b056ea-d6d4-4cce-8fe8-70a97b0d0916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_204de631-80d1-405a-a684-72578da6127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_67b056ea-d6d4-4cce-8fe8-70a97b0d0916" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_204de631-80d1-405a-a684-72578da6127c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b6354fdb-7404-4cff-a51d-8f97e38c89ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_67b056ea-d6d4-4cce-8fe8-70a97b0d0916" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_b6354fdb-7404-4cff-a51d-8f97e38c89ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e432c0bd-1fdd-4c5d-a49f-bd98fb27f744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_5ca2eccd-37d7-4639-9175-caae8644e668" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e432c0bd-1fdd-4c5d-a49f-bd98fb27f744" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_5ca2eccd-37d7-4639-9175-caae8644e668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_8e5b03ca-26bd-4b6a-9b8c-efc417b08c08" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e432c0bd-1fdd-4c5d-a49f-bd98fb27f744" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_8e5b03ca-26bd-4b6a-9b8c-efc417b08c08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_f1995442-2a43-4651-8c6b-703de8a55848" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e432c0bd-1fdd-4c5d-a49f-bd98fb27f744" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_f1995442-2a43-4651-8c6b-703de8a55848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_be924ef4-c17b-431e-9c0e-b095e61c42b6" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e432c0bd-1fdd-4c5d-a49f-bd98fb27f744" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_be924ef4-c17b-431e-9c0e-b095e61c42b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_631ea634-ce70-486d-b9f4-18a43ed1c6db" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_e432c0bd-1fdd-4c5d-a49f-bd98fb27f744" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_631ea634-ce70-486d-b9f4-18a43ed1c6db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_00cea5f4-89cc-47a5-b081-721c617bbd60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_c743752e-0d84-480c-9d78-5189a3d031ee" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_00cea5f4-89cc-47a5-b081-721c617bbd60" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_c743752e-0d84-480c-9d78-5189a3d031ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_16523e7f-534f-47c7-b6fd-a4c56f41ea39" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_00cea5f4-89cc-47a5-b081-721c617bbd60" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_16523e7f-534f-47c7-b6fd-a4c56f41ea39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_907cef3a-0234-4a68-9c26-46c48aab2052" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_00cea5f4-89cc-47a5-b081-721c617bbd60" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_907cef3a-0234-4a68-9c26-46c48aab2052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_a4e091e0-937b-4f25-9d38-15c20956716e" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_00cea5f4-89cc-47a5-b081-721c617bbd60" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_a4e091e0-937b-4f25-9d38-15c20956716e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_673eec07-2857-42cf-85f8-ff02d4140b2b" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_00cea5f4-89cc-47a5-b081-721c617bbd60" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_673eec07-2857-42cf-85f8-ff02d4140b2b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_fe5b60b7-052a-48c4-9507-20fa721ed084" xlink:href="cvs-20210630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_f3713e34-a3df-431a-a91f-440ca4605ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_fe5b60b7-052a-48c4-9507-20fa721ed084" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_f3713e34-a3df-431a-a91f-440ca4605ce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_bc84eb69-4759-4e80-92fb-5338c71ad14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_fe5b60b7-052a-48c4-9507-20fa721ed084" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_bc84eb69-4759-4e80-92fb-5338c71ad14f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_e4ceb3a3-7b9b-49c9-a90f-dcc6ee221e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_7c79b24b-5b6a-44fa-977b-7391c42f035c" xlink:href="cvs-20210630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_e4ceb3a3-7b9b-49c9-a90f-dcc6ee221e0c" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_7c79b24b-5b6a-44fa-977b-7391c42f035c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_d8dca423-018e-40ef-a356-43241517eb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_e4ceb3a3-7b9b-49c9-a90f-dcc6ee221e0c" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_d8dca423-018e-40ef-a356-43241517eb63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_3f4fadb5-d0d1-4db9-96cc-e1ed456c9906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_69d27f97-a4b4-4b87-ba06-25cb932ce658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3f4fadb5-d0d1-4db9-96cc-e1ed456c9906" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_69d27f97-a4b4-4b87-ba06-25cb932ce658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_28595633-f84d-4e54-9299-90bd8c9aaf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3f4fadb5-d0d1-4db9-96cc-e1ed456c9906" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_28595633-f84d-4e54-9299-90bd8c9aaf5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_66aed927-cd0c-47b5-9644-0dfa011bb793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_3f4fadb5-d0d1-4db9-96cc-e1ed456c9906" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_66aed927-cd0c-47b5-9644-0dfa011bb793" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_41737f42-fc63-425e-8dd6-388e8e4654d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_50e8cfb3-320b-4ac8-aae5-bf8957920e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_41737f42-fc63-425e-8dd6-388e8e4654d2" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_50e8cfb3-320b-4ac8-aae5-bf8957920e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_68f72005-c452-481d-9801-75a43eb02040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_41737f42-fc63-425e-8dd6-388e8e4654d2" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_68f72005-c452-481d-9801-75a43eb02040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2ff75a56-1de4-4fa8-9a1e-aeef9345e239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_b6771db9-014e-46d3-9b63-60607dfdfc35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2ff75a56-1de4-4fa8-9a1e-aeef9345e239" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_b6771db9-014e-46d3-9b63-60607dfdfc35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_bc39de19-48a1-4ea5-b686-69e397aea54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_2ff75a56-1de4-4fa8-9a1e-aeef9345e239" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_bc39de19-48a1-4ea5-b686-69e397aea54b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_fff2daf4-e896-427d-98eb-643b0b70f282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_80186a14-9c73-4d9e-b5da-dd70d8d09350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_fff2daf4-e896-427d-98eb-643b0b70f282" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_80186a14-9c73-4d9e-b5da-dd70d8d09350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_10017291-d0e2-4bff-a1e5-5995e33e908a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_fff2daf4-e896-427d-98eb-643b0b70f282" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_10017291-d0e2-4bff-a1e5-5995e33e908a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#OtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee2b4ddf-af28-44c9-8f81-751d8a897864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_603bf752-bfa4-453c-b433-4ee035092642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee2b4ddf-af28-44c9-8f81-751d8a897864" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_603bf752-bfa4-453c-b433-4ee035092642" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1c6c0b34-fa8f-481e-bb5a-9caa0e686ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee2b4ddf-af28-44c9-8f81-751d8a897864" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1c6c0b34-fa8f-481e-bb5a-9caa0e686ed3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b53bc685-8367-4287-8678-323b0eb89fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e0ef23ae-59db-4293-89e5-6c5209fefa60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b53bc685-8367-4287-8678-323b0eb89fa8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e0ef23ae-59db-4293-89e5-6c5209fefa60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_23010ca5-12b3-41e1-8780-cb5d22100c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b53bc685-8367-4287-8678-323b0eb89fa8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_23010ca5-12b3-41e1-8780-cb5d22100c43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_10369635-d236-4c26-88b0-607d38049ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_37d59617-75d1-41bd-b88e-b297c502dc49" xlink:href="cvs-20210630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_10369635-d236-4c26-88b0-607d38049ebc" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_37d59617-75d1-41bd-b88e-b297c502dc49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81d4fe07-d8cf-402a-8199-032c05e1d5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_10369635-d236-4c26-88b0-607d38049ebc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81d4fe07-d8cf-402a-8199-032c05e1d5cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_34c3a039-ef75-418f-a7b7-5757608f79f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_10369635-d236-4c26-88b0-607d38049ebc" xlink:to="loc_us-gaap_NetInvestmentIncome_34c3a039-ef75-418f-a7b7-5757608f79f3" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>cvs-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efef91c4-b90c-4f53-8e18-716aea49f04e,g:46f154a9-1618-4e84-a3da-cd42ade064f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended" id="i645cb64db39e4c09a135411887de62ed_CondensedConsolidatedStatementsofOperationsUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_acd0e4ce-0ccc-4dce-99e1-7dc4ed637ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_acd0e4ce-0ccc-4dce-99e1-7dc4ed637ac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5594645e-b041-4395-97e7-309af67475d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_PremiumsEarnedNet_5594645e-b041-4395-97e7-309af67475d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_29641e5b-3565-4a86-9a99-a00c65541736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_NetInvestmentIncome_29641e5b-3565-4a86-9a99-a00c65541736" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2f55e13e-188e-4cca-89fd-f0f779fb1972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_Revenues_2f55e13e-188e-4cca-89fd-f0f779fb1972" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9864a27c-79d8-4354-8138-cc6a169f0f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9864a27c-79d8-4354-8138-cc6a169f0f42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_16807ab6-a056-40f2-965a-319a6a97d90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_16807ab6-a056-40f2-965a-319a6a97d90d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_7cba20da-021b-43c1-9e22-777fe6422fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_7cba20da-021b-43c1-9e22-777fe6422fcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0bc951f9-0e2c-44c4-b04e-5f3759e7b70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_OperatingExpenses_0bc951f9-0e2c-44c4-b04e-5f3759e7b70e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d5645117-42dd-4180-9c33-92092d89bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_CostsAndExpenses_d5645117-42dd-4180-9c33-92092d89bfd0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1bd502a4-319c-45e5-909f-058d8caed863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_OperatingIncomeLoss_1bd502a4-319c-45e5-909f-058d8caed863" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b9afc15e-e8ef-4808-a7a2-d29dc5a6530b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_InterestExpense_b9afc15e-e8ef-4808-a7a2-d29dc5a6530b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8edcfd63-02dc-4ba4-a637-68d9345162b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8edcfd63-02dc-4ba4-a637-68d9345162b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15b53ecd-aa84-487c-96d4-361bac8c9dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15b53ecd-aa84-487c-96d4-361bac8c9dea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0d0525e0-8b06-4451-b86b-e99e23a41474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0d0525e0-8b06-4451-b86b-e99e23a41474" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_59590cc6-27d2-403a-b4dd-8d647e4f47ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_ProfitLoss_59590cc6-27d2-403a-b4dd-8d647e4f47ef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_61c0d7b4-2e75-445e-94aa-1020381e0c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_61c0d7b4-2e75-445e-94aa-1020381e0c73" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b1869a85-dc84-41ef-9129-f312589ff65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_NetIncomeLoss_b1869a85-dc84-41ef-9129-f312589ff65d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2228c6a5-9b71-4d8a-9150-a088a0eb2fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:to="loc_us-gaap_EarningsPerShareBasic_2228c6a5-9b71-4d8a-9150-a088a0eb2fde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_41c3b335-e63b-49bf-a398-861e503e4f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_41c3b335-e63b-49bf-a398-861e503e4f30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4eda2a92-bc64-4aad-8274-eea887666cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4eda2a92-bc64-4aad-8274-eea887666cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b8bcfd5-c1d1-4025-8ee3-d1effa8789f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b8bcfd5-c1d1-4025-8ee3-d1effa8789f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8935cca2-d095-4c60-8efd-a1f41feb9c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8935cca2-d095-4c60-8efd-a1f41feb9c17" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:to="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47695ee3-dea4-4282-86c8-057451778909_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:to="loc_srt_ProductsAndServicesDomain_47695ee3-dea4-4282-86c8-057451778909_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:to="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_db89871c-802c-431c-8ef5-6743ba0637f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:to="loc_us-gaap_ProductMember_db89871c-802c-431c-8ef5-6743ba0637f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_f9d54699-0ece-48c8-a56f-118014cdf1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:to="loc_us-gaap_ServiceMember_f9d54699-0ece-48c8-a56f-118014cdf1d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended" id="i1bbaf40f94794f5a90550f09a60c4445_CondensedConsolidatedStatementsofShareholdersEquityUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2dadb22d-bc84-416b-b3e7-7a4948369b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dadb22d-bc84-416b-b3e7-7a4948369b63" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d2580609-b16b-473f-a284-0de7d1b4293a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_SharesOutstanding_d2580609-b16b-473f-a284-0de7d1b4293a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f85ebd48-0f83-45b2-ac60-3e3018d35e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f85ebd48-0f83-45b2-ac60-3e3018d35e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_116f15ad-a5a6-4bcb-bde9-801253b804a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_ProfitLoss_116f15ad-a5a6-4bcb-bde9-801253b804a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6951fed4-f935-4f91-a08f-0eab0742fe65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6951fed4-f935-4f91-a08f-0eab0742fe65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1c89c38b-71d4-4b22-8979-a97394542c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1c89c38b-71d4-4b22-8979-a97394542c7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6db84240-d084-4807-b18b-d9f8d04e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6db84240-d084-4807-b18b-d9f8d04e04a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_38c246a5-37b3-47b6-b985-15e2a9ff025d" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_38c246a5-37b3-47b6-b985-15e2a9ff025d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_d888c9ca-92f4-4fc4-8bae-99a83a8cc14f" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_d888c9ca-92f4-4fc4-8bae-99a83a8cc14f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_3815a119-3375-4130-85f8-bd76b653be47" xlink:href="cvs-20210630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_3815a119-3375-4130-85f8-bd76b653be47" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_9e6861fe-41ba-4b12-87bc-d029b923df3d" xlink:href="cvs-20210630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_9e6861fe-41ba-4b12-87bc-d029b923df3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_79871086-8996-4256-8bba-4890bc4f7b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_DividendsCommonStock_79871086-8996-4256-8bba-4890bc4f7b0d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_b25b89f2-a9ab-4024-aee3-174f3dcb1481" xlink:href="cvs-20210630.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_b25b89f2-a9ab-4024-aee3-174f3dcb1481" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e5642bb0-0995-4263-97f9-d71846dba0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_992203c0-414c-4844-bcb4-f3ca9cd90415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2dadb22d-bc84-416b-b3e7-7a4948369b63" xlink:to="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0930a276-45c7-4b3d-898d-499755ed6485_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:to="loc_us-gaap_EquityComponentDomain_0930a276-45c7-4b3d-898d-499755ed6485_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:to="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:to="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3b4ac508-c01c-4e08-b408-574e3deeabc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_CommonStockMember_3b4ac508-c01c-4e08-b408-574e3deeabc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_6d711611-3443-41b5-8e69-6f36e3798bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_TreasuryStockMember_6d711611-3443-41b5-8e69-6f36e3798bf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_236894cf-f64b-4e56-a662-98b6c074602f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_236894cf-f64b-4e56-a662-98b6c074602f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4df90dd1-f1e4-4c9a-9d8f-835b87132b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_RetainedEarningsMember_4df90dd1-f1e4-4c9a-9d8f-835b87132b14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_45e4f26e-7bc6-4bf4-8c86-94436fea79ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_45e4f26e-7bc6-4bf4-8c86-94436fea79ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_57f646c2-54c8-405d-969b-befe4fbfc77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:to="loc_us-gaap_NoncontrollingInterestMember_57f646c2-54c8-405d-969b-befe4fbfc77f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e000ab37-0260-4a65-b494-f7a9d1ab3cda_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_e000ab37-0260-4a65-b494-f7a9d1ab3cda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c4e0ae15-e5b1-4a67-b381-16299586a7a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c4e0ae15-e5b1-4a67-b381-16299586a7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_946f09f2-6828-4dc6-ae9c-39e14d9557ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c4e0ae15-e5b1-4a67-b381-16299586a7a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_946f09f2-6828-4dc6-ae9c-39e14d9557ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended" id="id1b9fc90fc8140ac874d53be48192836_CondensedConsolidatedStatementsofShareholdersEquityParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9533f6f7-28e2-4547-a548-1dfbc1474e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9533f6f7-28e2-4547-a548-1dfbc1474e71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_96e34940-2e51-454a-a962-1349d3b28aca" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_96e34940-2e51-454a-a962-1349d3b28aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_e0669579-fe5c-4514-9747-c51ae581e150" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_e0669579-fe5c-4514-9747-c51ae581e150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_09ce898c-f0f8-4760-b621-8b3794caa499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_CommonStockValue_09ce898c-f0f8-4760-b621-8b3794caa499" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_518dc9bf-5e5a-46fd-88ff-ae2cbe0feca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_518dc9bf-5e5a-46fd-88ff-ae2cbe0feca4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_6a8a58eb-afcf-460c-a6fb-4cd49536be46_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:to="loc_us-gaap_TypeOfAdoptionMember_6a8a58eb-afcf-460c-a6fb-4cd49536be46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_cb1e221f-c497-490f-905f-d65dbf0728cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:to="loc_us-gaap_TypeOfAdoptionMember_cb1e221f-c497-490f-905f-d65dbf0728cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_476d4f31-d601-420a-8614-b4f7d039d5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_cb1e221f-c497-490f-905f-d65dbf0728cb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_476d4f31-d601-420a-8614-b4f7d039d5e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ie1f46d827dcb486280ec2e74921249a1_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_9b6b3bc5-6237-4eb2-8445-e3d6812f6b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NumberOfStores_9b6b3bc5-6237-4eb2-8445-e3d6812f6b52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_547e6013-3474-4079-a947-e7ece96c2d02" xlink:href="cvs-20210630.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_547e6013-3474-4079-a947-e7ece96c2d02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_33cff6f6-6356-4f46-8d18-7a4d70277084" xlink:href="cvs-20210630.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_33cff6f6-6356-4f46-8d18-7a4d70277084" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_b9fd0f2c-00b8-4e91-b60a-815351d34fed" xlink:href="cvs-20210630.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberofPatientsServedperYear_b9fd0f2c-00b8-4e91-b60a-815351d34fed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_0f4925d0-00d6-47ff-813c-c7678418c8a8" xlink:href="cvs-20210630.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberOfPeopleServed_0f4925d0-00d6-47ff-813c-c7678418c8a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_231eaf10-c349-401c-b60e-41bb8e973cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NumberOfReportableSegments_231eaf10-c349-401c-b60e-41bb8e973cf5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_c9e369ec-1ce1-496d-bc62-e6eb86efe420" xlink:href="cvs-20210630.xsd#cvs_HealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_HealthInsurerFee_c9e369ec-1ce1-496d-bc62-e6eb86efe420" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7761a381-e383-4912-8370-f6013b7fa7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7761a381-e383-4912-8370-f6013b7fa7d7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_71fa8359-0281-4108-9d03-3d0cdaad4166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_71fa8359-0281-4108-9d03-3d0cdaad4166" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_2c8b666e-17a5-46b7-ac61-77e12ceb313f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_2c8b666e-17a5-46b7-ac61-77e12ceb313f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_01b4174e-a8f7-4133-835f-84e70dd4c63a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:to="loc_us-gaap_SegmentDomain_01b4174e-a8f7-4133-835f-84e70dd4c63a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:to="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_170e7c96-89ad-4111-a666-d6bb79cee00f" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_170e7c96-89ad-4111-a666-d6bb79cee00f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_7ddb19cf-3454-41f1-92ed-21445cb1bc79" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_7ddb19cf-3454-41f1-92ed-21445cb1bc79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e6d7615c-19dc-423b-af91-3d52838f4a3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:to="loc_us-gaap_RelatedPartyDomain_e6d7615c-19dc-423b-af91-3d52838f4a3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2da3ac9f-400f-4a7c-bfbf-6bf53069bfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:to="loc_us-gaap_RelatedPartyDomain_2da3ac9f-400f-4a7c-bfbf-6bf53069bfdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_b472390f-2acf-4af2-b1a4-4a60aefdf41a" xlink:href="cvs-20210630.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2da3ac9f-400f-4a7c-bfbf-6bf53069bfdf" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_b472390f-2acf-4af2-b1a4-4a60aefdf41a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="iaf14559e9c644681a651ee4c256cf5b4_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2205954d-b157-4c58-8492-4809debfc072" xlink:href="cvs-20210630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2205954d-b157-4c58-8492-4809debfc072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_bbec540c-4e6c-43fb-aceb-fc0847739318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_us-gaap_NetInvestmentIncome_bbec540c-4e6c-43fb-aceb-fc0847739318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6a388950-86b0-4d0b-b157-62754dbc0d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_us-gaap_Revenues_6a388950-86b0-4d0b-b157-62754dbc0d59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cf7a1a05-ab00-45f1-9878-30cc69024166_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:to="loc_srt_ConsolidationItemsDomain_cf7a1a05-ab00-45f1-9878-30cc69024166_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:to="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a32da93-61ac-45ca-98dd-2c2ae9e523ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a32da93-61ac-45ca-98dd-2c2ae9e523ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_cedfdda1-de18-4cc9-a0c2-041d78b84f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:to="loc_us-gaap_CorporateNonSegmentMember_cedfdda1-de18-4cc9-a0c2-041d78b84f71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a273fffe-3f00-4e09-8157-378ca2f1800d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a273fffe-3f00-4e09-8157-378ca2f1800d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:to="loc_us-gaap_SegmentDomain_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:to="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_47199853-b483-4173-9004-bca9a388bafd" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_47199853-b483-4173-9004-bca9a388bafd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_aa968e9c-4e60-413a-ab6f-900a67b3b26d" xlink:href="cvs-20210630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:to="loc_cvs_PharmacyServicesSegmentMember_aa968e9c-4e60-413a-ab6f-900a67b3b26d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_c00b13d2-f4bc-448d-b754-c571eeb3fac4" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_c00b13d2-f4bc-448d-b754-c571eeb3fac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:to="loc_srt_ProductsAndServicesDomain_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:to="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_700e3b4f-2264-4674-9ac5-4dc4bbee1276" xlink:href="cvs-20210630.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_cvs_PharmacyRevenueMember_700e3b4f-2264-4674-9ac5-4dc4bbee1276" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_b17f4f53-3148-4400-afd0-b76b48d99ca8" xlink:href="cvs-20210630.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_cvs_FrontStoreRevenueMember_b17f4f53-3148-4400-afd0-b76b48d99ca8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_ad30f992-9154-42e9-91f9-84c760682c22" xlink:href="cvs-20210630.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_cvs_PremiumsMember_ad30f992-9154-42e9-91f9-84c760682c22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_5e0226e7-417a-4abc-a531-d8e498528db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_5e0226e7-417a-4abc-a531-d8e498528db0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d2dbd92e-8423-4969-b080-df97c18d2ea9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_d2dbd92e-8423-4969-b080-df97c18d2ea9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_85f2197b-c4df-4e42-bf5d-93b23c7107b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_85f2197b-c4df-4e42-bf5d-93b23c7107b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_40687bd6-210d-4278-96c1-7338f6ae62b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_40687bd6-210d-4278-96c1-7338f6ae62b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_4eea1fbd-6019-4b8b-a14f-a7ae3611fc5b" xlink:href="cvs-20210630.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:to="loc_cvs_SalesChannelOtherMember_4eea1fbd-6019-4b8b-a14f-a7ae3611fc5b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended" id="if88626a42f964d07a39d91149ee2b5bf_InvestmentsTotalInvestmentScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_8deb13f0-c6c7-4c1b-8b0b-2fcd44591ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_us-gaap_ShortTermInvestments_8deb13f0-c6c7-4c1b-8b0b-2fcd44591ad2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_dab7c777-1e5a-4acf-8938-7483a0919840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_us-gaap_LongTermInvestments_dab7c777-1e5a-4acf-8938-7483a0919840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9ed8afc7-366a-4170-b30b-6b374b350b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_us-gaap_Investments_9ed8afc7-366a-4170-b30b-6b374b350b20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:to="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_e92aba4c-f159-4bbb-97d3-725a0cac6160_default" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:to="loc_cvs_TotalInvestmentsDomain_e92aba4c-f159-4bbb-97d3-725a0cac6160_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:to="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_9dbed9bb-d52f-41a6-a6f3-f29ec26e1ffe" xlink:href="cvs-20210630.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_9dbed9bb-d52f-41a6-a6f3-f29ec26e1ffe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_db04155f-f151-4365-8699-8fcb5941057f" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:to="loc_cvs_MortgageLoansMember_db04155f-f151-4365-8699-8fcb5941057f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_019b4c8a-5a69-4197-a836-5d61fbd7f026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:to="loc_us-gaap_OtherInvestmentsMember_019b4c8a-5a69-4197-a836-5d61fbd7f026" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="id092670470a44dbda75df94015468fd9_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2389eaec-f933-4a2d-be3a-ed5ac3e0c74f" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2389eaec-f933-4a2d-be3a-ed5ac3e0c74f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c869ca62-cfbe-4046-92ab-44518a7ff996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c869ca62-cfbe-4046-92ab-44518a7ff996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d504b188-2a36-472b-8e82-48aec2b4ade8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d504b188-2a36-472b-8e82-48aec2b4ade8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_009621f4-a16c-4774-82c1-e0446ede58d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_009621f4-a16c-4774-82c1-e0446ede58d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3200661d-a39e-4a07-896a-3612bbbee0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3200661d-a39e-4a07-896a-3612bbbee0e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec723e63-133d-4c69-a357-0473190586f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec723e63-133d-4c69-a357-0473190586f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec723e63-133d-4c69-a357-0473190586f1" xlink:to="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_390ccc49-3897-41af-bf5c-3e1dc4e5e639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_390ccc49-3897-41af-bf5c-3e1dc4e5e639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f2f047c1-3a4d-4c44-bbf7-4c08d18020db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f2f047c1-3a4d-4c44-bbf7-4c08d18020db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7fb05e12-fe93-4954-b5e0-7c063d78b33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7fb05e12-fe93-4954-b5e0-7c063d78b33d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_91a680c8-5d61-40c9-9ddd-a28586dfde19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_91a680c8-5d61-40c9-9ddd-a28586dfde19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c3147fd9-13c0-4113-b6f4-b535c126c7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c3147fd9-13c0-4113-b6f4-b535c126c7c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_503beb38-8026-48f1-bcac-f25d94350253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_503beb38-8026-48f1-bcac-f25d94350253" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_4dd4a187-0c7a-4cfd-98ec-89d2bc3277f4" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_4dd4a187-0c7a-4cfd-98ec-89d2bc3277f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_56e04ab8-2e8c-4768-97c9-64149b1931b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_56e04ab8-2e8c-4768-97c9-64149b1931b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:to="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:to="loc_srt_ProductsAndServicesDomain_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f09d5f46-b5d7-41ff-ad36-ce75cc730e8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:to="loc_srt_ProductsAndServicesDomain_f09d5f46-b5d7-41ff-ad36-ce75cc730e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_71c8b18e-a569-4889-a82c-5f5d3a657c27" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f09d5f46-b5d7-41ff-ad36-ce75cc730e8b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_71c8b18e-a569-4889-a82c-5f5d3a657c27" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="i043bc1cc54cc400aacabf87d9d09df39_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_6459df25-e395-4b25-8a4c-96f68796f260" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_6459df25-e395-4b25-8a4c-96f68796f260" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_bbdbecfd-d8f8-446e-b103-19140fb699ae" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_bbdbecfd-d8f8-446e-b103-19140fb699ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_b32b91b6-c09d-4572-be55-38da83dc644a" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_b32b91b6-c09d-4572-be55-38da83dc644a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_896b9aa5-d893-4738-acf3-0facb4e4cc48" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_896b9aa5-d893-4738-acf3-0facb4e4cc48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_d87eb86f-376b-4a39-b341-41e15ea6eedd" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_d87eb86f-376b-4a39-b341-41e15ea6eedd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f657c0f5-36bf-4ea1-84fe-618382abb47c" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f657c0f5-36bf-4ea1-84fe-618382abb47c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_58e8fa18-d3a5-424f-8423-3811328669e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_58e8fa18-d3a5-424f-8423-3811328669e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_937725be-be7a-4d67-a738-1ba90db0c588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_937725be-be7a-4d67-a738-1ba90db0c588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_fb0dbaf0-28fd-447a-95c6-f4d7e4d35dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_fb0dbaf0-28fd-447a-95c6-f4d7e4d35dfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_60c87733-c42a-4c52-a22f-1b420f8ebb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_60c87733-c42a-4c52-a22f-1b420f8ebb3a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a278df29-ac2a-4640-b959-a70f5a6824d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a278df29-ac2a-4640-b959-a70f5a6824d4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d61a00a3-ac38-439d-a81d-4321804a210a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d61a00a3-ac38-439d-a81d-4321804a210a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f0eaa8b-4742-4e80-90b1-96bcb042547a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6f0eaa8b-4742-4e80-90b1-96bcb042547a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8a96f40a-c7d6-49a7-bac1-3a1465ebfbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8a96f40a-c7d6-49a7-bac1-3a1465ebfbae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ed2bb2e7-213f-409c-a803-c5618cb0b048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ed2bb2e7-213f-409c-a803-c5618cb0b048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_ce8c3cb8-e021-48e1-8902-ef9227161ed4" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_ce8c3cb8-e021-48e1-8902-ef9227161ed4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="i634ee142ebea4804bc0290516ead0470_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_d3b90f04-9dbc-4a59-a078-056719c8d6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_d3b90f04-9dbc-4a59-a078-056719c8d6c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828ea805-ac3c-4bab-8e35-21ab188325b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828ea805-ac3c-4bab-8e35-21ab188325b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_10280666-790e-4948-91a1-abc5d18ca2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_10280666-790e-4948-91a1-abc5d18ca2ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_369a7ad5-5947-4607-aefd-e4ca0f017a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_369a7ad5-5947-4607-aefd-e4ca0f017a1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f715ce12-da5c-447b-8e84-e3590ef394d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f715ce12-da5c-447b-8e84-e3590ef394d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1ffab3b5-e714-4622-8feb-e734ea551eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1ffab3b5-e714-4622-8feb-e734ea551eb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_a9f70f01-12f9-42b4-ab54-4bc52c2c97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_a9f70f01-12f9-42b4-ab54-4bc52c2c97b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_85e73a66-b7b4-4951-9e21-7a1470a62e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_85e73a66-b7b4-4951-9e21-7a1470a62e33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5d089cd6-b513-42c0-b5b2-824bd9b515bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5d089cd6-b513-42c0-b5b2-824bd9b515bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3d260ea-26ba-4f43-a208-b31f5f756d14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3d260ea-26ba-4f43-a208-b31f5f756d14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_856a6f10-bee9-4e13-ba7e-b46352c88d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_856a6f10-bee9-4e13-ba7e-b46352c88d77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_49563b53-c8bf-425f-9ad2-4db07ea78b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_49563b53-c8bf-425f-9ad2-4db07ea78b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_54ea2fee-0fc3-4dad-872d-b2dbab602d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_54ea2fee-0fc3-4dad-872d-b2dbab602d2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_cd27aa0d-0937-497e-adeb-b7141f7f7094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_cd27aa0d-0937-497e-adeb-b7141f7f7094" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f63914df-dd0a-46af-a844-16fa85d74e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f63914df-dd0a-46af-a844-16fa85d74e66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_239c0606-be2d-4ecc-8f1a-6e7460d219f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_239c0606-be2d-4ecc-8f1a-6e7460d219f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_dfd3ce40-6d13-4110-a778-5a5d3e6f6f49" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_dfd3ce40-6d13-4110-a778-5a5d3e6f6f49" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_bec4309f-5f5e-4262-9818-fc60e5645552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_bec4309f-5f5e-4262-9818-fc60e5645552" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="ib01ccf6b64b64ab2ae791c094036728c_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_76e60ac1-55a3-4014-a574-79fe3735d807" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_76e60ac1-55a3-4014-a574-79fe3735d807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_79e18a7f-3435-4e69-8645-5a51d4812497" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_79e18a7f-3435-4e69-8645-5a51d4812497" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_930e7a1c-6d43-44b9-9852-963142ea95a7" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_930e7a1c-6d43-44b9-9852-963142ea95a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_691368d0-9f9b-425d-9aad-aa210e69735e" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_691368d0-9f9b-425d-9aad-aa210e69735e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_46513458-4557-44eb-8157-66749a0fd63c" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_46513458-4557-44eb-8157-66749a0fd63c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_385941fc-194a-49ec-bf3e-bca0e86b524e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_385941fc-194a-49ec-bf3e-bca0e86b524e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_a66dda97-08ec-4ff9-8a34-c4110a5484a4" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_a66dda97-08ec-4ff9-8a34-c4110a5484a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_ae4f1464-d053-41f7-9dc6-8451487a96a3" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_ae4f1464-d053-41f7-9dc6-8451487a96a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f02a2570-81ea-4245-a204-a74ef9670037" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f02a2570-81ea-4245-a204-a74ef9670037" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_24c50f30-9dce-4b57-9cff-ca4aaaa6962e" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_24c50f30-9dce-4b57-9cff-ca4aaaa6962e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_21280e31-1af6-404a-9abb-8c44444041fc" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_21280e31-1af6-404a-9abb-8c44444041fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46bd3b8f-08aa-449d-a9b9-d77e85d34e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46bd3b8f-08aa-449d-a9b9-d77e85d34e95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:to="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e6500b47-0cf8-451a-86e3-4e6ef6bffc96_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:to="loc_srt_ProductsAndServicesDomain_e6500b47-0cf8-451a-86e3-4e6ef6bffc96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:to="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_657dbfb3-b80f-4231-8ff7-91fe834216ab" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_657dbfb3-b80f-4231-8ff7-91fe834216ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_ebae2d15-9448-4567-9672-096bf0ab2d78" xlink:href="cvs-20210630.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:to="loc_cvs_SupportingRemainingProductsMember_ebae2d15-9448-4567-9672-096bf0ab2d78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c0927b0-ac05-4d46-9324-5d9cbdff2e83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c0927b0-ac05-4d46-9324-5d9cbdff2e83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b4e887fb-0503-480d-beab-d631be449c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b4e887fb-0503-480d-beab-d631be449c8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1664fb44-735f-4f70-a3f7-1dc750b37ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1664fb44-735f-4f70-a3f7-1dc750b37ace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_a4d9f000-3cce-4be4-a6e7-3ccbca5f880b" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_a4d9f000-3cce-4be4-a6e7-3ccbca5f880b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="i2590358c3a9942978229acedd6edbf16_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_d8ab624d-0290-4f7d-b14b-ef873f83b125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_d8ab624d-0290-4f7d-b14b-ef873f83b125" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_b20b796b-41bf-4f94-84e1-4275a3c4a484" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_b20b796b-41bf-4f94-84e1-4275a3c4a484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_ba81bb92-e88e-49d8-8f98-d93b8c05f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_ba81bb92-e88e-49d8-8f98-d93b8c05f5da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db456235-55ce-4333-99fa-a794bd13215a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db456235-55ce-4333-99fa-a794bd13215a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_1c602a8b-8d4a-4c7e-8f04-7f1ea1276cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db456235-55ce-4333-99fa-a794bd13215a" xlink:to="loc_us-gaap_CommercialRealEstateMember_1c602a8b-8d4a-4c7e-8f04-7f1ea1276cd8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i27905795be6f4952b5f942604ab426e4_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_ed8d788d-be8e-4a12-bb65-3e0a502acb42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_189916e2-d8a4-4db1-953c-4a0b85f3a168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_ed8d788d-be8e-4a12-bb65-3e0a502acb42" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_189916e2-d8a4-4db1-953c-4a0b85f3a168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_ed8d788d-be8e-4a12-bb65-3e0a502acb42" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_8b23b098-2b18-4f01-b5c1-64cb5d80297f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_8b23b098-2b18-4f01-b5c1-64cb5d80297f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_19ef157b-56b2-40ab-a9d0-628c9cee19c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_19ef157b-56b2-40ab-a9d0-628c9cee19c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_7d962c9b-9f40-415d-99c8-5362510cbcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_19ef157b-56b2-40ab-a9d0-628c9cee19c6" xlink:to="loc_us-gaap_CommercialRealEstateMember_7d962c9b-9f40-415d-99c8-5362510cbcbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_feb5c179-f3d7-4c9f-8f48-81302c4aa79e_default" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_feb5c179-f3d7-4c9f-8f48-81302c4aa79e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_f2d2e3f3-3d53-4ee3-9bd8-90f34c902895" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_f2d2e3f3-3d53-4ee3-9bd8-90f34c902895" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_67bac447-962a-4c23-9589-b109b2f566ce" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_67bac447-962a-4c23-9589-b109b2f566ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_843e7456-89e9-4b5a-a5f7-73d8fb024239" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_843e7456-89e9-4b5a-a5f7-73d8fb024239" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_2b9f4279-e1fa-44d7-bcac-4b09fb207b4f" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_2b9f4279-e1fa-44d7-bcac-4b09fb207b4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_5bd6405b-3c30-45df-a8ba-980cfdc7c91d" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_5bd6405b-3c30-45df-a8ba-980cfdc7c91d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_b19b5fc6-659a-489a-a3a0-90e25d497fcf" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_b19b5fc6-659a-489a-a3a0-90e25d497fcf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_cdef065d-bcd0-4cf2-bf93-abac045a81e6_default" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_cdef065d-bcd0-4cf2-bf93-abac045a81e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_a617b342-ad5c-4b23-9ace-9dd1a4e72bf7" xlink:href="cvs-20210630.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Category1Member_a617b342-ad5c-4b23-9ace-9dd1a4e72bf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_4765ed08-6ff9-4d22-a0f4-25c2a0d2a2f6" xlink:href="cvs-20210630.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Category2To4Member_4765ed08-6ff9-4d22-a0f4-25c2a0d2a2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_6c06f5ec-9b16-41c1-94c1-95dd55a122b2" xlink:href="cvs-20210630.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Categories5and6Member_6c06f5ec-9b16-41c1-94c1-95dd55a122b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_1e7c3ddb-97ac-40b8-9919-b7b66815b2f6" xlink:href="cvs-20210630.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Category7Member_1e7c3ddb-97ac-40b8-9919-b7b66815b2f6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i5f52465ff4714500b87b4b6114c3f4df_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_28ba25a5-e568-4f77-844a-0c433ceb841a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_28ba25a5-e568-4f77-844a-0c433ceb841a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_4a7f66a5-2192-41d8-b9a9-2438b905d756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_4a7f66a5-2192-41d8-b9a9-2438b905d756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b8fcedc6-68df-4b9c-a4de-1ec6e6dd806c" xlink:href="cvs-20210630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b8fcedc6-68df-4b9c-a4de-1ec6e6dd806c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_285f2996-6fc2-4b05-8811-c1f549d255c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_285f2996-6fc2-4b05-8811-c1f549d255c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_b33e83f4-3dda-4f4b-bdf0-8ff2a8ec93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_InvestmentIncomeNet_b33e83f4-3dda-4f4b-bdf0-8ff2a8ec93a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3e78a7d7-964a-4e77-b13b-45d7ea4e6e04" xlink:href="cvs-20210630.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3e78a7d7-964a-4e77-b13b-45d7ea4e6e04" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1a0cc5a8-3ede-4d0a-8fa0-0c038568e43b" xlink:href="cvs-20210630.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1a0cc5a8-3ede-4d0a-8fa0-0c038568e43b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:to="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0bcd6b88-c569-4697-830c-7e04a9ffb853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:to="loc_us-gaap_DebtSecuritiesMember_0bcd6b88-c569-4697-830c-7e04a9ffb853" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_3b4a0bc7-376d-4975-9236-d39b3b4fdca3" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:to="loc_cvs_MortgageLoansMember_3b4a0bc7-376d-4975-9236-d39b3b4fdca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_49abe6e1-2e9e-4493-9844-8986fc5f03ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:to="loc_us-gaap_OtherInvestmentsMember_49abe6e1-2e9e-4493-9844-8986fc5f03ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:to="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee6be047-7b7a-4f91-890d-8f05dbb83782_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:to="loc_srt_ProductsAndServicesDomain_ee6be047-7b7a-4f91-890d-8f05dbb83782_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45cc71c4-e4eb-480b-a2a9-830bb972c41b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:to="loc_srt_ProductsAndServicesDomain_45cc71c4-e4eb-480b-a2a9-830bb972c41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_29eeaf44-3575-49f3-9694-561fd26ce798" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_45cc71c4-e4eb-480b-a2a9-830bb972c41b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_29eeaf44-3575-49f3-9694-561fd26ce798" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended" id="i8802de4bc5344cfb95d1a9ae154af0bc_FairValueMeasurementonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_9f2d46aa-04f4-42aa-9ab4-d460100b0bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_9f2d46aa-04f4-42aa-9ab4-d460100b0bd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0bd23cd5-2a47-4e09-a2ab-b75fc361c0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0bd23cd5-2a47-4e09-a2ab-b75fc361c0b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_79aa10e3-73e0-4786-8e97-8ff176bb4357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_79aa10e3-73e0-4786-8e97-8ff176bb4357" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c5e3556c-ee82-4f61-a813-0b6a94b46be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c5e3556c-ee82-4f61-a813-0b6a94b46be4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2f3d8dc2-0b5d-496b-b66a-f916a6bbcf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2f3d8dc2-0b5d-496b-b66a-f916a6bbcf71" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_60ffdd26-7a12-4f6f-bb69-6795f78950e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_60ffdd26-7a12-4f6f-bb69-6795f78950e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_22950e48-ef0e-4582-a071-60fd89bdd2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_22950e48-ef0e-4582-a071-60fd89bdd2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ba2761ba-a7bc-42b8-8beb-86be2bda6821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_22950e48-ef0e-4582-a071-60fd89bdd2d6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ba2761ba-a7bc-42b8-8beb-86be2bda6821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e87b003-f8ab-433e-ae39-99e4f8585545_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e87b003-f8ab-433e-ae39-99e4f8585545_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3e6b835d-ac90-4fbb-aeed-49026e6e8cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3e6b835d-ac90-4fbb-aeed-49026e6e8cdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a8ba4b16-d485-45c0-9949-46b7f1e5fa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a8ba4b16-d485-45c0-9949-46b7f1e5fa4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5dd509b4-c6c3-4941-8399-c9d355f647aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5dd509b4-c6c3-4941-8399-c9d355f647aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ccb22fb3-5bfa-4a40-831e-236deb92327d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ccb22fb3-5bfa-4a40-831e-236deb92327d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_20066148-a70e-494e-a460-7bbb3dcfd61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_20066148-a70e-494e-a460-7bbb3dcfd61a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bbc63c78-af4a-453d-a9ea-2f02d8c98c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bbc63c78-af4a-453d-a9ea-2f02d8c98c7d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_b9b9d98e-7bc0-4d60-bfaf-a994e4ee044f" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_b9b9d98e-7bc0-4d60-bfaf-a994e4ee044f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_185d3bf7-91a5-4bc3-9d24-e3fc6cb16c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_185d3bf7-91a5-4bc3-9d24-e3fc6cb16c00" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b72d87a8-6d8f-4214-b5ec-38d49c3035eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b72d87a8-6d8f-4214-b5ec-38d49c3035eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b1b1170b-fa1b-4664-8e4c-639030e05392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b1b1170b-fa1b-4664-8e4c-639030e05392" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0e55b8c5-571a-49a1-b7eb-185b757d0c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0e55b8c5-571a-49a1-b7eb-185b757d0c90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_62317402-9a04-4e01-93d3-932e57f006eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_62317402-9a04-4e01-93d3-932e57f006eb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="i32d278234f984c10b496ca7b33083307_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_20a3f64f-9058-4652-8e5f-d5f02ab16273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_20a3f64f-9058-4652-8e5f-d5f02ab16273" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c90a8725-1f0f-4115-b492-235bda8bb4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c90a8725-1f0f-4115-b492-235bda8bb4e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_905c658b-bac9-44a5-a3ed-d65543828292" xlink:href="cvs-20210630.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_905c658b-bac9-44a5-a3ed-d65543828292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_386ff23e-5b9b-4db0-9c20-7237d9beca11" xlink:href="cvs-20210630.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_386ff23e-5b9b-4db0-9c20-7237d9beca11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d18f48d4-9fbc-418d-b8bf-779a404ab659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d18f48d4-9fbc-418d-b8bf-779a404ab659" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6a8de382-e65e-4042-bf7a-5b331c412768_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6a8de382-e65e-4042-bf7a-5b331c412768_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e33f347-2034-4e8f-a90b-c2b2a65f0cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e33f347-2034-4e8f-a90b-c2b2a65f0cb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4cc90700-6fef-403c-8fda-ee34f2562ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e33f347-2034-4e8f-a90b-c2b2a65f0cb6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4cc90700-6fef-403c-8fda-ee34f2562ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_015b65e3-f39b-4d2c-9ee1-942ed551bd3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_015b65e3-f39b-4d2c-9ee1-942ed551bd3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_21f8d6b4-5f6c-4795-90fa-cbda8883ad16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_21f8d6b4-5f6c-4795-90fa-cbda8883ad16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c41e8535-f5ae-4c0d-bba0-0bda58b11870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c41e8535-f5ae-4c0d-bba0-0bda58b11870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3dfc9966-aa20-4a0b-967b-9ebbef7d4b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3dfc9966-aa20-4a0b-967b-9ebbef7d4b1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_5c8ba34a-e1bf-4063-a076-49088eaab96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_5c8ba34a-e1bf-4063-a076-49088eaab96b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_edea1881-c5a0-48d2-bf45-711a435720bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_edea1881-c5a0-48d2-bf45-711a435720bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_acbde7b9-2c2a-4f7d-a317-36c1c8bdb55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_acbde7b9-2c2a-4f7d-a317-36c1c8bdb55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_acbde7b9-2c2a-4f7d-a317-36c1c8bdb55a" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d0db04b9-1a78-435c-9144-28ae697ed35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d0db04b9-1a78-435c-9144-28ae697ed35d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3ff38699-54fe-479a-bade-16107fdb69d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3ff38699-54fe-479a-bade-16107fdb69d2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="i3bf30596287d40078200e9356f13d299_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_6f4bf2e6-9419-48dc-ad52-8214b8c4c41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_ac7f8f5a-9328-4007-a44d-f237d6b3adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_6f4bf2e6-9419-48dc-ad52-8214b8c4c41b" xlink:to="loc_us-gaap_SeparateAccountAssets_ac7f8f5a-9328-4007-a44d-f237d6b3adbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_6f4bf2e6-9419-48dc-ad52-8214b8c4c41b" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d82d9254-6b26-46b2-8c01-10f33c17360a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d82d9254-6b26-46b2-8c01-10f33c17360a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e67fd95a-b874-46ae-ade3-8391ffe726be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e67fd95a-b874-46ae-ade3-8391ffe726be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_411449cd-8960-4a05-a195-43b0b8f2b472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e67fd95a-b874-46ae-ade3-8391ffe726be" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_411449cd-8960-4a05-a195-43b0b8f2b472" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a20eae2-150a-4a2a-84ac-868174f1badc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a20eae2-150a-4a2a-84ac-868174f1badc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5ef6c9de-215f-4efe-bc06-475f62bcbe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5ef6c9de-215f-4efe-bc06-475f62bcbe5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_54c9242e-3510-42b4-9954-c4ed6633fe73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_54c9242e-3510-42b4-9954-c4ed6633fe73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a169347d-aec0-450c-9b8c-33ee19d14581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a169347d-aec0-450c-9b8c-33ee19d14581" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4528842f-eb1c-4642-9486-434d484092a9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4528842f-eb1c-4642-9486-434d484092a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_be075a6e-a573-45da-b9a2-67763197cf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_be075a6e-a573-45da-b9a2-67763197cf74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_450731f3-5a4d-4e94-90c8-35b49d7c6e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_us-gaap_DebtSecuritiesMember_450731f3-5a4d-4e94-90c8-35b49d7c6e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_48ffb17d-a327-4f7c-bbe5-2b9a5039ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_us-gaap_EquitySecuritiesMember_48ffb17d-a327-4f7c-bbe5-2b9a5039ec04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_ee20bf39-d482-4a83-9e12-afc00a94782e" xlink:href="cvs-20210630.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_ee20bf39-d482-4a83-9e12-afc00a94782e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e86c4286-7dbc-4a3e-9880-c1ece2340081_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e86c4286-7dbc-4a3e-9880-c1ece2340081_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ebaa563-1c75-4f51-b0a1-7a724c72ce09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ebaa563-1c75-4f51-b0a1-7a724c72ce09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_78b7dc70-670d-4545-9430-166089dea1c7" xlink:href="cvs-20210630.xsd#cvs_OtherReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ebaa563-1c75-4f51-b0a1-7a724c72ce09" xlink:to="loc_cvs_OtherReceivablesMember_78b7dc70-670d-4545-9430-166089dea1c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended" id="iea66dc3270d94d2d8466a7ec7e949c8f_HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_057e4209-bb95-4dc3-9dcd-2e54bd5f138e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_057e4209-bb95-4dc3-9dcd-2e54bd5f138e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_85d39ce7-b226-45e5-829e-09553d185bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_85d39ce7-b226-45e5-829e-09553d185bf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_4515fc50-a065-482b-8646-9703178734a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_4515fc50-a065-482b-8646-9703178734a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_92667323-e66f-4144-a51e-bf6195f7cd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_92667323-e66f-4144-a51e-bf6195f7cd4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_82277719-aba3-465a-95cf-c907d3bbd52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_82277719-aba3-465a-95cf-c907d3bbd52c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_03ea3ec6-8560-44a7-89e4-e9c76a5c1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_03ea3ec6-8560-44a7-89e4-e9c76a5c1bd9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d732b7fe-6b68-4004-ad9e-5f6b3a271874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d732b7fe-6b68-4004-ad9e-5f6b3a271874" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_0d1ae571-40e1-49d2-8249-6ad5d2a79510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_0d1ae571-40e1-49d2-8249-6ad5d2a79510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_df18b8a4-7d8a-4c57-9b86-395d2af3bfba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_df18b8a4-7d8a-4c57-9b86-395d2af3bfba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73199115-2572-4216-9f5d-80d06bd634f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73199115-2572-4216-9f5d-80d06bd634f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_776a8fb7-8fb9-4c06-989b-4fb9da26a083" xlink:href="cvs-20210630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_776a8fb7-8fb9-4c06-989b-4fb9da26a083" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_be150872-3132-47b2-b53a-67dfd7c0c43e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_adabe47b-11a5-4c51-abf9-ec6ccf8037ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d18a29fa-0e97-4ec1-b3fd-fefd1832d79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_70b9914b-6d31-4715-a03b-c3d3f699d86a" xlink:href="cvs-20210630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_8dc9d678-322f-4c0b-84fc-6f86ff73cd1d" xlink:href="cvs-20210630.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_8dc9d678-322f-4c0b-84fc-6f86ff73cd1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:to="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1959ae1f-ae5e-4238-ae23-f5eab21053cb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:to="loc_srt_ProductsAndServicesDomain_1959ae1f-ae5e-4238-ae23-f5eab21053cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_43cee424-56ef-407c-9dcc-11f1ed269d77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:to="loc_srt_ProductsAndServicesDomain_43cee424-56ef-407c-9dcc-11f1ed269d77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_d69bc183-f9bd-4dc3-b97c-f13baa4601df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_43cee424-56ef-407c-9dcc-11f1ed269d77" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_d69bc183-f9bd-4dc3-b97c-f13baa4601df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b49ef05d-e78c-463e-83a6-efd2a5115df5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:to="loc_us-gaap_SegmentDomain_b49ef05d-e78c-463e-83a6-efd2a5115df5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:to="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ad286841-689c-47f1-bc02-f26cf44a41cd" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ad286841-689c-47f1-bc02-f26cf44a41cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_9d1ed52f-175a-4402-850c-d88124c98d10" xlink:href="cvs-20210630.xsd#cvs_CorporateOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:to="loc_cvs_CorporateOtherMember_9d1ed52f-175a-4402-850c-d88124c98d10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="iadad8b68cee7405eb02a7ee8bc18680d_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a78f0b52-0019-4b4b-a5a8-2364fa0f3f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a78f0b52-0019-4b4b-a5a8-2364fa0f3f23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_1596b41d-aa8e-48d2-a597-8ec5582e68cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_1596b41d-aa8e-48d2-a597-8ec5582e68cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:to="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d240e2b2-1517-4f43-8eeb-b4556164247f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:to="loc_srt_ProductsAndServicesDomain_d240e2b2-1517-4f43-8eeb-b4556164247f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a05cfd74-e4c4-49e9-92be-48541ec48917" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:to="loc_srt_ProductsAndServicesDomain_a05cfd74-e4c4-49e9-92be-48541ec48917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_3d5ead0f-f0e2-4269-9a52-a73403ddc900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a05cfd74-e4c4-49e9-92be-48541ec48917" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_3d5ead0f-f0e2-4269-9a52-a73403ddc900" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#ShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended" id="i26a317da611b4eef8ba713c0e77f82ac_ShareholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bedf27b1-12e9-4ae9-89fd-03a9d37a59cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bedf27b1-12e9-4ae9-89fd-03a9d37a59cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_64bbf393-5d7c-46e9-9758-91c24ac5a0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_64bbf393-5d7c-46e9-9758-91c24ac5a0d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_880e6775-ccd4-4174-b187-fb7a41312b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_880e6775-ccd4-4174-b187-fb7a41312b51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e6a7d18-2da8-4dc9-9fa8-cb437f12f0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e6a7d18-2da8-4dc9-9fa8-cb437f12f0d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_2914cb61-4a99-4946-bf65-478ae5c5b7ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_2914cb61-4a99-4946-bf65-478ae5c5b7ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e6ff5d83-496f-4147-aabb-720cbe8e267e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e6ff5d83-496f-4147-aabb-720cbe8e267e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_fb68c36f-1732-4a68-b166-d7d600515973" xlink:href="cvs-20210630.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_e6ff5d83-496f-4147-aabb-720cbe8e267e" xlink:to="loc_cvs_A2016RepurchaseProgramMember_fb68c36f-1732-4a68-b166-d7d600515973" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#OtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended" id="i86e6a68b968943f79d44800bdfbe9fac_OtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:href="cvs-20210630.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2657bf5f-c938-45c2-8cd7-9e671a8cfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2657bf5f-c938-45c2-8cd7-9e671a8cfe22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ba4126dc-b8c8-487b-87d6-c95a0592efd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ba4126dc-b8c8-487b-87d6-c95a0592efd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b544c188-9330-4d98-838c-2767a47684de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b544c188-9330-4d98-838c-2767a47684de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_740b52b5-96c5-43bd-b926-6e8b9d67405f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_740b52b5-96c5-43bd-b926-6e8b9d67405f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edbd7363-2ba5-4fa4-985a-c8c02798afe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_235d24c7-0635-4846-a84c-b4ddeba8aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_235d24c7-0635-4846-a84c-b4ddeba8aa50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_7143983f-dd35-4524-8c65-9974840d40c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_7143983f-dd35-4524-8c65-9974840d40c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_c1e5e3a0-496b-4a0a-bfcd-a3b5a03b5628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_c1e5e3a0-496b-4a0a-bfcd-a3b5a03b5628" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:to="loc_us-gaap_EquityComponentDomain_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:to="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_277e5b55-bf26-4b74-b86f-c483abd1b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_277e5b55-bf26-4b74-b86f-c483abd1b6d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e266c451-680a-48fe-bb92-6f552de337a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e266c451-680a-48fe-bb92-6f552de337a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6a6ee484-3952-448d-9302-2b41cef10280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6a6ee484-3952-448d-9302-2b41cef10280" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_704e5597-a16d-44b3-bd11-6f61d6356740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_704e5597-a16d-44b3-bd11-6f61d6356740" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d6de0987-e338-484f-a573-d8f38255ebad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d6de0987-e338-484f-a573-d8f38255ebad" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ib804fc884ad5470c8f438e6e6e84fb36_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c454641f-f19c-4a9d-9603-60d0c14c608c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_cbe7508a-dc65-40d2-bc83-3baf1bbfd179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c454641f-f19c-4a9d-9603-60d0c14c608c" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_cbe7508a-dc65-40d2-bc83-3baf1bbfd179" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c454641f-f19c-4a9d-9603-60d0c14c608c" xlink:to="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:to="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_096364a7-3c76-4a48-b848-ed01501d1c86_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:to="loc_srt_LitigationCaseTypeDomain_096364a7-3c76-4a48-b848-ed01501d1c86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_107c6b4c-17f9-4323-8fb3-1066a2368e48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:to="loc_srt_LitigationCaseTypeDomain_107c6b4c-17f9-4323-8fb3-1066a2368e48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_b62cb9a1-9625-45dc-ab08-f86e338d5afd" xlink:href="cvs-20210630.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_107c6b4c-17f9-4323-8fb3-1066a2368e48" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_b62cb9a1-9625-45dc-ab08-f86e338d5afd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:to="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7b89256f-04fe-47e4-8321-b67098d4f2a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:to="loc_us-gaap_LitigationStatusDomain_7b89256f-04fe-47e4-8321-b67098d4f2a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_dadb8d1f-2b8b-40f0-aaeb-93674bc222ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:to="loc_us-gaap_LitigationStatusDomain_dadb8d1f-2b8b-40f0-aaeb-93674bc222ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_55dea3f1-0014-4139-9b39-f5b8df4c4776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_dadb8d1f-2b8b-40f0-aaeb-93674bc222ed" xlink:to="loc_us-gaap_PendingLitigationMember_55dea3f1-0014-4139-9b39-f5b8df4c4776" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="i39a8ea8f49074a6abbe7e27fac5893e6_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2e9b2d67-84fd-4dbb-a94e-ace57032ced4" xlink:href="cvs-20210630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2e9b2d67-84fd-4dbb-a94e-ace57032ced4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c501ce14-af9f-4b8c-9bc6-69b50f182d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c501ce14-af9f-4b8c-9bc6-69b50f182d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8f9fcc93-812a-45a1-8861-03f625bf88dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_NetInvestmentIncome_8f9fcc93-812a-45a1-8861-03f625bf88dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a9822255-de84-49b2-be87-d8af1f6f813b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_Revenues_a9822255-de84-49b2-be87-d8af1f6f813b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_41e359f0-412e-4947-992f-839670483273" xlink:href="cvs-20210630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_41e359f0-412e-4947-992f-839670483273" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_47362c17-8f8d-419b-bbca-0220fba83894" xlink:href="cvs-20210630.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_47362c17-8f8d-419b-bbca-0220fba83894" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:to="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fb030d65-b42a-4991-84b0-6f8da596540a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:to="loc_srt_ConsolidationItemsDomain_fb030d65-b42a-4991-84b0-6f8da596540a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:to="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e0a36546-0331-45c0-a948-ddcd0c8f4058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:to="loc_us-gaap_OperatingSegmentsMember_e0a36546-0331-45c0-a948-ddcd0c8f4058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e3c964dd-eb44-437b-b642-a2460598b58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e3c964dd-eb44-437b-b642-a2460598b58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_eb990d64-142c-476e-b64d-350be2087d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:to="loc_us-gaap_CorporateNonSegmentMember_eb990d64-142c-476e-b64d-350be2087d7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bcb7734d-3039-4738-8565-e41da93be248_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:to="loc_us-gaap_SegmentDomain_bcb7734d-3039-4738-8565-e41da93be248_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:to="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_34de82a0-3d72-4d79-a4b0-485abf053635" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_34de82a0-3d72-4d79-a4b0-485abf053635" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_b4d0db31-5343-4dd0-8a8f-02764501677a" xlink:href="cvs-20210630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:to="loc_cvs_PharmacyServicesSegmentMember_b4d0db31-5343-4dd0-8a8f-02764501677a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_757fa937-4ff4-4e84-9d16-88222e8fb825" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_757fa937-4ff4-4e84-9d16-88222e8fb825" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended" id="id56df041175a4fbe8628b673fb18cfc1_SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1d358bf4-df5b-43e5-a2f2-f5ffe2e7f162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_OperatingIncomeLoss_1d358bf4-df5b-43e5-a2f2-f5ffe2e7f162" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_77182ad6-afd3-43c0-821c-9447b3b43cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_77182ad6-afd3-43c0-821c-9447b3b43cc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_ebf69522-ca10-43eb-bf79-26b438e0fe6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_ebf69522-ca10-43eb-bf79-26b438e0fe6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_1efbe19d-dfa5-4813-9c25-a8b67682d9a3" xlink:href="cvs-20210630.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_1efbe19d-dfa5-4813-9c25-a8b67682d9a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_d7bfccc4-f69f-4cb8-ac16-8595d0c66de3" xlink:href="cvs-20210630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_d7bfccc4-f69f-4cb8-ac16-8595d0c66de3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_0cb86311-d454-4053-9bb7-e45bfe5e9ed0" xlink:href="cvs-20210630.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_0cb86311-d454-4053-9bb7-e45bfe5e9ed0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b2374c56-7e24-4f70-b206-90af9c6d5acc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:to="loc_us-gaap_SegmentDomain_b2374c56-7e24-4f70-b206-90af9c6d5acc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_67d7c522-f969-4b04-ba9b-3b7c067c0943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:to="loc_us-gaap_SegmentDomain_67d7c522-f969-4b04-ba9b-3b7c067c0943" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_5e54c23e-d0d1-4d1c-b8b2-357ae0b75893" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_67d7c522-f969-4b04-ba9b-3b7c067c0943" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_5e54c23e-d0d1-4d1c-b8b2-357ae0b75893" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>cvs-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efef91c4-b90c-4f53-8e18-716aea49f04e,g:46f154a9-1618-4e84-a3da-cd42ade064f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_a6c10044-b809-41f3-9f20-1f75d06149dc_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_284c5847-b9de-46f4-ab43-e987005a7a1f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_59495772-3464-46fa-91f1-ce2407d106a9_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_e61d1714-10f7-4a41-9859-4e7098a7544e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Separate Accounts by Major Category of Investment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_56f35c55-d05b-4e13-ab2c-d1226a642575_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_3d0a7624-f6aa-4ae6-b66d-d76d7b10e1d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_af043586-5505-489a-b340-121a00ce5333_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_c956b779-18ae-45c3-871b-a26619fb6e58_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_45cc4d47-b0cc-4d32-84be-41fa92aab804_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8258b599-790f-4d5d-9a3b-b375094fb638_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_b33c0ba9-b99a-4f1a-be8d-74aced52bc7f_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5a874f47-f211-49c8-b78f-b8043b7934fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_a6d6dd1c-8dac-4e29-b1f4-8dcee7ced02d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5a41197d-02b0-473a-9c6d-eb150e0ad427_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_5ce873c5-b524-45b1-b951-8c9ada6e17e6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_b1135b51-cf21-4738-be0b-20d3412b616b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_d1305f69-8feb-40df-824f-7eb75cf76574_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d130ca58-7815-4bf4-a632-c3489daa02d7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of receivables and contract liabilities from contracts with customers</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_22eb474d-abe6-4466-ad37-79ca795b5858_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8d931311-229e-445c-9a88-f0fa6665c57c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,742 shares issued and 1,318 shares outstanding at June&#160;30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_bb3f7f96-6a47-43e5-9114-d986699e15c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_332d884b-148b-43a6-8a72-4efef855a859_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_8c0a7b42-d7c3-42b8-945e-61bc313314d3_terseLabel_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt related purchase price adjustment from acquisition</link:label>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20210630.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_d1c2958a-47da-4afa-8d61-883cc72a84e8_totalLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ff45fff3-cea1-4bdf-800a-47190a7f9efe_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_9a322801-6712-4e10-ab02-551a01983d0e_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20210630.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_86f0f0ea-bedb-4369-9733-c8649ce6d831_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_fdf2bdd7-2e3a-4b42-b6f0-f94032dd6e5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities Available For Sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f56764a0-f886-4c9e-bb1d-67c2b1a43891_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_2b1ffd7d-5ed9-4af3-bd5c-cef37bcdd37e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f06f1ed4-324f-406a-aeff-d69baeb7340f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_337689a4-785d-4cd8-a025-a8a72f1717e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_4171c624-f16e-4136-adb6-97f20b52752f_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20210630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d8fac00e-e8a0-495f-93b2-a1a3ccdc2214_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_c652c46b-82a9-4743-a545-41f5060f5ec2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e496a945-91d8-47cf-913a-329077ca5cb5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_4b4193f8-059a-4cc4-a6b8-755e7ceb3913_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail/ LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_5b06b0cb-1eea-4c9c-bd6d-6c18902eb9e0_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_78c310ba-fc27-4fe0-b60c-7ee5541e63c0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_479a1f11-1eff-4b5a-8571-a391731c1bc5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_edf42d0d-2a82-4861-84da-ee0d09bb4456_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_510bb667-7eb5-4932-9862-ff8aa64c8f91_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_02425112-ccb0-48c3-bce7-894673024289_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20210630.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_8cab489d-a618-4f87-bc0d-c49cce46a162_terseLabel_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_label_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</link:label>
    <link:label id="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_documentation_en-US" xlink:label="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:href="cvs-20210630.xsd#cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:to="lab_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_c09f26d6-8587-4683-9c0c-99a1637a5d60_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_3abbcd25-59cf-4e0c-b061-3fecbb2da2cb_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20210630.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_358d9a1f-6054-4456-a6f1-895876c3285c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4d050007-6b5a-446a-ae83-4c24ad465466_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_cd2a927b-a3c6-478b-b9a2-b6e4d9716b33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherReceivablesMember_6754d3ec-8f8c-4e8d-b83c-96609c71e782_terseLabel_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_label_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables [Member]</link:label>
    <link:label id="lab_cvs_OtherReceivablesMember_documentation_en-US" xlink:label="lab_cvs_OtherReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember" xlink:href="cvs-20210630.xsd#cvs_OtherReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherReceivablesMember" xlink:to="lab_cvs_OtherReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_e37f9baa-0580-43d9-b854-88becd5fbc0f_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20210630.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_f1fc9eb1-7fb1-4482-9309-92ae00b3e563_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_7e0f053a-6e01-4cb4-b72d-70e1480f409f_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_2ba57244-4aa9-466c-b831-19c6a79cc0a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_a29da7e9-fd30-456c-8539-e755cb2daf44_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_58b56d12-72f4-4b03-a05c-937640e992e7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_79703532-9cca-4b3d-b244-c18ae2131acb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_1c97ffba-be8a-4941-9445-53c1f88d3d15_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e184f8c6-6138-4e47-bb76-0a1ebffdd07b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_786058d6-06e9-440a-8dd0-abd605c0c0f3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_68ea5c8c-37b0-474e-8cf7-adc37beaf0f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_7e7525b4-5346-4fe5-9e85-d1e1dbbb51bc_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_df0f3d45-724c-4d69-b248-f78a7084e627_verboseLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:to="lab_us-gaap_BenefitsLossesAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a3127021-90af-4549-bca0-d4141907367c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_4cc1e582-73dd-4a5a-934a-c2d461f99b7b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_1c954308-8178-47fa-b84d-57b0f9994227_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_427c7f19-b952-4445-85e2-d0b4bf817588_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_0fd17f66-3fc1-44bb-901f-900972ca171c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_da4b7b78-09c7-4c8d-b1a0-281be1d5892f_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss (gain)</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20210630.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_043ede45-7de3-4d61-bfef-bae1ad9ddaea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_9488d757-eb78-4aea-8c4d-a38a897b4ab0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_a1e5427c-a3b6-45f3-9f25-908f15a1ebb8_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_01630803-e0dc-4d3a-8108-6d1d2062352c_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20210630.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_46797798-8c38-4ba3-836b-a6a6559c825f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_fef3cc8b-8da7-4387-85af-d5fbbf6ee04a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3071ff6b-1aa6-4507-9395-b2aff300d5b6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1069a6fe-84b8-4312-9986-06dea8bdbdb0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_de7c3617-dedb-4502-9884-9adfbcc159bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_91d09efe-2416-4e0c-b32b-1f723b098d4b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_03869653-1c43-40b9-90e9-5058ac4a9a7b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_de887005-653a-4b9b-839c-c1cebf4c8c23_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_0e4b476c-871b-4257-a0dd-4f557f0d3195_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8651d450-877d-4378-9ce1-e347cebee445_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_6ee48cb4-46a0-4670-b8e6-62b72048dd12_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e1084a75-03dc-47a2-8144-4646b0cf3d79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_23108d33-87c3-4d97-a5b5-06b2d74825d5_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_60c621fb-a63c-4e67-9241-e6f17781e626_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b115cdc4-7eb0-414c-b5fd-41c0849636df_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_0af1aae9-f753-4d02-91b0-c5da6108d79c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_57168fb0-1a54-4478-b990-3981963cb50e_terseLabel_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:href="cvs-20210630.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeinContractwithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_74974543-28fd-4533-adb5-6646b29f1652_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_1c89c2a9-688b-4bba-b44c-8a817f5b0049_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_a7cc4c69-add0-422e-94fc-c40f72be02ae_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_1308492d-5352-48c4-9e8b-c01e341d4ffe_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_13770094-c3bb-444c-aa74-37d2a52e28be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_1913e2a3-fabb-4cc5-bc20-79b4df1aca53_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Prior To Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_9bbe1b31-7625-4a75-a51f-5e98e1cbcff0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_1d72e1f1-6ea5-45ba-8342-817feb0df79e_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20210630.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_327384e5-bba3-41f6-84ef-6b739ad810a4_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_274b30e8-e958-4308-a408-2eecae328a39_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_d5982331-a156-477d-afe0-2049177b551d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_b97cc77d-d319-4f0e-ae1b-8a05a3696e3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5722ab5d-24c4-49ff-916a-9d2cf4772ee8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_927abef1-97b1-47f8-a399-c8c5933e322c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6d9b051a-d9f0-4190-b9c6-eaf42d422987_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2e654293-31a9-4eae-810c-b8615c0b1f5e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9223de64-b7a5-4424-b2b3-3e99093c39a9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_bc8f8dcd-4744-4a98-8beb-3bdbd4b2aabd_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, number of leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases" xlink:href="cvs-20210630.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberofLeases" xlink:to="lab_cvs_GuarantorObligationsNumberofLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_e57cc5b9-4442-4e9a-a3da-385d2542c53c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_b5c8b934-b21d-43ca-9691-fdb1769af55b_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_f831afd2-c17f-452e-ad40-30094793de58_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20210630.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_bc79b786-8b97-478f-8b71-36beeeba4b77_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a947fabd-bd55-462f-9c1e-bf091bfad8b4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_40132159-e01f-4be3-ad91-6fcb8107768a_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_761cf159-9a44-4baf-bfb1-d2182daa9208_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f7c0689c-7215-4732-ba1c-d41256ff9f17_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_5e0e77fd-4527-4c52-bb5e-81de4e87cdc7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_192310c7-2ec9-4371-90ad-56a2d8ab4c5d_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, end of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_3257bdbf-68ed-4590-ab17-4ee2b698eec5_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_4e838291-3043-4e07-8ad5-00b1d17fb552_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_03ad3789-465a-4009-91d9-c7eadb2d95fe_terseLabel_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember" xlink:href="cvs-20210630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyServicesSegmentMember" xlink:to="lab_cvs_PharmacyServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_0241b6f3-d987-4886-97af-e77c2078ad84_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_64d8af35-406a-4454-bb8c-c53175dc5862_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20210630.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_a027bedf-ccc6-457d-9fd2-adc7bea3af3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_356c8e6d-3652-49c8-97d5-52999d9cbc84_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_2cf7d8c1-1967-4a5c-9fd2-68a85d2b86e6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_eb6dbdf5-ba4b-413c-910a-13829dc53b6b_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience-rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_964c9465-6c84-4bf5-803e-49f06c258a19_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits" xlink:href="cvs-20210630.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInsuranceBenefits" xlink:to="lab_cvs_PaymentsforInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d94a893a-7e2a-41a3-987c-58608e566e93_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_fa9fa42d-6261-41fd-a8d6-cc5cd185e0f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFee_35612703-2151-4221-9f65-bb45cf929c02_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_label_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee" xlink:href="cvs-20210630.xsd#cvs_HealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFee" xlink:to="lab_cvs_HealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_7068db9c-b6b1-4e31-bf36-d67669559dfc_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3f04a5af-5690-4db1-86c4-ca8a609f7c56_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_444deff5-7ff2-4926-b70c-b4290d01a221_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_16da9879-cc79-4886-a483-0b7f3f008068_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:href="cvs-20210630.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_b9ec9fc2-0ea8-4e77-94db-2970d5212dab_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6ccf725d-a165-497a-8b63-15f192b9efb3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_82b3d49b-b0b3-4ed1-9488-3450162e4efe_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_44a18fa8-9b40-4b61-b8cb-5038920ff71f_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20210630.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_168a59dd-98fa-4cce-ab2f-3693a39a9708_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_fb650259-994c-4407-bd30-d819446c6372_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_db1afbb2-fa96-45bd-97b3-2ea2f92ff98a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2ff67580-f98e-4e35-b1db-3272e49acc6e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before Reclass, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f7eb7f6e-90f3-4ab5-9425-3a3862db859a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_10f25ea5-09dd-40cd-9c01-615e7178c1d4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_5175c318-c928-4161-b492-75beb19782cf_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20210630.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_244c1df4-5baa-4657-9e85-b8d5d6a8d67b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_d05261e8-cdca-4293-a5a6-9b4e034f5e16_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_967f5439-4697-4d50-8da1-3781134641e3_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_c7553418-1471-44af-8a25-71bc83b0949a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_c0e5c4a6-34e3-4331-9ca6-7da56453655f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_504aacfa-27fa-42ca-a04b-20c17780fbcf_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3345a672-7aa2-4a92-a1f3-775cb7ac9a25_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_c5d1e586-b38b-4370-a4b2-3bfea8dd6d23_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_babfafbe-4c08-4724-af26-81497d92f81d_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_75d55d95-eed7-4d38-a450-100fdd47b97f_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:href="cvs-20210630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_5d2a0ac7-fa50-43e2-9da8-ff5e2ae81514_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_332984ae-8a67-4f1e-b34f-79ef8c439492_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_805f6896-fb47-4a01-8f45-1391e0bd2fe9_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_06ac5e1d-ee07-4321-83ba-901440f3dee9_terseLabel_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_label_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes and other noncash items</link:label>
    <link:label id="lab_cvs_Deferredincometaxesandothernoncashitems_documentation_en-US" xlink:label="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:href="cvs-20210630.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Deferredincometaxesandothernoncashitems" xlink:to="lab_cvs_Deferredincometaxesandothernoncashitems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_55d5001d-a489-4be3-9ff4-c3fc08d88f0a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4f12bb40-1b6d-457c-8c1d-cec991f38856_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_e82a4844-5744-43ff-b3ad-0453d15e1b75_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_9b074daa-1461-4b2b-9ef0-6c7dc4dfd1f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_6a0acee0-f8e9-4a62-a965-2a9e4425c6cc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a7f4c4e5-12ff-4ba6-8599-adae435e38e0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_6d4cb701-cb56-4093-bc54-953ee03b26b7_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_ab530e07-8911-4af6-a953-8407e0f12f02_terseLabel_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of pharmacy plan members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_label_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:label id="lab_cvs_NumberofPharmacyPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberofPharmacyPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Pharmacy Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers" xlink:href="cvs-20210630.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPharmacyPlanMembers" xlink:to="lab_cvs_NumberofPharmacyPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_24da403b-4eb9-433f-a9fd-76010988a426_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c4f021a0-3375-4fb9-8aaf-618dcb69b44a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_39a37495-3acb-494b-a287-b092fff29f08_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20210630.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_84d2ef16-124e-4a57-b948-18e48f5939a5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ca2a0618-8605-4eb6-bb53-1f4756d70e84_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_1b965396-dcd4-4d13-88ed-81039bc7bf8f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred but not reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_086b1fcd-7e19-46ea-a396-56a768ddfe7d_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2ab13839-41b4-4d59-b347-343782097f02_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_dcf573ed-feee-4664-bda0-5a0ed942bdcf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_13e47675-43f8-4415-8ea3-924d64e1c4e4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_37ebe7b3-b590-4b1b-9e5f-43e73e01d3fe_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Securities In An Unrealized Capital Loss Position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_b852b197-284e-40b0-9a1c-b7dad01bd67f_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_73def6ac-3f43-4a39-b1f0-db00a92eced7_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_f65309e1-f808-44b7-ba8d-704ebb923df4_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_d457520a-2ff9-4f2e-80d7-bce95a7330be_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_8f28838c-4d17-4722-852b-b54699df33c1_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e90f5240-656e-4fc0-bb21-85da13e702ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_3d5168a8-ff62-4c32-bc92-07e02094bed7_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d0b2fec4-a8ea-45af-b63b-de8263352040_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_287ccf5b-28f1-4ebc-bc6b-034144bd11bf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0fc1bbf5-a1d4-42f4-a5dc-3009f30d2872_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_2b874f63-f75e-4c30-b663-9e3a0eecc00b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_6e25587d-6d94-4559-8032-24c3cb179173_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_ed14839a-c800-4639-a55d-d2ba7f763078_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d5b84e4d-b256-4c6b-8760-c1663ab8cc20_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9092b3f9-fc5d-405a-b2b0-15178ecd812c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_1e08191e-3fde-4bbc-8e72-6f8978b0609d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CorporateOtherMember_1d20c352-465e-4e99-ad3a-f88300cd5dfe_terseLabel_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_label_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:label id="lab_cvs_CorporateOtherMember_documentation_en-US" xlink:label="lab_cvs_CorporateOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate / Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember" xlink:href="cvs-20210630.xsd#cvs_CorporateOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CorporateOtherMember" xlink:to="lab_cvs_CorporateOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_4a8b408b-f905-47fd-8453-3ff0ae2c9b52_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_12e04486-9972-4670-bf58-adf04f632c56_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_58818e4d-0f32-41b9-88fb-5739f7e6a255_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_e3007f07-1dd6-4065-bd58-8fa39c89d8c3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_b79c98b8-a6c0-40ad-86ec-b4a736ee568b_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2059eeed-8fa1-4e98-812a-4e7b74238f10_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20210630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_5c155093-ca65-4855-acbe-983044281440_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_71442c1b-2fd1-459f-8455-bce934e0333e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_90f60365-d01d-4e2e-8098-9267ce938fa9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_12e9668d-3c18-470b-a0ad-7ea3af45faf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a7e709f4-6ac6-4d9f-b2df-0639398b3076_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c389d04f-e4b5-417b-984b-d052d66941e9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8ced2758-845d-429b-b57e-2ded261a4b40_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_14ca4368-c39b-4842-ac4f-a2d9a6c034c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_45b97ea8-7f09-4265-a497-5412989a42f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2bf36e7a-1952-4426-b4e9-0d3cf9e23fad_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_97c87d27-e614-4f99-b7f9-9db219b3f955_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_05e8ed36-8c0f-4217-b4f1-9786e8f0df5a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_a553e199-0d93-4e0c-82cb-75d4aa5e8d07_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_104ca05a-2ec8-44e2-b44f-a878a21fd2d7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_6ed133b2-d799-4f5c-a3f2-866b1b5d4255_terseLabel_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_label_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:label id="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_documentation_en-US" xlink:label="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:href="cvs-20210630.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:to="lab_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b591a632-309e-443b-a8dc-9c8614d40955_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_29f3d72d-0488-4b00-9c7a-158b86343f05_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c3d30731-27a6-4bfa-b45e-779e8db28641_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d86224d-6657-434c-9933-679792f8fa81_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_a6bf98fd-dde8-4617-ac54-d30d19f03b21_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ebc0cc59-c4a3-40d1-ba6c-6c967a4064a1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72e1ebce-a355-44cd-9b6c-208e7c051bb0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_05ae8606-94ee-4a01-9f20-f069a99168b6_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate, Year Of Origination [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_28dbd031-3cfd-4894-af83-d1edc8bf1b04_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_81a3f513-3acd-46f7-8e09-0095061329cc_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_047f0a25-502f-4c09-ba82-9a4d9c8c9536_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4df176a3-6f40-4674-81e0-7c35ef8de863_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_a2c903e6-98ef-461e-9b74-a4c9fc5d28be_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b41067b6-19dd-4b4e-8ee7-192c31c8c5fe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4820ec30-2457-44a7-829d-ffd40ecf07da_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ee4c84c9-b88a-4160-80d3-0867d81e7a9d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_6b718690-de6d-49ce-8d9a-ed1e52182ffe_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_975694d8-18fc-4892-8575-91e086391db0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_66425893-7ec4-4aea-96d5-58adb3ce5987_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_89cfd07e-b87c-4394-bb32-4b7de87ddf84_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5444eb47-7eb3-431e-b2b8-431c8f478602_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_8a5d91c9-db44-4d8b-8fb9-a02d93fcbd45_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_e96f76a5-a707-40cb-adba-609b70e1d9c4_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_37f95ff3-c379-4c87-9443-6be2e8787889_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20210630.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_1c5feb04-c708-4ade-bb5d-6aa3135f5fdf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_135b0955-ff93-4fff-ba5c-f67e7bb24bd3_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9c032c54-3bf0-4d04-b4f4-2f512667cb54_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_85fa97c2-de07-4898-82dc-16fbacbcd85e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_02b0493d-3f16-437d-a9af-ed82e6e330a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_66b9049d-1d9a-4a6d-8877-fbfe36af1e69_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_c45d1092-4ea0-4210-b2ef-5bb557f7e040_terseLabel_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_label_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:label id="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_documentation_en-US" xlink:label="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care and Other Insurance Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:href="cvs-20210630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:to="lab_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_813958e2-3a77-4a37-a2fc-a48cb4f3f9d0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_619113c9-b23f-493b-a6a3-0a095fcb1466_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_47f340d0-d51f-42ac-a75f-c2a1c974f7d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f6b218fb-c9da-4995-bc36-0072afe164c8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_36538417-1807-4f26-9aea-e16ade2aa648_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_b51d10ce-ee17-4c4b-85c1-042db5423ce2_terseLabel_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_label_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_documentation_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear" xlink:href="cvs-20210630.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPatientsServedperYear" xlink:to="lab_cvs_NumberofPatientsServedperYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d056f609-16c7-4900-99fc-c0be9637f165_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_4b831b99-14a0-42a0-8138-cd568fa0bc55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_ebf6039f-0e78-41c1-8d0d-564db7a8b363_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5a135c5e-d4ff-4f57-86de-c97d4a56af9e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_64acf096-67be-4f57-84f5-ad97aa351aa4_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_4c995d5e-1712-43b1-a199-ff94992b826b_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_1fe84794-cd3a-4039-bbd3-dcc7cc5e9ed4_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20210630.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e10515e3-f503-4fb5-9bb7-45437d2f371b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_c4c14b3c-ce07-481f-a43b-c20603ff6cf9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_4dd1529a-8df6-4ad1-ad8c-278f23807a9f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_e981700e-9dfa-417f-a0b2-fe7919f2588e_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8bee099b-253b-459d-ae99-0d6c80b270de_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5a3181ff-bc54-41f3-878b-2e05089debad_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7e651fa0-cf22-4bff-9573-b494fc30ecc5_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9a42c249-9510-4c0f-b3ff-b6499f968d26_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_ff0483b9-97a1-4881-ba78-aadd9202acb4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_10429bf5-8f6e-4ec7-9ee6-626cded261ed_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_4dd08309-1a44-421d-900f-b54d2b8e7bbe_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20210630.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_f0d29b27-f83b-4183-9b9e-bfd6d7dd552e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_791d6a35-f7c3-4aaa-82b9-2a5fba22f7f2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_8d77c8bb-854c-4380-a60c-2482069da69d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_841f64cd-f0c6-453c-826a-e206963d1e8e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_39cfa19c-8532-4ee4-ad3b-08ed89cfbde7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_1a277c86-9c22-4f77-9dc5-e27c7ca78ae8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_5e37c218-c486-426c-ab39-a2f000c104f3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_e2fbef1b-42c3-42e4-ae02-927066f1ea41_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_9296930d-53bb-4c45-a75e-9968baae2ac0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized Financial Information Of Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_485b0d4e-fdef-40e8-a8f8-aeaef027292a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7bec3bf2-c2a2-4c08-8797-341100f1aee4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_be56b093-d117-445d-afac-911fb16652e7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_4e63ad2c-1589-4fe4-a20e-40bda6131743_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_31c1b249-14ee-4677-9c62-517b10300b1e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_34e5d8de-1599-4454-af3e-cef2a33412b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5381e5c4-a5b4-4150-8c32-069295a3fba5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_3c235e6a-d4e2-46da-85ca-eaee16ccf1e5_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_df96306a-c597-4de5-aa6f-8ce4974676d5_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20210630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_86f87f17-9247-4bf7-8d4c-f8b7646223e0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_49241131-b6cb-440a-8c05-3e6fc18a908f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_c9f8b443-8e75-4098-9dc4-082ae7cb4f45_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ceb5bc7e-ed51-4c6e-94c1-9e79277eb217_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_82c7acc7-2de2-47c6-90a4-f412049fdfe1_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_d2d4bbb2-0e0d-4111-bbbe-fef52fb1d8a7_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_012e27aa-43c4-4a92-aa0b-7342f808d915_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_6d67f981-8a40-46ce-953c-e2210f798908_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20210630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_a0182ea9-4706-491c-ba8d-28423bf8d9f3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6b9ea7c2-bb61-4061-be8e-4ca292fdec18_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_5052a891-22d3-4015-83b5-cb827564fcd7_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_fcae70b6-3ca9-4eee-a41c-086a1e561b77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_7346d10c-ad05-42eb-9569-00661045e98d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_9ec6445e-3396-41c9-ba93-10c605a37611_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_5d83beda-407b-4e69-b08b-b7a705d131a9_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_11a31292-67ec-4c71-ab58-26765f8b46a6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_52acd173-7912-44e3-9bf9-2ca91ed48f60_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b354cca-aee0-4a44-a24d-752ba691a373_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_74dbed0e-4a52-4743-8676-e90c6cdbbce5_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_814df91f-020a-45c0-9240-03cc2273c2b9_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_301a470f-4309-4ca4-91ce-32db5e5243b3_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interests</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20210630.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8425a096-db04-41d1-8005-f6020c4a0b39_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_de6a185a-0393-4e04-9392-a00fcac9639e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2aab933d-721f-42cd-a743-601cffb0c314_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_4f83ef68-d8ae-410e-ba38-7d1e8f3c87f1_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_0a2f3b21-1e09-4601-bea9-38a979d65945_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20210630.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_646a418e-f428-4314-8ec4-6cbf3dec6e5d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_48e3a470-948d-4301-96b2-2db49fcded21_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_3e2941a5-f43e-42e2-b329-2891aee5a0d2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6bcbd855-476f-4245-915f-a1a60dbf03cb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_f89fd29d-e11b-426d-9d55-38814e1c81f0_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20210630.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2580a4de-0d6d-4fbf-adfb-554e6f4351dd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fd53544c-6d9b-455b-abae-9a69cfbdbc31_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1dec5723-4bf0-4510-b1d1-45fa792d550f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_9651f031-d054-4d6b-b2be-761e82048e3c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_b0949c5b-9328-4a17-a363-e1dc22f47eb1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_7aeaabf3-c7c4-4caa-9cb0-1a59f31565b5_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_bfd7083c-87e2-4c19-8001-d8ddf8013998_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_7a89ecb1-54f3-4fdc-b8a5-05a7c26e3c62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_d4b9d0fd-979a-44b1-a9a4-95386145df8f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7cdf1aa6-5103-40b2-b82c-5219b8ee16c6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f195088a-3a01-4aec-903d-bdb686e6dc4c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_b60c439d-f12f-42a8-805d-0270b5b1d12c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_76b9290b-a6dc-4261-bd6c-c97bfdb5a8bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_48a0405e-29b1-4956-a486-a293c2017154_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_939e04ec-fe12-44e5-96d6-c1c169c6e645_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_f1187014-4873-4c49-9588-2fb07bd3d15d_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_49a5b536-e4b7-4aa1-830d-71b5ac0003d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_bf647069-7df0-49ce-82d7-89f7e7d510cf_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sample size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_label_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_documentation_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:href="cvs-20210630.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:to="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_373470a2-6d93-4ea0-b33b-41b6e9982fc6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_564c4d4f-7990-43f9-9b94-8daf5a3a0b79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5c3a87b6-0e87-4637-b04f-fa236cf847e8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1cf458a9-2a63-4cf4-a66f-473a9a5189b5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_4580c1fe-e5fe-4401-a570-c3ce1fe8c7f4_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db507fa4-bbc8-4afd-872f-3b7235738def_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_0e925ced-d626-449d-8cd8-e70e388806b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_b846f3dd-ed06-4445-8d07-b7d1049b87c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ceff404f-a0a5-4e16-8df5-43ed15566761_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_9c043a1a-790b-4d57-8e2f-1e122f620a66_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_88f6514f-e133-4efe-9caa-f7739566e078_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_d012e950-66a6-4d81-a4ea-1245f190c90f_terseLabel_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_label_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_documentation_en-US" xlink:label="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:href="cvs-20210630.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:to="lab_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_8ac95549-22a1-4292-91a0-11a969b93971_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eef96991-0cfa-4e35-b994-640056b27b06_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_659bdf96-eef8-4996-abd4-cf8dca20bdcc_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_57b16578-487a-4bf5-ac90-da6e89ff0295_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e28ab3c4-a280-4cd3-b939-b15d4d480477_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_c99fee97-de29-49b0-b24d-8750114b76c5_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_81dbd671-957d-43bf-8207-6aa8684701aa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_9c4b6533-0456-45f1-be94-3604fc28fc59_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_76180f48-55fd-41ea-95ce-eb97b55ac841_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_31723f1d-3fac-4ce0-a5c5-48f5bdac7630_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_f14eef03-3675-46d6-a710-32ab8e1f9600_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_91bc35d8-662c-4493-bbc8-2f9b416f5d64_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_d4db25c2-6bf2-4866-9d10-702d6da249fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_c153e88a-dbf5-4631-bc69-f5144f28933b_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_label_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:label id="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_documentation_en-US" xlink:label="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer Liability Redemption and Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:href="cvs-20210630.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:to="lab_cvs_ContractwithCustomerLiabilityRedemptionandBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_949d4472-b5f6-4f7e-b627-a70bf0c27848_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20210630.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_d6fe6b1c-f654-4f1b-946e-21ac71911ed5_terseLabel_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_label_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al [Member]</link:label>
    <link:label id="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_documentation_en-US" xlink:label="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliffe and Flaim v. Aetna Inc., et al</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:href="cvs-20210630.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:to="lab_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a044e6db-f171-4f93-a32e-467d213aa82b_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_cbcfc08c-195b-4cfc-bf29-16569e2e9759_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f84fbe24-c64f-40fb-ac4c-4f2e22ec36a5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_725ad710-afa1-4075-b3c5-a628f2cdc1fe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 424 shares at June&#160;30, 2021 and 423 shares at December&#160;31,&#160;2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_dc807977-8b30-435d-9c53-4c78d7cf5998_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8528305e-0e11-478d-8ab7-fc355b5b881d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2b86f43d-ca5d-4301-96bb-ae3ec4e99f4d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_31d43093-100a-4341-af57-f67b06dd1da2_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts liabilities with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20210630.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c7f68b0d-4729-4139-bb9d-984e610b2fcc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_27bc626f-203e-4062-947b-c2d749d7b998_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_42bcb31c-849a-4732-bc0c-f18e3745bf79_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20210630.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_3669d15e-fb97-4431-ba4d-9f6fca496981_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_162801de-2fa2-49bd-b23e-1f0bcbfae6df_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_57e3fcad-2d8d-44dc-8d4b-9b20620934b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_2d2b4ee7-7879-472b-8215-76c9f698e3f9_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8303659f-e7db-4bdb-b0c7-6b6f70720130_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_83111b7a-07f4-41e5-a0f3-0d53db6f2e7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_2ea0c8b7-5f69-48dc-beec-ea34feff7e64_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_b2ca6cc0-6fb5-47f5-ad39-8fcf665a4a99_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20210630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f3cffc3e-ef67-4af0-bc20-2c1c4fb07438_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_3e33830f-bb45-4a7f-bae2-672070f010ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_281cb16a-d24a-495f-9106-31789dfd0c65_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_e8b8d7ac-3718-4d22-a599-492f36ec7cac_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_3c0afb6e-1ccb-43ff-91fc-aca6a02d5317_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_e53deb4c-d476-4018-965d-2084cf0eda9f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b13d2398-138d-4369-8d89-26e200d51f86_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_da3c73af-06ea-4917-b98d-dafa38dd0d3a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_f15a3d4f-e687-4ced-9795-cc22124e9b4f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_5db6d219-34d4-445a-aa50-ec7d93c022da_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_27fcb2d0-c538-4194-a94d-abb754034293_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_21c27fbe-3202-4295-99c2-81dd32bcb34c_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury share held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_17359366-a6ca-4ddc-b2e9-812f7db9636d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_a55355e1-cfd8-4ae3-8593-18396f39502f_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_fd8a7ea5-9be8-4d73-88bd-0f29d81296f4_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_06eaf5f2-5939-402e-9d3d-719c02fe6369_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Copayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20210630.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_6a72ea1a-0ab4-4f68-afa9-92a9c52f6615_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_9dc1ea36-03d7-464d-8e4b-a484052f0d3c_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20210630.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_b34bddf0-ab9b-4a64-b64e-40fb3cb3e57f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_c531e2b4-13f8-4f05-abc8-de7de6c338d4_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_e1f9fbd6-6ba9-4a54-a35c-9954547b64a9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9ce30e0d-d6c5-44c8-a63c-521bbfa742c3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4ab1e16e-4ac9-4b0a-b2db-e2d07475fe57_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_867f9087-0c62-4e4c-a47e-118008b157bb_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_67f0d6c1-f799-4f4e-98c6-fb7ab2eefd0f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_10859e1a-a7bf-405e-802e-b829e7e6000c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_f40aeffc-37bd-4811-8ee1-df6631a2c271_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_67d7c2e8-09b9-4386-b4fd-c188e3e28393_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_81d6c60b-ef11-4ebb-8777-5a95f9e4709b_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_563f1773-f700-43e3-b537-ecd6e0410008_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_6a5c998f-7f02-49bb-94de-0cb0031758f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_9160a880-7d98-48e5-bd1d-44de27b815f8_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_64a69d96-eb59-46df-8409-30cef36331fd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to CVS Health:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_1ecdff9e-580b-4376-80a6-ec3aed1eba4a_verboseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_27e8199d-5ec1-4858-aada-3590ffecf132_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_e8405735-6594-4c53-8315-0d6bb1a4e743_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_fe224009-10b8-457a-a838-6a33652ac3b8_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_66fb923e-4fc1-4a17-9ddf-b2dc452b06e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_5713c6ff-fbc3-437a-8ba3-3b6b7f0d654a_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_66912614-3f8a-4aea-ba7e-58464978c433_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_1e14948b-16f5-42ed-9e97-0fb3be02c568_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_cc888a4e-08f8-451e-860c-a070afdb7b4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_3f711c35-cb13-493a-8e33-da483020dfb4_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_c4e0d5a9-2b09-4b2c-bb2a-04c6693391c9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_b6ce3fc2-c13b-4523-b438-f308a33027d5_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:href="cvs-20210630.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8f9504e1-9984-4f30-89d0-e255cfe55984_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_7206e832-5a81-411e-85ac-2cb1104f203a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_59699faa-fe12-44da-a434-b702cd19240d_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_74702b44-df1e-43df-ad3c-e97720df9e85_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20210630.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8d26c7c9-8487-4dbc-9e08-8a2c9ec1d2fd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_894c2964-368d-480b-a8ca-c7769a08ef20_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_276575c7-d93d-46f7-8df2-2637bc481685_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20210630.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_4dfcb90c-ee2e-4669-81ea-40abd1998d0b_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_76df2740-dcce-49f0-b2d8-96d4040646c0_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4c31ea6d-db82-40d6-a7fe-dd0b941736bd_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_2ce1b13f-9b95-4d73-a237-133448f464de_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6350a952-e2d7-4cef-999d-5fb7aac7ef19_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_6eee3ae4-3b1c-41e2-b70f-163db9f8a2ff_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_4bcc849e-1970-45ad-b0b2-7d46d315170b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd57992e-8fec-45a0-bb3d-f8bcff45d1f2_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f89fb9ea-3f45-4233-860b-69186e6d94ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7642c684-f84d-44ba-a0bf-c194b1734f02_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2318a721-9e6e-46d0-ad2f-cbbb5f50e8d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a16ec9f2-872f-4229-9434-c1581cbf4bb6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses recorded</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bc405b47-c2cc-4da5-a653-8662cb564361_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_9c323410-d11e-40b9-a1f6-aa078a960b78_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4c7cbcf1-4c3f-4ec5-a7c5-02661fc78b3a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c2f4a199-81fa-4c98-8cb8-ea80fe515b16_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_1fe2b3fb-cc71-4e12-9425-9df6e065c74c_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_74a89d69-5e79-4b9c-902b-42c6fbb4d2e2_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of the period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_276248a3-3a54-44c8-b51c-786ee1a3ba04_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_15baa5bd-7117-4679-bfe4-03a9741a028a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_ea9ce310-5c60-407c-82bf-1504a6a94752_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Balances</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b0bb7d65-b8db-4ca0-be03-ef35dc9a2a5e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8abc1e0-e9e4-4f66-802c-7c8efea4ed71_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2eda503b-77e2-4d96-ba97-201ecfc8b065_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_43a7f4c2-b81b-4de4-8884-ebcad7b2052c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1b80b6c-42f3-4ab1-abd5-19245b634dbd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive Income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d6811999-5e26-4069-951a-3743133c5862_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_ed2c7094-ff98-4e78-85ab-a2f559133fe4_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_dd9d3ac4-56e7-42cf-bf04-d5ff2e2c5467_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_536d0526-7ddf-4d94-bf67-0f879880c556_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1ac3fdf4-713c-4476-85e4-723aa079842e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_062e95db-785e-46d5-9be0-19076e58961d_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_2646b0fb-d744-45d8-a659-897bb7afc346_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_80b53295-99e5-4e7e-acc4-9f4ba87780c2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_98475e55-727e-4f37-94ce-c3e926cfe220_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5b482e46-2951-464c-a0df-164fed917ba0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_602f28dc-5398-482f-91ec-7df162f9d3ad_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_814a56e5-e5df-4b4f-9182-b66b8e9f3ecd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7676502c-03f9-4e3a-9ca3-e761500b45f4_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Earnings to Net Income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_58a10445-db2e-4b5c-af00-bc171b9ba02d_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_16f01f64-aca8-4f50-a2ab-41c16bda8a0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_35328acf-c582-4a01-b8b3-899caaa44175_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_6978b831-dd94-4eda-905d-163996f525c0_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20210630.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_ff981836-940f-4f9d-b96d-b8a44e7fadfe_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Mortgage Loan Portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20210630.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_aeb5c626-3bd5-4c26-843a-70e766c6eb2a_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f2b4d58e-78ac-46b4-9c40-b67c5368efd2_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b58f4cff-0847-4928-91f2-23c6d848d220_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fca69cea-3a39-44d9-9e6f-58c97e7598fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_8c9c612f-5d80-4a4f-9e16-d09017b0876f_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_4fa36837-6df0-472a-8692-238b82ce1227_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_2273bc1e-e810-46db-a979-7df8282fa421_terseLabel_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk in medical clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics" xlink:href="cvs-20210630.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofWalkInMedicalClinics" xlink:to="lab_cvs_NumberofWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_ed9232d2-6980-4851-8819-189fff833911_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_6427ac69-ade5-4171-9e26-4b6fb3ce8a0b_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_10defdb2-ad72-455b-8483-c50bd06b4932_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_f32a19cf-47f8-4e83-b6c7-89ca9d166fc0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_02ad1dd8-b933-4951-a272-6233fb11d9e2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_edc7bccb-9ccb-4e99-93b0-39c318626969_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20210630.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_ce86bc37-edf0-4a7b-99e8-a98a7013999e_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_538b9f86-cdf9-48d3-bc5e-e5e25cab3569_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_fe060714-26d4-4ce3-85d8-13e6cf1af63e_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Total Investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0570704e-ae8f-4a44-97f2-a5e1f35e71d2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_d58d0d7a-39a2-4e57-bf8f-d4c31c8d933e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_18f95d23-252e-49ea-b33c-ad9d772b6f58_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_1ff687a7-4192-4da4-a160-698ca6826836_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_2e2b82f6-bc17-4e6a-8a5c-ff3a80de6d03_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_477ff369-732b-4bdc-b259-9d436a7bca84_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_a4343573-8124-4ab4-b2f7-2f453737755f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_c4fe85f1-6906-41f3-9bf3-b559311ee6a8_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_f7bb5daf-0836-4baf-afc1-9be7816dbde8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_4d7be295-a73a-4f51-a64a-4075e4568cb7_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20210630.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_beb81974-9545-46ac-88f4-219b4caf960a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_ac043fae-6961-4cf2-894e-7fca14e68cba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_5a4cabe9-106a-4d24-8ae3-685bc01a9a4b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_0fc776a6-245f-45a3-93c7-52c0e1a1d629_terseLabel_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember" xlink:href="cvs-20210630.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2016RepurchaseProgramMember" xlink:to="lab_cvs_A2016RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_4b8afd6a-ebd0-45d2-9fe2-de023003c7cd_negatedTerseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition purchase price adjustment outside of measurement period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20210630.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b2135991-f167-45a9-8348-b60487eb4ecf_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_4c73a954-3ae0-43d5-84b4-0e3b5a6d1e3a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_5b44e329-7d2a-4522-938b-01aed932bea1_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_275483ba-e285-4d1e-bba6-6e14ebf42760_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_b82dc579-36b8-43de-8efd-6b9c3ca815ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_4f104cad-9889-476b-bf25-a72122571b92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_bd8307c6-2af1-4adc-839c-673da089be82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_60e40e21-8416-4456-8bb8-600bea6fcaf6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_f57485af-2687-49de-86bb-92dde14d831c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>cvs-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:efef91c4-b90c-4f53-8e18-716aea49f04e,g:46f154a9-1618-4e84-a3da-cd42ade064f2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20210630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_86f8f761-42ce-4aa7-be4b-a41958dd45b1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_DocumentType_86f8f761-42ce-4aa7-be4b-a41958dd45b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_07bea79b-474b-44ee-9526-f52f0369cfbf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_DocumentQuarterlyReport_07bea79b-474b-44ee-9526-f52f0369cfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7487c409-a2ec-41aa-8bb4-7a77b0e0087e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_DocumentPeriodEndDate_7487c409-a2ec-41aa-8bb4-7a77b0e0087e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_826b44d3-bc92-443b-8570-63c7775ec57c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_DocumentTransitionReport_826b44d3-bc92-443b-8570-63c7775ec57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_35e9203b-c8e8-44eb-adb2-3b44a8f0618f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityFileNumber_35e9203b-c8e8-44eb-adb2-3b44a8f0618f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bd20ff37-e584-49ce-9568-f2e1808f774b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityRegistrantName_bd20ff37-e584-49ce-9568-f2e1808f774b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_50e534f7-ac42-4f80-a905-2de13250676a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityIncorporationStateCountryCode_50e534f7-ac42-4f80-a905-2de13250676a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c7d90fae-e073-46d5-8ef0-db5f5b341d1a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityTaxIdentificationNumber_c7d90fae-e073-46d5-8ef0-db5f5b341d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6bce38d3-ea47-4024-b4b6-aedc7f9064e9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityAddressAddressLine1_6bce38d3-ea47-4024-b4b6-aedc7f9064e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a3a65f28-9ae9-488b-a585-58be5f504f04" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityAddressCityOrTown_a3a65f28-9ae9-488b-a585-58be5f504f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c3b22acf-c810-4324-9436-a3bc8f908593" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityAddressStateOrProvince_c3b22acf-c810-4324-9436-a3bc8f908593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_49efb8b5-96a6-48f4-8e1a-e488295706b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityAddressPostalZipCode_49efb8b5-96a6-48f4-8e1a-e488295706b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_277325e2-23fb-462d-97e8-fc77e43bd67b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_CityAreaCode_277325e2-23fb-462d-97e8-fc77e43bd67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0e74eb81-f4a9-42ad-b429-19e5f127688b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_LocalPhoneNumber_0e74eb81-f4a9-42ad-b429-19e5f127688b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8e5dffe1-482f-40b5-8ad3-3164b1076a6f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_Security12bTitle_8e5dffe1-482f-40b5-8ad3-3164b1076a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_121f3866-4136-4dbf-8e2b-6ea134efc90d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_TradingSymbol_121f3866-4136-4dbf-8e2b-6ea134efc90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0e07f659-a1ad-464f-b703-0bb95325e27e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_SecurityExchangeName_0e07f659-a1ad-464f-b703-0bb95325e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8340a941-1629-4b3f-b274-6311c6e25fa7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityCurrentReportingStatus_8340a941-1629-4b3f-b274-6311c6e25fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9bc6c890-69ca-4ae5-9f33-6a8b3194b5da" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityInteractiveDataCurrent_9bc6c890-69ca-4ae5-9f33-6a8b3194b5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_04ad092c-7450-4c76-8f53-373e418e00d5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityFilerCategory_04ad092c-7450-4c76-8f53-373e418e00d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6dc64a50-fffe-4bc6-9617-dc1c0e3901c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntitySmallBusiness_6dc64a50-fffe-4bc6-9617-dc1c0e3901c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ffa60fea-b0d7-4fbe-ab2e-6d0aa0c49237" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityEmergingGrowthCompany_ffa60fea-b0d7-4fbe-ab2e-6d0aa0c49237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b888c75e-1453-47d7-a215-47978f0eac3e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityShellCompany_b888c75e-1453-47d7-a215-47978f0eac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_7eb63fd6-f402-4ac5-b4f5-81c23a1201fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_7eb63fd6-f402-4ac5-b4f5-81c23a1201fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_68b415e7-af3b-4aec-84c8-c714af85f276" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_EntityCentralIndexKey_68b415e7-af3b-4aec-84c8-c714af85f276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f6659c29-a710-46a9-805f-78a5620311dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_CurrentFiscalYearEndDate_f6659c29-a710-46a9-805f-78a5620311dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f76ae57a-ae7c-4a0a-9203-293de988e955" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_DocumentFiscalYearFocus_f76ae57a-ae7c-4a0a-9203-293de988e955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f45005ef-86ce-4c05-9735-81bb12ebda2b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f45005ef-86ce-4c05-9735-81bb12ebda2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9588fddf-46a4-46d9-a02b-2067f4fc59aa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_a650f6d5-5a02-4b38-a40b-0ecc64185049" xlink:to="loc_dei_AmendmentFlag_9588fddf-46a4-46d9-a02b-2067f4fc59aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofOperationsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5261d1cf-767a-45a5-85bb-af210e2f3b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5261d1cf-767a-45a5-85bb-af210e2f3b7a" xlink:to="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:to="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_47695ee3-dea4-4282-86c8-057451778909" xlink:to="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_db89871c-802c-431c-8ef5-6743ba0637f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:to="loc_us-gaap_ProductMember_db89871c-802c-431c-8ef5-6743ba0637f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_f9d54699-0ece-48c8-a56f-118014cdf1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0f734d62-af47-437c-b200-321bada31dcc" xlink:to="loc_us-gaap_ServiceMember_f9d54699-0ece-48c8-a56f-118014cdf1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a0e22ab7-aae9-4dd1-89df-3e5bafab542d" xlink:to="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_acd0e4ce-0ccc-4dce-99e1-7dc4ed637ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_acd0e4ce-0ccc-4dce-99e1-7dc4ed637ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5594645e-b041-4395-97e7-309af67475d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_PremiumsEarnedNet_5594645e-b041-4395-97e7-309af67475d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_29641e5b-3565-4a86-9a99-a00c65541736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_NetInvestmentIncome_29641e5b-3565-4a86-9a99-a00c65541736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2f55e13e-188e-4cca-89fd-f0f779fb1972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_893440d1-1be3-4b8b-b48c-9fdeb2b455b5" xlink:to="loc_us-gaap_Revenues_2f55e13e-188e-4cca-89fd-f0f779fb1972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BenefitsLossesAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9864a27c-79d8-4354-8138-cc6a169f0f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9864a27c-79d8-4354-8138-cc6a169f0f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_16807ab6-a056-40f2-965a-319a6a97d90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_16807ab6-a056-40f2-965a-319a6a97d90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_7cba20da-021b-43c1-9e22-777fe6422fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_7cba20da-021b-43c1-9e22-777fe6422fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0bc951f9-0e2c-44c4-b04e-5f3759e7b70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_OperatingExpenses_0bc951f9-0e2c-44c4-b04e-5f3759e7b70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d5645117-42dd-4180-9c33-92092d89bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BenefitsLossesAndExpensesAbstract_48f5e9cb-38a1-40df-94c9-39cedf949b1a" xlink:to="loc_us-gaap_CostsAndExpenses_d5645117-42dd-4180-9c33-92092d89bfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1bd502a4-319c-45e5-909f-058d8caed863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_OperatingIncomeLoss_1bd502a4-319c-45e5-909f-058d8caed863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b9afc15e-e8ef-4808-a7a2-d29dc5a6530b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_InterestExpense_b9afc15e-e8ef-4808-a7a2-d29dc5a6530b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8edcfd63-02dc-4ba4-a637-68d9345162b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8edcfd63-02dc-4ba4-a637-68d9345162b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15b53ecd-aa84-487c-96d4-361bac8c9dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_15b53ecd-aa84-487c-96d4-361bac8c9dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0d0525e0-8b06-4451-b86b-e99e23a41474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0d0525e0-8b06-4451-b86b-e99e23a41474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_59590cc6-27d2-403a-b4dd-8d647e4f47ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_ProfitLoss_59590cc6-27d2-403a-b4dd-8d647e4f47ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_61c0d7b4-2e75-445e-94aa-1020381e0c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_61c0d7b4-2e75-445e-94aa-1020381e0c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b1869a85-dc84-41ef-9129-f312589ff65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_NetIncomeLoss_b1869a85-dc84-41ef-9129-f312589ff65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2228c6a5-9b71-4d8a-9150-a088a0eb2fde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:to="loc_us-gaap_EarningsPerShareBasic_2228c6a5-9b71-4d8a-9150-a088a0eb2fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_41c3b335-e63b-49bf-a398-861e503e4f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_52bd5f01-94ef-45b4-aed5-5d4d14bc4dd9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_41c3b335-e63b-49bf-a398-861e503e4f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4eda2a92-bc64-4aad-8274-eea887666cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4eda2a92-bc64-4aad-8274-eea887666cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b8bcfd5-c1d1-4025-8ee3-d1effa8789f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_eaf6279f-dd27-4f13-ac3d-622faf37e7f8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7b8bcfd5-c1d1-4025-8ee3-d1effa8789f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_8935cca2-d095-4c60-8efd-a1f41feb9c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a783a62f-90d4-4cf7-aae8-26b0d56c99ec" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_8935cca2-d095-4c60-8efd-a1f41feb9c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7855455c-4fd1-4b41-b1e8-fe553bbd0ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_23ea2c02-a655-4fc0-91ab-51f4b6ea19e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7855455c-4fd1-4b41-b1e8-fe553bbd0ccb" xlink:to="loc_us-gaap_ProfitLoss_23ea2c02-a655-4fc0-91ab-51f4b6ea19e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7855455c-4fd1-4b41-b1e8-fe553bbd0ccb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_7cc221eb-6c50-4ab9-9451-025b17c28e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_7cc221eb-6c50-4ab9-9451-025b17c28e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_30c94672-9691-479d-b065-09d478796c80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_30c94672-9691-479d-b065-09d478796c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_eadb410f-f81b-4ce3-ba81-d4c5f14cc82d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_eadb410f-f81b-4ce3-ba81-d4c5f14cc82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_05b3b4c1-db9d-4244-9587-dc8a67588957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_05b3b4c1-db9d-4244-9587-dc8a67588957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ed408d93-7a6d-4a9b-a4b8-e1be477b4f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_567f0170-8d71-40fc-a013-de89b0a14e50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ed408d93-7a6d-4a9b-a4b8-e1be477b4f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ed2a172-ea3a-43fb-b068-2dbaca021a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7855455c-4fd1-4b41-b1e8-fe553bbd0ccb" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3ed2a172-ea3a-43fb-b068-2dbaca021a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8176ad3d-0e57-4d85-bd51-cf711af7cac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7855455c-4fd1-4b41-b1e8-fe553bbd0ccb" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8176ad3d-0e57-4d85-bd51-cf711af7cac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_97cc6fcb-f57e-431d-8f3d-cd1eb4b29381" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7855455c-4fd1-4b41-b1e8-fe553bbd0ccb" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_97cc6fcb-f57e-431d-8f3d-cd1eb4b29381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:to="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1af6aeb8-b6e6-4093-9a02-c1b7cfffc004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1af6aeb8-b6e6-4093-9a02-c1b7cfffc004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_ccf6fbef-e52d-42f1-92a7-05fb1cf3b1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_ShortTermInvestments_ccf6fbef-e52d-42f1-92a7-05fb1cf3b1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_034b4b46-83df-4fb8-bf40-2581961aadb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_034b4b46-83df-4fb8-bf40-2581961aadb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_31cf2975-787c-4ff9-9fea-f1cbf0f31e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_InventoryNet_31cf2975-787c-4ff9-9fea-f1cbf0f31e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_dd10c6b8-7e6f-4bc8-b2cc-aba459de90db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_OtherAssetsCurrent_dd10c6b8-7e6f-4bc8-b2cc-aba459de90db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ac642f50-87cc-425b-ad36-543949631275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_AssetsCurrent_ac642f50-87cc-425b-ad36-543949631275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_353c7005-c6a4-43dd-bb0d-769c5a7a3987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_LongTermInvestments_353c7005-c6a4-43dd-bb0d-769c5a7a3987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7bfd06dc-775d-4ea1-a5f4-f602f5969393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7bfd06dc-775d-4ea1-a5f4-f602f5969393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2b274f7f-a7d7-4022-ad22-cf68a99c74db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2b274f7f-a7d7-4022-ad22-cf68a99c74db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2eab9d1e-d878-4288-8f22-04f07390a736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_Goodwill_2eab9d1e-d878-4288-8f22-04f07390a736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d6c098bf-acb2-4af6-862c-59e5c793db87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d6c098bf-acb2-4af6-862c-59e5c793db87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_718c2300-e8d8-4666-a5be-0a9c387e9113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_SeparateAccountAssets_718c2300-e8d8-4666-a5be-0a9c387e9113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0f8fe6c6-8fb5-4f8d-8366-ba8d7e8a8703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0f8fe6c6-8fb5-4f8d-8366-ba8d7e8a8703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8a39d44c-c6fa-4545-94c1-c9c8ecaf3e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5edc3f08-b1b9-4f22-9ec2-20f53d086902" xlink:to="loc_us-gaap_Assets_8a39d44c-c6fa-4545-94c1-c9c8ecaf3e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:to="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_9b2f50d9-e2d3-4ede-9439-fca9319ba56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_9b2f50d9-e2d3-4ede-9439-fca9319ba56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_340ccb5d-cfe2-40c9-b231-daa0608e85b7" xlink:href="cvs-20210630.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_340ccb5d-cfe2-40c9-b231-daa0608e85b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_fd799e7b-41a5-4067-9d20-3c40b79f3034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_fd799e7b-41a5-4067-9d20-3c40b79f3034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_74f2e98c-3434-4c40-899d-4a851dfc5d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_OtherPolicyholderFunds_74f2e98c-3434-4c40-899d-4a851dfc5d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8bd6d73b-0521-40cd-ae74-b21a8e246fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8bd6d73b-0521-40cd-ae74-b21a8e246fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_9144049d-2b6d-4040-84bf-cb218c64f03d" xlink:href="cvs-20210630.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_9144049d-2b6d-4040-84bf-cb218c64f03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a7cb71b9-93a4-4037-875c-585706123650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a7cb71b9-93a4-4037-875c-585706123650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d1bfa5de-5cae-4e9f-bd48-3b8c001abb29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d1bfa5de-5cae-4e9f-bd48-3b8c001abb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f9efe69f-3254-441f-b556-6c4608e2085d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_LiabilitiesCurrent_f9efe69f-3254-441f-b556-6c4608e2085d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fc8aa1fa-282d-4502-ab8f-e89dd96cec2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fc8aa1fa-282d-4502-ab8f-e89dd96cec2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0e305ca6-06ad-4149-91ed-59611d89aada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0e305ca6-06ad-4149-91ed-59611d89aada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_987c0fd8-a1ca-48f3-a135-8ba26b2d765e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_987c0fd8-a1ca-48f3-a135-8ba26b2d765e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_25b0a626-30e9-471f-9210-eb75f0dc198d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_SeparateAccountsLiability_25b0a626-30e9-471f-9210-eb75f0dc198d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_db5e6f7b-34f8-4f18-bac8-2c647ddff1a4" xlink:href="cvs-20210630.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_db5e6f7b-34f8-4f18-bac8-2c647ddff1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0c4897ce-f467-4544-839c-1383678a254c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0c4897ce-f467-4544-839c-1383678a254c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_35336bab-e85d-4e65-b623-90834ff6e2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_28b51bc0-c269-42ad-aeb5-9507b10d549a" xlink:to="loc_us-gaap_Liabilities_35336bab-e85d-4e65-b623-90834ff6e2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a9ad85eb-0b1d-4289-a604-4e787a8dcb0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:to="loc_us-gaap_PreferredStockValue_a9ad85eb-0b1d-4289-a604-4e787a8dcb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8b385c80-4566-451a-90ce-7d907950acda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8b385c80-4566-451a-90ce-7d907950acda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_49624122-178f-4cd0-9b47-dd49716ebfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:to="loc_us-gaap_TreasuryStockValue_49624122-178f-4cd0-9b47-dd49716ebfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c3f1f73-120d-44cf-95e1-1f1621d18c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4c3f1f73-120d-44cf-95e1-1f1621d18c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_98f780d5-02fd-47cd-a6ee-e7f06d0a28c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_98f780d5-02fd-47cd-a6ee-e7f06d0a28c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a7d5c9ca-be2a-4408-beec-8f5f5e06516a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_899f59ed-73d6-4259-9a97-07da607408cc" xlink:to="loc_us-gaap_StockholdersEquity_a7d5c9ca-be2a-4408-beec-8f5f5e06516a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b0c7e931-49d5-47af-83a4-1f52659f10dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:to="loc_us-gaap_MinorityInterest_b0c7e931-49d5-47af-83a4-1f52659f10dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_177bdd3a-b007-48ad-8b7c-2f3000d3e01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_177bdd3a-b007-48ad-8b7c-2f3000d3e01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_aab7bc3d-7fe1-4a2d-8062-dd3f9ae6413c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_364ba238-1337-40e0-80f3-dbef5f62ec6a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_aab7bc3d-7fe1-4a2d-8062-dd3f9ae6413c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d77c7fbb-f3cb-407c-9012-178ea1f96158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d77c7fbb-f3cb-407c-9012-178ea1f96158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_255eead2-a5cb-4a7f-9334-5c2e382ed54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_255eead2-a5cb-4a7f-9334-5c2e382ed54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_6ed5e00f-a895-4551-89bf-6488db8453aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_PreferredStockSharesIssued_6ed5e00f-a895-4551-89bf-6488db8453aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5863b618-eec6-416b-b320-ebdbf0a90433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5863b618-eec6-416b-b320-ebdbf0a90433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_99605614-dfde-4bc2-8101-396757342cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_99605614-dfde-4bc2-8101-396757342cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_04d11760-2ad0-4055-85e6-1cba7fd36c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_04d11760-2ad0-4055-85e6-1cba7fd36c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_0507e436-5b1d-4ea1-85d5-20f9e4f75931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_CommonStockSharesIssued_0507e436-5b1d-4ea1-85d5-20f9e4f75931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8cd503e4-0d1b-4850-be15-7bb05628bd01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8cd503e4-0d1b-4850-be15-7bb05628bd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_9a0c6c7f-aa39-4763-a1a3-c39829a7166a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_62df8f6d-ff47-41cb-ac61-d2cb4fa58432" xlink:to="loc_us-gaap_TreasuryStockShares_9a0c6c7f-aa39-4763-a1a3-c39829a7166a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_8a2f09df-c707-40f9-8156-75ddb6abd79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_us-gaap_ProceedsFromCustomers_8a2f09df-c707-40f9-8156-75ddb6abd79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_2f5731da-c67c-4312-b7c6-f31f0344d0d5" xlink:href="cvs-20210630.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_2f5731da-c67c-4312-b7c6-f31f0344d0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_7345cc87-c629-4f9c-9173-167044bc5852" xlink:href="cvs-20210630.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_7345cc87-c629-4f9c-9173-167044bc5852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_90f2715b-2043-479f-afdb-43211689e0df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_90f2715b-2043-479f-afdb-43211689e0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_8670849f-8dac-4784-a1ab-3c2b3904fe91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_8670849f-8dac-4784-a1ab-3c2b3904fe91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_4a002be6-ce94-450c-befb-b57b4657e710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_us-gaap_InterestPaidNet_4a002be6-ce94-450c-befb-b57b4657e710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_7ccbbddf-3070-4e91-a19c-bb9446cdf702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_7ccbbddf-3070-4e91-a19c-bb9446cdf702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06bdb3c6-37c4-4840-ac2b-646a49a1f0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51b02367-30dd-432b-b065-ac528cd6c3d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_06bdb3c6-37c4-4840-ac2b-646a49a1f0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f0dc0e4e-f324-4f3f-8976-a1b4cb3e4941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f0dc0e4e-f324-4f3f-8976-a1b4cb3e4941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_7ae62600-afa0-4916-be66-59316cb8a692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_7ae62600-afa0-4916-be66-59316cb8a692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4daafa53-e0b4-4e3e-95d0-79ec6c8893fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4daafa53-e0b4-4e3e-95d0-79ec6c8893fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3da8cbcc-a241-4138-8906-aedd14a99e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3da8cbcc-a241-4138-8906-aedd14a99e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_65e237a3-8a23-41ba-9c44-9bcfd5c29af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_65e237a3-8a23-41ba-9c44-9bcfd5c29af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_872e5743-5363-4d17-8c0c-bcee2305c80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e8d6b2a7-171a-419d-9486-1d8517b02add" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_872e5743-5363-4d17-8c0c-bcee2305c80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_69da37a9-cfbd-4780-bc5f-c9daa4577968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_69da37a9-cfbd-4780-bc5f-c9daa4577968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_62f878ed-49b8-4868-b382-e8551f688f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_62f878ed-49b8-4868-b382-e8551f688f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f38492fb-fc03-4b93-b0e6-96486ce0a1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_PaymentsOfDividends_f38492fb-fc03-4b93-b0e6-96486ce0a1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b8e47fb3-8ee2-4379-bd42-2b38f1501b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b8e47fb3-8ee2-4379-bd42-2b38f1501b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_378f1bb2-47b6-40b2-b71c-5b8d9ab7edb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_378f1bb2-47b6-40b2-b71c-5b8d9ab7edb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_24780aa0-5e0c-498d-8526-2bbda42fb745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_24780aa0-5e0c-498d-8526-2bbda42fb745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8aa9dfd6-7ddf-406d-9018-07253fb5e89a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0c0bc4f4-519e-4c30-b2bc-5cbaa3b56eff" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8aa9dfd6-7ddf-406d-9018-07253fb5e89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0c0c1d8e-ad8a-4b6b-92e7-31a5119e6a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0c0c1d8e-ad8a-4b6b-92e7-31a5119e6a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f51dc094-7c2d-441a-9bb9-22c556fc7520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f51dc094-7c2d-441a-9bb9-22c556fc7520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_475717c7-59d1-4682-8425-d35dabc9f609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_475717c7-59d1-4682-8425-d35dabc9f609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_caae4549-0c04-4232-8f50-501292a4111d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_517c7b98-9687-40cc-95e0-e6e72d231bd2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_caae4549-0c04-4232-8f50-501292a4111d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a53d227d-ac4e-4b8d-be31-11b69ebe027e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_caae4549-0c04-4232-8f50-501292a4111d" xlink:to="loc_us-gaap_ProfitLoss_a53d227d-ac4e-4b8d-be31-11b69ebe027e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_5d467762-f25c-46fb-a9f7-bd83020c8108" xlink:href="cvs-20210630.xsd#cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_caae4549-0c04-4232-8f50-501292a4111d" xlink:to="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_5d467762-f25c-46fb-a9f7-bd83020c8108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_84382dab-fb8f-454a-b622-bd0b445c63e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_5d467762-f25c-46fb-a9f7-bd83020c8108" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_84382dab-fb8f-454a-b622-bd0b445c63e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9f83c428-ebb8-4d73-be80-fc10b4b0a8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_5d467762-f25c-46fb-a9f7-bd83020c8108" xlink:to="loc_us-gaap_ShareBasedCompensation_9f83c428-ebb8-4d73-be80-fc10b4b0a8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Deferredincometaxesandothernoncashitems_3cdbb477-bd05-4288-9199-4549452bb028" xlink:href="cvs-20210630.xsd#cvs_Deferredincometaxesandothernoncashitems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_5d467762-f25c-46fb-a9f7-bd83020c8108" xlink:to="loc_cvs_Deferredincometaxesandothernoncashitems_3cdbb477-bd05-4288-9199-4549452bb028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:href="cvs-20210630.xsd#cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract_5d467762-f25c-46fb-a9f7-bd83020c8108" xlink:to="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b170559a-d5e9-41d7-ac70-f4c9b73eef26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b170559a-d5e9-41d7-ac70-f4c9b73eef26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f547ce82-6beb-407d-aa92-8d15f64b530b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f547ce82-6beb-407d-aa92-8d15f64b530b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3d95bcf0-e8ce-4df7-a0e5-f9569bf90905" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3d95bcf0-e8ce-4df7-a0e5-f9569bf90905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cfa6c84b-7038-4018-bb4d-9cc30e248575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_cfa6c84b-7038-4018-bb4d-9cc30e248575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ecb4c7e5-f380-4dda-93c1-2dfb9433831a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_ecb4c7e5-f380-4dda-93c1-2dfb9433831a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_87af6738-2d8f-425d-bcd1-a4f263de9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_87af6738-2d8f-425d-bcd1-a4f263de9bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2502769-b926-47a9-a8cd-5e17a549d5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract_03d884bf-1b18-422a-a9b0-9026862ccee6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2502769-b926-47a9-a8cd-5e17a549d5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofShareholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3e12696a-aab8-407b-a9a6-e45d6152cd17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3e12696a-aab8-407b-a9a6-e45d6152cd17" xlink:to="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0930a276-45c7-4b3d-898d-499755ed6485" xlink:to="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:to="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3b4ac508-c01c-4e08-b408-574e3deeabc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_CommonStockMember_3b4ac508-c01c-4e08-b408-574e3deeabc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_6d711611-3443-41b5-8e69-6f36e3798bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_TreasuryStockMember_6d711611-3443-41b5-8e69-6f36e3798bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_236894cf-f64b-4e56-a662-98b6c074602f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_236894cf-f64b-4e56-a662-98b6c074602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4df90dd1-f1e4-4c9a-9d8f-835b87132b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_RetainedEarningsMember_4df90dd1-f1e4-4c9a-9d8f-835b87132b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_45e4f26e-7bc6-4bf4-8c86-94436fea79ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d7b7e9e5-a504-4515-becb-509a1cd5f337" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_45e4f26e-7bc6-4bf4-8c86-94436fea79ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_57f646c2-54c8-405d-969b-befe4fbfc77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_aff49905-2c9d-40bb-96a3-bdd0605c6c32" xlink:to="loc_us-gaap_NoncontrollingInterestMember_57f646c2-54c8-405d-969b-befe4fbfc77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c4e0ae15-e5b1-4a67-b381-16299586a7a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_e000ab37-0260-4a65-b494-f7a9d1ab3cda" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c4e0ae15-e5b1-4a67-b381-16299586a7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_946f09f2-6828-4dc6-ae9c-39e14d9557ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c4e0ae15-e5b1-4a67-b381-16299586a7a1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_946f09f2-6828-4dc6-ae9c-39e14d9557ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2dadb22d-bc84-416b-b3e7-7a4948369b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bb6dc464-e394-46b5-a0a9-8f98837aad1a" xlink:to="loc_us-gaap_StatementLineItems_2dadb22d-bc84-416b-b3e7-7a4948369b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dadb22d-bc84-416b-b3e7-7a4948369b63" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d2580609-b16b-473f-a284-0de7d1b4293a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_SharesOutstanding_d2580609-b16b-473f-a284-0de7d1b4293a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f85ebd48-0f83-45b2-ac60-3e3018d35e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f85ebd48-0f83-45b2-ac60-3e3018d35e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_116f15ad-a5a6-4bcb-bde9-801253b804a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_ProfitLoss_116f15ad-a5a6-4bcb-bde9-801253b804a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6951fed4-f935-4f91-a08f-0eab0742fe65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6951fed4-f935-4f91-a08f-0eab0742fe65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1c89c38b-71d4-4b22-8979-a97394542c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1c89c38b-71d4-4b22-8979-a97394542c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6db84240-d084-4807-b18b-d9f8d04e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6db84240-d084-4807-b18b-d9f8d04e04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_38c246a5-37b3-47b6-b985-15e2a9ff025d" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_38c246a5-37b3-47b6-b985-15e2a9ff025d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_d888c9ca-92f4-4fc4-8bae-99a83a8cc14f" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_d888c9ca-92f4-4fc4-8bae-99a83a8cc14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_3815a119-3375-4130-85f8-bd76b653be47" xlink:href="cvs-20210630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_3815a119-3375-4130-85f8-bd76b653be47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_9e6861fe-41ba-4b12-87bc-d029b923df3d" xlink:href="cvs-20210630.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_9e6861fe-41ba-4b12-87bc-d029b923df3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_79871086-8996-4256-8bba-4890bc4f7b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_DividendsCommonStock_79871086-8996-4256-8bba-4890bc4f7b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_b25b89f2-a9ab-4024-aee3-174f3dcb1481" xlink:href="cvs-20210630.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_b25b89f2-a9ab-4024-aee3-174f3dcb1481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e5642bb0-0995-4263-97f9-d71846dba0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_SharesOutstanding_e5642bb0-0995-4263-97f9-d71846dba0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_992203c0-414c-4844-bcb4-f3ca9cd90415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_110eee88-f6b3-44cb-98ca-da945295544a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_992203c0-414c-4844-bcb4-f3ca9cd90415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20210630.xsd#CondensedConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9433863e-2ee8-4b43-9e73-a52b6fc62035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9433863e-2ee8-4b43-9e73-a52b6fc62035" xlink:to="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_cb1e221f-c497-490f-905f-d65dbf0728cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6a8a58eb-afcf-460c-a6fb-4cd49536be46" xlink:to="loc_us-gaap_TypeOfAdoptionMember_cb1e221f-c497-490f-905f-d65dbf0728cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_476d4f31-d601-420a-8614-b4f7d039d5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_cb1e221f-c497-490f-905f-d65dbf0728cb" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_476d4f31-d601-420a-8614-b4f7d039d5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a77a5c30-ed4a-4811-8f70-33d0be72aca8" xlink:to="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9533f6f7-28e2-4547-a548-1dfbc1474e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_9533f6f7-28e2-4547-a548-1dfbc1474e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_96e34940-2e51-454a-a962-1349d3b28aca" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_96e34940-2e51-454a-a962-1349d3b28aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_e0669579-fe5c-4514-9747-c51ae581e150" xlink:href="cvs-20210630.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_e0669579-fe5c-4514-9747-c51ae581e150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_09ce898c-f0f8-4760-b621-8b3794caa499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_CommonStockValue_09ce898c-f0f8-4760-b621-8b3794caa499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_518dc9bf-5e5a-46fd-88ff-ae2cbe0feca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_868f43f0-091f-49c2-a8c8-883d593887fb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_518dc9bf-5e5a-46fd-88ff-ae2cbe0feca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ca51282e-bcf0-4ced-b03a-fa449048eeda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0cfa69f4-0eac-4c94-8117-5928dddedd50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ca51282e-bcf0-4ced-b03a-fa449048eeda" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_0cfa69f4-0eac-4c94-8117-5928dddedd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4d57c995-d393-40e0-866f-fd07316ba7f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_4d57c995-d393-40e0-866f-fd07316ba7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4021505f-c6e6-47b4-8c91-795eb88a6860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4021505f-c6e6-47b4-8c91-795eb88a6860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_d8e84c97-aece-4421-b25f-7417c119057c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_d8e84c97-aece-4421-b25f-7417c119057c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_25eeaf8e-dd8f-418d-8652-0140165e6348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_25eeaf8e-dd8f-418d-8652-0140165e6348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_88fd063a-0b8f-4f67-98da-171d34a94a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_88fd063a-0b8f-4f67-98da-171d34a94a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ebf2f913-9f88-4012-abab-4e55835e50a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_ebf2f913-9f88-4012-abab-4e55835e50a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_715ae4b3-cca6-4c14-939d-74528ed883bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_715ae4b3-cca6-4c14-939d-74528ed883bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_76e0fab6-9419-459d-8e5f-8a5b56a91f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_76e0fab6-9419-459d-8e5f-8a5b56a91f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_6503279e-b82a-4c27-8909-cbd342099601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_6503279e-b82a-4c27-8909-cbd342099601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3e371c19-a99a-4b07-8c5a-8e7ceb066b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8565577-2a5e-4f18-bbe2-0bd1f4baf43f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3e371c19-a99a-4b07-8c5a-8e7ceb066b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d0fa8967-886a-4799-8d31-255e5904c7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_29dd8368-0ee8-4364-9280-10f44cb4271f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0fa8967-886a-4799-8d31-255e5904c7b5" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_29dd8368-0ee8-4364-9280-10f44cb4271f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d270e129-756c-4dda-91ba-71e84f566606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0fa8967-886a-4799-8d31-255e5904c7b5" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_d270e129-756c-4dda-91ba-71e84f566606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_375fa670-e157-445d-9b73-1251c6e745bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0fa8967-886a-4799-8d31-255e5904c7b5" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_375fa670-e157-445d-9b73-1251c6e745bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b933b73-2c05-4c35-bccf-b6e6ce405cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0fa8967-886a-4799-8d31-255e5904c7b5" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9b933b73-2c05-4c35-bccf-b6e6ce405cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0d67726b-ef67-4b64-94af-630fad952021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0d67726b-ef67-4b64-94af-630fad952021" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_01b4174e-a8f7-4133-835f-84e70dd4c63a" xlink:to="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_170e7c96-89ad-4111-a666-d6bb79cee00f" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_170e7c96-89ad-4111-a666-d6bb79cee00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_7ddb19cf-3454-41f1-92ed-21445cb1bc79" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_89ac4e6b-b105-4f18-966e-c788e86827c5" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_7ddb19cf-3454-41f1-92ed-21445cb1bc79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2da3ac9f-400f-4a7c-bfbf-6bf53069bfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e6d7615c-19dc-423b-af91-3d52838f4a3d" xlink:to="loc_us-gaap_RelatedPartyDomain_2da3ac9f-400f-4a7c-bfbf-6bf53069bfdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_b472390f-2acf-4af2-b1a4-4a60aefdf41a" xlink:href="cvs-20210630.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2da3ac9f-400f-4a7c-bfbf-6bf53069bfdf" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_b472390f-2acf-4af2-b1a4-4a60aefdf41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_8a3a99b3-e5ff-442b-986f-94b5b194f738" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_9b6b3bc5-6237-4eb2-8445-e3d6812f6b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NumberOfStores_9b6b3bc5-6237-4eb2-8445-e3d6812f6b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_547e6013-3474-4079-a947-e7ece96c2d02" xlink:href="cvs-20210630.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_547e6013-3474-4079-a947-e7ece96c2d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPharmacyPlanMembers_33cff6f6-6356-4f46-8d18-7a4d70277084" xlink:href="cvs-20210630.xsd#cvs_NumberofPharmacyPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberofPharmacyPlanMembers_33cff6f6-6356-4f46-8d18-7a4d70277084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_b9fd0f2c-00b8-4e91-b60a-815351d34fed" xlink:href="cvs-20210630.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberofPatientsServedperYear_b9fd0f2c-00b8-4e91-b60a-815351d34fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_0f4925d0-00d6-47ff-813c-c7678418c8a8" xlink:href="cvs-20210630.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_NumberOfPeopleServed_0f4925d0-00d6-47ff-813c-c7678418c8a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_231eaf10-c349-401c-b60e-41bb8e973cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NumberOfReportableSegments_231eaf10-c349-401c-b60e-41bb8e973cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_c9e369ec-1ce1-496d-bc62-e6eb86efe420" xlink:href="cvs-20210630.xsd#cvs_HealthInsurerFee"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_cvs_HealthInsurerFee_c9e369ec-1ce1-496d-bc62-e6eb86efe420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7761a381-e383-4912-8370-f6013b7fa7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7761a381-e383-4912-8370-f6013b7fa7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_71fa8359-0281-4108-9d03-3d0cdaad4166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_71fa8359-0281-4108-9d03-3d0cdaad4166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_2c8b666e-17a5-46b7-ac61-77e12ceb313f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_83d00c8a-587e-4862-a106-d1f2e0043f7f" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_2c8b666e-17a5-46b7-ac61-77e12ceb313f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_35a62755-3cf3-460a-93d8-5b6b04d0f622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a90c2cab-3a09-457c-8119-54755b84926e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_35a62755-3cf3-460a-93d8-5b6b04d0f622" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a90c2cab-3a09-457c-8119-54755b84926e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_94826595-c8ce-40ef-9623-f0f42386be69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_35a62755-3cf3-460a-93d8-5b6b04d0f622" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_94826595-c8ce-40ef-9623-f0f42386be69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b13021b-98e2-4a64-bb09-7e289396ad47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_35a62755-3cf3-460a-93d8-5b6b04d0f622" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b13021b-98e2-4a64-bb09-7e289396ad47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_107a7a89-07a1-452e-88b0-f85a70affa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_107a7a89-07a1-452e-88b0-f85a70affa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_1022066f-51db-42a9-ba1b-c71fadc29cc5" xlink:href="cvs-20210630.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:to="loc_cvs_VendorandManufacturerReceivables_1022066f-51db-42a9-ba1b-c71fadc29cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_5c654147-38b2-4df2-9d53-bd389e700d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_5c654147-38b2-4df2-9d53-bd389e700d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_78d80ea5-0f3c-44d7-8a6a-2d06e4003722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_78d80ea5-0f3c-44d7-8a6a-2d06e4003722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_544afd87-6de6-4053-b119-6f0013b68206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_544afd87-6de6-4053-b119-6f0013b68206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_854fcde4-0eef-4ee9-a64f-acf9789082d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fee68a19-dcdc-4bc5-971d-0925e6630361" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_854fcde4-0eef-4ee9-a64f-acf9789082d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3e130123-d888-4308-8a33-4a4c047b4b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3e130123-d888-4308-8a33-4a4c047b4b1e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_cf7a1a05-ab00-45f1-9878-30cc69024166" xlink:to="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_2a32da93-61ac-45ca-98dd-2c2ae9e523ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:to="loc_us-gaap_OperatingSegmentsMember_2a32da93-61ac-45ca-98dd-2c2ae9e523ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_cedfdda1-de18-4cc9-a0c2-041d78b84f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:to="loc_us-gaap_CorporateNonSegmentMember_cedfdda1-de18-4cc9-a0c2-041d78b84f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a273fffe-3f00-4e09-8157-378ca2f1800d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_29b013c1-6c86-4540-89fc-8a3b5dbb1753" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a273fffe-3f00-4e09-8157-378ca2f1800d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5a2b7a81-b3b8-42ce-9904-b53eba5c85d3" xlink:to="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_47199853-b483-4173-9004-bca9a388bafd" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_47199853-b483-4173-9004-bca9a388bafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_aa968e9c-4e60-413a-ab6f-900a67b3b26d" xlink:href="cvs-20210630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:to="loc_cvs_PharmacyServicesSegmentMember_aa968e9c-4e60-413a-ab6f-900a67b3b26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_c00b13d2-f4bc-448d-b754-c571eeb3fac4" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7c1bf8e-61ce-471a-9118-e156e00a169b" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_c00b13d2-f4bc-448d-b754-c571eeb3fac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0cf9682a-efa3-4a8c-8a6e-40baa63dc18d" xlink:to="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_700e3b4f-2264-4674-9ac5-4dc4bbee1276" xlink:href="cvs-20210630.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_cvs_PharmacyRevenueMember_700e3b4f-2264-4674-9ac5-4dc4bbee1276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_b17f4f53-3148-4400-afd0-b76b48d99ca8" xlink:href="cvs-20210630.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_cvs_FrontStoreRevenueMember_b17f4f53-3148-4400-afd0-b76b48d99ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_ad30f992-9154-42e9-91f9-84c760682c22" xlink:href="cvs-20210630.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_cvs_PremiumsMember_ad30f992-9154-42e9-91f9-84c760682c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_5e0226e7-417a-4abc-a531-d8e498528db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_34200d53-a97e-49c4-afb6-7cdc2c9863bb" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_5e0226e7-417a-4abc-a531-d8e498528db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_d2dbd92e-8423-4969-b080-df97c18d2ea9" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_85f2197b-c4df-4e42-bf5d-93b23c7107b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_85f2197b-c4df-4e42-bf5d-93b23c7107b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_40687bd6-210d-4278-96c1-7338f6ae62b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_40687bd6-210d-4278-96c1-7338f6ae62b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_4eea1fbd-6019-4b8b-a14f-a7ae3611fc5b" xlink:href="cvs-20210630.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_3ea2fd1b-5fe1-4f4c-bd2e-b97458635935" xlink:to="loc_cvs_SalesChannelOtherMember_4eea1fbd-6019-4b8b-a14f-a7ae3611fc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_e07a15bd-d7c6-474a-a8a7-e2cbc800af68" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2205954d-b157-4c58-8492-4809debfc072" xlink:href="cvs-20210630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2205954d-b157-4c58-8492-4809debfc072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_bbec540c-4e6c-43fb-aceb-fc0847739318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_us-gaap_NetInvestmentIncome_bbec540c-4e6c-43fb-aceb-fc0847739318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6a388950-86b0-4d0b-b157-62754dbc0d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c8949150-f8e6-43b3-a48a-0ac5379040a9" xlink:to="loc_us-gaap_Revenues_6a388950-86b0-4d0b-b157-62754dbc0d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_41a27110-4784-4c4f-9b47-b0c012b7a558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5a08c529-bb22-4130-9d11-494a39e7589b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_41a27110-4784-4c4f-9b47-b0c012b7a558" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_5a08c529-bb22-4130-9d11-494a39e7589b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9c251376-b953-480d-aa5a-3c1c77cd9f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_41a27110-4784-4c4f-9b47-b0c012b7a558" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9c251376-b953-480d-aa5a-3c1c77cd9f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5a7d96c1-5b21-4551-b299-d227335f4dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_1ce0f890-62d2-4b49-afb0-733024cc52e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5a7d96c1-5b21-4551-b299-d227335f4dcf" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_1ce0f890-62d2-4b49-afb0-733024cc52e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5d19daab-7a06-4dfb-837e-3382aed6f9d8" xlink:href="cvs-20210630.xsd#cvs_ChangeinContractwithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_1ce0f890-62d2-4b49-afb0-733024cc52e6" xlink:to="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5d19daab-7a06-4dfb-837e-3382aed6f9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a07d637d-6d21-4981-a04f-3ca6b9e41bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5d19daab-7a06-4dfb-837e-3382aed6f9d8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a07d637d-6d21-4981-a04f-3ca6b9e41bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_ee92c340-4913-4a00-85d0-6c21f866562d" xlink:href="cvs-20210630.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5d19daab-7a06-4dfb-837e-3382aed6f9d8" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_ee92c340-4913-4a00-85d0-6c21f866562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_3ec225ae-0bde-4bd2-bd11-1b84d3eb9816" xlink:href="cvs-20210630.xsd#cvs_ContractwithCustomerLiabilityRedemptionandBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5d19daab-7a06-4dfb-837e-3382aed6f9d8" xlink:to="loc_cvs_ContractwithCustomerLiabilityRedemptionandBreakage_3ec225ae-0bde-4bd2-bd11-1b84d3eb9816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_565632e7-bc49-4f4f-9ff0-4e05887b3c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeinContractwithCustomerLiabilityRollForward_5d19daab-7a06-4dfb-837e-3382aed6f9d8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_565632e7-bc49-4f4f-9ff0-4e05887b3c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20210630.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_69ba9cc4-4532-4ce8-91d0-299d4c118190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6bff6a9d-ae71-4345-bebb-379ea49ca6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_69ba9cc4-4532-4ce8-91d0-299d4c118190" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_6bff6a9d-ae71-4345-bebb-379ea49ca6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_322a4137-5599-4485-81d7-d1abb39d0c3f" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_322a4137-5599-4485-81d7-d1abb39d0c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_2ea625d7-4a68-4349-af6a-4b531e071a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_2ea625d7-4a68-4349-af6a-4b531e071a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_71f2e754-b599-42c8-a877-b940b5b9f09e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_71f2e754-b599-42c8-a877-b940b5b9f09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_d02457a2-fb51-446f-82fb-5fc53258a893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_d02457a2-fb51-446f-82fb-5fc53258a893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_abe33575-165f-4404-9e76-d359aa1cbc57" xlink:href="cvs-20210630.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_abe33575-165f-4404-9e76-d359aa1cbc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_dd83677f-0405-4922-b759-fd6afbfb6561" xlink:href="cvs-20210630.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_dd83677f-0405-4922-b759-fd6afbfb6561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_2b4f0519-5bc4-47bc-a958-cc4a4e6904e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_2b4f0519-5bc4-47bc-a958-cc4a4e6904e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_8dbdd9bb-78ff-44f3-ab00-69994f136498" xlink:href="cvs-20210630.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_e60c80ec-3b0a-4aac-a9a3-57eba8edb47e" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_8dbdd9bb-78ff-44f3-ab00-69994f136498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsTotalInvestmentScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_8325116b-19b5-442c-9de1-51347dc98e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8325116b-19b5-442c-9de1-51347dc98e39" xlink:to="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:to="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_e92aba4c-f159-4bbb-97d3-725a0cac6160" xlink:to="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_9dbed9bb-d52f-41a6-a6f3-f29ec26e1ffe" xlink:href="cvs-20210630.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_9dbed9bb-d52f-41a6-a6f3-f29ec26e1ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_db04155f-f151-4365-8699-8fcb5941057f" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:to="loc_cvs_MortgageLoansMember_db04155f-f151-4365-8699-8fcb5941057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_019b4c8a-5a69-4197-a836-5d61fbd7f026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_45de3328-990e-4b1f-8690-01380db3d7ce" xlink:to="loc_us-gaap_OtherInvestmentsMember_019b4c8a-5a69-4197-a836-5d61fbd7f026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:href="cvs-20210630.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_649efd4d-ae70-4478-8a42-f96dabbb8045" xlink:to="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_8deb13f0-c6c7-4c1b-8b0b-2fcd44591ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_us-gaap_ShortTermInvestments_8deb13f0-c6c7-4c1b-8b0b-2fcd44591ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_dab7c777-1e5a-4acf-8938-7483a0919840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_us-gaap_LongTermInvestments_dab7c777-1e5a-4acf-8938-7483a0919840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_9ed8afc7-366a-4170-b30b-6b374b350b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_4599bc18-cd69-4b0b-90aa-acd23dfae33d" xlink:to="loc_us-gaap_Investments_9ed8afc7-366a-4170-b30b-6b374b350b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_77ef86be-3f3e-496e-8a05-e5b4b5948fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_77ef86be-3f3e-496e-8a05-e5b4b5948fe5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec723e63-133d-4c69-a357-0473190586f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_dbfdf0d4-9968-4ab2-99fb-59070a2c01f7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec723e63-133d-4c69-a357-0473190586f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec723e63-133d-4c69-a357-0473190586f1" xlink:to="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_390ccc49-3897-41af-bf5c-3e1dc4e5e639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_390ccc49-3897-41af-bf5c-3e1dc4e5e639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f2f047c1-3a4d-4c44-bbf7-4c08d18020db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_f2f047c1-3a4d-4c44-bbf7-4c08d18020db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7fb05e12-fe93-4954-b5e0-7c063d78b33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_7fb05e12-fe93-4954-b5e0-7c063d78b33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_91a680c8-5d61-40c9-9ddd-a28586dfde19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_91a680c8-5d61-40c9-9ddd-a28586dfde19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c3147fd9-13c0-4113-b6f4-b535c126c7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c3147fd9-13c0-4113-b6f4-b535c126c7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_503beb38-8026-48f1-bcac-f25d94350253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_503beb38-8026-48f1-bcac-f25d94350253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_4dd4a187-0c7a-4cfd-98ec-89d2bc3277f4" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_4dd4a187-0c7a-4cfd-98ec-89d2bc3277f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_56e04ab8-2e8c-4768-97c9-64149b1931b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_deab4d10-4edd-40e8-ae7e-dbc82ef3d756" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_56e04ab8-2e8c-4768-97c9-64149b1931b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:to="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f09d5f46-b5d7-41ff-ad36-ce75cc730e8b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8c8d7d1f-9934-491a-b810-e8ca2e62b0fe" xlink:to="loc_srt_ProductsAndServicesDomain_f09d5f46-b5d7-41ff-ad36-ce75cc730e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_71c8b18e-a569-4889-a82c-5f5d3a657c27" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f09d5f46-b5d7-41ff-ad36-ce75cc730e8b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_71c8b18e-a569-4889-a82c-5f5d3a657c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_f74f52e8-daec-44a7-9de5-4afc11730a9d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2389eaec-f933-4a2d-be3a-ed5ac3e0c74f" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2389eaec-f933-4a2d-be3a-ed5ac3e0c74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c869ca62-cfbe-4046-92ab-44518a7ff996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c869ca62-cfbe-4046-92ab-44518a7ff996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d504b188-2a36-472b-8e82-48aec2b4ade8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d504b188-2a36-472b-8e82-48aec2b4ade8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_009621f4-a16c-4774-82c1-e0446ede58d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_009621f4-a16c-4774-82c1-e0446ede58d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3200661d-a39e-4a07-896a-3612bbbee0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_d5dd7d38-8fd9-48d9-95e0-dce6819ee008" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_3200661d-a39e-4a07-896a-3612bbbee0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_47b1195f-86ff-425b-98e5-6c68d312f617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_47b1195f-86ff-425b-98e5-6c68d312f617" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6f0eaa8b-4742-4e80-90b1-96bcb042547a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8a96f40a-c7d6-49a7-bac1-3a1465ebfbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8a96f40a-c7d6-49a7-bac1-3a1465ebfbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ed2bb2e7-213f-409c-a803-c5618cb0b048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ed2bb2e7-213f-409c-a803-c5618cb0b048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_ce8c3cb8-e021-48e1-8902-ef9227161ed4" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8382ea8e-2f43-48df-b3df-828740f8ec02" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_ce8c3cb8-e021-48e1-8902-ef9227161ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_1935b716-6780-4380-9701-7dcfd049d29d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_6459df25-e395-4b25-8a4c-96f68796f260" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_6459df25-e395-4b25-8a4c-96f68796f260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_bbdbecfd-d8f8-446e-b103-19140fb699ae" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_bbdbecfd-d8f8-446e-b103-19140fb699ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_b32b91b6-c09d-4572-be55-38da83dc644a" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_b32b91b6-c09d-4572-be55-38da83dc644a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_896b9aa5-d893-4738-acf3-0facb4e4cc48" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_896b9aa5-d893-4738-acf3-0facb4e4cc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_d87eb86f-376b-4a39-b341-41e15ea6eedd" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_d87eb86f-376b-4a39-b341-41e15ea6eedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f657c0f5-36bf-4ea1-84fe-618382abb47c" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_cc6167f1-f4b2-4631-9d13-10c1ab3b2365" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_f657c0f5-36bf-4ea1-84fe-618382abb47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_3e2663a6-b7de-4ad7-bf7e-e5288f1acb07" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_58e8fa18-d3a5-424f-8423-3811328669e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_58e8fa18-d3a5-424f-8423-3811328669e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_937725be-be7a-4d67-a738-1ba90db0c588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_937725be-be7a-4d67-a738-1ba90db0c588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_fb0dbaf0-28fd-447a-95c6-f4d7e4d35dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_fb0dbaf0-28fd-447a-95c6-f4d7e4d35dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_60c87733-c42a-4c52-a22f-1b420f8ebb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_60c87733-c42a-4c52-a22f-1b420f8ebb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a278df29-ac2a-4640-b959-a70f5a6824d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_a278df29-ac2a-4640-b959-a70f5a6824d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d61a00a3-ac38-439d-a81d-4321804a210a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_7280b3ab-1d1b-4cce-80ff-c170a964d94c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d61a00a3-ac38-439d-a81d-4321804a210a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_30ab7dec-82b7-4d2c-80b5-09f5fff24c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_30ab7dec-82b7-4d2c-80b5-09f5fff24c34" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a3d260ea-26ba-4f43-a208-b31f5f756d14" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_856a6f10-bee9-4e13-ba7e-b46352c88d77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_856a6f10-bee9-4e13-ba7e-b46352c88d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_49563b53-c8bf-425f-9ad2-4db07ea78b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_49563b53-c8bf-425f-9ad2-4db07ea78b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_54ea2fee-0fc3-4dad-872d-b2dbab602d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_54ea2fee-0fc3-4dad-872d-b2dbab602d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_cd27aa0d-0937-497e-adeb-b7141f7f7094" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_cd27aa0d-0937-497e-adeb-b7141f7f7094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f63914df-dd0a-46af-a844-16fa85d74e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f63914df-dd0a-46af-a844-16fa85d74e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_239c0606-be2d-4ecc-8f1a-6e7460d219f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_239c0606-be2d-4ecc-8f1a-6e7460d219f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_dfd3ce40-6d13-4110-a778-5a5d3e6f6f49" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_dfd3ce40-6d13-4110-a778-5a5d3e6f6f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_bec4309f-5f5e-4262-9818-fc60e5645552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5eeb3aee-8b1a-41ce-a23e-e89f366073fd" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_bec4309f-5f5e-4262-9818-fc60e5645552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_944672ed-0cc4-47d6-a265-fc190e6e89c4" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_d3b90f04-9dbc-4a59-a078-056719c8d6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_d3b90f04-9dbc-4a59-a078-056719c8d6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828ea805-ac3c-4bab-8e35-21ab188325b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_828ea805-ac3c-4bab-8e35-21ab188325b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_10280666-790e-4948-91a1-abc5d18ca2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_cdba2945-e7f7-4733-be55-7d4ecd44d5f8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_10280666-790e-4948-91a1-abc5d18ca2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_369a7ad5-5947-4607-aefd-e4ca0f017a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_369a7ad5-5947-4607-aefd-e4ca0f017a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f715ce12-da5c-447b-8e84-e3590ef394d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_f715ce12-da5c-447b-8e84-e3590ef394d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1ffab3b5-e714-4622-8feb-e734ea551eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_97a871c3-1da7-4389-94e6-a220c49b2725" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_1ffab3b5-e714-4622-8feb-e734ea551eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_eae025fb-dc5d-4e4d-a202-abd26f74b02a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_a9f70f01-12f9-42b4-ab54-4bc52c2c97b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_a9f70f01-12f9-42b4-ab54-4bc52c2c97b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_85e73a66-b7b4-4951-9e21-7a1470a62e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_85e73a66-b7b4-4951-9e21-7a1470a62e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5d089cd6-b513-42c0-b5b2-824bd9b515bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_fa23713e-6a07-4162-86e1-8c4651bfa341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_5d089cd6-b513-42c0-b5b2-824bd9b515bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_93b3c885-c488-41bd-b7fc-97348c8a9ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_93b3c885-c488-41bd-b7fc-97348c8a9ebd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:to="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e6500b47-0cf8-451a-86e3-4e6ef6bffc96" xlink:to="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_657dbfb3-b80f-4231-8ff7-91fe834216ab" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_657dbfb3-b80f-4231-8ff7-91fe834216ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_ebae2d15-9448-4567-9672-096bf0ab2d78" xlink:href="cvs-20210630.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c6e1d7aa-8c6b-4227-afb6-af174352d49b" xlink:to="loc_cvs_SupportingRemainingProductsMember_ebae2d15-9448-4567-9672-096bf0ab2d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5c0927b0-ac05-4d46-9324-5d9cbdff2e83" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b4e887fb-0503-480d-beab-d631be449c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_b4e887fb-0503-480d-beab-d631be449c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1664fb44-735f-4f70-a3f7-1dc750b37ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_1664fb44-735f-4f70-a3f7-1dc750b37ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_a4d9f000-3cce-4be4-a6e7-3ccbca5f880b" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c9f21d7-ed5d-453d-9060-4df8ec0c8941" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_a4d9f000-3cce-4be4-a6e7-3ccbca5f880b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0d8b56d0-d5bf-4b03-9c24-6c616af1154f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_76e60ac1-55a3-4014-a574-79fe3735d807" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_76e60ac1-55a3-4014-a574-79fe3735d807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_79e18a7f-3435-4e69-8645-5a51d4812497" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_79e18a7f-3435-4e69-8645-5a51d4812497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_930e7a1c-6d43-44b9-9852-963142ea95a7" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_930e7a1c-6d43-44b9-9852-963142ea95a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_691368d0-9f9b-425d-9aad-aa210e69735e" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_691368d0-9f9b-425d-9aad-aa210e69735e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_46513458-4557-44eb-8157-66749a0fd63c" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_46513458-4557-44eb-8157-66749a0fd63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_385941fc-194a-49ec-bf3e-bca0e86b524e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_9f222341-dba9-4b1e-ab63-adda98df9cdc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_385941fc-194a-49ec-bf3e-bca0e86b524e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7b4baab7-4fc0-424b-acaf-9accd88d7c6a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_a66dda97-08ec-4ff9-8a34-c4110a5484a4" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_a66dda97-08ec-4ff9-8a34-c4110a5484a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_ae4f1464-d053-41f7-9dc6-8451487a96a3" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_ae4f1464-d053-41f7-9dc6-8451487a96a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f02a2570-81ea-4245-a204-a74ef9670037" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_f02a2570-81ea-4245-a204-a74ef9670037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_24c50f30-9dce-4b57-9cff-ca4aaaa6962e" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_24c50f30-9dce-4b57-9cff-ca4aaaa6962e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_21280e31-1af6-404a-9abb-8c44444041fc" xlink:href="cvs-20210630.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_21280e31-1af6-404a-9abb-8c44444041fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46bd3b8f-08aa-449d-a9b9-d77e85d34e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd929e1d-8706-4486-81f2-eb617771f88d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_46bd3b8f-08aa-449d-a9b9-d77e85d34e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_11d75e28-bce9-4c7c-8698-b9e32c6367b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_11d75e28-bce9-4c7c-8698-b9e32c6367b4" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db456235-55ce-4333-99fa-a794bd13215a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_42b8416a-3fc3-4d50-b491-ef6c1f3c4cce" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db456235-55ce-4333-99fa-a794bd13215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_1c602a8b-8d4a-4c7e-8f04-7f1ea1276cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_db456235-55ce-4333-99fa-a794bd13215a" xlink:to="loc_us-gaap_CommercialRealEstateMember_1c602a8b-8d4a-4c7e-8f04-7f1ea1276cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_5bc30d8f-776f-441a-b890-8b5e2dd19fa2" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_d8ab624d-0290-4f7d-b14b-ef873f83b125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_d8ab624d-0290-4f7d-b14b-ef873f83b125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_b20b796b-41bf-4f94-84e1-4275a3c4a484" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_b20b796b-41bf-4f94-84e1-4275a3c4a484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_ba81bb92-e88e-49d8-8f98-d93b8c05f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_bc849035-5c3a-44a8-a142-ec363dd31566" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_ba81bb92-e88e-49d8-8f98-d93b8c05f5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d86727f4-8516-45c4-b6d7-919a14ea1cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d86727f4-8516-45c4-b6d7-919a14ea1cb7" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_19ef157b-56b2-40ab-a9d0-628c9cee19c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_8b23b098-2b18-4f01-b5c1-64cb5d80297f" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_19ef157b-56b2-40ab-a9d0-628c9cee19c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_7d962c9b-9f40-415d-99c8-5362510cbcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_19ef157b-56b2-40ab-a9d0-628c9cee19c6" xlink:to="loc_us-gaap_CommercialRealEstateMember_7d962c9b-9f40-415d-99c8-5362510cbcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_feb5c179-f3d7-4c9f-8f48-81302c4aa79e" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_f2d2e3f3-3d53-4ee3-9bd8-90f34c902895" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_f2d2e3f3-3d53-4ee3-9bd8-90f34c902895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_67bac447-962a-4c23-9589-b109b2f566ce" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_67bac447-962a-4c23-9589-b109b2f566ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_843e7456-89e9-4b5a-a5f7-73d8fb024239" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_843e7456-89e9-4b5a-a5f7-73d8fb024239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_2b9f4279-e1fa-44d7-bcac-4b09fb207b4f" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_2b9f4279-e1fa-44d7-bcac-4b09fb207b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_5bd6405b-3c30-45df-a8ba-980cfdc7c91d" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_5bd6405b-3c30-45df-a8ba-980cfdc7c91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_b19b5fc6-659a-489a-a3a0-90e25d497fcf" xlink:href="cvs-20210630.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_cf8a8d02-68ab-4d57-a790-a426edbe7b18" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_b19b5fc6-659a-489a-a3a0-90e25d497fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis_cdef065d-bcd0-4cf2-bf93-abac045a81e6" xlink:to="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_a617b342-ad5c-4b23-9ace-9dd1a4e72bf7" xlink:href="cvs-20210630.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Category1Member_a617b342-ad5c-4b23-9ace-9dd1a4e72bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_4765ed08-6ff9-4d22-a0f4-25c2a0d2a2f6" xlink:href="cvs-20210630.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Category2To4Member_4765ed08-6ff9-4d22-a0f4-25c2a0d2a2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_6c06f5ec-9b16-41c1-94c1-95dd55a122b2" xlink:href="cvs-20210630.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Categories5and6Member_6c06f5ec-9b16-41c1-94c1-95dd55a122b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_1e7c3ddb-97ac-40b8-9919-b7b66815b2f6" xlink:href="cvs-20210630.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain_69d636b1-3f12-4342-98d9-98acabfeaa1c" xlink:to="loc_cvs_Category7Member_1e7c3ddb-97ac-40b8-9919-b7b66815b2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_ed8d788d-be8e-4a12-bb65-3e0a502acb42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_9cfb5484-0068-4b43-8e4a-b832f5bfcbfa" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_ed8d788d-be8e-4a12-bb65-3e0a502acb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_189916e2-d8a4-4db1-953c-4a0b85f3a168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_ed8d788d-be8e-4a12-bb65-3e0a502acb42" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_189916e2-d8a4-4db1-953c-4a0b85f3a168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_00420aa9-971b-48a4-96de-468a39f0bc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_00420aa9-971b-48a4-96de-468a39f0bc9d" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:to="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_7f6cdeff-5673-41d3-bf06-2ab8eb16ce86" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0bcd6b88-c569-4697-830c-7e04a9ffb853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:to="loc_us-gaap_DebtSecuritiesMember_0bcd6b88-c569-4697-830c-7e04a9ffb853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_3b4a0bc7-376d-4975-9236-d39b3b4fdca3" xlink:href="cvs-20210630.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:to="loc_cvs_MortgageLoansMember_3b4a0bc7-376d-4975-9236-d39b3b4fdca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_49abe6e1-2e9e-4493-9844-8986fc5f03ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_6a471610-0c19-43ea-b657-c7d5c2bb0921" xlink:to="loc_us-gaap_OtherInvestmentsMember_49abe6e1-2e9e-4493-9844-8986fc5f03ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:to="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_45cc71c4-e4eb-480b-a2a9-830bb972c41b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ee6be047-7b7a-4f91-890d-8f05dbb83782" xlink:to="loc_srt_ProductsAndServicesDomain_45cc71c4-e4eb-480b-a2a9-830bb972c41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_29eeaf44-3575-49f3-9694-561fd26ce798" xlink:href="cvs-20210630.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_45cc71c4-e4eb-480b-a2a9-830bb972c41b" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_29eeaf44-3575-49f3-9694-561fd26ce798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_2cd06e64-f268-4e20-8167-c7fc17460da8" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_28ba25a5-e568-4f77-844a-0c433ceb841a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_28ba25a5-e568-4f77-844a-0c433ceb841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_4a7f66a5-2192-41d8-b9a9-2438b905d756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_4a7f66a5-2192-41d8-b9a9-2438b905d756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b8fcedc6-68df-4b9c-a4de-1ec6e6dd806c" xlink:href="cvs-20210630.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_b8fcedc6-68df-4b9c-a4de-1ec6e6dd806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_285f2996-6fc2-4b05-8811-c1f549d255c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_285f2996-6fc2-4b05-8811-c1f549d255c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_b33e83f4-3dda-4f4b-bdf0-8ff2a8ec93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_us-gaap_InvestmentIncomeNet_b33e83f4-3dda-4f4b-bdf0-8ff2a8ec93a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3e78a7d7-964a-4e77-b13b-45d7ea4e6e04" xlink:href="cvs-20210630.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3e78a7d7-964a-4e77-b13b-45d7ea4e6e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1a0cc5a8-3ede-4d0a-8fa0-0c038568e43b" xlink:href="cvs-20210630.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_90e02498-0199-47ee-89a1-6335da9a8aed" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_1a0cc5a8-3ede-4d0a-8fa0-0c038568e43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_2808f111-9740-4850-92fb-14b82eed2d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9e929524-1643-4cb5-961f-282d8fd3d8db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2808f111-9740-4850-92fb-14b82eed2d03" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9e929524-1643-4cb5-961f-282d8fd3d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_7c962c32-55bd-4085-b43d-60e706dde5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2808f111-9740-4850-92fb-14b82eed2d03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_7c962c32-55bd-4085-b43d-60e706dde5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_13c3cf40-ba54-4c4f-a40a-90bc44ed2571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_2808f111-9740-4850-92fb-14b82eed2d03" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_13c3cf40-ba54-4c4f-a40a-90bc44ed2571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ccfe1de2-0d45-4acf-bf71-6f61c353bf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_8a8e3da4-89c0-4139-a6ce-ab7d7d7e6e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ccfe1de2-0d45-4acf-bf71-6f61c353bf5e" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_8a8e3da4-89c0-4139-a6ce-ab7d7d7e6e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4e16b5ce-e01a-4961-bb4b-a8c66d59119b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1fa7edba-c623-4f95-a667-f728bfafa2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e16b5ce-e01a-4961-bb4b-a8c66d59119b" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1fa7edba-c623-4f95-a667-f728bfafa2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_e0bc8cff-1367-44a1-85a9-3af6cf7a7bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e16b5ce-e01a-4961-bb4b-a8c66d59119b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_e0bc8cff-1367-44a1-85a9-3af6cf7a7bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_f294ec23-cdac-4f4e-9265-34a3850f31da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e16b5ce-e01a-4961-bb4b-a8c66d59119b" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_f294ec23-cdac-4f4e-9265-34a3850f31da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c8f3d8db-2054-4bab-8004-ea7ebddcf9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c8f3d8db-2054-4bab-8004-ea7ebddcf9bf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_22950e48-ef0e-4582-a071-60fd89bdd2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_60ffdd26-7a12-4f6f-bb69-6795f78950e2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_22950e48-ef0e-4582-a071-60fd89bdd2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ba2761ba-a7bc-42b8-8beb-86be2bda6821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_22950e48-ef0e-4582-a071-60fd89bdd2d6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ba2761ba-a7bc-42b8-8beb-86be2bda6821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0e87b003-f8ab-433e-ae39-99e4f8585545" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3e6b835d-ac90-4fbb-aeed-49026e6e8cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_3e6b835d-ac90-4fbb-aeed-49026e6e8cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a8ba4b16-d485-45c0-9949-46b7f1e5fa4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_a8ba4b16-d485-45c0-9949-46b7f1e5fa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5dd509b4-c6c3-4941-8399-c9d355f647aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_5dd509b4-c6c3-4941-8399-c9d355f647aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ccb22fb3-5bfa-4a40-831e-236deb92327d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_ccb22fb3-5bfa-4a40-831e-236deb92327d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_20066148-a70e-494e-a460-7bbb3dcfd61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_20066148-a70e-494e-a460-7bbb3dcfd61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bbc63c78-af4a-453d-a9ea-2f02d8c98c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_bbc63c78-af4a-453d-a9ea-2f02d8c98c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_b9b9d98e-7bc0-4d60-bfaf-a994e4ee044f" xlink:href="cvs-20210630.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_b9b9d98e-7bc0-4d60-bfaf-a994e4ee044f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_185d3bf7-91a5-4bc3-9d24-e3fc6cb16c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_528b82ea-9066-4ab1-a2c9-d8f062bb178f" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_185d3bf7-91a5-4bc3-9d24-e3fc6cb16c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b72d87a8-6d8f-4214-b5ec-38d49c3035eb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b1b1170b-fa1b-4664-8e4c-639030e05392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b1b1170b-fa1b-4664-8e4c-639030e05392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0e55b8c5-571a-49a1-b7eb-185b757d0c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0e55b8c5-571a-49a1-b7eb-185b757d0c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_62317402-9a04-4e01-93d3-932e57f006eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b21796c6-13c6-4b1b-8fc3-36457e9ed4db" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_62317402-9a04-4e01-93d3-932e57f006eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6823145-e37d-45ae-8879-d798c799edad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_9f2d46aa-04f4-42aa-9ab4-d460100b0bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_9f2d46aa-04f4-42aa-9ab4-d460100b0bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0bd23cd5-2a47-4e09-a2ab-b75fc361c0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0bd23cd5-2a47-4e09-a2ab-b75fc361c0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_79aa10e3-73e0-4786-8e97-8ff176bb4357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_79aa10e3-73e0-4786-8e97-8ff176bb4357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c5e3556c-ee82-4f61-a813-0b6a94b46be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c5e3556c-ee82-4f61-a813-0b6a94b46be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2f3d8dc2-0b5d-496b-b66a-f916a6bbcf71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_30400c58-e1e2-4fea-b578-cde64e5beacd" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2f3d8dc2-0b5d-496b-b66a-f916a6bbcf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7b3f8f94-66ff-4c95-b139-ba8e418f38ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7b3f8f94-66ff-4c95-b139-ba8e418f38ff" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e33f347-2034-4e8f-a90b-c2b2a65f0cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_6a8de382-e65e-4042-bf7a-5b331c412768" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e33f347-2034-4e8f-a90b-c2b2a65f0cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4cc90700-6fef-403c-8fda-ee34f2562ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9e33f347-2034-4e8f-a90b-c2b2a65f0cb6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_4cc90700-6fef-403c-8fda-ee34f2562ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_015b65e3-f39b-4d2c-9ee1-942ed551bd3c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_21f8d6b4-5f6c-4795-90fa-cbda8883ad16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_21f8d6b4-5f6c-4795-90fa-cbda8883ad16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c41e8535-f5ae-4c0d-bba0-0bda58b11870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c41e8535-f5ae-4c0d-bba0-0bda58b11870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3dfc9966-aa20-4a0b-967b-9ebbef7d4b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3dfc9966-aa20-4a0b-967b-9ebbef7d4b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_5c8ba34a-e1bf-4063-a076-49088eaab96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b846db3a-93fd-4c3a-955a-17b5df9fe692" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_5c8ba34a-e1bf-4063-a076-49088eaab96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_acbde7b9-2c2a-4f7d-a317-36c1c8bdb55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_edea1881-c5a0-48d2-bf45-711a435720bc" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_acbde7b9-2c2a-4f7d-a317-36c1c8bdb55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_acbde7b9-2c2a-4f7d-a317-36c1c8bdb55a" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d0db04b9-1a78-435c-9144-28ae697ed35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_d0db04b9-1a78-435c-9144-28ae697ed35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3ff38699-54fe-479a-bade-16107fdb69d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_ae1fe18d-d9af-4d5b-8c0b-1a30a5a7d831" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3ff38699-54fe-479a-bade-16107fdb69d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_858c7b2a-2f53-43b6-ad0f-bb473675a0e9" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_20a3f64f-9058-4652-8e5f-d5f02ab16273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_20a3f64f-9058-4652-8e5f-d5f02ab16273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c90a8725-1f0f-4115-b492-235bda8bb4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5ed1a79b-cdb1-4545-88b6-cdc3bdbf383a" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c90a8725-1f0f-4115-b492-235bda8bb4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_65b8673b-20d9-4f06-a2ed-bb79429f432b" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_905c658b-bac9-44a5-a3ed-d65543828292" xlink:href="cvs-20210630.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_905c658b-bac9-44a5-a3ed-d65543828292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_386ff23e-5b9b-4db0-9c20-7237d9beca11" xlink:href="cvs-20210630.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_386ff23e-5b9b-4db0-9c20-7237d9beca11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d18f48d4-9fbc-418d-b8bf-779a404ab659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_9e178f48-3e60-4052-bfdb-6b0d57f86318" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d18f48d4-9fbc-418d-b8bf-779a404ab659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9b58fe94-535e-44d8-a720-61ac2d852a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9b58fe94-535e-44d8-a720-61ac2d852a3c" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e67fd95a-b874-46ae-ade3-8391ffe726be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d82d9254-6b26-46b2-8c01-10f33c17360a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e67fd95a-b874-46ae-ade3-8391ffe726be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_411449cd-8960-4a05-a195-43b0b8f2b472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e67fd95a-b874-46ae-ade3-8391ffe726be" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_411449cd-8960-4a05-a195-43b0b8f2b472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7a20eae2-150a-4a2a-84ac-868174f1badc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_5ef6c9de-215f-4efe-bc06-475f62bcbe5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_5ef6c9de-215f-4efe-bc06-475f62bcbe5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_54c9242e-3510-42b4-9954-c4ed6633fe73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_54c9242e-3510-42b4-9954-c4ed6633fe73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a169347d-aec0-450c-9b8c-33ee19d14581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_baaa0d43-b21e-4ef6-97c2-59b34db1b966" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a169347d-aec0-450c-9b8c-33ee19d14581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_4528842f-eb1c-4642-9486-434d484092a9" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_be075a6e-a573-45da-b9a2-67763197cf74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_be075a6e-a573-45da-b9a2-67763197cf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_450731f3-5a4d-4e94-90c8-35b49d7c6e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_us-gaap_DebtSecuritiesMember_450731f3-5a4d-4e94-90c8-35b49d7c6e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_48ffb17d-a327-4f7c-bbe5-2b9a5039ec04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_us-gaap_EquitySecuritiesMember_48ffb17d-a327-4f7c-bbe5-2b9a5039ec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_ee20bf39-d482-4a83-9e12-afc00a94782e" xlink:href="cvs-20210630.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f400f350-392b-4a03-99be-ee6b28c3a403" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_ee20bf39-d482-4a83-9e12-afc00a94782e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ebaa563-1c75-4f51-b0a1-7a724c72ce09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e86c4286-7dbc-4a3e-9880-c1ece2340081" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ebaa563-1c75-4f51-b0a1-7a724c72ce09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherReceivablesMember_78b7dc70-670d-4545-9430-166089dea1c7" xlink:href="cvs-20210630.xsd#cvs_OtherReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0ebaa563-1c75-4f51-b0a1-7a724c72ce09" xlink:to="loc_cvs_OtherReceivablesMember_78b7dc70-670d-4545-9430-166089dea1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_6f4bf2e6-9419-48dc-ad52-8214b8c4c41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_8cc7c3f0-0cae-488d-b93e-01d213db646f" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_6f4bf2e6-9419-48dc-ad52-8214b8c4c41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_ac7f8f5a-9328-4007-a44d-f237d6b3adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_6f4bf2e6-9419-48dc-ad52-8214b8c4c41b" xlink:to="loc_us-gaap_SeparateAccountAssets_ac7f8f5a-9328-4007-a44d-f237d6b3adbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_e967582c-3a8f-4f5d-b019-8793101e9dd5" xlink:href="cvs-20210630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_c9007b64-be6b-465f-a2bf-b9e441cf0f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_e967582c-3a8f-4f5d-b019-8793101e9dd5" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_c9007b64-be6b-465f-a2bf-b9e441cf0f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_55daa37e-acc3-424e-85f0-f8e7e31993e4" xlink:href="cvs-20210630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_3dcc311f-7291-4c9f-898a-05a24cda6230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_55daa37e-acc3-424e-85f0-f8e7e31993e4" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_3dcc311f-7291-4c9f-898a-05a24cda6230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_72f8c21b-2550-4da2-a218-3c89cc89956f" xlink:href="cvs-20210630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_72f8c21b-2550-4da2-a218-3c89cc89956f" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:to="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_43cee424-56ef-407c-9dcc-11f1ed269d77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1959ae1f-ae5e-4238-ae23-f5eab21053cb" xlink:to="loc_srt_ProductsAndServicesDomain_43cee424-56ef-407c-9dcc-11f1ed269d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_d69bc183-f9bd-4dc3-b97c-f13baa4601df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_43cee424-56ef-407c-9dcc-11f1ed269d77" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_d69bc183-f9bd-4dc3-b97c-f13baa4601df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b49ef05d-e78c-463e-83a6-efd2a5115df5" xlink:to="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ad286841-689c-47f1-bc02-f26cf44a41cd" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ad286841-689c-47f1-bc02-f26cf44a41cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CorporateOtherMember_9d1ed52f-175a-4402-850c-d88124c98d10" xlink:href="cvs-20210630.xsd#cvs_CorporateOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f1490db3-cbc1-4ca9-b74f-e144dbaebd4d" xlink:to="loc_cvs_CorporateOtherMember_9d1ed52f-175a-4402-850c-d88124c98d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_27ec0a64-ded6-42a4-9d96-e68dd9f24bc7" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_057e4209-bb95-4dc3-9dcd-2e54bd5f138e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_057e4209-bb95-4dc3-9dcd-2e54bd5f138e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_85d39ce7-b226-45e5-829e-09553d185bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_85d39ce7-b226-45e5-829e-09553d185bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_4515fc50-a065-482b-8646-9703178734a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_4515fc50-a065-482b-8646-9703178734a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_92667323-e66f-4144-a51e-bf6195f7cd4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_92667323-e66f-4144-a51e-bf6195f7cd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_82277719-aba3-465a-95cf-c907d3bbd52c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_82277719-aba3-465a-95cf-c907d3bbd52c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_03ea3ec6-8560-44a7-89e4-e9c76a5c1bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_03ea3ec6-8560-44a7-89e4-e9c76a5c1bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d732b7fe-6b68-4004-ad9e-5f6b3a271874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ccf00ead-8e29-4672-a9ad-249846fd602e" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_d732b7fe-6b68-4004-ad9e-5f6b3a271874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_0d1ae571-40e1-49d2-8249-6ad5d2a79510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_0d1ae571-40e1-49d2-8249-6ad5d2a79510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_df18b8a4-7d8a-4c57-9b86-395d2af3bfba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_df18b8a4-7d8a-4c57-9b86-395d2af3bfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73199115-2572-4216-9f5d-80d06bd634f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_1137da2f-c8c2-4688-b4bc-57862093efc5" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_73199115-2572-4216-9f5d-80d06bd634f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_776a8fb7-8fb9-4c06-989b-4fb9da26a083" xlink:href="cvs-20210630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_776a8fb7-8fb9-4c06-989b-4fb9da26a083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_be150872-3132-47b2-b53a-67dfd7c0c43e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_be150872-3132-47b2-b53a-67dfd7c0c43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_adabe47b-11a5-4c51-abf9-ec6ccf8037ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_adabe47b-11a5-4c51-abf9-ec6ccf8037ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d18a29fa-0e97-4ec1-b3fd-fefd1832d79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_c7daffe0-a951-40b5-a4e7-f8de994b4aab" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_d18a29fa-0e97-4ec1-b3fd-fefd1832d79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_70b9914b-6d31-4715-a03b-c3d3f699d86a" xlink:href="cvs-20210630.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_70b9914b-6d31-4715-a03b-c3d3f699d86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_8dc9d678-322f-4c0b-84fc-6f86ff73cd1d" xlink:href="cvs-20210630.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_6b20043a-107d-4a55-99d5-8b89420eb797" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_8dc9d678-322f-4c0b-84fc-6f86ff73cd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_70a9621e-a217-4393-8317-36d3b263a2c8" xlink:href="cvs-20210630.xsd#cvs_HealthCareandOtherInsuranceLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract_70a9621e-a217-4393-8317-36d3b263a2c8" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:to="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a05cfd74-e4c4-49e9-92be-48541ec48917" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d240e2b2-1517-4f43-8eeb-b4556164247f" xlink:to="loc_srt_ProductsAndServicesDomain_a05cfd74-e4c4-49e9-92be-48541ec48917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_3d5ead0f-f0e2-4269-9a52-a73403ddc900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a05cfd74-e4c4-49e9-92be-48541ec48917" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_3d5ead0f-f0e2-4269-9a52-a73403ddc900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9197d0fd-659d-409d-b1f7-1ac5746fd9c4" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a78f0b52-0019-4b4b-a5a8-2364fa0f3f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_a78f0b52-0019-4b4b-a5a8-2364fa0f3f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_1596b41d-aa8e-48d2-a597-8ec5582e68cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_4d248771-68a1-4cf4-9f3a-dd31110ffea9" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_1596b41d-aa8e-48d2-a597-8ec5582e68cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20210630.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_341379b6-8bd4-4293-b55e-9e9726b8adc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fe1f3c39-1319-4d9b-a13e-82616f20dae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_341379b6-8bd4-4293-b55e-9e9726b8adc0" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fe1f3c39-1319-4d9b-a13e-82616f20dae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#ShareholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ccfdad0b-30d0-48eb-90c3-dab6a9bfe8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ccfdad0b-30d0-48eb-90c3-dab6a9bfe8b3" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e6ff5d83-496f-4147-aabb-720cbe8e267e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2914cb61-4a99-4946-bf65-478ae5c5b7ba" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e6ff5d83-496f-4147-aabb-720cbe8e267e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_fb68c36f-1732-4a68-b166-d7d600515973" xlink:href="cvs-20210630.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_e6ff5d83-496f-4147-aabb-720cbe8e267e" xlink:to="loc_cvs_A2016RepurchaseProgramMember_fb68c36f-1732-4a68-b166-d7d600515973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_67dca36a-a875-49cd-b5af-d5e896df20b2" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bedf27b1-12e9-4ae9-89fd-03a9d37a59cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_bedf27b1-12e9-4ae9-89fd-03a9d37a59cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_64bbf393-5d7c-46e9-9758-91c24ac5a0d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_64bbf393-5d7c-46e9-9758-91c24ac5a0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_880e6775-ccd4-4174-b187-fb7a41312b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_880e6775-ccd4-4174-b187-fb7a41312b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e6a7d18-2da8-4dc9-9fa8-cb437f12f0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_acf7f05e-2fc5-4199-abe3-57f59473198e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9e6a7d18-2da8-4dc9-9fa8-cb437f12f0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20210630.xsd#OtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_13ab4ad8-3f7b-45c6-89ec-58335c63a6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a19da800-e6ed-4131-9bc5-fddf8396e4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_13ab4ad8-3f7b-45c6-89ec-58335c63a6b9" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_a19da800-e6ed-4131-9bc5-fddf8396e4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f59f445c-e13f-4fc9-b03b-8dec7f62715f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_866856b9-9019-4e39-a893-88661f476018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f59f445c-e13f-4fc9-b03b-8dec7f62715f" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_866856b9-9019-4e39-a893-88661f476018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#OtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f46d7e7b-54b9-4319-978e-74d164778e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f46d7e7b-54b9-4319-978e-74d164778e81" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_88dd30d3-3ed4-4261-bf93-ccfd0dcf6307" xlink:to="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_277e5b55-bf26-4b74-b86f-c483abd1b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_277e5b55-bf26-4b74-b86f-c483abd1b6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e266c451-680a-48fe-bb92-6f552de337a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_e266c451-680a-48fe-bb92-6f552de337a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6a6ee484-3952-448d-9302-2b41cef10280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_6a6ee484-3952-448d-9302-2b41cef10280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_704e5597-a16d-44b3-bd11-6f61d6356740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_704e5597-a16d-44b3-bd11-6f61d6356740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d6de0987-e338-484f-a573-d8f38255ebad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7667102-bd69-41e7-95ac-2856d40d44da" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_d6de0987-e338-484f-a573-d8f38255ebad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_532aa836-99ce-42c0-91db-5bb23455633e" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:href="cvs-20210630.xsd#cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2657bf5f-c938-45c2-8cd7-9e671a8cfe22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2657bf5f-c938-45c2-8cd7-9e671a8cfe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ba4126dc-b8c8-487b-87d6-c95a0592efd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ba4126dc-b8c8-487b-87d6-c95a0592efd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b544c188-9330-4d98-838c-2767a47684de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b544c188-9330-4d98-838c-2767a47684de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_740b52b5-96c5-43bd-b926-6e8b9d67405f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_740b52b5-96c5-43bd-b926-6e8b9d67405f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edbd7363-2ba5-4fa4-985a-c8c02798afe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward_b9836210-d343-4b9e-a1c7-4e6454dab68c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edbd7363-2ba5-4fa4-985a-c8c02798afe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_235d24c7-0635-4846-a84c-b4ddeba8aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_235d24c7-0635-4846-a84c-b4ddeba8aa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_7143983f-dd35-4524-8c65-9974840d40c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_7143983f-dd35-4524-8c65-9974840d40c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_c1e5e3a0-496b-4a0a-bfcd-a3b5a03b5628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_85c32088-4a10-4110-95bd-6c24a30f8be8" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_c1e5e3a0-496b-4a0a-bfcd-a3b5a03b5628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20210630.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_044e3d7d-af4f-40c7-bd7c-f54d1785f96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_19e2bfd0-9d38-46cf-b27c-2a71780489ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_044e3d7d-af4f-40c7-bd7c-f54d1785f96a" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_19e2bfd0-9d38-46cf-b27c-2a71780489ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c460a514-72dd-4f10-ac6a-57eb68e28090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fbeaf8a-8d3c-4811-948a-2f162a9a9eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c460a514-72dd-4f10-ac6a-57eb68e28090" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7fbeaf8a-8d3c-4811-948a-2f162a9a9eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9a95372e-bee3-480d-9086-ef744172e1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ccaa94bd-40a1-4d1f-8d8b-c950a5ea492b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9a95372e-bee3-480d-9086-ef744172e1be" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ccaa94bd-40a1-4d1f-8d8b-c950a5ea492b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_9bad1ba2-1b63-4b91-aa45-5d7de02d0a52" xlink:href="cvs-20210630.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9a95372e-bee3-480d-9086-ef744172e1be" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_9bad1ba2-1b63-4b91-aa45-5d7de02d0a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_558598a8-fe71-445d-ac82-ad0271a9c164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_9bad1ba2-1b63-4b91-aa45-5d7de02d0a52" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_558598a8-fe71-445d-ac82-ad0271a9c164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_37163bfe-6fd7-4caa-a0e4-0104b4a587ad" xlink:href="cvs-20210630.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9a95372e-bee3-480d-9086-ef744172e1be" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_37163bfe-6fd7-4caa-a0e4-0104b4a587ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74cd30a3-8ced-468c-a116-c4dcf935ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_37163bfe-6fd7-4caa-a0e4-0104b4a587ad" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74cd30a3-8ced-468c-a116-c4dcf935ffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4eb138e1-fcc2-4dc1-bfa0-e56dc1ba2e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_37163bfe-6fd7-4caa-a0e4-0104b4a587ad" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4eb138e1-fcc2-4dc1-bfa0-e56dc1ba2e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_144fb1e3-0f08-4e3e-a358-b1459c3d1d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_37163bfe-6fd7-4caa-a0e4-0104b4a587ad" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_144fb1e3-0f08-4e3e-a358-b1459c3d1d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_eb461223-6695-4d80-8057-e7d2d15eff1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9a95372e-bee3-480d-9086-ef744172e1be" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_eb461223-6695-4d80-8057-e7d2d15eff1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2bbd38c8-559e-42af-85fb-af035c6c3049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_eb461223-6695-4d80-8057-e7d2d15eff1e" xlink:to="loc_us-gaap_EarningsPerShareBasic_2bbd38c8-559e-42af-85fb-af035c6c3049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_84a77c8a-b1a1-455e-a9ac-43ee43bbe874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_eb461223-6695-4d80-8057-e7d2d15eff1e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_84a77c8a-b1a1-455e-a9ac-43ee43bbe874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20210630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8586a6fb-79ab-4530-a3a5-12c8a1de10ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8b968db1-cd04-49a5-b4c9-736f3840037c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8586a6fb-79ab-4530-a3a5-12c8a1de10ba" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8b968db1-cd04-49a5-b4c9-736f3840037c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_601a8f74-19f1-4cab-a239-cc50c9e11dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_9beac4e6-3c5c-4570-802e-2c170baacd0c" xlink:href="cvs-20210630.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_601a8f74-19f1-4cab-a239-cc50c9e11dae" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_9beac4e6-3c5c-4570-802e-2c170baacd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_69edad0b-66bc-48d1-8862-7186a7f97fdd" xlink:href="cvs-20210630.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_601a8f74-19f1-4cab-a239-cc50c9e11dae" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_69edad0b-66bc-48d1-8862-7186a7f97fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_601a8f74-19f1-4cab-a239-cc50c9e11dae" xlink:to="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:to="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_107c6b4c-17f9-4323-8fb3-1066a2368e48" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_096364a7-3c76-4a48-b848-ed01501d1c86" xlink:to="loc_srt_LitigationCaseTypeDomain_107c6b4c-17f9-4323-8fb3-1066a2368e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_b62cb9a1-9625-45dc-ab08-f86e338d5afd" xlink:href="cvs-20210630.xsd#cvs_RadcliffeAndFlaimVAetnaIncEtAlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_107c6b4c-17f9-4323-8fb3-1066a2368e48" xlink:to="loc_cvs_RadcliffeAndFlaimVAetnaIncEtAlMember_b62cb9a1-9625-45dc-ab08-f86e338d5afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:to="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_dadb8d1f-2b8b-40f0-aaeb-93674bc222ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_7b89256f-04fe-47e4-8321-b67098d4f2a5" xlink:to="loc_us-gaap_LitigationStatusDomain_dadb8d1f-2b8b-40f0-aaeb-93674bc222ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_55dea3f1-0014-4139-9b39-f5b8df4c4776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_dadb8d1f-2b8b-40f0-aaeb-93674bc222ed" xlink:to="loc_us-gaap_PendingLitigationMember_55dea3f1-0014-4139-9b39-f5b8df4c4776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c454641f-f19c-4a9d-9603-60d0c14c608c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_e65d88e7-3369-4d99-8ee9-9eca3bcc846d" xlink:to="loc_us-gaap_LossContingenciesLineItems_c454641f-f19c-4a9d-9603-60d0c14c608c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_cbe7508a-dc65-40d2-bc83-3baf1bbfd179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c454641f-f19c-4a9d-9603-60d0c14c608c" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_cbe7508a-dc65-40d2-bc83-3baf1bbfd179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_475a2ff1-df45-4f1d-bc26-b6647bd44c26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0494dcf6-d619-4a3e-ac36-04ff2249c342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_475a2ff1-df45-4f1d-bc26-b6647bd44c26" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0494dcf6-d619-4a3e-ac36-04ff2249c342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_e9090924-0bd1-46b5-b874-71902cfcda24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e7d02c30-2c15-42b0-917b-41073c6b4dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e9090924-0bd1-46b5-b874-71902cfcda24" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e7d02c30-2c15-42b0-917b-41073c6b4dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7e1c6986-d54b-495f-88ce-ae3d90f39751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_e9090924-0bd1-46b5-b874-71902cfcda24" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7e1c6986-d54b-495f-88ce-ae3d90f39751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8c2ac211-53ff-4d57-8b90-0102e199c406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_acbf1a14-b624-41e5-97ba-82026c907762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8c2ac211-53ff-4d57-8b90-0102e199c406" xlink:to="loc_us-gaap_NumberOfOperatingSegments_acbf1a14-b624-41e5-97ba-82026c907762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_743ba296-3a8b-423a-beda-699869ee4b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_743ba296-3a8b-423a-beda-699869ee4b4e" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:to="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_fb030d65-b42a-4991-84b0-6f8da596540a" xlink:to="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e0a36546-0331-45c0-a948-ddcd0c8f4058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:to="loc_us-gaap_OperatingSegmentsMember_e0a36546-0331-45c0-a948-ddcd0c8f4058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e3c964dd-eb44-437b-b642-a2460598b58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e3c964dd-eb44-437b-b642-a2460598b58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_eb990d64-142c-476e-b64d-350be2087d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_c8843c1b-ceac-4d3e-809e-82c660b9c282" xlink:to="loc_us-gaap_CorporateNonSegmentMember_eb990d64-142c-476e-b64d-350be2087d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bcb7734d-3039-4738-8565-e41da93be248" xlink:to="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_34de82a0-3d72-4d79-a4b0-485abf053635" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_34de82a0-3d72-4d79-a4b0-485abf053635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_b4d0db31-5343-4dd0-8a8f-02764501677a" xlink:href="cvs-20210630.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:to="loc_cvs_PharmacyServicesSegmentMember_b4d0db31-5343-4dd0-8a8f-02764501677a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_757fa937-4ff4-4e84-9d16-88222e8fb825" xlink:href="cvs-20210630.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3f493d29-bc4f-4000-b677-581d3ab61ecd" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_757fa937-4ff4-4e84-9d16-88222e8fb825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_367c9d08-1aa4-4b30-9a07-7a9ba175aa2a" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2e9b2d67-84fd-4dbb-a94e-ace57032ced4" xlink:href="cvs-20210630.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_2e9b2d67-84fd-4dbb-a94e-ace57032ced4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c501ce14-af9f-4b8c-9bc6-69b50f182d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c501ce14-af9f-4b8c-9bc6-69b50f182d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8f9fcc93-812a-45a1-8861-03f625bf88dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_NetInvestmentIncome_8f9fcc93-812a-45a1-8861-03f625bf88dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a9822255-de84-49b2-be87-d8af1f6f813b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_us-gaap_Revenues_a9822255-de84-49b2-be87-d8af1f6f813b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_41e359f0-412e-4947-992f-839670483273" xlink:href="cvs-20210630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_41e359f0-412e-4947-992f-839670483273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_47362c17-8f8d-419b-bbca-0220fba83894" xlink:href="cvs-20210630.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_9614562f-8dbe-4c8d-afe0-153ab36e7f6a" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_47362c17-8f8d-419b-bbca-0220fba83894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20210630.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_18865d6d-e71e-440d-a50b-cac58f930a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_18865d6d-e71e-440d-a50b-cac58f930a7a" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_67d7c522-f969-4b04-ba9b-3b7c067c0943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b2374c56-7e24-4f70-b206-90af9c6d5acc" xlink:to="loc_us-gaap_SegmentDomain_67d7c522-f969-4b04-ba9b-3b7c067c0943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_5e54c23e-d0d1-4d1c-b8b2-357ae0b75893" xlink:href="cvs-20210630.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_67d7c522-f969-4b04-ba9b-3b7c067c0943" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_5e54c23e-d0d1-4d1c-b8b2-357ae0b75893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_3aa8e164-1dae-4150-af8c-8866ba2a3bbf" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1d358bf4-df5b-43e5-a2f2-f5ffe2e7f162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_OperatingIncomeLoss_1d358bf4-df5b-43e5-a2f2-f5ffe2e7f162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_77182ad6-afd3-43c0-821c-9447b3b43cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_77182ad6-afd3-43c0-821c-9447b3b43cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_ebf69522-ca10-43eb-bf79-26b438e0fe6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_ebf69522-ca10-43eb-bf79-26b438e0fe6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_1efbe19d-dfa5-4813-9c25-a8b67682d9a3" xlink:href="cvs-20210630.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_1efbe19d-dfa5-4813-9c25-a8b67682d9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_d7bfccc4-f69f-4cb8-ac16-8595d0c66de3" xlink:href="cvs-20210630.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_d7bfccc4-f69f-4cb8-ac16-8595d0c66de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_0cb86311-d454-4053-9bb7-e45bfe5e9ed0" xlink:href="cvs-20210630.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_f0c1f337-dd33-4b11-aedd-c7957a39a4ff" xlink:to="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_0cb86311-d454-4053-9bb7-e45bfe5e9ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cvs-20210630_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20210630_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 image_0.jpg
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M8CP"QDV&OE,?==G<6M%1788O[>=\GHO[9NU9#=4;(J)U5^C'38%^V2K$G?3
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M1$1$1$1$1$1$1$1$1$1$1$1$1&^O%PK2R 7[BQ<N("4Q$88CQ^ WXPNX._=
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M%WY3HBWPVW< 'K.^A*Y+OQ*KNN/?O@<.39N!PUNV(B(P"#G9YY&T9S^B^H]
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M'D*ZZTF<.>6%>/] )(9'(BDV%IFI:<C-R<'ERY=599&G5:QYG3%(4W)!&EM
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MZ>)0F)6-AP\?JJ;?ZDCG,,I.>1<O(WC';NP:.PGN7?L@IDFKJEF7!BT1;.L
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M?3<BCI]4,DFTGS_T$9$XFY2$]-0T7#AW#F<2$U7*1VQ@$"+</!![\ CBM^Q
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MZ8W @:\C>.PD1,V9A\0U&Y#A'X@CJ6E&%KJ67_YI*X5A"V0\&)VU+Q0!'\R
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MH-$3$?O=,AR-BC&'D_E;[1\D2>)AQ0A-=^Z8^61"37I*"J+] Q"R=@/V?K$
M4=-F(.WM"<@8/!()/08ALGT/A+?NC-!F'1#6N"VB*#;4]D1LC28F.2BN<@,D
M6I5<J3Y2*M9'&N672K^OM$H-S-<I1"0PS8-E?3Z&U[&N%UFO)4(;MS'WX?UX
MW_CN Y$Z8#B2WQR+J/<^1-#<>0A>L1IA.WV1$!N+D]G9YG V#VD_R(=+<PX=
M1I3/#@1^]2WBW_\$AU\?C2/#RKZ2WIV*,*:\K%R#$PF)^-\'-,F)ZW?QP@5S
MV#\E*@IA6[8BX-M%B)XU%RGCWT?2\-%P]!V*V,Y]$>G5#:$M.B+,PPL1#5HA
MJDXS1-?T0&SUQHBK:O5CE89P6+V59/5;JHM>=.Y)]FVB50ZGGHRUKD>9+-KJ
M]?!&5D]ZMD=8RTZ(L.X=V[D?DOJ\AM2A;\%AO;NB/IF-L&\6(V3CCX@,"L*A
MS$PC+/!P?FF^KWC-0X<.&2GBBR^^P( ! ]"Y<^<R+XH /$Q/R83B 0]REQ5\
M)U$ZH& Q;MPX(PR5Y;-U[]X=??KT,;(+GY&"!]- N';%P98@^$[:OW^_D6DH
MLLR<.1/OO/..6;/V[=N;E!J*'91K*E:L:(2-YY]_WAS,?_KIIPNM9YYYQM2S
MSSYKY(@77WS1?);7H"3 :[9MVQ;]^O4S]YH]>[811B(B(G#DR!$C<MABGSOA
MW%!>82]3IEFR9 D^^>03DWQ"T8%2#26J6K5J&6F$<_/G/__9B&,L5_/"N;/G
MA9^C3-2@00,S)UQGRB#<-Q02F!Q$H81B0L%4GJ2D)'S__?<FQ6?8L&'HTJ7+
M??<5DXBX#A18^'SIZ>EFW]QO I"ST+)^_7I\^.&')DV'8VK1H@4\/3W1J%$C
M,U_L)_8!_\L_\]D;-FQHQL/^\_/S0^:O[Z:BX/N8PA7OS?ZAO/?IIY_BK;?>
M0J]>O>#EY67ZC8(,[\][\;Z<<XZ!]^??L_@]W%_???<=0D-#S3N>UV=/[MRY
MTZ3><&VX]F6USYE\Q#TQ:]8L(P3R/58<;&'NE/7OU]6K5Y?Y^\FNCS_^V"0G
MV6F,[M[#0@@AA!!"""&$$$(((8000@@AA!!"""%$27BL11K6C6O7D'?R)+(2
M$A&U8C6\1T_ UMZO8D>';MC3MC,B)DU'RL;-.!8;CPO6]]F_,5X'"$O.;VD@
MUGQ>M]:! L,9:XY/'3R$$XG).!$6@6Q?/^Q?MQ$17WR%'9.G8QM38(:\@2T]
M!\+WY1X(;-$1 4W:(J!>"P37]D1430\D5&]B4CK2K$JO]OM*M2JQ6F/$6U^/
ML+Y_G_4Y?MZ?UVG9"3L[]L267@/QHW6?;>^\BQU3IB-D[GPD+EV)_9NWX4C
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K$$(((8000@@AA!!"""&$$$(((1X+_C_*CPI[SL!:G0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>cvs-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20210630"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20210630.xsd" xlink:type="simple"/>
    <context id="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0594fd101b564f96833fe922d849fd0c_I20210728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="ie37da30b820144b09569aab8a05e7f28_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb62f039bb8842bc8ef8d95a854f9da4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8d69c899161043de9c5695babe9a5226_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i919b19b29e644269b1afa564f760f9a9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib5e9b5e20d3e45f48dde1f569d67ed38_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if904a9513ecf4d9c83fa99b4032188d1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7ecd6a626d1b42619b0531a785259c3d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i89a9847c4ef243cb940e602fdd9eb982_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ief51a7c21e12418191bfc6502162bc0b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0b0b6dd0f718499caf0d4c90979480e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76f7761a4b9349978ab4d5316305bf43_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie2849a2c586c46ca9f53db41bc644dce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69913db1407a480f8ffe4f65326387a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a68f85e6ae54b538e5f5597d97d1b7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic95472b2b89f4a878e888b2c6008da19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie15d8aea22554cdbb76b87171c699449_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i725e600ffd0e4474a684a511d91bf159_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i454f0a28269d4702bfc7afcb9aa5b5da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c46bc10f72646959e1ea5748cb11a97_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia9bb9213ec2f4b83bf72ed648ff095bb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifef9fce1a4ab4fd2a6594fc95e1d677e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i10bd9c2fefdf4b9b91c9e4c4c6e1c65d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iba7043ec64d945079d428818e5fbaca9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iad9a72643612492c9389741defc77a60_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie383aef477f142c8a4ee9589eb871023_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9058898b3da04168adb83a7684c321ab_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idc698fc867dc4bd5a40b8b39c3e3163b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibeb9d976268a44c29a6827a32bf43b47_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib40fe1673abe4a33b8ac7cd76c227e06_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic1568266e931446589f92de497dd53eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0958e630b333456980651efb292c7c53_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i85e278d7295144ed994bb3fc2ee59a4c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2d57ce235fd24cb692f4d0236f176f1c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i286be063e99e48df99369d829e93c217_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia5414e6cf48f414195513e58f1463f45_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idaf5fc475d1e49ff9053858c7255bf55_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i240be611ec6b458ab8544f6e424d4ab4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i76b917a9650e493f8ed240df994cceff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9761a7d58dca45aba855e8b41e1dc1f3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9c23afe3b82047c6929678c19cff2d07_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i10016feda33d45238a3ea372b54a6eea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifa87c9699e7d4b7ba3c7265c59239a90_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5ade08e12deb4ce9b6e638145fd412fb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i79b5c733f51b48d3a973b7f1be17e3c0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i81c686e301544071b819b02df1403210_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibb200c306c77462da3c260709207f142_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6aabd0ef5b1048f4ac916396b08d7b25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia31e862a1d4b443ea4f8845ae925852e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i72d4f602c6ed4d0ebf494b7979f86f67_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a66d45936d84142bdd6e849ecbe7789_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1e00411b2aaf43f8921414ab0ea39785_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie970b254b4ab4fd9949e74e9ab2d6b22_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibb4e231b6ed34804a0fac5206c9a3d5e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i98608eeed8d14d428759190c950b5465_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i76b30c2fa6a049fe966b44f48240fa3b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0da4d83180d243299812ac6a2eb3e7ab_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i98b9da8b49334c78a02939885c5ff91d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibb6047b3685b46b296c06bf8cda6cf5e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1ed30a7f990b49dbbd6fc681ed4e164d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i06487711e13e4c548dc075099d2dcf4e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i73d0d505da7c43e1ba4f399a5cb33457_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2a885a54dd1743b0ad1cfc07e3045822_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9281f3b7011a4d5bba7f90551405ff6c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic6087bf853b04c018d9664fc1da50a2a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia7490b026d6d4a8d8ffe46672b4ef377_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib744df2f5180441d84b1f3233fef9a67_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i01b81dca43f14167b65754c7fe593052_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icc66c36f5a22420d886ff33223ea53c2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i33b6cfdbb5a84b37bb82d80f4997197b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6d8629ee1c19401daa61e8d5a614d5df_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id5049524449d410199f77b0d7237ac47_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib291fbdf9f5b46998ad02b3172e8ed1e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0934f4bb5efa44ef900ff2ef426e56c9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i13fe73a518a24b02a40a1f3440e71f50_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0a8adba1de1f4894a089eed1e7c97186_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i25119c25c92b4f2db55b1b12c814d98f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id50e79715dae484d8bb0b80b30835854_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i022278e3d45b4b6e87ac5a6324a5b7fb_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i84f5fcae96f94664bcccd015f8aaef7e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i223cec6898e447328115d33128bf3b5b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iab4c8b62b63f480793c7a4aadd30e7d2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i03db7eb72302412682bc5861ee38dfc3_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5037b7672ca64770b57ccbefe27214a1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie162e65831a24d7ab6410600ff4e0eb5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id0838c3d504c4b0ba188c00aa78d7033_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8f6a3d3df86b4fc6877832fc49952ae8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic26532a4b62d467aa9a8517bc7419919_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i48e7456f591546feb889d8098d55bd2b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80f9e4113d044d07a6f887feda963f25_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i572b532a257b4eb29f5818e465112777_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie0e466ab07004cd0914feafe9a6bf57e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4b2d360907ea45f0b08862db70c4d3d7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4aa1afd1040f44cf8547b63d41dbe591_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie3bca70c57704131aa24ce446c205802_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic6c46eed192d41dc99861555299a540a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i28be049ff18f43fbaf9cdd9ef79e8fa0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1dcce512f8f4473389ed02f496c8b487_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e5bd3d12817424a83bdab3e1ef08149_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i44034671f9c84fe8b2a64b71bb298348_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0ce4e1b8cd247a3afa48a6db26e4e70_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i032e4e9b3eda4cb18d91840ce8d0e1dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0e5c7ea4581f40a28c6c335f145013dd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9e2905eda41a471f8d885c44663f8134_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia3a0d48a02bb422399156ace038008ad_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i70c50ebb9b454e83b240a67beba32866_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i496dec9258b04dcb9203d4d4c27ff56c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7b9d1860aea74e00ad2c89291bc24962_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i60ddfcc881984e29b4f64377dfc996c2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ce75e54f582485ab1f2e764803ce78c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6d12aed0d38d43b7913ac1ed40d9742d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if3901d540d984bdbbe7954d01630c93e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib63e5fbf23624c13957ee808a92953b4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0a382aa8220f4a0a8e22b91b4225625a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic571fcb252b9454580ca0b9a68a73d74_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i571c2782d55d4067ac07ad878ad2cda0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id584afc20f824cb5b10632de8cedc4e8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7d48d9893b4e4e8fa0ae931e8905c5af_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5825e37024df49d08a5c01af8e8c0cbe_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i86e6aad25c1b48e18ec4aedb16181989_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ieabfd20c74d44f14b5f7309d49ff43fd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if1150195ef084b308adc08d5b6fd6d37_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i277b57b4d1bb4be1b4eed74758be2d3a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5c845f14e279418b852581196c54f9c8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i920cdf64d2fe4196a7c51badf2e4b2ee_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70267249c6134e0184dcdf8d3a4b67cf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i820e7e5dad1e4cc99afe17c533670331_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib6172f9453d340f39d59d5101635a85a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i411456f412ea4846a96be3b32e388bd5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8fa3071f0b9a448599732f89a137d911_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i79016db736f64c5bbe4e068ac2adcd98_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1e4ac40a398f427cb77a2094a1e447e7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i24a50869ac304742b49b405bf41bdc02_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i600ff56b85734cbba43e0b25e8b6f595_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ice379e0dacf9467da98333a95b5e13ff_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i29c79146b5294d08add1c3efc10db8ce_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i54e8d73c14454d5aadcdd542013be434_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib920548c0b1a454d81f1407f3de6be03_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if479dca3854347d3be7f823a1683f8b5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i364787c47e394a57938aa7f7999c533f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i166554c720f64af9bcbc5fd85e9bcee6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib6fb5e05c3b6493da3da36f60554098b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f45cc0df9464d56aeaa2320aaed3b45_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i212fe2f3583e496088a7a5e86f5f1b17_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i759569ae7b9b48af8ea1770c353db400_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6889ed969d4544329ba1c263b5ac4e03_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i92f22972f46042c297c7c89259a121c6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4bcd11287bf94b91819f67ab1137751f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i11dcc6b36e054b7f83db5e8213b3e4a7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifd33f24ebc4242b4a184fe50093ba8f1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if8f434ba89a2463491a53e466c45f175_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7c500e6eec404740b845bbc6749d9816_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia5560473d23f4f238af0827e871ebe16_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib0190811d39f4835b7c199890587db0d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i92367a9e55d345ae84f133238ad6f0c5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i140296fa522140e8b9fff9b2f366d8e1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5770294e42ea4e908f315f226b548613_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id320ea86e20d46c5b18c7cc290be409c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia8b3699d17ab4bc49abd7de1d430af9f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i64696f2811204153b3a4db3e0624abce_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9bd9f5dd41194be8aa3c1c1db6ac93fd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c96c74db01f4ec1ba8c3b7ed9abcc0e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i48dbcd0e840b41f0ad881ba4a5cb6ce5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i216530e358d54f83b2e18ae38bb5be13_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2e8bbdf8e1364bb78dd9cb3211b8052e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie91de92b5d1d44a68fa60bf2e45aa5d2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iadd2c902bbe145308ec3aa05c17b567c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ffc9a8dd41244b8acff67f5bde3ea2f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2efc32665c704f25894100c8ce4d0df7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i95dd9befbed24089a9f86d2e656a2894_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iee48290a6467466dbd923d0cdeae5c9e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie3466d17106d4ff0ab52299c6a6ab8e9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8f50e02b79ee45deb02a3ed6774b2cb0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i125594ebf3e84110a3111697a3b48e4e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia0b811b19b1445fa845554f632a26d2d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i095ac5b05f56430b92c8170b133a7866_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if937cafeb43442a9aa8e67151c4d0301_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iadff063171ac423d92c2da8077c58172_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id8164c11b7854ff18ddfd168e0890d44_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i207199ecb13645e897faf29de46c250a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8fd1ce170b5c4a62b7556fdc2322c872_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i39233506c97a4bffa7f4b9b02c27354d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i64ced488010e4594a0781af33f4169d5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i587dd0796ad94946b28c9400be32b020_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i650d317e298a41ff8c04c7c3675c3c0e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i286440c966274717b8d93a9e931b1209_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5672950bdb32444195bac533201af94b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if96971f980314cc6824c828891c2a32b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i630fb69c6df2418b968902ada8401a5a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ife997dbd130a4d2e9fd1499ba1bea839_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1703ae8e098b46b78e9927eaf75be8bd_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0e954630bc78462e89281fe898f9064b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i04b88e9ad43344949030a683b6a00df5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8ed80d35553c4d40a468c52a12055be7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iba7c706ce4764a0da3369af23605e185_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i77c07f5d814342089f6740d390c7572a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i432117100b93456f8cf6f278d0e673e9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i560d1a79f1ab4e93b2f826080d1e1e98_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i050986668b0745f78bd6639177dc57d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i785d26b7ae9b4b46858aaedd48a3f463_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cf6c37f26e849ed865434c8e9ca659c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67da0ed9c4d447b49163344869bcabfe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37114866aaba41cfb18a68f2cd2fde62_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8d6f559cac05474bb144a75f235bcb09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bb425d67a354590bedb80036ca60278_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3590ee0301174d61875cb4de2bb00cd8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i50eced10560845d6a9cd175c5552eb84_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icb104d269b9f4f0ead4974de98e0e425_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i05fa8546b543495c817f8870574cf91c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie04051f399d14d09899ca54b68a00a7b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7fc4d19ba499475caf61a593859df3d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id78f486649f54627bfd2a824897634ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie21351c4bab548df85d81dd9c1d15ac9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74a11c9f2c994687b6022db81270ca31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46b3488cc73943e4acd89188f2b451fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifbf240305fb945c386be358ec6c9c573_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8a1de2913fe54b508792cc352b2f82bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80430002c1a3435e8f4abfa75c0919f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i330716651f3445f2b16d92e604e21dce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if91258c802ea4a78a5826616a1737d80_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia0b8c6a6f20c461db287f9f793fbf9d7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idb1943f336d24144a589379cf6e74715_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i486f1122037e48ebba56da0ba8464796_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i23b4441f7bf64f9db07dd58f12b394b5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1483e14fbc3a4929b38090e7dde2ad45_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic7cdf1afe2da4dde8c7318e6ab1a8301_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i91df7cc733e2416eae8bfe2970841365_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3f598f62b58f44329684aa34ad736af0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i450c5941c7d942b0a54ddb1a32a20443_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4873ff3af0794784807c3e3ca3789caf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib600a4f1216f44378cf6f1b44d67d7ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaef7062893e5408eba53ca68b4edd0b0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48bd9aac481142a2b07aba094d9e81af_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf1b8df1cc2643e8a0309a06abb7aca0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if924b5acfea142f0ab260a1dea210427_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i007ade0d31a744fa85eece461d2ea04a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48f755a38a33470f981cf406c956dd12_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic06ba18385514181b60ef5b38d07c7c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9b2d1fbfab6345c08006daadfad4a310_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iceb56897df794c4191f6c4c04564d9c1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i220a807050aa4c2ea3679d48640b0fc3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i131e208f966e4264a055bb71305599da_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i33523e15d5dc4123907ac3a0675f494e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia890bdfab1f54e6ca2e37c25ed5811f8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i367b52fbb0a240aa82bd1a02d8a324f3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0ab34f008298435eb46af52c54f017d6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icdb3058d4ed94963aaae1af4e53a426b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7d6ad7d715e9485e80a9f39a359e966e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic274db3d35ee4f3ebc05cc96aff41eb0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i299180676e0a428090878a4e964ae3c3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie28ecf2d0aa0430b9c1cb966f93498b7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iabefdd8927e1421d870bbc8356276157_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaffe79f8b7ea41698ffc230904de27f6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i83f1ed1f5a7f4f3bb16d0358da0bb94f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i449532a2d62a4951a3f3831a08a4fda3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idd9f2126c084443d9eda652a4acefb7f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i44e0a13ad4d0459196454862400790b9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3c188280b0cd4569a3ce9e68984969a2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2aff7e212dba4f1fbf45ee44721fbe81_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie247c0296a5e402b85463bc03fbab6c1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id39dfb11efc44ccb81323ee1fcf29437_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i54610f9931e549eca4055d422845c143_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if427cb3fea58401c8674f141a28396a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15d5490a569a400b8f3dcd7e8f5deeb7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d587f40c2be4fea92c1a51b110451cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b64b0dd3c184cf68f39f81eceb5b2a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i885cdcbd4dcd428eb8b3f2c4bf5ca941_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id753e4b7a848420eb1bf019e0dff3575_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie652cb275f004e0a8ec39116d03c51b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i218aea3dada84f1fa06872e0f38b36c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d49cacf71ba442b8c626e29ceaba33b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6753c528bf954911905b7a442393bd2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3911cc7a050a463a9917d1b270dee929_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66926c144af6454b87ae1b8f6716f4b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3111a7bacfde42758aa324b189e45891_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3732b9eaa81d40fabbf3b7dcf14af188_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8412f07e8a547df9a2fcec0a4836635_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51b11270b11c465a83657fcd47ed4efa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2162ee28ee3f4ffdbcd637de827d5019_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie79e56a852074e97a192b8b7beff8f36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06bd1e75b881405f9702ac7ddbce9775_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f79cb2e161946d4929d70a5ba4b004e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad22fdfddeaf4656861bd7eeb9c94c0b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i48f663f5fccd4951aadd8900a4387256_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7007437bd44f4d68ad1ad8bd03e2f923_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateCreditQualityIndicatorAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica882fe4d91740f2b81b3646815ff854_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54f0ffb4cb5747e5ae102f05f6be5426_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9fdbba4396e465aa67202f3d051bf09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie98081acc8c6408991f4c8cfefb17661_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaea822d1827147c99d73617628295d8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc598c056391483daf070cbea7830172_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0bfcd29b10f48ae92b73e7e61315ccd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i517df693ba094adcb6a72f956951017a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie42822d1eacc4a8eb4231d4dc693ea43_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie3d1e2584e2e4ece9d9ce0724718c49e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i635b7d77a86447cbbde8755fc40a8123_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5bdeac025f774c94829e3eb2edfc85ed_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i42d87419632b4611adab279ece7e7ab5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2b888f576f9425dbc1db1dd81427da5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2dc660620ba647f4b99c1bf75a1627fa_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i16505c15a33845cc90e5567fa18ee168_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6d7b0bb4b38a45ffab552ab679c7ed71_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if766f5d0385a41e6b60c61a94201bd04_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i42f9c017860948b99f0fb8dea97d4d51_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib882de119eac484b9d951f61870fc5f9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie0b4a3cd76c34e31b91ed92d1872d19c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4c2fbf0383914cbeb84f216152e87705_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if510787ec69a47dab801c3bc8709accf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2e17fbacae7443ed952ba5013f247779_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i210cfc37361e470c839857aa7665fd2e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5756d6da663844dd8e3245d0308e243b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8122e2ed870645328446a41f8f459934_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4774aadb10b74dcd88e20d1880176f2b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1d647a560d834ed7bec26a73aea83cce_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i51f256ca262f46f29af5968001b43da2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4937f0b48be141ada107552f5c969303_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6ec3859c325c4e37bdc207864784224c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibcd344f786334eeba5b6b5f3e83b93d8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaf06625a4a7e42ad8768a5601e932198_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if648025f3229424d9fb2cb50b21a4d8e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0a83e5029cd544968b3f62662c6606dc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib243fd82757e4fa48ebb957b2b99c657_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i666e214c5a9044248a863407bd0eb6d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48d697cff45d428eb1ade196d28a9895_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i72c9463581a84b608a88153478abae38_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iff11c38224d54e13923ab497bfa6a493_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if0ee846d07ec4f5da014c0cbee5f6325_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaafc729b92494245ab81e716ce94cb2a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i59d54b47fd594fef8e068ff8c673c092_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie1649f3335c0494e81c99fc59c8b29f5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if652301e5b5943129f8dabc5c8548671_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id7bcca6c60a14999a5c77af4ebe5e5ae_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5e6325064a1c495391cc89279cb2514f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idaf38374d2b44debb4cab8d016415de6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i22d3dfbf8c9f4ac0bb704473ec643a62_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia08106700a614dff9824cb0fe4668155_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibc2aabed88fc4d488c491b6a45904991_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i508570dbfe5849138bc3977ff2cb5ef7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i72735f55bd18494cacc33cb8c99b64d9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4f512df7d4da495d8f781fb880dc0284_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3fb024b2608349f0b1205f18ce388c77_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia30edaab02914ed1a4fb09da02b3afef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43462d31172f47d98a4a3224e271ebd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic544aea1c1a74584aca18be496ce9788_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2bd934620d014afeb56e178d35779aa7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibed7dee2937d4edda5a4f4eea940e0c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41c79aea9b744926b279baefd7888c7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc1767b92b5c4de5a2e23e7eb3179d2b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8aa429dd3d3443068ab973df732e3c5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5804356b138422d80717a1da9579a89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib901721cf1bc447e858860d4cb20ce74_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63b4df452eaa45da9e4f334a54e4276b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7e5f228a57743f1b6ea83a254776653_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife856c95fabc422e946de71df9f85f7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd180ab75d5a4fecb68db3e8d283b9f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85785249c39f4629a053294868f4fcdf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie19ff9770b3940188b1c9822a1c6d9b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22a1418e8df34c6cb73572ce728f62ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86f5a355792b49a293afec62f4455847_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2374f86f801462a83df1f2c38872a96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8cd73f6a957430db9ad4fba0bb5ee64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bd730a9a7384fcba46ad7b64d43e6d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09ff8669b4a54e3e90a5ab48256328b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d20c989c3b64c90ac3cd629c8bf4640_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i04a0e0235a7c4490a5d9ce38d2dec0f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0dc3ba5e04941c187297fe40513dde5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3854b6138a7e4b6ba179f9daaf4bf706_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18930979d5f444fc9ce85d4aea31a3a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icdb74a304f8a449c904b5ac5ed9a47d3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b89a5844183436683430ac9c92e2493_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ff75c2db4cc4af1b847def76f22a529_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7c828dc2e7148ec8b99c9d153298510_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i492d50e843c848998eb35ba39503a0c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73382bef295f429781872fe2001fc529_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25c677e6daec4e8780d801dfa6da3c94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29e642c930d94a8d9996ce4bed724ae0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b5b641cecaa495588a4e4dba1cafd61_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i118929ebf94a4e06be11a3ad3b27a03d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6584062de818418fac5ed71f5a372118_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34356136fef34ea68725d0b2dedc1d87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i854709c930d6449fb02d80ed81b53e55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c3a89719074423b8d52bc27096fff9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a115fbfb91c4616a824c7ad041c71b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c2e12ab2ed44a1685c511613129c6ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifdb7d9bc6a274f09859f00ab5e174888_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if5abce7dc4f744fb8be00645bffc65db_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iad91cb1314994e379923841f48edf212_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iffde036edf014ed291d1a23247cc772a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a2cc0aef0ef434ca7a520686e5a5a11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae628a7e9e9d4d70990367c3408854c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i076f74e1a0eb466192510067a9c8a7c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idac6c16e9b5b4dc8a02816d8c21aeafa_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8968fff252724607a7a65bdc9378629e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib9e44f82810c440485338f4334976121_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icdb59237beda4ebaacb4ab8eb6a97d0b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0244059f9628439f877b719efced6c7f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie43a8645a41a4ef2a7ef116fc6539527_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5eaea3134fed4570a85d692327045a39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ef4cf2bbf004e71ac5c7cca1cfd3a50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34b9eb3d66c14bc28cb0cc540b80fc4c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7857397f0c414fe58b62068caf0af267_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaebacd56446c4171843144f398469d81_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib77cba1c8ec74b5ea417e97bfc25f625_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i01eb9253c97c4e5b9250d83998bcec06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44630855078a48b9908bbdadf53bc736_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c30b37500e14214ad5855fdc0950616_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic242a2b931a4468b8b353b6e0aef8bcd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22db164f3ee140ce9151bfbea89bff98_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i09809fb393924acb85b3db48f54103ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8f077ab3271f495385d381d572fbe9e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5b390a8e65e1443bb33e8ab459655c77_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64ece45dfbc249c0a0e2afea4e637eba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30f3983821e94ff09717ee684cee383a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58bd0bd6852b45eea2c0896f18f97044_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17e39654116145cdb653f9ed90d33e64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8097a507fc364b0bad573079ff802eb0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaba58e1397ac49f68fb7f5f0f5837ff0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3d0846f2bdb423fad6dde41f494d94d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib452e1f428b347f39293769ac08d9478_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4101cecc5df744f5a0b26d331861ca9e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id118d34f2b5c4d3f8bef18af6def2414_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0152c20c97aa43078a0e9f51783dc116_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i59c04e7fb5d44ae6997958c568ba3a08_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie92993780db143b7b0e4a20bccee8f39_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:CorporateOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifdec0af0fd9f4f60ab69ce914af06e6a_I20161102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-11-02</instant>
        </period>
    </context>
    <context id="i112799dbf93348fca843c7d691faf8b1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i142f058b8bb74591a7b7633b6055fdb8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if03a3ed387264a22b8a9acf639af05bf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic645e74bfbdd4334929938f94e38d35a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5a0fedee6ab64c609195f894c49bca7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1eb18023bf9b4744abf0271e233e621d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia293eeb507694d29b061f167f11864bd_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia17321eb57374b8abc46c944d2885a9a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1b04b502bb5c4952b90f134d823c69b7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i79d9fd45dcf3482cacd29cdd9932e790_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3220f907b164c859ca1b0dc2c4f6b28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2abba1f0810f4477917b3b690bc38448_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2bb9417d47fc43f1897e27292ba0ceeb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i07261151d31f426a8232fcb0f14da1ae_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i49a9782f5451439dbac16821699f7854_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9bd049c214e14e6b8653d68bd8a3e2f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5bb4c36eb3df4620a92deefe268baac0_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i5232fdd455f74d7da74de09d354498c3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75c8fc3eedf24bee8f01fff1c288efc4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i834cc5cc64384c53bbdae7fa265c9dc1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea949437ea7642b58259e785c86e9340_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if1e3563999254ce18bebe63113318168_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ica622595b996421496158a8950271496_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37226568eaa9431f82f538d433d5910d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0cb51c1fc52c417391c987b64935b747_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id6cde7cf62354c9f90d8f5d1b6beed42_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id0f1fa309d244561b4d4255b13e72185_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib1728a5a6a3242af80ab519ee500c71c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7aff438e903c4976a85160658a6e3ebc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i44713b7441b84d789aa571d6a659979a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic1631ebf77054c36aadaba422e742499_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7ccd57de85dc4077979b39a24f44206e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3da72faaf2b4475f838efca9f0889b65_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ic2f056bb44964d78b883cc1b11fb04a6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i70240851d9624b2b833aff8775606301_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2e9af44465864c999326af45d83b0a2a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34955bacc9344a75bd20cc975c6d72dd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1b0c7405c7a44354a5b01c38a42318c7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i699e98c5cf6e484bb4ad38af546870e1_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i70b16429cf7d4b5ebba7b368990673d2_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="i001dccf76afc4c24992b25b72dcb6e28_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffeAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia726d6239ffd4749b438a44af233681b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieddd6943d58948fca9da637d49a68e16_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i622f60133e0f447ba5a9b36b96bae65d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7fb82e1b7ebd4c54be9d1622a6b266a3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i13fec49e4db045d598a854e6be36041f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i468fcff0a66441fbad1b998c36682c15_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id11782f1722a4ab1a431f51a8b8bb767_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fba9e2c34f44e5ca1e106a2a73285b1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5fb80760bed64a4ea52ff1222cfcd13d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5662cc7cd70b4808b16a82e9bc2161b4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3c0ccf7e987345a8a9c4f161c072bb04_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i563c6cc59100449cb1b087e6d683b97b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i18d1e96563e740f186d85a4df1469291_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i23673f3bf56a41a982c19211f550e038_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i259c3a6a85d34cad9bb1f18eb7f79a6a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icdd42d2ed15e435daff26e80bcb970ea_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i71be5af836584a6eac396f68bf46ee96_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idc5e6d1bf7764728ba7479982f03642e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i63c7a1d3118640968e9a75f187d6b40b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i93fdab396b0143ccba07019b56d386ec_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3bd6ea18260343fe8d826574d00c787b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37c5177a6cd544aea90d592c291b5439_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7592f4455e574a298526d9bc23a5566b_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="location">
        <measure>cvs:location</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF8zLTEtMS0xLTA_92641017-db34-4b84-b044-c19c04802e9a">0000064803</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF80LTEtMS0xLTA_8b63331c-e8ed-498c-aa27-6b0931431148">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF81LTEtMS0xLTA_242a2ad5-2e8f-431b-af32-175e18d1a05e">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF82LTEtMS0xLTA_b4c14f70-944f-43e8-b375-4b36985e2707">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80L2ZyYWc6YmQwM2EyNThkYzc1NGUzZGJjN2Y1NThmZDcwMTk4YjEvdGFibGU6MDNmNDk4MDZiOGUwNDJlYTgyNjQwODliZjYzZmU3NzgvdGFibGVyYW5nZTowM2Y0OTgwNmI4ZTA0MmVhODI2NDA4OWJmNjNmZTc3OF83LTEtMS0xLTA_a461b6fb-a6c2-4139-b699-0f9343b5e8c0">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_25a5ce81-9390-445c-9d04-19bbb524680f">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_61ff17c9-97ed-4555-9af6-e3678e84c702">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_827ca4af-45d2-4722-b7e8-1ab1c7ebfae1">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0wLTEtMS0w_908a6944-01b3-44e3-9dc1-2018aba1d3c3">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="ibb4e231b6ed34804a0fac5206c9a3d5e_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMC0xLTEtNTUy_56466a58-8dbc-48ef-95d1-dc25d931058a">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM184Nw_28ea11d4-7c2c-49cc-b244-dc2a7fe634a0">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMw_e20dcfc8-529a-47a8-8866-e85602138ab5">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMjU_5bb2623e-6225-48c9-b293-3d7a29932d73">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMx_6b2bd942-f7c2-457f-b9be-b6de750abd04">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMy_5184afd9-1e73-413b-a53b-1a09d3bdd83e">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDMz_5ddf6288-837c-4fe2-bc96-a7eb02d771ee">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6OWM5NjQ0ZDE3ZDU1NGRhOGE5MDJkY2Y0NTQ4NzJiZTgvdGFibGVyYW5nZTo5Yzk2NDRkMTdkNTU0ZGE4YTkwMmRjZjQ1NDg3MmJlOF8wLTAtMS0xLTA_a86eabff-9319-4531-989c-9aab68f9b8aa">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6OWM5NjQ0ZDE3ZDU1NGRhOGE5MDJkY2Y0NTQ4NzJiZTgvdGFibGVyYW5nZTo5Yzk2NDRkMTdkNTU0ZGE4YTkwMmRjZjQ1NDg3MmJlOF8wLTItMS0xLTA_5dadbfb5-a24e-4303-ad1d-6f9364a7b440">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTEtMS0xLTA_f128c5d8-d589-490a-b7b1-64c64d4bf307">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTItMS0xLTA_38afaedc-e8e1-4062-9e64-c6a6e2f60153">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTMtMS0xLTA_05fedac6-761b-45d4-bf93-aa33306344db">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8wLTUtMS0xLTA_4be05edd-c5be-46de-8d51-88f700015de1">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8zLTUtMS0xLTA_a700d560-dfb2-4d5e-b03c-09fd398de743">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6ZjcyMDhkMWU2ZGM2NDc2OGEwNTA4ODIxN2NlOTkzNjUvdGFibGVyYW5nZTpmNzIwOGQxZTZkYzY0NzY4YTA1MDg4MjE3Y2U5OTM2NV8zLTYtMS0xLTA_736246e5-a95c-42de-8822-ca7ed95e922e">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6YTRiYjQxZGI2YTQyNDdhYmE5ODAwNzc2YjM0MzI5MWYvdGFibGVyYW5nZTphNGJiNDFkYjZhNDI0N2FiYTk4MDA3NzZiMzQzMjkxZl8xLTAtMS0xLTA_ebb7b9e1-a45b-4871-a488-4ae9b81b2c6a">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6YTRiYjQxZGI2YTQyNDdhYmE5ODAwNzc2YjM0MzI5MWYvdGFibGVyYW5nZTphNGJiNDFkYjZhNDI0N2FiYTk4MDA3NzZiMzQzMjkxZl8xLTEtMS0xLTA_83d8ee1b-55a2-441f-a580-2be6bf960cf8">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6YTRiYjQxZGI2YTQyNDdhYmE5ODAwNzc2YjM0MzI5MWYvdGFibGVyYW5nZTphNGJiNDFkYjZhNDI0N2FiYTk4MDA3NzZiMzQzMjkxZl8xLTItMS0xLTA_cce83107-5e64-42bc-a64a-f2c5516496d3">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDM0_c85fe629-57d4-493c-a628-f32f85f9c6c3">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDM1_caccf899-5720-458f-8e45-fe7ef04e621b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6MzczZDc0NGRkYWFiNDc4MzhhOTI0MGNjZjBmMGIzYzEvdGFibGVyYW5nZTozNzNkNzQ0ZGRhYWI0NzgzOGE5MjQwY2NmMGYwYjNjMV8wLTAtMS0xLTA_3907c8ea-998a-4238-b9e5-391446eb9971">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6MzczZDc0NGRkYWFiNDc4MzhhOTI0MGNjZjBmMGIzYzEvdGFibGVyYW5nZTozNzNkNzQ0ZGRhYWI0NzgzOGE5MjQwY2NmMGYwYjNjMV8xLTMtMS0xLTA_77343c62-2a5f-4bc3-8245-9042c061a237">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGFibGU6MzczZDc0NGRkYWFiNDc4MzhhOTI0MGNjZjBmMGIzYzEvdGFibGVyYW5nZTozNzNkNzQ0ZGRhYWI0NzgzOGE5MjQwY2NmMGYwYjNjMV8yLTMtMS0xLTA_d52d339d-096f-4ceb-87a5-42641d51ed18">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18yMDM2_0e41812f-66c1-4ab9-9f5a-851ae477ca09">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0594fd101b564f96833fe922d849fd0c_I20210728"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xL2ZyYWc6Zjg3MWEzYjBmMWQwNDZmNzk2YzlkZDQyNzNmZTIwMzMvdGV4dHJlZ2lvbjpmODcxYTNiMGYxZDA0NmY3OTZjOWRkNDI3M2ZlMjAzM18xOTgy_4e04f395-45ce-41b1-9d8e-17a2191cc6a4"
      unitRef="shares">1319574744</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie37da30b820144b09569aab8a05e7f28_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy0xLTEtMS0w_eb73dfb4-23e5-4c4f-a46c-d0caa0387377"
      unitRef="usd">50525000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb62f039bb8842bc8ef8d95a854f9da4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy0zLTEtMS0w_ad4153ea-d571-466a-abd9-b993bbbc3304"
      unitRef="usd">46355000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d69c899161043de9c5695babe9a5226_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy01LTEtMS0w_f1fb6b1a-8045-446b-a84d-58a955cabd45"
      unitRef="usd">97912000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i919b19b29e644269b1afa564f760f9a9_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMy03LTEtMS0w_e8a86a66-2912-4074-9636-ebc556428a92"
      unitRef="usd">93358000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC0xLTEtMS0w_cfb8bd6b-f705-4be0-a85f-11a6fd51c589"
      unitRef="usd">18983000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC0zLTEtMS0w_67cc84cf-6a41-4174-a125-0eaca2b47daa"
      unitRef="usd">16927000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC01LTEtMS0w_8a516843-24d9-4335-8707-ee4c04ace5a3"
      unitRef="usd">37943000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNC03LTEtMS0w_84f99832-0319-4d5f-b154-a6ea5bad2c16"
      unitRef="usd">34567000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5e9b5e20d3e45f48dde1f569d67ed38_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS0xLTEtMS0w_9e6cb09e-88b9-42ce-9eda-fc7a9a4d7eed"
      unitRef="usd">2819000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if904a9513ecf4d9c83fa99b4032188d1_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS0zLTEtMS0w_54757c68-8a5c-4d5b-9b2f-d54aa63851a5"
      unitRef="usd">1875000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ecd6a626d1b42619b0531a785259c3d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS01LTEtMS0w_1062eba0-2061-4a32-91b9-6f2b856f8283"
      unitRef="usd">5272000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89a9847c4ef243cb940e602fdd9eb982_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNS03LTEtMS0w_12c4f6fa-148c-4f1c-966c-fa5f9d8e3549"
      unitRef="usd">3825000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi0xLTEtMS0w_1ce09391-e484-4597-8ada-944f8921fe89"
      unitRef="usd">289000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi0zLTEtMS0w_4fb57558-5935-4984-a34c-0509e554a102"
      unitRef="usd">184000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi01LTEtMS0w_6e4aeb3b-ea29-4421-b0cb-2ff0c1eaecdb"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNi03LTEtMS0w_452a6af6-cd43-40e7-a17d-a7324179d2d9"
      unitRef="usd">346000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy0xLTEtMS0w_ec0c0c58-83bb-4ac6-8cff-63e0f5acde86"
      unitRef="usd">72616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy0zLTEtMS0w_176d3182-8a1b-4bc2-b4cd-025eb82214be"
      unitRef="usd">65341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy01LTEtMS0w_f6b67506-96f1-4648-97c5-6796f79592d2"
      unitRef="usd">141713000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNy03LTEtMS0w_06c7b8ff-edc3-46fc-95ad-04ecbabdffd6"
      unitRef="usd">132096000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0xLTEtMS0w_6ec2eb5e-4888-40bc-bc80-0f34cad8c5e0"
      unitRef="usd">43520000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS0zLTEtMS0w_e560577e-780c-437b-9273-0b4466b6c710"
      unitRef="usd">40242000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS01LTEtMS0w_f2ead627-e23d-4ded-ab5f-96730ffc8ec7"
      unitRef="usd">84414000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfOS03LTEtMS0w_e797a6c0-87e1-4b64-aa5e-9d26e8e64f22"
      unitRef="usd">80589000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtMS0xLTEtMA_7757903c-e5ea-421c-ba88-b0c7e4d126f9"
      unitRef="usd">15901000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtMy0xLTEtMA_2f2d5820-6a74-45b8-9370-9e70d1cb9e1b"
      unitRef="usd">11751000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtNS0xLTEtMA_fd4718e9-c9a1-4d3f-a3aa-587708ea6195"
      unitRef="usd">31605000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTAtNy0xLTEtMA_cbd5fb84-b397-4ab9-9547-2bef54d046bf"
      unitRef="usd">26138000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:OperatingExpenses
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtMS0xLTEtMA_183b510d-4da1-49c8-b2bf-87d7a500c66e"
      unitRef="usd">8869000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtMy0xLTEtMA_0c963736-d792-4c72-8060-2910cf22b5b3"
      unitRef="usd">8668000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtNS0xLTEtMA_461c7a96-f1d3-444e-9a82-77394b4e4414"
      unitRef="usd">17791000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTEtNy0xLTEtMA_77fa99ad-8866-4df4-ab85-544887e99baa"
      unitRef="usd">17231000000</us-gaap:OperatingExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItMS0xLTEtMA_d9330e60-b8d7-47df-8b56-306e971ed36e"
      unitRef="usd">68290000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItMy0xLTEtMA_9906ee7f-c1a0-4e6b-9314-cbcaa8a1d05a"
      unitRef="usd">60661000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItNS0xLTEtMA_bacafb1f-c048-4be3-b98a-f5f42799a923"
      unitRef="usd">133810000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTItNy0xLTEtMA_92e5b453-01be-4413-92a4-a28cc36e9d7b"
      unitRef="usd">123958000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtMS0xLTEtMA_b8764cba-728e-4bd6-a4aa-c1a55a7dd402"
      unitRef="usd">4326000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtMy0xLTEtMA_2363ec44-2b60-4d1f-8e4a-b3f3157d42dd"
      unitRef="usd">4680000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtNS0xLTEtMA_81c277bd-5c00-49f9-a6c1-39a7cd1a5385"
      unitRef="usd">7903000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTMtNy0xLTEtMA_e42b8e3f-5048-4e6b-be00-93053e0e95bb"
      unitRef="usd">8138000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtMS0xLTEtMA_3e866f1b-98a0-4151-a5ed-dbc814eda18f"
      unitRef="usd">636000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtMy0xLTEtMA_fb7af746-8c01-4cf3-8611-27d71aa409f5"
      unitRef="usd">765000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtNS0xLTEtMA_5948342f-053d-4eeb-983e-d58db3e1a72b"
      unitRef="usd">1293000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTQtNy0xLTEtMA_b1069f22-ebb1-4e3b-8df4-5c9431e9b496"
      unitRef="usd">1498000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtMS0xLTEtMA_fbc3e3fe-e601-4004-b1d1-9e890c8122c8"
      unitRef="usd">45000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtMy0xLTEtMA_fe83fad4-93bd-4879-b126-15d1cf6ca7da"
      unitRef="usd">45000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtNS0xLTEtMA_5e7996fb-dbba-454f-8c99-e9a0097c7b17"
      unitRef="usd">95000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTYtNy0xLTEtMA_0df0de4e-ffa3-4abd-972a-cb077835eb0e"
      unitRef="usd">99000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctMS0xLTEtMA_cd301440-59b3-49b5-8da2-e5a0ab3f3c6d"
      unitRef="usd">3735000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctMy0xLTEtMA_37da4baa-d8e2-40fa-a7bd-b3c9b2a600d8"
      unitRef="usd">3960000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctNS0xLTEtMA_e0297277-feb3-4aaf-bce1-4533f15b652b"
      unitRef="usd">6705000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTctNy0xLTEtMA_371866ee-95a4-4a31-affb-dcc1e3ec6405"
      unitRef="usd">6739000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtMS0xLTEtMA_b655f688-94a5-456f-8463-e0dec08c797b"
      unitRef="usd">944000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtMy0xLTEtMA_90d694cd-792f-4e9e-ba32-5faf7f9a2b32"
      unitRef="usd">974000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtNS0xLTEtMA_1a18b61b-5ace-4460-9d89-3fe55bca87ac"
      unitRef="usd">1690000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMTgtNy0xLTEtMA_fe25b9d3-9720-4727-b465-5f95cc085cdf"
      unitRef="usd">1741000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtMS0xLTEtMA_8fd15d73-8517-43e6-ae59-8b6c314de955"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtMy0xLTEtMA_5022c42e-5b01-44d3-b3a0-b2e5b908cb72"
      unitRef="usd">2986000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtNS0xLTEtMA_0cd72c6c-0e0d-4c47-bb59-51902c94b7a3"
      unitRef="usd">5015000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjEtNy0xLTEtMA_f7fd791b-e6ac-44cc-bae6-abdf6bf576eb"
      unitRef="usd">4998000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItMS0xLTEtMA_c6fce611-9787-4ed9-9380-171685c77902"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItMy0xLTEtMA_fb3e4f81-9e7f-4250-875b-cc6405aee017"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItNS0xLTEtMA_1f93a451-7ee0-4dfd-b91c-0769208cb538"
      unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjItNy0xLTEtMA_1628e4a6-4a67-487f-9264-d5eef1028a92"
      unitRef="usd">16000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtMS0xLTEtMA_6cfc0e1f-aa9b-43b7-aa2f-32792d2be965"
      unitRef="usd">2783000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtMy0xLTEtMA_7987637c-d5cd-4473-b6cf-40367492bd8a"
      unitRef="usd">2975000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtNS0xLTEtMA_f8d202ca-8aad-4aa3-b191-6fe583801d88"
      unitRef="usd">5006000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjMtNy0xLTEtMA_20c3f6e8-1cff-4bb4-ac89-3789d62c179f"
      unitRef="usd">4982000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtMS0xLTEtMA_1bdb0071-8560-4f6c-8fd9-7dfb0a044c29"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtMy0xLTEtMA_ae811525-bf0d-41a5-9a1a-3da8868eff26"
      unitRef="usdPerShare">2.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtNS0xLTEtMA_33e1ca68-19e1-4fe5-9f18-c68cf06d0a1b"
      unitRef="usdPerShare">3.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjYtNy0xLTEtMA_51cac0fd-e52f-4695-933e-52659535956a"
      unitRef="usdPerShare">3.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctMS0xLTEtMA_4543860d-4df9-410c-a77e-026b30da0d9c"
      unitRef="usdPerShare">2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctMy0xLTEtMA_a3972817-e5f3-4dd1-a740-f16a6d49d2cb"
      unitRef="usdPerShare">2.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctNS0xLTEtMA_a7f8da0d-7343-4211-8e16-a5af257c589a"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjctNy0xLTEtMA_cfc726c5-88f7-47c7-881d-f2c1fe8fd7aa"
      unitRef="usdPerShare">3.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktMS0xLTEtMA_bc107ec3-c42b-4663-81b5-91ef64fe7ab2"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktMy0xLTEtMA_7d781cbe-27b0-41f9-8e1a-9c4247883a02"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktNS0xLTEtMA_2a638b23-079c-4989-9da1-ad726bdb2e28"
      unitRef="shares">1316000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMjktNy0xLTEtMA_52eeca50-599a-4b94-ad18-ffbee93ae56c"
      unitRef="shares">1307000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtMS0xLTEtMA_09c5700d-b163-4906-907b-6497c55a7a70"
      unitRef="shares">1327000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtMy0xLTEtMA_585a11b9-388b-4398-b35c-a464fa5cbb29"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtNS0xLTEtMA_e79d023d-fce9-4b43-9f1d-4b6d71fc369e"
      unitRef="shares">1325000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfMzAtNy0xLTEtMA_c5d36d97-4e4e-4d06-ba76-a061d994560e"
      unitRef="shares">1313000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtMS0xLTEtMA_29d1e457-37b1-4bf9-9e78-0887462c5a29"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtMy0xLTEtMA_001c6edc-2566-429c-8ef4-a79a39c8a193"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtNS0xLTEtMA_33208732-c8ef-4022-a65b-1decf7419f42"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8xOS9mcmFnOjFhNDk3ZDI4MmI1MjQ4NWRhYmI0NjM3NDFlY2M2ZGMxL3RhYmxlOjRlYjA0MTM3ZjVhZTQwMzU4YzY2NTFkMWFmMDQ0NmQ5L3RhYmxlcmFuZ2U6NGViMDQxMzdmNWFlNDAzNThjNjY1MWQxYWYwNDQ2ZDlfNDEtNy0xLTEtMA_2916ee5d-aaca-476d-97ff-b3515425a9a7"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi0xLTEtMS0w_8fd15d73-8517-43e6-ae59-8b6c314de955"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi0zLTEtMS0w_5022c42e-5b01-44d3-b3a0-b2e5b908cb72"
      unitRef="usd">2986000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi01LTEtMS0w_0cd72c6c-0e0d-4c47-bb59-51902c94b7a3"
      unitRef="usd">5015000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMi03LTEtMS0w_f7fd791b-e6ac-44cc-bae6-abdf6bf576eb"
      unitRef="usd">4998000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC0xLTEtMS0w_9fb94dc9-506e-46f0-94f3-7324a29d9415"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC0zLTEtMS0w_e9e59e50-d422-48dd-a1e0-366c3c2747c1"
      unitRef="usd">524000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC01LTEtMS0w_89579f77-96e5-4fe2-bcca-c93827d8bf33"
      unitRef="usd">-237000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNC03LTEtMS0w_54b664e9-a261-4d0b-91cf-fd2d852a91c4"
      unitRef="usd">213000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS0xLTEtMS0w_e0bb609b-0311-4f2f-ab66-c58f08650fe9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS0zLTEtMS0w_187fe24a-7f3d-4d8b-ac7a-dba20dc0282d"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS01LTEtMS0w_5273ff4e-1cb8-45af-a09a-369e615ec586"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNS03LTEtMS0w_ac621634-1610-4281-9854-e69e1ffb5e28"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi0xLTEtMS0w_d0310ae6-9ae0-4786-90bc-ecceb20d2712"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi0zLTEtMS0w_6ee7153e-4191-4caf-af11-5ea2d4413638"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi01LTEtMS0w_6cd4da63-0fd5-49e6-aac3-9c3bae7405f1"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNi03LTEtMS0w_aff79c9c-f8ab-4467-977c-8f888f5d42f1"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy0xLTEtMS0w_554a7521-1352-4738-883b-067de5b3b25f"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy0zLTEtMS0w_5a73791a-c8be-423b-a06f-c20edcb7002a"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy01LTEtMS0w_f58f1797-487f-4dc1-ad62-533ea926a84c"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfNy03LTEtMS0w_5d391eb0-b015-4f88-bad5-e859cb81d21a"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC0xLTEtMS0w_d3f75bd0-6474-4f3a-b514-dc73f409d98b"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC0zLTEtMS0w_afabbe6c-93a5-40e7-9f99-a60cf18ff3ce"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC01LTEtMS0w_4c3b0959-828b-498f-8fa7-0de655da5979"
      unitRef="usd">-244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOC03LTEtMS0w_c27ea184-c2a6-466d-9653-87400e46dd02"
      unitRef="usd">194000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS0xLTEtMS0w_700312f8-ee16-4474-b5a9-e7b985d2550c"
      unitRef="usd">2939000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS0zLTEtMS0w_09742255-51f8-4fa9-afc4-4f6aaae2003e"
      unitRef="usd">3512000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS01LTEtMS0w_67599156-ec16-4e2c-bc66-1d51cbdba181"
      unitRef="usd">4771000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfOS03LTEtMS0w_2374be49-31aa-4f15-b119-0bf8daa5ca62"
      unitRef="usd">5192000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtMS0xLTEtMA_c6fce611-9787-4ed9-9380-171685c77902"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtMy0xLTEtMA_3d3ec9ce-66f6-431d-8438-f0cae11b4842"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtNS0xLTEtMA_1f93a451-7ee0-4dfd-b91c-0769208cb538"
      unitRef="usd">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTAtNy0xLTEtMA_1628e4a6-4a67-487f-9264-d5eef1028a92"
      unitRef="usd">16000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtMS0xLTEtMA_c0310de3-e934-48bb-89bb-6bbc42788a1a"
      unitRef="usd">2931000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtMy0xLTEtMA_49bc1e2b-c057-49ce-b3e3-748da443979e"
      unitRef="usd">3501000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtNS0xLTEtMA_f94c5bec-d6ee-4d02-81e5-4da9bad68e98"
      unitRef="usd">4762000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yMi9mcmFnOjMxMzA3NzliNjI2NDQ3NzdhOTM0MGJiMTQxODVmZmE0L3RhYmxlOmYyNzBhNzI1OTQ2MzQ4N2Y5NTA4MDEwOWJlODZhMjc2L3RhYmxlcmFuZ2U6ZjI3MGE3MjU5NDYzNDg3Zjk1MDgwMTA5YmU4NmEyNzZfMTEtNy0xLTEtMA_e9f75e8d-0766-4420-9b36-2679fade893f"
      unitRef="usd">5176000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMi0xLTEtMS0w_5d198605-6893-47a7-ace3-29c5729d84b0"
      unitRef="usd">7119000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMi0zLTEtMS0w_55058523-9201-4431-a153-e6c87734b5e9"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMy0xLTEtMS0w_eef59d6e-ecb1-46bf-8b63-3c5148b07855"
      unitRef="usd">3006000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMy0zLTEtMS0w_2c5a26fa-7eb8-45db-a96b-f773ba0fb0d1"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNC0xLTEtMS0w_0c2d0498-f446-46f7-b51b-0822a69da012"
      unitRef="usd">24164000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNC0zLTEtMS0w_967389f4-c70e-43d5-be81-8ab4e1460d80"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNS0xLTEtMS0w_2ab3d28d-a629-4e8a-8dbb-66d1eac08b41"
      unitRef="usd">16979000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNS0zLTEtMS0w_6ace5948-bea5-46f7-b8a7-52d9552afcd0"
      unitRef="usd">18496000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNi0xLTEtMS0w_587588be-65f5-4d1b-b215-0d330897f6f2"
      unitRef="usd">5291000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNi0zLTEtMS0w_60a15bf4-225c-40fa-ae7e-5a7ec5fd9272"
      unitRef="usd">5277000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNy0xLTEtMS0w_ff610652-394d-431d-903f-de9512af4f02"
      unitRef="usd">56559000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNy0zLTEtMS0w_d985ce8f-4eea-40b5-8bd9-c0f26ba59e41"
      unitRef="usd">56369000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOC0xLTEtMS0w_bbc7766a-5d1d-4dd8-9755-505bc2eebcaf"
      unitRef="usd">22136000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOC0zLTEtMS0w_6e702d34-ef08-43a8-a610-16f401c44118"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOS0xLTEtMS0w_9e0c430b-d448-47ee-93a2-21491c756aa8"
      unitRef="usd">12664000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfOS0zLTEtMS0w_82858dfd-7df9-43ea-9c15-0125636302af"
      unitRef="usd">12606000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTAtMS0xLTEtMA_869a11e9-f767-43a5-8fa9-649f4f24b217"
      unitRef="usd">20476000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTAtMy0xLTEtMA_5243c18b-e877-4d7d-920a-2915d933621d"
      unitRef="usd">20729000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTEtMS0xLTEtMA_c50ea360-ef03-4234-8540-276ca16f7c5c"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTEtMy0xLTEtMA_6a66d14a-b60c-4145-abec-ec3e8f644d0e"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTItMS0xLTEtMA_1b13fd1b-1f7a-4f3d-819e-1a890fb1a3af"
      unitRef="usd">30080000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTItMy0xLTEtMA_ca3635fd-138c-4257-a9fa-d1b2319bd431"
      unitRef="usd">31142000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTMtMS0xLTEtMA_99976aca-bc72-4949-8036-58c3c5253226"
      unitRef="usd">4880000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTMtMy0xLTEtMA_0023fdef-7392-4601-87d4-b03c9a00917a"
      unitRef="usd">4881000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTQtMS0xLTEtMA_409b2b01-e132-473b-a00c-9e6bd9b54428"
      unitRef="usd">4817000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTQtMy0xLTEtMA_3930573a-ceca-4242-bfaf-eb004d660a5e"
      unitRef="usd">4624000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTUtMS0xLTEtMA_0a257d6e-0584-4482-adbb-f5cc7a92a799"
      unitRef="usd">231164000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTUtMy0xLTEtMA_594392bf-e8a5-4ae2-9969-37be0c3492a0"
      unitRef="usd">230715000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTgtMS0xLTEtMA_51d4b4de-d5b5-4e7b-90e9-d1e5b0cf1756"
      unitRef="usd">11052000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTgtMy0xLTEtMA_13d44175-5ba4-49a7-ba2c-5b6ae1091f40"
      unitRef="usd">11138000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTktMS0xLTEtMA_9bbbb4d8-4dda-4894-bcf5-6b3cea7277df"
      unitRef="usd">17225000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMTktMy0xLTEtMA_affe403a-6854-4940-978b-a0ab6b927d7d"
      unitRef="usd">15795000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjAtMS0xLTEtMA_12493069-6993-4c42-9380-8595ce86a91e"
      unitRef="usd">8414000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjAtMy0xLTEtMA_5eb5d702-c94e-43d0-b294-2227b95a8113"
      unitRef="usd">7936000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:OtherPolicyholderFunds
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjEtMS0xLTEtMA_e3eb3dcf-c0c6-4e8e-b975-f31e4c7b7e10"
      unitRef="usd">4567000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjEtMy0xLTEtMA_61075170-47be-414e-97a6-121f5dea5eca"
      unitRef="usd">4270000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjItMS0xLTEtMA_b081d6fe-9261-4e61-afec-62afc195a323"
      unitRef="usd">14827000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjItMy0xLTEtMA_f3669286-a15c-4e39-9df4-936b6b1724ab"
      unitRef="usd">14243000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjMtMS0xLTEtMA_7a5fdb76-424a-4744-b72d-5e99b2b9be9e"
      unitRef="usd">1375000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjMtMy0xLTEtMA_0a837ba0-cdc3-4be7-9ca7-79f5781973b4"
      unitRef="usd">1557000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjQtMS0xLTEtMA_30b0b68f-639f-4fd0-83a8-03b72727b77d"
      unitRef="usd">1791000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjQtMy0xLTEtMA_11ab8e86-3ead-4fa1-8651-b8a19409c2e7"
      unitRef="usd">1638000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjYtMS0xLTEtMA_7f0ae4dc-0cc4-46f7-af60-24df23a8e7ae"
      unitRef="usd">60000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjYtMy0xLTEtMA_ff649e06-b25d-4961-aa76-ccd81a1b3b48"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjctMS0xLTEtMA_36b786d5-ad30-4cf2-91c8-a48470481bf6"
      unitRef="usd">59311000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjctMy0xLTEtMA_420ad695-63de-46ae-8404-01bc3aa67fcd"
      unitRef="usd">62017000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjgtMS0xLTEtMA_3120be78-5983-445d-8191-63fbacfbef51"
      unitRef="usd">18509000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjgtMy0xLTEtMA_8142d927-061f-40cb-9bbc-ba932c043853"
      unitRef="usd">18757000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjktMS0xLTEtMA_8c93a722-c11f-4b34-a1d3-8cc09d8bc94f"
      unitRef="usd">59294000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMjktMy0xLTEtMA_d2caf180-c21f-4a0a-8981-0927d3e3b549"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzAtMS0xLTEtMA_21a00600-1856-43fa-9e84-06033f5e602b"
      unitRef="usd">6557000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzAtMy0xLTEtMA_81086409-7d73-4b69-9b7e-990141662d47"
      unitRef="usd">6794000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzEtMS0xLTEtMA_7d5b8a9f-34bc-4ce9-904f-5adf222d6104"
      unitRef="usd">4880000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzEtMy0xLTEtMA_df8cb65c-f1fe-4141-9127-7da6d0a7b9b4"
      unitRef="usd">4881000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzItMS0xLTEtMA_91da1f97-707c-4963-976b-dc8aab2a8f19"
      unitRef="usd">6734000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzItMy0xLTEtMA_47f2994b-ade0-4938-b5a6-24bada3a3835"
      unitRef="usd">7007000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzMtMS0xLTEtMA_5643e183-0911-49b1-b424-62645ec3e7d1"
      unitRef="usd">2314000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzMtMy0xLTEtMA_acce22bf-8aec-4750-9e6e-bff8a22fa982"
      unitRef="usd">2351000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzQtMS0xLTEtMA_c5561ba4-f602-4a5d-b5dd-ac849106e721"
      unitRef="usd">157599000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzQtMy0xLTEtMA_e145fcc8-e026-450b-babf-2fffe199a332"
      unitRef="usd">161014000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzMx_55029632-bdec-4f70-8523-5f684527b32d"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzMx_b382bc04-4228-4538-8b2a-159859757807"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzM1_be83711b-b705-4d64-805f-51009047ca9a"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzM1_e5876e37-bdaa-4e6b-af9b-fb3bb59a1ee5"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_085a5d4c-dab7-4fe3-9637-0260d23d2a50"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_216b465d-8285-4fcb-829e-e8700f098f17"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_b228e685-01ad-4534-9420-49c186b40989"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMC0xLTEtMC90ZXh0cmVnaW9uOmNhNWJmYTM0MDU2YzRmYmZiZDYyNDBkMTc5NTEyODhhXzU3_de0e1de7-ebcf-4f0c-a30e-ddbfa3cb5fc3"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMS0xLTEtMA_e135dd40-b080-4176-b538-03f8370ec078"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzctMy0xLTEtMA_ce41c85f-c528-4a8b-b2b0-31b7f8651ee2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzI4_037bbf6c-f5d3-4358-ae73-90ae3e6451ee"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzI4_42422701-991c-4cd6-a67d-8c38158360f3"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzMy_2dd71a9c-5501-4a4c-8237-0dd16c3619c0"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzMy_75b553e5-5eb0-4da8-bf8b-f2753c831122"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzU0_7bf2d098-a948-4f87-acf8-8da1dafd6c1d"
      unitRef="shares">1742000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzc1_241d6b05-e591-4619-9162-99c69a5e5a54"
      unitRef="shares">1318000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzExOQ_722213d6-f890-42c0-a7d3-d5be2680a5f8"
      unitRef="shares">1733000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjE5YzBhMTgyNTM4MzQxYWU4YTM1MjU1MDY1NDJmMGZlXzE0MA_bd7babf4-f8fb-4b0a-8239-b9deba0f7bea"
      unitRef="shares">1310000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMS0xLTEtMA_6f67ebe5-e1b3-4a74-b9d5-11b806f23df9"
      unitRef="usd">46995000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzgtMy0xLTEtMA_1b6a7d76-5341-498d-b1fb-4cb5e4c26cd4"
      unitRef="usd">46513000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjNkYjZjZjJjMTZmZTRhOTU5MjhkNGQyYTkyNGU0NzIwXzI5_4349fe08-ccc1-4796-9d67-6dc01d428137"
      unitRef="shares">424000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMC0xLTEtMC90ZXh0cmVnaW9uOjNkYjZjZjJjMTZmZTRhOTU5MjhkNGQyYTkyNGU0NzIwXzYx_d2cd06ee-84b8-4d57-b254-061daf6fa4cd"
      unitRef="shares">423000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMS0xLTEtMA_1c198ce3-8b99-4c06-977e-d58474ee6e11"
      unitRef="usd">28252000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfMzktMy0xLTEtMA_391a021c-7a64-4e6e-a2a6-e6540bbca989"
      unitRef="usd">28178000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDAtMS0xLTEtMA_6f4ac8e5-43f7-4a53-aab3-2ad29b93f40b"
      unitRef="usd">53331000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDAtMy0xLTEtMA_132dd228-0a08-43c1-a0b2-bafe5ce77a45"
      unitRef="usd">49640000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDEtMS0xLTEtMA_b14df73d-3083-4728-b40d-21e50ef87622"
      unitRef="usd">1170000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDEtMy0xLTEtMA_cb3a31f8-9a35-42dd-91a3-c2f28ec109a8"
      unitRef="usd">1414000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDItMS0xLTEtMA_a1747fa7-14d3-4a7b-8eeb-66f6da416300"
      unitRef="usd">73244000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDItMy0xLTEtMA_acb1d889-9128-4030-ac70-81b769e5b101"
      unitRef="usd">69389000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDMtMS0xLTEtMA_63dec13f-c5c1-4f9c-9310-4a7af977ddd0"
      unitRef="usd">321000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDMtMy0xLTEtMA_9dd27d50-4914-484c-9566-55870eae3cb5"
      unitRef="usd">312000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDQtMS0xLTEtMA_916e61d3-1dd9-4c9e-a32d-731c9a6c3dae"
      unitRef="usd">73565000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDQtMy0xLTEtMA_059a2963-46f2-40df-a766-316a1a63f742"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDUtMS0xLTEtMA_9e2701f4-4d1a-41db-a7f2-580811a601bc"
      unitRef="usd">231164000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yNS9mcmFnOjVlMDY3ODJhNDE3OTRmYjE4NWEzNWYwNTlmNmQwM2IyL3RhYmxlOmZmZTU5NjJiNDJiNTQ4Njc4MWU0ZmFjMDk1OTNkNmMzL3RhYmxlcmFuZ2U6ZmZlNTk2MmI0MmI1NDg2NzgxZTRmYWMwOTU5M2Q2YzNfNDUtMy0xLTEtMA_3875b474-41d1-4117-b183-2ac7be7ab3ac"
      unitRef="usd">230715000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMy0xLTEtMS0w_6bb2d221-7a3e-48de-b470-1620d6561f25"
      unitRef="usd">136621000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMy0zLTEtMS0w_da6a4875-57ce-4e1a-ba82-90e7756075d7"
      unitRef="usd">129218000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNC0xLTEtMS0w_a51023f3-cac3-4024-8f91-fa3aefc537f5"
      unitRef="usd">79316000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNC0zLTEtMS0w_2cdc90bf-e896-499e-8bc4-4ffc37350629"
      unitRef="usd">76381000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNS0xLTEtMS0w_fa017faf-daa0-4cb8-a555-ca8cf0b400a5"
      unitRef="usd">31245000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNS0zLTEtMS0w_13cb2da4-85be-4ccb-acf4-1b9e77ec36f0"
      unitRef="usd">26483000000</cvs:PaymentsforInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNi0xLTEtMS0w_b491abfe-ddb9-4d03-aa00-dd6f66056335"
      unitRef="usd">14900000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNi0zLTEtMS0w_84dcbbe1-2344-4131-9b7c-6b16faf2e675"
      unitRef="usd">14688000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNy0xLTEtMS0w_54d22d5a-c4e3-4555-907e-3378f9c0cd71"
      unitRef="usd">394000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfNy0zLTEtMS0w_ccd88de6-e07c-43e9-bd53-b2ecde320388"
      unitRef="usd">395000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOC0xLTEtMS0w_010fac45-c6f4-4b0b-96bf-7ee5f5bc63e2"
      unitRef="usd">1263000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOC0zLTEtMS0w_f8ee1f27-48b1-40f6-8db6-bfac0f042364"
      unitRef="usd">1407000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOS0xLTEtMS0w_56d69dbf-d478-49cb-8f3f-05f0a276ba86"
      unitRef="usd">1552000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfOS0zLTEtMS0w_8441d794-b606-4200-999e-fd0cadadc2f3"
      unitRef="usd">230000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTAtMS0xLTEtMA_d10b53bf-349b-4b01-92a4-4b4309e38dcd"
      unitRef="usd">8739000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTAtMy0xLTEtMA_15f158a7-d9e2-4340-91f1-1287c2ef1eed"
      unitRef="usd">10424000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTMtMS0xLTEtMA_ea226add-e3e1-4c41-b7f6-a968b316d167"
      unitRef="usd">3947000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTMtMy0xLTEtMA_327bf033-6931-4719-9650-e954cde1c405"
      unitRef="usd">2710000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTQtMS0xLTEtMA_bbf09801-76ec-40e6-8f34-f5d3a8d12e21"
      unitRef="usd">5570000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTQtMy0xLTEtMA_3ed13a0f-d1e6-4cf8-bb1a-b63d66ec05e9"
      unitRef="usd">3688000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTUtMS0xLTEtMA_7d687b1d-6fcc-4173-81d3-cf03d95e84a8"
      unitRef="usd">1315000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTUtMy0xLTEtMA_4d930b51-4235-4014-930f-92952739e357"
      unitRef="usd">1190000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTYtMS0xLTEtMA_c791f982-bd9e-4597-bcde-f1c9dd2e0d6f"
      unitRef="usd">108000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTYtMy0xLTEtMA_609acf54-cf00-4d17-993d-021b236007c9"
      unitRef="usd">768000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTgtMS0xLTEtMA_0fda6b7c-f139-4e22-b319-134de8788acf"
      unitRef="usd">-72000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTgtMy0xLTEtMA_d16e4c2b-9cb3-40f6-b188-1b093d6c9196"
      unitRef="usd">-6000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTktMS0xLTEtMA_94a71155-9159-4671-a239-488787640ac2"
      unitRef="usd">-2974000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMTktMy0xLTEtMA_45c06633-a334-4e11-8ce3-94e2be93432b"
      unitRef="usd">-2930000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjMtMS0xLTEtMA_d35d6e71-abf7-40f6-b54c-778d4ba09973"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjMtMy0xLTEtMA_19de5d83-0336-41d3-b1c1-da541f494a32"
      unitRef="usd">3946000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjQtMS0xLTEtMA_3b2ab592-2a01-4c66-bb8d-41f9f5ab5e29"
      unitRef="usd">5423000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjQtMy0xLTEtMA_71f7b553-5ec8-429f-8be1-cb44a36a9187"
      unitRef="usd">1016000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjYtMS0xLTEtMA_a02d34af-f83d-4368-8d57-9ab1d72e732c"
      unitRef="usd">1306000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjYtMy0xLTEtMA_012f46f0-4d70-4ef1-8ddf-1552f52bd627"
      unitRef="usd">1315000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjctMS0xLTEtMA_d179c85b-5778-4584-8c5c-e028273b9905"
      unitRef="usd">330000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjctMy0xLTEtMA_9c60dfbc-2647-4615-9833-098138652f1c"
      unitRef="usd">166000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjgtMS0xLTEtMA_fb5897e0-8266-4f66-867f-10bb77833cac"
      unitRef="usd">159000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjgtMy0xLTEtMA_1e05a81f-3168-4001-95fc-373a89dc2945"
      unitRef="usd">68000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjktMS0xLTEtMA_92ec7887-7d5d-4238-8f4a-f3b36f13e659"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMjktMy0xLTEtMA_1cf986f4-73f5-4491-b815-4aa3f436dbb5"
      unitRef="usd">-16000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzAtMS0xLTEtMA_e14268b8-cc58-4d01-abb4-06dc1c78d80d"
      unitRef="usd">-6558000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzAtMy0xLTEtMA_4b6f0433-bc7a-4753-a24e-ff92c23845d7"
      unitRef="usd">1697000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzEtMS0xLTEtMA_a8d1dda9-36a2-42a5-89a7-0444a3604007"
      unitRef="usd">-793000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzEtMy0xLTEtMA_ad162956-8725-4bd0-a4da-7fea55ce90e1"
      unitRef="usd">9191000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzItMS0xLTEtMA_ec049333-09c0-43d4-8206-4269dd0def8c"
      unitRef="usd">8130000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzItMy0xLTEtMA_7835f33b-15e7-4b63-acfd-2c7a724c3c4b"
      unitRef="usd">5954000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzMtMS0xLTEtMA_a8184a18-a228-440f-acb8-13b4ca5da8ab"
      unitRef="usd">7337000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjgwMGY3NGY0YWI3ZDRjZWZhOWM1YWY2ZjBmNGUyYTBiL3RhYmxlcmFuZ2U6ODAwZjc0ZjRhYjdkNGNlZmE5YzVhZjZmMGY0ZTJhMGJfMzMtMy0xLTEtMA_c41784e2-a3f7-44f9-9ffc-2c09987289c7"
      unitRef="usd">15145000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMy0xLTEtMS0w_0cd72c6c-0e0d-4c47-bb59-51902c94b7a3"
      unitRef="usd">5015000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMy0zLTEtMS0w_f7fd791b-e6ac-44cc-bae6-abdf6bf576eb"
      unitRef="usd">4998000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNS0xLTEtMS0w_06cb4bef-425a-4eb0-8e13-dd425f402e19"
      unitRef="usd">2263000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNS0zLTEtMS0w_4a8a5010-77c2-4d27-905f-b5bb051d3315"
      unitRef="usd">2188000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNy0xLTEtMS0w_bc0935f2-af17-4090-afee-e492019e3b8e"
      unitRef="usd">232000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfNy0zLTEtMS0w_038001a9-cbe1-4b4e-bb8d-9d285c48046a"
      unitRef="usd">179000000</us-gaap:ShareBasedCompensation>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTAtMS0xLTEtMA_acf0a901-daeb-478d-a70f-0b81b3569ba7"
      unitRef="usd">-370000000</cvs:Deferredincometaxesandothernoncashitems>
    <cvs:Deferredincometaxesandothernoncashitems
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTAtMy0xLTEtMA_6a386e49-0bff-4f93-acee-50b559039efa"
      unitRef="usd">-101000000</cvs:Deferredincometaxesandothernoncashitems>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTItMS0xLTEtMA_18943d72-feae-40cd-b85c-10b2761d02ec"
      unitRef="usd">2384000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTItMy0xLTEtMA_eba7be0e-a131-4f63-843f-70427362aebb"
      unitRef="usd">2233000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTMtMS0xLTEtMA_cf8b944d-a649-43b8-938c-dfcfdd28ae5c"
      unitRef="usd">-1517000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTMtMy0xLTEtMA_5b1a9416-32c6-41f8-b815-516a64b93b6f"
      unitRef="usd">-1003000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTQtMS0xLTEtMA_e7052a3b-679a-4439-8441-7cc49b5178b3"
      unitRef="usd">145000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTQtMy0xLTEtMA_f493fab9-83f0-4c77-ba2a-896c55168a27"
      unitRef="usd">560000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTUtMS0xLTEtMA_6c48c16d-2edd-4dd5-b3e7-994a865bb590"
      unitRef="usd">1702000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTUtMy0xLTEtMA_bad7f639-542d-43aa-bee8-eb8efc30c49b"
      unitRef="usd">1671000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTYtMS0xLTEtMA_31e19a42-9b91-4c96-a77c-180afcd61403"
      unitRef="usd">104000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTYtMy0xLTEtMA_9ce743f3-4a47-43b0-965a-ad860701776a"
      unitRef="usd">-415000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTctMS0xLTEtMA_e53ef281-5831-41b8-b866-4e3795998bbd"
      unitRef="usd">805000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTctMy0xLTEtMA_0539f5f9-0ce5-4ae0-a5c7-fc6b7ad079bc"
      unitRef="usd">3694000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTgtMS0xLTEtMA_38874729-bfd3-4f1d-b5bd-38d1d327cfda"
      unitRef="usd">8739000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8yOC9mcmFnOmMwOWFiNDk2ZDc3NzQ0NjJhZGIzMGI2ODg2ZTFlYTM3L3RhYmxlOjE2MDZlMTVmNjY2ZTQyYzQ4MTMzN2JjNzQyNzY4MGQyL3RhYmxlcmFuZ2U6MTYwNmUxNWY2NjZlNDJjNDgxMzM3YmM3NDI3NjgwZDJfMTgtMy0xLTEtMA_fe3feee0-58ae-4b59-a4aa-3e14fe59880d"
      unitRef="usd">10424000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="ie2849a2c586c46ca9f53db41bc644dce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0xLTEtMS0w_4bd2e7ab-5a5e-4725-8447-d159c865dac8"
      unitRef="shares">1733000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i69913db1407a480f8ffe4f65326387a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0yLTEtMS0w_d6fc320c-70ac-458c-bb12-56729a35e2a1"
      unitRef="shares">-423000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a68f85e6ae54b538e5f5597d97d1b7a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS00LTEtMS0w_0a84bc09-a75e-41f3-a855-f96d170c8ee1"
      unitRef="usd">46513000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69913db1407a480f8ffe4f65326387a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS01LTEtMS0w_0e4e0e55-99e9-4e56-904b-60b9f137bedb"
      unitRef="usd">-28178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic95472b2b89f4a878e888b2c6008da19_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS02LTEtMS0w_3358903f-acd4-4545-b9df-75a1eb668d78"
      unitRef="usd">49640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie15d8aea22554cdbb76b87171c699449_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS03LTEtMS0w_ec696316-2d4d-4159-b3fb-e76beb38cd30"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i725e600ffd0e4474a684a511d91bf159_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS04LTEtMS0w_66c58be8-2295-4b12-a115-1a5e9382b11a"
      unitRef="usd">69389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i454f0a28269d4702bfc7afcb9aa5b5da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS05LTEtMS0w_b41964d8-af1f-4d8f-87ea-26b26dc515e9"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0xMC0xLTEtMA_0671816c-a1df-406e-8cc7-ea460d938635"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1c46bc10f72646959e1ea5748cb11a97_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi02LTEtMS0w_22dd4b1c-1f49-4fcd-8d91-23fc62d3821a"
      unitRef="usd">2223000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi04LTEtMS0w_6663a3c1-7ada-4c35-a1b1-b01b7f17ee16"
      unitRef="usd">2223000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia9bb9213ec2f4b83bf72ed648ff095bb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi05LTEtMS0w_a3b194cf-18a2-47b7-b23d-3bab662e86f2"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNi0xMC0xLTEtMA_7e483037-4a77-45fc-ac6e-44a767e0d625"
      unitRef="usd">2224000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifef9fce1a4ab4fd2a6594fc95e1d677e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNy03LTEtMS0w_70e99d65-499f-4f89-b9fb-02768dfcb856"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNy04LTEtMS0w_fb6dcbdb-3db9-4db1-bc55-26d9e89df15c"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNy0xMC0xLTEtMA_58e2b5b7-5990-445d-9b15-12ede7ef8467"
      unitRef="usd">-392000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i10bd9c2fefdf4b9b91c9e4c4c6e1c65d_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC0xLTEtMS0w_638a7cb2-7131-416b-97d8-4ad2255f642e"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iba7043ec64d945079d428818e5fbaca9_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC00LTEtMS0w_d19de74a-a420-4773-878c-7708f957b4bf"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC04LTEtMS0w_796a9b6e-2d7b-496a-99b5-d6c3c32bf859"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC0xMC0xLTEtMA_67465ea4-a0d8-4965-bb1b-8fb0e843ac54"
      unitRef="usd">214000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="iad9a72643612492c9389741defc77a60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0yLTEtMS0w_9880108b-ee15-44bb-9f49-0d4a889dd2ae"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="iad9a72643612492c9389741defc77a60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS01LTEtMS0w_149e934d-1cee-4830-85d7-6f78c36e137e"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS04LTEtMS0w_60158616-8c30-4410-893c-739c9e7269f5"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0xMC0xLTEtMA_01cb7145-a734-4353-88c2-3d0d8d084bf0"
      unitRef="usd">76000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i1c46bc10f72646959e1ea5748cb11a97_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTAtNi0xLTEtMA_ea9d7e3b-8549-4e63-b9ff-dbb7721c9e63"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ib31af1a587bc4739b49ebab8bc7252a3_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTAtOC0xLTEtMA_0bb90b90-fa84-496b-aa62-84f54ea6eb8b"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTAtMTAtMS0xLTA_88a276fa-ffd8-4166-924d-a7f5273e84f9"
      unitRef="usd">660000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ia9bb9213ec2f4b83bf72ed648ff095bb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTEtOS0xLTEtMA_f5cd0d9c-9f74-418a-99a8-5cf66de2821f"
      unitRef="usd">1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ifd9722e278bc46d4806d6a0545ac688a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTEtMTAtMS0xLTA_59d7c1a3-c5c2-4576-b2ad-c4c80d087318"
      unitRef="usd">1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ie383aef477f142c8a4ee9589eb871023_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMS0xLTEtMA_5c4dfcca-d995-4ba9-b4b9-3c1a5eb4b940"
      unitRef="shares">1735000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i9058898b3da04168adb83a7684c321ab_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMi0xLTEtMA_36db3ec1-bc73-4af3-afd1-819eacb01b4d"
      unitRef="shares">-422000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc698fc867dc4bd5a40b8b39c3e3163b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNC0xLTEtMA_7f316f1b-dc43-491a-8c8d-695b7e031c8c"
      unitRef="usd">46727000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9058898b3da04168adb83a7684c321ab_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNS0xLTEtMA_45a7ecfd-6122-49bf-af2f-c7a1b7b7e8dc"
      unitRef="usd">-28102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibeb9d976268a44c29a6827a32bf43b47_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNi0xLTEtMA_4aa8c7d9-a28d-4739-bb92-b5044b10290d"
      unitRef="usd">51203000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib40fe1673abe4a33b8ac7cd76c227e06_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNy0xLTEtMA_e83d1cff-27fb-452d-bd6d-0db022f1d86d"
      unitRef="usd">1022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1568266e931446589f92de497dd53eb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItOC0xLTEtMA_f91577c3-0492-40c7-aca7-ef07d31164e3"
      unitRef="usd">70850000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0958e630b333456980651efb292c7c53_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItOS0xLTEtMA_9314d8cd-06c2-4187-a556-60a027891aa7"
      unitRef="usd">314000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMTAtMS0xLTA_ce73730e-5d0d-4613-872d-92f0c8c9d24b"
      unitRef="usd">71164000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i2d57ce235fd24cb692f4d0236f176f1c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtNi0xLTEtMA_8e12dd01-d510-4217-a10a-26eb5998f898"
      unitRef="usd">2783000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtOC0xLTEtMA_224aeea5-9f1c-4cb6-ba0c-e997ee06a6bb"
      unitRef="usd">2783000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i286be063e99e48df99369d829e93c217_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtOS0xLTEtMA_7fb2391e-741b-4e0b-8a93-2bd35cae9e8d"
      unitRef="usd">8000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTMtMTAtMS0xLTA_13a57390-c1f4-4dd8-b500-9a6319bfac5f"
      unitRef="usd">2791000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia5414e6cf48f414195513e58f1463f45_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTQtNy0xLTEtMA_e602c6bd-1689-4110-9185-9ef741b13b51"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTQtOC0xLTEtMA_a540e61d-757f-4650-bb89-2292c5fd8f51"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTQtMTAtMS0xLTA_d01e70cd-d1e6-453b-94e4-b284e5007f01"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idaf5fc475d1e49ff9053858c7255bf55_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtMS0xLTEtMA_cb9e9599-a9b3-44d8-9a5b-00ddb566082b"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i240be611ec6b458ab8544f6e424d4ab4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtNC0xLTEtMA_6bb3e726-1da8-4905-9248-e5ab6d18d2d2"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtOC0xLTEtMA_e1a62478-51b1-4ebd-a444-809b50843865"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtMTAtMS0xLTA_315e81e6-9cfa-46d3-92a2-ef3676c1a49d"
      unitRef="usd">268000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i76b917a9650e493f8ed240df994cceff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMi0xLTEtMA_bb169a23-a4f1-42d3-a193-eeba9fd4fd7f"
      unitRef="shares">2000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i76b917a9650e493f8ed240df994cceff_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtNS0xLTEtMA_5fa47889-de68-4757-999e-4d5000eeb54a"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtOC0xLTEtMA_865155f8-a2cd-4b1e-b7ec-508444b7ac3d"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMTAtMS0xLTA_6799f244-aafc-487b-94b9-10e0bd3a0f83"
      unitRef="usd">150000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i2d57ce235fd24cb692f4d0236f176f1c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTctNi0xLTEtMA_74f9acb4-3013-43e8-b8a2-1212def9d55b"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i3a9980cde78749e29848fb58fb628de2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTctOC0xLTEtMA_9bbef948-e15d-4664-a16c-0ec030808591"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTctMTAtMS0xLTA_76f4f4e6-2977-4ace-a706-39fc1873090b"
      unitRef="usd">655000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i286be063e99e48df99369d829e93c217_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTgtOS0xLTEtMA_74cf09d6-6d8b-4e51-8147-a41cf9597281"
      unitRef="usd">-1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTgtMTAtMS0xLTA_52dbe585-a8af-404b-8a0b-ab4ce7648f0a"
      unitRef="usd">-1000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i9761a7d58dca45aba855e8b41e1dc1f3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMS0xLTEtMA_6a3c9efa-5ff3-48ec-9373-edf74af8e9f6"
      unitRef="shares">1742000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i9c23afe3b82047c6929678c19cff2d07_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMi0xLTEtMA_cff07a43-78b1-48d4-8ad0-27781b033506"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10016feda33d45238a3ea372b54a6eea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNC0xLTEtMA_eeafa215-8c4d-4f77-9a29-602cb5b96bbf"
      unitRef="usd">46995000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9c23afe3b82047c6929678c19cff2d07_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNS0xLTEtMA_0e8aad1b-d954-41a3-87f6-7e7282581202"
      unitRef="usd">-28252000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa87c9699e7d4b7ba3c7265c59239a90_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNi0xLTEtMA_ea666da2-4f48-41af-91bf-75375d18ab73"
      unitRef="usd">53331000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ade08e12deb4ce9b6e638145fd412fb_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNy0xLTEtMA_d1907957-064c-4aed-83b5-40607f0f104f"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79b5c733f51b48d3a973b7f1be17e3c0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktOC0xLTEtMA_bb71edff-0285-4c49-98b1-5aa676ffd77b"
      unitRef="usd">73244000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81c686e301544071b819b02df1403210_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktOS0xLTEtMA_5009c319-e36b-4708-8ddc-46f428c73d02"
      unitRef="usd">321000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMTAtMS0xLTA_d2539223-f14a-4b9b-8b20-3a2b4d79264a"
      unitRef="usd">73565000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTcy_44f68e91-8309-4843-997d-77c151cf2a98"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTcy_452fd7fb-8628-4bb4-945d-d066295290a2"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTcy_f7a5e22a-af07-4661-bfc6-5e9046449491"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMjI0_0bc9386b-6b67-4ae0-9064-1541208ba582"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMjI0_8c28e16f-7513-4686-8fd0-be0787b5d688"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMjI0_ae3993bf-7e29-4d1d-9e43-622d1d5888db"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMzk3_036a4cff-9c5c-49ff-8d4b-244214962e75"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMzk3_59a880d1-512f-47aa-9371-499cb4a0b94b"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i85e278d7295144ed994bb3fc2ee59a4c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMzk3_91689046-50b3-42fc-b4e2-a7fcae6e30b8"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:SharesOutstanding
      contextRef="ibb200c306c77462da3c260709207f142_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMS0xLTEtNTUy_1a3a273c-82dc-4868-a858-30755776ad9d"
      unitRef="shares">1727000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i6aabd0ef5b1048f4ac916396b08d7b25_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMi0xLTEtNTUy_3c24294a-83fe-4fad-bd4f-da9998c2f8aa"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia31e862a1d4b443ea4f8845ae925852e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNC0xLTEtNTUy_6c173928-5673-4e72-ab3c-179342e32921"
      unitRef="usd">45972000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6aabd0ef5b1048f4ac916396b08d7b25_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNS0xLTEtNTUy_01170ae2-3cfd-4dbf-baf0-e5f84c37dee0"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72d4f602c6ed4d0ebf494b7979f86f67_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNi0xLTEtNTUy_870281b5-5191-4fb1-9c7a-3ff5d93ce4b8"
      unitRef="usd">45108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a66d45936d84142bdd6e849ecbe7789_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNy0xLTEtNTUy_6cb7edbd-a851-4b84-bbc6-6a532886c9e0"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1e00411b2aaf43f8921414ab0ea39785_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtOC0xLTEtNTUy_767509c1-32ac-4d1f-a37c-0e167cbb67bd"
      unitRef="usd">63864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie970b254b4ab4fd9949e74e9ab2d6b22_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtOS0xLTEtNTUy_398b5124-3516-406b-9c68-ca6b2a76f167"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMTAtMS0xLTU1Mg_c3f728ce-8d77-4a43-94c7-376194fce336"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i98608eeed8d14d428759190c950b5465_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktNi0xLTEtNTUy_57d164e0-790b-4848-a8a6-9e39366c9552"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76b30c2fa6a049fe966b44f48240fa3b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktOC0xLTEtNTUy_f7f2d015-f1d8-4e9d-b50e-f9e070d54da8"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0da4d83180d243299812ac6a2eb3e7ab_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMTAtMS0xLTU1Mg_c65fc5fa-829e-4c89-ab40-651d938b254a"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i98b9da8b49334c78a02939885c5ff91d_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtNi0xLTEtNTUy_300709f8-ac8d-4853-adf0-2fddc1ecd634"
      unitRef="usd">2007000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtOC0xLTEtNTUy_d1b3a702-5df4-4d71-beab-b6ccde7ffc0a"
      unitRef="usd">2007000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibb6047b3685b46b296c06bf8cda6cf5e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtOS0xLTEtNTUy_64ee8d50-8945-49ae-a068-0ffa606fee3b"
      unitRef="usd">5000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzAtMTAtMS0xLTU1Mg_b87af7f5-8577-46c9-a414-48feab26d872"
      unitRef="usd">2012000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ed30a7f990b49dbbd6fc681ed4e164d_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzEtNy0xLTEtNTUy_e26c5300-fc21-4748-82da-35959d5876a5"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzEtOC0xLTEtNTUy_43540278-d482-49be-bf0f-853f4f6e5c87"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzEtMTAtMS0xLTU1Mg_4d0e5ce0-e147-4828-a30a-3d81d6b5da5e"
      unitRef="usd">-332000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i06487711e13e4c548dc075099d2dcf4e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItMS0xLTEtNTUy_9ad9db8d-df2e-44ec-9780-6a585891e57f"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i73d0d505da7c43e1ba4f399a5cb33457_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItNC0xLTEtNTUy_bcbbc22c-8e07-4d02-b2a5-ba0f973d0626"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItOC0xLTEtNTUy_678b4596-010c-47fc-8a5b-8e6d0cfe443b"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItMTAtMS0xLTU1Mg_e688ef7a-d36c-4d24-b8bf-23857f67feea"
      unitRef="usd">208000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="i2a885a54dd1743b0ad1cfc07e3045822_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMi0xLTEtNTUy_086fddac-c03b-4336-aee3-c5cf54003721"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i2a885a54dd1743b0ad1cfc07e3045822_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtNS0xLTEtNTUy_c5d53360-3c2f-4371-a2b8-c5945515b120"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtOC0xLTEtNTUy_7565c5af-b593-4e44-a25c-9f6d62ad6754"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMTAtMS0xLTU1Mg_7e88a179-777f-46a7-beee-056ccfc11686"
      unitRef="usd">53000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i98b9da8b49334c78a02939885c5ff91d_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzQtNi0xLTEtNTUy_0fd2aba3-0e4a-464f-b1c0-2ec580b5e1a4"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ib6bc272d78df4a169d78d5ee6ac0a23f_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzQtOC0xLTEtNTUy_248ec406-666d-4c91-aa1e-eda036cb3f3a"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzQtMTAtMS0xLTU1Mg_1d18768d-0cb9-41cc-a8e1-2542e311b9df"
      unitRef="usd">657000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ibb6047b3685b46b296c06bf8cda6cf5e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzUtOS0xLTEtNTUy_8a247b5a-e324-4485-9686-177ebf159099"
      unitRef="usd">23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzUtMTAtMS0xLTU1Mg_650cb146-2fae-4a81-bbf4-22aa39a3f359"
      unitRef="usd">23000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i9281f3b7011a4d5bba7f90551405ff6c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMS0xLTEtNTUy_207c27d8-37f0-439e-917f-162379ad0837"
      unitRef="shares">1729000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ic6087bf853b04c018d9664fc1da50a2a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMi0xLTEtNTUy_9faadd55-3305-4b8c-86b0-635cdf0c51e7"
      unitRef="shares">-424000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7490b026d6d4a8d8ffe46672b4ef377_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNC0xLTEtNTUy_c7407ad0-d847-455f-a7af-7540f8ac4463"
      unitRef="usd">46180000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic6087bf853b04c018d9664fc1da50a2a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNS0xLTEtNTUy_bc106cb1-4cc3-4ad4-961c-e50bd551252b"
      unitRef="usd">-28182000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib744df2f5180441d84b1f3233fef9a67_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNi0xLTEtNTUy_771f6f93-a993-4314-8c9f-cc694f0e479f"
      unitRef="usd">46455000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01b81dca43f14167b65754c7fe593052_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNy0xLTEtNTUy_7f31a9b3-e8c6-4c55-a95e-756c79b9e9b9"
      unitRef="usd">687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icc66c36f5a22420d886ff33223ea53c2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtOC0xLTEtNTUy_0a522a56-409a-435d-ac0c-477f3432fee9"
      unitRef="usd">65140000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33b6cfdbb5a84b37bb82d80f4997197b_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtOS0xLTEtNTUy_3f07ac95-7043-4ebd-874b-a8b14622654a"
      unitRef="usd">334000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMTAtMS0xLTU1Mg_8b6e7683-f546-48a7-adf8-fa486e20a066"
      unitRef="usd">65474000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i6d8629ee1c19401daa61e8d5a614d5df_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctNi0xLTEtNTUy_22f3a5dc-97c2-4f09-a611-f1c7a2219fc2"
      unitRef="usd">2975000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctOC0xLTEtNTUy_f57ec0c8-d9b6-4b8d-b9d1-80a67eba02a2"
      unitRef="usd">2975000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id5049524449d410199f77b0d7237ac47_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctOS0xLTEtNTUy_c4353624-6144-470d-8864-fbd148f3f582"
      unitRef="usd">11000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzctMTAtMS0xLTU1Mg_99c76105-1c4e-4cc3-90db-99066f258bd7"
      unitRef="usd">2986000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib291fbdf9f5b46998ad02b3172e8ed1e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzgtNy0xLTEtNTUy_c8667aee-602a-44e0-8b0d-dda28153da26"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzgtOC0xLTEtNTUy_4c8d6336-ef74-43c4-9aaa-0e60948eef5f"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzgtMTAtMS0xLTU1Mg_d405953f-dda5-47bf-a6e1-e281a74f0105"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0934f4bb5efa44ef900ff2ef426e56c9_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktMS0xLTEtNTUy_0f3b451b-a4fb-41c6-b2ba-2fa2cf5422bc"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i13fe73a518a24b02a40a1f3440e71f50_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktNC0xLTEtNTUy_f5c764c8-c4cd-4356-94a2-de618b57fe99"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktOC0xLTEtNTUy_d3b3fdad-df7f-4164-ba47-9da494676533"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktMTAtMS0xLTU1Mg_87374c1d-914d-420e-b4f8-1758a896050c"
      unitRef="usd">96000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i0a8adba1de1f4894a089eed1e7c97186_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMi0xLTEtNTUy_2b695517-9fa0-4060-9712-c785e9a61767"
      unitRef="shares">1000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i0a8adba1de1f4894a089eed1e7c97186_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtNS0xLTEtNTUy_30e9e76b-eb8c-4b7b-9ec8-3f4acb011479"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtOC0xLTEtNTUy_fc19a57e-4ca5-492a-a435-6e0d7c45bf6e"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMTAtMS0xLTU1Mg_75f60ed6-afaa-4297-b437-acab066a66d0"
      unitRef="usd">53000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="i6d8629ee1c19401daa61e8d5a614d5df_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDEtNi0xLTEtNTUy_59d1b8a1-0b1f-48f7-9ef2-a6c7f9a7858d"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ie5a964aac6094e8197a74c1242e23074_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDEtOC0xLTEtNTUy_25c722bc-4a3d-44e8-813a-82b5886dcb1e"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDEtMTAtMS0xLTU1Mg_283293cb-7169-419f-97c7-68a99c68de54"
      unitRef="usd">662000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="id5049524449d410199f77b0d7237ac47_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDItOS0xLTEtNTUy_4bb25f28-311b-454e-bfc5-2f8b6704ed34"
      unitRef="usd">-12000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDItMTAtMS0xLTU1Mg_8a1abb19-5878-4d75-bd3e-34f6d1ef8779"
      unitRef="usd">-12000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="i25119c25c92b4f2db55b1b12c814d98f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMS0xLTEtNTUy_fe13cb16-f499-4bba-9290-c7c4bb16fd64"
      unitRef="shares">1732000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="id50e79715dae484d8bb0b80b30835854_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMi0xLTEtNTUy_aaa59c91-2c8c-4bc6-9fae-f2004158076a"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i022278e3d45b4b6e87ac5a6324a5b7fb_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNC0xLTEtNTUy_656f23d1-9cb7-4002-9602-2f38a0e35d47"
      unitRef="usd">46276000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id50e79715dae484d8bb0b80b30835854_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNS0xLTEtNTUy_5fe81db8-f08a-46f5-8dd9-5969e92e53e2"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84f5fcae96f94664bcccd015f8aaef7e_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNi0xLTEtNTUy_3359f0be-b6bc-42ca-be92-652ba94fd473"
      unitRef="usd">48768000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i223cec6898e447328115d33128bf3b5b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNy0xLTEtNTUy_c3cb2f10-4ef7-42a8-a0ce-3a84453c96b6"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab4c8b62b63f480793c7a4aadd30e7d2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtOC0xLTEtNTUy_07a32566-10d3-4dd9-a2dc-889e1275923a"
      unitRef="usd">68022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03db7eb72302412682bc5861ee38dfc3_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtOS0xLTEtNTUy_3db5a065-475a-4ba5-9a54-76718c7242db"
      unitRef="usd">333000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMTAtMS0xLTU1Mg_e40a30cc-b8e0-4c45-9bb3-9d712b29be96"
      unitRef="usd">68355000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTM5Ng_657374ad-d418-4299-9820-f7195dfd8459"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTM5Ng_b6bebc31-94c7-40ad-9c67-bff166a4f5e4"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTM5Ng_cfcd3733-20b3-4034-9270-e72f90492c83"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwMQ_01f253aa-3f2a-4049-a399-b57055d0d3b7"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwMQ_ad54758e-2a91-4939-bd7b-bc51ba4ac68c"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwMQ_e9efecf0-a170-4da6-8695-3591c6642c26"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwNg_ac689499-776d-4818-83e0-92fc971b1154"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7b3c5984f04b49c583e02a25e4d11fe5_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwNg_b9bab6d3-c2cf-4e48-98e3-e9c205832577"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTA5OTUxMTYzMTQwNg_fb1fb150-085c-4b6f-aefe-bf4437d3e6c4"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5037b7672ca64770b57ccbefe27214a1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfMTY0OTI2NzQ0NTMxNw_a7bf8cff-3835-4030-b805-19a24d06b8e0"
      unitRef="usd">3000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMjI_f046ba7f-6589-48b2-b951-682f6e170f38">Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation (&#x201c;CVS Health&#x201d;), together with its subsidiaries (collectively, the &#x201c;Company&#x201d;), has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 108 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) continues to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#x201c;2020 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $367 million and $358 million as of June&#160;30, 2021 and December&#160;31,&lt;br/&gt;2020, respectively. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#x201c;ACA&#x201d;) has imposed an annual premium-based health insurer fee (the &#x201c;HIF&#x201d;). The HIF, which is payable each September, is not deductible for federal income tax purposes. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the three and six months ended June&#160;30, 2021. In the three and six months ended June&#160;30, 2020, operating expenses included $248&#160;million and $519 million, respectively, related to the Company&#x2019;s estimated share of the 2020 HIF.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $10 million and $3 million in the three months ended June&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $19 million and $23 million in the six months ended June&#160;30, 2021 and 2020, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $22 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2021 and 2020, respectively, and $37 million and $43 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other &lt;/span&gt;&lt;/div&gt;comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTgx_e2e95c81-f2a1-4de5-8dd4-753ebda17b2d"
      unitRef="location">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMjE2_5a591ce3-7013-4832-9698-da14a86ead36"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <cvs:NumberofPharmacyPlanMembers
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMjk5_4db4984c-7921-4c0d-82a9-b52c130253c4"
      unitRef="people">108000000</cvs:NumberofPharmacyPlanMembers>
    <cvs:NumberofPatientsServedperYear
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMzc2_90b05a3e-7788-4f65-9a75-059e46d27280"
      unitRef="patient">1000000</cvs:NumberofPatientsServedperYear>
    <cvs:NumberOfPeopleServed
      contextRef="id0838c3d504c4b0ba188c00aa78d7033_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfNDc3_5d611163-0872-434f-b976-8e1d42d0b532"
      unitRef="people">34000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMzE_dc5e7961-6cc3-4640-a4a2-16b7d2cf73af">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Health Care Benefits segment is one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Pharmacy Services Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI2Nw_a7ca484d-a531-4d8d-9146-591479855774"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfStores
      contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfNDQ5OQ_e2e95c81-f2a1-4de5-8dd4-753ebda17b2d"
      unitRef="location">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="ie162e65831a24d7ab6410600ff4e0eb5_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfNDUzNA_5a591ce3-7013-4832-9698-da14a86ead36"
      unitRef="clinic">1100</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNTE_d0205140-c561-46aa-bb49-ce74c2db0e87">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#x201c;2020 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#x2019;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTM_adc69d42-f9aa-43f9-953d-51e36dc42523">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTM_b0d3aba1-0108-4f41-8423-ee0d1c73d3e4">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#x2019;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNTQ_20784d10-a93d-4b82-a327-1174154e39ac">Restricted CashRestricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNDA_4a650027-cb4d-443c-893f-6f8fd108bc05">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMS0xLTEtMS0w_5d198605-6893-47a7-ace3-29c5729d84b0"
      unitRef="usd">7119000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMS0zLTEtMS0w_55058523-9201-4431-a153-e6c87734b5e9"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMi0xLTEtMS0w_2ab6556b-e0b3-48c0-88e3-cf8be2505204"
      unitRef="usd">218000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMi0zLTEtMS0w_0c9db9c1-f0a6-471c-a038-02eb0c0c86bd"
      unitRef="usd">276000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMy0xLTEtMS0w_4d3df0cc-cabc-4dd3-b5f0-5ee33e2fdab0"
      unitRef="usd">7337000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjcwZWYxZDQxMmM5ZTQ3NTVhOGQ1YzczMTY1OTEzNDk1L3RhYmxlcmFuZ2U6NzBlZjFkNDEyYzllNDc1NWE4ZDVjNzMxNjU5MTM0OTVfMy0zLTEtMS0w_bdc36cce-0980-4755-a587-a9d6ef80d40a"
      unitRef="usd">8130000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzE_f8394151-53e1-40dc-aac8-52985bf687e9">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzI_3576c45b-b70e-4269-b78e-2ec42d6cf815">Accounts receivable, net is composed of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMS0xLTEtMS0w_b1a9ff26-fe1e-487c-809a-286a7f84e756"
      unitRef="usd">8021000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMS0zLTEtMS0w_fef1266f-e8a0-48aa-99b6-0623bfe612ae"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMi0xLTEtMS0w_af98423c-790a-43e0-8369-aeb3eb61b7b6"
      unitRef="usd">10955000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMi0zLTEtMS0w_b9e81a63-adb2-44e9-ab8c-5a15a2a6b0ea"
      unitRef="usd">9815000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMy0xLTEtMS0w_4b284baa-57df-45a3-b947-582926106a4f"
      unitRef="usd">2942000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfMy0zLTEtMS0w_0c870b05-4729-4879-b2a5-55c18cb36b8e"
      unitRef="usd">2628000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNC0xLTEtMS0w_16d232e9-d548-47b1-ad93-b4beaeea926f"
      unitRef="usd">2246000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNC0zLTEtMS0w_2ca706c8-c720-4776-9752-456ced36979c"
      unitRef="usd">2198000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNS0xLTEtMS0w_ac82a758-26bf-498b-a0f8-4ba24d272d42"
      unitRef="usd">24164000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOmM2ZTRlNzFlZDg4MTRhM2ZiMjdhMWMzMWI1N2QyNDVmL3RhYmxlcmFuZ2U6YzZlNGU3MWVkODgxNGEzZmIyN2ExYzMxYjU3ZDI0NWZfNS0zLTEtMS0w_ab6e2a2f-d0b2-4a06-af11-a016726f72ef"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfODg5Mg_7bd3d1fc-4b58-43c6-bf60-65bb2a38f35d"
      unitRef="usd">367000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfODg5OQ_ee51f7fc-41f3-4ae6-b7b3-1be0e4174fa9"
      unitRef="usd">358000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTk_b760022d-ffcf-4738-8fa1-fa35bae4135b">When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTQ_ba18aa11-40c0-48c7-945d-a2918a268774">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables disaggregate the Company&#x2019;s revenue by major source in each segment for the three and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020   &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy network &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mail choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice program.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f6a3d3df86b4fc6877832fc49952ae8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy0xLTEtMS0w_00c50e62-3158-4ab4-a8ba-3425b0560dda"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic26532a4b62d467aa9a8517bc7419919_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy0zLTEtMS0w_42ab88b6-d585-4a1e-8d2f-2e1293f1ac86"
      unitRef="usd">38153000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48e7456f591546feb889d8098d55bd2b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy01LTEtMS0w_fd58916b-5d17-4e55-9d52-f21ad2c32404"
      unitRef="usd">18873000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80f9e4113d044d07a6f887feda963f25_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy03LTEtMS0w_fe6ef5b1-b985-456e-a516-96a4de0fd683"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i572b532a257b4eb29f5818e465112777_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy05LTEtMS0w_43fa97ae-52ac-4d03-afd0-f6db3280f48c"
      unitRef="usd">-11094000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0e466ab07004cd0914feafe9a6bf57e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMy0xMS0xLTEtMA_ed5b21c7-b1e8-4caf-a1a4-a1cb871b6b6c"
      unitRef="usd">45932000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b2d360907ea45f0b08862db70c4d3d7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC0xLTEtMS0w_13014151-28e1-4b74-b5f5-4793828bad9e"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aa1afd1040f44cf8547b63d41dbe591_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC0zLTEtMS0w_654b7d3c-0a6b-450e-b54d-d88ec2076607"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3bca70c57704131aa24ce446c205802_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC01LTEtMS0w_6b24d742-57e6-498b-a3d7-55774ca790cc"
      unitRef="usd">5254000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6c46eed192d41dc99861555299a540a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC03LTEtMS0w_ed282d4e-48d8-4348-afeb-d8bbacbc8257"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28be049ff18f43fbaf9cdd9ef79e8fa0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC05LTEtMS0w_26cd3a56-aa75-4df7-82b6-d720b36e3081"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dcce512f8f4473389ed02f496c8b487_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNC0xMS0xLTEtMA_590c4903-2c39-455b-9334-8af42771d3f2"
      unitRef="usd">5254000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e5bd3d12817424a83bdab3e1ef08149_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS0xLTEtMS0w_e9015b32-ba70-461a-8dec-cf48a76802e8"
      unitRef="usd">18968000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44034671f9c84fe8b2a64b71bb298348_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS0zLTEtMS0w_871042d0-0787-45e8-bc51-07cc267db661"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0ce4e1b8cd247a3afa48a6db26e4e70_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS01LTEtMS0w_4e40103f-6e3c-4b49-a922-d5f66649a243"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i032e4e9b3eda4cb18d91840ce8d0e1dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS03LTEtMS0w_6da35108-2433-41ec-9120-dde48e73af7c"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e5c7ea4581f40a28c6c335f145013dd_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS05LTEtMS0w_8a35e44d-2285-4a69-91ee-ec8b8fd4d7b9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e2905eda41a471f8d885c44663f8134_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNS0xMS0xLTEtMA_db5fb826-201a-4443-8597-71f8cc0539f3"
      unitRef="usd">18983000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi0xLTEtMS0w_5ac72232-33cc-4c53-9197-c421d0ff76c3"
      unitRef="usd">137000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi0zLTEtMS0w_7edff7b7-ae5c-414e-93af-06f62bae570e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi01LTEtMS0w_e879954a-98fc-4052-96f5-b9da631118fb"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi03LTEtMS0w_b169da7b-18c5-45a9-8fa9-1e018e0ff63d"
      unitRef="usd">152000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi05LTEtMS0w_12960994-319d-4283-9d40-5e871df73978"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNi0xMS0xLTEtMA_b043e3c6-cec2-432b-83c0-04fd2159c3ad"
      unitRef="usd">289000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3a0d48a02bb422399156ace038008ad_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy0xLTEtMS0w_3495d18f-e797-43fc-8cd7-f2a4df0be94f"
      unitRef="usd">1420000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70c50ebb9b454e83b240a67beba32866_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy0zLTEtMS0w_0ac2fe43-c209-40ff-abb5-993caa0e91b4"
      unitRef="usd">161000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i496dec9258b04dcb9203d4d4c27ff56c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy01LTEtMS0w_6e536851-bbed-44c6-9917-ed1683f8ea09"
      unitRef="usd">601000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b9d1860aea74e00ad2c89291bc24962_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy03LTEtMS0w_da6cbe03-66eb-409a-9bfe-f3e74e20cea9"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60ddfcc881984e29b4f64377dfc996c2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy05LTEtMS0w_df01abf1-e2e6-4a7c-9ce2-65efc99eafef"
      unitRef="usd">-39000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ce75e54f582485ab1f2e764803ce78c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfNy0xMS0xLTEtMA_b8857115-6daf-4fd9-9fef-618579f8de2b"
      unitRef="usd">2158000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC0xLTEtMS0w_275ef5d8-b8f7-4fd2-97b7-b594dd9dedfa"
      unitRef="usd">20525000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC0zLTEtMS0w_76ca90d6-3f43-40f1-b8f4-a13a0a7033cd"
      unitRef="usd">38314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC01LTEtMS0w_95e52917-dee5-4b75-8c67-e3daecbe4bdd"
      unitRef="usd">24728000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC03LTEtMS0w_84c58998-3852-4e5c-8723-085a569d850c"
      unitRef="usd">182000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC05LTEtMS0w_827e179d-9403-43b8-8ad2-008493033f28"
      unitRef="usd">-11133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfOC0xMS0xLTEtMA_9744f6e3-8384-4a89-8baf-8e3de2dbc7b5"
      unitRef="usd">72616000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d12aed0d38d43b7913ac1ed40d9742d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTEtMy0xLTEtMA_ae04c450-be87-483a-9d91-6561ddc2993c"
      unitRef="usd">22918000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3901d540d984bdbbe7954d01630c93e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTItMy0xLTEtMA_d93e7852-c260-4fab-97b2-c6657fa45eb4"
      unitRef="usd">15235000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib63e5fbf23624c13957ee808a92953b4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTMtMy0xLTEtMA_92d87c1b-47a4-47a0-bdc0-323d43779ea8"
      unitRef="usd">161000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTQtMy0xLTEtMA_37fa1391-dd92-469d-b6c8-977b079ec4a5"
      unitRef="usd">38314000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0a382aa8220f4a0a8e22b91b4225625a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtMS0xLTEtMA_f9e90cbf-c6ca-44b8-a433-5fae97445dfd"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic571fcb252b9454580ca0b9a68a73d74_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtMy0xLTEtMA_66d5a354-ed2b-423e-9d6d-0a578f0e0585"
      unitRef="usd">34645000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i571c2782d55d4067ac07ad878ad2cda0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtNS0xLTEtMA_7f4e1499-cecb-4463-affc-0ef9f7082912"
      unitRef="usd">16870000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id584afc20f824cb5b10632de8cedc4e8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtNy0xLTEtMA_674b3c63-295d-4a98-8b58-c631080b0ea2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d48d9893b4e4e8fa0ae931e8905c5af_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtOS0xLTEtMA_126a9b58-7fda-4cc4-9db7-16cb83cf9ff9"
      unitRef="usd">-9741000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5825e37024df49d08a5c01af8e8c0cbe_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTgtMTEtMS0xLTA_71a51895-3938-42e5-abc3-7b5da7589129"
      unitRef="usd">41774000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86e6aad25c1b48e18ec4aedb16181989_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktMS0xLTEtMA_ed2f1837-5435-4337-8218-cf662dab0364"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieabfd20c74d44f14b5f7309d49ff43fd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktMy0xLTEtMA_95336477-3621-4263-916b-a012cb49cea0"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1150195ef084b308adc08d5b6fd6d37_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktNS0xLTEtMA_402341d4-4661-4af6-b2f8-dfc9e3d5bfe1"
      unitRef="usd">4653000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i277b57b4d1bb4be1b4eed74758be2d3a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktNy0xLTEtMA_35101d00-7704-484a-b0d7-b773d550b293"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c845f14e279418b852581196c54f9c8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktOS0xLTEtMA_674b02c1-71d1-49b7-b0b7-a4e2c3c85a0f"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i920cdf64d2fe4196a7c51badf2e4b2ee_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMTktMTEtMS0xLTA_e9124463-4d75-4f8a-97a9-62aa0e665e92"
      unitRef="usd">4653000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70267249c6134e0184dcdf8d3a4b67cf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtMS0xLTEtMA_7fbd1efa-69f8-437a-b693-f2001a855768"
      unitRef="usd">16913000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i820e7e5dad1e4cc99afe17c533670331_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtMy0xLTEtMA_21ade81e-7d74-4444-a194-5fd1a3efb387"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6172f9453d340f39d59d5101635a85a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtNS0xLTEtMA_04e12d94-f58c-4c2f-9767-dc77d9d1e4f6"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i411456f412ea4846a96be3b32e388bd5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtNy0xLTEtMA_af8694c9-a951-4c0e-9cd4-79a9eb06600c"
      unitRef="usd">14000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fa3071f0b9a448599732f89a137d911_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtOS0xLTEtMA_9502af82-7faa-43e1-b25e-b103637fc2f2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79016db736f64c5bbe4e068ac2adcd98_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjAtMTEtMS0xLTA_c527022e-18eb-4aa3-ab03-08b05207f1f9"
      unitRef="usd">16927000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtMS0xLTEtMA_547cd718-c728-4528-828d-1bd5f42e47ee"
      unitRef="usd">127000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtMy0xLTEtMA_26b6cc8d-bab6-418b-8838-59e8f586f37a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtNS0xLTEtMA_46f4dbef-bee7-4164-a86a-5d7f36d69788"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtNy0xLTEtMA_5386f1e1-05a7-4a43-91dc-7e0a45565945"
      unitRef="usd">57000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtOS0xLTEtMA_7f91bfa3-29b0-438e-93fc-34c667541e59"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjEtMTEtMS0xLTA_217f5069-6398-4b16-a9ab-be284d944510"
      unitRef="usd">184000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e4ac40a398f427cb77a2094a1e447e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItMS0xLTEtMA_18ec7dfd-9c94-4b95-9a0d-764f09832df0"
      unitRef="usd">1428000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24a50869ac304742b49b405bf41bdc02_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItMy0xLTEtMA_0cd4d139-5449-4ece-ae71-553e01233746"
      unitRef="usd">244000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i600ff56b85734cbba43e0b25e8b6f595_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItNS0xLTEtMA_8c094ed7-8cf6-4341-9c5b-30df1152c2fc"
      unitRef="usd">139000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice379e0dacf9467da98333a95b5e13ff_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItNy0xLTEtMA_49315b85-2e86-4da7-99e3-89c3305a5bd4"
      unitRef="usd">15000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29c79146b5294d08add1c3efc10db8ce_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItOS0xLTEtMA_630457b1-09b3-48b8-b552-c832512a7fc6"
      unitRef="usd">-23000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54e8d73c14454d5aadcdd542013be434_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjItMTEtMS0xLTA_64eed779-09a2-445b-a100-e741fee0cb12"
      unitRef="usd">1803000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtMS0xLTEtMA_831c508c-be05-49e6-9f66-3f0659930350"
      unitRef="usd">18468000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtMy0xLTEtMA_3c312594-9386-4e5f-90a3-20df1959b6d1"
      unitRef="usd">34889000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtNS0xLTEtMA_5c116a43-39e4-4ff0-938c-4e3329d1af4d"
      unitRef="usd">21662000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtNy0xLTEtMA_038f0d5b-df43-4ae9-a15d-def3d9c75039"
      unitRef="usd">86000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtOS0xLTEtMA_34d4a4b2-07c6-40db-8e08-5abcb7924f23"
      unitRef="usd">-9764000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjMtMTEtMS0xLTA_94eba419-4ea2-4f1a-bd7d-b5988b9adebd"
      unitRef="usd">65341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib920548c0b1a454d81f1407f3de6be03_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjYtMy0xLTEtMA_be49a97b-3202-4f7a-9f15-8799e72e6e87"
      unitRef="usd">20536000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if479dca3854347d3be7f823a1683f8b5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjctMy0xLTEtMA_96a16e7d-33c1-417f-ab88-0d9d9eb36598"
      unitRef="usd">14109000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i364787c47e394a57938aa7f7999c533f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjgtMy0xLTEtMA_6a019acc-713e-43b1-b0bf-836700bfacc9"
      unitRef="usd">244000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjA5NDQyOTc1NDk1MjQ1YTQ5YmVlMDNjNDRjNWY3NWVmL3RhYmxlcmFuZ2U6MDk0NDI5NzU0OTUyNDVhNDliZWUwM2M0NGM1Zjc1ZWZfMjktMy0xLTEtMA_f70a20aa-ed91-499b-afd3-6ffc0a99c3bc"
      unitRef="usd">34889000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i166554c720f64af9bcbc5fd85e9bcee6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy0xLTEtMS0xNzI_79a5143a-5151-4d32-83a9-00123b58ecac"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6fb5e05c3b6493da3da36f60554098b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy0zLTEtMS0xNzc_4a426c86-1d62-4bd1-aabd-fcf1f31510d6"
      unitRef="usd">74294000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f45cc0df9464d56aeaa2320aaed3b45_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy01LTEtMS0xNzc_ee5f839c-8e90-479a-b25a-c1ba21e33cac"
      unitRef="usd">36758000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i212fe2f3583e496088a7a5e86f5f1b17_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy03LTEtMS0xODI_d1675663-d973-4107-8d43-2d7f8985a73c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i759569ae7b9b48af8ea1770c353db400_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy05LTEtMS0xODI_8a799d7c-17d8-44d5-b59e-2478295b251f"
      unitRef="usd">-22168000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6889ed969d4544329ba1c263b5ac4e03_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMy0xMS0xLTEtMTgy_82839d18-ced1-4b5d-b005-b806b92db4bf"
      unitRef="usd">88884000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92f22972f46042c297c7c89259a121c6_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC0xLTEtMS0xNzI_3702daf2-27a7-471c-a564-ca0e7fda4630"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bcd11287bf94b91819f67ab1137751f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC0zLTEtMS0xNzc_bea8ddb2-09bb-42f7-8c49-94958576f601"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11dcc6b36e054b7f83db5e8213b3e4a7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC01LTEtMS0xNzc_fa97bd6d-75ed-4b79-91c2-569236ee482b"
      unitRef="usd">9896000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd33f24ebc4242b4a184fe50093ba8f1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC03LTEtMS0xODI_655ba69d-7ec6-47c3-aae8-4174838d1fb2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8f434ba89a2463491a53e466c45f175_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC05LTEtMS0xODI_09142c04-efda-4773-bce6-19a1d02972e2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c500e6eec404740b845bbc6749d9816_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNC0xMS0xLTEtMTgy_29999cf4-d665-4a85-8845-0cd9e9b09942"
      unitRef="usd">9896000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5560473d23f4f238af0827e871ebe16_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS0xLTEtMS0xNzI_d5c262f6-0432-42ec-8239-6dc991f5f79f"
      unitRef="usd">37910000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0190811d39f4835b7c199890587db0d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS0zLTEtMS0xNzc_cc51940e-c945-48ba-8570-21bc7ca7fe1c"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92367a9e55d345ae84f133238ad6f0c5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS01LTEtMS0xNzc_c2605cd2-c31a-41a9-96d4-1adf05ad96d9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i140296fa522140e8b9fff9b2f366d8e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS03LTEtMS0xODI_91b7b4a4-a39f-4da7-bc1e-6a393ff33ef7"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5770294e42ea4e908f315f226b548613_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS05LTEtMS0xODI_6dad172f-314b-4974-90df-51806e0d80f9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id320ea86e20d46c5b18c7cc290be409c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNS0xMS0xLTEtMTgy_867b8b95-4dcc-4033-a7b1-66d93bf623f0"
      unitRef="usd">37943000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi0xLTEtMS0xNzI_d8f4ed47-cdd6-471e-b276-a2f8174875ff"
      unitRef="usd">285000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi0zLTEtMS0xNzc_2471cc58-b1ad-461c-ae43-dd210af699b4"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi01LTEtMS0xNzc_ed5e3f3f-05d7-4415-b8c2-cae3741cbbdf"
      unitRef="usd">46000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi03LTEtMS0xODI_0e1aef48-5ee1-45c9-afb3-ae7a08393535"
      unitRef="usd">255000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi05LTEtMS0xODI_b5a5415a-07ce-42c6-9f29-1ad2a03f3af6"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNi0xMS0xLTEtMTgy_8e34341f-0389-4a58-822f-663c3d6df52c"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8b3699d17ab4bc49abd7de1d430af9f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy0xLTEtMS0xNzI_97d3cc65-6ee8-4058-96b2-8b304fba5afe"
      unitRef="usd">2813000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64696f2811204153b3a4db3e0624abce_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy0zLTEtMS0xNzc_1259b4bc-a4ad-43b6-8df4-52ed7506af4b"
      unitRef="usd">341000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bd9f5dd41194be8aa3c1c1db6ac93fd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy01LTEtMS0xNzc_95069437-7c1e-4a78-84bb-85590d40c1f2"
      unitRef="usd">1302000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c96c74db01f4ec1ba8c3b7ed9abcc0e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy03LTEtMS0xODI_85fa414f-dd32-483c-a484-b18a7c5016a0"
      unitRef="usd">29000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48dbcd0e840b41f0ad881ba4a5cb6ce5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy05LTEtMS0xODI_5447ae25-ae62-4a27-ad98-d5d6c64456be"
      unitRef="usd">-81000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i216530e358d54f83b2e18ae38bb5be13_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfNy0xMS0xLTEtMTgy_dbe0369e-8462-43f3-81c6-2d2738041d3b"
      unitRef="usd">4404000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC0xLTEtMS0xNzI_b9faa472-2316-48d5-aaf6-0a4ec35815a6"
      unitRef="usd">41008000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC0zLTEtMS0xNzc_0b31019d-342e-45ba-8421-8b35f85e1b48"
      unitRef="usd">74635000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC01LTEtMS0xNzc_565a6fbb-742c-4b4b-b851-67a561c51da6"
      unitRef="usd">48002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC03LTEtMS0xODI_9deb4473-ea26-4d91-8d4e-a11420519de0"
      unitRef="usd">317000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC05LTEtMS0xODI_9269b204-00cc-4fdb-804a-7b76b166ba0b"
      unitRef="usd">-22249000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfOC0xMS0xLTEtMTgy_d1a64bc1-9f95-45f3-a635-b66e8d3dd485"
      unitRef="usd">141713000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2e8bbdf8e1364bb78dd9cb3211b8052e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTEtMy0xLTEtMTkz_aaf88d9f-dde3-4147-a7c3-263a6012ed60"
      unitRef="usd">44811000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie91de92b5d1d44a68fa60bf2e45aa5d2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTItMy0xLTEtMTg2_6f9b6997-6896-469e-9a95-90b286d96626"
      unitRef="usd">29483000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iadd2c902bbe145308ec3aa05c17b567c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTMtMy0xLTEtMTg2_6cb48087-21b7-4490-a6d6-52de37bcd04f"
      unitRef="usd">341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTQtMy0xLTEtMTg2_15511087-a903-4bba-847f-9926888abec9"
      unitRef="usd">74635000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ffc9a8dd41244b8acff67f5bde3ea2f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtMS0xLTEtMTk3_6b7bc59f-4f79-4a0e-a109-65493137dca0"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2efc32665c704f25894100c8ce4d0df7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtMy0xLTEtMjAy_f932a521-59af-476d-828b-9df2c3fdc2b9"
      unitRef="usd">69419000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95dd9befbed24089a9f86d2e656a2894_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtNS0xLTEtMjAy_318f74ae-a150-4d4e-a8b9-8c03a8cd09d2"
      unitRef="usd">34225000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee48290a6467466dbd923d0cdeae5c9e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtNy0xLTEtMjA3_dcf3b82b-6ad6-406b-a97e-5f5cf7ade114"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3466d17106d4ff0ab52299c6a6ab8e9_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtOS0xLTEtMjA3_1f26e85a-5fad-47d3-baa4-a970b69bde8f"
      unitRef="usd">-19998000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f50e02b79ee45deb02a3ed6774b2cb0_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTgtMTEtMS0xLTIwNw_a89666a3-68ea-49e4-b7eb-d66eb042f358"
      unitRef="usd">83646000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i125594ebf3e84110a3111697a3b48e4e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktMS0xLTEtMTk3_c8734538-d685-4083-9c2e-40035ba1b050"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0b811b19b1445fa845554f632a26d2d_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktMy0xLTEtMjAy_397955c9-528b-48cc-b573-5a6bd96eb908"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i095ac5b05f56430b92c8170b133a7866_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktNS0xLTEtMjAy_7fea76a6-3e33-4987-8925-6749f3308ada"
      unitRef="usd">9861000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if937cafeb43442a9aa8e67151c4d0301_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktNy0xLTEtMjA3_34c546ba-8899-423a-a8e2-f176ac72e9a4"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadff063171ac423d92c2da8077c58172_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktOS0xLTEtMjA3_da1c5d8a-d361-4c31-903e-0635e56eb122"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8164c11b7854ff18ddfd168e0890d44_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMTktMTEtMS0xLTIwNw_81e437aa-fdec-4a66-b327-78a50c38f1f8"
      unitRef="usd">9861000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i207199ecb13645e897faf29de46c250a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtMS0xLTEtMTk3_eeb7c124-172a-4041-bfff-dc82c9bf2ee2"
      unitRef="usd">34534000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fd1ce170b5c4a62b7556fdc2322c872_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtMy0xLTEtMjAy_62fe6a8a-c0d4-418c-98b4-d0a0464abace"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39233506c97a4bffa7f4b9b02c27354d_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtNS0xLTEtMjAy_c1194841-efd0-4e9f-8944-9679fcf11e63"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64ced488010e4594a0781af33f4169d5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtNy0xLTEtMjA3_9aeea1ec-12f1-4b93-82b4-b28351937ef2"
      unitRef="usd">33000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i587dd0796ad94946b28c9400be32b020_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtOS0xLTEtMjA3_1efa7fcf-7e17-421f-90fa-30965224ca86"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i650d317e298a41ff8c04c7c3675c3c0e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjAtMTEtMS0xLTIwNw_0fd646ec-176b-4648-860b-2cdbc1be5d30"
      unitRef="usd">34567000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtMS0xLTEtMTk3_32502457-6183-45ad-96d6-e711813ccc73"
      unitRef="usd">220000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtMy0xLTEtMjAy_2bed7200-9676-4059-9537-ce5f94e6a4bd"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtNS0xLTEtMjAy_bd314a35-bff4-42b6-acb9-8dd3f5d280e0"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtNy0xLTEtMjA3_dfdfff80-3e21-4d02-b947-e032b6b65f5a"
      unitRef="usd">126000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtOS0xLTEtMjA3_29828dbd-4697-4df0-9453-c688cf53fb16"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjEtMTEtMS0xLTIwNw_412593af-9af5-4a50-8930-676bac74a820"
      unitRef="usd">346000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i630fb69c6df2418b968902ada8401a5a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItMS0xLTEtMTk3_92fd48dc-750e-4cde-98e4-d6f95b586139"
      unitRef="usd">2912000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife997dbd130a4d2e9fd1499ba1bea839_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItMy0xLTEtMjAy_73caa1c1-0d16-45b6-ad9d-7ed5dff9c5da"
      unitRef="usd">453000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1703ae8e098b46b78e9927eaf75be8bd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItNS0xLTEtMjAy_9ff7ec41-09f3-4a49-8ad5-dab386861074"
      unitRef="usd">325000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e954630bc78462e89281fe898f9064b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItNy0xLTEtMjA3_62190ff8-d9e7-46f7-b6a4-48d200032a53"
      unitRef="usd">17000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04b88e9ad43344949030a683b6a00df5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItOS0xLTEtMjA3_d2e8cf8b-c58a-4550-989e-c150a988adf7"
      unitRef="usd">-31000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ed80d35553c4d40a468c52a12055be7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjItMTEtMS0xLTIwNw_7d6cf7ac-6680-4386-8ac6-8e069c49ab00"
      unitRef="usd">3676000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtMS0xLTEtMTk3_d5288e7d-2a07-48b4-bdd8-321b7624c4d4"
      unitRef="usd">37666000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtMy0xLTEtMjAy_64db5680-a4af-45a7-b233-20f92348afe2"
      unitRef="usd">69872000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtNS0xLTEtMjAy_78721e17-80fb-4367-b763-0eb29e8d6d9e"
      unitRef="usd">44411000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtNy0xLTEtMjA3_ecbd9b77-2e35-4e14-ab4c-914a897fe1f9"
      unitRef="usd">176000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtOS0xLTEtMjA3_110f5ddb-7d94-4d44-abb9-cd3652c423b5"
      unitRef="usd">-20029000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjMtMTEtMS0xLTIwNw_8493b24e-5048-48a7-9a31-3a59dda0ec13"
      unitRef="usd">132096000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba7c706ce4764a0da3369af23605e185_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjYtMy0xLTEtMjEx_46a7b160-f9bc-4b64-96da-aecb8b81409d"
      unitRef="usd">41636000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77c07f5d814342089f6740d390c7572a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjctMy0xLTEtMjEx_9d2f88f7-02b1-4e31-8301-a9cfbd0d8213"
      unitRef="usd">27783000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i432117100b93456f8cf6f278d0e673e9_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjgtMy0xLTEtMjEx_9ae8fcdd-217f-43e3-b3fc-8e9112f9b044"
      unitRef="usd">453000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjQyNjg5OTYyZjZjMjQzZWVhOGVmMmJiNzY0ZTUyYWVlL3RhYmxlcmFuZ2U6NDI2ODk5NjJmNmMyNDNlZWE4ZWYyYmI3NjRlNTJhZWVfMjktMy0xLTEtMjEx_33d229ea-2cd8-498f-af72-e37b05318211"
      unitRef="usd">69872000000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNjE_feeed2ca-d6a8-4ad8-9d44-586f7f26ca17">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMTA_b023d27c-7ffc-40cb-bf1a-e72103e4fd59">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMS0xLTEtMS0w_b1a9ff26-fe1e-487c-809a-286a7f84e756"
      unitRef="usd">8021000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMS0zLTEtMS0w_9e66ec0c-ca1b-470b-9cf6-c2c7b91d808b"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMi0xLTEtMS0w_7fb8dd6e-ee4b-487d-8ef9-69fbd175fab1"
      unitRef="usd">79000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjFkMjAxYWE4NmQyODRhMmZhYWQ5MDE3MjM5MTBhYzM1L3RhYmxlcmFuZ2U6MWQyMDFhYTg2ZDI4NGEyZmFhZDkwMTcyMzkxMGFjMzVfMi0zLTEtMS0w_6de237a9-b50a-47dc-b799-4f5d0350175f"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMi0xLTEtMS0w_6de237a9-b50a-47dc-b799-4f5d0350175f"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i76f7761a4b9349978ab4d5316305bf43_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMi0zLTEtMS0w_892451d8-6683-419c-831a-747bd7ae28e4"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMy0xLTEtMS0w_3e4d9277-f2e3-4f19-9ef4-1e4911a945a5"
      unitRef="usd">183000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfMy0zLTEtMS0w_9e1fa3c8-5825-4e82-923b-1c3aad3b40c6"
      unitRef="usd">179000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNC0xLTEtMS0w_e9c75305-16ea-441c-a784-bd8ca3ce3d4d"
      unitRef="usd">175000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <cvs:ContractwithCustomerLiabilityRedemptionandBreakage
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNC0zLTEtMS0w_14b1c0af-8578-4b45-bfeb-e13cee81b4ce"
      unitRef="usd">174000000</cvs:ContractwithCustomerLiabilityRedemptionandBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNS0xLTEtMS0w_7fb8dd6e-ee4b-487d-8ef9-69fbd175fab1"
      unitRef="usd">79000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i39f7c3dcc5d9411e886418c91d8ba82b_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RhYmxlOjM4YTA0YmZlMGUwMDRkNWNhY2ZhYzc5NTk2NzIzZWI1L3RhYmxlcmFuZ2U6MzhhMDRiZmUwZTAwNGQ1Y2FjZmFjNzk1OTY3MjNlYjVfNS0zLTEtMS0w_e07b3cd7-96ea-41c1-bf26-7e3cccc23937"
      unitRef="usd">78000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:HealthCareEntitiesPolicyPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwMjg_5e9a3843-4a97-4f2c-b52f-588c5b8c89ba">Health Insurer FeeSince January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#x201c;ACA&#x201d;) has imposed an annual premium-based health insurer fee (the &#x201c;HIF&#x201d;). The HIF, which is payable each September, is not deductible for federal income tax purposes.</us-gaap:HealthCareEntitiesPolicyPolicyTextBlock>
    <cvs:HealthInsurerFee
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTE3NTU_23c3826a-5055-418d-b015-150f5f620184"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTE3NTU_383bf6e7-d8bb-4f10-ad66-292b26e6bbaf"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDM0MA_84dd4b70-d069-4e80-9c8e-54d63ec237b1"
      unitRef="usd">248000000</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDMxMw_e0c7b85a-cf6a-4759-b9fd-3674bec24f1a"
      unitRef="usd">519000000</cvs:HealthInsurerFee>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzM_2582b4f8-2eca-4133-b6bb-90ff697b3425">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $10 million and $3 million in the three months ended June&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $19 million and $23 million in the six months ended June&#160;30, 2021 and 2020, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $22 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2021 and 2020, respectively, and $37 million and $43 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTIyODQ_48f9dbb9-6c31-4ceb-a9c9-88e141df01dc"
      unitRef="usd">10000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTIyOTE_bcd92fe5-f3b6-47ff-94c2-587a9dc2adf0"
      unitRef="usd">3000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDA1OQ_dc682475-b1f0-47d9-975a-8cf1f5a5ee10"
      unitRef="usd">19000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDA2Nw_22d1ecc1-c0be-4086-b837-30543d7df19d"
      unitRef="usd">23000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i560d1a79f1ab4e93b2f826080d1e1e98_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI1OTk_2d10d5fe-6e7c-44f5-93e0-7151f4a84d98"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI2Mzc_7fffb382-0ed0-4630-9abc-ad2bef5c9356"
      unitRef="usd">19000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTI2NDQ_cc146cd4-9efd-470d-af46-9eaa2a8999a0"
      unitRef="usd">22000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDI1OA_6482aa57-e36b-4a0b-8c52-92e75f635c8c"
      unitRef="usd">37000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTA5OTUxMTY0NDI2OA_fc2ba890-5ca5-47ad-aa3b-835f8473d694"
      unitRef="usd">43000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zNy9mcmFnOjRjOWUxM2I3ZWFkOTRkZjc5MGI2MGRhZThmNDgzOGQ0L3RleHRyZWdpb246NGM5ZTEzYjdlYWQ5NGRmNzkwYjYwZGFlOGY0ODM4ZDRfMTYwNzc_00248a85-baf7-4edd-a3e9-343aa145fd13">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#x201c;ASC&#x201d;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other &lt;/span&gt;&lt;/div&gt;comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY4NQ_2855b321-1ae3-440f-959f-70a6bd278b01">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;There was no allowance for expected credit losses recorded on available-for-sale debt securities at June&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At June&#160;30, 2021, debt securities with a fair value of $886 million, gross unrealized capital gains of $110 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at June&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at June&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at June&#160;30, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of June&#160;30, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the three and six months ended June&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at June&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and six months ended June&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021. Net realized capital gains include the reversal of previously recorded credit-related impairment losses on debt securities of $42 million and yield-related impairment losses on debt securities of $1 million in the three months ended June&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $3 million and $42 million, respectively, in the six months ended June&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, and $10 million and $21 million for the three and six months ended June&#160;30, 2020, respectively, related to investments supporting experience-rated products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDU5MA_fc24731f-1cdd-4968-91fc-b26bb4a578e2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.106%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="i050986668b0745f78bd6639177dc57d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi0xLTEtMS0w_2536d597-b77d-4204-b546-f0a48f49a0ef"
      unitRef="usd">2878000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i050986668b0745f78bd6639177dc57d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi0zLTEtMS0w_5c250af8-e017-4c15-9782-7569bcc070dc"
      unitRef="usd">19468000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i050986668b0745f78bd6639177dc57d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi01LTEtMS0w_10e02153-41fd-4850-a69f-4fd32239b4a1"
      unitRef="usd">22346000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i785d26b7ae9b4b46858aaedd48a3f463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi03LTEtMS0w_eac82a70-2887-4d60-9a14-e0ffe0835876"
      unitRef="usd">2774000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i785d26b7ae9b4b46858aaedd48a3f463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi05LTEtMS0w_2acfd3e7-507d-46bd-a57c-e53501e0f299"
      unitRef="usd">18414000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i785d26b7ae9b4b46858aaedd48a3f463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMi0xMS0xLTEtMA_17cda792-fc13-46c8-9064-8e0a8c6b1d40"
      unitRef="usd">21188000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i0cf6c37f26e849ed865434c8e9ca659c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy0xLTEtMS0w_976395c2-e425-4dbe-a5f0-ce65e976771a"
      unitRef="usd">128000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i0cf6c37f26e849ed865434c8e9ca659c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy0zLTEtMS0w_de8baa75-a61c-433e-9d5f-c97c407bf791"
      unitRef="usd">848000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i0cf6c37f26e849ed865434c8e9ca659c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy01LTEtMS0w_607c4775-7c98-458b-adac-2221a2b74e1c"
      unitRef="usd">976000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i67da0ed9c4d447b49163344869bcabfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy03LTEtMS0w_c88f57e1-628a-4d82-8cae-1e7e2d305256"
      unitRef="usd">226000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i67da0ed9c4d447b49163344869bcabfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy05LTEtMS0w_e6423201-d954-4283-b09e-3cc4d72772d6"
      unitRef="usd">821000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i67da0ed9c4d447b49163344869bcabfe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfMy0xMS0xLTEtMA_0c4c20aa-8575-465e-9de1-df6f26c712cb"
      unitRef="usd">1047000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i37114866aaba41cfb18a68f2cd2fde62_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC0xLTEtMS0w_a9fe1842-1dcc-4614-93ed-d51683c34885"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i37114866aaba41cfb18a68f2cd2fde62_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC0zLTEtMS0w_ce847d8f-e2e9-4a50-b977-03a9e9ec37d5"
      unitRef="usd">1820000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i37114866aaba41cfb18a68f2cd2fde62_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC01LTEtMS0w_8138e2e5-3fd2-465b-9f68-c802a65021d5"
      unitRef="usd">1820000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i8d6f559cac05474bb144a75f235bcb09_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC03LTEtMS0w_ba15342e-4b15-48cc-a14c-6e29035b83e5"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i8d6f559cac05474bb144a75f235bcb09_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC05LTEtMS0w_21c30eb9-3c84-4726-beee-c5cb85409a5b"
      unitRef="usd">1577000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i8d6f559cac05474bb144a75f235bcb09_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNC0xMS0xLTEtMA_b9a17fc2-4a15-450c-b34a-92bff0b3d1f3"
      unitRef="usd">1577000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS0xLTEtMS0w_fb634c54-7bad-41a7-bd0a-e58df5da6ac4"
      unitRef="usd">3006000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS0zLTEtMS0w_349b610a-78d3-4f73-80e1-a464a10c781f"
      unitRef="usd">22136000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS01LTEtMS0w_7a0859db-f0a4-4560-9a4f-0ba92ad1bcb3"
      unitRef="usd">25142000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS03LTEtMS0w_c66f7df1-99e8-4ef3-a20d-d18603c43107"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS05LTEtMS0w_9cfa4a75-7808-4440-b852-c69f29c6e6bb"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjg0OGFlZGI0ZjM0NjQ1ZDU5YjE1YWFiYjc3NzZlNTA4L3RhYmxlcmFuZ2U6ODQ4YWVkYjRmMzQ2NDVkNTliMTVhYWJiNzc3NmU1MDhfNS0xMS0xLTEtMA_bcdedccf-d751-45e7-a0d0-509f184aacd7"
      unitRef="usd">23812000000</us-gaap:Investments>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY3OQ_c6ee7b29-b50a-4819-bd10-6435b106708b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;There was no allowance for expected credit losses recorded on available-for-sale debt securities at June&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results. At June&#160;30, 2021, debt securities with a fair value of $886 million, gross unrealized capital gains of $110 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy01LTEtMS0w_d3e978ec-893e-4d10-ac43-9bb8cf9a4daf"
      unitRef="usd">2320000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy03LTEtMS0w_9c99acc0-3592-4516-8147-44f176f0e502"
      unitRef="usd">91000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy05LTEtMS0w_6d0ea7d9-507a-4dff-bca1-f9a52d96a3dc"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMy0xMS0xLTEtMA_1ac5c9b9-46f5-4965-b910-6678e3d80a73"
      unitRef="usd">2410000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC01LTEtMS0w_e52ff4a7-3fdc-4a5b-8476-49d6e550f36a"
      unitRef="usd">2978000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC03LTEtMS0w_30fe7c44-a66a-4646-b73a-bf1da42e991c"
      unitRef="usd">168000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC05LTEtMS0w_0349546d-e60f-4ee3-af53-f6c3a5f4eaf9"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNC0xMS0xLTEtMA_b99ed923-852f-4e8c-b187-e3265940da9e"
      unitRef="usd">3144000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS01LTEtMS0w_fef3a909-be01-4f23-816a-714a4acf127a"
      unitRef="usd">8754000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS03LTEtMS0w_52c7c540-2dde-466e-8c76-38c1ce7a730c"
      unitRef="usd">822000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS05LTEtMS0w_dcba0316-0992-4189-8066-567aed55b093"
      unitRef="usd">14000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNS0xMS0xLTEtMA_8860b199-82e8-4db8-afb2-75df4dbf9be1"
      unitRef="usd">9562000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi01LTEtMS0w_8d24bb22-fb6f-4345-8206-baeae82fb1e2"
      unitRef="usd">2652000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi03LTEtMS0w_cddf27bf-d3f6-411f-a7c5-a6be2563fa9a"
      unitRef="usd">247000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi05LTEtMS0w_70e1be83-60ab-452d-bd63-9d0c5315c7b3"
      unitRef="usd">6000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNi0xMS0xLTEtMA_dce3815e-123f-4ec0-8dfd-086868231ec2"
      unitRef="usd">2893000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy01LTEtMS0w_1c8d5f52-7afb-4d92-bcea-d21be5930968"
      unitRef="usd">812000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy03LTEtMS0w_d4b7f6c7-152d-4f68-8c42-e757362e08ab"
      unitRef="usd">20000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy05LTEtMS0w_6a283f41-2722-4b32-aef2-8d9a414ba2d8"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfNy0xMS0xLTEtMA_72f2bc47-e35c-42d1-a14b-cf247a70e978"
      unitRef="usd">829000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC01LTEtMS0w_fac3f636-1300-493e-adf4-32010987f90b"
      unitRef="usd">1023000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC03LTEtMS0w_aa1cb2da-d107-4a29-832e-aa0c6f00cbd1"
      unitRef="usd">63000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC05LTEtMS0w_4ec8435d-840a-435c-8877-615747179e49"
      unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOC0xMS0xLTEtMA_5d253003-1af3-4203-a27e-2ed3bc697ad2"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS01LTEtMS0w_aeefd16f-f0f7-4b28-a85b-c7594fe87054"
      unitRef="usd">2372000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS03LTEtMS0w_bfe14c58-150d-4299-a30c-11e6b91f7e5a"
      unitRef="usd">26000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS05LTEtMS0w_10acdb47-96ef-46ee-9230-d76884e257f9"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfOS0xMS0xLTEtMA_5434fc7b-1d26-4167-b85f-bef8fc3a0f16"
      unitRef="usd">2397000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtNS0xLTEtMA_a26f9fd2-f207-4aa1-9bf0-45d41a4ed87d"
      unitRef="usd">27000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtNy0xLTEtMA_44b9376a-21e8-417e-8e01-16f2daa5a104"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtOS0xLTEtMA_da43fc02-e882-4e90-a745-171e52be7dc5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTAtMTEtMS0xLTA_c462de47-a2f3-401d-854e-2143afdf634e"
      unitRef="usd">30000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtNS0xLTEtMA_019fa7e5-6bf8-4286-9a39-e566aa481067"
      unitRef="usd">20938000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtNy0xLTEtMA_dc156960-4f28-4a6e-9b25-6afb7b02b0ea"
      unitRef="usd">1440000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtOS0xLTEtMA_cfa8b953-3176-4b2f-964a-33e9bd544286"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTEtMTEtMS0xLTA_206baff4-cc50-4ec7-8120-2cbeb17dc04a"
      unitRef="usd">22346000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtNS0xLTEtMA_92c7cd18-53ed-4107-a71b-2299089a91b6"
      unitRef="usd">2341000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtNy0xLTEtMA_835d8b2a-b658-4b09-b80b-4f7fab69a326"
      unitRef="usd">128000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtOS0xLTEtMA_50bd0f8f-d521-4c10-a865-765e591d424a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTUtMTEtMS0xLTA_38676f62-be3c-4465-b5bf-fd2cc6fa23ae"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtNS0xLTEtMA_92f080a4-4f6b-47d3-90e2-205190de92a6"
      unitRef="usd">2556000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtNy0xLTEtMA_ed120e42-45c2-4004-941b-49b935ce1904"
      unitRef="usd">172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtOS0xLTEtMA_7940cdf8-f205-401d-afea-6d770037f97f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTYtMTEtMS0xLTA_c644ca03-1163-4095-8e08-3df6b9fcc835"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctNS0xLTEtMA_816c4ba1-5c26-458b-829c-1fc0b191c3f2"
      unitRef="usd">7879000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctNy0xLTEtMA_cff11a80-6866-4216-ad6e-b819f4a8b77e"
      unitRef="usd">1023000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctOS0xLTEtMA_60b56157-0016-45fc-b95e-3c531d4f9621"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTctMTEtMS0xLTA_a57f2459-b244-4094-bc87-f770cc8297a2"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtNS0xLTEtMA_772a3bbd-0373-44dc-b855-35ad7bb366ee"
      unitRef="usd">2595000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtNy0xLTEtMA_2a640c56-9b0c-49ef-bbe0-8fa768b4c32e"
      unitRef="usd">324000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtOS0xLTEtMA_b435077f-8a19-4a52-bc8c-0f9a39466602"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTgtMTEtMS0xLTA_6630d2d3-61c3-4778-9a9f-092ce50afb33"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktNS0xLTEtMA_30cced57-e069-43b9-b34e-c23f41a9a97a"
      unitRef="usd">673000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktNy0xLTEtMA_d0c910e0-9246-4952-9211-94f0053aa410"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktOS0xLTEtMA_5128247d-f39b-4cc2-b170-2e134184ae63"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMTktMTEtMS0xLTA_51ff6481-9414-4462-b783-10b8e538ed21"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtNS0xLTEtMA_419253cf-542b-4a5a-a79f-9dd0f7f7cdb8"
      unitRef="usd">962000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtNy0xLTEtMA_b3b03bb9-6a42-4c24-a639-10060cf8d7c3"
      unitRef="usd">84000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtOS0xLTEtMA_5550c63d-9504-4868-b45a-bee048d55650"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjAtMTEtMS0xLTA_a47bc45d-348e-4f4b-a053-14b174079b66"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtNS0xLTEtMA_250bc6ad-bafd-423a-a0f6-0c70e4e0b280"
      unitRef="usd">2369000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtNy0xLTEtMA_76af4880-1474-4d33-86b4-bc8b25a96d65"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtOS0xLTEtMA_0454bdb7-e512-41c9-9da1-3e769ea02cac"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjEtMTEtMS0xLTA_aa6229ba-ee2f-4f2a-907c-cb365b31f095"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItNS0xLTEtMA_b0524751-e49e-403d-b3a9-6f4398dc1483"
      unitRef="usd">21000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItNy0xLTEtMA_e8525773-87ee-4cfa-9fab-ff3da3741a1b"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItOS0xLTEtMA_b26b6a1a-ea51-4139-8687-87f434c19f38"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8a1de2913fe54b508792cc352b2f82bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjItMTEtMS0xLTA_84e2e808-f998-4b9e-8741-49fa947e2afc"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtNS0xLTEtMA_005552f3-0405-4172-9f10-c4ec4e6245d1"
      unitRef="usd">19396000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtNy0xLTEtMA_bb3c3a11-ea55-4ef6-98ae-cae70f5e9277"
      unitRef="usd">1803000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtOS0xLTEtMA_78bcedad-6f5c-4ade-8524-3e39852ab38b"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjYxOTVmNjM5ODBhNTRiYmM5ODFmOTIxZTViOTg4ZmY0L3RhYmxlcmFuZ2U6NjE5NWY2Mzk4MGE1NGJiYzk4MWY5MjFlNWI5ODhmZjRfMjMtMTEtMS0xLTA_b5d86149-9155-41cf-8857-c706624b7907"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMjEy_8ac49336-8a2f-421e-95f2-fa2d417b9132"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMjEy_c4119d31-e0a5-4997-83c9-5eaf2b9c6a83"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDkw_bc43b09a-6942-49ed-9fef-7e7b1ddcf300"
      unitRef="usd">886000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNTI4_060880bc-470c-40bc-b171-3345104a8dfe"
      unitRef="usd">110000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNTcw_83caa04d-0cca-4bde-a772-59d9e379ab50"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i330716651f3445f2b16d92e604e21dce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNjIx_b58b701b-c636-4fd3-a6ea-427d7c5ffda8"
      unitRef="usd">919000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i330716651f3445f2b16d92e604e21dce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNjU5_786e6a05-9da1-44b6-9d77-641c5cd3db68"
      unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i330716651f3445f2b16d92e604e21dce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNjY2_768393c4-46aa-421d-a349-a00381bde943"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY0MQ_860cfb53-a420-4bff-8a9d-f8b952e1c6a1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at June&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.690%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMi0xLTEtMS0w_f9bc87a1-645d-4ee4-a734-4c2256dacc5c"
      unitRef="usd">1168000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMi0zLTEtMS0w_4efa7bee-e73c-44c1-8c9a-7e152ea6166d"
      unitRef="usd">1183000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMy0xLTEtMS0w_7740239d-e8b3-4433-808c-9431c8748819"
      unitRef="usd">7095000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfMy0zLTEtMS0w_969bcd5f-a334-4a75-a2e7-7b98b4931b7c"
      unitRef="usd">7397000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNC0xLTEtMS0w_7c981ddb-db25-4a61-94f4-76162ce28653"
      unitRef="usd">4418000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNC0zLTEtMS0w_0703d3e5-bf1c-4975-8ff9-09ef0dc58452"
      unitRef="usd">4682000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNS0xLTEtMS0w_23b5e8dc-ed00-401e-8713-44b50ed28c3d"
      unitRef="usd">4050000000</cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNS0zLTEtMS0w_530a04de-a117-4e68-b883-67a50e83e71c"
      unitRef="usd">4777000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNi0xLTEtMS0w_2fb0ab27-fafa-420e-9770-aad04d2a7630"
      unitRef="usd">812000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNi0zLTEtMS0w_26083012-a195-47fc-8fb9-c9e84731431d"
      unitRef="usd">829000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNy0xLTEtMS0w_e5235870-c483-4a2c-a347-8751a015fb9f"
      unitRef="usd">1023000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfNy0zLTEtMS0w_07c9b93e-b317-4b3c-a25d-a1ff8b31f7f7"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOC0xLTEtMS0w_386e1924-4157-45a9-bcc8-c4a06a61c139"
      unitRef="usd">2372000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOC0zLTEtMS0w_0f70705d-2209-4dfd-abd7-51e57e5a4bac"
      unitRef="usd">2397000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOS0xLTEtMS0w_817c4802-96f4-4396-b263-c67c75a69094"
      unitRef="usd">20938000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjFhNDg4ZDYwMGYwYTRmZWRhNTU4YzNjOTZmMDc3YWY3L3RhYmxlcmFuZ2U6MWE0ODhkNjAwZjBhNGZlZGE1NThjM2M5NmYwNzdhZjdfOS0zLTEtMS0w_fd7fbaa5-a270-466b-acc3-2ef3be2e039b"
      unitRef="usd">22346000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY3NQ_6e06dc28-0352-4557-ac47-e4e1525674ec">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at June&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.505%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.380%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting&lt;br/&gt;experience-rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting &lt;br/&gt;remaining products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xLTEtMS0w_28e83e50-48d5-4aa9-af60-c74715e95f20"
      unitRef="security">15</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0zLTEtMS0w_456514be-9cdc-4c92-93bb-d8adf80dccc3"
      unitRef="usd">76000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC01LTEtMS0w_f3064748-6818-4fa8-ae66-2e269b8c099e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC03LTEtMS0w_af39309b-467d-4448-9b65-cb21ce7b61f4"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC05LTEtMS0w_1a7c9be2-42f8-4739-afb3-83c0e2dae9f4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xMS0xLTEtMA_ba9cdc91-f10c-49bb-8873-6c7c0b2c0055"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xMy0xLTEtMA_6f773ad4-35d6-4e13-bf02-4ef39d9a7f68"
      unitRef="security">15</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xNS0xLTEtMA_5da1a629-f192-4d5b-a05c-b8a27558509b"
      unitRef="usd">76000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3bb425d67a354590bedb80036ca60278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNC0xNy0xLTEtMA_bec0ff47-353d-4e77-97f7-be46fe781045"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xLTEtMS0w_072ab027-4fa6-4c0f-8575-9dd67a7fc94e"
      unitRef="security">146</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0zLTEtMS0w_904d0949-c877-4ad7-a889-317da1af0bb0"
      unitRef="usd">302000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS01LTEtMS0w_aa3127f1-e289-4597-84a5-64da6e0eade8"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS03LTEtMS0w_59d21b48-ce1d-4649-b71e-6ea500989f26"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS05LTEtMS0w_f4185ee6-36ac-4b69-95ea-d9eb2089b930"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xMS0xLTEtMA_00c3da10-09b6-4bf5-b772-1377397fcb5f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xMy0xLTEtMA_e9ac4a4a-5df1-4ffb-b00f-08849d3fae2f"
      unitRef="security">147</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xNS0xLTEtMA_6c35abf3-ae1c-4cf9-b0c0-9d35cbcf8255"
      unitRef="usd">306000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3590ee0301174d61875cb4de2bb00cd8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNS0xNy0xLTEtMA_51e0d5d7-85fb-4119-b6ed-a7cc1d66e200"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xLTEtMS0w_87da415d-46da-46b1-a66a-ec1d22040660"
      unitRef="security">807</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0zLTEtMS0w_bce85d61-7601-40bd-bdf8-ad922e7a016e"
      unitRef="usd">1125000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi01LTEtMS0w_e1212ee5-8826-4edc-bd96-9a6a9d649e8e"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi03LTEtMS0w_814fb532-39c0-48df-ba8b-7f267de0ce4b"
      unitRef="security">8</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi05LTEtMS0w_9fe41ec1-c419-44df-9f79-c201fb20de67"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xMS0xLTEtMA_ea082899-0bca-4f39-b41e-476c09206f82"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xMy0xLTEtMA_7a99d155-fa59-472a-b84e-1005f691b28e"
      unitRef="security">815</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xNS0xLTEtMA_fb6c3428-d95a-4ccd-af68-7da68e82a44d"
      unitRef="usd">1134000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i50eced10560845d6a9cd175c5552eb84_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNi0xNy0xLTEtMA_e6a9f377-b686-484a-a1b9-b2b4699b586a"
      unitRef="usd">14000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xLTEtMS0w_d4532cd1-32f8-49c7-aa89-b46f68670629"
      unitRef="security">237</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0zLTEtMS0w_1a4dd5ae-1d24-4608-911e-c6a11cb3cc9b"
      unitRef="usd">374000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy01LTEtMS0w_97725285-5eb2-4e24-b68b-8fcd823ad4a2"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy03LTEtMS0w_4d0bc10d-ca55-4a81-89dd-e4fdd412ca59"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy05LTEtMS0w_29742af4-96a2-45af-8dcd-47a8355c2ed6"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xMS0xLTEtMA_fafdb56b-7642-4897-b2b9-be765c9c2bf7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xMy0xLTEtMA_c6fbf838-7bc5-4fbc-9227-f20089d2b30b"
      unitRef="security">239</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xNS0xLTEtMA_be521c02-6bf6-49b2-8188-93e6b6ab420e"
      unitRef="usd">376000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icb104d269b9f4f0ead4974de98e0e425_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfNy0xNy0xLTEtMA_f6b10d67-98db-4361-be52-475e5500508a"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xLTEtMS0w_6f0a522a-b418-4ea4-8986-5f23f80192cb"
      unitRef="security">100</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0zLTEtMS0w_c6a99f38-50d4-405c-940d-b16a85348af1"
      unitRef="usd">398000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC01LTEtMS0w_5acf1c37-7e40-40fa-a53e-346db8a78175"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC03LTEtMS0w_f3f29058-04e2-4a0b-8325-81e9ee6505f2"
      unitRef="security">5</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC05LTEtMS0w_8f47db31-d9c2-491b-b099-96b47096361f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xMS0xLTEtMA_07cba379-8d8a-4a80-bbef-91faf1fd627b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xMy0xLTEtMA_3bb1551a-0857-4790-a37d-8e83e38f35c8"
      unitRef="security">105</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xNS0xLTEtMA_cec011c7-4288-4735-a341-c651ea17ce19"
      unitRef="usd">398000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOC0xNy0xLTEtMA_3da5bf3e-860f-489c-9fce-74fd3dc27739"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xLTEtMS0w_1ad5af41-9949-4220-a952-31c85b7710ce"
      unitRef="security">85</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0zLTEtMS0w_68574ce4-2e7d-48a6-a6ec-4de30b8f8880"
      unitRef="usd">241000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS01LTEtMS0w_a3fb7d8d-ebb3-4a93-ae79-f7d2b8eef943"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS03LTEtMS0w_7023fc5a-1fe5-4586-b984-47c21af44d16"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS05LTEtMS0w_bcd553e7-5a13-40be-8f59-b2d8d777595a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xMS0xLTEtMA_d99f18cc-1114-45b3-a14b-4f0f4ad86699"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xMy0xLTEtMA_16a87549-b29c-4a5d-9406-90bec17536b9"
      unitRef="security">85</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xNS0xLTEtMA_798a444c-9a2e-4af1-ba45-db1a99f0b916"
      unitRef="usd">241000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfOS0xNy0xLTEtMA_de99ff16-098a-4aa4-9089-94d427bf6f6e"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMS0xLTEtMA_1141edb7-644a-455f-a6ea-ea889bee41f7"
      unitRef="security">272</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMy0xLTEtMA_e1fb8da7-6589-4e51-b1a0-8f6c39805ba2"
      unitRef="usd">505000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtNS0xLTEtMA_c0a7745c-2ca2-4e7e-9682-2d9b384b445f"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtNy0xLTEtMA_a2f621fc-e3ab-4f05-9195-f397272b90de"
      unitRef="security">24</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtOS0xLTEtMA_a5f9f6f5-ab07-499b-baab-cf82c72fb9b0"
      unitRef="usd">28000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTEtMS0xLTA_ccd0e2c1-100d-4604-b6c3-7d164d3490aa"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTMtMS0xLTA_382c1cd1-e7c2-4e88-b508-58a56bd77984"
      unitRef="security">296</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTUtMS0xLTA_e2693501-f169-49d9-ab85-0c5192468e2b"
      unitRef="usd">533000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTAtMTctMS0xLTA_6e091ff5-dfc1-445a-97bb-ee3aaa62e2b8"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMS0xLTEtMA_78c73628-cb42-493d-8ff6-9a137dff7332"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMy0xLTEtMA_4dbc8b5e-017e-441c-a3b8-f2f00c21a72d"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtNS0xLTEtMA_7c53aaef-fac5-4864-8a45-32a929a06825"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtNy0xLTEtMA_175818fb-58f7-4440-a230-67f7a97d423f"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtOS0xLTEtMA_8188992f-0da0-4d1f-a7f7-bf3b932d0af1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTEtMS0xLTA_a3060a6b-4be0-4277-8964-6f18c086a573"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTMtMS0xLTA_35dc1984-f41d-4ebe-93c5-f085636f7b59"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTUtMS0xLTA_f2bc44b8-7de8-463a-8557-0b918eef6ef3"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie04051f399d14d09899ca54b68a00a7b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTEtMTctMS0xLTA_19b1df3d-cf51-4a68-880b-f040318ff7b5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMS0xLTEtMA_e66be686-6ebc-43f0-b13a-e250810c63e6"
      unitRef="security">1663</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMy0xLTEtMA_4cebae23-9c61-4094-873e-f908d0e565fe"
      unitRef="usd">3024000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItNS0xLTEtMA_b57bda26-f37e-442c-955a-eb35fc7d598b"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItNy0xLTEtMA_4afe4d55-333c-4e39-acfd-a2aacf576209"
      unitRef="security">40</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItOS0xLTEtMA_671b7767-6e55-4a90-b369-39e6bfc0d45e"
      unitRef="usd">43000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTEtMS0xLTA_4b7c4d49-7ae9-44b8-945c-6837642bb389"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTMtMS0xLTA_201aa61e-d33a-444b-9c8d-8b153a96fec8"
      unitRef="security">1703</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTUtMS0xLTA_3796c21f-beb5-4140-b836-759a57914d99"
      unitRef="usd">3067000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTItMTctMS0xLTA_cc61725d-f2fa-4e7c-aeb6-c51ea85e36d8"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMS0xLTEtMA_13035943-d626-4a0a-ab43-68bcc293ae14"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMy0xLTEtMA_928e5d5e-7a0f-4219-9b68-81c401b2c8a8"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtNS0xLTEtMA_d6b0c91a-e906-421d-8d42-5b2144b2e1c2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtNy0xLTEtMA_25308e99-c701-4797-8f75-407850adb52d"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtOS0xLTEtMA_454b71c3-ad5f-45ec-afae-4578665ce869"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTEtMS0xLTA_93c9a90d-c849-42c4-86de-97d475b42b6b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTMtMS0xLTA_d1036ef0-a0f5-4f4a-89da-314cf8e4c899"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTUtMS0xLTA_ff8c009e-1cde-43ad-ba2c-b74695b78dd6"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7fc4d19ba499475caf61a593859df3d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTYtMTctMS0xLTA_3bd6b983-db0f-4aa5-8558-167ad5d4723a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMS0xLTEtMA_8b5702ba-499d-41a5-9517-1189489b8c2b"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMy0xLTEtMA_a01349b3-64d1-4517-9af3-243e0a132c47"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctNS0xLTEtMA_a10f44a0-34ee-494a-b26c-e859a21f52f8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctNy0xLTEtMA_4123855d-698d-450e-9b48-37c8012f0d3e"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctOS0xLTEtMA_425d974c-14b5-4fae-842d-96b86dfd7ff2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTEtMS0xLTA_e03c653e-677d-461c-b804-e391e5210a5e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTMtMS0xLTA_2b48a482-b442-424e-8969-c8daf3d97738"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTUtMS0xLTA_5c41f0b1-769f-484a-93b7-4cbaf3cdc544"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id78f486649f54627bfd2a824897634ce_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTctMTctMS0xLTA_fd86f9af-ebc9-4510-99db-7659ae852f9a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMS0xLTEtMA_e1bea36b-bc85-4b26-b1f0-85baa300cf5e"
      unitRef="security">145</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMy0xLTEtMA_2cd2f841-94f4-4ab6-8551-3645df62330e"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtNS0xLTEtMA_322faf0a-5c33-47b8-bb1e-69a7efdac4be"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtNy0xLTEtMA_6c6f50bf-94f9-4f0c-ab4d-eccd53f073b2"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtOS0xLTEtMA_25219227-f665-4ef1-88b0-0eba8cb5dc4c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTEtMS0xLTA_eef3c5c0-97f6-4bc8-9709-f95da3d0d025"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTMtMS0xLTA_8c28ff04-6e5a-4467-9e49-dd620e2c6928"
      unitRef="security">147</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTUtMS0xLTA_9f119257-bcd3-4617-9584-7d92bec06623"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i0ec92f9d6bd64340bc9be357f92a47f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTgtMTctMS0xLTA_286a4332-26c5-428d-ba11-8e3dde802c7d"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMS0xLTEtMA_6fb89211-f88b-4c22-82e8-8cd0e34d7222"
      unitRef="security">41</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMy0xLTEtMA_c752c99f-f466-4f2b-9d24-6845d7fd5f8d"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktNS0xLTEtMA_6d3af79a-a1fc-45cd-b2c8-9c7f26105a0c"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktNy0xLTEtMA_9cba98fe-98c5-4210-a957-704cf94c0a45"
      unitRef="security">5</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktOS0xLTEtMA_a30b858a-862e-4786-8d1a-5c1efedbbee9"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTEtMS0xLTA_9d98dd19-c766-47bc-96e6-4804d80b822c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTMtMS0xLTA_fac2c98f-1468-4a23-8088-a6085a9f917a"
      unitRef="security">46</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTUtMS0xLTA_5fbca630-a538-4251-ad7d-68bc59575ba8"
      unitRef="usd">74000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie21351c4bab548df85d81dd9c1d15ac9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMTktMTctMS0xLTA_f7d4241a-62b8-43dc-9ee7-dcae510e7919"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMS0xLTEtMA_c42dc793-59b9-47d7-a423-6cec2ab1f7fe"
      unitRef="security">23</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMy0xLTEtMA_daf7d112-bf38-4c35-904e-6c1cbabca74b"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtNS0xLTEtMA_e063d124-15f5-41d2-a1c1-8f0daf6e9c92"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtNy0xLTEtMA_cb077216-6fe9-42ee-a121-fe7839c4c820"
      unitRef="security">3</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtOS0xLTEtMA_7f78b561-79ce-44c8-b93f-da3d08784837"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTEtMS0xLTA_815d9ddc-f7b4-4e14-b138-2b76c8938406"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTMtMS0xLTA_4ab84aa5-0ab1-421b-82f7-af8663d3fc8e"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTUtMS0xLTA_89c1f27a-4ba1-49f1-b263-fa79b8809f22"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i74a11c9f2c994687b6022db81270ca31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjAtMTctMS0xLTA_bda0275b-3a01-48ba-9dcc-2aa602ae8f97"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMS0xLTEtMA_ec81fa85-c92f-4982-b0d6-5e32b0b28ad3"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMy0xLTEtMA_3a930293-80af-49e0-a2de-8cd6db29d429"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtNS0xLTEtMA_d65849fe-5604-4afd-b652-77a5b85dbe72"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtNy0xLTEtMA_caadaa57-313b-4190-85ed-4a0779b48656"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtOS0xLTEtMA_26974a32-3b9c-4f80-a6af-db31484203f6"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTEtMS0xLTA_6df4355c-1417-41e9-be7a-a372da4b570f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTMtMS0xLTA_7dfcd098-aded-4d0d-a89c-527e67ecbf53"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTUtMS0xLTA_2fe25986-9faf-496c-8c40-6e188c0bf0fa"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i46b3488cc73943e4acd89188f2b451fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjEtMTctMS0xLTA_2d2b2084-6065-4e3e-aa2a-6c3b10d4c7a5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMS0xLTEtMA_d60d7bb7-4565-40df-9985-5566e1ffbec7"
      unitRef="security">156</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMy0xLTEtMA_cc01eb2a-7758-43f8-8dcb-9b05e0f5cb4e"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItNS0xLTEtMA_ec0ca9e5-36d8-4398-a8cc-d778dfaeb006"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItNy0xLTEtMA_ab74e085-4497-4de7-836e-7941a15ebb7e"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItOS0xLTEtMA_413a89e3-b41f-42f7-beb9-a424f1a24876"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTEtMS0xLTA_bc9968b0-6e88-43e9-b81d-7fc50657e040"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTMtMS0xLTA_a72a4a83-57b3-49ad-99a5-42935ba34ea7"
      unitRef="security">205</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTUtMS0xLTA_260474bd-f478-4d00-b2cb-7214824baedb"
      unitRef="usd">297000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ifbf240305fb945c386be358ec6c9c573_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjItMTctMS0xLTA_abc446ef-6144-45ce-ad03-384fbd424207"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMS0xLTEtMA_c8058696-ea67-47a1-bad0-bdf20ad271ad"
      unitRef="security">468</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMy0xLTEtMA_1bf196a0-e7e9-4d10-9d00-54a45ba1a44e"
      unitRef="usd">869000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtNS0xLTEtMA_06ee281b-b810-40bd-84af-ea194dab8bea"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtNy0xLTEtMA_dfce3826-4d85-4d65-93b1-00238c891ec0"
      unitRef="security">59</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtOS0xLTEtMA_0ec96b59-0499-4ef8-b152-942cb24fdff8"
      unitRef="usd">46000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTEtMS0xLTA_4b11e2fb-1941-4ace-a08b-42d864a5eaa7"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTMtMS0xLTA_ea5d384d-1bfa-4cc6-a165-bc94e55002cf"
      unitRef="security">527</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTUtMS0xLTA_fc5682cc-8d82-4fbd-a5b8-bac065595462"
      unitRef="usd">915000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i0b0b6dd0f718499caf0d4c90979480e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmM5ODJhNjUxMmI2MTRmYWFhZTU1ODEzMDQ1NGIzZmI2L3RhYmxlcmFuZ2U6Yzk4MmE2NTEyYjYxNGZhYWFlNTU4MTMwNDU0YjNmYjZfMjMtMTctMS0xLTA_4db34271-2916-410f-9a87-6665720c0990"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy0xLTEtMS0w_90817b3a-e1d2-4873-a44e-2c6192a0cc2e"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy0zLTEtMS0w_7e238a5c-3cee-40d3-b5ae-39b6e834f14a"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy01LTEtMS0w_e37df885-35b2-47d7-afe5-62e1eb1c34a7"
      unitRef="usd">23000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy03LTEtMS0w_b0475915-a239-4102-8555-a5023e78c738"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy05LTEtMS0w_a86ae277-bd11-4338-906a-ae6ca9f16434"
      unitRef="usd">23000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMy0xMS0xLTEtMA_b42b0c90-bee4-4373-b92e-779876b59a09"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC0xLTEtMS0w_9aca6d4d-2ae7-44de-8b2e-51117dfd0462"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC0zLTEtMS0w_bd5a2960-d003-4156-89f1-3669aa830212"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC01LTEtMS0w_348fdcb7-2ac6-48b4-8c7c-791e4ce1b7e2"
      unitRef="usd">1005000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC03LTEtMS0w_f4203f45-5fd7-4868-be0e-800f86062421"
      unitRef="usd">7000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC05LTEtMS0w_36c53fcb-3949-4dd8-8a83-44e6840b3a3a"
      unitRef="usd">1006000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNC0xMS0xLTEtMA_8b5066bb-57cb-4974-82ae-cc8594be112f"
      unitRef="usd">7000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS0xLTEtMS0w_64d20fec-85a2-49a5-85ee-177ef81f8598"
      unitRef="usd">15000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS0zLTEtMS0w_36297f87-7959-4df2-9b95-8bb62b108159"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS01LTEtMS0w_b70c2799-c2fe-4b4e-929a-0e46a8cff275"
      unitRef="usd">613000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS03LTEtMS0w_f2bb7152-7b63-4f61-ab90-7a67229fe791"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS05LTEtMS0w_48dfe0c6-c8b0-42f0-b3dc-8569f8f82521"
      unitRef="usd">628000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNS0xMS0xLTEtMA_f8112dd2-d562-4a3b-a668-9bbf4bb6b6a8"
      unitRef="usd">11000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi0xLTEtMS0w_1db3c0b7-b3b5-4a99-ae9c-cfb9e2417f72"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi0zLTEtMS0w_4feec7b6-7748-47be-a69e-2fff1d60ffd8"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi01LTEtMS0w_920bdffd-030e-4e6f-bb4f-32a07242b10e"
      unitRef="usd">236000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi03LTEtMS0w_0421d090-1f04-400f-9c6f-185435aa1dc1"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi05LTEtMS0w_0cfe45a2-1a00-47ad-a122-faa65a73fe46"
      unitRef="usd">238000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNi0xMS0xLTEtMA_ccc0241f-a064-4062-b313-f0abb76acf22"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ia0b8c6a6f20c461db287f9f793fbf9d7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy0xLTEtMS0w_9b4bc622-26a5-460d-a3a1-74f961028c26"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ia0b8c6a6f20c461db287f9f793fbf9d7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy0zLTEtMS0w_ab2e1805-03a6-4be6-9eeb-c2649b67a5bd"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="idb1943f336d24144a589379cf6e74715_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy01LTEtMS0w_0cc31e6c-efc4-4d59-8c4f-9c889f492f5e"
      unitRef="usd">398000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="idb1943f336d24144a589379cf6e74715_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy03LTEtMS0w_0cd84e92-fef3-42b9-887e-14073956261d"
      unitRef="usd">3000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy05LTEtMS0w_0b6cdf34-1510-4ead-aa72-c09a010bbd91"
      unitRef="usd">398000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ifd2bd752cd3a43d782a31f44cde4eb8d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfNy0xMS0xLTEtMA_85751c44-bb74-4406-a360-aac89a60853f"
      unitRef="usd">3000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i486f1122037e48ebba56da0ba8464796_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC0xLTEtMS0w_6abb6c50-2a37-4b33-86c5-7cf9e250180e"
      unitRef="usd">6000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i486f1122037e48ebba56da0ba8464796_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC0zLTEtMS0w_06b3fdd5-f488-43ed-bff5-7869a6521956"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i23b4441f7bf64f9db07dd58f12b394b5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC01LTEtMS0w_a4e23aa1-fcb9-42e9-8270-230bee137315"
      unitRef="usd">235000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i23b4441f7bf64f9db07dd58f12b394b5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC03LTEtMS0w_84923724-c5b9-4d63-8abe-d4e4a3a6d022"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC05LTEtMS0w_91e47e56-28a3-4493-bfea-3b484992d63a"
      unitRef="usd">241000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i05fa8546b543495c817f8870574cf91c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOC0xMS0xLTEtMA_49bc05e9-30b1-4828-b73d-bae8180da928"
      unitRef="usd">5000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i1483e14fbc3a4929b38090e7dde2ad45_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS0xLTEtMS0w_7459f206-8ea0-4ff6-a8c1-7ed092832ba0"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i1483e14fbc3a4929b38090e7dde2ad45_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS0zLTEtMS0w_a554d1b4-470f-4d89-b41d-33f9f73eda5f"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ic7cdf1afe2da4dde8c7318e6ab1a8301_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS01LTEtMS0w_2bbb1171-3d67-4327-815a-723301158da3"
      unitRef="usd">532000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ic7cdf1afe2da4dde8c7318e6ab1a8301_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS03LTEtMS0w_cc6b5e8a-5ead-416f-bd53-2fa73dcc9077"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS05LTEtMS0w_350dccd7-72b5-45d9-b6db-246e97c3c28f"
      unitRef="usd">533000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i2b23b8ac74ed4bfd9882f4487b6758b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfOS0xMS0xLTEtMA_4408845f-6ec5-441a-9a7f-dc4a2a19a597"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtMS0xLTEtMA_a39213c4-2af8-425a-beec-8e84cda1cd4e"
      unitRef="usd">25000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i80430002c1a3435e8f4abfa75c0919f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtMy0xLTEtMA_94be47c6-2f6b-4a0d-8e8b-c66744a1f09d"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtNS0xLTEtMA_8d77b840-f36b-490b-a528-18f91b00aa2b"
      unitRef="usd">3042000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="if91258c802ea4a78a5826616a1737d80_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtNy0xLTEtMA_173ec53f-0151-4f71-96a0-a264a15de297"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtOS0xLTEtMA_d841ceb3-80e6-476e-9e26-5a58c244f334"
      unitRef="usd">3067000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjJjZWViNzFjZjBmOTQ3NDdhNzFjNTRiYjI1Y2FkOWY4L3RhYmxlcmFuZ2U6MmNlZWI3MWNmMGY5NDc0N2E3MWM1NGJiMjVjYWQ5ZjhfMTAtMTEtMS0xLTA_f29e8cb0-dae8-4b0c-bc3b-60a7086489f9"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY3Nw_824758b6-4d24-4187-85e3-374bfa2a2244">During the three and six months ended June&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi0xLTEtMS0w_7632170c-6041-4313-bd18-f053a2552a3e"
      unitRef="usd">73000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi0zLTEtMS0w_e6ff0dba-59bc-4b4e-8267-f322398312ff"
      unitRef="usd">16000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi01LTEtMS0w_0f17a318-62a3-4fef-8bb8-db1d00d4ef38"
      unitRef="usd">120000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMi03LTEtMS0w_9d484790-9029-4199-a8a2-195c5052d28f"
      unitRef="usd">24000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy0xLTEtMS0w_6674711f-0f21-4deb-8424-0814ce7575d2"
      unitRef="usd">82000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy0zLTEtMS0w_59a30599-fd80-422e-9b42-1723ca271504"
      unitRef="usd">33000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy01LTEtMS0w_3c8419be-be3c-4acd-b5ec-de2d0e616e02"
      unitRef="usd">172000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfMy03LTEtMS0w_8b6a629b-c725-421e-84b2-b77a2a5a72a8"
      unitRef="usd">77000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i140dfce8f2a04caea0777130c117bf89_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC0xLTEtMS0w_8ba4303b-4b6e-4bd1-8184-65ed321a07c9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="ib4e0eafede154b01bea9c357e4b5d11b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC0zLTEtMS0w_78beda06-ea0e-4ab1-890c-acf4459041af"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i6ee74064462e4564b4f1a2a5aa04eed4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC01LTEtMS0w_4b0b9490-775f-467d-8c08-88e1c455c7c9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i39736cf438a64a86967b667aa3b53b0d_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjgzMTAyYWVmZTk4ZDQ5NmU4YmE0YmQ5NjJiMzhlZDZhL3RhYmxlcmFuZ2U6ODMxMDJhZWZlOThkNDk2ZThiYTRiZDk2MmIzOGVkNmFfNC03LTEtMS0w_e33fe1db-9e5a-4fda-8c65-b6f05be963b3"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDcxNw_a893452c-3176-455b-b021-fe5f604519a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the Company&#x2019;s assessments at June&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i91df7cc733e2416eae8bfe2970841365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0xLTEtMS0w_0c1143f8-7d39-450e-9b99-f735698f8c9d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3f598f62b58f44329684aa34ad736af0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0zLTEtMS0w_239100c0-d0bb-413f-b8f0-3dc3105dbc4f"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i450c5941c7d942b0a54ddb1a32a20443_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy01LTEtMS0w_d4b085ee-9a29-4c25-8550-932b269894ae"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4873ff3af0794784807c3e3ca3789caf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy03LTEtMS0w_7b0ac067-ee42-4540-8ebb-73795d7e8540"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib600a4f1216f44378cf6f1b44d67d7ea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy05LTEtMS0w_327b9901-936c-462d-9683-9933009cf08c"
      unitRef="usd">23000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaef7062893e5408eba53ca68b4edd0b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0xMS0xLTEtMA_b0145336-8785-4d66-b1f9-a9050ab5b064"
      unitRef="usd">30000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i48bd9aac481142a2b07aba094d9e81af_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMy0xMy0xLTEtMA_7746507a-1b1b-4a1a-9df1-ee6d7a40b342"
      unitRef="usd">53000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaf1b8df1cc2643e8a0309a06abb7aca0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0xLTEtMS0w_1d9d4cb0-1961-4f49-9fb3-0db61ae702b3"
      unitRef="usd">118000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if924b5acfea142f0ab260a1dea210427_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0zLTEtMS0w_df5eb2c2-cd81-46cb-827b-c1bd2db444f0"
      unitRef="usd">57000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i007ade0d31a744fa85eece461d2ea04a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC01LTEtMS0w_1aa9197a-85d5-42dc-af70-a13761c3bff9"
      unitRef="usd">88000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i48f755a38a33470f981cf406c956dd12_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC03LTEtMS0w_20c42a4c-6bae-479e-871a-b77b059183ef"
      unitRef="usd">73000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic06ba18385514181b60ef5b38d07c7c8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC05LTEtMS0w_43c4bbfe-a798-4f8e-a285-7fcfc4c58d77"
      unitRef="usd">71000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9b2d1fbfab6345c08006daadfad4a310_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0xMS0xLTEtMA_1e9d5c77-0a27-4d1a-aea8-e796d63ed5c9"
      unitRef="usd">490000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iceb56897df794c4191f6c4c04564d9c1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNC0xMy0xLTEtMA_e9557de3-e351-4448-b04e-22bf5bdce05a"
      unitRef="usd">897000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i220a807050aa4c2ea3679d48640b0fc3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0xLTEtMS0w_005eb5c7-3c41-41de-bbf2-949b8ed603b2"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i131e208f966e4264a055bb71305599da_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0zLTEtMS0w_da3a14cc-2a4f-4119-bd17-a55ea370a09e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i33523e15d5dc4123907ac3a0675f494e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS01LTEtMS0w_236325b8-0463-49cc-86fe-5ecb4a065b0d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia890bdfab1f54e6ca2e37c25ed5811f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS03LTEtMS0w_6028a058-4472-4a44-89cd-c7d02e28205d"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i367b52fbb0a240aa82bd1a02d8a324f3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS05LTEtMS0w_7eb503b1-9cb0-4f8b-9651-cd5f487ebee8"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0ab34f008298435eb46af52c54f017d6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0xMS0xLTEtMA_d49fbd5a-48e2-4c36-9a4a-668546ba35fa"
      unitRef="usd">11000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="icdb3058d4ed94963aaae1af4e53a426b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNS0xMy0xLTEtMA_e5ad7051-d15a-4988-86ca-2d9d3f30425f"
      unitRef="usd">18000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7d6ad7d715e9485e80a9f39a359e966e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0xLTEtMS0w_cfc25f8e-f31e-4dab-86f5-54aaeb8df28e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic274db3d35ee4f3ebc05cc96aff41eb0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0zLTEtMS0w_f6a0eb86-708f-406b-96ad-d5e4903a8b85"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i299180676e0a428090878a4e964ae3c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi01LTEtMS0w_704217c1-93dc-4197-91db-3665fca5f720"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie28ecf2d0aa0430b9c1cb966f93498b7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi03LTEtMS0w_53533fe4-96a6-4bab-ae53-2e785858a430"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iabefdd8927e1421d870bbc8356276157_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi05LTEtMS0w_28dacc4e-686e-4984-90dc-861bd2ed02d2"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaffe79f8b7ea41698ffc230904de27f6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0xMS0xLTEtMA_0da5024d-e2aa-44a6-abec-8639f565fbbf"
      unitRef="usd">8000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i83f1ed1f5a7f4f3bb16d0358da0bb94f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNi0xMy0xLTEtMA_86915167-de26-4da7-a280-a8d5d2f15e57"
      unitRef="usd">8000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i449532a2d62a4951a3f3831a08a4fda3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0xLTEtMS0w_e4e1af2a-a002-4d2e-a484-325aeb130436"
      unitRef="usd">118000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="idd9f2126c084443d9eda652a4acefb7f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0zLTEtMS0w_50d4a0b9-bbc3-444d-bf3f-831c544c5f0b"
      unitRef="usd">57000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i44e0a13ad4d0459196454862400790b9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy01LTEtMS0w_8b314e29-8313-4d17-a825-fc1267352ae5"
      unitRef="usd">88000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3c188280b0cd4569a3ce9e68984969a2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy03LTEtMS0w_2d6bbfd2-2421-4143-8539-cffbcdf954d7"
      unitRef="usd">76000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2aff7e212dba4f1fbf45ee44721fbe81_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy05LTEtMS0w_3cec3bee-3870-46ab-a570-d9559f17f783"
      unitRef="usd">98000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie247c0296a5e402b85463bc03fbab6c1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0xMS0xLTEtMA_5787580b-969f-439f-b2cc-fb6927bc20c1"
      unitRef="usd">539000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id39dfb11efc44ccb81323ee1fcf29437_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfNy0xMy0xLTEtMA_b161c6ee-cbdc-4b7c-b319-149840ad7d6d"
      unitRef="usd">976000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i54610f9931e549eca4055d422845c143_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtMy0xLTEtMA_870f29de-2c65-4bb2-8429-02953ea5548e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if427cb3fea58401c8674f141a28396a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtNS0xLTEtMA_92b421bb-bf94-43c8-8783-3669f3d2b31e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i15d5490a569a400b8f3dcd7e8f5deeb7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtNy0xLTEtMA_30a1fe28-5dee-4f9e-b037-41316b5782f8"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7d587f40c2be4fea92c1a51b110451cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtOS0xLTEtMA_7e0800c7-870b-4651-9e5c-43751b309a48"
      unitRef="usd">22000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0b64b0dd3c184cf68f39f81eceb5b2a1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtMTEtMS0xLTA_f5fb6ad2-82e2-4909-841e-fc49e47166f6"
      unitRef="usd">37000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i885cdcbd4dcd428eb8b3f2c4bf5ca941_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTAtMTMtMS0xLTA_f9ec58f4-223c-4c2f-b753-d2f09df63737"
      unitRef="usd">59000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id753e4b7a848420eb1bf019e0dff3575_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtMy0xLTEtMA_f2a2a0af-9cbb-4bff-9751-6a31eec55eb0"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie652cb275f004e0a8ec39116d03c51b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtNS0xLTEtMA_ce06258d-4633-4cc5-9270-2f401de9fd1f"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i218aea3dada84f1fa06872e0f38b36c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtNy0xLTEtMA_4da2a42d-bf42-4496-8afe-98e3becfd3b6"
      unitRef="usd">91000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9d49cacf71ba442b8c626e29ceaba33b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtOS0xLTEtMA_793e350f-9db1-43dc-a5ba-15a52d4b97f0"
      unitRef="usd">124000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6753c528bf954911905b7a442393bd2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtMTEtMS0xLTA_efd8493a-0f5d-4278-8b46-fc309da88edb"
      unitRef="usd">595000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3911cc7a050a463a9917d1b270dee929_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTEtMTMtMS0xLTA_9be58ae8-8b69-44b1-8c2e-a7ed50affc88"
      unitRef="usd">952000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i66926c144af6454b87ae1b8f6716f4b0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItMy0xLTEtMA_2f6ac8cb-3b89-4fe0-9f89-1c5b5c3d58eb"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3111a7bacfde42758aa324b189e45891_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItNS0xLTEtMA_03a89f8b-0b5e-40c1-be69-26e01b5d5be8"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3732b9eaa81d40fabbf3b7dcf14af188_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItNy0xLTEtMA_4bfd1056-11c4-4f58-a3b3-31a1ca0ae751"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib8412f07e8a547df9a2fcec0a4836635_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItOS0xLTEtMA_f6a34143-3d3b-4785-92a1-240b61e16a41"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i51b11270b11c465a83657fcd47ed4efa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItMTEtMS0xLTA_b47ec557-75a6-4d22-beb3-1e16ccfcd953"
      unitRef="usd">29000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2162ee28ee3f4ffdbcd637de827d5019_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTItMTMtMS0xLTA_5b8006e8-d219-4171-aad9-c435da5a0e6d"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie79e56a852074e97a192b8b7beff8f36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtMy0xLTEtMA_9d0b441c-c7fe-4015-899e-281cb6f1f9ae"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i06bd1e75b881405f9702ac7ddbce9775_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtNS0xLTEtMA_f679e0bb-1112-47a8-b70a-b52bb217dc3a"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2f79cb2e161946d4929d70a5ba4b004e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtNy0xLTEtMA_b79318e7-d7a1-4faf-8389-5c16aa5e584d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iad22fdfddeaf4656861bd7eeb9c94c0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtOS0xLTEtMA_6de9b60a-8b84-4b33-abf1-655b5112ec54"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i48f663f5fccd4951aadd8900a4387256_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtMTEtMS0xLTA_0d8c1d1e-7919-49a0-9e3d-09d719a48036"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7007437bd44f4d68ad1ad8bd03e2f923_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTMtMTMtMS0xLTA_bf6a6e09-6457-4f34-a1e0-c5a892dbdea9"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ica882fe4d91740f2b81b3646815ff854_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtMy0xLTEtMA_cc1afc7d-00a8-4944-8df1-7e7ce37cd695"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i54f0ffb4cb5747e5ae102f05f6be5426_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtNS0xLTEtMA_9cd868fa-abca-4ab2-8b52-5a189bfa8751"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib9fdbba4396e465aa67202f3d051bf09_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtNy0xLTEtMA_e61789d2-7655-45fc-9b34-ed35d96b4e37"
      unitRef="usd">94000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie98081acc8c6408991f4c8cfefb17661_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtOS0xLTEtMA_3a5c3da3-c85f-4564-82a4-cebe316931e8"
      unitRef="usd">150000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iaea822d1827147c99d73617628295d8e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtMTEtMS0xLTA_36c19b68-3a4e-4059-8719-f69c01f501ae"
      unitRef="usd">661000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ibc598c056391483daf070cbea7830172_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkzMTQ5ZTFkN2MwYjQzZTk5ZmExYWVlOGEzZWYzMzJhL3RhYmxlcmFuZ2U6OTMxNDllMWQ3YzBiNDNlOTlmYTFhZWU4YTNlZjMzMmFfMTQtMTMtMS0xLTA_3e93e13c-9c84-4573-afcc-9d2a0de32cf4"
      unitRef="usd">1047000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDY2NQ_ecdcc8e5-d489-4dc4-bb43-0c169dda366e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the three and six months ended June&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.283%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021. Net realized capital gains include the reversal of previously recorded credit-related impairment losses on debt securities of $42 million and yield-related impairment losses on debt securities of $1 million in the three months ended June&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $3 million and $42 million, respectively, in the six months ended June&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;(2)Net investment income includes $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, and $10 million and $21 million for the three and six months ended June&#160;30, 2020, respectively, related to investments supporting experience-rated products.</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia0bfcd29b10f48ae92b73e7e61315ccd_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi0xLTEtMS0w_50c7563f-87db-41d9-a845-581fe1ca8578"
      unitRef="usd">160000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i517df693ba094adcb6a72f956951017a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi0zLTEtMS0w_06d45133-379c-4213-97cb-ee9f51572f8f"
      unitRef="usd">146000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie42822d1eacc4a8eb4231d4dc693ea43_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi01LTEtMS0w_c7047c09-e163-42b1-a05c-3a6a795b0e00"
      unitRef="usd">317000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie3d1e2584e2e4ece9d9ce0724718c49e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMi03LTEtMS0w_ac506c91-3f3d-4a24-a098-f495ccfd4044"
      unitRef="usd">290000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i635b7d77a86447cbbde8755fc40a8123_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy0xLTEtMS0w_6e3b03eb-13f2-4f9c-bf65-8689de1b9ded"
      unitRef="usd">13000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5bdeac025f774c94829e3eb2edfc85ed_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy0zLTEtMS0w_91fd9e5a-cd27-4b40-af5a-0a0db6615058"
      unitRef="usd">15000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i42d87419632b4611adab279ece7e7ab5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy01LTEtMS0w_e4c26fcf-eaff-45b0-8a22-9b44cdc5dd3a"
      unitRef="usd">28000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia2b888f576f9425dbc1db1dd81427da5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfMy03LTEtMS0w_7d6123a8-80c5-4834-bf1a-c8ca3388c2c0"
      unitRef="usd">30000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i2dc660620ba647f4b99c1bf75a1627fa_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC0xLTEtMS0w_17853b0c-6e18-48b8-a4e5-642e4b2061ce"
      unitRef="usd">112000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i16505c15a33845cc90e5567fa18ee168_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC0zLTEtMS0w_249b8348-3d94-4ee6-8098-2d9fe3645a77"
      unitRef="usd">-20000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i6d7b0bb4b38a45ffab552ab679c7ed71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC01LTEtMS0w_fdf269a0-e942-4121-bc30-3484ad7f861d"
      unitRef="usd">198000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if766f5d0385a41e6b60c61a94201bd04_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNC03LTEtMS0w_322d28be-7a19-4770-aa58-2b7367f5304e"
      unitRef="usd">27000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS0xLTEtMS0w_fdf978c0-2dd9-4ea3-8732-4fb6681dd8ea"
      unitRef="usd">285000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS0zLTEtMS0w_edded50a-a059-49c5-b206-ff6b5cfff2ec"
      unitRef="usd">141000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS01LTEtMS0w_e34bc244-41fa-499b-8965-ae02f95e2d20"
      unitRef="usd">543000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNS03LTEtMS0w_423fdc9a-17ce-44a3-b82b-6eecbfcbbe09"
      unitRef="usd">347000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi0xLTEtMS0w_ed9e89e7-11f3-47a3-8011-8a3f04d2c205"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi0zLTEtMS0w_70ff5235-0eda-4f57-8a00-d5a239b21327"
      unitRef="usd">9000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi01LTEtMS0w_55aea1f8-d740-4ee0-82c7-2a81920556cc"
      unitRef="usd">17000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNi03LTEtMS0w_bb9c5616-7ac5-4745-b6f5-af10d7e20157"
      unitRef="usd">17000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy0xLTEtMS0w_a4a64064-dd09-4f23-b9d0-b786ce632484"
      unitRef="usd">276000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy0zLTEtMS0w_2db9b7c5-f42a-4c41-b733-7ec7e3fb50dd"
      unitRef="usd">132000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy01LTEtMS0w_40bd1453-7121-4b12-b7a0-633650aca209"
      unitRef="usd">526000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfNy03LTEtMS0w_2a0aea7d-d98e-4f47-a9f9-1d7d2211718b"
      unitRef="usd">330000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC0xLTEtMS0w_22b1f4dc-ea31-4f39-8bd8-54f6a9a405ca"
      unitRef="usd">13000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC0zLTEtMS0w_119b751e-8b0a-462b-a564-051ec56c3277"
      unitRef="usd">52000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC01LTEtMS0w_8fccd884-380b-47ba-a455-b7ced0b76eea"
      unitRef="usd">60000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOC03LTEtMS0w_77ddff0e-9657-4e7d-be6e-c650197f622c"
      unitRef="usd">16000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS0xLTEtMS0w_f39eed11-2bb4-43f2-8229-da8bb7a494a5"
      unitRef="usd">289000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS0zLTEtMS0w_0af00daf-af1f-4a87-8603-f69f0e865f1b"
      unitRef="usd">184000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS01LTEtMS0w_886ddfee-5774-4e2e-9a66-64421b4eb668"
      unitRef="usd">586000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOmNkNDQzNjgwZDBjMzQwZWM5OGQwNWZiMWRmNTdiZTFlL3RhYmxlcmFuZ2U6Y2Q0NDM2ODBkMGMzNDBlYzk4ZDA1ZmIxZGY1N2JlMWVfOS03LTEtMS0w_5b1bbfc2-96f4-4b2d-92cc-ff611ee6a076"
      unitRef="usd">346000000</us-gaap:InvestmentIncomeNet>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTY0OTI2NzQ0NzU3Nw_93d7b726-990e-4c50-858e-d887090e642b"
      unitRef="usd">2000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTY0OTI2NzQ0NzU5Nw_d8b89ef1-03fb-46d8-b7fd-f055c6af75ee"
      unitRef="usd">32000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMzk5Mw_3151d900-cf66-4e20-97be-9848ec974e8b"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMzk5Mw_66ef4b47-3b28-4cec-9c97-f7c26f0271e4"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU1MA_91d43a04-eaca-4174-97cd-53d358f91a75"
      unitRef="usd">-42000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU2MQ_9eebb045-0729-4d03-bfaa-3f8595b834af"
      unitRef="usd">1000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU3Ng_3efc4f4b-b51f-4ea2-a5dc-b9d22f1bcfcf"
      unitRef="usd">3000000</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzU5Mw_d49ae27c-a938-4aab-bf3b-6ea3dd94fb40"
      unitRef="usd">42000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="i42f9c017860948b99f0fb8dea97d4d51_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDI2Mg_4a3e498b-6c28-449f-aed5-b658b33a164b"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ib882de119eac484b9d951f61870fc5f9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzUwMg_b09af680-49fb-4fed-ae31-eabfa2628528"
      unitRef="usd">19000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="ie0b4a3cd76c34e31b91ed92d1872d19c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzA1OQ_caead480-b88b-4fb0-bac1-94977191431a"
      unitRef="usd">10000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i4c2fbf0383914cbeb84f216152e87705_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfMTA5OTUxMTYzMzUxNQ_d6822f5e-5b1f-4d28-8950-4c1ceb8f92db"
      unitRef="usd">21000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RleHRyZWdpb246ODRiOTlkMDI2MzFhNGU1ZGE1ZTI1ZTcyYTMxOTYyMDBfNDcwOA_5a77e31c-c9ec-468f-a8f0-fce37b7c8b87">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi0xLTEtMS0w_0bd8899d-5da3-45a5-af72-9bdd3ccc4cad"
      unitRef="usd">919000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi0zLTEtMS0w_ac490c6b-45c4-4d4a-89ba-b328f5b6ee4a"
      unitRef="usd">1419000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi01LTEtMS0w_92912490-a160-4956-a552-486cb06589c3"
      unitRef="usd">2267000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMi03LTEtMS0w_46c58691-b0f4-4bbf-8916-852b4fd6692c"
      unitRef="usd">2142000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy0xLTEtMS0w_1eb976de-82ef-43ba-be88-3fb3019ef878"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy0zLTEtMS0w_5fdc9451-0c41-418c-94c8-19b6b39a370a"
      unitRef="usd">23000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy01LTEtMS0w_a0da39d5-78c1-4b0d-abd2-b28b2b7458b4"
      unitRef="usd">42000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfMy03LTEtMS0w_39442850-bef5-41b6-afaf-7a0953fe535f"
      unitRef="usd">43000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC0xLTEtMS0w_56241730-1a35-4855-b80b-2bd13b1c1265"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC0zLTEtMS0w_ac22d89b-0609-4b53-92f0-9dbf4e665d64"
      unitRef="usd">21000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC01LTEtMS0w_1f0313a5-2159-40e9-8788-027fc8d51162"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80MC9mcmFnOjg0Yjk5ZDAyNjMxYTRlNWRhNWUyNWU3MmEzMTk2MjAwL3RhYmxlOjkwYWYxZTJiZGYwMjRlNWFiNzVlNTU5ZjM1YjFkMTkyL3RhYmxlcmFuZ2U6OTBhZjFlMmJkZjAyNGU1YWI3NWU1NTlmMzViMWQxOTJfNC03LTEtMS0w_74108199-a266-4782-adde-ddcfaec96d0e"
      unitRef="usd">56000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc3OA_ebcc000f-4d60-44f5-bc30-5c867f7786ab">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#x2019;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#x201c;Fair Value&#x201d; in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 or December&#160;31, 2020. Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2021 and 2020, there were no transfers into or out of Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $100 million and $29 million of other receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="if510787ec69a47dab801c3bc8709accf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMTQzNQ_4ed50a6d-5fbf-496c-82ad-0f834b524704"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMTQzNQ_c052477f-a846-4cd6-959b-40a3e1c3e592"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc3Mw_b4b2575f-7db0-425b-ba61-996c77b59f39">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi0xLTEtMS0w_dfc4dc53-ad31-40b9-b7a1-317361fc1433"
      unitRef="usd">3538000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi0zLTEtMS0w_114eb078-a340-415b-98f1-70879981c687"
      unitRef="usd">3581000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi01LTEtMS0w_6e4541ea-c082-4ede-b528-68537c2b4a15"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMi03LTEtMS0w_ada422f4-a2dd-4561-9938-40e21b0da252"
      unitRef="usd">7119000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i210cfc37361e470c839857aa7665fd2e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC0xLTEtMS0w_4e38008a-4053-483a-8fff-98c65dfd1f3b"
      unitRef="usd">2365000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5756d6da663844dd8e3245d0308e243b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC0zLTEtMS0w_aa69485e-5825-46ed-a0ec-13c897922d4d"
      unitRef="usd">45000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8122e2ed870645328446a41f8f459934_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC01LTEtMS0w_a61e9282-d969-498d-bc11-0edc9f80d2ad"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4774aadb10b74dcd88e20d1880176f2b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNC03LTEtMS0w_52b6153b-490c-4fbd-90ee-c3eb010f4663"
      unitRef="usd">2410000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d647a560d834ed7bec26a73aea83cce_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS0xLTEtMS0w_7860bc51-0fd3-411f-b625-1d2945eb2eba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i51f256ca262f46f29af5968001b43da2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS0zLTEtMS0w_f44f1f78-97c3-4862-b6e3-7b02eee5074e"
      unitRef="usd">3144000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4937f0b48be141ada107552f5c969303_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS01LTEtMS0w_686fefa2-010a-4a0f-a8ca-ad5df66c2144"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6ec3859c325c4e37bdc207864784224c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNS03LTEtMS0w_b8bf0c46-446c-4f33-ae62-7b75b4f3c829"
      unitRef="usd">3144000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibcd344f786334eeba5b6b5f3e83b93d8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi0xLTEtMS0w_703b9923-a10b-438f-81a6-1bfe40ccdd2d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf06625a4a7e42ad8768a5601e932198_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi0zLTEtMS0w_6e4917ae-ee82-4fff-9f8f-c816b45b0b0a"
      unitRef="usd">9521000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if648025f3229424d9fb2cb50b21a4d8e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi01LTEtMS0w_0ebd28d7-e42c-4234-a958-e1a29722ca66"
      unitRef="usd">41000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0a83e5029cd544968b3f62662c6606dc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNi03LTEtMS0w_ecb4463f-a571-4c23-987b-f453cffd65d4"
      unitRef="usd">9562000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib243fd82757e4fa48ebb957b2b99c657_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy0xLTEtMS0w_de744a88-e8aa-4917-90d6-fba8992dbd5e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i666e214c5a9044248a863407bd0eb6d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy0zLTEtMS0w_154a7ed2-ee4e-4042-bce2-6dff6a5d7a4d"
      unitRef="usd">2893000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48d697cff45d428eb1ade196d28a9895_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy01LTEtMS0w_c8ffcc49-89d0-4afa-aa0c-10fc65ff05fb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i72c9463581a84b608a88153478abae38_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfNy03LTEtMS0w_a02dedcc-5386-4f33-a4bf-46453a26a8cc"
      unitRef="usd">2893000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iff11c38224d54e13923ab497bfa6a493_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC0xLTEtMS0w_f321afb7-cc53-4564-bb49-a806ecaf3696"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if0ee846d07ec4f5da014c0cbee5f6325_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC0zLTEtMS0w_37a328ca-e2ad-4936-852a-5b1b43ab8466"
      unitRef="usd">829000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaafc729b92494245ab81e716ce94cb2a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC01LTEtMS0w_c0677985-7b14-4833-ad3e-3746cb2ce18b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i59d54b47fd594fef8e068ff8c673c092_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOC03LTEtMS0w_b37f9e40-54cb-4231-a031-c25334827ba1"
      unitRef="usd">829000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie1649f3335c0494e81c99fc59c8b29f5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS0xLTEtMS0w_a33a3bda-9fdd-4fba-87e4-2d88e47d2f8c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if652301e5b5943129f8dabc5c8548671_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS0zLTEtMS0w_5d147929-5487-4aea-89e5-7c2be4b734ac"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7bcca6c60a14999a5c77af4ebe5e5ae_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS01LTEtMS0w_9b9e58d5-e6dd-4d7f-954b-946181c66913"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e6325064a1c495391cc89279cb2514f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfOS03LTEtMS0w_90e4ec82-871e-4972-9959-2f9b4b51111e"
      unitRef="usd">1081000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idaf38374d2b44debb4cab8d016415de6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtMS0xLTEtMA_750239ca-353c-4595-8ced-8b71743ac22e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22d3dfbf8c9f4ac0bb704473ec643a62_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtMy0xLTEtMA_893df882-3dc3-4fbd-acea-6845f0fdd04d"
      unitRef="usd">2397000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia08106700a614dff9824cb0fe4668155_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtNS0xLTEtMA_66d9ee83-54af-467f-8204-28df2b60245f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibc2aabed88fc4d488c491b6a45904991_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTAtNy0xLTEtMA_42da68f8-da34-435f-b885-f531b4ddca72"
      unitRef="usd">2397000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i508570dbfe5849138bc3977ff2cb5ef7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtMS0xLTEtMA_21169b74-965d-4a36-bb94-86bb86f8c741"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i72735f55bd18494cacc33cb8c99b64d9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtMy0xLTEtMA_0c08524b-6c0f-4bae-90fd-a85b31ba21d4"
      unitRef="usd">29000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4f512df7d4da495d8f781fb880dc0284_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtNS0xLTEtMA_5342d038-3a05-4023-8e68-f89262317365"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fb024b2608349f0b1205f18ce388c77_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTEtNy0xLTEtMA_66375450-55e9-4109-9f2b-2b10d565c5e5"
      unitRef="usd">30000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItMS0xLTEtMA_f9fdbb4f-01ba-4af0-85e8-c8694c217996"
      unitRef="usd">2365000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItMy0xLTEtMA_eecdc705-acb1-4fd4-82d0-fb2553c2681e"
      unitRef="usd">19939000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItNS0xLTEtMA_f393a08f-94b1-4292-b943-d6bbddd4f3cf"
      unitRef="usd">42000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTItNy0xLTEtMA_31cbd248-4d92-4444-9a1f-1a66c6591a04"
      unitRef="usd">22346000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtMS0xLTEtMA_58d0f368-f24f-478c-9b6c-3a5be360ce13"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtMy0xLTEtMA_c163817e-f568-46d7-abe6-8032e254f14c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtNS0xLTEtMA_b751a10c-1cd9-406d-b25a-d0c7488ab524"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTMtNy0xLTEtMA_ca647514-97fa-4b1c-9673-ea9ebb374906"
      unitRef="usd">60000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtMS0xLTEtMA_6a8aa2d4-e576-456a-8d67-9fa5a799c981"
      unitRef="usd">5933000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtMy0xLTEtMA_6ed6381a-600c-402c-93bb-a215c14aa367"
      unitRef="usd">23520000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtNS0xLTEtMA_a16be233-f809-454e-bc9f-38504c7f32c0"
      unitRef="usd">72000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTQtNy0xLTEtMA_46231c24-30f0-476c-a535-a349353e76bc"
      unitRef="usd">29525000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctMS0xLTEtMA_ac8746f2-036c-4fb9-a457-eb9aa3174385"
      unitRef="usd">3985000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctMy0xLTEtMA_2139c224-2c07-4fac-8961-5ee5ce50045a"
      unitRef="usd">3869000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctNS0xLTEtMA_f81f032c-dbf3-460e-a742-72216f8cd151"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if510787ec69a47dab801c3bc8709accf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTctNy0xLTEtMA_15599f12-0856-4ab5-a63f-aaa4d630ec9d"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2bd934620d014afeb56e178d35779aa7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktMS0xLTEtMA_ce568b64-ec91-490f-ba0b-ae637e4fd2fa"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibed7dee2937d4edda5a4f4eea940e0c1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktMy0xLTEtMA_d0406885-ed86-4d2f-ac01-077238664010"
      unitRef="usd">99000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i41c79aea9b744926b279baefd7888c7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktNS0xLTEtMA_580a3634-b0e8-47fe-ad78-b0270761666b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifc1767b92b5c4de5a2e23e7eb3179d2b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMTktNy0xLTEtMA_8c1dca98-0e41-4d96-932b-aaf2098047f5"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8aa429dd3d3443068ab973df732e3c5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtMS0xLTEtMA_866caf15-6fb4-4c7f-8f41-14f4f55e3b60"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5804356b138422d80717a1da9579a89_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtMy0xLTEtMA_4f62517b-ff4d-4d30-bcfa-14c44a8303e2"
      unitRef="usd">2727000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib901721cf1bc447e858860d4cb20ce74_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtNS0xLTEtMA_e6ee5b32-8615-437c-bd58-a17e502e55a4"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i63b4df452eaa45da9e4f334a54e4276b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjAtNy0xLTEtMA_c17cb5a1-b169-41d0-9359-2d036f33879e"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7e5f228a57743f1b6ea83a254776653_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtMS0xLTEtMA_b3e724b7-09fa-493d-a668-76b7078643d4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife856c95fabc422e946de71df9f85f7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtMy0xLTEtMA_4dc475d4-08a7-44d2-9262-fcc21dab9036"
      unitRef="usd">8842000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd180ab75d5a4fecb68db3e8d283b9f7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtNS0xLTEtMA_f24b5f8c-0d1d-4420-ba38-26218bc4ebd2"
      unitRef="usd">52000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i85785249c39f4629a053294868f4fcdf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjEtNy0xLTEtMA_81e302bc-d2c8-4093-88d9-941e57138c67"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie19ff9770b3940188b1c9822a1c6d9b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItMS0xLTEtMA_e5c45b30-71a2-466f-a664-b5fc2309a9cc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i22a1418e8df34c6cb73572ce728f62ac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItMy0xLTEtMA_a29f49da-62f5-4e5e-8ab5-460c2ebddede"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i86f5a355792b49a293afec62f4455847_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItNS0xLTEtMA_ee3f6d5a-ea28-4716-9d17-bbf84cdbe41c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2374f86f801462a83df1f2c38872a96_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjItNy0xLTEtMA_a704d1e5-0367-49d6-92ac-476e15a37dd2"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8cd73f6a957430db9ad4fba0bb5ee64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtMS0xLTEtMA_c11979f8-df48-443e-8f93-f165907ded73"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bd730a9a7384fcba46ad7b64d43e6d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtMy0xLTEtMA_770209e8-5077-4e5c-add3-55a2d774c377"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09ff8669b4a54e3e90a5ab48256328b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtNS0xLTEtMA_6120cf46-47f4-43ca-a944-33233cd1674f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d20c989c3b64c90ac3cd629c8bf4640_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjMtNy0xLTEtMA_6c32963f-2d65-4316-8581-49b327fa3941"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04a0e0235a7c4490a5d9ce38d2dec0f7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtMS0xLTEtMA_4bbf75b8-72c4-4a84-b653-7dc23bddb96d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0dc3ba5e04941c187297fe40513dde5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtMy0xLTEtMA_1c263bd5-0478-4440-84fd-7200bfd78243"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3854b6138a7e4b6ba179f9daaf4bf706_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtNS0xLTEtMA_b6196785-3dac-42db-bdd4-daf08f767c33"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i18930979d5f444fc9ce85d4aea31a3a7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjQtNy0xLTEtMA_493651ae-b630-4740-b41b-948b1f3df6cd"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icdb74a304f8a449c904b5ac5ed9a47d3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtMS0xLTEtMA_3d508e67-a5a1-428d-953e-b2ae9b815481"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b89a5844183436683430ac9c92e2493_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtMy0xLTEtMA_0072fb20-1b2f-45b1-be81-3f31b7909611"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2ff75c2db4cc4af1b847def76f22a529_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtNS0xLTEtMA_da49f2f1-5c8b-4dea-b920-e39234e313e8"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7c828dc2e7148ec8b99c9d153298510_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjUtNy0xLTEtMA_42776f02-b8c1-41d3-a476-e830126a7a30"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i492d50e843c848998eb35ba39503a0c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtMS0xLTEtMA_3f53b15a-828e-4aee-b778-f8ccb55584ff"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i73382bef295f429781872fe2001fc529_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtMy0xLTEtMA_428472bb-d935-41ff-9ad2-4ae2d432dba2"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i25c677e6daec4e8780d801dfa6da3c94_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtNS0xLTEtMA_4d99216e-b91a-47aa-aae9-f8a5c2559c5f"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29e642c930d94a8d9996ce4bed724ae0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjYtNy0xLTEtMA_19179859-5162-437a-ada7-12446531fe4d"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctMS0xLTEtMA_c88ebc07-dea6-4664-80d4-83813f0078c7"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctMy0xLTEtMA_fd37b3e4-16e5-45be-8892-ebd9c6c76e4d"
      unitRef="usd">18764000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctNS0xLTEtMA_f8d23451-53a6-4407-b498-b586df7cbd5e"
      unitRef="usd">54000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if510787ec69a47dab801c3bc8709accf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjctNy0xLTEtMA_4a692ff7-c038-4761-8d0b-d76aa663cf1b"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtMS0xLTEtMA_2ff0ba00-b0f9-4773-a512-a1cb8b0e6112"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtMy0xLTEtMA_eb93612a-ffaa-4d61-af7b-0082a3baeeb1"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtNS0xLTEtMA_05993d4c-00f6-45d8-9f95-a248b903298c"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if510787ec69a47dab801c3bc8709accf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjgtNy0xLTEtMA_22f77d13-7cdd-4015-99e8-70490e682610"
      unitRef="usd">47000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktMS0xLTEtMA_7af287c7-dc33-43ae-9faa-21a31fa41684"
      unitRef="usd">6372000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktMy0xLTEtMA_6f7aa5be-2671-4428-8243-4df609d867d6"
      unitRef="usd">22633000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktNS0xLTEtMA_43f96429-3562-4e16-b662-19de8ce31a0d"
      unitRef="usd">84000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if510787ec69a47dab801c3bc8709accf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOmNmODMyMDAyODVmYjQ0MjlhNzc5MTdkZTBmMzkwOTk5L3RhYmxlcmFuZ2U6Y2Y4MzIwMDI4NWZiNDQyOWE3NzkxN2RlMGYzOTA5OTlfMjktNy0xLTEtMA_998292e2-58bc-48f7-8a2b-6c65781db106"
      unitRef="usd">29089000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc0NA_c0ff04c0-9c1f-4a9d-aba0-3b738ed31488">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC0xLTEtMS0w_17aa2dfe-682d-4b0e-8e72-0f6fac37f63c"
      unitRef="usd">976000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC0zLTEtMS0w_069c09af-8b9a-4dc5-a746-98db2600b046"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC01LTEtMS0w_9453a097-b6d8-4182-9c9d-ba18dde9182c"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i6584062de818418fac5ed71f5a372118_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC03LTEtMS0w_a884a017-1544-415d-bc3d-26a3cc3d25a6"
      unitRef="usd">992000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNC05LTEtMS0w_80d43ea4-c10f-460e-a84b-10f8ff0f5565"
      unitRef="usd">992000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfNS0xLTEtMS0w_45507a62-4e35-4c2a-9396-b97e9afa883b"
      unitRef="usd">129000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC0xLTEtMS0w_237b6f47-cbbd-492e-af62-59d96badce4e"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC0zLTEtMS0w_e0142c99-010d-4b52-871c-5204a03e2d28"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC01LTEtMS0w_6e9bb0ca-58f8-448c-831a-33463b24dc7d"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i6584062de818418fac5ed71f5a372118_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC03LTEtMS0w_3a61acab-5bd3-48dc-b301-dd4ffcb57595"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOC05LTEtMS0w_8b28ff6b-dc1f-4db1-927e-1c7d0794e706"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS0xLTEtMS0w_d0e8e23d-c4d7-46fd-ae07-68625b81ce48"
      unitRef="usd">324000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS0zLTEtMS0w_3511c2e8-c8ba-4de3-ab29-61f304dc8c02"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS01LTEtMS0w_0730c2f8-b53b-49ef-a713-d50e9c96019b"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i6584062de818418fac5ed71f5a372118_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS03LTEtMS0w_c60e74e6-39a3-4e6e-886b-f36b331c6572"
      unitRef="usd">363000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfOS05LTEtMS0w_cbce04be-2758-4e5b-9c17-6a9e4a100d95"
      unitRef="usd">363000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1b5b641cecaa495588a4e4dba1cafd61_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtMS0xLTEtMA_a70d6abc-4d14-4bd0-a5d0-b5a2da7ea752"
      unitRef="usd">59354000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i118929ebf94a4e06be11a3ad3b27a03d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtMy0xLTEtMA_2e8901fe-34d5-4b77-9b40-8e24f8a47e1b"
      unitRef="usd">68364000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib75ac40c5bd54d60b12bd3c382ee72f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtNS0xLTEtMA_b53d2668-0e4a-4899-9768-8b759b149f8d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6584062de818418fac5ed71f5a372118_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtNy0xLTEtMA_a01f9f8c-8d4f-4ce4-9384-13755139bb1b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3b6f0b7bbfb840dd9e39e525b1c87ade_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTAtOS0xLTEtMA_6c0bb4e8-e428-4e1b-9d91-9cf21a583a3c"
      unitRef="usd">68364000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtMS0xLTEtMA_7af3579d-6650-4fb3-a8fa-01e78d66b9df"
      unitRef="usd">1047000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtMy0xLTEtMA_25e32571-0549-4466-acf4-3e33e5baf20c"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtNS0xLTEtMA_6d2beb2f-f34a-466f-8a3c-5de7cd728592"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtNy0xLTEtMA_612a2321-c86e-4a53-ac76-6cb7ee14a308"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTQtOS0xLTEtMA_06476a5d-a072-462f-95d4-c93fc23b3eb6"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTUtMS0xLTEtMA_c835f498-2e60-4df0-84c2-5aaa7e351bd9"
      unitRef="usd">145000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtMS0xLTEtMA_a6cf2cc3-59c9-46e4-87a6-660cb6b902a9"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtMy0xLTEtMA_16acb3c7-4baa-477c-b67f-e92dce04ba45"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtNS0xLTEtMA_6a60bbc1-ddaf-49a4-be38-ba80a1f96e68"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtNy0xLTEtMA_c544a25d-ded3-4f72-9560-d55ae685a924"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTgtOS0xLTEtMA_ddbe2615-7c5c-4814-814a-061e078b624b"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktMS0xLTEtMA_6c5d960a-b828-4381-9277-27c0aa657282"
      unitRef="usd">322000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktMy0xLTEtMA_89bbb8f2-00ee-4ec8-a63c-7653cb22a39c"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktNS0xLTEtMA_5ceebcec-af38-4f2c-9193-3cab54c668ab"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktNy0xLTEtMA_46db4b5c-9c77-4f47-85a5-1a09cdef9b71"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMTktOS0xLTEtMA_306ac22e-acf1-4bb8-89f4-58f627bb9744"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if5c8b3882eb447689c15b9b6dd5ba95e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtMS0xLTEtMA_8af3da3f-a761-4421-98f3-00a282fe45a7"
      unitRef="usd">64647000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i34356136fef34ea68725d0b2dedc1d87_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtMy0xLTEtMA_34ef4419-7e7c-4503-8db0-fb8d630fb565"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i854709c930d6449fb02d80ed81b53e55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtNS0xLTEtMA_e1a07ae0-d381-4e68-b555-09d2f92c8a2f"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2c3a89719074423b8d52bc27096fff9b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtNy0xLTEtMA_b7ff4fc9-92bf-45f8-b009-941284e6ef1b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4a115fbfb91c4616a824c7ad041c71b6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjBiYzc1ZWNlZTkzZTQyNTg4ZGVjOTNhNGQ3MWQ0NjRjL3RhYmxlcmFuZ2U6MGJjNzVlY2VlOTNlNDI1ODhkZWM5M2E0ZDcxZDQ2NGNfMjAtOS0xLTEtMA_0f82fe1b-b4be-4dfd-81d7-c44b735b2c38"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjc0MA_052e5c1b-a1ac-4fd6-942f-994a7068926b">Separate Accounts financial assets as of June&#160;30, 2021 and December&#160;31, 2020 were as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $100 million and $29 million of other receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="i9c2e12ab2ed44a1685c511613129c6ea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0yLTEtMS0w_cb224976-c707-44c8-bde9-d65ded01dd21"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifdb7d9bc6a274f09859f00ab5e174888_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi00LTEtMS0w_7e73d287-6571-45df-8a9d-e0ec7852183d"
      unitRef="usd">227000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if5abce7dc4f744fb8be00645bffc65db_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi02LTEtMS0w_322eafc5-7511-400e-aa10-304c254af51c"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iad91cb1314994e379923841f48edf212_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi04LTEtMS0w_00a0221d-ad5b-41f8-b733-253dda93f4e2"
      unitRef="usd">229000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iffde036edf014ed291d1a23247cc772a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xMC0xLTEtMA_7da2cc01-4a81-41bc-a3b9-f195117bd6d2"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i4a2cc0aef0ef434ca7a520686e5a5a11_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xMi0xLTEtMA_8ea42416-6e2c-4717-99e7-2164a6e1cf63"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iae628a7e9e9d4d70990367c3408854c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xNC0xLTEtMA_e59d388b-16b9-4eb1-ba37-d64e174a923b"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i076f74e1a0eb466192510067a9c8a7c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMi0xNi0xLTEtMA_b2b82b64-6254-4467-96d9-b48314286b9d"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="idac6c16e9b5b4dc8a02816d8c21aeafa_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0yLTEtMS0w_640af503-c70c-4d79-b683-e1a9f954a977"
      unitRef="usd">1075000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8968fff252724607a7a65bdc9378629e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy00LTEtMS0w_54bc3a75-4954-4bff-94d9-08f19574db37"
      unitRef="usd">2961000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib9e44f82810c440485338f4334976121_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy02LTEtMS0w_2e189bda-71de-4424-bc39-86ce1f8aaff6"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="icdb59237beda4ebaacb4ab8eb6a97d0b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy04LTEtMS0w_b6956cff-137d-49f3-aa5b-41c3501498d1"
      unitRef="usd">4036000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0244059f9628439f877b719efced6c7f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xMC0xLTEtMA_fefaa545-9d96-4acc-a05d-7af6f837fcda"
      unitRef="usd">1465000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie43a8645a41a4ef2a7ef116fc6539527_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xMi0xLTEtMA_e40c31d1-827b-4997-9db0-e83dbef02784"
      unitRef="usd">2634000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5eaea3134fed4570a85d692327045a39_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xNC0xLTEtMA_6096b189-c411-4f05-8ae8-98a18bc21bb0"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i3ef4cf2bbf004e71ac5c7cca1cfd3a50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfMy0xNi0xLTEtMA_fb5778e3-1d40-43e5-a9b9-4708705ea525"
      unitRef="usd">4099000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i34b9eb3d66c14bc28cb0cc540b80fc4c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0yLTEtMS0w_8bd9ea4f-ee4c-4f1d-95de-523e63a9e911"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i7857397f0c414fe58b62068caf0af267_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC00LTEtMS0w_c5756d84-418f-4692-ae2f-e47baea28a5f"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iaebacd56446c4171843144f398469d81_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC02LTEtMS0w_3007bb3b-92ce-419f-a169-9530662bd4f4"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib77cba1c8ec74b5ea417e97bfc25f625_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC04LTEtMS0w_478275e5-1213-49f2-84b8-81862bd831c4"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i01eb9253c97c4e5b9250d83998bcec06_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xMC0xLTEtMA_49ae9566-90e7-45f2-94c0-e1591e3df533"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i44630855078a48b9908bbdadf53bc736_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xMi0xLTEtMA_87c07934-64a1-4841-9845-424eb2ba595c"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1c30b37500e14214ad5855fdc0950616_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xNC0xLTEtMA_5eca8d11-dfc9-4460-840a-623c25db2aaf"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic242a2b931a4468b8b353b6e0aef8bcd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNC0xNi0xLTEtMA_edde119a-a735-43ab-b7d5-0b349d9b1410"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i22db164f3ee140ce9151bfbea89bff98_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0yLTEtMS0w_8ead8efb-81c0-4d52-bff1-f30ddc6f5436"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i09809fb393924acb85b3db48f54103ea_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS00LTEtMS0w_09296b68-65ca-4372-9028-e1598545c03e"
      unitRef="usd">513000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8f077ab3271f495385d381d572fbe9e7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS02LTEtMS0w_52e14dc7-6ce4-4c85-bd98-e90a7eeb57ad"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5b390a8e65e1443bb33e8ab459655c77_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS04LTEtMS0w_62cc67d4-4594-4006-9ec1-d729fee9e1b3"
      unitRef="usd">513000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i64ece45dfbc249c0a0e2afea4e637eba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xMC0xLTEtMA_56f216d6-c8bd-420b-814f-091f5909654a"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i30f3983821e94ff09717ee684cee383a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xMi0xLTEtMA_2829e7e8-896b-4a76-abd0-1792b437c5a4"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i58bd0bd6852b45eea2c0896f18f97044_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xNC0xLTEtMA_933469ec-3ae6-4d89-8608-9d21016fcaf4"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i17e39654116145cdb653f9ed90d33e64_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNS0xNi0xLTEtMA_40604561-7805-43cc-9914-01a88cb9357d"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ibdbbda77a99d4c8ebc628f3af3da765c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0yLTEtMS0w_b619e184-6f13-4781-952b-cdf1f467e6fd"
      unitRef="usd">1077000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5399bf83d83746fea2ea6ce590a2d4fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi00LTEtMS0w_f9f24459-af29-45b4-a893-aeef9b6820c3"
      unitRef="usd">3703000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i2e17fbacae7443ed952ba5013f247779_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi02LTEtMS0w_a68ea0fc-3856-43db-95c3-ff8b492c5aeb"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi04LTEtMS0w_2c7166f0-bafc-4635-8023-aa7cea25e601"
      unitRef="usd">4780000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia30edaab02914ed1a4fb09da02b3afef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xMC0xLTEtMA_ccc437b1-d185-4a1f-9518-398693efb676"
      unitRef="usd">1467000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i43462d31172f47d98a4a3224e271ebd1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xMi0xLTEtMA_0ecbd7bb-c6b0-4ee0-9211-f6f636709347"
      unitRef="usd">3385000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic544aea1c1a74584aca18be496ce9788_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xNC0xLTEtMA_278ecca0-4229-4d8a-99c7-f71714082f2d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if510787ec69a47dab801c3bc8709accf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RhYmxlOjQ5NjU5MDdkOWVkNzQzOTNiZGUzODJlNjgzOWJhMzU1L3RhYmxlcmFuZ2U6NDk2NTkwN2Q5ZWQ3NDM5M2JkZTM4MmU2ODM5YmEzNTVfNi0xNi0xLTEtMA_55dbc728-80a0-4983-85a0-46cdcb4b6358"
      unitRef="usd">4852000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8097a507fc364b0bad573079ff802eb0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjY4Mg_5b85102a-7da8-4f57-a914-9c50c2889553"
      unitRef="usd">100000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iaba58e1397ac49f68fb7f5f0f5837ff0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80My9mcmFnOmU5YzFjMzVmOTdjZDQyZGRiZTMxMGM0Y2UzZjE3OGE2L3RleHRyZWdpb246ZTljMWMzNWY5N2NkNDJkZGJlMzEwYzRjZTNmMTc4YTZfMjY4OQ_7384548d-897c-47ae-ab3c-c9d1627e7855"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMTgxMA_b1675fb1-743f-42bb-9e0d-63c1d6ffa037">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the six months ended June&#160;30, 2021 and 2020 in the table above exclude (i) $5 million and $29 million, respectively, related to a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $27 million and $20 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets and (iii) $99 million and $119 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $709 million and $420 million, respectively, in the six months ended June&#160;30, 2021 and 2020, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;30, 2021, the Company&#x2019;s liabilities for the ultimate cost of (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#x201c;IBNR&#x201d;) plus expected development on reported claims totaled approximately $6.4 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at June&#160;30, 2021 related to the current year.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMTgxNA_4b3f3d27-cf2f-4a4c-888d-daf86216e484">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the six months ended June&#160;30, 2021 and 2020 in the table above exclude (i) $5 million and $29 million, respectively, related to a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $27 million and $20 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets and (iii) $99 million and $119 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#x2019;s unaudited condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="if3d0846f2bdb423fad6dde41f494d94d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMi0xLTEtMS0w_b67a574d-a386-4dd7-88b6-a06d3d933758"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ib452e1f428b347f39293769ac08d9478_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMi0zLTEtMS0w_1cd7eb08-a267-478d-9a15-bf6d90fa145d"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="if3d0846f2bdb423fad6dde41f494d94d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMy0xLTEtMS0w_c18d33c2-8d0f-4d2c-bf0d-93bf4c2f5567"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ib452e1f428b347f39293769ac08d9478_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMy0zLTEtMS0w_9c04f52f-466c-4722-9071-c59835bc07fc"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="if3d0846f2bdb423fad6dde41f494d94d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNC0xLTEtMS0w_461095bf-7bd7-4d83-8869-0f1e111027ee"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ib452e1f428b347f39293769ac08d9478_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNC0zLTEtMS0w_d4bf5852-5fe7-4e97-8eb6-c64be67aebd1"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNS0xLTEtMS0w_317169f7-3207-4645-bca3-9f200da0c4b0"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNS0zLTEtMS0w_49ccc86e-f8ba-4cc8-8a3a-6bd7c3214d42"
      unitRef="usd">412000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNy0xLTEtMS0w_5ab33f34-738a-4949-be48-1692bba97b40"
      unitRef="usd">32183000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfNy0zLTEtMS0w_f50a2760-558f-4af9-a05e-32631a3fc4ad"
      unitRef="usd">26390000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOC0xLTEtMS0w_27d0f292-f9b9-43a0-996a-c25b7ec34aad"
      unitRef="usd">-709000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOC0zLTEtMS0w_c115010a-f605-465a-b839-a927d47c1927"
      unitRef="usd">-420000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOS0xLTEtMS0w_b36e0ca9-ec09-41df-ae30-5fb529183431"
      unitRef="usd">31474000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfOS0zLTEtMS0w_8b670a9d-1ff1-44db-886c-fdf16f53df01"
      unitRef="usd">25970000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTEtMS0xLTEtMA_f1430385-d2b7-4609-a29d-37f3b4bef06c"
      unitRef="usd">24600000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTEtMy0xLTEtMA_a35e024f-79f0-450c-be91-3587684f7f3f"
      unitRef="usd">20223000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTItMS0xLTEtMA_76201872-bb07-401f-a2c6-e8af68083687"
      unitRef="usd">6409000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTItMy0xLTEtMA_6cb759a6-f97b-41bc-aa40-469ab03b19de"
      unitRef="usd">5704000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTMtMS0xLTEtMA_048459ea-1e87-4e70-aef3-64109f332751"
      unitRef="usd">31009000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTMtMy0xLTEtMA_4c22341d-53b8-4e5b-b2ed-1d2a21c621d8"
      unitRef="usd">25927000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTQtMS0xLTEtMA_e27744d0-fe4f-48eb-ac92-d10f66198bfe"
      unitRef="usd">5000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTQtMy0xLTEtMA_7f047c95-6e1c-44c2-a9ee-0c36788b34fc"
      unitRef="usd">29000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTUtMS0xLTEtMA_3a8c9c8b-0ce9-4fdd-a14f-6332c5583e45"
      unitRef="usd">8396000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTUtMy0xLTEtMA_47e63926-3150-4b7c-9c74-11dcb57e3aef"
      unitRef="usd">7358000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTYtMS0xLTEtMA_d1c0b055-ec20-48c8-99b4-7872ef20f6b0"
      unitRef="usd">18000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTYtMy0xLTEtMA_946dba87-ef27-444f-b38c-bc5dcfcd049b"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTctMS0xLTEtMA_d0279d83-bd36-4d0e-9569-9e31de2c5a65"
      unitRef="usd">8414000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RhYmxlOjQzN2M4ZTZhZmQ2MzQwYWViYTRmMDNiMzNlZjg0ZWEzL3RhYmxlcmFuZ2U6NDM3YzhlNmFmZDYzNDBhZWJhNGYwM2IzM2VmODRlYTNfMTctMy0xLTEtMA_e223c75e-120c-4728-b2a3-99017fcb5268"
      unitRef="usd">7362000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i4101cecc5df744f5a0b26d331861ca9e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMjc3_e27744d0-fe4f-48eb-ac92-d10f66198bfe"
      unitRef="usd">5000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="id118d34f2b5c4d3f8bef18af6def2414_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMjg0_7f047c95-6e1c-44c2-a9ee-0c36788b34fc"
      unitRef="usd">29000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMzkx_59db69e7-8134-46fe-b8ff-c61658e89570"
      unitRef="usd">27000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i0152c20c97aa43078a0e9f51783dc116_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMzk4_fda18601-ff7f-45cc-a826-1706c9c10c28"
      unitRef="usd">20000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i59c04e7fb5d44ae6997958c568ba3a08_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfNjAy_e402c8f2-e035-4dba-a16e-ae33a4478f1b"
      unitRef="usd">99000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="ie92993780db143b7b0e4a20bccee8f39_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfNjA5_8ab52d7e-cd96-43ba-a204-5870d4d1fc99"
      unitRef="usd">119000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i7a47d1a84d684029b068833d76ca3bc4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfODc5_27d0f292-f9b9-43a0-996a-c25b7ec34aad"
      unitRef="usd">-709000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i9a48808adae44efe95905fcfc33fcc84_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfODg2_c115010a-f605-465a-b839-a927d47c1927"
      unitRef="usd">-420000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80Ni9mcmFnOmRmMTcwMWExYTljZDRiOTRhMWZmMGY0Njk0ZmJlN2NhL3RleHRyZWdpb246ZGYxNzAxYTFhOWNkNGI5NGExZmYwZjQ2OTRmYmU3Y2FfMTY1OQ_cf2d7e1e-d4f4-4eed-836e-a4296a4a8ece"
      unitRef="usd">6400000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTIxOA_9aa916cc-cd5a-4ace-8d9d-635c12690577">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2016, CVS Health&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) authorized the 2016 share repurchase program (&#x201c;2016 Repurchase Program&#x201d;) for up to&#160;$15.0 billion of the Company&#x2019;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2021 and 2020, the Company did not repurchase any shares of its common stock. At June&#160;30, 2021, the Company had remaining authorization to repurchase an aggregate of up to approximately $13.9 billion of its common shares under the 2016 Repurchase Program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;The quarterly cash dividend declared by the Board was $0.50 per share in each of the three-month periods ended June&#160;30, 2021 and 2020. Cash dividends declared by the Board were $1.00 per share in each of the six-month periods ended June&#160;30, 2021 and 2020. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ifdec0af0fd9f4f60ab69ce914af06e6a_I20161102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTk3_bd407786-3911-486e-96d1-0ee17d5ef23f"
      unitRef="usd">15000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfNjI4_00d3a8bc-2c4c-494f-b544-faf7475f8363"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfNjI4_1a574d54-afa0-46ea-82fe-797d1f426d5f"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i112799dbf93348fca843c7d691faf8b1_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfNzcy_047b88b1-5ed7-41a1-9241-391f07e45fde"
      unitRef="usd">13900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfODk4_05ef578d-880f-43e1-b88a-070820450a49"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfODk4_7e6cfdec-cdab-46ce-9005-e845f82074a7"
      unitRef="usdPerShare">0.50</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTA5OTUxMTYyOTIwMQ_e3d874af-3c02-4540-af11-5ecc592f4fb2"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF80OS9mcmFnOjRlNTNlMzAxYjkyYzRhYzU4NjczOWYxZGEzMzBjYmZiL3RleHRyZWdpb246NGU1M2UzMDFiOTJjNGFjNTg2NzM5ZjFkYTMzMGNiZmJfMTA5OTUxMTYyOTIwMQ_e4642bd1-e06d-446b-b9ec-460622fbe1a6"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RleHRyZWdpb246NjA1ZDJjY2U1ODUzNGRlMDg5MzM2MTg0Y2NmNzUxN2RfNzky_e56c1220-885e-496e-b2a2-88009ce8fef7">Other Comprehensive Income&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income for the three and six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$214, $681, $(273), $195 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(18), $(44), $(1), $57 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $0, $(7) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(4), $(4), $(9), $(10) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(8), $0, and $(8) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($1, $7, $1 and $7 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RleHRyZWdpb246NjA1ZDJjY2U1ODUzNGRlMDg5MzM2MTg0Y2NmNzUxN2RfNzg0_08fea43d-a357-422f-acb8-7e99beadfc38">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income for the three and six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;$214, $681, $(273), $195 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(18), $(44), $(1), $57 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $0, $0, $(7) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(4), $(4), $(9), $(10) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(8), $0, and $(8) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($1, $7, $1 and $7 pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of period balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of period accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of period accumulated other comprehensive income &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i142f058b8bb74591a7b7633b6055fdb8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy0xLTEtMS0w_c0643f49-b26e-4761-bda9-61e1456184e0"
      unitRef="usd">828000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if03a3ed387264a22b8a9acf639af05bf_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy0zLTEtMS0w_981c15c6-7a9d-4b2d-a30c-0cc2615f6aa1"
      unitRef="usd">463000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic645e74bfbdd4334929938f94e38d35a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy01LTEtMS0w_7b90d944-895e-412d-adc2-2f0a5b4b6ea2"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5a0fedee6ab64c609195f894c49bca7c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMy03LTEtMS0w_a20e3849-aa74-4754-b4bd-d922e59fc5e1"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfMTA5OTUxMTYyNzg4Mg_e3512258-ff05-451f-abf7-a9836cd6bfc2"
      unitRef="usd">214000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfNjI_737b158d-cc95-46fc-98b4-723c30989172"
      unitRef="usd">681000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfMTA5OTUxMTYyNzg5MA_28cf9740-b36b-4c2a-a185-e1395cc7cb39"
      unitRef="usd">-273000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0wLTEtMS0wL3RleHRyZWdpb246ZjhlN2ZhNmIyMTQ0NGFiYWI4ZDk4ZTA2MmRlYTY0YTNfMTA5OTUxMTYyNzg3MQ_5fd2716c-f045-4804-9c35-231edacbcb5d"
      unitRef="usd">195000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0xLTEtMS0w_51b99813-2d9e-4a18-a231-b7ed70b8594b"
      unitRef="usd">164000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC0zLTEtMS0w_14025d21-0bef-4ebc-8aba-8ff2edf0354f"
      unitRef="usd">560000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC01LTEtMS0w_70edddb1-96cb-43f6-84c0-a55fb76e1c14"
      unitRef="usd">-236000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNC03LTEtMS0w_d709e55f-0596-49dc-b050-a2a3b2537e71"
      unitRef="usd">166000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfMTA5OTUxMTYyNzg5MQ_9e2a1cdd-abad-4aa9-8af0-d8cd348439a1"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfNzc_00802def-649f-4d03-9673-facd4d74cb93"
      unitRef="usd">-44000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfMTA5OTUxMTYyNzg5Nw_bbf6f922-fb6d-4c84-9826-2e054876f751"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0wLTEtMS0wL3RleHRyZWdpb246YWI4OTZiYTNlMGYxNGM0YjgwZDMwZWJkYWJjZTVhMDVfMTA5OTUxMTYyNzg4MQ_42931fc7-fbc2-47cc-bb82-cd20927d58d0"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0xLTEtMS0w_af424131-b686-437f-8e9f-3959ac0238cd"
      unitRef="usd">15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS0zLTEtMS0w_bc9ac57a-cf98-4e70-b05c-a6041712982e"
      unitRef="usd">36000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS01LTEtMS0w_750e087f-5f9d-4fc4-8f72-7f0984bcb0e8"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNS03LTEtMS0w_f02fa15e-f665-4253-830a-e2703654bdd6"
      unitRef="usd">-47000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi0xLTEtMS0w_b5dc0a1e-46b8-4c57-a55b-d478fbc7d2c4"
      unitRef="usd">149000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icd7f88462377417ba49a7838e7f9e2bd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi0zLTEtMS0w_85a3411c-4f15-42e0-ac20-8519f82e3b2a"
      unitRef="usd">524000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i79c9083eeca0415db9f22c251d11304d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi01LTEtMS0w_fde6bd16-a330-48ee-a556-807a90396713"
      unitRef="usd">-237000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i38558a53cb5243399a843d7ec85afdba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNi03LTEtMS0w_e10eec23-5838-4136-84ae-27fb3bb3f194"
      unitRef="usd">213000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1eb18023bf9b4744abf0271e233e621d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy0xLTEtMS0w_9df26990-d64b-4201-a45d-203074508ecf"
      unitRef="usd">977000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia293eeb507694d29b061f167f11864bd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy0zLTEtMS0w_7dcfdc6f-6912-4a43-aac8-06ba6a2d9cd4"
      unitRef="usd">987000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1eb18023bf9b4744abf0271e233e621d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy01LTEtMS0w_b41ce29f-5848-4aa1-a8ca-bc5a45cd2ba1"
      unitRef="usd">977000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia293eeb507694d29b061f167f11864bd_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfNy03LTEtMS0w_64df47f7-e3cf-445d-985f-9e3313eddda9"
      unitRef="usd">987000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia17321eb57374b8abc46c944d2885a9a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtMS0xLTEtMA_50b64272-343b-4d4f-b1b4-fd0b7b987ef2"
      unitRef="usd">5000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b04b502bb5c4952b90f134d823c69b7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtMy0xLTEtMA_d0f140d3-c90d-47e1-b9a7-8b72c3212384"
      unitRef="usd">-8000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79d9fd45dcf3482cacd29cdd9932e790_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtNS0xLTEtMA_c46db3f5-87a0-404a-beb7-4966960df17d"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic3220f907b164c859ca1b0dc2c4f6b28_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTAtNy0xLTEtMA_ea4d7e66-abfb-46cd-be2f-50a7fc93ef87"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2abba1f0810f4477917b3b690bc38448_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtMS0xLTEtMA_218b206d-95d0-4bdf-97d1-32019a301e38"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2bb9417d47fc43f1897e27292ba0ceeb_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtMy0xLTEtMA_f46a2921-3d53-4faf-9c6f-1fe2658b4a24"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i07261151d31f426a8232fcb0f14da1ae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtNS0xLTEtMA_e6b3a164-cf95-4054-8ef4-3ea2772caa77"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i49a9782f5451439dbac16821699f7854_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTEtNy0xLTEtMA_cc9aecf3-77d1-4a65-b281-1508ee7839bf"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2abba1f0810f4477917b3b690bc38448_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtMS0xLTEtMA_7ea27047-da15-4981-94e2-33c561601d46"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2bb9417d47fc43f1897e27292ba0ceeb_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtMy0xLTEtMA_e99b4016-3efa-4cb9-a3d0-7872a2fc3178"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i07261151d31f426a8232fcb0f14da1ae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtNS0xLTEtMA_7ace9e02-ad5c-46b2-9d43-6f74583ec33b"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i49a9782f5451439dbac16821699f7854_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTMtNy0xLTEtMA_e6f1a5f4-65ca-42e9-9b49-e10dd49865fe"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bd049c214e14e6b8653d68bd8a3e2f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtMS0xLTEtMA_7a1623aa-25e3-41c0-b790-4706620a7f87"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bb4c36eb3df4620a92deefe268baac0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtMy0xLTEtMA_19fc4fa6-2ce7-48e3-adc0-221714cb458c"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bd049c214e14e6b8653d68bd8a3e2f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtNS0xLTEtMA_cabcf0a7-7324-4c47-a872-66bd23a702ce"
      unitRef="usd">6000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bb4c36eb3df4620a92deefe268baac0_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTQtNy0xLTEtMA_432e66dd-81e0-4721-a5c7-a83811dad3ea"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5232fdd455f74d7da74de09d354498c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctMS0xLTEtMA_cdd14e4b-292a-48f9-9865-7f846ab72bbd"
      unitRef="usd">244000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75c8fc3eedf24bee8f01fff1c288efc4_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctMy0xLTEtMA_8469129e-62c1-49e8-a501-ad2db1b41a6c"
      unitRef="usd">270000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i834cc5cc64384c53bbdae7fa265c9dc1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctNS0xLTEtMA_2d1d758d-0434-4d0e-a499-09ca57074db9"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iea949437ea7642b58259e785c86e9340_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTctNy0xLTEtMA_2a70b0c2-4e82-487b-938b-2b1e7a024013"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4NzQ_244e5e89-0b4b-4188-9584-4c286c1ac667"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ica622595b996421496158a8950271496_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4ODA_068df5b7-4b1f-42a8-a345-50e3b332604e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4ODY_28dfee99-a196-4e09-93fc-f288d7a01818"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmNiMDM3NGQ5ZmUzZDQyYTFhNWJlMWE3OTJmNDA5MDEwXzEwOTk1MTE2Mjc4NjM_bfd059ba-d23d-41ab-9a33-44d07e85edfe"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMS0xLTEtMA_117bc586-f2ff-4be3-a7c6-388c1e5dea96"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ica622595b996421496158a8950271496_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtMy0xLTEtMA_8610a336-fd2f-4cee-a0fe-64a24423bbeb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtNS0xLTEtMA_b25ca85c-7232-4d38-a6c5-8c6c5fa94e5f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTgtNy0xLTEtMA_d2c4c3b8-efce-4907-9ce4-ff5384e05b88"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzEwOTk1MTE2Mjc4OTE_42616257-ae64-4e0d-9228-84a9d000f269"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ica622595b996421496158a8950271496_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzc3_ca8c4078-ee36-4e10-b863-103ef7e8ad2c"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzEwOTk1MTE2Mjc4OTc_676232c2-2a4b-46eb-baac-864f1aa98d35"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjJhODI4YWEwMDQ2NzQxMWFhMmNhOTM2ZTI0ZWRlMGYzXzEwOTk1MTE2Mjc4Nzk_3b068e3d-a307-457a-826f-3be6fa8208d4"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMS0xLTEtMA_bcca14c7-cb08-4001-b905-6d16e45f1770"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ica622595b996421496158a8950271496_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktMy0xLTEtMA_e4e5029f-14bb-4695-a0b2-ddb1ecd882c3"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktNS0xLTEtMA_d2eede0f-329a-401b-abe6-a719cefb2f70"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMTktNy0xLTEtMA_5ce24f70-eb8f-4a86-b866-173328853927"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if1e3563999254ce18bebe63113318168_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtMS0xLTEtMA_55ee5e2c-3312-4b3d-a8db-6fc78601f82b"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica622595b996421496158a8950271496_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtMy0xLTEtMA_f3a6f12d-fc0e-4cc1-a3be-c05fd5cded03"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i37226568eaa9431f82f538d433d5910d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtNS0xLTEtMA_23f0083e-7528-4898-950c-ab330a3380b1"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9c125cdbdae4cb5a8d6a584e793d56c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjAtNy0xLTEtMA_c0455cf7-5059-4442-a371-9b6c672e060d"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtMS0xLTEtMA_269a8531-cb0c-4a1a-a959-1c30afd1b052"
      unitRef="usd">241000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cb51c1fc52c417391c987b64935b747_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtMy0xLTEtMA_a39ffa55-be9d-4818-a23f-39bc57d91a41"
      unitRef="usd">267000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtNS0xLTEtMA_24ed7ce9-bfe1-420e-b369-75efe78dafcd"
      unitRef="usd">241000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cb51c1fc52c417391c987b64935b747_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjEtNy0xLTEtMA_13f9f3b2-d382-4ab6-8f3e-acb54af66929"
      unitRef="usd">267000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id6cde7cf62354c9f90d8f5d1b6beed42_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtMS0xLTEtMA_51eed524-c23c-4f03-898f-a1035bb82d79"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0f1fa309d244561b4d4255b13e72185_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtMy0xLTEtMA_c468aeea-1dca-440e-bf65-8a01c9d85110"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1728a5a6a3242af80ab519ee500c71c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtNS0xLTEtMA_672eb289-33a6-4cf4-897e-69bb1a9f004e"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7aff438e903c4976a85160658a6e3ebc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjQtNy0xLTEtMA_2b320d63-70bc-4f65-b534-e235df5ea1ea"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc5MDg_a33c1bc5-f729-4f07-9373-8460b2c67bdd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc4NjQ_8db42a90-3c4b-4a5d-b289-9e455e57df47"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc5MTQ_b253405a-7da3-4c80-bc15-c98d9c58b156"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOmNmODZmZTljYWRmMDQwZmNiMTczNDBhYTg5YTZkMzZhXzEwOTk1MTE2Mjc4OTg_b46b4339-34c9-4e0e-a79e-453ad0e50dbf"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMS0xLTEtMA_3296ae1a-ec60-444c-8a4c-1b82b87b58c2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtMy0xLTEtMA_82b92aa6-6d63-471b-82d8-681d43e6bece"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtNS0xLTEtMA_6c5f6ced-b0cf-4259-98f3-e031ce311c97"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjUtNy0xLTEtMA_e6c066b9-414b-4f3e-898b-da2d49410320"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4ODc_c4ef82df-62cb-4e0d-b628-d1693a1bef75"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4Njg_1afee91a-01de-44c6-b3a2-861e118de17a"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4OTM_98d09799-0e14-422a-a331-6b908384fe12"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjA5OWQ2NDMzNGE1YjQwMzJhZDYxZTk0YmQ5YTI1YzQ1XzEwOTk1MTE2Mjc4Nzk_1f9e2d52-9b08-4350-b615-f1d0b2fed432"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMS0xLTEtMA_ab084e46-e38a-4897-8068-02e6a1d4a0a5"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtMy0xLTEtMA_860a9f25-cd53-477c-a623-84a241e96ee8"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtNS0xLTEtMA_7fc53059-4e09-42dd-92da-b5fef211686c"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjYtNy0xLTEtMA_7d367583-2b9c-4108-b6a6-2d1a9e353bf0"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i44713b7441b84d789aa571d6a659979a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctMS0xLTEtMA_2505ab65-3ba5-4c7e-b3aa-49b5030f4510"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia421bfc3856a4123abc4c4d4ec761e56_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctMy0xLTEtMA_d6434aed-6da3-4e43-8d68-19a0b7f518f6"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic1631ebf77054c36aadaba422e742499_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctNS0xLTEtMA_de7b6a05-5271-4722-b154-debedc6c7575"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i23ffa3a276834b2792aa7b9fd0399f3b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjctNy0xLTEtMA_667f00a5-9f79-4771-9992-26206246187d"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ccd57de85dc4077979b39a24f44206e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtMS0xLTEtMA_bd5071f4-b69b-46f3-b3c9-87769aa59050"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3da72faaf2b4475f838efca9f0889b65_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtMy0xLTEtMA_9a6c0415-104d-454d-85b9-7f9431ffef8e"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ccd57de85dc4077979b39a24f44206e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtNS0xLTEtMA_a043388c-5b8d-4012-940a-89f8682b8b92"
      unitRef="usd">-54000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3da72faaf2b4475f838efca9f0889b65_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMjgtNy0xLTEtMA_b470ba02-17b4-4dce-a221-8d2d57e50879"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2f056bb44964d78b883cc1b11fb04a6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtMS0xLTEtMA_dd097b97-ce17-42c7-a116-5f0bacb96afc"
      unitRef="usd">1022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70240851d9624b2b833aff8775606301_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtMy0xLTEtMA_e4a709b4-189c-4c0c-9786-0d04cea9e483"
      unitRef="usd">687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e9af44465864c999326af45d83b0a2a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtNS0xLTEtMA_0ce796aa-2d68-4055-a776-7ef0c977e0ad"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i34955bacc9344a75bd20cc975c6d72dd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzAtNy0xLTEtMA_8f831e01-67ba-4a6a-ae47-310ef8ccca71"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtMS0xLTEtMA_e2177e77-fb97-45b4-a490-149d1a656960"
      unitRef="usd">148000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtMy0xLTEtMA_24cb9152-6336-4207-86e3-3121489e6c3a"
      unitRef="usd">526000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtNS0xLTEtMA_b5336e3f-93b3-4bb9-a74a-8b5e0444fccd"
      unitRef="usd">-244000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzEtNy0xLTEtMA_6cf57901-c0f0-4b39-9e36-79e0ecc0bd16"
      unitRef="usd">194000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b0c7405c7a44354a5b01c38a42318c7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItMS0xLTEtMA_5686015d-e962-4c4b-8261-40ab26dd9378"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i699e98c5cf6e484bb4ad38af546870e1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItMy0xLTEtMA_059f2c3d-aa6d-4a4f-9236-cc770cde969f"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1b0c7405c7a44354a5b01c38a42318c7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItNS0xLTEtMA_4a73a9ab-545f-4c3d-b5af-b2f48f138b60"
      unitRef="usd">1170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i699e98c5cf6e484bb4ad38af546870e1_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RhYmxlOjg4YWYzZjcxYTRkNTQ3NTNhMDFiMDE3NTMwMDU2NmFmL3RhYmxlcmFuZ2U6ODhhZjNmNzFhNGQ1NDc1M2EwMWIwMTc1MzAwNTY2YWZfMzItNy0xLTEtMA_f86d0e92-d18e-46bf-96a2-7315f16e8333"
      unitRef="usd">1213000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i0ca74acf39df4d5dba5a78e6057bf9c4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81Mi9mcmFnOjYwNWQyY2NlNTg1MzRkZTA4OTMzNjE4NGNjZjc1MTdkL3RleHRyZWdpb246NjA1ZDJjY2U1ODUzNGRlMDg5MzM2MTg0Y2NmNzUxN2RfNjcw_11e82751-7fe9-43e8-b9b6-4b14bfede10b"
      unitRef="usd">13000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfNTQy_9b718e52-ed5a-46d7-9793-fb9290a4c4ff">Earnings Per Share&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 8 million and 9 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2021, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.  For the same reason, stock appreciation rights and options to purchase 17 million and 15 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMTM1_29badf54-10d6-4b7c-ade3-e7c500fad82f"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMjE5OTAyMzI1NjQwNA_697819d6-1387-498f-899c-76f193b0b99e"
      unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMjE5OTAyMzI1NjM5Mg_4211ac69-c41e-4ee1-b0fe-bc26f0aabdad"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfMjE5OTAyMzI1NjM5OQ_e35a65d8-e981-4acd-a2cb-31764f387595"
      unitRef="shares">15000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RleHRyZWdpb246ZjM3ZjcyZGU3MjJkNGZhOWI2YTM3NzY4NjQ1MzI3ZDlfNTg2_70cbec49-2bc1-4b85-b287-cda1d6843741">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share for the respective periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to CVS Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi0xLTEtMS0w_15fb29ed-d04b-4ce7-b541-108c482b72a8"
      unitRef="usd">2783000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi0zLTEtMS0w_9e4778e5-9df7-4db0-a7cb-c8d32faa0ef5"
      unitRef="usd">2975000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi01LTEtMS0w_bed357d9-1e4d-4535-abed-8931bdb7bdec"
      unitRef="usd">5006000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfNi03LTEtMS0w_68018c52-4a64-4e7d-83c9-fdcadb6ef96d"
      unitRef="usd">4982000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS0xLTEtMS0w_bc107ec3-c42b-4663-81b5-91ef64fe7ab2"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS0zLTEtMS0w_7d781cbe-27b0-41f9-8e1a-9c4247883a02"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS01LTEtMS0w_2a638b23-079c-4989-9da1-ad726bdb2e28"
      unitRef="shares">1316000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfOS03LTEtMS0w_52eeca50-599a-4b94-ad18-ffbee93ae56c"
      unitRef="shares">1307000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtMS0xLTEtMA_c4cd104d-6f7a-44b0-9376-20e382edf358"
      unitRef="shares">8000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtMy0xLTEtMA_e68f5c7a-8478-4486-8d17-2e7acb07a643"
      unitRef="shares">5000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtNS0xLTEtMA_fd26252d-d56f-496b-88d1-8b714c3a37fe"
      unitRef="shares">9000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTAtNy0xLTEtMA_7e4a877d-0e5e-465e-9c27-f21721e6b316"
      unitRef="shares">6000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtMS0xLTEtMA_09c5700d-b163-4906-907b-6497c55a7a70"
      unitRef="shares">1327000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtMy0xLTEtMA_585a11b9-388b-4398-b35c-a464fa5cbb29"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtNS0xLTEtMA_e79d023d-fce9-4b43-9f1d-4b6d71fc369e"
      unitRef="shares">1325000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTEtNy0xLTEtMA_c5d36d97-4e4e-4d06-ba76-a061d994560e"
      unitRef="shares">1313000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtMS0xLTEtMA_60a0b7ee-9b59-4680-969e-bd7afa65cdc4"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtMy0xLTEtMA_31acf0b4-604b-48f2-a9b5-34591996a3dc"
      unitRef="usdPerShare">2.27</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtNS0xLTEtMA_1bb54b1b-7d87-4760-8b27-82b44659586b"
      unitRef="usdPerShare">3.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTQtNy0xLTEtMA_763b0e1c-35d4-48f0-9908-93924808af1b"
      unitRef="usdPerShare">3.81</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtMS0xLTEtMA_52d20699-b6a3-4505-824f-4cc07433d232"
      unitRef="usdPerShare">2.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtMy0xLTEtMA_2be2c368-8ca6-4d08-9d7a-784a83c5b7c4"
      unitRef="usdPerShare">2.26</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtNS0xLTEtMA_e8347739-4d33-4dc1-818d-c635e6c68968"
      unitRef="usdPerShare">3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81NS9mcmFnOmYzN2Y3MmRlNzIyZDRmYTliNmEzNzc2ODY0NTMyN2Q5L3RhYmxlOmQ1MTc3MzNkNmMxYzQxMDZiYzBhZmIxZjJhY2EwOTRhL3RhYmxlcmFuZ2U6ZDUxNzczM2Q2YzFjNDEwNmJjMGFmYjFmMmFjYTA5NGFfMTUtNy0xLTEtMA_029899c6-15cb-46b1-a9c7-71b2a97acd2e"
      unitRef="usdPerShare">3.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMjc4MzU_3fe9f8c3-8336-46cf-8e58-686fa8e7b8e1">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. We believe COVID-19&#x2019;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of June&#160;30, 2021, the Company guaranteed 73 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;), state insurance and health and welfare departments, state attorneys general, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In June 2021, prior to the start of the New York State Court bellwether trial, the Company reached a settlement with Nassau and Suffolk Counties for an immaterial amount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the U.S. Department of Justice (the &#x201c;DOJ&#x201d;) served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed a complaint-in-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;intervention in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#x2019;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#x201c;HHS-OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#x2019;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#x2019;s minimum medical loss ratio (&#x201c;MLR&#x201d;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involved, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. In June 2021, the government withdrew this CID and indicated that no further action is required from the Company with respect to the April 2020 CID. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;), was dismissed with prejudice in February 2021. Plaintiffs filed a notice of appeal with the First Circuit after their motion for reconsideration was denied. The Company has moved to dismiss the other federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Waterford&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;). In March 2021, the New York Supreme Court, Appellate Division (First Department) dismissed the consolidated &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Labourers&#x2019; Pension Fund of Central &amp;amp; Eastern Canada&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; case; plaintiffs&#x2019; motion for reargument was denied and this matter is now concluded. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#x201c;Aetna&#x201d;), and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. The Company also received a related document request pursuant to ERISA &#xa7; 104(b), to which the Company has responded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <cvs:GuarantorObligationsNumberofLeases
      contextRef="ief51a7c21e12418191bfc6502162bc0b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMjAxNA_a0e2c0a0-afc9-42da-8a93-887564b70ce9"
      unitRef="store">73</cvs:GuarantorObligationsNumberofLeases>
    <cvs:LossContingencyAuditMethodologySampleSize
      contextRef="i70b16429cf7d4b5ebba7b368990673d2_D20120101-20121231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMTc5Njc_59090da9-f4b3-4121-a6f7-ce7cb1a5f2d2"
      unitRef="member">200</cvs:LossContingencyAuditMethodologySampleSize>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i001dccf76afc4c24992b25b72dcb6e28_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF81OC9mcmFnOmY4OWU2ZWNhNWE4MzQ3NzViMjA1N2MwZTc2OGI3MjNjL3RleHRyZWdpb246Zjg5ZTZlY2E1YTgzNDc3NWIyMDU3YzBlNzY4YjcyM2NfMjIwNTg_7d801cec-84af-4bb6-bc2d-62dc236092ef"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMjMyNA_7ec0dcd0-03b9-4c0b-8e93-88db5b6fa7ed">Segment ReportingThe Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the Company&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.6 billion of retail co-payments for the three months ended  June&#160;30, 2021 and 2020, respectively, and $6.2 billion and $6.0 billion of retail co-payments for the six months ended June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and six months ended June 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;(3)In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfNDE_48dc462e-90d0-4cf7-8c6f-800508b28663"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMjMyMA_e1c5054d-881b-4f9d-8416-f4d155416c4b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,764)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.6 billion of retail co-payments for the three months ended  June&#160;30, 2021 and 2020, respectively, and $6.2 billion and $6.0 billion of retail co-payments for the six months ended June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy0xLTEtMS0w_8d55df3d-384c-439c-b700-a29dc9be84a9"
      unitRef="usd">20367000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy0zLTEtMS0w_356950f2-129f-46b5-800e-111f2f5c33ab"
      unitRef="usd">35745000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy01LTEtMS0w_5709286b-393f-44c5-a604-3dd23e065b55"
      unitRef="usd">16185000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy03LTEtMS0w_5fbf6c6c-135b-4535-aefa-407dff485004"
      unitRef="usd">30000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMy0xMS0xLTEtMA_699b5a44-a30a-4608-8866-0397ec150f01"
      unitRef="usd">72327000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia726d6239ffd4749b438a44af233681b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC0xLTEtMS0w_af2ff859-2589-4128-a16e-139ea24dc3c9"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieddd6943d58948fca9da637d49a68e16_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC0zLTEtMS0w_d6f6ba59-0545-44fb-8b8a-9b71a791bed2"
      unitRef="usd">2569000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i622f60133e0f447ba5a9b36b96bae65d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC01LTEtMS0w_018de17c-b7a3-4fb4-86c7-317a0ee53616"
      unitRef="usd">8543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNC05LTEtMS0w_3b7c281b-eb9d-440d-9b07-d85d24ec3b4e"
      unitRef="usd">-11133000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS0xLTEtMS0w_5ac72232-33cc-4c53-9197-c421d0ff76c3"
      unitRef="usd">137000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS0zLTEtMS0w_7edff7b7-ae5c-414e-93af-06f62bae570e"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS01LTEtMS0w_e879954a-98fc-4052-96f5-b9da631118fb"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS03LTEtMS0w_b169da7b-18c5-45a9-8fa9-1e018e0ff63d"
      unitRef="usd">152000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS05LTEtMS0w_12960994-319d-4283-9d40-5e871df73978"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNS0xMS0xLTEtMA_b043e3c6-cec2-432b-83c0-04fd2159c3ad"
      unitRef="usd">289000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i7fb82e1b7ebd4c54be9d1622a6b266a3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi0xLTEtMS0w_f046f747-4b0e-43f0-bb82-3f431bc2e944"
      unitRef="usd">20525000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i13fec49e4db045d598a854e6be36041f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi0zLTEtMS0w_2761e61a-3668-493f-b0f2-e56d3485bf11"
      unitRef="usd">38314000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i468fcff0a66441fbad1b998c36682c15_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi01LTEtMS0w_dcc4118a-daf5-423a-a1ba-88f161c6686e"
      unitRef="usd">24728000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi03LTEtMS0w_680b9151-720a-40ba-99b4-37c525083c37"
      unitRef="usd">182000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi05LTEtMS0w_38749f12-5f60-441f-8434-328706d7e648"
      unitRef="usd">-11133000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNi0xMS0xLTEtMA_933d8347-e2b6-411b-bee1-ba858cda901f"
      unitRef="usd">72616000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy0xLTEtMS0w_f87d48dc-28b3-4ee9-901f-1fb01a3380d5"
      unitRef="usd">1614000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy0zLTEtMS0w_4f06035d-5740-432b-949d-8484c54ab9cc"
      unitRef="usd">1755000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic064b31facc649dd89a7b940b50bf747_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy01LTEtMS0w_ebb86a5b-b841-4070-a39d-37594c51ca5d"
      unitRef="usd">2049000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic0a9b9b3e6194ab885f8f4000c7a5ef0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy03LTEtMS0w_826c6f24-1709-4612-8e21-aafcf5342350"
      unitRef="usd">-369000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4625af6fd0b84a899db5ce13b01b5932_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy05LTEtMS0w_5c55ca79-c04e-4946-84ac-34971cd2815d"
      unitRef="usd">-162000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfNy0xMS0xLTEtMA_d4275774-6391-4271-948d-da09c6e4b747"
      unitRef="usd">4887000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtMS0xLTEtMA_823039f6-9eb2-4062-bd70-c2c387a15eee"
      unitRef="usd">18318000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtMy0xLTEtMA_c2bf793e-c77c-4da3-a9e8-0438c60b99f9"
      unitRef="usd">32623000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtNS0xLTEtMA_06c56568-4b37-411f-8698-eba9a1adb7e4"
      unitRef="usd">14187000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtNy0xLTEtMA_32e5d994-cade-448d-9f24-a919f04937cb"
      unitRef="usd">29000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTAtMTEtMS0xLTA_e65c662e-aec0-40dd-abbf-f1cc7b4be835"
      unitRef="usd">65157000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id11782f1722a4ab1a431f51a8b8bb767_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtMS0xLTEtMA_24cca750-6919-43aa-a666-af618ba235e7"
      unitRef="usd">23000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fba9e2c34f44e5ca1e106a2a73285b1_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtMy0xLTEtMA_8d73a186-832f-465b-9035-8e990b028eaf"
      unitRef="usd">2266000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fb80760bed64a4ea52ff1222cfcd13d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtNS0xLTEtMA_8a31c35d-f171-4570-8d12-58542187b588"
      unitRef="usd">7475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTEtOS0xLTEtMA_f744c8cc-2344-48b2-82ea-553f4d166ee5"
      unitRef="usd">-9764000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItMS0xLTEtMA_547cd718-c728-4528-828d-1bd5f42e47ee"
      unitRef="usd">127000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItMy0xLTEtMA_26b6cc8d-bab6-418b-8838-59e8f586f37a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItNS0xLTEtMA_46f4dbef-bee7-4164-a86a-5d7f36d69788"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItNy0xLTEtMA_5386f1e1-05a7-4a43-91dc-7e0a45565945"
      unitRef="usd">57000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItOS0xLTEtMA_7f91bfa3-29b0-438e-93fc-34c667541e59"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTItMTEtMS0xLTA_4fb57558-5935-4984-a34c-0509e554a102"
      unitRef="usd">184000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i5662cc7cd70b4808b16a82e9bc2161b4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtMS0xLTEtMA_1d575487-a4c9-497b-a313-7bddd3571d63"
      unitRef="usd">18468000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c0ccf7e987345a8a9c4f161c072bb04_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtMy0xLTEtMA_c11199ff-5b77-4a67-91f5-e9cce64c4d5b"
      unitRef="usd">34889000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i563c6cc59100449cb1b087e6d683b97b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtNS0xLTEtMA_d24ec04c-307c-4d1a-9440-cddea3e5017e"
      unitRef="usd">21662000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtNy0xLTEtMA_90ea9821-f384-476c-965d-ec65c1fc82a2"
      unitRef="usd">86000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtOS0xLTEtMA_5ba9213e-cf44-4217-8327-729b437185c4"
      unitRef="usd">-9764000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTMtMTEtMS0xLTA_68b4486f-4e9c-4f27-b2d6-5237125546dd"
      unitRef="usd">65341000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i22c89c592daf4ce698d9e73349be4d99_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtMS0xLTEtMA_8e1f145d-c9ef-48f7-af9e-eea65d0f83f1"
      unitRef="usd">3464000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtMy0xLTEtMA_8b4dfcd5-29f9-4140-a83f-7b948f87773d"
      unitRef="usd">1327000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2129d4e0737846108996cfd04a6a8aa3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtNS0xLTEtMA_10bf30d0-2553-468c-afb7-be5785372bcd"
      unitRef="usd">1057000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i201cddfcb8a040bcb7c6506a1d8a45e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtNy0xLTEtMA_eafa5f7a-3784-4a94-8bba-8a57a5b8df30"
      unitRef="usd">-343000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id518a9923cdf4c5ebffd4f5b0b2eddaf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtOS0xLTEtMA_2ac6c5bf-4a35-466d-b67c-e1f4fc7cf1cc"
      unitRef="usd">-177000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTQtMTEtMS0xLTA_e28719cd-ac52-4bdc-8bf4-a9c5643a0369"
      unitRef="usd">5328000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtMS0xLTEtMjMx_92d379fa-29bf-4636-8fc9-83ea80623334"
      unitRef="usd">40682000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtMy0xLTEtMA_c64db17e-bcdb-4809-a34b-31a291314218"
      unitRef="usd">69058000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtNS0xLTEtMA_3de4ba85-d15f-42a2-83b7-070b302365db"
      unitRef="usd">31325000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtNy0xLTEtMA_b6ac51eb-5b43-45fe-b2bc-208a3475ebc2"
      unitRef="usd">62000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTgtMTEtMS0xLTA_b7471d73-9e27-4bab-acc9-e4532a61eae4"
      unitRef="usd">141127000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18d1e96563e740f186d85a4df1469291_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktMS0xLTEtMjMx_556f2c12-fce4-40ba-a779-117c8b144f13"
      unitRef="usd">41000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23673f3bf56a41a982c19211f550e038_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktMy0xLTEtMA_1177a827-bebd-4214-addb-e3c00d47abe0"
      unitRef="usd">5577000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i259c3a6a85d34cad9bb1f18eb7f79a6a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktNS0xLTEtMA_140ddf7a-3ee9-4359-b342-0dc9d5c1e4f0"
      unitRef="usd">16631000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMTktOS0xLTEtMA_65a4ed58-9dd4-4525-9ebb-5da852df450f"
      unitRef="usd">-22249000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtMS0xLTEtMjMx_a603abd1-0ac7-49cd-9181-c53409257817"
      unitRef="usd">285000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtMy0xLTEtMA_2471cc58-b1ad-461c-ae43-dd210af699b4"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtNS0xLTEtMA_ed5e3f3f-05d7-4415-b8c2-cae3741cbbdf"
      unitRef="usd">46000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtNy0xLTEtMA_0e1aef48-5ee1-45c9-afb3-ae7a08393535"
      unitRef="usd">255000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtOS0xLTEtMA_b5a5415a-07ce-42c6-9f29-1ad2a03f3af6"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjAtMTEtMS0xLTA_6e4aeb3b-ea29-4421-b0cb-2ff0c1eaecdb"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtMS0xLTEtMjMx_4e28a24f-0340-476f-817c-e4998516c3d5"
      unitRef="usd">41008000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icdd42d2ed15e435daff26e80bcb970ea_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtMy0xLTEtMA_0c73819e-006d-4048-bdf5-7fbb6e82cd84"
      unitRef="usd">74635000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71be5af836584a6eac396f68bf46ee96_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtNS0xLTEtMA_2a6e78ad-dea6-49be-b365-5b2085700904"
      unitRef="usd">48002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtNy0xLTEtMA_b534c25e-ba53-4d65-9027-d45225211978"
      unitRef="usd">317000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtOS0xLTEtMA_6790c7d3-71dc-4146-ad4a-b1fc564967b8"
      unitRef="usd">-22249000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjEtMTEtMS0xLTA_ef07fdb9-a264-47c5-9567-e6c93de81e7a"
      unitRef="usd">141713000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i135fa65f85aa4cc9b316162f6e59f706_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItMS0xLTEtMjM1_6715d797-af3c-4f32-8dad-dcc73aab1040"
      unitRef="usd">3396000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItMy0xLTEtMA_9cfa4a13-23de-4f98-8611-2735db4045c0"
      unitRef="usd">3262000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i94a323fa7c394a148fd9033ff54e500e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItNS0xLTEtMA_7dea62b2-29e3-4ca6-984c-88cf8b9e54b3"
      unitRef="usd">3443000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i45ebff3d70984bd4b3973469cb2c039d_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItNy0xLTEtMA_27d02a2c-c705-4724-b4db-73df03d82857"
      unitRef="usd">-672000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if6124aa6d93248f3adda4b98c8381b71_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItOS0xLTEtMA_0382d243-5ece-4753-aa42-be4b7447700b"
      unitRef="usd">-337000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjItMTEtMS0xLTA_3e01635b-0050-45b6-8d37-b25078a9d326"
      unitRef="usd">9092000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtMS0xLTEtMjM5_e4aa2fbd-7a46-4fcb-9c50-285bec643c36"
      unitRef="usd">37415000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtMy0xLTEtMA_5e669bc2-1b64-49b7-9a85-a81b9939e4ba"
      unitRef="usd">64741000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtNS0xLTEtMA_257f58b6-4cad-40c0-be58-407c919a5bcf"
      unitRef="usd">29544000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtNy0xLTEtMA_d604b63b-d0b0-42a2-acf2-63561f4b0785"
      unitRef="usd">50000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjUtMTEtMS0xLTA_1e212907-0e89-4d0e-b43c-9301bffcb1f2"
      unitRef="usd">131750000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc5e6d1bf7764728ba7479982f03642e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtMS0xLTEtMjM5_63638045-3f0c-46ff-a5f2-46e0e9de9b02"
      unitRef="usd">31000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63c7a1d3118640968e9a75f187d6b40b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtMy0xLTEtMA_e66123c1-f78b-4236-a00b-9eada1beb372"
      unitRef="usd">5131000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93fdab396b0143ccba07019b56d386ec_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtNS0xLTEtMA_fee5ef9f-b95c-4c60-aa21-a698b339ee5d"
      unitRef="usd">14867000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjYtOS0xLTEtMA_cb5659d7-b564-4086-bbae-9e928bef4dea"
      unitRef="usd">-20029000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctMS0xLTEtMjM5_f9751291-8c76-4be1-973e-6cc173e849a6"
      unitRef="usd">220000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctMy0xLTEtMA_2bed7200-9676-4059-9537-ce5f94e6a4bd"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctNS0xLTEtMA_bd314a35-bff4-42b6-acb9-8dd3f5d280e0"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctNy0xLTEtMA_dfdfff80-3e21-4d02-b947-e032b6b65f5a"
      unitRef="usd">126000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctOS0xLTEtMA_29828dbd-4697-4df0-9453-c688cf53fb16"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjctMTEtMS0xLTA_452a6af6-cd43-40e7-a17d-a7324179d2d9"
      unitRef="usd">346000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i0152c20c97aa43078a0e9f51783dc116_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtMS0xLTEtMjM5_dcb423fa-de9e-407b-8953-2940c5820e31"
      unitRef="usd">37666000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3bd6ea18260343fe8d826574d00c787b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtMy0xLTEtMA_f8e32635-5f02-420e-91c9-ff46bcda90fe"
      unitRef="usd">69872000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37c5177a6cd544aea90d592c291b5439_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtNS0xLTEtMA_b4a4153d-3222-4940-a43b-33e1fd8ffaf2"
      unitRef="usd">44411000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtNy0xLTEtMA_9e511070-b7db-4196-b2d9-85b2ca26c9bc"
      unitRef="usd">176000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtOS0xLTEtMA_d36b49ee-03b5-493c-976f-e0260af9047e"
      unitRef="usd">-20029000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjgtMTEtMS0xLTA_f9939836-62a4-4acd-abf1-e46141784cdc"
      unitRef="usd">132096000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i286440c966274717b8d93a9e931b1209_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktMS0xLTEtMjM5_a4130830-4014-496c-bac4-5d6b152159eb"
      unitRef="usd">4955000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktMy0xLTEtMA_3f363d83-df56-439a-8015-e531bbac249e"
      unitRef="usd">2508000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9f385593dd35473baa97c369cdeb6bb3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktNS0xLTEtMA_6577d2e6-6c03-431e-a0d9-5151bbfcc660"
      unitRef="usd">2959000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if96971f980314cc6824c828891c2a32b_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktNy0xLTEtMA_9097db10-0b11-4e92-9cc6-93f8fc44162c"
      unitRef="usd">-628000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i70d5e77862144f848946a45ece34f2ed_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktOS0xLTEtMA_22bbd158-0cf0-4791-904e-b3831669cb7f"
      unitRef="usd">-353000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjBlN2Y1ZTNhNzk1ZDQ3ZGJhYjVlMGFmMDI2NWQ1MDVkL3RhYmxlcmFuZ2U6MGU3ZjVlM2E3OTVkNDdkYmFiNWUwYWYwMjY1ZDUwNWRfMjktMTEtMS0xLTA_2a3ba67c-a3b6-44c6-b9e5-b046ac51dc3f"
      unitRef="usd">9441000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="ia11e13202c4445e6a37ca5f8792d72ea_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTczOQ_f59b8881-0589-4576-8453-e97cc911f026"
      unitRef="usd">2800000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="ia3a1d636766441b7a36fd924414bb6c6_D20200401-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTA5OTUxMTYzMDI1Mg_d305e4c8-80b2-4fd0-857d-20387fdedc16"
      unitRef="usd">2600000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i869bd5883f0144cabf2dcd12402b9d42_D20210101-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTA5OTUxMTYzMDI3NQ_3253c095-1096-46f8-bd3f-9d44d1f080ad"
      unitRef="usd">6200000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i5672950bdb32444195bac533201af94b_D20200101-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTA5OTUxMTYzMDI2Nw_13b0ab02-f5cb-4145-88c6-148e987799b3"
      unitRef="usd">6000000000.0</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMjMxNQ_6986c1d4-69ac-4c9c-80c7-45a7662bfbbf">&lt;div style="margin-bottom:0.3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;During the three and six months ended June 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. &lt;/span&gt;&lt;/div&gt;(3)In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s unaudited GAAP condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi0xLTEtMS0w_b8764cba-728e-4bd6-a4aa-c1a55a7dd402"
      unitRef="usd">4326000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi0zLTEtMS0w_2363ec44-2b60-4d1f-8e4a-b3f3157d42dd"
      unitRef="usd">4680000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi01LTEtMS0w_81c277bd-5c00-49f9-a6c1-39a7cd1a5385"
      unitRef="usd">7903000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMi03LTEtMS0w_e42b8e3f-5048-4e6b-be00-93053e0e95bb"
      unitRef="usd">8138000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy0xLTEtMS0w_219e1703-fbc3-4333-8169-813481d1fa81"
      unitRef="usd">582000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy0zLTEtMS0w_65afdb7f-e4ec-4fe0-9709-0b837e766c60"
      unitRef="usd">578000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy01LTEtMS0w_a68cc518-2d07-4d9f-9e72-aa25e120e88b"
      unitRef="usd">1169000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfMy03LTEtMS0w_f3049a17-933b-4591-b74e-9e24be59b0c8"
      unitRef="usd">1164000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC0xLTEtMS0w_b6507a39-aba5-4ea2-bf9e-245cb7965df2"
      unitRef="usd">40000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC0zLTEtMS0w_6654a1d3-fb10-4d2c-9ccd-2834749c20b5"
      unitRef="usd">70000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC01LTEtMS0w_462fb5ef-8e71-4f47-8667-f5344546344f"
      unitRef="usd">81000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNC03LTEtMS0w_eb392d1f-845c-422e-895e-c635c4fe52f2"
      unitRef="usd">139000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS0xLTEtMS0w_a1cabf1d-b415-4858-a773-b281f3c93a62"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS0zLTEtMS0w_77d98143-3c8a-4eb5-81b6-96b6fbdb98c8"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS01LTEtMS0w_e8b5de3b-e6a9-42f3-9c0a-429d1482c10f"
      unitRef="usd">61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNS03LTEtMS0w_ea76b8a1-509d-430d-a6a5-50bcf2775961"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy0xLTEtMS0w_d4275774-6391-4271-948d-da09c6e4b747"
      unitRef="usd">4887000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i04a4e906df484689b56e7e0400e297cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy0zLTEtMS0w_e28719cd-ac52-4bdc-8bf4-a9c5643a0369"
      unitRef="usd">5328000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id1573f503fff49429b0a3fa8185af85c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy01LTEtMS0w_3e01635b-0050-45b6-8d37-b25078a9d326"
      unitRef="usd">9092000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i5330b269227f4bfb84627091d2be50f6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RhYmxlOjFlMDVkMzA0OTQ1OTQ5N2M4YjE2NWNhY2Q4ZGQwYjUzL3RhYmxlcmFuZ2U6MWUwNWQzMDQ5NDU5NDk3YzhiMTY1Y2FjZDhkZDBiNTNfNy03LTEtMS0w_2a3ba67c-a3b6-44c6-b9e5-b046ac51dc3f"
      unitRef="usd">9441000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i7592f4455e574a298526d9bc23a5566b_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF82MS9mcmFnOjIxYmY4OWVlOTI4YjRjNWZiYzM5NmI5ZWI3NDFmYzE2L3RleHRyZWdpb246MjFiZjg5ZWU5MjhiNGM1ZmJjMzk2YjllYjc0MWZjMTZfMTY0OTI2NzQ0NTc5MQ_83ccec36-9b41-4c40-b5cb-9c75cc7b2096"
      unitRef="usd">-61000000</cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC00LTEtMS0w_d19de74a-a420-4773-878c-7708f957b4bf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC00LTEtMS0w_d19de74a-a420-4773-878c-7708f957b4bf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtNC0xLTEtMA_6bb3e726-1da8-4905-9248-e5ab6d18d2d2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtNC0xLTEtMA_6bb3e726-1da8-4905-9248-e5ab6d18d2d2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNC0xLTEtMA_7f316f1b-dc43-491a-8c8d-695b7e031c8c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNC0xLTEtMA_7f316f1b-dc43-491a-8c8d-695b7e031c8c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS00LTEtMS0w_0a84bc09-a75e-41f3-a855-f96d170c8ee1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS00LTEtMS0w_0a84bc09-a75e-41f3-a855-f96d170c8ee1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNC0xLTEtMA_eeafa215-8c4d-4f77-9a29-602cb5b96bbf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNC0xLTEtMA_eeafa215-8c4d-4f77-9a29-602cb5b96bbf"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOC00LTEtMS0w_d19de74a-a420-4773-878c-7708f957b4bf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTUtNC0xLTEtMA_6bb3e726-1da8-4905-9248-e5ab6d18d2d2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNC0xLTEtMA_7f316f1b-dc43-491a-8c8d-695b7e031c8c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS00LTEtMS0w_0a84bc09-a75e-41f3-a855-f96d170c8ee1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNC0xLTEtMA_eeafa215-8c4d-4f77-9a29-602cb5b96bbf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzcz_7ba59080-144a-4d96-9494-2eb8324b1fe6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMi0xLTEtNTUy_9faadd55-3305-4b8c-86b0-635cdf0c51e7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMi0xLTEtNTUy_9faadd55-3305-4b8c-86b0-635cdf0c51e7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMi0xLTEtNTUy_2b695517-9fa0-4060-9712-c785e9a61767"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMi0xLTEtNTUy_2b695517-9fa0-4060-9712-c785e9a61767"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNS0xLTEtNTUy_5fe81db8-f08a-46f5-8dd9-5969e92e53e2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNS0xLTEtNTUy_5fe81db8-f08a-46f5-8dd9-5969e92e53e2"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtNS0xLTEtNTUy_30e9e76b-eb8c-4b7b-9ec8-3f4acb011479"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtNS0xLTEtNTUy_30e9e76b-eb8c-4b7b-9ec8-3f4acb011479"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtNS0xLTEtNTUy_c5d53360-3c2f-4371-a2b8-c5945515b120"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtNS0xLTEtNTUy_c5d53360-3c2f-4371-a2b8-c5945515b120"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMi0xLTEtNTUy_086fddac-c03b-4336-aee3-c5cf54003721"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMi0xLTEtNTUy_086fddac-c03b-4336-aee3-c5cf54003721"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNS0xLTEtNTUy_01170ae2-3cfd-4dbf-baf0-e5f84c37dee0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNS0xLTEtNTUy_01170ae2-3cfd-4dbf-baf0-e5f84c37dee0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNS0xLTEtNTUy_bc106cb1-4cc3-4ad4-961c-e50bd551252b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNS0xLTEtNTUy_bc106cb1-4cc3-4ad4-961c-e50bd551252b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMi0xLTEtNTUy_aaa59c91-2c8c-4bc6-9fae-f2004158076a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMi0xLTEtNTUy_aaa59c91-2c8c-4bc6-9fae-f2004158076a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMi0xLTEtNTUy_3c24294a-83fe-4fad-bd4f-da9998c2f8aa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMi0xLTEtNTUy_3c24294a-83fe-4fad-bd4f-da9998c2f8aa"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June 30, 2020, March 31, 2020 and December 31, 2019. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtMi0xLTEtNTUy_9faadd55-3305-4b8c-86b0-635cdf0c51e7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtMi0xLTEtNTUy_2b695517-9fa0-4060-9712-c785e9a61767"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNS0xLTEtNTUy_5fe81db8-f08a-46f5-8dd9-5969e92e53e2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDAtNS0xLTEtNTUy_30e9e76b-eb8c-4b7b-9ec8-3f4acb011479"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtNS0xLTEtNTUy_c5d53360-3c2f-4371-a2b8-c5945515b120"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzMtMi0xLTEtNTUy_086fddac-c03b-4336-aee3-c5cf54003721"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNS0xLTEtNTUy_01170ae2-3cfd-4dbf-baf0-e5f84c37dee0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNS0xLTEtNTUy_bc106cb1-4cc3-4ad4-961c-e50bd551252b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtMi0xLTEtNTUy_aaa59c91-2c8c-4bc6-9fae-f2004158076a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtMi0xLTEtNTUy_3c24294a-83fe-4fad-bd4f-da9998c2f8aa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMg_61c27b6a-515f-4baf-bf87-76a3383d27bc"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMTAtMS0xLTU1Mg_c65fc5fa-829e-4c89-ab40-651d938b254a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMTAtMS0xLTU1Mg_c65fc5fa-829e-4c89-ab40-651d938b254a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktOC0xLTEtNTUy_f7f2d015-f1d8-4e9d-b50e-f9e070d54da8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktOC0xLTEtNTUy_f7f2d015-f1d8-4e9d-b50e-f9e070d54da8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktNi0xLTEtNTUy_57d164e0-790b-4848-a8a6-9e39366c9552"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktNi0xLTEtNTUy_57d164e0-790b-4848-a8a6-9e39366c9552"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326), which resulted in a decrease to retained earnings of $3&#160;million during the three months ended March 31, 2020.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktMTAtMS0xLTU1Mg_c65fc5fa-829e-4c89-ab40-651d938b254a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktOC0xLTEtNTUy_f7f2d015-f1d8-4e9d-b50e-f9e070d54da8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjktNi0xLTEtNTUy_57d164e0-790b-4848-a8a6-9e39366c9552"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzNA_077cb67e-9728-4495-9bb6-1fbbc2cc39f9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMi0xLTEtMA_36db3ec1-bc73-4af3-afd1-819eacb01b4d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMi0xLTEtMA_36db3ec1-bc73-4af3-afd1-819eacb01b4d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMi0xLTEtMA_cff07a43-78b1-48d4-8ad0-27781b033506"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMi0xLTEtMA_cff07a43-78b1-48d4-8ad0-27781b033506"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS01LTEtMS0w_0e4e0e55-99e9-4e56-904b-60b9f137bedb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS01LTEtMS0w_0e4e0e55-99e9-4e56-904b-60b9f137bedb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0yLTEtMS0w_d6fc320c-70ac-458c-bb12-56729a35e2a1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0yLTEtMS0w_d6fc320c-70ac-458c-bb12-56729a35e2a1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS01LTEtMS0w_149e934d-1cee-4830-85d7-6f78c36e137e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS01LTEtMS0w_149e934d-1cee-4830-85d7-6f78c36e137e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNS0xLTEtMA_0e8aad1b-d954-41a3-87f6-7e7282581202"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNS0xLTEtMA_0e8aad1b-d954-41a3-87f6-7e7282581202"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtNS0xLTEtMA_5fa47889-de68-4757-999e-4d5000eeb54a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtNS0xLTEtMA_5fa47889-de68-4757-999e-4d5000eeb54a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMi0xLTEtMA_bb169a23-a4f1-42d3-a193-eeba9fd4fd7f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMi0xLTEtMA_bb169a23-a4f1-42d3-a193-eeba9fd4fd7f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0yLTEtMS0w_9880108b-ee15-44bb-9f49-0d4a889dd2ae"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0yLTEtMS0w_9880108b-ee15-44bb-9f49-0d4a889dd2ae"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNS0xLTEtMA_45a7ecfd-6122-49bf-af2f-c7a1b7b7e8dc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNS0xLTEtMA_45a7ecfd-6122-49bf-af2f-c7a1b7b7e8dc"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItMi0xLTEtMA_36db3ec1-bc73-4af3-afd1-819eacb01b4d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktMi0xLTEtMA_cff07a43-78b1-48d4-8ad0-27781b033506"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS01LTEtMS0w_0e4e0e55-99e9-4e56-904b-60b9f137bedb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfNS0yLTEtMS0w_d6fc320c-70ac-458c-bb12-56729a35e2a1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS01LTEtMS0w_149e934d-1cee-4830-85d7-6f78c36e137e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTktNS0xLTEtMA_0e8aad1b-d954-41a3-87f6-7e7282581202"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtNS0xLTEtMA_5fa47889-de68-4757-999e-4d5000eeb54a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTYtMi0xLTEtMA_bb169a23-a4f1-42d3-a193-eeba9fd4fd7f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfOS0yLTEtMS0w_9880108b-ee15-44bb-9f49-0d4a889dd2ae"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOjA0MjNhMDFkMDBkODRlMDE4MTk3MTEwNzIwMzY5OGJhL3RhYmxlcmFuZ2U6MDQyM2EwMWQwMGQ4NGUwMTgxOTcxMTA3MjAzNjk4YmFfMTItNS0xLTEtMA_45a7ecfd-6122-49bf-af2f-c7a1b7b7e8dc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNzc2_1d4b37d8-14e2-459c-9911-86fa2ce2f1e6"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNC0xLTEtNTUy_c7407ad0-d847-455f-a7af-7540f8ac4463"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNC0xLTEtNTUy_c7407ad0-d847-455f-a7af-7540f8ac4463"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNC0xLTEtNTUy_6c173928-5673-4e72-ab3c-179342e32921"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNC0xLTEtNTUy_6c173928-5673-4e72-ab3c-179342e32921"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItNC0xLTEtNTUy_bcbbc22c-8e07-4d02-b2a5-ba0f973d0626"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItNC0xLTEtNTUy_bcbbc22c-8e07-4d02-b2a5-ba0f973d0626"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktNC0xLTEtNTUy_f5c764c8-c4cd-4356-94a2-de618b57fe99"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktNC0xLTEtNTUy_f5c764c8-c4cd-4356-94a2-de618b57fe99"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNC0xLTEtNTUy_656f23d1-9cb7-4002-9602-2f38a0e35d47"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNC0xLTEtNTUy_656f23d1-9cb7-4002-9602-2f38a0e35d47"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of  June 30, 2020, March 31, 2020 and December 31, 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzYtNC0xLTEtNTUy_c7407ad0-d847-455f-a7af-7540f8ac4463"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMjgtNC0xLTEtNTUy_6c173928-5673-4e72-ab3c-179342e32921"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzItNC0xLTEtNTUy_bcbbc22c-8e07-4d02-b2a5-ba0f973d0626"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfMzktNC0xLTEtNTUy_f5c764c8-c4cd-4356-94a2-de618b57fe99"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RhYmxlOmYzZjA3MmQ1ZDlkYjQ5NDQ5NzIyOWVjMzM0ZDQyN2QyL3RhYmxlcmFuZ2U6ZjNmMDcyZDVkOWRiNDk0NDk3MjI5ZWMzMzRkNDI3ZDJfNDMtNC0xLTEtNTUy_656f23d1-9cb7-4002-9602-2f38a0e35d47"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmRhN2ZjZGU5NmFjMzQ1YjJhZmMyOWZhODRhNTIwZWQ0L3NlYzpkYTdmY2RlOTZhYzM0NWIyYWZjMjlmYTg0YTUyMGVkNF8zMS9mcmFnOjA5YzM3NjIwNmFlMjQ2NDFiNDFlYWY1MmY0ZTk0NjM1L3RleHRyZWdpb246MDljMzc2MjA2YWUyNDY0MWI0MWVhZjUyZjRlOTQ2MzVfNjA0NzMxMzk1NjQzMw_ac9ea038-9e5e-4528-9154-b8106c7e26e4"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159975768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,319,574,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821163431752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 18,983<span></span>
</td>
<td class="nump">$ 16,927<span></span>
</td>
<td class="nump">$ 37,943<span></span>
</td>
<td class="nump">$ 34,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">72,616<span></span>
</td>
<td class="nump">65,341<span></span>
</td>
<td class="nump">141,713<span></span>
</td>
<td class="nump">132,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">$ 43,520<span></span>
</td>
<td class="nump">$ 40,242<span></span>
</td>
<td class="nump">$ 84,414<span></span>
</td>
<td class="nump">$ 80,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">$ 15,901<span></span>
</td>
<td class="nump">$ 11,751<span></span>
</td>
<td class="nump">$ 31,605<span></span>
</td>
<td class="nump">$ 26,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">8,869<span></span>
</td>
<td class="nump">8,668<span></span>
</td>
<td class="nump">17,791<span></span>
</td>
<td class="nump">17,231<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">68,290<span></span>
</td>
<td class="nump">60,661<span></span>
</td>
<td class="nump">133,810<span></span>
</td>
<td class="nump">123,958<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">4,326<span></span>
</td>
<td class="nump">4,680<span></span>
</td>
<td class="nump">7,903<span></span>
</td>
<td class="nump">8,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">765<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">1,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income tax provision</a></td>
<td class="nump">3,735<span></span>
</td>
<td class="nump">3,960<span></span>
</td>
<td class="nump">6,705<span></span>
</td>
<td class="nump">6,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">944<span></span>
</td>
<td class="nump">974<span></span>
</td>
<td class="nump">1,690<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,791<span></span>
</td>
<td class="nump">2,986<span></span>
</td>
<td class="nump">5,015<span></span>
</td>
<td class="nump">4,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,783<span></span>
</td>
<td class="nump">$ 2,975<span></span>
</td>
<td class="nump">$ 5,006<span></span>
</td>
<td class="nump">$ 4,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to CVS Health:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to CVS Health, basic (in dollars per share)</a></td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="nump">$ 3.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to CVS Health, diluted (in dollars per share)</a></td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="nump">$ 2.26<span></span>
</td>
<td class="nump">$ 3.78<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares outstanding (in shares)</a></td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">1,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 50,525<span></span>
</td>
<td class="nump">$ 46,355<span></span>
</td>
<td class="nump">$ 97,912<span></span>
</td>
<td class="nump">$ 93,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 2,819<span></span>
</td>
<td class="nump">$ 1,875<span></span>
</td>
<td class="nump">$ 5,272<span></span>
</td>
<td class="nump">$ 3,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821165387656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,791<span></span>
</td>
<td class="nump">$ 2,986<span></span>
</td>
<td class="nump">$ 5,015<span></span>
</td>
<td class="nump">$ 4,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains (losses)</a></td>
<td class="nump">149<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="num">(244)<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">2,939<span></span>
</td>
<td class="nump">3,512<span></span>
</td>
<td class="nump">4,771<span></span>
</td>
<td class="nump">5,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 2,931<span></span>
</td>
<td class="nump">$ 3,501<span></span>
</td>
<td class="nump">$ 4,762<span></span>
</td>
<td class="nump">$ 5,176<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821255534760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,119<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">3,006<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">24,164<span></span>
</td>
<td class="nump">21,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">16,979<span></span>
</td>
<td class="nump">18,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,291<span></span>
</td>
<td class="nump">5,277<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">56,559<span></span>
</td>
<td class="nump">56,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">22,136<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,664<span></span>
</td>
<td class="nump">12,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">20,476<span></span>
</td>
<td class="nump">20,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,552<span></span>
</td>
<td class="nump">79,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">30,080<span></span>
</td>
<td class="nump">31,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,880<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,817<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">231,164<span></span>
</td>
<td class="nump">230,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">11,052<span></span>
</td>
<td class="nump">11,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyClaimsandDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">17,225<span></span>
</td>
<td class="nump">15,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="nump">8,414<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">4,567<span></span>
</td>
<td class="nump">4,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">14,827<span></span>
</td>
<td class="nump">14,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,375<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,791<span></span>
</td>
<td class="nump">1,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">5,440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">59,311<span></span>
</td>
<td class="nump">62,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,509<span></span>
</td>
<td class="nump">18,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">59,294<span></span>
</td>
<td class="nump">59,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">6,557<span></span>
</td>
<td class="nump">6,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">4,880<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">6,734<span></span>
</td>
<td class="nump">7,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">2,314<span></span>
</td>
<td class="nump">2,351<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">157,599<span></span>
</td>
<td class="nump">161,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,742 shares issued and 1,318 shares outstanding at June&#160;30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus</a></td>
<td class="nump">46,995<span></span>
</td>
<td class="nump">46,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 424 shares at June&#160;30, 2021 and 423 shares at December&#160;31,&#160;2020</a></td>
<td class="num">(28,252)<span></span>
</td>
<td class="num">(28,178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">53,331<span></span>
</td>
<td class="nump">49,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">73,244<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 231,164<span></span>
</td>
<td class="nump">$ 230,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsandDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims and Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsandDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821165418664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,742,000,000<span></span>
</td>
<td class="nump">1,733,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,318,000,000<span></span>
</td>
<td class="nump">1,310,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">424,000,000<span></span>
</td>
<td class="nump">423,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821251158232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 136,621<span></span>
</td>
<td class="nump">$ 129,218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(79,316)<span></span>
</td>
<td class="num">(76,381)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(31,245)<span></span>
</td>
<td class="num">(26,483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(14,900)<span></span>
</td>
<td class="num">(14,688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(1,263)<span></span>
</td>
<td class="num">(1,407)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(1,552)<span></span>
</td>
<td class="num">(230)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">8,739<span></span>
</td>
<td class="nump">10,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">3,947<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(5,570)<span></span>
</td>
<td class="num">(3,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,315)<span></span>
</td>
<td class="num">(1,190)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(768)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,974)<span></span>
</td>
<td class="num">(2,930)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,946<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(5,423)<span></span>
</td>
<td class="num">(1,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(1,306)<span></span>
</td>
<td class="num">(1,315)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(159)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(6,558)<span></span>
</td>
<td class="nump">1,697<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(793)<span></span>
</td>
<td class="nump">9,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">8,130<span></span>
</td>
<td class="nump">5,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">7,337<span></span>
</td>
<td class="nump">15,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">5,015<span></span>
</td>
<td class="nump">4,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,263<span></span>
</td>
<td class="nump">2,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_Deferredincometaxesandothernoncashitems', window );">Deferred income taxes and other noncash items</a></td>
<td class="num">(370)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(2,384)<span></span>
</td>
<td class="num">(2,233)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(145)<span></span>
</td>
<td class="num">(560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">1,702<span></span>
</td>
<td class="nump">1,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">104<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">3,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 8,739<span></span>
</td>
<td class="nump">$ 10,424<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_Deferredincometaxesandothernoncashitems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_Deferredincometaxesandothernoncashitems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821161932872">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th">
<div>Total CVS Health Shareholders&#8217; Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Common Stock</div></th>
<th class="th" colspan="2"><div>Treasury Stock</div></th>
<th class="th" colspan="2"><div>Common Stock Including Capital Surplus</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64,170<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">$ 63,864<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 45,108<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,012<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,007<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(332)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(657)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(657)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,474<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">65,140<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">46,455<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,170<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">45,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">45,108<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,998<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">194<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,355<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">68,022<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">48,768<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,474<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">65,140<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,180<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">46,455<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,986<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,975<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,975<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">526<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">96<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(53)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(662)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(662)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,355<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">68,022<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">46,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">48,768<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">49,640<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,224<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,223<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(392)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(660)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(660)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(660)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,164<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">70,850<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">51,203<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,733<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">49,640<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,015<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(244)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">73,565<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">73,244<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,252)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">53,331<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">321<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at beginning of period (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,735<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,164<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">70,850<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,102)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">46,727<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">51,203<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Shareholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,791<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">2,783<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,783<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive Income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">148<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">268<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchases of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(150)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(655)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(655)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(655)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding, balance at end of period (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 73,565<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,244<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,252)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 46,995<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 53,331<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
</tr>
<tr><td colspan="17"></td></tr>
<tr><td colspan="17"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June 30, 2020, March 31, 2020 and December 31, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Reflects the adoption of Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 326), which resulted in a decrease to retained earnings of $3&#160;million during the three months ended March 31, 2020.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of  June 30, 2020, March 31, 2020 and December 31, 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust and treasury stock includes $29 million related to shares held in trust as of June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of June&#160;30, 2021, March&#160;31, 2021 and December&#160;31, 2020.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821163455576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2016-13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury share held in trust</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Decrease in retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (53,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (49,640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Decrease in retained earnings</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158068408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (&#8220;CVS Health&#8221;), together with its subsidiaries (collectively, the &#8220;Company&#8221;), has more than 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with approximately 108 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. The Company also serves an estimated 34 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,337&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $367 million and $358 million as of June&#160;30, 2021 and December&#160;31,<br/>2020, respectively. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and six months ended June 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurer Fee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the three and six months ended June&#160;30, 2021. In the three and six months ended June&#160;30, 2020, operating expenses included $248&#160;million and $519 million, respectively, related to the Company&#8217;s estimated share of the 2020 HIF.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $10 million and $3 million in the three months ended June&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $19 million and $23 million in the six months ended June&#160;30, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $22 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2021 and 2020, respectively, and $37 million and $43 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other </span></div>comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158101432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,136&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was no allowance for expected credit losses recorded on available-for-sale debt securities at June&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At June&#160;30, 2021, debt securities with a fair value of $886 million, gross unrealized capital gains of $110 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at June&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,938&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at June&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at June&#160;30, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of June&#160;30, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the three and six months ended June&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at June&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and six months ended June&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021. Net realized capital gains include the reversal of previously recorded credit-related impairment losses on debt securities of $42 million and yield-related impairment losses on debt securities of $1 million in the three months ended June&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $3 million and $42 million, respectively, in the six months ended June&#160;30, 2020. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, and $10 million and $21 million for the three and six months ended June&#160;30, 2020, respectively, related to investments supporting experience-rated products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821157998856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s unaudited condensed consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;The Company&#8217;s assets and liabilities carried at fair value have been classified within one of three levels of a hierarchy established by GAAP.&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the methods and assumptions that are used to estimate the fair value and determine the fair value hierarchy classification of each class of financial instrument, see Note 4 &#8220;Fair Value&#8221; in the 2020 Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 or December&#160;31, 2020. Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021 and 2020, there were no transfers into or out of Level 3.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Separate Accounts financial assets as of June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $100 million and $29 million of other receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158090168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,474&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,362&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the six months ended June&#160;30, 2021 and 2020 in the table above exclude (i) $5 million and $29 million, respectively, related to a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $27 million and $20 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $99 million and $119 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $709 million and $420 million, respectively, in the six months ended June&#160;30, 2021 and 2020, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;30, 2021, the Company&#8217;s liabilities for the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;) plus expected development on reported claims totaled approximately $6.4 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at June&#160;30, 2021 related to the current year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158180552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2016, CVS Health&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized the 2016 share repurchase program (&#8220;2016 Repurchase Program&#8221;) for up to&#160;$15.0 billion of the Company&#8217;s common shares. The 2016 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions. The 2016 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021 and 2020, the Company did not repurchase any shares of its common stock. At June&#160;30, 2021, the Company had remaining authorization to repurchase an aggregate of up to approximately $13.9 billion of its common shares under the 2016 Repurchase Program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div>The quarterly cash dividend declared by the Board was $0.50 per share in each of the three-month periods ended June&#160;30, 2021 and 2020. Cash dividends declared by the Board were $1.00 per share in each of the six-month periods ended June&#160;30, 2021 and 2020. CVS Health has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158090168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income</a></td>
<td class="text">Other Comprehensive Income<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$214, $681, $(273), $195 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(18), $(44), $(1), $57 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $0, $(7) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(4), $(4), $(9), $(10) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $(8), $0, and $(8) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($1, $7, $1 and $7 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159690920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. Stock appreciation rights and options to purchase 8 million and 9 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2021, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive.  For the same reason, stock appreciation rights and options to purchase 17 million and 15 million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the three and six months ended June&#160;30, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159722312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of June&#160;30, 2021, the Company guaranteed 73 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the unaudited condensed consolidated balance sheets), with the maximum remaining lease term extending through 2030. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), state insurance and health and welfare departments, state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of several states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In June 2021, prior to the start of the New York State Court bellwether trial, the Company reached a settlement with Nassau and Suffolk Counties for an immaterial amount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the U.S. Department of Justice (the &#8220;DOJ&#8221;) served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations in connection with an investigation concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. The Company has been providing documents and information in response to this subpoena.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the U.S. Department of Health and Human Services (&#8220;HHS-OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, HHS-OIG or otherwise, including audits of the Company&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company received a CID from the Office of the Washington Attorney General, Medicaid Fraud Control Division, on behalf of the State of Washington and all other states, as well as the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The investigation involved, among other things, possible retention of overpayments and possible submission of false claims for Medicaid reimbursement relating to drugs prescribed by providers who were excluded by the applicable federal and/or state Medicaid programs. In June 2021, the government withdrew this CID and indicated that no further action is required from the Company with respect to the April 2020 CID. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">), was dismissed with prejudice in February 2021. Plaintiffs filed a notice of appeal with the First Circuit after their motion for reconsideration was denied. The Company has moved to dismiss the other federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">). In March 2021, the New York Supreme Court, Appellate Division (First Department) dismissed the consolidated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Labourers&#8217; Pension Fund of Central &amp; Eastern Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> case; plaintiffs&#8217; motion for reargument was denied and this matter is now concluded. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two ERISA class actions were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna Inc. (&#8220;Aetna&#8221;), and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health care company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158140760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment ReportingThe Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.6 billion of retail co-payments for the three months ended  June&#160;30, 2021 and 2020, respectively, and $6.2 billion and $6.0 billion of retail co-payments for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div>(3)In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821170303208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Health Care Benefits segment is one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pharmacy Services Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on public health insurance exchanges (&#8220;Public Exchanges&#8221;) and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of June&#160;30, 2021, the Retail/LTC segment operated more than 9,900 retail locations, approximately 1,100 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. In accordance with such rules and regulations, certain information and accompanying note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) have been omitted, although the Company believes the disclosures included herein are adequate to make the information presented not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020 (the &#8220;2020 Form 10-K&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods presented. Because of the influence of various factors on the Company&#8217;s operations, including business combinations, certain holidays and other seasonal influences, net income for any interim period may not be comparable to the same interim period in previous years or necessarily indicative of income for the full year.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continually evaluates its investments to determine if they represent variable interests in a VIE. If the Company determines that it has a variable interest in a VIE, the Company then evaluates if it is the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether the Company has the ability to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance. The Company consolidates a VIE if it is considered to be the primary beneficiary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of VIEs for which the Company is the primary beneficiary were not significant to the Company&#8217;s unaudited condensed consolidated financial statements. VIE creditors do not have recourse against the general credit of the Company.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted CashRestricted cash included in other assets on the unaudited condensed consolidated balance sheets represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable, Allowance for Credit Losses</a></td>
<td class="text">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Contract Balances</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock', window );">Health Insurer Fee</a></td>
<td class="text">Health Insurer FeeSince January 1, 2014, the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) has imposed an annual premium-based health insurer fee (the &#8220;HIF&#8221;). The HIF, which is payable each September, is not deductible for federal income tax purposes.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $10 million and $3 million in the three months ended June&#160;30, 2021 and 2020, respectively, and expensed fees for the use of this network of approximately $19 million and $23 million in the six months ended June&#160;30, 2021 and 2020, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $19 million and $22 million for pharmaceutical inventory purchases during the three months ended June&#160;30, 2021 and 2020, respectively, and $37 million and $43 million for pharmaceutical inventory purchases during the six months ended June&#160;30, 2021 and 2020, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification (&#8220;ASC&#8221;) 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other </span></div>comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for all health care policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareEntitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821257261928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Reconciliation of cash and cash equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,337&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,130&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net is composed of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company&#8217;s revenue by major source in each segment for the three and six months ended June 30, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,741)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2) </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,168)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,811&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020   </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of receivables and contract liabilities from contracts with customers</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,021&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821157830232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Schedule of Total Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.384%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,136&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities Available For Sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,754&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was no allowance for expected credit losses recorded on available-for-sale debt securities at June&#160;30, 2021 or December&#160;31, 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results. At June&#160;30, 2021, debt securities with a fair value of $886 million, gross unrealized capital gains of $110 million and gross unrealized capital losses of $1 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at June&#160;30, 2021 are shown below by contractual maturity.&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.690%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.692%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,418&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,938&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Schedule of Debt Securities In An Unrealized Capital Loss Position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at June&#160;30, 2021 and December&#160;31, 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,067&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at June&#160;30, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.505%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.380%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting<br/>experience-rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting <br/>remaining products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,067&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Schedule of Activity in Mortgage Loan Portfolio</a></td>
<td class="text">During the three and six months ended June&#160;30, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.285%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the Company&#8217;s assessments at June&#160;30, 2021 and December&#160;31, 2020, the amortized cost basis of the Company's mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Schedule of Net Investment Income</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the three and six months ended June&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.283%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $2 million and $32 million, respectively, in the three and six months ended June&#160;30, 2021. There were no credit-related losses on debt securities in the three and six months ended June&#160;30, 2021. Net realized capital gains include the reversal of previously recorded credit-related impairment losses on debt securities of $42 million and yield-related impairment losses on debt securities of $1 million in the three months ended June&#160;30, 2020. Net realized capital gains are net of credit-related and yield-related impairment losses on debt securities of $3 million and $42 million, respectively, in the six months ended June&#160;30, 2020. </span></div>(2)Net investment income includes $10 million and $19 million for the three and six months ended June&#160;30, 2021, respectively, and $10 million and $21 million for the three and six months ended June&#160;30, 2020, respectively, related to investments supporting experience-rated products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses for the three and six months ended June&#160;30, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,142&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159676024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the condensed consolidated balance sheets at June&#160;30, 2021 and December&#160;31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,346&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,520&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Fair Value, by Balance Sheet Grouping</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the condensed consolidated balance sheets at adjusted cost or contract value at June&#160;30, 2021 and December&#160;31, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.284%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Schedule of Fair Value of Separate Accounts by Major Category of Investment</a></td>
<td class="text">Separate Accounts financial assets as of June&#160;30, 2021 and December&#160;31, 2020 were as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.408%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.243%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $100 million and $29 million of other receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158125544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract', window );"><strong>Health Care and Other Insurance Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the six months ended June&#160;30, 2021 and 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of the period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,474&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,704&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,009&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,927&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,358&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,362&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the six months ended June&#160;30, 2021 and 2020 in the table above exclude (i) $5 million and $29 million, respectively, related to a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $27 million and $20 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets and (iii) $99 million and $119 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the Company&#8217;s unaudited condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareandOtherInsuranceLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care and Other Insurance Liabilities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareandOtherInsuranceLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158027080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">$214, $681, $(273), $195 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(18), $(44), $(1), $57 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $0, $0, $(7) pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(4), $(4), $(9), $(10) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of period balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $(8), $0, and $(8) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($1, $7, $1 and $7 pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of period balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of period accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of period accumulated other comprehensive income </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the unaudited condensed consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included in interest expense in the unaudited condensed consolidated statements of operations. The Company expects to reclassify approximately&#160;$13 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div>(3)Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the unaudited condensed consolidated statements of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821158027080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share for the respective periods:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159684248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Financial Information Of Segments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.478%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,525&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,314&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,616&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,764)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,249)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,713&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,411&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,029)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,508&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total revenues of the Pharmacy Services segment include approximately $2.8 billion and $2.6 billion of retail co-payments for the three months ended  June&#160;30, 2021 and 2020, respectively, and $6.2 billion and $6.0 billion of retail co-payments for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Earnings to Net Income</a></td>
<td class="text"><div style="margin-bottom:0.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income to adjusted operating income for the three and six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:0.3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,903&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,887&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,092&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,441&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">During the three and six months ended June 30, 2021 and 2020, acquisition-related integration costs relate to the acquisition of Aetna. The acquisition-related integration costs are reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations in operating expenses within the Corporate/Other segment. </span></div>(3)In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s unaudited GAAP condensed consolidated statements of operations for the three and six months ended June&#160;30, 2021 as a reduction of operating expenses within the Health Care Benefits segment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821251275656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> people in Millions, patient in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>patient </div>
<div>people </div>
<div>state </div>
<div>location </div>
<div>clinic</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>patient </div>
<div>Segment </div>
<div>people </div>
<div>state </div>
<div>location </div>
<div>clinic</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPharmacyPlanMembers', window );">Number of pharmacy plan members | people</a></td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPatientsServedperYear', window );">Number of patients served per year | patient</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFee', window );">Health insurer fee</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 248,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 519,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction, expenses from transactions with related party</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">19,000,000<span></span>
</td>
<td class="nump">23,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Related party transaction, other revenues from transactions with related party</a></td>
<td class="nump">$ 19,000,000<span></span>
</td>
<td class="nump">$ 22,000,000<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="nump">$ 43,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | location</a></td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk in medical clinics | clinic</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPatientsServedperYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPatientsServedperYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPharmacyPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Pharmacy Plan Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPharmacyPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159972392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,119<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the statements of cash flows</a></td>
<td class="nump">$ 7,337<span></span>
</td>
<td class="nump">$ 8,130<span></span>
</td>
<td class="nump">$ 15,145<span></span>
</td>
<td class="nump">$ 5,954<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821256377112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,021<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">10,955<span></span>
</td>
<td class="nump">9,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">2,942<span></span>
</td>
<td class="nump">2,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">2,246<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">24,164<span></span>
</td>
<td class="nump">21,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">$ 367<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821171165464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 72,327<span></span>
</td>
<td class="nump">$ 65,157<span></span>
</td>
<td class="nump">$ 141,127<span></span>
</td>
<td class="nump">$ 131,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">72,616<span></span>
</td>
<td class="nump">65,341<span></span>
</td>
<td class="nump">141,713<span></span>
</td>
<td class="nump">132,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">45,932<span></span>
</td>
<td class="nump">41,774<span></span>
</td>
<td class="nump">88,884<span></span>
</td>
<td class="nump">83,646<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,254<span></span>
</td>
<td class="nump">4,653<span></span>
</td>
<td class="nump">9,896<span></span>
</td>
<td class="nump">9,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,983<span></span>
</td>
<td class="nump">16,927<span></span>
</td>
<td class="nump">37,943<span></span>
</td>
<td class="nump">34,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">1,803<span></span>
</td>
<td class="nump">4,404<span></span>
</td>
<td class="nump">3,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">18,468<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
<td class="nump">37,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">34,889<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
<td class="nump">69,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">21,662<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
<td class="nump">44,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">20,367<span></span>
</td>
<td class="nump">18,318<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
<td class="nump">37,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">18,468<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
<td class="nump">37,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,968<span></span>
</td>
<td class="nump">16,913<span></span>
</td>
<td class="nump">37,910<span></span>
</td>
<td class="nump">34,534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">1,420<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
<td class="nump">2,813<span></span>
</td>
<td class="nump">2,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">35,745<span></span>
</td>
<td class="nump">32,623<span></span>
</td>
<td class="nump">69,058<span></span>
</td>
<td class="nump">64,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">34,889<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
<td class="nump">69,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">22,918<span></span>
</td>
<td class="nump">20,536<span></span>
</td>
<td class="nump">44,811<span></span>
</td>
<td class="nump">41,636<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Mail choice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">15,235<span></span>
</td>
<td class="nump">14,109<span></span>
</td>
<td class="nump">29,483<span></span>
</td>
<td class="nump">27,783<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">38,153<span></span>
</td>
<td class="nump">34,645<span></span>
</td>
<td class="nump">74,294<span></span>
</td>
<td class="nump">69,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">16,185<span></span>
</td>
<td class="nump">14,187<span></span>
</td>
<td class="nump">31,325<span></span>
</td>
<td class="nump">29,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">21,662<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
<td class="nump">44,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">18,873<span></span>
</td>
<td class="nump">16,870<span></span>
</td>
<td class="nump">36,758<span></span>
</td>
<td class="nump">34,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,254<span></span>
</td>
<td class="nump">4,653<span></span>
</td>
<td class="nump">9,896<span></span>
</td>
<td class="nump">9,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(11,133)<span></span>
</td>
<td class="num">(9,764)<span></span>
</td>
<td class="num">(22,249)<span></span>
</td>
<td class="num">(20,029)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(11,094)<span></span>
</td>
<td class="num">(9,741)<span></span>
</td>
<td class="num">(22,168)<span></span>
</td>
<td class="num">(19,998)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (81)<span></span>
</td>
<td class="num">$ (31)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821164637432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,021<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821163853480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeinContractwithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, beginning of the period</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage', window );">Redemption and breakage</a></td>
<td class="num">(175)<span></span>
</td>
<td class="num">(174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, end of the period</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeinContractwithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeinContractwithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractwithCustomerLiabilityRedemptionandBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer Liability Redemption and Breakage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractwithCustomerLiabilityRedemptionandBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821251118184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Total Investment Schedule (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 3,006<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">22,136<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">25,142<span></span>
</td>
<td class="nump">23,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">2,878<span></span>
</td>
<td class="nump">2,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">19,468<span></span>
</td>
<td class="nump">18,414<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">22,346<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">848<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 1,820<span></span>
</td>
<td class="nump">$ 1,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821160010984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">$ 20,938<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">1,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">22,346<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit losses recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">886<span></span>
</td>
<td class="nump">919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,320<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,410<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,978<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,144<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">8,754<span></span>
</td>
<td class="nump">7,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">822<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,562<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,652<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,893<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821164128040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet', window );">Less than one year</a></td>
<td class="nump">$ 1,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet', window );">One year through five years</a></td>
<td class="nump">7,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet', window );">After five years through ten years</a></td>
<td class="nump">4,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet', window );">Greater than ten years</a></td>
<td class="nump">4,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">20,938<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">7,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">4,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">22,346<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,397<span></span>
</td>
<td class="nump">$ 2,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821171067992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 3,024<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">3,067<span></span>
</td>
<td class="nump">915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">815<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 1,125<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 374<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">376<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 398<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 505<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821161771288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">3,067<span></span>
</td>
<td class="nump">$ 915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">3,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159402936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821165330200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 976<span></span>
</td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">897<span></span>
</td>
<td class="nump">952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017 | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Category 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Category 2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Categories 5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior | Category 7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821164620392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 285<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss (gain)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience-rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">160<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="num">$ (20)<span></span>
</td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains or Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsorLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821157881832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 919<span></span>
</td>
<td class="nump">$ 1,419<span></span>
</td>
<td class="nump">$ 2,267<span></span>
</td>
<td class="nump">$ 2,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821161466616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Measurement on a Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 22,346<span></span>
</td>
<td class="nump">$ 21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,410<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,144<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,562<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,893<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">7,119<span></span>
</td>
<td class="nump">7,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">22,346<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">29,525<span></span>
</td>
<td class="nump">29,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,538<span></span>
</td>
<td class="nump">3,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,365<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">5,933<span></span>
</td>
<td class="nump">6,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">3,581<span></span>
</td>
<td class="nump">3,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">19,939<span></span>
</td>
<td class="nump">18,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">23,520<span></span>
</td>
<td class="nump">22,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,410<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,365<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,144<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,144<span></span>
</td>
<td class="nump">2,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,562<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,521<span></span>
</td>
<td class="nump">8,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,893<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,893<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821160836536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 976<span></span>
</td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">59,354<span></span>
</td>
<td class="nump">64,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">68,364<span></span>
</td>
<td class="nump">75,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Total | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts liabilities without a fixed maturity</a></td>
<td class="nump">363<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 68,364<span></span>
</td>
<td class="nump">$ 75,940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821160016712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 4,880<span></span>
</td>
<td class="nump">$ 4,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,780<span></span>
</td>
<td class="nump">4,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,036<span></span>
</td>
<td class="nump">4,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,077<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,075<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,703<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2,961<span></span>
</td>
<td class="nump">2,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821161618040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">8,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember', window );">Corporate / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of the period</a></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of the period, net</a></td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">32,183<span></span>
</td>
<td class="nump">26,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(709)<span></span>
</td>
<td class="num">(420)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">31,474<span></span>
</td>
<td class="nump">25,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">24,600<span></span>
</td>
<td class="nump">20,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">6,409<span></span>
</td>
<td class="nump">5,704<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">31,009<span></span>
</td>
<td class="nump">25,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of the period, net</a></td>
<td class="nump">8,396<span></span>
</td>
<td class="nump">7,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of the period</a></td>
<td class="nump">8,414<span></span>
</td>
<td class="nump">7,362<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_CorporateOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821164045208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Incurred but not reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Decrease in prior years' healthcare costs payable</a></td>
<td class="num">$ (709)<span></span>
</td>
<td class="num">$ (420)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821251436632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Nov. 02, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember', window );">2016 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821162029704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">$ 71,164<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 65,474<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">148<span></span>
</td>
<td class="num">(392)<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">71,164<span></span>
</td>
<td class="nump">68,355<span></span>
</td>
<td class="nump">65,474<span></span>
</td>
<td class="nump">73,565<span></span>
</td>
<td class="nump">68,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">828<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(236)<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="nump">987<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other Comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period</a></td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,022<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821164071368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 2,783<span></span>
</td>
<td class="nump">$ 2,975<span></span>
</td>
<td class="nump">$ 5,006<span></span>
</td>
<td class="nump">$ 4,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">1,313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic (in dollars per share)</a></td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 2.27<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="nump">$ 3.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted (in dollars per share)</a></td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="nump">$ 2.26<span></span>
</td>
<td class="nump">$ 3.78<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159361432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>member</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>store</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberofLeases', window );">Guarantor obligations, number of leases | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyAuditMethodologySampleSize', window );">Sample size | member</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember', window );">Radcliffe and Flaim v. Aetna Inc., et al | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberofLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberofLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyAuditMethodologySampleSize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Audit Methodology Sample Size</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyAuditMethodologySampleSize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_RadcliffeAndFlaimVAetnaIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159520280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821159771640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 72,327<span></span>
</td>
<td class="nump">$ 65,157<span></span>
</td>
<td class="nump">$ 141,127<span></span>
</td>
<td class="nump">$ 131,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">346<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">72,616<span></span>
</td>
<td class="nump">65,341<span></span>
</td>
<td class="nump">141,713<span></span>
</td>
<td class="nump">132,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">4,887<span></span>
</td>
<td class="nump">5,328<span></span>
</td>
<td class="nump">9,092<span></span>
</td>
<td class="nump">9,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">18,468<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
<td class="nump">37,666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">34,889<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
<td class="nump">69,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">21,662<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
<td class="nump">44,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">20,367<span></span>
</td>
<td class="nump">18,318<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
<td class="nump">37,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">137<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">20,525<span></span>
</td>
<td class="nump">18,468<span></span>
</td>
<td class="nump">41,008<span></span>
</td>
<td class="nump">37,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,614<span></span>
</td>
<td class="nump">3,464<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
<td class="nump">4,955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">35,745<span></span>
</td>
<td class="nump">32,623<span></span>
</td>
<td class="nump">69,058<span></span>
</td>
<td class="nump">64,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">38,314<span></span>
</td>
<td class="nump">34,889<span></span>
</td>
<td class="nump">74,635<span></span>
</td>
<td class="nump">69,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
<td class="nump">2,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Copayments</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">16,185<span></span>
</td>
<td class="nump">14,187<span></span>
</td>
<td class="nump">31,325<span></span>
</td>
<td class="nump">29,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24,728<span></span>
</td>
<td class="nump">21,662<span></span>
</td>
<td class="nump">48,002<span></span>
</td>
<td class="nump">44,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">2,049<span></span>
</td>
<td class="nump">1,057<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
<td class="nump">2,959<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(11,133)<span></span>
</td>
<td class="num">(9,764)<span></span>
</td>
<td class="num">(22,249)<span></span>
</td>
<td class="num">(20,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(11,133)<span></span>
</td>
<td class="num">(9,764)<span></span>
</td>
<td class="num">(22,249)<span></span>
</td>
<td class="num">(20,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="num">(337)<span></span>
</td>
<td class="num">(353)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,569<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
<td class="nump">5,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">8,543<span></span>
</td>
<td class="nump">7,475<span></span>
</td>
<td class="nump">16,631<span></span>
</td>
<td class="nump">14,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">$ (369)<span></span>
</td>
<td class="num">$ (343)<span></span>
</td>
<td class="num">$ (672)<span></span>
</td>
<td class="num">$ (628)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139821164048216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,326<span></span>
</td>
<td class="nump">$ 4,680<span></span>
</td>
<td class="nump">$ 7,903<span></span>
</td>
<td class="nump">$ 8,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">1,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Acquisition purchase price adjustment outside of measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,887<span></span>
</td>
<td class="nump">$ 5,328<span></span>
</td>
<td class="nump">$ 9,092<span></span>
</td>
<td class="nump">$ 9,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Receipt related purchase price adjustment from acquisition</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MRM$XTUM",$J'=N!4K_'4?=32'\^YQH#JM9N27Q^#H_L(]P+G' -JJZ?8JH\
M"L>6Q@)0 8FL ;!1-#X:]([DY.C:KF3U8WM?VJ 5WU:BNXHY?#W<R7YH;R*-
M[]?X<HZ![PM\N>QN7+7[[@+X<UH_YE6#"O8@F_+&D2Q;=7>GVKT(OFDO#>^Y
M$+QL']<LS5BM /+_#YR+_8MJX'"S/?L?4$L#!!0    ( )DT!%/^%Q4V' 0
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M28/N2C=;VL[FXOWA@O(T=19[.#06(L8R1M>#V NPR0 V>1WL3JB"0#("_WD
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MN]-2Z5/9K$_W_SR*YX0XQUY*T&:L6?)*M<IFM;>?)U*D*SQM_7/1PN92NDU
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M[73VPI!=M:R<50?@;D,K.@_#X!" @L?VH HI@3I.\&QR> ]C(-!$2&Z"-BL
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M'V.9\!<(T&1,W1&)QL%B<:U5>NYQX .V7D'-X!>=-_K;U96KU09BJ[=%BXG
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M20/P_:I&UFW^H W<+X!]_[]02P,$%     @ F30$4Z3@<O=M#@  '2X  !D
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M&E[PSQ.$_8ZPSX3];U/;R<D49R_,*DG5ZRL$DE'Z25WML/I;626YR'IWDDI
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M;/<U^WRM ;3P#/P5"(I=$$51AMI944HOBR.ZCH[INN$#V<>^#&%=;556MC+
ML1/+WTN1S0""4Y@ZT1N*KUZ\B6R[TW\OWO7QWGXXV="^Y.S:)LQCR&,/CO_I
M(%\0.D/0<00.QC'R/!=H$(/5YEF1, PAA-4''7NGJ^^8 <S]>S/WE][<8WM)
M@^OW\[(<TT=,'Y'XQ!%@B]ZNGN0 $!D$)Q[E\<!K0T9BB2 2<4RY/J+^;21B
M]&VMOP[E:(_G"LR.GLWGW48)_MK"3>M>T\K7M':S/37F>Q[U@G24?[CO\+RT
M+H, (HN6LI$1?>4XI+-JB?I%IX'CP!T4D 1S^23N?,%V-UR:1I:/V\;\]D)
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MWK=GRHJ/U9HLV?$WS-3%ZYQ03W/"R 0UH0&#1Y!Z15LW96T8ZS;GV'L,GJU
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MYD;H&^BENX'!^KG3BQ' 5%1M*4X/4&YD+2NN.[KW" T>PZTD8G?A=O6SH7I
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M\+/.,=_7[Y-;6]^2C6]7R8N [VK=@V$<01(G@Q?PAMM8AP%O^ VQ"IW#;[Y
M"V^UJZW0&<)[*>9222_1P5^7<^<MU<S?+QA.MX;38#C]+TC^3BCX6" LC*(N
MDWH)/KQSA5DYH# A,V5E-&I2,(OF32'T$D%J*!K,C#&S@%FUF'EM QB)._D
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M2+5,M<,"]'UAC-\LV,#V]GOQ+U!+ P04    " "9- 13V O@!6@#  #/!P
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M26(?(!7!/N!-64FR:31(G#AJ;Z J&A_+OI,3*UBMF/)H$'A)-$9!$-EK6+[
M-8607L?CK#3RQ-J2M5 0"H!$XA'1&<M9RBC-]4%V!];@LH9KHHEAOTR_%0C)
MFNS!0&#X*4('GR1A'KR-.G0=TRD'+H:C"=MROI&3(5@*"R([Q/ %MKPED-%)
M;HRBVSQ'$RQ7H );T<_MT.LO,3>VE]'!<Q2KX/_>;"F[GZ1X6*[)N/+XX$,W
MPIZ;F<JEI/[<QO &3@^K8BPC:QZ3$XR7AE"":,4K+(0M[3_+]>:I_FKKX@9<
MMQ4A$L4@EZ]N//;PZ;_H0Q/'2C\"$B]4ZK'C:E8T93A@8UJS"_!W%NFZZL=E
M\7T+LBH1QXMZC4#,*2>+^_2DDG/U_46 0M$H9&G(<D34T[/:4)9L8NLB#<Q-
M@^WGQV>T"60EJR!4:U*%DYJ(L=60;39E0UBP:5]DJ(R.3]@EC<P$)ZA;H'0-
MI<@LI<493*L61AH('O".$O;8C/VF URC[!IM 3E3SMH(?D]7%M"V2KNL@ZR,
M,>]8ILE4QX?\8-$B9!JP&2G_0^E7&*SW9@WD1TG><ETNC:(+ 4<47P.20[=%
MQT@0.8D.+NU,N6_50_(4Y+?EFE[HN[6$'F0'Z7\,"' )E[P.:Y-LU"#@9=/;
M+9$]K&Q?AW6R;Q6GS)/,*9F/+P4[< )/L4^^I?.NW@F-BJ\X:OR0=?B0$6"7
M#I@5\\RZ[XL%"=6@014T,['R%0)V%WVGX%%G@BBH*!'*'V!O+4DY;$?9UPT!
M )4A6!7$B";GMZ!7$I*J'\$7WA\\20.)J>.5^IDX,PN[G=IPV%(P8EX&O PH
M#/P<$E"!;K\<=3!*=0*[ ]C?\_3;LAG%$W/,#&_1@QJ\ *]N&40@A.HVXI-#
MNMW3G&Z\(.F$B$ZRBKI\V8MT-'[YEE_F[*&NK0I%+Q#141CJ.2 JOK<D?"$)
MS,.WU5W?;9#9(<RCEP,4HK"0E\*)'$4$IY1^"I;D($MQMXTGP0V!":R#W=IZ
M9$ ><]KE<DE2-YAC28R)N.2T^/Y]939#J#O=6@@V%F7JO?QKV=)253<DDZ<:
M-.R2DE<ARZA2XYFMI ZIKCEU!40M2P#LV(HT=U/2B5T,\2%O)V'Y$MM)\^7?
M@#$&RQ,=5"L*ZT,-#+NP41&P*HFY] =5DUATH!4L#)?<2@UE^I EVYAT\Q+[
M),$EY2D&$7(O.[[R*IH;\NA4G-"QE"HP"H:KYTR,K4VL?":(.B X%F **%U:
M#\!3XD9C]>Z3P]TH0[% <A,-'VU=Z]."=8$125PD)O9TC8U8[%5W2XX(]J-#
MQ+HVY%RP4Q7,U2P+S&,A[_>Q7FKI6\MR"8TS@N[]3C(EB-J&QLBS5*%@OR\U
MHTXR&W#\U: )3K'6/G>>R*]W$G$3.)T#TC(S==<$ DV<N+%8$.*XIZQ%*6>2
M<-=E4_2<.L2]4B46E_G!_?S(/(L^ T*H8$$:>AG*2#"CT1VBX0Q^%6P6LH,.
MF^ZE/& 0KVMN=!LMR.$%T4GX:&!:SB1X4,,%"GZ*,47,'VM^/?';6!&B4H7F
MZ7XPZS_(CD6F=J%L%#8EMXVGQ2_..YY+[K@I.98!82 JB78RD$2A@PJ&AC'\
MF9:*:@NO3@&SH&5"%MZ$"Z3BW64K4DL*(ZL)4U@\6N_[8./-TAR4EX(^]F:@
MZMH&D?ZZE*0ZF".!O]@V+2Y(+;0&[N<(A6P/Y(+2+%[L@42(\&(,'*D"1X#I
M$'O48Q\>UNIX#954NR*,=R&>"L"74NZ<Y!D$W\6U$NXRS+]AMY&" ) L%!B?
MYWBW@6O5!,4L($S)66=AG_^(]912EKX,$C(0<4ZQTEA-U]N0/@_VEXOA&?&4
M81T'21=DV%ZFHXQ%Q_B8K&$58AN?C.<HF.0&EG@?8UEU*[Q8;#ZBNM3$.1-B
MU>MGK_:C\!>Y"NR-^TDRQ^O(4A_I8WNZ!E>$Y;1*,E.VH:XI"F8/EK<H6:4X
MN-MH]F>T>53#TG'#P>N%!J_%#SYNS .]<4X8R(5N#1_3'-N@:.%)!5B>Z1=>
M+QOE.4.+GI&$&'7&./STNFQ'2H+%:I.3@@_+*D;W$N++V%LJ,0R[&*IX(9NE
MI:A$M?W\5,/7C)FVEG [P@$13#@83L''Z#@H64A]ES759?5#77%7C]5PN#%W
ME+O]G X'<; 7QE)8B?W8=/ ;P;,DHK*ET!C4UTF&X\65F\@I4*W<4*Q%U-==
M-<8V-]M*$ZIW'S,OJG,C[L-/QT'D+,B/\P+$WD.%Q-?=%'E>^50#=01T#<3=
MEHG ',AV9I@209)-G. 5:[ZTH; $'ET95YJDHTL=E3,I;XEO.E7"J60$^+.6
M2_(WLD3SGC*<I\4SLVH1/FU/B\M?;XK+DA(#_3L020D,186&O,UI<5\21)XG
MEUR;\ETYWY>..MTREJ5%O0<,9"[ E8;*35]Z/$)CC%A5V7"A*>B.]B=AW<_-
M'($07 U>>R(L3,PZ<;$V5>.S*UQ\VV)G)?BA?"+,M<\3<$I2]<L=MF:HWZ,0
MA[1$%$A2-LE7^. :$*6X\G%,R-\I.@%,2#RK9-2VFMHM/>BY8C"@9EJ00?'6
MK,?6(_C>4 I)J5Q;A]\)QG,3T8  Q2OTAE*%\]TD""#II,1%! &L0.SKJ45)
M>C/B@N9@'%")[V2R'/LF:Y'O23XU*\A5G>.3_UF;<BG]AB0!&D/02E\F";^+
MF+B[\6I $G8%P\->B6J:25[S)T(C!/.NR]8TY.Y?D<,)R<3$<V:M*B'O+%Y?
MI-(33=:<O@ONDQ%4!"JA:,[-7Y+4U.3FJG,;"X>%'VG[ 6(&"GZ][;%]?4(X
M>!=Q"PDM,4X!5G07B;<=0E<D0Z9;Q(/2EI]O8[>Q'82FG(]>-;(UKS/.)"G.
MJMQH@?H%R6?QFC\FIJ:CO]EPY3OAZ/U75R^+U]UI<?[EV9,'G)CR4I#TW!ZQ
M+*^A!:M]T_)F93NB'$,=I9:6/*XW4L?W27Q +OAB2"TS"!;!; GV:%.M%MPK
M;>&"XA%(RFQ$CI=.BXNLZIAT<&J'Q=W'"C@1;(:R#M*3DG JZ0G8CPOWJZ_L
M6(X!O)RT!(%G];5#3WEW;>:.*))]K] 72BD)["&U4VC!>[38B'+,M24>603;
M21QY9!7J6].RB1]?:U8NA00LFK\COG&4L)"0?-*-5UVL^(=^ML13\6?DQ&/I
M\(@/__!R>>>Y'U!Z ;->5:RY#R7"U^:V^!?UP0AR%K6:FZ:Y-3S#T%M?^XEI
MY[):20-*R),(Y:^!FLM1#>YBT34$$L2J:0<I+$_,<'!.34@%/!7W?7Z6%II"
M74KZ&QTAJ+R\].:G  4Y?96G YFJLKCZ_B)XHUY I>>I;)3_C0LJ+L%8:0=(
M@' 'VS1A.--=JJ*G<M%30=D)3EV+W]UQ@W[(!>*55H\?R1K:/'Y*#?JF&XSD
MS[:V:V(J@XO':K.FG>6%@HOTR>?P-V"@.! \\'<"4@D.E>^9/[B6Z'\O;_)?
M%)]F6[R)U$[B>N9G1XUY^.UKD>4 IDE'6H^7@:G?K%M&AN3D*SE50G+QHY1I
M"61_!%;?=..A\_-Z+9@Z13Q?)0KF#5_ 8V\XX72WH3-%O+EZ_:^@B8J (E(_
ML>U)@-U>-E@>-I1:!3Z"]U6 [\N#$9-'P)^A\C1*;;OVQ+VS+.#MV//64-*@
M42CEF4S(IR<;+*<;&I.C'A>.M\!T4H63BF:4A 2, _+92X?A Z[@4)NOZE'I
M4:HB9Z+#;%D[1#G-IVC;W<$PF_MFER#:K"@;G&<939W49NE)+ V\I*[*W.#&
MEDCU,[FZ[V'*?6@?6!XC"_VNJ'958YC_7I7TR(.C<('*7]M\ S_%G=YA.;17
M?]V [>G5Y_M>,K <3CMR^TYZ-XEG@]Y-[L8$[0=.Y*C8'7<ND'_! 7=*'R?:
M%8+AH*.$IQHB2Z;]>(B,G96I82_YT6?''OV3<.NOR $VE7P8GP[JCS8P?<!%
M:?^']-/EK1Y)D3;Q7H"7C%_'P;<D1T22'-"@->K1&"Y"";>E=4-[A7KJ ]-V
M<QI'<^/2?R$K4I!SN_)&(LW>":(I%3U,/QB*E%K8"J_X-![6<=(M3EKMPPX3
M>R\"+5EWM%X5@E"A<B9ARG2%0Q(>0]=1K#=(-9@>3_K.PZ(U?H@+UV)Z2ES@
M7!IL<+7[& %T;$GWPZZ-E-K+#6E';[5KI90/0Y9D?U)?)6GKF%.YGX.,?8W<
MT.D0O_G<MZ1',QM_F#V*C&0"*:T;"M#^0!5#6L^.>F3V.3$ZDGC"YLCAF'7Y
M.]:P=Z2"8])A%6N'2:B;Q-[T(I\SX"BBGGADHKUH.A2,;;E'<\"^E7DJ$^Q;
M#/,L\(=B0RUL^M.U?-9+;6L,$6>A<]C7\TI_U#J)*R:;&-*V1IDK85R(96<L
MU'MBH[(2Q8#FS1OTDD++1]KG>6Y?"?6-6B&G0.8IV\_DBX,.Z:FJ^T$D=;?U
M/$STYG!)EZ]NR*>Q5-//VHE)11-)"$YJCNE9,@@>4*G;M^,Q10Q +7_'!&N/
MI3K!T'\<"D+>UKGPN.RQ;^!F"OZ =;=2Y@GFQ0Y>\5@)@YO+<JZRPI'R,CZY
MZ'FS-A6<I77B7NEH4.7/?U.QU0VA)S[5]<G6HB1ZU=-A'KU%Y\O'=^:[T%;B
MS5+25:*F@1OT.2H-;P?[2YAJHZYPOLM4%-3RN:A90:V(@YQJC5[;MPRJJ<K-
MA1H])W94SG6T<L*VERR[=!($0\<-H2%CVE-OC2OB$>!>>)K9\*JKV=+97O".
MDYIBSE/MV1%CI$^OF0N-;^';#QYK6R[;SA'^)T(CEMH;63JI?$(<4L&-[/Y8
M0S@!D0O314WI3)@BW4 ^S^V_O+ZZUH_)A/H]@G<76QU:6I3^T N&6:FUG*O3
M0A:WTT)HD\40NT#H\P-+J8VU(JCLMAC%I)" )&^/:[FB1J3:.1,>4='B\3Q(
MVB-(+%T<B![5A?N)<RD.QV^XQX9/[] )"]&PY-S)$1WCR$$+MV3(9[QSY-C(
M/-IAI#'X:(^,N YE(0Y"-5VN*.KMQ=6OL1@J]@U:Y@W#L4U/!2Z<%)UN,M3G
ML0:=G@+R.LM]:&,3<YKK]-D^!=GW/=!!DS.\.<W5XJ-<9?I$^J5KF8],9VK"
MO8!\>.A@$#N]Z,FIM0V'.QE#E)-8KOUE8\O$)&ETIPQ&'+KA'I^TNGPDY_EC
M;-;_<81W.NSW__''FY,W+WZ(,D HB<[QD"P<PXE[TG42-$.+C^K\%_LN8*^W
ME[O@7/1OM-07/^A91+ZW0/%Z:- 1"=6#G8_.9^J@MY;;$ 8E&YR$%M==TRWE
M-"%)>?#>J=++MK(#9'>#73AJYSA?Y*,03NZ A$>^^>H6FGBJ9[E%#(6HA)09
MI:P/(A): ?=$FO<8>L-)'A[!]#UWE]()C&@;?;\MK].5:VIGD4;,OGOO3\.=
MGYT%VRN._&/*L"[KY.QT7*=T..A9>YC>?1ZX6!L@;LAR8F8KKDA)C8L*"DA+
MZ^.4$Q? 3/"2==4[JDD9A73)A4K)466_W?B(Z$R/IA%$@U@<^(@CYN:TN+&$
MY[#HQ]$ RZ5?2<[BB$V<D+&(^4C.O/W=XW4NRQ'YQRQT*NG9A4N>5P<9PG@6
M*G8^ATYK;H35;,$'B?8-_X$#1*H_K2O$#J'SWOG6^]X,?2?WHX6]Z18S[2ME
M,\>G8X*E<1SP3*GHI$#GCE-(\ VQ0@%7$,/4?3:5=B%3VU/)%2<'XNLV.59Q
MAWV=VUIZ63V^H%GC+E'GJZ1];K7=>-+]$"Q?&DVVD!(0!=J4SJE.X724\ZTA
MZPD)U&] QC[$)*'MQ#@#R%H77T>4P45M>I#Y:*?[L>=<!^7-L@>&0;CM6U1S
MPQEE(W\'NL^W^0@9'!2;8[L3_3SC\#1>U--V@>-Y0S,Q?U9<CW/$&'0"05CK
M75@H!:L20>G!J%FA?K)(LS<I"HK8:8I3%&O2G2/>NG"?,H>>P1&_>ODV.&%M
MYIIE%B_D*+AG9S;17BRY&C[L(MW?%+/&8R]W.#U^IZNR3J.<1^P/^>+B\GXB
M-21;^-M8-.!&O2MMH_1LNWKSTW3BV8M1GF<^ACCQ+<O<BI*^&AIHH<!,ED<G
MT7*J+N(9*8D,N,*K/IIV_D_GD@D?$6\9%+TJIVHXQVH)5'2[6S4@*Q=K@F?!
M10#-,F8A9F#)%*N-7<]'R*9,=*1)/"*1&%E*LO__.6.?-!CZ5H./<3E'[[]!
MPS#W@$D.VXR#*CWO84]\U3VH"9^!HTL!Y5X#WD).(>*79%R.@N&.DR2CFZ57
MV Q'^D[)*@*X=,5;6W4!7'!8\:OMEV#*"]=0+ZUP/U=&GW*<1KE!:N#RM81+
MX0$V)GALWIMXK,,K'U_[D8I:/,YLZUR<LG8+$:3D=J.\.K'JY!8UN;DJ=A@F
MN2>?D55+*-G:,',\)I+WRNQ)'$EAW<, >1D*!9I*J[G4M=7!'_;B=D17;'(3
M6C2:1[*>]%V42A'4FZ&KWLGY U@%.?[VC+K[6NWT2GM>OYK%WOCL2'3:9YX(
M$)6B^!@$-[O[9V;"4:G>$[=].WS2K3B5Q/W(D99XB(4/R^KY%A'!9.1P,E;/
M3O#9N+P=GKMM!7S*\L3,^'V.!\/E>@@Y ^-AE;]#@@HVX>XZK=HDS9F,EP+\
M#PZ$#T4G#;;A[%=^]5.:1C[BW5[^?!GO]Z"3V'M5#I]#OBLC]=Z*1;CVS*P!
M'/@@WV2K@,0]V&2Y8U1;V)18X7URXB3I^8SARL+V;CC1VR%]5R3?NG>I&>U7
MMES;XCDAX>=\-TW,I?'A [IDS%O6^-5;0Y$DJ]W//7QY;"L7#@ .Z=48#D"S
M[-]A^^AF.+DKD?;*)Q^Q2WRVR.QIROFCT^(ZRIQO5$&PJR8>YL.43?0]SVFI
M6%9?C51,XU.4FL+MI(K$D"X_6,D$F?;@H ZYN76W%2>K%/,LV:VMRDIIGSUH
M!;J)0GZ1]R1/,.DW0I8+2D8]4'@A5SEY.Q>[_T;2$>W_F\$8;6 IR%P&A'=?
M.!'34P\2GFO*(;8'ORSG'=<"_=9>ZQD_OGZ/7!8=M\1:Y3H+?S+@LFS+NF0&
M/$UL0\C_IBPO^Z5DU".W?6.TTR.7<D#[EM$/.PGQ_^-RU(:=&[,9? ,'PX';
MKOC^[8N;B[V:?&(7[]"-G+MF@4_5. 1]C'L*3INA+:7SRP<2_%&\PR,]H#1A
M%,Q[" 19:3I+GQX>?)CD[T%(&)6-$$DD=B2VV?U<-C3P*VR '&&2>]7 1?-U
M\;:LJX9.OE&_6J0XJ"<-\)RK+-/?_PV6_E-,^-QWJ"YL/59\^6P]#OYV9M,N
MRZ5L)"# RLZMG)8HP8[JT*JG=^'XS9<E/CE[=/_= S(G;;PFFB&57A^A>=,=
MW;59O0N'LD+3T.,98WUA7[11,_7H;+#EKBV.>_9[//ZTJPF-\-K)GBJN)DR"
MS]NK2_^)\U[[#6@AU^PK8AK 9/?PBA+^\Q^//H?:/SI[<G_^@$L0AU=628S*
M5T22?DM;PLMP9_,=+AFR>AZM+.0T1;C,Z? @_F$'Z0?N"[$MX3\O=LDM,EE8
MK4-^+/#9"V@H8)PE_0\$;[5](G34$>KT><C\PIW8A1!"QZQY_&?>S \Q(0W)
MLK/= >53=-!GFC0O:VJ+(:OGTRB2)UP8!EE\ST/CBTHS/U!LMIVE79487T91
M;E,'Z'Z=/MY^?M"<0>'>DNX,F.GM:5RWX@N7J25FQ@T\FGV^>P?/1,O.+ 0M
M1>@F&OJ1CV+NM_.,3NZAB)I](BEN?5-54N_VT=@J#!^2N0_HQ*JK8OB57O5*
MCF1)F2]MU>-;IO5/%V QD03'.Y+(!;DB[ QYCD'N#TJ:G[5P'H@8XZT=,W]\
M-%YK,N-F8*[/CR)=F!"JU^2]WW0U42>=#6E34'[4^JB8RH(8_X=6NZF[E:A5
M*(F&)DS81PR?WW9_2F;_CA_X1*HN3?8%:(--<EM$HEIA1V?)S57-+L:P,7^_
M=]H@-I^DP_&)?)KN2#[8 TWBV3/?<N;,4NZM6_3A&M*]:PG!]H';KN94A'!C
M10J[&!M*,(?&#,Y/ZW/Y#?OE)'>D<D69\-Y1\%'#E.PDP;ONZN08O+_'A1^@
M\2R5@F+!62L%$WS]2\G67$2X?A*KGIT*3-(I*8NT@S?],@#E8,GY9+4>NO0Y
MO=2SH>M"Y"R:;Y/@%B@N0,QW>>X\7*;&,I%VH%%E1I(7OC]DNJEL:OE)=3Z<
M'4KO-99N0O'LH5O1PI;"V"4%AW"O)3_N^P6.'([66HA<8:<W=<ZROYVQ#G U
MNTA*'*XD@KP(>)?#]UO+,<N8]UC"36]#:[C&@*GCR9N28"OH=MZ[&?:#I^3.
MQ$K+67^?S0\?^C" KRF"X:>IL/1*^]28&T?K&;$A-O80^XT-90VHFI%&R?32
M@[NX';X@-<I(Z,C5"P:HZW+D.RH/OMCX@U+^U;CY22=*POCLS@,?0H8EZ-G[
M;!-:K ;A8LYYB5WTID.Z=H3SDK;UUW^#S="VGG; (8ARJ31[B^L[_-+OMC /
M5(PBVV/YAI!6+Y4,K)]<5MK_<JR'^H$6X>D&6WJG]8=P4Y6MTJIJ3(+[9DGK
M]GMX)T"?6@+I[XBW<R'ZWQIO]2=>X_L/N<@Y1,N=DL'@-=AQ?XE+FW0^Y&9!
M\G/!J\P49V]].Q$Y$('0'/D([4>*HLD?HY':HK":T5T?+L(Z6BH,-B[9Z[1.
MGA?#0V_1+*V3AEO5PV/A^IJL%73F;Z/0S(.'N9'E\G<3*(^LH/DCS6GD3M(-
MTU!AEEV=2UKP5^^"VF]Y_-0+H?+'CE\/)<6@H]=#)5?4%4O:GI:;=-5NA6O;
M4J&8J*A._-DB3V=2D66,(/>VA9HO@8X]^*%72TS_41!]/?W#(,E029O!E!CZ
M?IFO84\>^ H^-JD*_68MT$5J(\*^<4(]7GQ-._@4HV"8@2M)(&%#YX%")WCN
M?<.?PI@81RM:_D;V1B\AY'L/>[D._".J)K=+'CRN\,,>NVI;0IEXJF,?TWCX
M$KN"><E8LS]P'_L@O.:%.M/1Q !'QO^E:]M.+2TU!]J9<7B-G$FN P[YH\-:
M$2;!'/YNN_V[/_GDCL[OCX'J49_I._M\AX@>':7X5>^)F>G=ENQ,9!W[(\JE
M*7++77YG1T8PQKF_M<>)/F381"PZ434C)6%]YY?_$SM\.O4'"1\F?P(22&7)
M?^A2;R.1OP89/BW\W]*\D#\A&1^7/\3YJJ0:,UV_O<"K9Z=??'9/+I+TOPS=
MAO^@Y+P; (OX1U ,Q:$'\/VB0WRHO] $X2^,?O=_4$L#!!0    ( )DT!%.Y
MF>,Z%PL  %(@   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;,5:6V_C
MN!7^*T0:% F@B:V+)7EN0":S[6[1V1ULIMV'HBAHB;;8D44O2<7Q_OI^AY1E
M.;;CS.Y#Y\'1A3R7C^>N>;M6^JNIA+#L<5DWYMU%9>WJ]6ADBDHLN;E1*]'@
MS5SI);>XU8N166G!2[=I68^B\3@=+;EL+MZ_=<\^Z_=O56MKV8C/FIEVN>1Z
M\T'4:OWN(KS8/OA9+BI+#T;OWZ[X0MP+^X_59XV[44^EE$O1&*D:IL7\W<5M
M^/I#0NO=@G]*L3:#:T::S)3Z2C<_E.\NQB20J$5AB0+'GP=Q)^J:"$&,7SN:
M%SU+VCB\WE+_B],=NLRX$7>J_D66MGIWD5^P4LQY6]N?U?I[T>DS(7J%JHW[
M96N_-II>L*(U5BV[S9!@*1O_ES]V. PVY.,3&Z)N0^3D]HR<E!^YY>_?:K5F
MFE:#&ETX5=UN""<;.I1[J_%68I]]?R\6@-BRG\5*:2N;Q=N1!5EZ.2HZ$A\\
MB>@$B91]4HVM#/NN*46YOW\$<7J9HJU,'Z)G"?ZM;6Y8/ Y8-(["9^C%O8ZQ
MHQ>_5$?VK]N9L1H6\>]GR"<]^<213_X(A,^2(,][;5:\$.\NX%I&Z =Q<4CW
M2R78G5JN>+-A%3?,5EH(!O_4W&EE_ 83L.\%KVW%[K@6[(-HQ%S2T\\5AQT7
M&W8/!K(0AO&F!'G+93WZ^Y>[@('H&@Y"?SE8:3#F5HQ^LI706_(W;"#'G_^4
M1V'VQO2\&04"$&SP9,5I-YO+AC>%Y#63C8\B<,? \;9'*!65%/.!5J4HI L!
M2_X54ES1'EH<C=_<_?3QD[L,WUPS\<#K%OR,H[J5IR,[H =\X;&&44C S:*M
MN7-L:2"?XU;2L@I&8!7C=:T*T@+;5*L=:$N%]T,F3A=LYL8(8P9'P<#5J=P4
MHL,-(C\1=;"&J?E13'I&%(!*)WKY7P0'NNX5DTVAEB)@ZTH6%8,Z"$ZPLY).
M\^DJ=O77V]O/;"FX:;4 >(]%W3J]B;T$]\*2,- 5IO>;.S*ZI[-M%G)6"Z=L
MI[IR]B&M6,+*)'8UFP"$N&6-D.Z=%C6!"$")OM)@A13 "D!J3FH]:X$E &6-
M(@ISBN1'%[8(/+K>D/C]GCWD[^$GM%&+0L$4:^D4,L08#XRJ9<F/@?D4)LB_
MM_[D*; 9I3L&"=B\U0X";+3BT9+)<;V#FD#KX >=N5;+0V+.+JW0B/_T]"37
M/==DK2%C/2DAK )1@:TT[N4*WMEI2: <,5^_GHFFHCMS]!SX#-#:C8<)KT!L
MQ8T=1( AP35, RE.ZP-.,"G>\'KSFSAWM#Z*@$)I;MB/JGGESFO'K]-I3UQ6
M2E/4"N@$J$7@*M#L9:>*]95JZQ(&:7'";I>$?+0'I)!3I&TIXBD=P,CQ" 0D
M+JP*C@FU/51B!0/A=='63@**)44!-]D!18KY\YTKQ*2UD\JX$#:T:3J](YS.
MQ97.,?=@L,KRVKQF/R#TRKIV#C-,+(?IY"J\WJ:30?8  :BY-:GO:@F-._^[
MBJZQ<,#SBTMIPWJ"H1H0?34 \@^B:<'+>0K\26A82E<I@0N[Q+H@3C-<Q),@
M2R:X"-,@S.DB'N/':1^]P546!7&4[<NGMPS + HFZ93EP22)^UU781B$<7S=
M/_@1E;-L'H2Q;G_G76&<]2NV?\-)U%]'^91](8 '#,?!))JP. _B,&%1$F11
MSL(\VK&$O&F8LMN3/GT%LS;7+,2R!+_99 (=QLF47<7I]!J$4@">!'F>[<$Z
M?@FL(<F5$XB0(HKI20)8">AHN@=K.@G"R4E88X@4I2G+@B2;[&"=!EF:G$4U
M.D1ULGL4YLE34"%UDN8L)J6G.-,@32.6IST_R!HGX7E(8Y A2,E>PF ,IE=Q
M$A.D67;-0 1G=2\?_Z#I)N,@Q8$#PBEX.+"))9EN&NUA'":PB9.V"XTFP23+
MR/+3.-RA' '[9'H.YBC?'4R2LFBRNYT NR<00Y+Q.&=9 E83EN2XBR!WMN-&
MPF9A_!*4XVF*WPC: G&XW56:P62OXA@H Y-I].V&&\/20@<A7 K(D+W"I1-<
M3/;C01B3SXQ/@!H3J%A"=I^GV0#4<3".SH,*:0\B0I3VUW%R@"PD3^$I,(8\
MBUB20 ]PS](=RQ#..)Z^("0DP=0%@PE.*L(U0D(:Y83L)"9D$P#SGV_YYX+]
M$WF[+'.8&+980B:J<QA?K;1ZE&@%1+UAE]%-SF8^Q;B$C@=I_P!$M<LIR$ZO
M5GSC$Q955L3+]T!+[W7BB-<1/;*4@"KXE7!#@'KCVX_+]";:9YS>C%_(V,#9
MOYGMC<MXQ\R+B6%>W)7+\MC:!5JZ[I3=5$-:Z4H<%-RJ0$6%VL2NA6B<H,=Z
MP>V!!,^?ET-IU"F\ZQ-WG>">)J=+S3W=O(3K"N(MQ7)&/@JD#V78MK]%+1WP
M5UW3]_G^?KMQU_LU&D61+YP^40,J&E<YW54*M.!B89:\8<(W$(JM9/&5M2O?
MJW9+J>\NM%QY(0G)YF1CTIG%RLM,V,L&FO/2VTPA<"2^OE^2@:IV43DZX%??
ML%\J=S*R@P)5Z P-U(F3V._0=P4;57W:-]"G<7<MKD''5K[B->GCVMRG5209
MQC<W1M0:G^2[[YRDP@N]Y?6Q O @K0X+4K?=98+=U4]GNCCD6235U/U-<TH!
M63 =4T63([[G[/9LTTNQ;X)$/<E0H04ABD3Z3=AM\6LKC:2-K[P/E\Z#%]H3
M*Y2QONI-QBP;LQSA/)X.M[%5JXL*73XU9L7V<)TCJ-92MT$2=:IL>S2I2@1R
M!/,TW&6AO9O3^>&RJP<ONR+FLDNSE[\_*1SK# <:#D)6Q1]$-Y#QSKMMTA>-
M?&;D0.8/>M1WN?[0N\& Q5+82CEOI#:J;9S"?B[B>C;TI(!WR;5$^B$GU[P4
MN/T*9]R6#JYAIQFA&;FC)'.KY(I6J <*&M:X/K!K=M'*(9J*HFI4K19(,,AP
M#]0<L@;!F&;LSLII\N..L.]FG=Q0Y89]I'F-M.)5C611'E,<GMI-9.@H'[SF
M4C.4&BZ9EM3TS]N:$07/D/98X<Z>W))&.U([PW$AF#**I?A52C?F<DG$M8)<
M:]=V>XF7?+/M>NE\P)I#,!]*S@^)I-G.;W;'?#C$X6TI:8'S5J!?BH:F77N!
M"-',"A\"53\EI$  JCO;%H\KVFM<ZXPW@N/D^ZQUBWSH8O*AH.[,Y:S=S:H.
M8_]^#J91IGT1"*42WF)*''=A87G[4S%GRFLMG08G,@_R3*N[?*7*MJ"QKI]$
M=OFBFXUTIWUTOMJ7QMM*AM<G,]V6BYMF=#P 8%DZ/^,U55)/-=V'HCL*9C?(
MNK2!S6M0].//?ISI*ZK?NGD.50LG(3@22E!7W;IQ";;5FV!OV#-#\2'(&?9'
MG.>/Z_E)EQOX4HFO=#]C/C+^.HKIF9$8U6>GQF*4=G_'9.R',T<TG#[Z$.QS
M5W-RHH8E[DN%&QYA!RZDCTZM*U3I-$"@\[]C,#RANW/LW:>!)[X&>K.-/SUC
M%';9HU&2/HWX4"5^GV[G\))/![8OA&PF"MX:<6!_ <ZREE_%'IU.]X"XD39\
M/O?A$Q ,PIYRTW;8%*@5[E-&5P^ I,LNS:%_0@X$ -/E C]\=&=XF$7FPG,X
M).)"^H,TE+BHH/G8ZJUO?7/9%PR=^IG":3]>#@,!A+P5MN%=0GH1-5_W_A^S
MDN=WXB/;L0^3H\%W7D3PA?N:34D+/N<_^?9/^P_FM_X[\6ZY_]K^B>L%D@FK
MQ1Q;QS?9Y()I_P7;WUBU<E^-T9L@7;C+"AV.T+0 [^=*V>T-,>C_&\'[_P%0
M2P,$%     @ F30$4Z9F?2+6$@  \3@  !D   !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&ULM5MI<QNWEOTK*$UJRJFB)%)2O-M5%&-/E(G?4YE.4J^FY@/8
M#9*(>PO0+8KY]7/NQ=)HDJ(MY\T76VPV+NYZ[@+P]:8VG^U:J5;<ET5EWYRL
MV[9Y>7YNL[4JI3VK&U7AFV5M2MGBHUF=V\8HF?.BLCB_&(^?GI=25R=O7_.S
M6_/V==VUA:[4K1&V*TMIMM>JJ#=O3B8GX<%'O5JW].#\[>M&KM1<M;\VMP:?
MSB.57)>JLKJNA%'+-R?3R<OKR24MX#=^TVICD[\%B;*HZ\_TX29_<S(FCE2A
MLI9(2/QWIV:J*(@2^/C3$SV)>]+"].] _3T+#V$6TJI97?RN\W;]YN3YB<C5
M4G9%^['>_*2\0#\0O:PN+/\K-N[=I\].1-;9MB[]8G!0ZLK]+^^](I(%S\</
M++CP"RZ8;[<1<_FC;.7;UZ;>"$-O@QK]P:+R:C"G*[+*O#7X5F-=^W:N5Y5>
MZDQ6K9AF6=U5K:Y6XK8N=*:5%4_"7]^_/F^Q'ZTZSSSM:T?[X@':3\6'NFK7
M5KRK<I4/UY^#S\CL16#V^N(HP9^[ZDQ<CD?B8GPQ.4+O,@I_R?0N'Z!W2.#_
MF2YL:^ L_WMD@ZNXP15O</60=M4*'MR*CZJI#>US2(G'27Q:*S&KRT966[&6
M5BSKSB <B)Y<%$I8MX5]*7Y2LFC78B:-$M>J4DO=VI&X74LX;[85<V7N=*;P
MZ*-JI2[.?_DT$[+*0=V FFS5^3_;M3(CL5GK;"V(3*YL9O1"Y6)!\7MV< \1
MI"16#[[@>13:BKI2HEX*;"0J27'YG__Q_&+R[)45!3"%+)$C2HV%3V+7M:.6
M$;5%H-:8^D[G>.?LRSN2QF@O73D 8R" S$99Z!':$&V-78I&E*I<@.8(KXJL
MKBRBVKV^T: .&MH,V $72V4)G&2!5:7\K$19F[ 5F,]5INE[*^0">+A/XROX
MKY=+,"6D6)A:@FU9K9S^#)35\N8C<5<7\&)@*HO&S)?*G.;: /IZ+6H\!X&,
M><^[#-LX5122WK+1/W25%1W; F( &K!%X[UH!*FP5<$K%VHM[S1<IPA;-(6L
M2!EN&912 =E9D$PV<J$+\$P[?. 7(/ TOP/RX"4F&!_/NZ8IW$)/\O;'V[A.
M#QTCV27(P-2BV+WI6Y6MJ[JH5]NA#L*ZK[ (K%T'%\PYY<! WHFA^Q+ITGH_
MRX'7FL"$$D_/6[LV=;<"8Z ZJ^] %)9+]_Q]2'26$EUT%@!A <ST]<7XU=>\
MS*].7GT/OF$N<GF*"2L+'XN(RT@7RW[NBJVXG##,CK^LDAC!+EV1OSH/4D*5
M35%OE1$KB-RP:R&\==YQS"!W%0JFMVU'7H4GC33M:8NL[PR($ 4G7L>C'2?;
M"48'"5$M\4F0?216T+6I2N>_7<7HV#\[M0T"!P&<APT*A&W@G/E1]XULC4:T
M>$<)N(Q"@O:&7@_$V),-0!6P ->Q%)B@510"E"4\]X_:Z'8;$-%H^QD ;V(
MT:X^X%C.K+:M_1Z$A!?SAO93N1>2WW_([8 +G-?V.*.=263A-?#_P>=T/CL+
M3.YEI$$"V?\V1)XW*:'AL@-K$0P#.(44D2)"\(?;ZP\Q"BSPDN)C '6L 5!'
M/>10%P_MGD+K:D2"EUU!<-OO,X(/4%+M>:E42XY[")TH6VA2+?PS05;;(&'
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M(#OF"<^C)SP_:LAIR"$?D7'U'8'9(6]X-)'XR,1'7&=R5.1<1Q#4%$6]<7F
MPM;[.XIQR]-,W]Z&Y_W;HWA20T5I0H7[=11Q)>_B4-O5.D=T]2+JZL5CQ1R1
M<=WF+,',<?H+2W!(D<=W^)WR1([.I* BF.9Q49J'/)L&'LZMALIK=W#7'T90
MU7LG=<$&,:I0=+8\Z&;ZGM,-;@JZ'!3R!GDZN>\20@_JR[6F,39/3A-B9$-C
M^&P;<:[;.(LPKKADKZ")J!M&\6<L1A'L!EOP_19]69]:$C(TI/(L]JY0Z*7J
MR^Y@I4$6BIJ3#[GHFEJ<O/.#&T0G7(BXX%)EVY"0Q99'G)SY14%U-4\K+\>"
MJNAC@3D9][>.QD>=818.(Z]]K73P=M$C:8CX),V=_52Q+Y .]A:+0J_\,*[V
MLS(^" L7+<2JKAU8I6-CV8?RX>Q,Y8FS@D\$Y*W>@]SYGJMZW]UCS^LN^VS#
M0/^CVL!;G5-U%4) *;I7$@BO])+N5> -YP,#VOV6;CQ+-4FVJYZMH''%(<'2
M&9&_ZN"KAB"MF\QXY0Q#DO(^JHV_0&>!8/A,USO T3[??)^.3\N2$",Y2S?@
M;V0+F*N.^UQRTVURU%_\3,P=F1OQ7AW,!H\F,M<$D#]+%.V&IO7B8CRY<@JY
MA2G(W6Y-W89;B+#E=+FDN1'%)%^HF&;],#F]:,$3M;QSLWX"YIH.+K3[2(L
M!MAL+)YX)(.]BZW;.IR[SZ;) ,E2A5N3RB5QPE,/A$2IN_+4F2(]9B2/5FHP
MW?CIYOWPC!8/XO@<H2:W+)62^#RG61<-2D;T%16%\*(.3'H@C ?'ONMMY;UH
M.D/\'3?X16_PBR\4<FY4?2L-7/U3TH@=-/RW$ANT =P[(;.AP*+#3G0K/ 8(
MK1M!ZARJG?,A%AW*_#*+#6GR17]KQ2DW'K7*_O#_P/TF?^E@V)ET"'$.1K[H
M\Q7+W=B"PIZR7PIVU(>Z0W=W7\)?FO-ICP^>XMQ^R(0_NZ#K JJ?%L5Q$'F(
MWQR?OX-/E[HH0L!\=QD_^A%>NS:*CBSX>JF;RPV.X7@9S>+H8@:?X_C8\/=X
MOIZ7X6'<=Y,70\XN]EBS^O[QC!W.XD._8=:=7_FME#057U,!GXGSN/$5JJ&]
M(1R7YF686IP]UG,!3J8MB \'4^ZN7KQFDOIR?+7'BWYU]&:K^#1N]VB2AN]T
MS94+:INN;.C^19IK]@UR$3_S715'52$(7/U&]^UJ #6@)H/(V W54*@(_Y9;
M?7?Y;,C*U>7?8.4;W6@:RY60">*9K9M<V-C.A:1![/G1NW.=7MT^*U6Q'"(0
M 4 G[0M5S#TE1HFX_N][=<_*U_KTL<S1WPN?7!X%^W^HS> VO$&)#A7YCIE:
M))X73?.:SW.(OW\@P?T+G9]_=C##'-V4?G_QTC9PD#<G+)RY4R>/Y62NZ;QY
MN0U>E"PE!=ZX5/M)WL/94+_%LPR4$2^<N[R/0YYD[;R%B%RQ7=?X+T;Y^^G\
M.M87VMH.+$SGOS*YT\G%Z%'\//F$QC 3SZ[&7%S K-9OBV!@,MJ?:LDAE;Z
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M+^#[98V.VW^@#>*O'-_^'U!+ P04    " "9- 13).:P7; (  !G&0  &0
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MTN"X8Z9>LK5ZIF/&;K@Q?[9CHLTW5T]US,#UMU9/=LS :#,\[)AH/R]QXB@
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MW+K>,[UT6@M<$.GP*!MW0(>;3)A8M?*WA[FR=!?QPY(N?ZC= OJ_4,IN)TY
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MX[&^1__F<Z=<ULS@A1)//+?E+!@%D&/!&F'OU?8*=_GT'5ZFA/%?V+:V:11
MUABKJITS,:BX;"5[W=W#D</H(X=DYY!XWFT@S_*263:?:K4%[:P)S2D^5>]-
MY+AT15E93:><_.Q\R;3D<F/@#C6L2J81OCRPM4#S=1I:"N#,PFP'MFC!D@_
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MM:!V!G1>*&7W"Q?@\+.:_P502P,$%     @ F30$4[02W1"K"0  "!L  !D
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MI/7@"&F"(CO54VU;=DA.IUVOJ0X0T*\D?;0/B=A,]>LAC-='27JMA=:N=0#
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M()N*@G=:[.6?AUC6\IO8D=/[[I$V\H;/9JY] H*MMD<4ARQ'LAE9=#57ZWD
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M\L?(%:;Z2&UV^AOF+6*@NE"34XK0C\,CUHXH/SGP^QULVL*F%V''5%\]F.6
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M5 YYC?RQJ&4AN*OR0GMN&>ZH)IZ7'4S,4&0R/\>F%U.:A-8]70$H5D\=BQ\
MI:2R_0.(XKB''R,LF/HG3J'WZ=.^]-TQ(QZ8S4R.<>'8[\.]Y$ ^64EJLP/
MN+(U* )@5"AF^S4(QD(N>@@R/AS[G?@OU587OEMF7"06,[-C7"B6T]F1KJKB
M4-KDN"@LD3-U7!1CR'9M (IRT>?:C/O&?O_]DTYVU398)84./NE,/Z25;QH1
MXS,)FI<H8MPIP6\,$8X=7-"%:E]G\07 ZCB(6[1& (QAA"Q8#,"HX+R',F)<
M.O&[]%.8$-SIXCE=VQ9?]FI\*)DY.B?&PQ)_?#Z"+^;>.DFQ+4T0C$D[NHT
MF&"<AC9?+HPK*4@/7\;+DR$OW^2YR^#G7U>^VV><*>$S,V6\+?%'I".8$N[,
M8H+8GA""8<Z)S90+8Q(A8C,%P%B=>O4P93P^\7O\7QYUD;0K&'=ZTZ159?"_
MX+4>TKA>HN;ED1IG3/T!K$_*CDTO?2/E=DH,P' ])6W?", 8XM)F$(!1P7 (
M,TB-%%"_%(S.BBG@ZJEC,P!R0BL 1*3M6R 0Z5D!H$8)J%\)AJ<G=0-N2/@
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MX8+>!3 >0.LSK=W6\(VA?6F*?U!+ P04    " "9- 137C<2=-$"  !@!P
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M04*$8%B7Y4 %"41N7;U25Z]3EUT,EZ9>,UL/1JBFR8$*6S7U2TW]3DU3,E-
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M*U#7GSB7/T_:SU'ZSX^F_P%02P,$%     @ F30$4ZNL(791!   X!,  !D
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MG%Q2C&/@UMC_!>4<,8Z)FIFA!8*#A,'=BH'.XSE^^BPQCK%;KC]B$2&&&23
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MX/$BV4U<$0H4I2&>;NFU22\B8Y4^+#*!J'0R0 4&N&,X[LX4F<RF7\ <;&;
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M#%7<=D7'R*4[SI^DP<O!-1?X@P#* G!^)J79=FR ZI>C_QM02P,$%     @
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MSUFIOKJSF8T#:7@ *\4!0=S72G';2EE+>"1F:@GSSN_%<VZK*_*RS,:!.3R
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MU)_?%H7Y_J*Y,>%X)\K9_U!+ P04    " "9- 13+BO&7(D$  #($P  &0
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M*L,$;53#$XAQE*A: '%J"\NH,UDR'AEQZ6*P1XS =#$!,7A678SGN?; C)O
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MC(%K@'J^9DR^W&@'S>'=_%]02P,$%     @ F30$4S#'GQ"[ @  7P@  !D
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M,#]E0XR3\;_;!UD'6;]TQT$$=!I1+R$"8H[P?:T+1$QG-"K2,42&*!92"T3
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MOZNJ]O5-_XC6_3-Y+_\/4$L#!!0    ( )DT!%-"4!^S: 0  -<6   9
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;+V8:V_B.!2&_XH5S8<9:=O$=B!0
M =(,G='.JEU5T[E\-F# FB1F; -%VA^_=DCCW##,$NV7-I=S3MYSDO>IZ]&>
MBY]R3:D"+TF<RK&W5FISY_MROJ8)D;=\0U-]9\E%0I0^%2M?;@0EBRPIB7T4
M!'T_(2SU)J/LVI.8C/A6Q2RE3P+(;9(0<?A 8[X?>]![O?"%K=;*7/ GHPU9
MT6>JOFV>A#[SBRH+EM!4,IX"09=C[SV\F^+()&01WQG=R](Q,*W,./]I3CXO
MQEY@%-&8SI4I0?2O'9W2.#:5M(Y?>5&O>*9)+!^_5O^4-:^;F1%)ISS^P19J
M/?8&'EC0)=G&Z@O?_TGSAGJFWIS',OL)]GELX('Y5BJ>Y,E:0<+2XV_RD@^B
ME ##$PDH3T"7)N \ 6>-'I5E;=T3128CP?= F&A=S1QDL\FR=3<L-:_Q60E]
ME^D\-?E$F #?2;REX 9,B1 'EJ[R"R1=@-+]:4RD9$M&%V!V  ]T1V/P]IXJ
MPF+Y3F?_S5-!YULA3(4;\.WY'KQ]\PZ\ 2P%CRR.]5N3(U]IT>;1_CP7^.$H
M$)T0^-<VO04X^ .@ ,&6]*D[_9[.=3K,TH-JNJ]'5<P+%?-"6;WP1+WJB!P%
M<5$09P7QB8+OI:1*WCDJA46ET"GMD0NUTM8#,2?MDS[F][-\X^_=9!CU1_ZN
M/,YF# S"J BJ*.L5RGI.91]_;9DZ &F^#J88;15W+-$K/Q@-:^):8L)>N[9^
MH:WOG/\#(S,69ZI<+R$JRD7.5C^G.RJ5YIP"<YXJH3$E06R?H>VMUH" )7O1
M/M(8,A,YM,TC:O3:JTW#%5$1/RC$#ZX7K_\67*1_T%"'45CKH"T&M?<P+'H8
M.GMXX.GJ1E&1:)C/5)NP87-L0]RK2VM&]</^*2/ P.(V<,O+L G!/^"C5$S/
MCY89Z_@ 88GH\$JB0$L[Z,;=>:;D!<J#"FJC=(94A5EJ0C<V+[0MM/"$;GIV
M9]S\0<Z)N$*J#5C&0C=D.S4O;)*VT8,KI-J#93'L7VG>O$#%EP/<K[NW)2SJ
M#<-3 BW=H1OO1_NB_V!?RV XN-:^EH70#<,+[-OD7.-%NT*JBRB+011T85]D
MH8?@_V3?_$&NB3A#J@V4UI5NTG9J7W0>RLZ0:@\6R@A?:=^\@%.8*Z0JS,(=
MN>%^M"W^?=LBBU_4N]*VR&(0N3%XWK:HR;?A$-4GV0R"071JF):!*.K$NY9X
MJ(-EYV7??7-!65\T.T.J#5C,(C=FN_5N$[>XC^M=M 1%L+T/;*F,SRQ.S_HW
M+^#RKS.D*LS2';OI_I4K$O^^>[&E+T97NA>7_J%W4_"\>W$3<4WWM@2==B^V
M*,1A%^[%%GRX@W7G15\^;JXHZ^YUAE0;L+3%;MIVZE[<9&[3O6U!)]UKN8S/
MK$W/NS=J;.ZT+9Y;PMH6SWYIU]%L^3X2L6*I'AU=ZKS@-M+]B>,NZO%$\4VV
M$3GC2O$D.UQ3LJ#"!.C[2\[5ZXG9VRSVLB?_ E!+ P04    " "9- 138+!,
M<DH%  ",)   &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6R]6EUOFT@4
M_2LCJP^MU W,)[AR++7)5MM5JXT2M?NPVH>)/8E1^7!A;+?2_O@=,.&"P1.(
M$"\QX'OOW#G'G)D36!R2]'NV44JCGU$89Y>SC=;;=XZ3K38JDME%LE6Q^>8A
M22.IS6GZZ&3;5,EUD12%#G%=X40RB&?+17'M)ETNDIT.@UC=I"C;19%,?WU0
M87*XG.'9TX7;X'&C\PO.<K&5C^I.Z:_;F]2<.565=1"I. N2&*7JX7+V'K^[
M$B)/*"*^!>J0U8Y1/I7[)/F>GWQ:7\[<O",5JI7.2TCSL5=7*@SS2J:/'V71
M635FGE@_?JK^L9B\F<R]S-15$OX=K/7F<N;/T%H]R%VH;Y/#'ZJ<$,_KK9(P
M*_ZBPS'6$S.TVF4ZB<IDTT$4Q,=/^;,$HI: V9D$4B:0O@FT3*#%1(^=%=.Z
MEEHN%VER0&D>;:KE!P4V1;:931#G--[IU'P;F#R]_"B#%'V3X4ZAW]"=VLI4
M:H7>KU;)+M89JGW]^EII&839&Q/X]>X:O7[U!KU"08R^!&%H&,D6CC8-Y66=
M53GXA^/@Y,S@?^[B"T3=MXBX!'>D7]G3K]7*I.,BW6VF.P:&"@M284&*>O19
M+-ZVH$"?XKW*M/D!:_3/9Y.(/FD59?]:AJ75L+08EIT9MAI*/J$NLTSI3CR/
ME411*;]#]TOF^V;N^SIJG4&X"FHTR:HFF;7)6[7:I6D0/UHFS*M:?$J<136L
M& WG8R5>A]!KX=P1Y'/2C;-7->GUPQG]A_[2&Y4B<T4%>WD?JLP"@E_5]Z?$
M?EX-.Q\-^WD+5NR>0M^.(?-NX+$+2NCVAOY*9ALDXS5:Y0?JQ\XP$!I<;!3@
MFN;B*4G ('"8C$9#6:J!<0WD4J#;0=CWSS !@HCMBEAGXEK=:Y3E%P(=6&\!
M#%J&V:3X@_!A/A[^O"TO+A6G!'1%S<_="R"5V*Z5=09^-[]^_:LG!Z!SV)N4
M Q! [(_'@=^^!TX)L(4T6P2QQ':U;"A1$D5)G._SBIWO7B&=FFVAC00"DD?<
M*4D@H( $CT9"6:J.,,?TA(:N($&[B2"U#:%=+^M$?%9[%2)LFSX('*&3X@[*
M1^S;N$&XLXZ%V/-.@>^(8L([@SPH);$K90?R+UR6"8@>$9.R EI([)N^0:QX
MSTJ2-:39(J@FL:MF-Q_]%V<"XD?FD[HP$$-JW_\-\F%NU[W!3XU81Q03O)L+
M"N))[>+9S<6099J" M)I/7'-%(_HBFD+YY8GMH4T6P0QI3T]<5.CAB_8%&21
M3FJ=*6@C'<\\T[8Q;M%A"VFV""I*^UOG(QW$-G60/CJI9::@A'0\TTS;CIAZ
M[NDNJ2N*^F<$B8%RLO[.N43^A8LU Q%DDWIH!HK(QO/0K,M#G^Z@.H*P+\YP
M OK)^GMHX*3_@LUJ_QF<U$TS$$,VGIMF;9],Y@*?4M$1)2@[PP6()^OOIH&+
M(0LV Q5DD_IJ!C+)QO/5['E?;0UIM@B"ROK[ZII.#5^P.4@CG]1A<]!'/I[#
MYGT<=E?0.8?-04WY4(=-;=,'^>.3.FP.:LC'<]B\[9U/-TK6D&:+M<<O0[TU
M?>%RS4$"^:3>FH,>\O&\-6\;YQ8?MI!FBZ"<?*BWIH.6:@X"R"?UU@)D4(SG
MK47;-;>>O-E"FBV"8(JAKIH.7*0%J)Z8U%4+D$4QGJL6S[MJ:TBS11!0,=15
MTY<MT@($44S[0+KV1'K$1]*B]5B_18<MY-BB4WM5)']/YXM,'X,X0Z%Z,#GN
MA6>02H^OOAQ/=+(MWAZY3[1.HN)PH^1:I7F ^?XA2?332?Y"2O4"TO)_4$L#
M!!0    ( )DT!%.JH .M_P0  /H4   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0T+GAM;,5876_;-A3]*X31AQ9H(Y&2/Q0X!A*G0ULTF)$LV\.P!T:ZMKE*
MI$O2<?+O1TJ*Y)@2XPS!]F+KX][+<P\OSZ4XW0GY0ZT!-'HH<J[.!FNM-Z=!
MH-(U%%2=B UP\V8I9$&UN96K0&TDT*QT*O* A.$H*"CC@]FT?+:0LZG8ZIQQ
M6$BDMD5!Y>,%Y&)W-L"#IP?7;+76]D$PFV[H"FY WVX6TMP%392,%< 5$QQ)
M6)X-SO'I/"H=2HO?&>S4WC6RJ=P)\</>?,W.!J%%!#FDVH:@YN\>YI#G-I+!
M\;,..FC&M([[UT_1?RF3-\G<405SD?_!,KT^&TP&*(,EW>;Z6NR^0)W0T,9+
M1:[*7[2K;<,!2K=*BZ)V-@@*QJM_^E 3L>=@XG0[D-J!'#K$/0Y1[1"5B5;(
MRK0NJ::SJ10[)*VUB68O2FY*;Y,-XW8:;[0T;YGQT[,O0'.]1G,J <V%T@HM
MZ".]RP%],O?%1G#@YJ%8HOF:\A4@QE&_S_M+T)3EZH/QOKVY1._??4#OK,L5
MRW,S:VH:: /:#AVD-<"+"B#I 3A"5X+KM4*?>0;9<__ )-MD3)XROB#>@-^V
M_ 1%X4=$0H([\,R/=P\]<*)F J(R7M03[SNC=RQG^A&9-8EN^8:R#,USR@J%
M*&\NS[._33&8]:/1YP>SAA6@/Z]%GB-3S#LJL[\\4.(&2EQ"B?VUD-IY3<MY
MW53S^A'=P8IQSOC*5H)> ]J 9"+[B#CHKCFM!AJ5 UDEN9^-DV@T#>X[X T;
M>$,_4Z#4Z1,?EB9/RJ,FYNC?I@R&_..2K888[B4[B7'<G>RX 38^!EBYQBZ
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MZDYH+8KRTO2M#*0U,.^70NBG&SM <]PY^P=02P,$%     @ F30$4]349H?
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MOZ1B9*B= YTOE+*;C0O0_ID-?P%02P,$%     @ F30$4Q7;01H= P   @H
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M(0TSY2#OKR@5NXT*4(U]XS]02P,$%     @ F30$4\_L8GZ5!P  ?RT  !D
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MT/3JG8MK8AM' W476F>OT35BV+9N\L%X!W=?:XU'PP>8_B7%;U!+ P04
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MC.L2O^ON+U>N#P8VXYV09#=DXH5LLS1F2_QFNX=,N0L=J :$8$ -","@&A"
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M,N.?S.^?OM0]9>>!&=-BX5'S9OR+^9>DWKRYZT+"0[L$@% D#.W< >\"N?V
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MN3Y*NOZBY+(Y*_E5*BT0S<>Y2&>BK 'Z]ULIU>.7NH/N0._Y_U!+ P04
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MP-.((Y@"T( A4=2?@T?G4; ]IX+=C^_%+U!+ P04    " "9- 13EXJ[',
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M   2'P  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-V<ENPC 4!=!?0=E6Q'B
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M<' N>&UL4$L! A0#%     @ F30$4YP/F!?N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ F30$4YE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " "9- 13;4BAES@%  !D%0  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ F30$4WI49#">
M!@  Y1X  !@              ("!>PT  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( )DT!%/^%Q4V' 0  /\.   8              "
M@4\4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "9- 13
M(7VN1U,'  "X'P  &               @(&A&   >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ F30$4T8VR-@# P  B@H  !@
M     ("!*B   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M )DT!%/Y;SL"F@<  ,L?   8              " @6,C  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " "9- 13U#_V#@T1  !S:@  &
M            @($S*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ F30$4R-*G%E1 P  U@L  !@              ("!=CP  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( )DT!%.]AI.Z_1@   U,
M   8              " @?T_  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " "9- 13I.!R]VT.   =+@  &0              @($P60
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( )DT!%-"/_,/
MP0@  -<9   9              " @=1G  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ F30$4Q((1G2*!0  "0\  !D
M ("!S'   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "9
M- 13V O@!6@#  #/!P  &0              @(&-=@  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( )DT!%,B]()>\P0  %0.   9
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M970Q."YX;6Q02P$"% ,4    " "9- 13).:P7; (  !G&0  &0
M    @(&%Q@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M )DT!%.G+.2X7PP  (PJ   9              " @6S/  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ F30$4Z?,)%<B!@  JA(  !D
M             ("! MP  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " "9- 13'%)8%T0$  "_"@  &0              @(%;X@  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( )DT!%,WE"1J"P4
M %H.   9              " @=;F  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ F30$4WI3&X'_ @  N 8  !D              ("!
M&.P  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "9- 13
MM!+=$*L)   (&P  &0              @(%.[P  >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( )DT!%.H$ZX$5@0  *D0   9
M      " @3#Y  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ F30$4T/&G8:L @  = <  !D              ("!O?T  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "9- 1304"  +\"  #%!P
M&0              @(&@  $ >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( )DT!%.RJ!NOQ H   %-   9              " @98# 0!X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ F30$4QOZK19U
M @  =08  !D              ("!D0X! 'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " "9- 137C<2=-$"  !@!P  &0
M@($]$0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( )DT
M!%.6+AKY3 ,  !8-   9              " @444 0!X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ F30$4XTW^J1K!@  BB0  !D
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M=#,W+GAM;%!+ 0(4 Q0    ( )DT!%.+VG$FO@8  )4R   9
M  " @>LV 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
MF30$4RXKQER)!   R!,  !D              ("!X#T! 'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " "9- 13,,>?$+L"  !?"   &0
M            @(&@0@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( )DT!%-AV"N4! H  )]7   9              " @9)% 0!X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ F30$4T)0'[-H!
MUQ8  !D              ("!S4\! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " "9- 138+!,<DH%  ",)   &0              @(%L
M5 $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( )DT!%.J
MH .M_P0  /H4   9              " @>U9 0!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ F30$4]349H?  @  V 8  !D
M     ("!(U\! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )DT!%/X/$*5 P(  %<$   9              "
M@55T 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ F30$
M4Q/F5^2R!P  W"L  !D              ("!CW8! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " "9- 13*1^;EL@#  #F#   &0
M        @(%X?@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( )DT!%.]O@E*_P(  (D/   -              "  7>" 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ F30$4Y>*NQS     $P(   L
M ( !H84! %]R96QS+RYR96QS4$L! A0#%     @ F30$4Z<OWK)%!   W"(
M  \              ( !BH8! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M )DT!%.*,79?SP$  #,?   :              "  ?R* 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( )DT!%,RX8'AQP$  !(?   3
M              "  0.- 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     \
- #P 6Q   /N. 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>542</ContextCount>
  <ElementCount>368</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110102 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2121103 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2126104 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2130105 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2132106 - Disclosure - Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncome</Role>
      <ShortName>Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2135107 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2138108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2140109 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2322303 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2327304 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2333305 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncome</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2336306 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2341307 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails</Role>
      <ShortName>Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2412407 - Disclosure - Investments - Total Investment Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails</Role>
      <ShortName>Investments - Total Investment Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2413408 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2414409 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2415410 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2417412 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2418413 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2419414 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2420415 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2423416 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>Fair Value - Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2424417 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2425418 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2428419 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2429420 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2431421 - Disclosure - Shareholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDetails</Role>
      <ShortName>Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434422 - Disclosure - Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails</Role>
      <ShortName>Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2437423 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2439424 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cvs-20210630.htm">cvs-20210630.htm</File>
    <File>a06302021ex101.htm</File>
    <File>a06302021ex102.htm</File>
    <File>a06302021ex103.htm</File>
    <File>a06302021ex104.htm</File>
    <File>a06302021ex105.htm</File>
    <File>a06302021ex106.htm</File>
    <File>a06302021ex151.htm</File>
    <File>a06302021ex311.htm</File>
    <File>a06302021ex312.htm</File>
    <File>a06302021ex321.htm</File>
    <File>a06302021ex322.htm</File>
    <File>cvs-20210630.xsd</File>
    <File>cvs-20210630_cal.xml</File>
    <File>cvs-20210630_def.xml</File>
    <File>cvs-20210630_lab.xml</File>
    <File>cvs-20210630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20210630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>79
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20210630.htm": {
   "axisCustom": 3,
   "axisStandard": 18,
   "contextCount": 542,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 491,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 5,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 10
   },
   "keyCustom": 56,
   "keyStandard": 312,
   "memberCustom": 28,
   "memberStandard": 44,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110102 - Disclosure - Investments",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121103 - Disclosure - Fair Value",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126104 - Disclosure - Health Care Costs Payable",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130105 - Disclosure - Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132106 - Disclosure - Other Comprehensive Income",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncome",
     "shortName": "Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135107 - Disclosure - Earnings Per Share",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140109 - Disclosure - Segment Reporting",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Investments (Tables)",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322303 - Disclosure - Fair Value (Tables)",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327304 - Disclosure - Health Care Costs Payable (Tables)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333305 - Disclosure - Other Comprehensive Income (Tables)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336306 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341307 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofPharmacyPlanMembers",
      "reportCount": 1,
      "unitRef": "people",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails",
     "shortName": "Significant Accounting Policies - Cash and Cash Equivalents, Restricted Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ie0e466ab07004cd0914feafe9a6bf57e_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i0b0b6dd0f718499caf0d4c90979480e3_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412407 - Disclosure - Investments - Total Investment Schedule (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails",
     "shortName": "Investments - Total Investment Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413408 - Disclosure - Investments - Debt Securities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414409 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415410 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i140dfce8f2a04caea0777130c117bf89_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417412 - Disclosure - Investments - Mortgage Loans (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i140dfce8f2a04caea0777130c117bf89_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id39dfb11efc44ccb81323ee1fcf29437_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418413 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id39dfb11efc44ccb81323ee1fcf29437_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419414 - Disclosure - Investments - Net Investment Income (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420415 - Disclosure - Investments - Realized Gains (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423416 - Disclosure - Fair Value - Measurement on a Recurring Basis (Details)",
     "role": "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
     "shortName": "Fair Value - Measurement on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinancialLiabilitiesFairValueDisclosure",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i1b5b641cecaa495588a4e4dba1cafd61_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424417 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i1b5b641cecaa495588a4e4dba1cafd61_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425418 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i6f1f71fefe76481c94a3ecb9ca74d5b0_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i0b0b6dd0f718499caf0d4c90979480e3_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428419 - Disclosure - Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Components of Change in Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "icc7c66e844f8437abd00e7ff0a93dcb1_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429420 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431421 - Disclosure - Shareholders' Equity (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDetails",
     "shortName": "Shareholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i85e278d7295144ed994bb3fc2ee59a4c_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434422 - Disclosure - Other Comprehensive Income (Details)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
     "shortName": "Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ic4a269d865e84dfba2f627d264bb9960_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437423 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439424 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:GuarantorObligationsNumberofLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "store",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ief51a7c21e12418191bfc6502162bc0b_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i26aa46eccc1f4fbea8025f767a6335a1_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:AdjustedOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i77a15d3f8d594e32b14284d683b3a2d6_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "ibb200c306c77462da3c260709207f142_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i6d4e8d62d9d94573b24a74fd6434ea02_D20200101-20200331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i76f7761a4b9349978ab4d5316305bf43_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "role": "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "i76f7761a4b9349978ab4d5316305bf43_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20210630.htm",
      "contextRef": "id1573f503fff49429b0a3fa8185af85c_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 74,
   "tag": {
    "cvs_A2016RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Repurchase Program [Member]",
        "label": "2016 Repurchase Program [Member]",
        "terseLabel": "2016 Repurchase Program"
       }
      }
     },
     "localname": "A2016RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Schedule of Activity in Mortgage Loan Portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income (loss)"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]",
        "label": "Adjustments required to reconcile net income to net cash provided by operating activities: [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsrequiredtoreconcilenetincometonetcashprovidedbyoperatingactivitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "negatedTerseLabel": "Acquisition purchase price adjustment outside of measurement period"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "Categories 5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "Category 1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "Category 2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "Category 7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeinContractwithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability [Roll Forward]",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeinContractwithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "label": "Change in operating assets and liabilities, net of effects from acquisitions: [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "ChangeinoperatingassetsandliabilitiesnetofeffectsfromacquisitionsAbstract",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]",
        "label": "Changes In Accumulated Other Comprehensive Income (Loss) By Component [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ChangesInAccumulatedOtherComprehensiveIncomeLossByComponentRollForward",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractwithCustomerLiabilityRedemptionandBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer Liability Redemption and Breakage",
        "label": "Contract with Customer Liability Redemption and Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractwithCustomerLiabilityRedemptionandBreakage",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CorporateOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate / Other [Member]",
        "label": "Corporate / Other [Member]",
        "terseLabel": "Corporate / Other"
       }
      }
     },
     "localname": "CorporateOtherMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Credit-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss (gain)"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Amortized Cost, Net",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_Deferredincometaxesandothernoncashitems": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits and amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Deferred income taxes and other noncash items",
        "terseLabel": "Deferred income taxes and other noncash items"
       }
      }
     },
     "localname": "Deferredincometaxesandothernoncashitems",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberofLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number of Leases",
        "label": "Guarantor Obligations, Number of Leases",
        "terseLabel": "Guarantor obligations, number of leases"
       }
      }
     },
     "localname": "GuarantorObligationsNumberofLeases",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareandOtherInsuranceLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care and Other Insurance Liabilities [Abstract]",
        "label": "Health Care and Other Insurance Liabilities [Abstract]",
        "terseLabel": "Health Care and Other Insurance Liabilities [Abstract]"
       }
      }
     },
     "localname": "HealthCareandOtherInsuranceLiabilitiesAbstract",
     "nsuri": "http://www.cvshealth.com/20210630",
     "xbrltype": "stringItemType"
    },
    "cvs_HealthInsurerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.",
        "label": "Health Insurer Fee",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts liabilities without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsorLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains or Losses",
        "label": "Investment Income, Excluding Capital Gains or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsorLosses",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LossContingencyAuditMethodologySampleSize": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Audit Methodology Sample Size",
        "label": "Loss Contingency, Audit Methodology Sample Size",
        "terseLabel": "Sample size"
       }
      }
     },
     "localname": "LossContingencyAuditMethodologySampleSize",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorAxis",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateCreditQualityIndicatorDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain].",
        "label": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]",
        "terseLabel": "Mortgage Loans on Real Estate, Credit Quality Indicator [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCreditQualityIndicatorDomain",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Mortgage Loans On Real Estate, Year Of Origination [Axis]",
        "label": "Mortgage Loans On Real Estate, Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate, Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Copayments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interests"
       }
      }
     },
     "localname": "NoncontrollinginterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPatientsServedperYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Patients Served per Year",
        "label": "Number of Patients Served per Year",
        "terseLabel": "Number of patients served per year"
       }
      }
     },
     "localname": "NumberofPatientsServedperYear",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofPharmacyPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Pharmacy Plan Members",
        "label": "Number of Pharmacy Plan Members",
        "terseLabel": "Number of pharmacy plan members"
       }
      }
     },
     "localname": "NumberofPharmacyPlanMembers",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Walk In Medical Clinics",
        "label": "Number of Walk In Medical Clinics",
        "terseLabel": "Number of walk in medical clinics"
       }
      }
     },
     "localname": "NumberofWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Receivables",
        "label": "Other Receivables [Member]",
        "terseLabel": "Other Receivables"
       }
      }
     },
     "localname": "OtherReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsforInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Insurance Benefits",
        "label": "Payments for Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsforInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "label": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyClaimsandDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims and Discounts Payable, Current",
        "label": "Pharmacy Claims and Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsandDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Services Segment [Member]",
        "label": "Pharmacy Services Segment [Member]",
        "terseLabel": "Pharmacy Services"
       }
      }
     },
     "localname": "PharmacyServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Revenues from external customers"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Schedule of Proceeds and Related Gross Realized Capital Gains and Losses From the Sale of Debt Securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_RadcliffeAndFlaimVAetnaIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radcliffe and Flaim v. Aetna Inc., et al",
        "label": "Radcliffe and Flaim v. Aetna Inc., et al [Member]",
        "terseLabel": "Radcliffe and Flaim v. Aetna Inc., et al"
       }
      }
     },
     "localname": "RadcliffeAndFlaimVAetnaIncEtAlMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "terseLabel": "Receipt related purchase price adjustment from acquisition"
       }
      }
     },
     "localname": "ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail/ LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Schedule of Mortgage Loan Amortized Cost and Credit Quality Indicator"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience-rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Schedule of Total Investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchases of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury share held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Five [Member]",
        "label": "Year Of Origination, Period Five [Member]",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Four [Member]",
        "label": "Year Of Origination, Period Four [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period One [Member]",
        "label": "Year Of Origination, Period One [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Three [Member]",
        "label": "Year Of Origination, Period Three [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Period Two [Member]",
        "label": "Year Of Origination, Period Two [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination, Prior To Period Five [Member]",
        "label": "Year Of Origination, Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "label": "Yield-Related Impairment Loss, Debt Securities, Available-For-Sale, Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20210630",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r122",
      "r166",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r192",
      "r196",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r122",
      "r166",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r192",
      "r196",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r306",
      "r308",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r127",
      "r135",
      "r141",
      "r247",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r412",
      "r415",
      "r417",
      "r418",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r127",
      "r135",
      "r141",
      "r247",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r412",
      "r415",
      "r417",
      "r418",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r127",
      "r135",
      "r141",
      "r247",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r412",
      "r415",
      "r417",
      "r418",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r611",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r199",
      "r350",
      "r352",
      "r493",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r199",
      "r350",
      "r352",
      "r493",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r128",
      "r129",
      "r130",
      "r131",
      "r213",
      "r214",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r295",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r384",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r13",
      "r35"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r24",
      "r204",
      "r205"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r53",
      "r58",
      "r67",
      "r68",
      "r69",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r48",
      "r58",
      "r67",
      "r68",
      "r69",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r69",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r50",
      "r51",
      "r52",
      "r58",
      "r67",
      "r68",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r56",
      "r57",
      "r58",
      "r543",
      "r581",
      "r585"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r67",
      "r68",
      "r69",
      "r124",
      "r125",
      "r126",
      "r399",
      "r576",
      "r577",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r128",
      "r129",
      "r130",
      "r131",
      "r141",
      "r213",
      "r214",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r295",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r383",
      "r384",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r494",
      "r495",
      "r496",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r207",
      "r250",
      "r252",
      "r253"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit losses"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r110",
      "r274",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r67",
      "r68",
      "r69",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r119",
      "r174",
      "r187",
      "r194",
      "r242",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r392",
      "r400",
      "r435",
      "r460",
      "r462",
      "r512",
      "r541"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r46",
      "r119",
      "r242",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r392",
      "r400",
      "r435",
      "r460",
      "r462"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r222",
      "r225",
      "r529"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r222",
      "r224",
      "r528"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r222",
      "r226",
      "r530"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r222",
      "r223",
      "r527"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r227",
      "r531"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r215",
      "r218",
      "r259",
      "r517"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Total",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Benefits, Losses and Expenses [Abstract]",
        "verboseLabel": "Operating costs:"
       }
      }
     },
     "localname": "BenefitsLossesAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r32",
      "r112"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r15",
      "r113",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r102",
      "r112",
      "r115"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r102",
      "r444"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r332",
      "r333",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r227",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r258",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r292",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock Including Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r23",
      "r25",
      "r331"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,742 shares issued and 1,318 shares outstanding at June\u00a030, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r63",
      "r65",
      "r66",
      "r76",
      "r522",
      "r556"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r63",
      "r65",
      "r75",
      "r390",
      "r404",
      "r521",
      "r555"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r74",
      "r83",
      "r520",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of receivables and contract liabilities from contracts with customers"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r337",
      "r339",
      "r351"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r337",
      "r338",
      "r351"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities, end of the period",
        "periodStartLabel": "Contract liabilities, beginning of the period",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r350",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r350",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r196",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r79",
      "r493"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r219",
      "r259",
      "r266",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit losses recorded"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r234",
      "r264",
      "r269"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r234",
      "r264"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r234",
      "r264",
      "r269"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r234",
      "r264"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "terseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Debt Securities Available For Sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r230",
      "r260",
      "r269"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r231",
      "r261"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r232",
      "r262"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r379",
      "r380"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r110",
      "r169"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r350",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r331",
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r217",
      "r360",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to CVS Health:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r142",
      "r145",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r418",
      "r419",
      "r523",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share, basic (in dollars per share)",
        "verboseLabel": "Net income per share attributable to CVS Health, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r145",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r418",
      "r419",
      "r523",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share, diluted (in dollars per share)",
        "verboseLabel": "Net income per share attributable to CVS Health, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r67",
      "r68",
      "r69",
      "r124",
      "r125",
      "r126",
      "r129",
      "r138",
      "r140",
      "r160",
      "r247",
      "r330",
      "r331",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r417",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r576",
      "r577",
      "r578",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r33",
      "r101",
      "r241",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r16",
      "r20",
      "r237",
      "r538",
      "r606",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r420",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r420",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r421",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r420",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r420",
      "r421",
      "r423",
      "r424",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r311",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r311",
      "r360",
      "r361",
      "r366",
      "r368",
      "r421",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r360",
      "r361",
      "r366",
      "r368",
      "r421",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r421",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r311",
      "r313",
      "r314",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r368",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r420",
      "r421",
      "r423",
      "r424",
      "r425",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r426",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r228",
      "r229",
      "r238",
      "r239",
      "r240",
      "r251",
      "r254",
      "r255",
      "r256",
      "r257",
      "r263",
      "r265",
      "r268",
      "r269",
      "r312",
      "r328",
      "r408",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities at fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r217",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r270",
      "r271",
      "r462",
      "r511"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareEntitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for all health care policies.",
        "label": "Health Care Entities, Policy [Policy Text Block]",
        "terseLabel": "Health Insurer Fee"
       }
      }
     },
     "localname": "HealthCareEntitiesPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r174",
      "r186",
      "r190",
      "r193",
      "r196"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r139",
      "r140",
      "r172",
      "r381",
      "r386",
      "r387",
      "r558"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Shareholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r153"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r273",
      "r275"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r71",
      "r168",
      "r452",
      "r453",
      "r524"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r99",
      "r106",
      "r114"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r166",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r192",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r44",
      "r462"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r82",
      "r559"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r80",
      "r81"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Schedule of Net Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Schedule of Amortized Cost and Fair Value of Debt Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r237",
      "r509",
      "r532",
      "r609",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r119",
      "r188",
      "r242",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r393",
      "r400",
      "r401",
      "r435",
      "r460",
      "r461"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r119",
      "r242",
      "r435",
      "r462",
      "r514",
      "r546"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r38",
      "r119",
      "r242",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r393",
      "r400",
      "r401",
      "r435",
      "r460",
      "r461",
      "r462"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r564",
      "r567"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of the period",
        "periodStartLabel": "Health care costs payable, beginning of the period"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r566"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r537",
      "r564",
      "r567"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of the period, net",
        "periodStartLabel": "Health care costs payable, beginning of the period, net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r43",
      "r119",
      "r242",
      "r296",
      "r301",
      "r302",
      "r303",
      "r309",
      "r310",
      "r435",
      "r513",
      "r545"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r610"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r612"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r102",
      "r108",
      "r111"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities",
        "verboseLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r61",
      "r64",
      "r69",
      "r73",
      "r111",
      "r119",
      "r128",
      "r133",
      "r134",
      "r135",
      "r136",
      "r139",
      "r140",
      "r149",
      "r174",
      "r186",
      "r190",
      "r193",
      "r196",
      "r242",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r419",
      "r435",
      "r519",
      "r552"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r64",
      "r69",
      "r139",
      "r140",
      "r396",
      "r403"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Comprehensive income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r142",
      "r143",
      "r150",
      "r153",
      "r174",
      "r186",
      "r190",
      "r193",
      "r196"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r135",
      "r141",
      "r157",
      "r213",
      "r214",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r295",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r383",
      "r384",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r494",
      "r495",
      "r496",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Recently Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r331",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of stores"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r174",
      "r186",
      "r190",
      "r193",
      "r196"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r454"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r45",
      "r462"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r390",
      "r391",
      "r398"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r445",
      "r447",
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before Reclass, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r70",
      "r445",
      "r447",
      "r451"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Other Comprehensive income (loss) before reclassifications, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r49",
      "r56"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r62",
      "r65",
      "r67",
      "r68",
      "r70",
      "r74",
      "r330",
      "r445",
      "r450",
      "r451",
      "r520",
      "r553"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive Income (loss)",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r54",
      "r56"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r56",
      "r59",
      "r60",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r107",
      "r566"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r86",
      "r89"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r97",
      "r98",
      "r105"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r561"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "verboseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r22",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r22",
      "r462"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r518",
      "r551",
      "r562",
      "r586"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r96",
      "r104"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r92",
      "r95"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r84",
      "r85",
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r90",
      "r370"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r61",
      "r64",
      "r69",
      "r100",
      "r119",
      "r128",
      "r139",
      "r140",
      "r174",
      "r186",
      "r190",
      "r193",
      "r196",
      "r242",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r390",
      "r395",
      "r397",
      "r403",
      "r404",
      "r419",
      "r435",
      "r525"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r277",
      "r462",
      "r533",
      "r547"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r560"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized capital gains"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r206",
      "r210",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r31",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r58",
      "r67",
      "r68",
      "r70",
      "r445",
      "r449",
      "r451"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r186",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Earnings to Net Income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r14",
      "r119",
      "r242",
      "r296",
      "r301",
      "r302",
      "r303",
      "r309",
      "r310",
      "r315",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r535",
      "r563",
      "r564",
      "r567"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r367",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party transaction, expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Related party transaction, other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r367",
      "r457",
      "r459",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r217",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r12",
      "r19",
      "r115",
      "r614"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesCashandCashEquivalentsRestrictedCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r331",
      "r378",
      "r462",
      "r544",
      "r580",
      "r585"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Decrease in retained earnings",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r124",
      "r125",
      "r126",
      "r129",
      "r138",
      "r140",
      "r247",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r417",
      "r576",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r165",
      "r166",
      "r185",
      "r191",
      "r192",
      "r199",
      "r200",
      "r202",
      "r349",
      "r350",
      "r493"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r117",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Contract Balances"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r72",
      "r119",
      "r165",
      "r166",
      "r185",
      "r191",
      "r192",
      "r199",
      "r200",
      "r202",
      "r242",
      "r296",
      "r297",
      "r298",
      "r301",
      "r302",
      "r303",
      "r305",
      "r307",
      "r309",
      "r310",
      "r435",
      "r525"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r58",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r536",
      "r588",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r536",
      "r588",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Separate Accounts by Major Category of Investment"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r80",
      "r81",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r174",
      "r177",
      "r189",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized Financial Information Of Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "verboseLabel": "Schedule of Debt Securities In An Unrealized Capital Loss Position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r161",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r279",
      "r280",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r161",
      "r163",
      "r164",
      "r174",
      "r178",
      "r190",
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r540",
      "r587",
      "r588",
      "r591"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r542",
      "r587",
      "r589",
      "r590",
      "r592"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Shares outstanding, balance at end of period (in shares)",
        "periodStartLabel": "Shares outstanding, balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r20",
      "r515",
      "r516",
      "r539"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/InvestmentsTotalInvestmentScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r569",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "terseLabel": "Incurred but not reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r161",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r185",
      "r186",
      "r187",
      "r188",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r272",
      "r278",
      "r279",
      "r280",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r41",
      "r67",
      "r68",
      "r69",
      "r124",
      "r125",
      "r126",
      "r129",
      "r138",
      "r140",
      "r160",
      "r247",
      "r330",
      "r331",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r417",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r576",
      "r577",
      "r578",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r160",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r330",
      "r331",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r41",
      "r330",
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r22",
      "r23",
      "r330",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r23",
      "r28",
      "r29",
      "r119",
      "r209",
      "r242",
      "r435",
      "r462"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r68",
      "r119",
      "r124",
      "r125",
      "r126",
      "r129",
      "r138",
      "r242",
      "r247",
      "r331",
      "r375",
      "r376",
      "r377",
      "r384",
      "r385",
      "r388",
      "r389",
      "r402",
      "r417",
      "r435",
      "r445",
      "r446",
      "r451",
      "r577",
      "r578",
      "r643"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r329",
      "r331",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r565"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years",
        "verboseLabel": "Decrease in prior years' healthcare costs payable"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableComponentsofChangeinHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r228",
      "r229",
      "r238",
      "r239",
      "r240",
      "r312",
      "r328",
      "r408",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r40",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r40",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r40",
      "r332",
      "r335"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 424 shares at June\u00a030, 2021 and 423 shares at December\u00a031,\u00a02020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r128",
      "r129",
      "r130",
      "r131",
      "r141",
      "r213",
      "r214",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r295",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r382",
      "r383",
      "r384",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r494",
      "r495",
      "r496",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r121",
      "r360",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r360",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueMeasurementonaRecurringBasisDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r144",
      "r153"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted shares outstanding (in shares)",
        "totalLabel": "Weighted average diluted shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r142",
      "r153"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average basic shares outstanding (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CondensedConsolidatedStatementsofOperationsUnaudited",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 13
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r625": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r626": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r627": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r628": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r629": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r630": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r631": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r632": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r633": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r634": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r635": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r636": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r637": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r638": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3337-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>80
<FILENAME>0000064803-21-000028-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-21-000028-xbrl.zip
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M Q0X]^8F$3=DK*##4%?A2"U3$OQX,"8E<<?#CSE\H*H9[Y+6"+_0>V,8)'$
M85 ;#M2[S9'1V ,3=>*[2"3I+%@0XT(=)!%I1H/5'_)%"H@)4TT=?ES#G*P_
M301@S8/U@O:3-K5EF^:307_8G7,U7,X+SUP@U)N=3O5,P9&9HKH< W57MCT\
M"X!G@(3GRK2G3$/X\.#H?2HM3J3&382'ZRC9/]H?Q/,[=8,P3\@,F<+KTJGK
M93&9%Q<B 72?R]/IJK_):!G,4?ACLQ2IBF6S5<(:(UYT5KV,3DL>"= Z/>![
M$PRR(#Z&8B@<WQX<2B_,$:'AQ\R)XLP)@WF0,0&9)F[N]YQYD+J+!?FE"#2@
M#,TGXM__#FDF/7R?#\I4#$/CD#/8GS3EG^![+PDT3(%:W 9QJ &L)NXLXA T
M8)$2P;D+PG":A_C/2-P ''&]0!ZR)/?4DR@& VB  LE]4B/!0R;M8)  /<-5
MH"46AF#[EQ?GH>_PQOGNW+T10/%@#>AYZP%2+/+,Y5 7').I'NB,8E?IA>J5
MO=(+>SP#VL@TCB(1XLV)B*=R*OXNR@6W@5Y*3-L<"A?_N,F#$!<%2X<3P!($
M8@*A"@X[!7DDNB<IA^@PW9G13QPI@_<M%L(-B0Q/! A#<,_<O4=^(+Z)Q(-%
M^!)5=F Y"L8>(;"?9_<:CW:FN[!G:3Z)$U_N(?^&;.$&4*R\G65<E.A.6PL3
MA@WSA ](3Q!:)(B#GEB3A(^>BX2/!RP*5?3O%4+V)O3&07_4';(-,UI*MD%H
MV.QL&B4AQ+>U[<SMF/8,"+*V%E9S"K\2G\R@/^X.=JX0*FJL=[L"!J$J::&
M$H&? ZZB9S%0(@3P6J4P%EP,G@ >A";VA.6)B9N2+PR^K_LJ2:36Y%X/6QT5
MGT;.I)Y"N1K& _8<S/,YL57C NU6 "O:.=G?!09YCPZ&($X4]RM6HRF]X4V
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MH]P<Q\L6OC5][W6A;# ZZ8^W9TR3T)@^#'>!UGW.10*DZ"KPXM615ZN L-6
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M27BY.:5$A.R(1]>/%[K!/.7HG1W\53E^Y!"\&&;RV@]D\A/!40&P)APUHV7
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M!]?3-NJF.A4VDE'8#&^N+#Q!,H9TP&(5AJA<AD%2# =C#)CU4J;+(D_2W.5
M8[H*7^< 8+LS.-HU/9XZ)K*RT*=I4JQ$I;HF9LT02%7NE"QQ!Z?]?F\:@]JU
M,QSK^,>*HWZUO-T:(DF3J2;&<]H1X.W#"K-4+XY,4'B*8D_C<I2@5,UDT'TK
M@<)C%($G5-O)>AT/';7#*1,&.)\84E*' @&'EU9PMM6+-$5"$MF,V(&V@&]E
M""Y?:!:6!IG0+0* RD$_IC"Z#.H-S0FKA[Y7!)T5!*.MW7A[A[(XH[(#6-X6
M"*I?ZK^GXI6+T'HN@YL4@6 P,96ZVY@E4]8+&D]NF2PM.=5T/?QH\V$"G/&1
M9ZO([L@HKA/(AG+%3/0LRA?-B3$-"+/XMF#3#ZQ3VTI0%)AB4@!2W+9^K.0>
MX?YN[6Z2CM6&[U3BFY1_6HMG=T?^.0/6K\7G,LDB?]J5T3QC&Y576C*;#!_>
M$CZEW':D?J+6@&>G2I=UY.'J?B%TP(L^V*V),S+$ND8"&L.966N.I$:LVZO4
M&T?B+!(QE]E6+1%?0#RF BM/;?],=LR,)<]D:SWE5W$F3PE3SV1@L?+J2 ?/
M)GU+JPXHY_#+7J+8)'I%EW"NH0EXF;8V<JBXU'61RNK!C(U[*KFK B.Z.+M"
M/**Y:^F2G5Y=$- :>N\^HE-MJ=VK.YU*YBU7:,/,NAMF=FC#S+;_V?TPL_59
MY 8Y8DVK+1<0=HD>JRH9S6*->?_=TB)X2XN)IGF*B:4DYTSS+$\:2KS*)(8V
MY1>4L5"4:780W0J Z0V(5&SL:J/Y%/H+\T0]4]:>*YY5J=8]K3,5O<EE$FN1
M6\%7\PS3627Q0@%/*GZR=3<#NI6'- E_ZF*!LN@QP&"E1'C4\7L/E"/9V]5L
MSYC)O#TCA:0I,B01RE/05NAF^];S3NJ/A]V752_F"Y<K3GX0DPSUF&U;TM?*
MK\4=G62%#8@OU0L5SF$1&[-V3GW#T[URL:7=5OJ7"#1/20IE.-_\',V)\72:
MBJRG<Q9Z9K5->5+7"C!U*C)T^[G["SBI9)CA40<.V:I&"PISMQA$>%KKBO68
MK/">/FU+FIG),F-ND@5>L&"Y0I:FDPXO[;,EWRSE"DN/;;K 4KF8_4==DB=I
MX)/=>%()\"[Q<,,2TZLWJBI\!*8KJ!20H8LO]@I_L9K2IML<-(;W=B]"8=@_
M[L#!6\'=3K$,PS;,*ACH3C4@$(^HZPAWV6B5?(MPAS2+O:].O.#CQG\YB+K>
MC/";<MWP2ZP/*CQ9-IHP)2V5;&[BAEJ\*\H+2A&Q=&'^;@*CR_98*^M+&\%,
M- ,_!L$<1?U-"X9-_95'_<,.GIZ3[I^>SZ@0?$&CV*?I=$N'2!?N];R$2#@Y
M3]E0-VWL\]$0;]?&. J69>"O[+>V??M[-W6:P7[W$?<';&BYT?J/"F5_EX86
MDG5X%D7$LFZ[65A"T([=$F!1L8N+1F0O%?S2^(YO-U":^WO&I0DHR8N%GH<*
M.\=_&:Q7C=Y:.[UU1\M0R@7&HCF_"8Q%V(*><1D#.IKRC&FEH])8>1;/7<PC
MI(HP@(]9R(I\H?T6%^G!21$HUQ9@;$87-X?C863,3:D$2"T<3UL2UM+PJ0G.
MRL91\!(5"-+3#8#HQ GL,10918^6=*7;I-H_X#:.Y6,YJ/5VW'@_SE/9CG/T
M:I<Q&"[75C[\<G%Y<?WEZO3+Q:=+Y]./SI>?SYW/'T\OU\QI>3Q17M&F]74$
M!P#KZ(X,<H94)>:6.P8E@;LV+I:TL:XU8I9->BG;2C+1I'A5?<G<Q@6*)5FF
MA?#SJXOK4^WGO\"#%KDAYHT(C&7#<-M6BRI+.^1GJ>8]<E?S%.4828@7\9WL
MU$P>(.0QLQAKO/1:F_N16T3ZRZL$NU".>R1'W7-2 6:M9:"%R)X;4D6N:\,Z
MN@%70&Y\%8NL]6+],WNSTCQ)XIQWH7X5F3AM#,$HQ::%0QK^7SDZP##VW$V"
MU&" ;@DE>\5RS(X?-$F6(ZO%9WO.BJ9YL %L>_-@TZE,7M%MMK045/3(OH#E
MLLR8^,H2RR'3V(5#^?(:L ?.9.!S(:X5'+KL]6OS-YABBII@T6:U%7UY&I6=
MX 8&M:U6I2!Z*MR=DN[RHO*< ; O[5Y8F5HI ]\R^#H2]S!7E7*ID$^==)%0
M1T;2L7WN%H[A]*E@TI6(!96YAG5C>YNR=[FZ1TLA0K/S!5:AP"32K%J2SNQH
MB-EK6$Z/T(5*G,5ZIB@YX6X$'+>, WFSF"9>JB2'@8/52Y5.UX7:RJ:ROG-J
MG""YQ/92^AHC$<LE02J9TB8!'^F8YT46<;%D_TIU'B,70Z^F@9][ 5KAS7E,
M*\';QD4T=]T:_9LL6]&0>K?7K.IM5&08%J%9'1 :D-([GY/8$W#RMV#!>"G%
MHH/N0\ZS[$2?]E5V6(4/=.Y_0F\"416L@!#=XS\);[;CYZCS2U)N2YUJ0]-Y
M)V4S=.H!<T&U.LJ( ?2(/$\Q LAEF:?:I:A--)!I+R-9=TCF254;F)6"-?O8
MG@I3T.6;5&,GU0O]#J1'EHE]-KE1\GL1<-#48![;L!&3THV-B0E@T= @1"$5
M).T;EE_05,B3/BE-F@)G%T6C=IK<"AD9:X9,:]5!Z$FWJ!IS8Z"-SV@CJY"B
M/,1=L)%!]:KOEOY42F@'T;H<="4KCJ+<1#J ZM=!%OHII]_"?;II-HW)01XZ
ME7W.8?S& #*O2H%&UX'%Z#+5CY0N&U3;W:#:(QM4N_W/3@?5+A,*-B@#<(N=
M$,C-GN_>%QF2%Y(.%G0)*^H))&?:6JRIK$KNO FPTKY+_ ,>4P6=B&N@'DEI
M :5SLJ)70=OLEJH09#8A$XVIZ,9$^ OFQ'$)B@,V\(*_DCBXJC12=_P\5T65
M;V*QE[IF&*L/(!0"PFS!];,4)573R(S8OIF(6IPA3O6#C<?D?5,&U()?<;#(
M@0)G*8FCP%/'+!59)@M"<Z\C5Q4/\]S0R]D2EQEV@8GT5*59'.M"0VI"#ZAW
M=_)<#E$ 9@?5Y"6]ZW#39;$CST'G%HN__*]4YV3[A)0/*=!5]4$ 9)JB>U:D
M8*SM]GBV-VYF/Y8T,2LV SN-1<Q]@&_ R4"202?4*$I2JA'(VX2GD"(+N$R3
MW;#GV+#V'3N57NV%XOL4O^%S)4[8C3F6UL5M(<Z,-F*6$+0LHD]9F9[RMI/
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M^/BX^WBP&T3W/]\-?L9''?[L!4$L=YW$^>&?_\!OX+]2./_\?_[QOW9VK+/
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M'G3UF%[ZP4='N_NO,^3CY8?<'OOZV&]8YEO/3]R=TR"*4H9YNA2/C-5["]K
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M"!OZ2EW#6KY[WX)@+^2[AB6HY#$#F77N,QR:)\+U=BX8C'XTDG8B'>!37_C
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MM6_1[,'1&\3=CJLY]N+WOO5GOS>P3@?]LXL[J_?+H-__W+^ZT[-<A1SI6([
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MU3/KEM@FUTN_WZM>)92NP")TT6__KKYF?6CXV:+6]=#PJ,VV4:0;5/<0@3U
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M/*C>%K4I%#+@&XM0C+Y(4BR4#17D(GR=8'WG%A$'$=>V)?U[<<_5HQ/QA7K
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M*QVU$H>:%>^J_#N%><U1@^9.]PD]O=MT:F./#MMTZ@:F4]?0VIL5#1K3C>0
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M=>FAL=DU.T(&ORHL<P&UV%SO+'.55Z8)C%?<A]IPG%';I7!PXL2TQ_LIAAR
M-N#H12J\L*4'&]VQ+EUIC[%E? *F%T.Z7071HY@V83.KI$2MME1E$HNB$2O,
M1!2ZC&UM6&I*['*8,;]Y\VB>K-TJPEN"42WOI<0D?2INP_ _B 17X1?JTK<H
M7TWCT94GU<835\%/5A^26B.[^EUK5;\B?2*B6!3X(!Y.@[!&,F^-"+1M=O^6
M9#K O:@/ %)+J"VA5A/J+04VZ@3_TM+JAM+J^I71S\30VS)ZZJIJ!DO9U42I
M]1P?Y952!7>U9]_C%;-OG@RB:J0<G5 5*^<=E;F'5"_.T+OZ-S?.'<[M:B\G
M+"WK7)G_XB%P'5W/XP3I,.&$EWE!_)*3<0V6>MR>2Z^I0TU"+YB"H#NA]A0)
MIF?6)Z0A?$OJ 0[5 $,/>[P:95=8M:+0GQ3A<-;YP=8!N=K[@XO;7B=K88*%
M_^1)"R(.=U'6ISM,$U6?7.ZQC>QT:[C[V?M'3\USL#:>3OP'%U1M%?N[%(\U
MREOQ/ Q3QATK2CW,<H[D?>IQEAZ6X#I<M^J02U3]#2=_!_1S.Y+X15:$AXF_
M?Z6^K>[E]"9*_ANZ*G/8P/I @#T@IC *)JEW3W$:Q(VGS$:'P6-5855U75XG
MAVA0$;A',<V 3/(%QU=(KB-6P3PX9#TQR?K:D.D#3T9?<!K9N@*W35S.2>5]
MF[B\,8G+7'G/G $T*U6;K&0,"Y1(M+BS;SDB\JOXCXA .8JMS]@MVZ5.6)VL
M6IA!=ABE1^&LPM^S-\6$R3*6PB/H&L>*Q4@FV+Z,H% :=@2XJI-6?<Z!N+(T
M-@'AB!5<'8)C H&I4EJHLI(2G#T]E8[1'J[8 JT4F\ONX,XW((KO)9TU7*%I
M"F_*,\#4BZQM6"Q I5%H"XACB=78] -ZB^ IH?2!PE1/-*2'B4\MTK8[I<JU
M.7WR5(4[OH%2;/'T(F@B2IK'"K<'-_!$(618/MV-XC7&O.(1IMAX= RD[Q%P
M!A6[(5B<GAFL,ZP$_@"<R SJN+$]!OJ7JLP<&(PA*:H9,]8-XTQ67'#IP[:*
M@CY+#,0YQ+NQ992F\:"2:5 Y%%@X+TP@L P[%$S8.,5LJ C6@H52(>>>4T9R
M>G&IE#^=L*[@3K"KG5.L[]8S5DD$0&'R/H#U7A_YLGYE@'TNL]9-W>M3_1<#
M[W!"B>[82$7BG5)C/S7LCLI#*7^;]1[TS$KRK&_P#%I&G"/O/@0:8,T/?/Z
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MQC]Q9YV.)7T[G0PC73G.?L%8VBEUKC)N(0>._C[#%U5I\U]@"SL:];WPH_4
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M)\E$<V,;7C:%\]/@]\IU6+P,H'J$042A0,X:C63E?+986:,((^66 S=+SR4
M0!0<VWF[^/**Q59WKV8K5I!ESU@UR<JMJAYQ?=),R6S&%B.NGU(M2B;?X2P
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M9<$^2".%0QF#080D,)1>\,A!+UOXY:R(Z5PHU)(EQGU"*D98<"_.T%$H''1
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M]=@;'J.\&I\@J<I. JWVAGXBY>?P/6SWO #V7:I^P%]VR3(KL7/)I%+?8Y$
M7/Z&6]DNNJY8=] IN&X;'0O^;?IQFKPJH$.**8GQXT]0?;5A512^#)OE3*\L
MOP1@(6"U'9PW2!(BI7/J>,(&,?5Z25\E2RMK8M]L3F.MZ+5TI]K] !4.78A'
MXT$DRE"MFV4YQP9);8ET,D[J@P9.G&(Y4TL ^,9,+YWJ?F@@F<=&8\W=[E0
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MG>S5#S___>7]9O3,G<Z3?"(41%"K8"9UW4+)$U59Z:ZXGC@-W?_1*X%KM<_
MX!J;]_K7<Y/<?_2+T, 9^#);X0__F1&JWD@6@M-+N69XZ39+OY!+IX: <+6I
MRAS;L-^J&9^IOZ#7AC#K4!($PL:@HNHGD(S"DJI:.BC@,99E%*@A^?O%Q8='
M+Q+8,3PJ[_R0XDE(#7E]#"A]3PF]6XU'-D,68Q!XC%08! ^ ![@M,;2D\]S
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ME)IE)L]L$02%7MWY05D+@HGZ5:=U I8?S]06SS@ZSS_D1(4;Z6)2>W6C5=N
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M<[O4)9[!.1"#LC],W.!TSPS8W1CEC-J_JZ9#/CK['+0,8/MCV%*K0IV(\"\
M2R,83] /)80X?M_D5SCIJ5H*)1UY!U7C'3/B)( 96=0 'D_5N;I!&(:S4$N-
MO:L<CN/^:EOS 'L=Y*J;UOQ,+3DHDAJ^01]P8'K$)G-N6G8F5F;*/P<=&1Y(
MN*[Z:,MML>6@U[I8K3V0OI 4:JQ$VRSJ-HM%P8LU5-8;W DI<1,4E$>BHOG4
MET8\?EHUGJ0NKM2#R;2C.N/%IDJ690?&X6:^'CP'[C.&26K*3-UC%L6,7<^A
MTR[9_;S3+TE!;7@F[XM;H!_>"*,&.BXE6%Y5E<J^W-3X\:II7?H1+%EO.9ZI
M1[S"0'.]65IU=![5B>B,E%TM>$L(DN\Z2BS>O"Z520YUL3@>^"DI@C=%#C&#
MY UJX->:,N02<2PT7B3^"H>S_6=C2W#MN[SN[%]374Z)IR!I_FA:9/LA#A^7
MLXVLNA$F.=&CQ_$]3^''ZD?%@8HU8FU4C^!QR'@P_;#%[CJ&&RMXS6 1E,ZL
M^0C"HS((6$,U@/PC(A[2I8"T^Y5Y=E,2N(9$5K*P67<\B7?IJ Q* ;;4:.,6
ML\#NTFBT^7L56OXXDGT3Z],^/ZP^[7=DJZI-:"-1!(MA$,'_86W=+T:R:&$A
M_F2K)^,R(>/;@(%X(B$]A\2]WW$55F\384TG8CFF8C/0M#IU4?BQ$."./\-*
M@*=/DP_37Z?:L%*[#8BU<C\]S/D*-!8#U><ITJN?ZGN^:Z WX5ZWC.,0 >95
M23TR3A45&D[SWF.!P[O(P%"]5NM@HYK849_.[83[EH,,X:B0J]TOD*4P#:&1
MNQEV/FBL-BY,#^AV6A.7M7.$?7/??)MJ,S/VNOT:@F,>W]+,SX]Y_*_(XX<U
M^)X4]BZEFZ6-@L;<9Y8"2K'+%O(\X$D&-CV&B-3+7YOV,)/<QSC@VG2\<X6-
M=9NWXG%0RST:LZ9TK_\\KB/PJPB*0$]85!W-"F-O*8VV*-LEV=\<T[P;]/XI
M"+_#>18^SF"T\"< :<4##KRTM4*-BX9%"HT:UT6K\FD+#ZDJG1NE>[P$ I26
M-6U@.34:$X8"8+*9M@+>!G$I_17+NMA:21,U!1O@<*:8JI*POYX^397LX_^X
MYP%\SRN(! "H7[FJ\"CZZZE<ANCU7^8<E25L3YPN2UCU#*$X>(=<?"S/]3/4
M2)+X6)YO&8G???.PT9S:HWG(6,!,&W+ZM>RSX68'ZT_ "RVJ8G7-VUYG=E.S
MD;051B+E;*%%]B5-H&.[,B%%+M^<Z(V*=PJ(OP4%!(DBB2[(SYRM/!PU)O]V
M=X!H0,0L>M4*F $;2)+LF!WC?%:6YZU>*.0Q/AS@@'UGK[ $R;+M3VV[/K;'
MPD5#]Z@)'X2<-3:K'[D1%>H-QX*J%CC56$_L_07/?GCPZ?$**E]M15]LU]##
M6+S86.CAV6&%'L+ TJ#(/D"#0;YIBWLLS$%%5[\-^K^S/R )))SS<VMF9VIF
M'P&@64A8QE ,:&-NA9"VW@+*@^YMH>7QWJ7S5M*M0U"ZZAHM<V6!( L:VB"#
MQS*QG&')6+%F]!E-GN9/)!LIO8/("<ND YA$G(P;BL.(90!(T!?1$6"!7MX4
M!%4!UE?3+K%:;YW5ZQ++=OF]X9ML/=X:KM=,:?IFK[:%!G3[G0B]A[+=@KH6
M^,Z@<A59U]1X.MOM_>(>W\,T=T]VKM"@<8)51O:VD7;)!8H!SWY)3)"\X-R7
MP:B9SD>%CR-L$"#('V,_G%#D5GO=67AK3$SD(-YZ(RE&]/_O)KVA^&ZI&NW
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MJ3NXQ&AROM_(+]976#%&&X-SD!Y7)OSVND%*>6JZTK42K[^H'\+V.O_AV1/
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M==B40K <#8\#HX_',.SF&MWDPY.&S2G!:58OVG])>D-:-/_],NH9Q# $A1Z
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MG; 8X3V-CH&2 %,B%99'FI38A/3U5F0G0>1AK6:I-P;U]->;MLF;"C27LJE
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MMR%_Q8#=@0"8HS?28& D/+_?>:C]D: !_:HWY&"09[]R$1S2H\54.31H\['
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M$#YYH)/(%HZM)ZMWF#L'K4XT4ZBN62P$$R=:,J5YBD8O+Z>GT[.]GF0E*'.
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MDW$:\WNO($!Y=B?8GM\[,M35.D,5/366$3 Z'[VRHN7ZCD_<5+[Z51;[(H=
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MD:2O2*IJ=^WH:BQ;[!C+W=D0@?<.; MSF0&6#>^-K]X<O'Z!'D]FQ-KM7=4
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MH4 *R0[EE/*YCA#21Z$IMYBG\"A!SV,G<7PLP;0?#BN8=EF4RYDZ9.CH6:
M=5#J^7H]'Q$LT?@I1<*O\78A5#/8AJ.FEQK.X!]K[LW!C<+^#R(1* 5[65S!
MV0'EF90@T+OU;==MJ"#":D-QG"?>S7=V5M00J_;OC%7VY@;7&6HB"(_3T"@.
M@=\9AP@THM)DFSFHB).+B4[(T!?K35OK]E@:,F0X3E_\K=/G 8U=?SS/5I"2
M@*])<4,('W A$E9=H:\IXDAE&^94QM(/\Z_;FD\ C)4JC:EKCLUDVGILY,7F
M^ [\SF.H+B?WY&<2 >6)%.OD)JLV2K"P7"FT;L+6.]&'&:U$ZJR#+(O[RGB8
M&9<E-82"MB9[/U/J +5=E^HX=09@6.4J,^=36:=26\1M;L/7<NT2GJ,8M:Z*
MFZ(B;@4.))@"NMW?24DF%-9SB.^Z5#>E38@?6[L0^EVD7X^N2Z2S++:[&>:$
MJ*#4 8_@>=1"T]^<:7!KA@>MOUXU:BT@! (.88OV4FC5)QP01<U2+D$ TF39
MY&!ZJ^N@=\5V1:TBQY3$2@UN5<Q+=5LVX'!@_!%<T76X]E9)9$=&.YM[S<QN
MEF1S9Y;5GVU;2ITOGXNU9\P<:[^LVJ^S8^W75]1^12R6/1DHNI?70U,Z*;ZP
M[Y4&V5Z#[/$U^P-V3;+V8LF9,YO/K1QF)=Z&0?SXC"FU^A":V*\]._AMUMF7
MY"3GE\=D:K?.EBL-30%$69/>/(1:A=\U:YX)]SPR]<E.88LSZSCIQ:J/52*1
M'TI1S!K0B!*DU]EP-;.?LB\%F.Y?>*;QW_# ]_@P_"?W5N(ST,ZA6N\,E#&\
M(#P:,+.@AHV.#HYYB+,7M)GZ$QMN_=-&V4,/_IX72PUJ.07NK=R':47/#.D2
M1@O@K.*(FK1!%=]F+(E>%=X&4%7"X0ZJUM=8)]8624'\TDAXP^S#Y(JZ@9RB
M*:YM5Q+17A=9CC]75M4)(.93VJ*Z^^YM$P\U9-50QV"_*@]MW9;*C!++ZEO9
M12!>58F!&;]#F#%&4*.$#;<4#3ML!"@7\I@.Q%DYBRP*ZCM;5S;*V*LI_TA:
MMW54D%)6YG?4L-XU&S41WM9^D")UFG@GNK#>3H@Y@1\U&.M+\HKY C4Z91)M
M*'*JPT8G3$C<%F2;4_"6GP-F)FA2K<+QIEPR@^3AV//-L N]D8PZB)Z<[S<]
M-\&UMF()]SL(E&" Z6T%&?.R4\N&O+'40\0W MFU0_"@5;%G8PD]4ZM*E_.8
M/AA4WC!'U$2?')?SFP76QA)GW:U,SJD,]:P/-!B96YJ/W=P[_:.!-3G/2?4*
M]NA1QK9UFG/EK:X3>?:<+,J5,O\*O6(YQPO)PDS5_"(R!062S,'6#VI<E5A?
MV):=.;!IB<#1P-!"#E'(MLG8"#(5@A2[44]X]AQ[.1AKPL%K 1/;&(W8,\:8
M".S%4,$-_9("GO(HB8^NZ8B'_FG'EC>7ENL[/FJYG,4T6$MGKI<C02F&E"*G
M^&56#8@9 9AEZP$-G51%UF*MP")B>KC-C\;:T2&UN.WL/\MNQH0\'-@ANK3&
M',@R%(B'5W<R'PB:!+M/\HN#)P]F:6GB0C>SJL7U @V]8]=S]R!.SD)6(UYP
M[DT\]=E: <"^X,Z*>>;TYO(*FX53 BS+:@"*\RW3; 7]NVL32MRZT@;?QG\Q
MY3\0)7UXH6A2=X:P&\MA$DO:O3BLI-U;Y=Q=915G0-Y0COH>C69C6(J=R]_9
M838R2(H5ZMW[*;!0]HOV%5809+?@BN,F0+=\K:ZG+!,%)LJ;0F< N/V=0_]6
M.S%&C=5!QEX&7$YGE4D5P/"X.A0M6.6BJ+.-@&\6?;6%U]BE!^$(6T(UBFLH
M9,@TLH[3_$ZGK7EUL),I?^^@$DA#.JIB[%!* VI;3?ERM685NO!PV*6R,M@\
MIB<!]4LVX4X%72?FPFSI*8B4-716.8G;J1XOA9"8#W)?HR;'Z(]2YG"2I^IL
MF03>&&M P%VQ6AK0)3&-!.%E<1L:U.WGDV#$@  !L!ZIV:R-F'?1]Q Y3\U9
MRE,!%;(;J,E AA=I@'(:*_P:0(ZRPO.?$.3]>I=J0!!Q-BG4B5*5Y&I![CKK
M./AE+&M<\GRBHQ9\_D)^IEU3T*QT])>]#$M*4UE[P>?<-5O0AMC046;73W5:
ME4--?>G0[5Q0A$5?7G!MZ@(J90",$^;_IBESNM"\9$K0;/; HCL'1!7ZU7I-
MUJ'1HQ'6U$%T#=/C/$V2MXO #K24IV_JA/93V9G]8Y$>) <31=EK#2\UR/84
M#III.BW)G>0::X0MPC5!@L F@JK$!.5JIW,DJ$]V4_1!Z>QA>K"B)W@A/$WR
MHE+7MW>>J0C#0TTZT$_9NWTXZFI)\8[O;%0G'.5*ZRK="<BPQ[2NG=8]/Z9U
MOR*M&[:K]P;@\5V4_4%H^KUJ^7'.S)[//E;C)%"4@-'!&)U>E[!,2..;#I/[
MP*F,P<N-!1Q^/*R P_N5A/T@V$ @%1\W,T88SHT/84/G/S;$FRR*>//:REH!
MRAD4G\X)J409<&FOHU[GL6+MF9BO#%?RN]X2X*ITUQCZW+3*TX<8,[G]RP:Q
M\[GR#0,8;"6BD^N83'"%U>D _[2:NI1?"(:).E\?T 9A9[Y]3S/4N4RR50JB
M.LI@MVZ:W"" !.#S30"$+#1B2J#>%'XO2!SK$B1,JVLX?NZ:P40$.6DR8O0'
MJ7%.^XC0Y%(0%T  N?H>,R,5W5*G0O%6RC&-\QPQOM3SO?M28Y^A_29Y&9W3
MS\*H'5*N*ZO?"68RI@9LA(^L7>M86"@"IFX3;BD'/BWL=,OJFM$,H.]N4:ZI
MP$5CC#OE@)V%C*\'C[WIH%W=2 ST*Y#C#'MZ@Q:K_5I%/JS08N]TKUXJ2\M9
M\3-?X:VO6RBX$:W#^GKAJ.D [+G55?B-M7.\,>PZPPQK!M!;ZMW6=U8'FJU>
MO5><.G('-]0A50I]8L:LL<'SYAJK0(G)K%7#O<8R.2C4*_RPFP1*K0?,KYM&
M$SE9?36I+A(=?1?R^?3TZ2'4A!P>$U6<SI?3\L6-AH 0W*1@:,H*UUF17+5?
MK\ V04@Q*5%S"YNWP1'K;+CIRZ717$R25[2)3;MJ6W A"ZEH:GP%@R2K/VLD
MO%_4%FWJP>8&O?NL=@M2,# T7VU1>\_)*<;T9P879)',RW:^64(: X(&Y,&)
M'@P^7P:@5/G_;@3EV:H-6Q:@)/(&7[/XHE:!2G"Z>=%*-F = (M&4]*I40<S
MD>I (N?5R1FGI9QWR(MNWI:S0T!%5U[D23[9-P4IKQ5"\$F5_H0;LC@C),C,
MUA["0'-9#*80R=R_HQ^X.\W:@@_:=.$MY^V(OHQ) 0D++Y3?UC@DJ%EMBT4E
M=258Q>UB Z"S8B>UX!!D8XO NX&OU$'HUBC8_JENB;S?EV$E+FD- EALG7E=
M!YS;)#DM:RN2CHUDJ*D%KL1,/$($Z H9<W-*7THYR>Z#QMZUT'"P7S,=+<76
M!:I%H*6A 8^AYCW==M+ME/L7R3Z!C&91%:MK#C[HJ%XJ[K+<3FW(1=DN2;_>
M*L-2+?-$6WE>3Q $+?JL%5 \Q\7%#@Z5D3 :* C0*V9,L&0.:ZET\LQ?G&XJ
MR=*!R0$,0CNYE>)I#9+<NUW??;&SRJGNFXW(_(D'L<CY-E98MP6!;AB2,U,:
MH#X>&(QS'7=&E_6&Z-'<$<)B)R<OZ?WLHH5=;I\^J 0A%!A".;!'-DU^0X96
M&!;G&,EAI&ZI#NTY/H\B8!P'0K[XXY[Y9?!P0/&"A<G;[':8Z0/4@<GZN@>M
M5@1$65-B;1= &D7OQIYH$,Q@R/YLE4*Z@:P5FYQUH\[9^JIHV:XD)9;M8(L:
M.]2/#P;/Y%VM4+*6[K:_.DZ]MIAXYGO6%;Z+.R'FE5N#3[1%L?1V=0JW66Q:
M7"G;E ]EUTUUO6@\EXU$W4LB.I[YP>@2+<C==IS9(=LF:"3$7=P_8ZK_V3'5
M_[4=W <5!HD3<O?#(",(@80YF28)I].^+@1!QT'ZU2&(8$&>6,:QH$*2'.,*
M#XDKC-];>9C?X-9L!FAI/&8;* WEYB?I,S+ D/.)KL?;H&FLVV!,$;$$T)VN
M&.,_?&L#[R"M.K.SK:W])R1%C7(1>-0#%'CV^Q B(!<=Y?U$F*MRB;MJW#JQ
M&X,7-MZL-TS.?,^30Z@HY3VJB[T.(23/>.@F?S%N&$)UF,<V^=>80:0=%UBP
M1'!=@2Z97G^)%,)[:KZ%^$U5?BZHDP4Q]9?*Y2-ND]I!(]*:@_NXH*URPVV]
MR/GT<=["<7;)?)IH2=QD947DG("K/*O*[EI()B40191O#Q@AE2TU[:.5G[@
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M!( 1.ZEH"--TLOH,U).UZSMF^-XQ)IR<C%QYN/3=(U =9,])!QFA#8,2F16
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M 1.WQFL1P)R[TC5-B$%#L1%3YH2.NU#R6"D/!O*,&CO':D?4H^PHZ^CN%@W
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MJT+]^A!N>;,J3^/BK@4:T-?)[_KM=G*Z^1CRE 5%$A+K2?G:6X#-@Q?3J+;
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M_BJ=YS,B5Q@[0RSWC48UIU'L\6?W%'S :0#K:"]KF3OJ:5+#Q7CWR6B-$2/
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MS7N:E51^YL*K:@;1K0-$PUA+4+2-CN'OX#(EGX@$W-!H$/CSP<GQJ ,0(ND
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M(W+H6J_2HQ5K&+@BYF3NN+Q*M_WG5&%]#3E%-\%HY'8^ITN7K*I2A-83\;-
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MX##%D2X&<*V!;"R?_/%4(H "/!6M/:_.>_4GN.$'/+??'O[/R +;]:@78]E
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MWAP?OGK3PI(XN+>Z5?["FF_U\N5Q4_V\)Z,TE)UU@3Y$[SMV_>\4=]L1K-@
MI_[URY^F]\4='39'X$MMXU@P.QFX:<N57_=! TM^J[=,4V9[WV#O&_QU#MW;
M;.%]RF:SH.Q611Z,57=/6M\;%YC91G;*&P3>EE@6Q0DROY<P'?9(E1910IW&
M)R<_Z3T3P3<IFNM.L#3FTPFR-CC!3SFY3T]>'[YX\VK-DWM(;_G4D_S5R^-F
M3^[S6^VV\FPO[^#NQ=&"]_7.G>[>P?-.=Z:$L^1+L7IBM:O(17JIC\HF0]I,
M_K:LP*84T6AK?(@;6!$Y7 6LXHNW/WDW)24YY]['CU\&_^ROWKWS/D;?X%%*
MI,&"F:Z&[U$TM6R]D^/CT]/!/_AZOL3/5>%].O+&9;P*[H;O3:QY?KY^^7KD
MO7WY]O#5Z6EWC#B8MUKSO#P].5WCK09\'CS_=)Q7Q5% :Y1.QD*L8._!^%<$
M'ITT1F,//&K<=L \#L^NT+3W)"@M*J.;T=68,-S*SE;IE=2<7()K</$,QQMQ
M/5&AF-R,_[LD4C9R3+= AYTM\NG1FTVN&<V&1QTDGF=UA+BC7&\:Z/VK;T V
M]E_@/_SJF*14__ZWEV]^NHX0OR6W?V+D,)S5^AX)XF#@Q@OX_C0 %_=H?.1W
MB==MXQN^.S[V?COR;G.D4[LIX>7^'#V[-T<GK];974TOI,R6___ABZ.W^/5[
MA"1,@T2&#IF_>>>5=YO<:]Z')+,DV;=I_J_.3@Z/3U\?'L/_>[&-+W!V%^0)
M''T1;,XS[_3MZ:LG9+&'\QIMP:AWGJ5IX+T/D)]X&U\*PC9Z'>_=V^/#%V_?
M'+YX>?IZ&U_$C:J]-\<O#]_"_W]U^N)5;VM'D\-[P"]I@D\OQ(5W='<TH:5'
M$>4DFP6]T>1@WZR?!ARA>836OB2R+M8'/O1^N8'=ER1!7@S7\1_LB'<X3MMY
M0)KTYN_;^/SC]^._>7#"'Q^_>_5N*T]XB"JHM_HJ.V+KY)V\>/WZ^,WIZ:MC
M>*VM?J5@(4?*;\C'>)9$S&X"?^<2S,TJY=[EPX^7_[N-;WH=S632"-QQ,?YX
M^P_O[//UE\_7X]O+SU=KVH3^)$9+(NL)^=[A)T@:-! 2H^_6\;"-+\)Q\^=E
MQ*[%DP$70WB'$PA?HZCT?@M6V_CXG[ =X2P+Q9!^&;\^? 7AQO'IX8NM/!MN
MIGF0EM@-^B4X\D[>ONH!<0[X-=R UO-V8:?H>/85HFO?O3Y\]_JD&Y<SX!>I
MQ;-OCX\/W[QZ=?CVS5/:!H;S.E;D6N(RFR8QMFHS"*Z,@D55_/ 8]BD^Q^LA
M!_[/"(_W(?%?V>?9@8C8^QM;"\I\'[\[A,AX*Y,3*HY4K_/RU0NPXF]?O'N[
ME78<? 9Q%Y03Y-T@9=1D]50XS)_QOUNY0G3\_5WAMP6)^OY8>T,CP3IHU&DM
MW=408C_2GCS@B?U+EJ;+NWVI=5]J_<&1Z?_ W;U_!#D^[QXK:6$EFQ#N/5:R
M<=OM6/-.)?[TS:O#UR<OGH#0'\Z+M%3BWYR  W]ZTFV+MK4*_Q5N?!0>W;%I
M6B^#,30PZ+/PNDV]9O;8&**[\>P#"Z,B%QF*A,#P(M&/=X LX9H*)ZT6$WY\
M8L11GQIY120"PDI-ON:N_2\6=F+$7\1Y]!1^LJUBR)ILBB'KB>OQ(HFF99ZE
M\92XQ T9TT95%[VKQZBB!/0NY4(2QD7B;2./SLSZ%CL4KMXJAX5XQ^Q/D7ES
MY]K8IZADCH7LZ</RTT</WJ\(YHI^BAC-TZ@4=G,(YN'?#]$$?* (-L&RRHL*
M6YGA.9=Y-HW"*L?762+%5;_,,^S =S\-5)IN\RIGCE2(U1#*Y.TPVHID3*RL
M+!!17[9F91L ]IL6Y1CT&'DOCEYL=(!B$9-PEMA=0/2N3"O7R2]+2]DC[0KD
M^@V6I!&0S429'I>V6L=LS>A&\N)%G_4ZZI8FE\8?5[A5SF@4<<\CUD<@=4[:
M/]3M\#AM'WL+QO3V/%ZQCF6,]S:PUP;R6*%(WDP3+*MQE&,O 2=-"!E)DV):
MH>Z]FLFL/H6[ZH;]DB;HN7;N0Z,ZA%R6TSR>H"SL02S.6W/EUU>ST>!SW>"&
MQ"9O;/B'U@HIR/\G:I,W/Q4V/7. ),M?T^PAB<(Y$QFPOO)=1'Y'&O(%XV5,
MC-;,H%THIP(O>7K\$VQG<'?T=7-&5$4A_?GD)UP$^I-!V/S[K$JG8A!@!.[A
MY=!(^9Y<-U(LF3PP6N+9??#1?B?W[61UA*A&P+S-P"K&<%IKL,N58EJ:Y0LP
M A/%]WV7548/1B\/OWX']]HM4K!&IYGN*$Y7MHQ2$IF>F3O*2DYAL[?SCVNI
M;NMQ2#$BKF^QADDBD5.ADD][W>TU]IK]AV6I-DK+7I*0U]W+L/Y#L0ZAHB@S
M/N@T":HBD@;]>*2X<Y7>D"+I[IF#V-I?'%RP8,!*S;1Z4?5 1 P.3["K9OM@
MNB71\QGK8V&5BJ?F:*,V9:RE#T2=!;T!T?"R,CG^XVD<VKB/.GZ.RZ=$!3@P
MY\\OK; <_G" @A=U%J!&*DR)LS6NN9Y4PY%W4Y&V@OI:$:$4/3X+>+;!\FX[
M9&A1M.#T8+)12: U:;N9[UL";F?]M<I%M$H"&\XFK_],XILINRYRI6+8]\Y&
M;]B@9/*ZSB&E08'.ACY#49VMXW!_U!=I."/=1_7W>!D[>PR&6W(,8LKA2Q*4
M*.MWY&U4S.#V'Q?>EX_CVP^?KS]YES?>E^O/OUZ>7YRK6&=\ []5(<[XRO[]
M^-?QY<?Q^X\71^KO'EYM_//%U:WW97Q]>WEQXQW !\\O/EQ>P27?7WS\_-O(
M.__L77V^]7X;7U^/X9/TG;.S7Z['9[][GZ^]L\^?OGR\N+VXNKBY\3Y_H+^_
M_WQ]_?FWBVOOT_CVXOIR_/$&/TG?/+_XWU_HF_Q)]2X^/>S%__UR#9?Y^+MW
M?GES]G%\^<G[>#E^?_GQ\O9W#SX&QO,"KGP-+WF%5_S\Z?+FYO+SU8WWX?KS
MIXY;PXQ=?5:/3S<>7_WN_<_EU;FO;NA[E_ 2E_#.<-&;V_'M+[>?KW^'WUZ=
M??SE_/+J9_J*?8E/%]=G_X ?Y.%\[\/E+8T /N68A_/LEX_C:^_++]=?/M]<
M^/ 05X>75Q^NX7(7GW#,>0PNK\_IX[][UY<__^.61NK#]<7%.;P0O=6OE]>_
MW%S0[S_#&^*(GU_@)%V<W<*3XRKX!,/JO?^=GM+,Y^\X2F>?KZ[@@P@5^^WR
M]A_N&#7G1\T'#-IEBC+2T;VQ:]UYAESI&:,;=AVQ**$J6AS YDA8YRI9^78,
M/TP/A=])GGZSQ4K:IR-V#W"$DSB8Q$G,XE^NB*EQ-.ORT V%0W1^DZPH,!D$
MX5V\@/\;!HM@CK]0MX@Y:HV^P9%51%KLZRN<&WLI1!METX2"[5$VC=L.&.'0
M[Z,\W$6T=3"LRW)4R\XP/S,U"KN87QUY00X>/WIVE59X5GM3YT E6=1>%97/
M8.ZGL&0/=3GC$]C4/ X2NHRN M[E637GJ$-Y*+ZUX:TZQ5+^[-&N-K\W=5\M
M(43/:2Y\*<FI=?W0S9/,/::V]F+;U-:\WTBSD / LVI1L3V%HQ:BC/A)0FQ#
MF)@.?&WFS8(X0?5O5"?_%N53+%U@7 Z.2 AG".E+RQ]@Q?HJ=L*@7.VZ=I[
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M%,HW6:L?Z<.;S@G'76_I[!-_#5:7.,95*A,M&0KV#GEY^NY1Q=D-C_"O7_D
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MJ?7J02J(?\&S^J#Z@-ZE\511=$S3U9BY!7P>-ZN10EBP,9HW"@_=Q,':^>:
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M>7G^NYR!?T@76CJ>)U\"\?G\1/JE_<NA]-'A<\,S<,BEX]H_T5X[>K:70_1
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M'H;Q_-D0@79]Q>SW(4ZDR08H]&$BI[] =.Z.(  J&HA1*L3K%*:2#J5J=H=
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M;]LMY/?BVHD$"@+@DV$N6(!VL%0GZS(3$PA7S.?.\7%G%3?B[LY=T^1-C."
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M>7%^B4PHM:^R@7%7;X1#*E5HJ;\II*7WZNW?<OQ?<11FZ5ST05N?A8 A;P8
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M&N_H4W\T0(W7GD"H_>/X@YW:^_%J;U2$D^A!_&\ZEW.\"XI/N*_4_J%[KMX
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M]M?8! OLB4^Z%F;#)]C!@8VPP=9 @YP];>M@]C,8XO3SW<%@R'X9D5^M(=D
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MKWDV?<&Y%Q:)LI("M&4;:G5<ATIP79SC;44G=</,BC'1Y,C@(1N MMIU7)?
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M']EZJZ2A%>WQ=(S+=L@K(OK$L.JZ855J^%V+B>KWMV4V?#*9'DBDR06CCT<
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M0G?Y>:Z[L:FUYTK4>$P^IY]NXX>@>+'>;7P\COTE_#/-9N'K_P502P,$%
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MO!R9>/;J9:ROA([_OJ6'_?Y!LC_:V=O?B7>'+_HR2I+^(.X/!NIP1XV&_QD
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M[DQTJ7!$6).W\DIE0CJ1*Q6K&)[[I(2T2JC/D?;,TA3N(:+_,# $KKS%%:^
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MZ _P"%72'/U.G1>519$!.W&!!44?P%(+ V6S &8'!ZT 92[YA:Y)/,.[0CC
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M(UCQ>@[TP@@EZYU"; 4U$7D7QI8CC9';DWZ!7I$5*/88P#KZ'CG&1HVR2]*
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M12@T9_/GG5NW<70*0U #@9 +?<%!YYDP$LY.!NMCINX8LF!XM^6?S2S*<D0
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MUY]H*L3D; :@U-WH@AB!/5TJ'Y/+Z;CO;9 'AKU?PU^IF.5X'BG.I",Z"]\
MD>'Y(5Z56,L&%HB :M:K.A#"$]O<5GJBJ$#],Q/L7>WC(*AUDWP6*U V$]X!
MJFU1!3*C/5?XK_#/%WZE'_-W80^\@>PT&J SX&6!X,/ZISDD!,!XP:'#F:'@
MRLKMWO-] R7FI."D8<&7AR*6\Z*!B0"8B9(<4<$R+FUZ\3X:6VC?T%C"KT=F
M,C+=TGRQI/W!?FF"QO6- =*':&_D)</8'L-R!Y&)"%=! QABU\-/@;&0M80^
MQR<T&:<*#2I^7[SVX):67RP8J;D36':*QZBXF%C,(OH8C@M/:ZC@_)4]2\).
M !D\-*1V(]@573JB+O]5D%7N.J46;#6\VC?1<D/;#"U)_MS3*<S=%Q]PU789
M#BW&*HGM71^=NKOV8=@_UAXC7@Q#UQ/FZM^5*N#."W\*,^@@!*#&#1+%:* @
M_GD;"M90C#?5LY.-\"N:CFT?M%5O40V#VZ@"$"[&L)F%=('/&6][I'$5UP2-
MQ-.05/Q5Q==,T"T"UNB5L3D34$R[[6>Y!D8E$SL1*1.=,)0K,K#"%;GMQ_ZN
M?2;!#?@L>*(!*XJR//8I)L*V)9D($@ER\BQ-NJRNM3JYD.$:7G=ZU#\]^U[N
M(OO*>NN##Q:[JK;$[;1F2<AZFE J02L9.9!<CM%@+R*G1#9C#T0&8-EMN281
MQQFJ4=SQV"^;M;?:[!&M6]&XZ!\=XYZOG.^H:58R)N::>\0HSA*7(?Z=14"
MR$/XM=:1DY.UW\>>WE]4.1T9U3M@S>A\RXPQ'OCWGMSW>5E/[ WW21PN\ZI
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MJ::D!YI^Z2%;\JE=BY K1NJ<Q+*%)@PV4'#LU:X0X:-G)P_+5[0)47%[2VJ
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M3.**_]2%F>IBR188\<<Y$WMN$*]T/<=^"KCY1-MB*^4L$P@+A6\G_H;]>C:
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MNI5T\%*HN!V5G# =B^Q%65F5"&T=]L]2,TM(@4C$9- GUR8&O]DI!V6T&8$
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MHXB\S-14H'62*L\A? E8 ,*CY+KVENYQAEGPS_%._MGJ1?C\H,"Z*KUN#8%
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M>/!13ZG\5TU#_^9\+%8^\YD#V]5%W?D0'@+=E=T\9(?/09:N_@LF]RW5^7\
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MJ9-1CK6[M6\FCVPULX/[J()'0-E";59YQ6O[RK7\'&0^3!W]#5!+ P04
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MZ*TH9A*EC-B+(Z!-DZD[#>CVYU\V#W@MRK$*EQS&"$Z=? CF,*5C;,U[WSW
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MLPH$1AE/8%W$^)R+&IUK[XN;D6=0<J#"TE+ BJ##3F'(VH<DMG9Q:N.\>;R
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MEZ<P=G3OT\>SQOH>KG_:A+__'NP??CS;/\SW\H'6S_]-C7-__CDOSS%88T3
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M8XDQE0(X[0Y%:3U8>>^1L]F[=R%)EX22T>4FZ69B35E*4<MD<Q!V,.@UW<G
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M/YVOC2</L/%"81R0(Y*!^X$E,E@Y)#D$C$)8916N^&D1%^$4@,]6\J  ?%(
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M;#11P!^, J<4<1T"LB1BQ*3TS%/%E2=+JX(^NF=S@?N4X?[;=%.-?7A@>%6
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MF<"\ ^0< R:B!!,% L)\)$D.!6D2#8@ZG247=\OF2:""YP?%\]2Y3A1,!R3
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MH$*P($04WC"<+(7V]B5M$K8Q)=M+?X8M$S(%\HM#?KH_E,5>J9SLDBM>((K
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M+TK(M ]"UB8I0JDSF<7X]38QQ8>Q%2A^L#($!<4/C>*I^)" >"+>"!2+M'U
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MN\V0&E6KQ[%OJ[@R5A>W=)US*DL\OW0W/JDL4LAG+O+Y8Z88N$2<&&I!2&V
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M%1TI[0[(Y\Q(UXY0$P.UBB FG=!$"ZD<UBY&XI&\'>5?B9."Z:5A>A((E(R
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M.7LB(8NL\!Y%B173VIF(/',:::F90F'4$PEA0G$QY[+-R4GT,MH$;J* 6<M
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MKV=U-YG6X"QFHW5X/ML_U8[Q<;#3.@+:,N8K+5C57O41L!O81'$PK" HK(A
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MNRD%J4(,.L_^??2R MZ)0S ^JWI#3\(H\F5"Q2@<H"20A-Z7%<]][]]]>[G
M7#8QK?$V;(".)V(LU)>.<[R^66=ETC?6V=U*#TXU[80=AHI\M5-[1DQK6WER
M-2"GG]NY.%^MRZ^]8\:6?*]YQ5MSV@%L2E\3BY/8.9L9[:"(*X;<J0^":G<.
M7*/=7Q@.C"(!+Z@8-OSJU'Z*M?5>WPH&G_$F?P[4P-6:>>D:-QA_1:'A BW7
M[UD8MNT>U_-W/_1^[/_:GIJ=F1UW<RA\_J6+)\#F0.RF!#B3]3P98[=9[1&K
M'@34CG5M8-GM?(=+C(5\P>G;[T9G8,Q4/QQ?$IC_]'?MQ8TQ=Y?),U17FS[V
M;.F'T9]T01J.SQ?G8-&8OG9%*@M[O 5#YI2?8('&FSB'_Y_%[F"\S\)IN]L>
M#/NU*3(=V\1$RU=]"18$,-7SA7O^M7C1E_,7G7J,)ISY)E^>\NFS?O9!P9;/
M,C$ S57+8GO&<S-3_-\1$,=IK-!WIV0JP4!&AV A]6<%!.+I6:=W#H0\UUL\
MJ[86B'<[C"J9J4Y?8.D'PU'>5?#.&=!6- 1,JA<01!1&,I[C[:5-MB2,-21,
MIV7ZSNP(YSA;:]W3>O]F@C&8?P\-SG*@0!\6=7R##HCM9.13?PQ8%2 M2UZ7
M?JRD--LH%V7LIR^@D  6<C95%DRX%A@#<&4+._=CKY\-SS$B]MN#3YF73 4H
MWW4L<#/;\A_9DA@_YGZ^7PSCAZSM["NV756C-%L]RR.KDEBRE3V>@;L8YXMW
M+W?&@]PX_5OIM@L4I$'*=\JH+PYR@EIC<<B:)(U@6:>*9/D88QY-IUZ77PZF
M"%)%K=7'8C,U4>T>N'K[N+OL])G;C-D6SE \ZF15-;O/]N3(;3J6;AQFH;\,
MV;.F;>=M";(]IY4N<9#FVP/VCP95UOOTY_513@X+G+XU\45<?KOQ%H<[P 7G
MOI*O/W^S9R /M??A*@G,$C-#JLI?$$-V(+48Q[^,W5U@9U=3VN\=]^TI2!(
M5([V!3MO6)U93T^HZP]>C3]8](M=N1-F8-VI/<XU?()AU(<].07L:GDG4%9'
M75:*&V"S6OL9;DY^$J<8OPC32XJ[GL PANWZ*]5?]<:!3[(O<^1 *B_REOC5
MG^2-.YN%-_4W7TT^F.[3:G7Z[<\Y5/WJZVR/5VR,?)7'9?SMB3S4@UMPL,36
M']T<+5;'D W&!LCB<GQG&<:^)'ACO/<O\_!7)_GS>_OBUF\O242NO 7J?^Z
MLOI&7L'L!UM\OR9Q>4I.QKMS*B^5NLM1I[ YNR-0>L-Y*;K2N]E<$*\P<LYH
M;"!ZSXUNLDL&L=,97'2*3QSJ7P!)LK8&.WIL+4QV;_X\.QTK2K= =8]A7^=5
M!9Z6A2!CW_9,/<R3JDL)ZT$;MD.L(PSN)$KP3DNX_<]_$<5_OIMQWRS7XWXB
M*R^_^951#=/EGWP2VO:X"QP.H'68SQ"[Q]M3K99UUV?K04O5\3$U<-1;+0/<
M*/M=*E=W9Q2[W^SVS(==F5HG<+7.&'RRE[S:F9U>]QC!I4_'BF&"@1.<!Z&8
M0OO8#5_IH=K-$[*RS07YXU6R,G["J;$[.X:O3?T,C+/C@^S#[U0L928#O>4Q
M)L#0VIZ=/WBH!6>8+P@P^6):/Z&.LQOG%)(ZUNP2@1^KA5!BS3; "9H[(;Q^
M6Z+-GG:TV>'>'SE1]%;Q9G>O59NOG:8B,']@VNOF+UXP$+]$!^H_,]L,GDN,
MMM=%^<.YMY?YZH7 \:5X\)LRVI(KMKB$YNI<L;M)^[IL 7XT_/^[X?S+X?_>
M<.YUC#(HKK&QFL5$I*4XB$B-WKKB/M\]I&V4R;1TL#:QFQID-DV<L&=U]DY]
MWM./8!3G1+C,O[+=,HO,&,=N5$6NJI\O/N"8B4VHY<PUDIDB\,S,Z)[_&!X\
M0.V'&\YCQ:WEW1A&-\MB7)P;7J=]'2QZVY;\:CE<ICNHN?E@=%;%N5P6PC,)
MTKIH-TR.*28!.#:[6NJXF_@U^E%UFR67W[ .9*KW3&U/U)?LQ.-\4I9=+9UV
M=C-MMTY&\./96>/V56=1L]"A?%R=#T%.Z_.0Z2-F(]^W*\M@<AYYX3G;W<]@
MJ]4IC? P>=?#5'4'BR>?E7Z 73VH ^+ZW?:W^L.QQW'L6_#_&;5K]8,F-E,;
M?GD\3KJI'/S5>4/9[>O:[6\F;IIL4-<;=&Z96]W: LT0527 Y7W:KX(8S^!E
M%\8U.W^;&N'9M+;]XY@#U8 19==@Q;"J$,8%<_;BR=7.1=*T DFZEXS-I;S,
M$CKVY?#HU8> *1:$8^2%!(-46HN<XP;YJ+BGP>&HU;V&@JV8JE@M;@;A^83<
MAGB<OTM'%HI43,M-K%2E(H=]SG(=JW.LY<S%$_LY1\3$#-M988PKQ<"]^Z$2
MXJF6Z(\FSK9^/!Z-M=5"V.P[T'3]F2-K<I:2@>>T746XM'Z:2XU\]VKFBIO%
ML&;E %1I@6>-HSIW6OL7AU8AU*5CVYZJX^6@G0OU/ZH(V$XO'X$# N;O=H"H
MC;5Z-2.7SN]U4V9G><:@).&G9WF(8Z<Y7+S&V_JW%T^"<LVD"O#LU'/YVXL7
MTYCUN67KG;:'\,/M5E[C.F+_LG#V_.;\0TZ?+9_<Y^'W<\6F^)]1)B/ @ZHP
MI.6 IS$SAE_!I+5@3<>A5M49%:B%']NE QAV)P<!P>+9, Z;^CCJ^H6HJ=;<
MI;]SP;S$XZHN^>F&O?DHOOE%O8S\O.B"6NI<$N[\_RIUFG]2Y=74Y7 FY=O&
M7ME)9;?Y;5Z],;W(]'2U(4BSU.#T80>S7R])[ZS='6>7SQ_N#]<#BA.NGIF\
M#1]'@PE''MME^<J];J>*4:FA /8E %M5%6GA!]V8\SZR=S]5T2W)MOL3&;&3
M_/C:B*PMQ<D&FF <V!'M7AC,Y&JG]4OT=C28AC:.#S]\]<9G@.S>:) /#(;5
M&?/E.WC>/)F%5DSCLF "W>3(90:1)]6DG<\?0>18AAP7.!M$]<S#?%%@A_5#
M=\^7G@:6[+R"!S<^[^]7D;G34+'3Y<?/@@@3\+EZM"Q:%1V=S&V[PN$J]S';
M4-D(G]T]7[&*0LD_NX1ESKOF'I!CS@K'P)P79GEP=/#!!B]-X!0E Z22LV20
M$2P@02*3P7,J*+O +,LJW?,J.1R8=98@F+B<D,H)TIPR%",.Q"L66*Z-W5S^
M_V9&O#(5GE_@3;$";J?C)BIS-+8&YJGAQ!R8Q&2BWI=<#7+!.LC?R5JG@O#V
MN"']Q1"R/_=?S0*F+G<ZM,<USBLOZ"1($(;=/]]IO>CD".^L$RIE R_\A+[:
M3F;4@W%?&9C+^J!KWFX!AGN:]1EHSX:L6Z,XU;QG>^)UR?9'S*7F*UNCSG2=
MN?Q 58>8_3GYP*Q=;9H<F3PF*1?WPZ"N+0J;  RTQ3TVO4Y>?3O,L<LYD<)>
MLJDFU]A>N "\[LX/-?O@K]E+DSU>C24_^?BGU9E)OF^=H%MS"9O#3 :U/[9Z
MZB\G=8V?^0%,\C[JG(/S:G*J=(BQ;,&5:EF .U?CKQ_TM >/-)B5G<HL9B[K
M- O0C+"-DU!])D25L05;?C$N?$[B!^/;3*>BHJVABAF$P;EXI9QM N2]@#49
M6W"=]C3/(T]NQIB5L:7U)<>E9S8ZMQ83+KK,FW\(:G>JQ?!5!>#,R4.ONET%
M3[!->J,^D'E[#!1[4*_])&RN_LD2*'^'PY;CYKO9=00WY[SY\B/E[QT1+Q?(
MB]H%'D7D)'(;L>:,$ *4&QAQ),HVBZ;=-;&W@Y,7W9#_>O6?41LT0A;<WV,.
M]<MI;9=_7EL 3Y#X'QZ]_4"QTCP0C*P!HXP[39%E5"%"%">"1V:L7]YS3#AC
MHJ!<8,,E]M8YJKC10JD(IAU9-A1F"]#*4W^+(HP/IJTN%];O3L3\HU=U'^9]
MDN/ T5H/CCT\W]5,8Y[<&IS$_+,I60-->EJ3_TD[+CMNR)7O-,N@75:%L$X5
M1;HD=:,Z)(>G':3S*N_.UK']_0BBTY\X8"\Y9(;W .<GT>4SS_STL'!<C+,V
M!_K+,S2AJ&/';<[L"['2-#EO 1XE)S7T/\5A*XVZH7(AY19*8$ID?7T&^ZZ_
M<U%?KI)^<,<5+/Q)#*-.?)VR,/S:Z7V9I:[:SM[,<W^4:?-3=DP<[KWXP*T4
M& ,@><<!GSCS2!N6D$PZ 6QIY[%H5HV*!*+2^U(=<&4&GZEAC@UO3_W$U3:O
M>X3!BSA31#\* IGE]NI$RL')]L7+CK/7%\3LIK=:/&.<U:ZY&,\TI46V?PS,
M*.=6B$D$QQ+S&Y=PF+#)G(:$*H0Y&\3GDQ<_Y\2DCCU_WJX".E'UHY_'5Q]3
MT$LR-ZK[U1_/&-D.KEG9L __A<F=QQ_O5!\]&X:+GRFR0SF[\F.\0Z[\[+K+
M$KK#F?JARU[_&=/T;@:K;W399]7\UG,,RY@WR/_=8EM+X3W/Z=G7%EG<&CFJ
MY4(.3K6(ZS84S.K4%5]?OG^_N]!68]H79C)=J\U$+23W/!?7//G6[J2U5:4I
MLU9;X0%Q?KRMQS,7\TV\)O.!%^;C.S+@K/]T7!480^,A>Q]C2C\W0CB^K^:J
M67AYE09;WAG?>^@Q]F== <]<1:F%UF3\\S."6YLP+_]]=\\__]S]?,M&/?@*
MO:3NL%+Q]6Z %\.7MM_/X03-ZI/X@\SZY._3KYW7'SW<]^^O[_?>?CTXS>SZ
M+3L\^O,$OD/^_N:_ 8LFKX%Q'^Y](I/?P+U&[^D?\O#;+YWW'W_]=+CWZOSO
M;YW.X9XGAW^] O;]Y\?<T>[PXQ_BX.@ OS[Z,QV\PU__??1J"']_^2 ",5IB
M@20P<<255<CF+"9JO%#4!,T=WMI5VX1<;#2]=&"R;C')GZXH+M=HIN]B];)V
M*W!7X&X)[K##3H: DR*:&^-MPH%[@XTR7.-8ET7&M^O07.!N_7#W;09W @LM
M*$,&UBE[( BR1# 4I==*,>Y$-!GNM+A8:KFA<+<R1TW5/QO%49<]KS]=Y7K]
MQY7F#%UM1BX%[8T&KQ_G:LO-/>=/8 Y[W1QD695H+:!T<U!JSW$P:IT40CH4
ML<NIXQXCG3N5^Z1=I(!8%/.M74HN]IU8$9(NE_P[)5E+M[S2A?#DQ?/'N441
MS[L0SQEGP-X$9SQ!"5L))A+QR&*F$:;188^]EBZ >"K9(/%<D^.JNK?:4:+A
M_.!HU1.3<1;)50<B/TCRQ@<9#"8N]$;Y6&3RZ,587-L$/1K$OR?GV?<":!;?
MF/MFT1BK:(SS.4+' PL)>X^\=1[Q$!AR(F$D8F0LTA1L[51C3*W7RER#?&V&
MUZT@;4':QOGM"M+>$]+.N+D+GDG8^0@;C8&;"X&LT I9$V1,&I89VZU=O4W8
MQ:IKFXJT%;=_5D707),U^;U@[<:4ZGV0X.+?HX\@?3"%@Y(S>/CMU8>DF>%$
M$"18)(CC $:N]1H):K1P26H5S7+H,&>&,AF!VA /<A:MBA$S2H.QBBD0O*50
MOA>3E+;9[#^>\.'O3L;L\?O3QZ]*&U1&:*A2M',V4@XXK+/G<MK,.-^DTZM;
MT$U*_$S>GWU[>]K@(==!F+M*5?1IV@>T3NRJT\@O!M;NM.XM7G8R&X>YXL._
M>[ >H"%_K5-UNL>S'?*T!7/_ Q-*>BX<<@I'Q*DT\$I'1*/G-$B?-!'+@HDU
MYC%&Z1@%OJ.Q%I%H0WE*PG)N+J1H7[(SQR4#!G7I^!Q).HXYGT;$/O^N[*X0
M1'JI2'WW,4KP:0D^+<&GFQ-P68)/2_#IDN.^;ZNJ_%,V7H).2Q16 _SF8RK]
M5WMX\G),N:L<]\,X?/F8SE-/#^C[H]\[A]]^[;S?.^8'1[^?P#OM@X_AY."O
M@V\'?^V30_KV_'#OS]-EG\W?W]YW#G_[@QW\]>>GUWO'7P]_>_7M_>G^^2%]
M]17&_/7OCW^P]WO[,/;WBR&GCEB3$I4H10*,5BN/<FXTHEI:E32/2LCLLZGT
MPV;$8)60TP)VF^NZ+F"W;K";.:A33(1*F5#4%@/868N,<1)A29E+41)J8Q5?
MCS<&[)Y"P.F?L1NJ.HE5Q\)1+MTXZ@-9OX:IEE"V>R!HN0M1O3:P- =S*S/G
MT"]@M0I8S0>BVF1RH4"/E,&YO&/$2#-ID(V.12>)4R[W,,+;1H@&!;N56-3-
M(1U%@-<OP'/'X29J8B5#-CB*.(\@NTY[)"P1EEKI<+2Y%9TF39+?I^#H>M./
MI^W1Z:T)Q"6/_OCPYQX\/./U&,Q@YU'FV-T7""U$/SJJN0-#1ZB0$!>6(6>X
M0D)30R4LF^5I:Y=N&T[79/(TR(53A/@>/1=%B-<LQ/-)+UK!"@K$%37926N0
MHU8@(3S1WC'I=,Q"+.FML]+6*,1/P351MRDLCHAF\(AJ->9LE^(S_2'L.7PY
M1R"(#)11L%V"X!H R!&P9PRP".ZBC=$"BZ@(!.5-2KDK7HC-(Q!%>M<EO3/F
M0+U56'J-O*(Y)%])9)2@8 A('P.3L'P^2R\Q3<IG?PH^B'IVY_^L\V;M5>&?
M)0VV)&<]!I(VB6^>(7T!^A\#^ODX'NLUM4IH1*5+B!OMD,4)")NSE >J:. 4
M@)YO$[GF8DHES;4@:4'2AR#,!4G7AZ0SRFR=C-32A +.QW862V03 :L7$ZG
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M"/L3$'90YCX*0A/(.E>,:1,#IHD;Z;7C>E4?76'RS9+X^9,% 62=&\P0]<R
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MXP0WW!.'!X8D#2RG1(-ONKSM&MJF,A2KS'AG_!%ON^?_L#]RO64C++X_B&E
M1OW3Q^59A_U>-W:F<]WDWBE+/__&,/<*<OV_R]S3 .R$J8>5?I>BW_W9.(81
M+$AJ O&)2@(V*6*S4D1DJJ2U@@K9!%UW0=TZD+$L*AXX=:*R6V6WN[TD4=GM
M3MAMIO)R$(Q+"\2*XB1*,A-+2RY8\?Q::;V*K.F!;LRMG;^5W2J[K3>[K?@.
M266WNV"WF;B6#(RIDHHN; (".=/"<P%Y3@C<288:>-S9XVQ7*5[9K;+;EK/;
MJJ_85 K[40J;R;<1)M,H/8D9>0Q<LL0Q&4E,640;M*3"[NP95>FKTM<&TM<R
ML<X57#]:O.]ZY;A;<MQ,+%- ! >>$XH2AP"-GIA$#9&N""'+(7/1-$]77V<5
M+A[.K Q7&:Z%#'>_%[0JK]VY<VTF<FLA>0>LY$F7R&UFCOBH(_'2&N.MB\FC
M_:GDK@"V+@K<)*X[G<CT+,N&O%:=Y[' &#,/+/"18O_,]])73WR;;ZBSK+.L
MLQQ=(8#YKV)+WIYNNSKRWR.'@C*<=UZEP<=NP(%C=S@:=/U9(Z3#D3LY2;W'
M-][T7,6%]#K&9HVQHJO0"^,F=C].QYX,0<K['ZOF&O5# ^LDC3[U!Q\Z4PBM
M=#+JD5Q@-D].^\-NP?/C0>JY4?=C>E*(D(CFTU>7U0U3&6!G[R?V/Q>S_AD7
M^>'8>VG;<='<V-;Q\>+FX76/N#$6H+><2C"!>N9*XJ]AF0'56<2D?*(U /GP
M%N#KV?0*G\ ZJST1N!UH &I';&:2&&UMTCRI5)I*<;HKQ:T]^"U.UZ]C;-88
M*\KM7F]-9M]U>V@(]-$Z6#\=IO,3OY42<Y_Z]M87YLJ@;0Q.& D"=!0^Z6RX
M<$P9D8U?Y+I]E?IW*_7#K-2W"K<FZ4B$"(P TYDX;PRAT4:;O%#2EL:QL,OH
MJI(J6Q2XJF-LZ!BUE%M+U*]Z$W9&. H%VN@ .@D+3FHKC',ZHX%E2XOFQ<M6
M5 EX*PGX;E8"*D>9=2$0S40B(#PCGOI,3&F9C3_@2W;3JT35,39KC'JAN2V*
MR.)I$.,%O"ZT6=.G5K9 &Z-*U,N+K=<R/LQJ&5E3QZES)$6+=K:UGK@<!5$Y
M!^I0_Q,^W,WEQ17 IEKI=8P[L])_'CD\E!>>W?'1/S@[1@H-X]\+\75/SER#
MA5D'^[$;O.N>- ?XBH82$G+E8$+C>__'#W[>F_<@UU'J* \ZRD3P0QGBZ[C(
MIVX<'4VU@IE/3<B<7G[$>>3ML]'-'[EI?O>HW/ R)\:OQ'!F_CVZR-$]=>\2
M\8/D/J!\Q,D^=KU/[GRX\_/\%N#ZSR[@U6>_>0?&_UXAE;$V$\IM'*]%5B%!
M#-QJ2"IDIX.DF@8VUL#P,RD^+6J3RM0&:J-*J(-QKQQ$+F2F(#)3/+&=&[X'
MA3T765"3/0.5J&$VRZR$XZBG"2%VOG':2MYRH<O+\]"(<-S#GCL=IL?3'Y[$
M[O"TY\X?=T^:G6@^]&0RUN0071-T:\[*^.7+-7U$Q^LZL2<GWSQY^5'STA65
M9/R:H(^T9C>^3!_=_-JWAF4X(?9CPW[[-6%@Y9.UC[BY^=5VS=4\4E:NR5SM
M(^!J3>:*!U:NS<+B9!7E"PW['2=3*U*H[50T-0,^[H[PR\*<L-+7)2HT<T5K
MN#]H>/LQZK-I,,Y&>''2P0GT\*_#11Q.<S;8=ZVLKY6)>UZF;RS*SMZ_DNN-
MCCJ_ND%J).LOZ23E[FB1=5C&A-BD)9NF$#?K-<W/7^UZK=5Z_)E&KMO[N5F.
M_QS^NL4K\6M_<%KH)8T78]$([J8NQXLRH6%Z5]KO-0ORO-=%+;^AWVT&S*_X
M^(7^\*#$9EV:4,?\BJSW+:?%UN%5]W-G']]U-.P\1V$<._\^.TD=07<[G'+V
MT*&?A3RI#^V"JY-\N$G>]WVJATDR?M\?=-[U^W'X\W!Z%;&\;?AC=P_7(=!>
MQZACW%<BQAKD(5Z8.[=("=[0)(;-3$-@2DD)07.:%;AL??!!YFADPA]3&J<A
M,,K&:0CL>VD(7]*@']WPJ+;UN"EYX8_S@_?OY,O#U^<X0QS_CR]O_OG[Z.7O
M?Q_O'_^[>_#E-7V#W_7ZG[][5Y,7#IZ]X"^??9 '[_]]?(#/<O#LH/?FG^?P
MYI_7YZ^/7XB#]W_V#@[Q.?_Y.U\D+KRBGP^^O'BKK9,,A".2248@"DZ,<);0
MTD;32Y.""SM[__M_&<[XD\V[)E#I:T/IRZOL9:(R"*_ BNC*_ZNL*)(:M<8O
M25^U-5&[..S+)8>%M^" JV 485%Q CXRXIR/)(?,LD!>HU'M[&G8Y?;6J=Z5
MPBJ%W5=_XPPR!!I+(U2(4KGD'!<EU3!%X4%6"EMK"F.S%):2S$;80$RRE !J
M9<1SZ4A@WG&6A&C4,*%VM5Q5?Y]*897"[J%514X\"VE$ JNH,4X[F8S*,C//
M=#4BUY6]Q)2]7CY[\38RI:52@D2K!0%&-3$1!.%19V.-=%I4([+25SN>;9EB
M[EI:J:Q+VEL/QF63'-.:!B%%]#C\ ORU>#'WRF8/QF9RELU01ED;=2!,1T,
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MKOHJ_-9CWE-FJ6$L"IO1(I5>!V:ML50:'3V-U2Y95[C/A1I"D,P"3218U$O
M>$>,U)1PYH,.3N?$-CDSM>+],I5 *.ULDC(*D"X9R$R((NNCRC14/\3:XGTN
MRH#"G<H0.0F".0+,66)5!,)<S%2ZB+_8BO<MP#L#RJW*3G*./R;C+9J/UO,L
ME(HF+1)GJ,A^8&3/110L\]J# ^)08R,0G28^L$04_BYR%B)EC8J[J*#>7%!+
MK1'5D-!L<Y!0?R^WNS/GRDLPBBV;QUR%>&N@/A=,4-%%IGDF@H$G8#402V,F
MDAFJ$HV&YBK$MP'O47":G%&)TP@J2,\,6FV!6^H34!NJ8VZM07_EWH+2'M4T
MM-)C" 2H$,1ISPCJ:U;XK+C(=.R9@S8)^2V[MX#@Z'1//J;AJ-3SQ1\#HJ'>
M8+C1#!$R.R6SD<Y!"-8+IECQ/R=ILZ:+A!;F.[;A^K^X6/X7S>I7VEF&=KI7
MX@$F0XJ@28BQ)"JA1>&Y5L3Q;$JNDI:Y7/8TLD4!S)JTL&*4&F5]E,:@A&$
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M[U4[69D3HSQ8",0CG2V&XAO*=8?XKD!\V 9\5^IL&.I+I8Z76*/1"G1(BQS
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M>S B(V K QQ09(C2DC<:/57)CD;H9^H[J+LP9YLPOA3F&$I5)NW %12,\4I
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M%,3M@.^ 'Q#@N^&_ILN_HO<A+:P@&P%C80)0SH$/;/[;EJ%'>$O&Z4X .T<
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MGT^X/F%)]+I(K#%I8@LU1.U%$(6]CZ(H8X\M;!U9K=9Z<&A"5<*"+R0 :[5
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M#")YB2)9G9)6OF2#';L;@%U=?<Q)LX)4$5R!J&/AA6 30FHG1#IV5P2[<VT
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M6-MIS"1%0*U%3 "Y9%M**Q2O0T?L^B(6=0HA5.M=C:!M25F5I$H)"K0O:+M
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M\#6[77XVAO&)$,7YI"STLMQ#>X/K^N[X:#R<]'\:T3Z>#-_0=VVNA7EX16O
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M1?1)M)+C/'^95%B<U.] 7ET@V\B.<P)?BXU0J0:2+M0:LO,FRWC-F;H.V65
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M*83)($1)%V:<U72A)\?L)%V()V:LCXYH%E.I;0\$06R)42&Q;)S+6=7V5@N
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M%P"U7NO@T6 W*6CP:/XA=)/5/@<NL^*RRM-'Q.<D' W:<"W1-F><B1*.YL2
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M?-M:7<,Y^>OKYI>_]K8V_H-C^L]E_^_';;0<'0LQ$K1!(@'G+)HCF9)H0A2
M,LR6C$AV.5G[UUN&(69@O=9-N@B;M'T2MBDUE$>TCQ58-)(C%:A8:X'T&R)$
M#<%;L;0"E]U=M]V53V.&U5WY[';E1>IL?]OV/JML.2?9ETJ$P0"QABO"$Y5@
MM,I:%NI\5H&SNC.?^\X$%.K K6 Y:-R9@1/0 <T8;S@)D=/2)5>:2)=6I/YI
M5.TI5/F'4<75C4S^*ZI2EI.Z1"Q?4:+)NT$:5>GXA=TG#GG3+.;Y"UX\LI%R
MGL8N4E5#4#^O-/=VU%MSU"ND>DSN1ER3R*3+P(&54*0RBH#0F9B$.INPTKI
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M?!^)TL/?'X[)7^'XC7W_&F,OB> 8B> 58M1+9)0I$3.8F>"=QX4!N6!=*!@
MXXW@A_T$6T!=<_UAOT:Q$S@ (./9;&*'B1#?#^>G@R'0V!JM VU/*N1+C!*?
MK,A[# <UP&1PEHYJ!<>J^1POSH#);?X]$N!PO$@T?C^0[G]69ITI4%&I5"!:
M"0Y:LA&*!*PL9B)P14IA,JO!=[Q[%!G%$2%C^=""&,K*4F@?J*#!@8"GL(BE
MP2]Y#RZI8-Z:4@16>*V,]UIR3BU1&MZW]AXF,8NE94M?,.5CG!@'AB94  6%
M@E2=1M=.8L-?=@K=-^_.E^[JYW?IRV^3F#_PR;LDW@]Q)K&+<QX ),_YU,^'
MTW01#(P?^Q Y<?62R4]O3^CX/!4,UB233!&'_V.F/QS>UH<KY5M8%,C7I?7W
M0S<_K77KSK<J]:9HOZ(-;,]B?OE7.DJ,]?$*NWV'6,*>&-Z[A*B=?^-T,S%K
M$9(S1%L*4$1T &P(6C+-2>$=>\WY7OVETVF+MR<>F:G7;Y$.L,(?]>B]OICM
M_;"T$6?#,>KN^NJ&77YLGQ9EB5@%^/B7&]]EL7&7Q<&-@-V5WKZ,=CC9CAK3
M4'5S;B$D>%DJ>ZJGL?S*[ \_?7$*(/,2!O]Y-+%O[UB\.GY1B5=GKSX>$WCS
MV5^CXX_/+OY]\A<\.QH>GSW]>/S1DN=/7A7'+X\NCLF??%6\@I$IB%X7,$=Z
M].:WM\>_PKS^>49>O3RBQQ]?L>,W?X*X]HS^^V04CE_^>?%:&8&EYP1YQS5B
MI1-("45CN@Q1A6:6A;!ZRP9"BU""X"R#8,IRHV6@3A7PHRJH%WL##Q+K>422
MZ<+O'=8;/H ='Z0M7Q>.K@R(&V^TS\YHF:WU] 0XNT)& G1:_25:/,@M,.)F
MN&NV"2ZIP>PT77^S=+TNXDVVF,6:0?'2F[^?H'0O#\[\_'3B#@;)?)D4(A_E
MV;@OR?PTR]?L>;KRHOITOIC:4PT*VJ6*4GKQ;/MI;U=6FA[!X;HA7%!PJ[UH
M;!%//V1!(+8;?)RV)"WS>5CEYBRZ[(S.=-M,??3R"+\&5-0N<(9PX:*F%/O\
M.D^1%Y871=!.DK!WN)[R5JM,B6JN1R%;2-7H*>1V*.3-4_[\Y:,+^!W#W]\?
M/WI=*B&Q E+!5 K$ $41Z'<6B1+4.FH*HQ3 ^'JR=D,OF22BA UP=1;_D #I
MO0<,FRSF((2/XS6_/S"+>?ZKKTXK:Q41U> T;%0LXG@P4#I@^-ROHV)4+Q(.
MGDZ]3[0Z&WZHE/ 8*0W?^FTQ]MDD1(O]0:2X?5!FHDX2B69T 3/Q5B]F<1 _
MG,)T_-0.X==SN(Y@)6F.)R ?@FP(C^BL;>AWH#Z<^ %<%V_]/#^;+ MQ^M7"
M\T[ I/;CGZ<>)NO3CP,? KQ^\'ZR&#EX/3S3DO'!8/!+M:H9T#K,5<^BZ6)V
MP\"^A<S(GFWO@&V/^-'):T8PUK94R#+L$?,>(U,$T&LL*4.AM7&IJ,IZ^:2O
MP/DMY/7T!',G!//\S]>><EUR)Y%7$B.FK4.:6(,H%B4+@/U<Q?9=ZTV#[Q'0
M%\M O^Y<^J1J<8-JYPM[ZMUBY-<)]6<]&]I'8_<D[\3+%&+PS2JE)^2U*"Q<
MSTPA8BS0J9$<&0*2B74:@]+!J&!X5<F\ <_Y%?6VZ*D*D]%H\CXJ:*"RZ6@W
MG8SM<#1LJ-S$,TXD? 5Z;PFXROB:_7BI5;"CNO+E<*C&=I<"#%I[8 IJ@,T9
MZ?.9_['^X2<WG)V/],6/PW%:8OK23\NJ\H90@/2^_'%K'CLHLHFL2LVKWEQ]
M?) ^6@G2R)_QXH"6^-*/BX/+/_O4L+@X &#[HF$__1F5K)_L?9IL69 K#?N9
MQ-+/YG^KM4<WA"MF_KREJ+S/&6-SKFFZ9[/C>? TWJ_IEHQW[ "NUTO+0CW\
MG7D!<L?5]N6*I'.WX:OUFM. /P[G\#+[V5W(<P59?9)]:#\N8">F.0[LV3@+
M896<.-O/OX+PY\_G^6>XR?(/Z:[+/^KL9[P"85TG%F^W22G*A]M:\%5J]#^D
MC2NV 4$/=&]ZHMH*47T+92"3BJOGH&U$C6.#(M)1T7^\"EE]8\U*^DG>4MN7
M6B<=3Z*0\:DY]4\N/]EO;+^Q]^O)VR[F=%EP5GD@^%W$@.2;N8TSUIV$L^CA
M>_S?%X/_>#V:GZZ$FGU!C>P'6BID%_(?=[+F])5=;D!_;5F]1^_T<)3S'1\G
M;T\W2S(Y+>Z[<RTG/)[]B8]>6GKT\?CM\=G1AU<?__QP].3?X:N//\/\GGWX
M%^;YBCQ]__SE7Z>K"8__/OG[ XS[\8C\25Y]_.7-\9.G[X_/?GMS].LO9Z_>
M_')V!&M]]?(1/_[UEW \K)(=7Q3O7V,>#%'>(5<P@YCU AG.,,*%M$P2(XB6
MH)WL"[FM=,=[E"?>0]4NK>UV"VWW4+4;4/6Q@2KEF1#2<Z1<$(@Y4R MK$%6
M.AI['Q<^\ A52JP'#O10U4/5;D+5;0:L]E!UHU"%&Z@RWE$NG$+8,X<8IQQI
M^!N2BF+CC#!P0'N'?!]NGAZJ>JBZ)U!UFS&7/53=*%31!JI*66!I.8G]T1AB
M7@!*4:M0<%8[4_J@2K=WR/:5W*5NQI61;B4E%;,$1'?@<>C'N$=C? OE^I_X
M\>1L.+Y1Y^IGY(!^C!T<8TMA!0FT1?)0[#0;_)-^\:Y)F<J) _LY#KKO+[DC
MN;;U,3W*IW2\.#-^^CRDK(39\S:?HY?UKBOK/7_1,?8;BPOA+466$8-865(D
ML>%(81]*%KS0AL3:AO3K&^+V3;%VFKEOTT#>,_<-,G=K'A=.2&R-1T28 C$<
M%)(>:Z2 V9F0DNHB,W?1,_?#9N[;-"GWS'V#S-T:E(DNJ32$HD(H&RLC**2<
MQD@[04KC#/%$YIN[;T7[L)G[-HVP/7/?('.W)EA.O+>:%X@KI1$SB@%?8XE"
M,-XKJCTO;;ZYUTLHW/NFE_?%DO T5TVI"P7$G.BV0O47&1*NZ@Z[[XBU!4/"
M:CECFVMTZE'E#DJO7>Z,4%<T\.X/?1$??C2=ZO%)KL'98]4UL.KHY:-N#T;+
MK(/3<J@, M"*@;*AJ"CA[#R5Q+M N=Q4U.O>^[5[IMZN :%GZKMFZK;KB2]E
MB.W$D&1" E/+$DF'!2)>:&L*H4M&]PX?8%Q=S]3;-1ST3'W'3-WI(!<<*0DG
M#CE>!L14:9 $KD;2",PLU52$C>44>Z9^2$R]!8-!S]1WS=3M32T\TU((APK/
M8W\R^$=9(E @6!#L2T-QN7>X2V&E?<A!#CFH"JY]3=#!U_6EO.](M@,1"55I
MQ#4+:(]HUT*TIUV#0JR.+XK"(8-+"F)*42)5"(-*!HHDYUIHD1K=4K(M\^?.
M]+'=HN/CVX:&'8AGZ*%A6]#0"CL<%$^,C4)42H,851(9RBW2K&1!<VL,4=GM
MR7IHZ*%A5Z,A>FC8$C1TC!M>*%<0ZE"PL1^C812I@!W\5#J!@Z5E[!41I8:O
MMEKVT/! H6$'8BEZ:-@6-+12@P4EL71*(.:91\R!0F&T*)$N2NR48KPL,C1\
M?0OWVX*&K>2[;3&WI+/@#0WK=R4#II_EG<[R6RAANMXL[ZL*E>YTWF0_QHWD
MD=X7P_;/FU+F^F(/#Z780]T%:+M&=_*YKK?+L<-%+^U>0=K]LVL^+PM=&.$]
M4H:#(ES* BG0?9%Q0@==<NLLVSLD!QCOD$^P+S73H\]5T.<K[?H]^MP,^K2Z
M-L7:AL(P5*;ZH3(0I.&4$&5<8:5*39V-Z//UOKL>?7KTN67T^4K708\^-X(^
M'2< -H8S@PT2+C:,%F6!I"$"26(8*[GBLC1[A_1 %CWZ].ASS]#G*[T3/?K<
M#/IT0C%+:@J/+:+<L2C[@.:E"HD4583)0NJ ,_KLDN;UC45C/MD<=/G5:>0[
MM]"K@^>F)3XX\+QILU5%5SU\7@L^_^X:KCAQI"B50@:T1,1XP4%N8P$Q:PO!
M*'6$DF2X^FKA;?=*6O3X\\#QYZ8-5SW^?"'^M.(;B-'$TE(B:749PT1 <G-"
M(R&9EM1R([+AG#S DCH]_CQP_+EITU6//U^&/]T(5DF9$%0!]%"0?YS%"(X'
MR+2DW)<6+HU21O51?'4MC1Y_>OQY8,:K'G^^$']:^:<@2BIE2X2YC=6 #49:
M68$$-D0KH:TC/N'/+M4+3>:K'U*2>=-X-$\N-1,?VOQ[I,7A>)&*VZ<6JYEQ
M#O_'3'\X7.Y;&ONO9M+1(ECG5:DM91SV(%BBX,IDFI/"._8ZUC7J?*E:[E+3
M5B)JF!J.G1_/?T3Q+S?.MFL]Y4ED6WE0K_3VW_[3TK9@=9![V2X=U18DEF60
MB.4(AO-48N#1V#U.-'#BQW;H9T^&,SN:S!93_Q+>^/-H8M_>,6(\?]P@!GO^
MS]_DWW^.3X__><K@/?3XXW^'1V\>X6-R]/[?EX :OSZC1V^.WP#WC_Q__KKX
M]Q]W;@@K_WUSPO]]^>\(T '#^!^/GU@:WWGTY&\*Z $(](J]>F,OCLAQ.'IC
M8>R_7]/@59"6(DDIJ#VE#4AZ+E$I2]AM+XST.(,Y,)!WCV)R XY)>' *AAG-
MN!.&<:\X=QH7EJLB[ T\X/ Y',5\N@#0Z!S$0(_=8.DHUAEVA1TOY]45SLX'
M^/G)K2Q&<RR PCP6@K$2O@A8I^!_94&H]V*O,XD;8)HTXH_#.:";O0(3/W[^
MWV=/4"S(?N5=NLG97R8GI+F^//6#>KX#>+_S9Q67Q]V?Q>[1_MUD],X?#/[Q
M ^-'0_^N_<;__?\DP>*GV6!X=JYCJ<7Q8+*8#LQB!B^:S6()A<FYG^I(28.I
MGRU&<_B3U;/301A-WB=*^R&V.QF.-1":'L4WNV$BE/,I"!936/'@_7 T@E</
MW'3XSH\'YF(PAUF?^,G)5)^? GE6KX\%'(!RXX<SF.5T.+](?W"+:::]24@?
MULO\:>FW#6N)'_]]\.(@C7(RFAB8H(<93L[B2^,?X9=9Y F8WJE^-X2EQ+^>
MIE[;L,ZI'RSFP]'P8W[_N9[/_70\^ZF9YWQX!ENS#R(1[%/Z:_WV )0P/%N,
M%K/!R)\,9[GKRT#/!N\]; ?\=P(#P-9Y!QL\@B'F>IZ' *2$B9Y,8 O&N>A+
MW/MSF&H^T.ZJ#P8O3R<S7^WV1=[C*2QN&D_[ DXCG>C;\>3]R+L37Z]Z/IV,
M#@:/X,'J7/?3L-7L&XI*1P<[X[=*&L,9R+,69 X]'._#D//NN^UD,7*17+2+
M*\DS/H.]F<(@!^W40&B=P-\OJI</AN.XT?">^/S4G\0^.Q/8D?/I!&2A>#'"
M_(;C=Q[.Y20=1D4"(ST\@Q]/8#*S^6 Q.]@1OK\F:OWN-6S6KPL]U7#%=PJD
M[C!Z_>SG[SU  E:*I\. 'T2F1+C/8$(7,;$+2'@ZF)TO(@ $(-AQ2N1+++8P
MLZ$; LSX=+AVM(@'/?AY8AHX> %44''[[S !./7T4?G3&%@G4X77]C0.]_YT
M"#_$0?W_+H#Q +O"$-@FM7,R>OQVNCB?VXO]--B1GLY.]6@T.Q@\&P,APER!
M^N,\WI_"DG3*4XP9*O4<+X ^8W4F^&@6Y[2\3B#3=T.7/CVIS[ &O+61FL6E
M$0<3,VI(.DXU<1,HC)'K\A/ /6=IUO%5((W!-@PS0$X]O.1\,9TMX)4172(@
MC/U[^.KDO +R:F9QZ&%&U3PJ@$Y\VZ2&PF;";@AP-4O,#O=.W(X$ZIW3 A2<
MUL_!T/"]-#L+W#^>5^\"C(0'&DFBQAM8Y=+6-9O1[-L,EG &[ S?@?F>C[2%
MS8Z0/EF<G.;3KK<'5FY/82WPMI,IP$1<3=0CSL;#<+%T0&E&XXL-6]Y]ZKV.
M+__?Q7":QYK!,[-P 302TK?K*ZQ^[6Q0#7O)4<>M"GHXBF.=Z;<^/=2\X#P7
M^HIPZN(2,F'E*2Z35X.J&R8'#TZ6E[3?T,H,],%A -T0B*,&Y/:*:\ 8R&2V
M@&WMK*O&_PT+&L9R9CK=9G$UP]E;^$'/ES>R$AJN--]TD\%\?EN,?5:4:;$_
MB#K+\BXT%.(&EZ<MQRU<,:WXP+$6EF"/"<,2*VR"+3F,7Q)C"_/ZV2:+[K/C
M7VIUR;Z;_5A!\V3ZO)UXSDF>A 3>LYTQK=R^HO3HP_&CU[KPQ!:Z0#I8A1AQ
M&DFM0&V2@I?,B,)ZM7<HUE.(,_%UB'\V^,Y_J&^#%K"6$ +D@TQ6EUT+^3I(
MTH^)M]049,=I@N@H-HV&VH!H"#)J)6DNQAK>%\>,D@Z,F']*F<GI52!^@B@4
MJY-Y/Y]]#R\8@I09OWJF/X"L>%;!5IQS![837%<+F28$(P4M#@8[<L%?4TRI
MN.!B\ M@%K MG-4L8=A^O%'?^CE<V&EC*YD[ M'S)"D?3\;HOY,1W _Q+OTK
MHD:T2\:-^6,R&=T+@>?OA-,G]1Z$N <C#=*R_S"<)5$:+BP0*K(VD&2::$ !
M.'63^&DM?N=[.*)@?A!$CW&2F=-^ JU]!P^<34">K3Y?G$=*/P=)R$Z'!AX8
M@>8"1)BNM4H47[K4 $V'D79!8YOG623:M0E)AUD1.0?2MA=54^!6F(:ES:)>
M EPW#+ZK42V?PD:KX4J^/8O1;K4L\6-B6E!P?GH_=//3VE3>^5:V7/Y8M%_1
M!A:QF%_^E8XQU,):_?3V+?Z)-&*ZQM+N=/X]G;:FSQ./#-R>;P$D8;(_ZM%[
M?3';^V%I3:"4HNX&KJ[]<L[XE-'G<T:<%:,/$<)CK+BDIF28>$48*007)8WN
M"2EOV.CSR<UN";KA16"=">BIF?J!&3+Z+XGH.EK)A^>)H9+ DB527XE?\"PP
M9&+GK*]7TF3FHFB'BUPUFHQ/4 +V9%]H&#QI_I%?VK^TMH**?^J/,G>MRK^Z
M!=/!"<CP4P"2BVP)2'K'I-9*0#7.]U^Z5"8;A>FN#01@XVRX.)O5TG\V520H
MJ"2S)-/63\$BLVVCG>[C"F$J-(*)3=XOS1?&2,*>C5:/.-=W<4.C2A$M)2',
M?'ZH>LE@KC]X&/?%Y*R!P'11SP#61GI:GT*[QO\</6]DTCP[$)XGL,M)=("7
MC"= :Y,I G4G#.>-90AE.XQO, S4"2 0/XL.D2%<Y:X]_<&CQX]VQ7KP2?('
MA944A<K"\1]^/)Y=C-X!K&M096O&2 ;E6503XUY%'<I=0KMIA,%+ "5@HV-0
MZ2?3MX-'R=*\,F!BHTCH,&BZ8>:S9<W@.]B!D;<1XT>@9T=J),5/G?'37_!/
MWT=2G/K3+((EIHTZ"_PUSL[#<-&6EB5[X\,D3S;S8:6_+ZGYYWZ>KHM*.\_D
MO9@FA1@H(?K'*LVK^\KXNDD2!4%'<3JKN]W-B-I@M771/-4^%G\%<<=&60Z+
M)78&.IYU1,V.G)GT[WFBO>%9DBAS5VG8R+"8PTDL<92!G3X_APLZ.N[6;N+/
M "#HJ_-HIHMJVF0,(\ 638 8XE )^2HDJ-[;1<ELDHO37YI\?+?_<![%XB6^
M;)"B!<F,O%EC34RM&_M?HX/ZJC?0>"-X;;!,;K)#)HFEL5CN-U;=I)$.(P:F
M E*1*N)N?E8=GF\TQE=SK*EO'1Z[EJL5#EN[%*(Y90B'<#J,VD[TV8Z6S121
M>F#%B4!&%QU$/9ND@P(F.=6C$&>Q+(8NH7&E:$1.6,3W)!:9@L08J:Z#P34T
M[R_M3*O?1VFV,VX^4]!MTJ71V,7?^1J9.W;;S+W519NDU9K:JG?>"Z1-UP[L
M@EV^ #?*%VX"GS02?CQ^P*@WD<PCRG0UI99>SK+.-%O3F3*)14I&LTI+.H]:
MTGZ"D?67#V>M\F#A"R=Q+K78 .];3",196/Y_@ HN_+>V,&9CS:,V>GP?' V
M_-!Y>8 CG*P(*YV+<]:@0S)R36H!:@G$&L&E V4Z>Q=J8JGP:G6/\^56L\(*
M>7>%NHN\U\X#.,4  M"5+H&5B%]P3474K#61%L+@FWDEG4.+@[0O;@&FF56+
MC\,D@21'#:PVWS8M9J4EQ3$&T910@\#R L^BZ;2&H?:M<>0-:^NL)1I?0<R,
MY-'*N(G.NAM5^0Z!=N<)9+2#VS.^&"#63]]EC3"!32U2-1N^*YQZ78_*L/84
MI8/[J\6F/UJ?THXL[?-.XL[]D*Q9PW'R"R?G"I!(8O D"S4? "N-HP@\R3[,
M:"U?]J4UEU:S44#B4S.<3ZM?6A_FBN<-GHNV,OCOU+\;^O==5US"BWBOIO&!
MOB8+N,K]?L7OV44[._>),38/6\%#'ME<;(K)N33C[[8.I?5./TYFAPR!1["[
MZ>;_O_KL_*?JUZ$;O  6&]HH(5<R\>.C%[4L7/N.6YFN(^C%'T&+#!7$ 7M7
M=TCE;YX#08_]1:,Q[K?S>C)=G R>CF%:-F//(W<V'(/@4;GCOXM/5M-Y\O11
M(YJW-\"2#ULOYJ>3W+QQ5P#ADP?T^R:2;[<I46'3CG(_$F^\M6V#%V<1FI&+
M^S6T\R4FB5ZI!+21GO-02UMU#>JN#']9M*XDJ>@VBZ[*80S[2"IR=2NT<X@2
M=2*Z**Z?+Z;G$]!PHI<S4DF4/Y/W+&OEW94U.G2%$GD=\=;S_FW"@B@ZM _5
M@[4WU!)RG$>W2YPU/.P_^#-0EF(0@S[3)[X2R+,^$>WBH&C#79.Q*?)*"A*!
M7;KP>E7*:((#8/K1 P-?F$[.LD$AWLOQO\/Q#<?J77K=7 ((H!V"3'UV.Q&$
ME\RA/N7L'YUGS>=\.GP7#W!^.IRZYL238)XE^K3=)H;MP(=9\4@NY4IQ6B9N
M,W$7^;0JY2Q9Q3YUOWSJ&DGZ .AH;41)Q0$A1/::5T8C@-&._&4GL_FLE6JS
M,COS#5-43!5-!'.0A(:1W^'VT5,WBJ)YQ4UP+UE@KGL!9EWFR-IYY&@[7<#1
M)6::M(60J\.H-R.%,X#0UQ4 06" LS*ZL0> JC^!G:F]MLW6UCM>2:?5QG;,
M"HTQ8T5->*='BRS&)[,EB)I3F U\ 52"8=) WOG1Y#P+]$WL3SWG+FUF2T%G
M$I/LBJ^6G\FE.UKZ\OOTY>1RK]9FFXA*F,0D6@+K'<AXO+(D^"![_=>_7<GZ
M5QMD?UU'C%]N]*AH]DI+24Z=2ITXB-ZR!O;7#,57._C(6XWA!:!\^&[H%LG@
MT :"Z).3R!AS?YD=>8/=Y5XPS-,/UI_/FSB]]T. !]AW[U;B*O0XGD:%,-FC
M6^'0_*(3(CC(.VV[E_'29KO&,P=\-GG?8E5'05^,,\---C$0$%ICHDL4%\TI
ML?];?-_R)W!V'I:7D:RZE0'#85!WT=!2JY!74UQFT 8-LCEP'E<0? I1U)4U
M:=KX4LY]E[XZ*)_M>]%4/,]\6)-W':F:P:6)CXE!1]58U:Q@HZ(?+-GKA\ZW
MD:(=BT&CH28>BX<\Z\;YP%-9+&NC':]M<6S)O U\>M%>'_'HQK7SR U@Q$@N
MV2Q9SVLQRO?>Z>1]%&P XB:#&=#+/)'UQ *B[B_91MO QS<+=U*%?E=AC)TY
M[D?3Q/0B&ZMG?CX?Y9: *?(HR9$Y%FR2C<L@2-IYY0;+=UX=0]&AW_JJ;0\A
M6=1A:DM(>E4;;GQQ1QAH [T.!M&P$_,:*NVR#5A-%LRN7+$2VPFK6Q(G5FW4
M9LF\UHB<%E!N%+\,W!CEUE%U1'$X#[]F8;]Q(@'$-!)3(]36S#9;S,ZK2#OX
M0F9*$'5 CTO6W%I*3I$JZ:DDI+9NQBH>H"/^P(I.IKK2D;L'DO;^D]L1EOBN
MB0=K3F49OP]Z5_TG7/5R=USUUT_>^*Q??L6/7\A@#*-*4248D4:)(#75C =I
M#>?X[OSX.>W+17$VK>_'Y(F-3^T=_CVK9;O'BQD0FDYF.^ KX*G6L'<?))$E
MO39:R2KLK2QVZ6]5E*4;@FP?;>[9!A-5H%J0RUIPPL]T4;OLJ%D*IXZ6]<6P
MEH!!TO,G?BTRL[GRIGX> U//3_7T3.?H!H"?[#O(XD,5;I3#B-UT<9*\DO%Z
M!^2-SJ3Z9H$#C!,?+)I#L\VA@?)I?<P!:1ZN O8=W'K5U9VA;=:8#AM;18Q]
M2*ZL>59$V[5&!=&G_9M?G.?(C/-1E-K@[\LFBA$<>>7CV&]4X1P\L&3AK/^4
MKL+HF*T#HQHG1OO.+ C!:B;1[;UDI('IISCRI<E'/_)BGCT.2^:8_+KH])@D
MDT84.&QCCJJC(I+!-](-"#NKFM:PDMS28N'P_2ATI8A9O>'W0&K_%![\\?/1
M8,6@_VSIAKS>\AKX!FH'!*\N,TQN(?/T\R@1]<OKL'LBH27'5?>Q%4$"+@>@
MI'%%+8.XK^<I#M=>;M>]X\T(.L%^,LB>5Q[$Q7#9$IG@X46RB3^J;.*#7VM;
M[[)Q=F&B*CQK,HAJ.^1E'-I*T1$#$Z#%7]*N)\'7)/6MTZT[ZY'I:=B+172D
M5M[_"N!B[%5"*QB^QH@Z!^!=#*697[16M1IF]KM181UPKR<0$R JMVN5EY-R
M.=9FD68.YQ[M9(M9LI^%'$R=L'JV%%-:+7GB%G8^^T+D&:S%QR2#(UP9?AB-
MP7 BYQ,0SAOQO4.R[Z)!&Z;O.JZ39T]F&YP5,=/ 1[M@G+Z;V$6;3#L<YZ9C
MM8R^7[.,\5E&KU^7#)[[#07-:A)*(GI%)G4,7*7?/ZD=!#&? N3?,S/4'9)9
MX[&ENZE#2OD49^NQ1 G\<Q)/HL%+5Y9"JG*>8:4-S'QW;^.^5:_J[%1GA%VY
M(JYI>/][G*+V7^1S\1^B<_]@\+,_';_U@W<'@\?_?3%XK*,/8OH6=C;Z2BJ#
MP5V:ZGV4T X&WV5774U$CU/46IT$]E3/8L+J$HUUP_V^3W$3CX",1C$03=9:
M<AQC 62@1RD$K4&;*AT.".47;Z:+*)[!UUBFN8XH%,D.KN%1[41*87GO@!6R
MV3"ZFT'$J9T R:E>(=)L/1.HDA6CY2WB2H:<[)GJ? 1_^ ,4Y\&3VKS6>%(K
MG1FD_XXTFGV;[ZJ("EVKXD^2 %U)!UF:'OSESQ;CVK T]=%35LWR;#B#WZ-U
M*>6LQ43\&@+/H]/67&P4G",[1Z]$*S@GQ$GR<<R(RZDC[8(,;!Q(\G7BW#!9
MC3MKR9]'AJ[\LRG>Z_*7?Y/RW^.<\QS)M[++Q6/ZO>.4?=0Z5U_4H+?[:T[!
MO$_@)DSB6HPF[7CP?XL:4C3N_*''?A15D*,H S4^Z8Y O)2IU(1]9$TD<WU-
M%%&^B)\U<F72ZEKEJ8FH3KF<V3=>^<A/)[/S",OP8V0OV*MYM'G7E^%PZE"T
M?EVTNE0$A4B8E=+7"C =,73>)(\G->[]T,$M%HW9RVPR.1].@"FU6=30L[3F
MLZ6=Z7C*K3ZO0H.?1?X?'*<_QTWMCO[\/,4<=W;TNZ,GOP^.)P<#(@OV?7*9
MU5S6*4UP"7(? \J<KD+W\]/A),X<AKITMG')B[/S'$%=Q]" &@BL *B0-@@0
MU[^+^D!5>Z *=;951B8 6]0>EC!X69$X&#Q:BO?L)&17X?=7'ZO176&; 0SG
M.6&ALU.=:.P<YM=:@U?C7I.D<YGFLSRUCE5@*6QP772[.EJFO*U(^[78^JB:
M:238]=EN$E]K$:O-4KA,UNJ(B)FP9]EZ?,DJ*F&O&R!4CU]%M<VZ,FHBS3>+
MZ7 6_139$K]1KK23-M:Z26?L2 +I;U&J;",B+Q$J/[W<=/(QO;?*ZEU*/8<U
M3YO(QXBJKV(&0E;F,EL9/QJ]]^D-\^FPCG)J'>+:GN;0_\8]DF=^#(J<7E1W
M0@B3410 ,ZI5">& /*UC([G2[L%%F2Z-WT"GRQ(<*;I17TV06,ZHGD6M8SG6
MZ_EOC?J4'&O+CLJT<7KPY.FC1B"99D6L/O9,2_5O*71HUM%+NND!C=JS1DD;
ML+U+2+:][V?M?0]X%*7Y/[+H=9%*K31>2OC*V.?XK;R&\;+MHWOGG$_F/GOV
MW@TGH];'DL)V*UC=+'(\JN3+[I._P)4(&YCO.'A@FTI<-NSD?=]]RORD":][
MXG]DB^^R.?^KS7H[8:ZZ-=O=$@N=MQNZT=:0Z'42$_=B0<$=V=;K:OH1X.Y4
M:<_&A1T+//PYWG(W'0WYZ2ED:\:.[<N[@\'SLW&R(D2%Q>9"8O$"^4\.KH[&
MH+LEJ$^:?UY,%NM*1"T?9=M/5W-4'2F@%B ;N\'SY$R\VM!+TL*+)\>O&G&A
MTB1;BQ(:CE$?:O")4 .U.Z$&&Z,)/AL=L!)-P(M""$<UYDHR("UE@J+>TX %
M*8VF=UL5()LI:T$J"4_G,4)JLIB!-ET91'<+I78A:KRUYK:FXB5[;M<C-)Z,
MT>SM,,G%X\4T21S10S>JC$0UY$:;SC1JE[D,V\@OVW-F37U#4 IC"D ,5(Y!
M58-WL',KMA\'?TA1L[',2B5^Z]J^6=E<XSS\NR149YG>7T=(?T!FU*P=+D87
M'7/B4F)%8[G0K1*7\ROBD[#[<-RQF,"R*ME6 JB4_&5%9L6@MVJW;JBB-9M7
MGPWLA1WY1"*U$%N5CYM%6WB,BGZW3&/7L65<83F1G+:OFBW=1%5I:RR;^()=
MHY>N(%&NFE<:<GG\[$E+*5<2-#8:0AM!8R,E;=CW-=7^4JZ^7.4'>,D&I"O%
M0G7 J_%2-1 8#7&C.*W\VL_[KH J\ZOA;-.C/U_VZ!?:Z;Z&AN%0[P&J?=JR
MD$I<3N]S8N\G# =5?E_.WU].Y>OD=71L"M-AN@U!QJ^KM+1VN$[AO$A#50G*
M%!2>J3FGYE7IJM.8=UX5"8KC5(%T.:LL;WIEVGM_6E\@W3B/;,?3E<UL\X--
MTD 5:-Y\I0[X@'6@24#CJC1-\^):+3G(-2,?G4WBHBM.:Z+&9[ZS,YMC(K.[
M=SZ91$_,/*=HQ,<[)8.:E5?6_7;U51).=X;-]G5= 2D%Y;()Q!JAU:$ @>44
M'7T>(6@ZK!+R=/YCXR->?6D=5SEVK4?YNV7[SRKLG<<*<S4%I.34JKYT+N*3
MK$HUW>3 D1@&U&2%U-5+DS6WW@ZW2-LWR\B>>15TU5P#\$R_@36L5,-*'J/Y
M:1O/WW%$=3QC\8NI1%2R\;L-C]P#%%L)!X[2V&9?4EM1Y=*HIKH*S:;8IKI$
MP')<TZ><2U4^1%W%/-5^K>[8UL>TWQ1]J8.4==6BH&OUWYC\U"U+D-_5.=O&
M&;:?^&Z%LBMR;BDUOG<YE[T-8?Q<Y:/T[CJ!HDZ3;9R2$4:72*[SP5IQFTW9
M.FM^CJNMYX<.:Z\M:??)^I.1&T<OHF!V7XSY<;I5I8H89YF#2C:"IY\FSHLJ
M1,Q JM/NTXDG/7J8/DL$495[J(3-INY-$T1:WWFSYO',0W7AH#2#_X5;?I@C
M0YL;9CBOL3?A<"-.+@4=':0!%]%Q7D=_U+1WYBT(I<-9%F-C83];]S&($?JS
M>5,NJ@OW&[-2.[Z[JLAHK>&U0FXJOF<NFG2_^F;J9/M5MT.J795\<LVWFRLX
MZEWGE4AD+I8@$&:;JAKN#V+)@7FN(MY*QW5"?'5;+4O;U;TWRU=I+GDVSA7-
MISG,+"=X-7==*OS0A+1,8\[C;-"67)_F/5VZQNW$I<MN.,UZQ2S'(2_O:95+
MF<&^>OHL[<*HSOY>=>VXH3X93V;1C!$GVNHL*R/G#-<JP"%212J@5%?\:HJ#
M+1/3(Q?C30#JJP-,]?/K#_]X\D?UYWA%U6<$4EZ^KIM4PVK^31HQO#4JQ2FE
M(4\KE<T HNTL)FX73/27M9NH*J"1"35)+DF:[8J&D?)6=FV945N-<#+SS2,5
M::7Q:F%Y94+Y)FD'BH]6"Z]?O$S%366ZE/J8"MO%REZ9PSHEV2[AL63JKV*]
MXT6YGTXN"@[Q^AG.8U^W7/4NCWC6Q$4F6UH5SU1)TW\]>O+?-GPZXQMP60T,
MEQUZE^":@L.;\].KYV$-U>NC7=$M>2:KA-.TTRFV?^F<&MJO:YTTG+RD=VS>
MU<%G=S7-+U-_KDZ22M0OL4G*T4YU]=8&&6Y>],975[E;*<.\L29TD&MUV7!D
M&9(J*TJUP<_&29P ]NK$HU\2\?&?MF[0?Q9P.ZV7'OK/?UZ@Y\]^;6D@2J&Q
M?ERDA<M4A17J0@UG5-&WE7 55J^ E;(0*3MYUMYO<:G/?JW*="8W0Z6R-5E=
MF4+O@0Q4E67%)'-G2LSV^7;/ '4&:#-Q,)>37 LT,F(C8'1Q*5->NJ/3C0B$
M<BD4)\M\K3 G,SI, ==)A>\!+ X&?S<%;NM)=::R'\.>UO3FN(*43@]RW52?
M)W-Z&L%/IZDP0:Q7U<)W74TBK7.FSV*63L[AGTX^U+4L+VW9D*%SI6>#* PN
M&5$V",<,]\9H86@IE2I*01V)S>U@VW-S.TPPH;C;O &1;N^&WT$%:#NJ7:10
MX:-V#UZD&;^ H_YV6SB\M/SXC7W-5:$*IQ4*S%#$8&.1+H- U@MKL.:!.+)W
M2(IBO8E#??5G.?)S6'RF7:?P=DO#.26G:L4 -_\J?<_:V,%(Z9E46_]02ZT5
M&;8$V^!_)-MI^\H-?;0V\$FZ*FHY:2-$ KBE=HG=.M<U*\.?XCR[%3FCA@ L
MOR:B7'+;'0Q>#*,Z 8NF[?T_\U%B[9BF+[F2-^!'JW)$#*FO_Y6]7L:I5K%O
M0Y2Z*+;4MZ[>JS4_6UNJL"V(TA1@2?4Q*J/E)R==ERIJ=B!.M:ZCG"<[;VH&
MS>JB05,_GTYT*E#==S/XQ%5&BQV/6_AL',)*W$+PFDL2N)2\8%AJN%%*83@M
M2,$<+^XT;J$&B4G8K\J>)'$O50-L)*Y9,JQMD@,V(NNR I%YH2[8DEDAA;HW
MKYXNO:JJDA,S1G4*C9[%2IOC3O&T*P",&;I<:J76L^);6[B(A5ER,9/W53F<
MC6)X-$^<^,KY$-$XSJ JFI3<PIGE6\!]YZ,4"5!8?0+36%6U(WI.LI *"OUP
MUGY=SW+V17PP[>-P<[T@DP+VTV$-UVZHO-MU?8=EZ:P%J>7OP"64NLCE:23C
MJ[_L=%I])]DCNG;)JBIKL^/+]7;BYN\/_EB8$2C93S]46UN+\DW.0H7F</O
M1NT/*GUAT'5D=+7!5H?<M%/1IAE[(]777"JCDZR$C4)R]/M?C3)2I<'N+UV]
MC2T\)>_M;ZA^D]T6J5Y<KDX4;7=MY;@K%)B_4NO+>Z"&?,H4VS!I:\ !YH@I
M'+N_KO4RR(W3).6@M $L*87\297B7Y/ED^>_;0XDJ-ET.6[@,LL&?)IX^C0Z
M\2L35!6TXC<F(6RTRG3A*(O ,2@ U.)T,)>&$=QV;$#4P^/>W@.J3\KWD=X4
M\G19^$H,;+U: ,I2WDCE2PHI[J3RN2Y96YM3VT0-?GAF%@!/^467%-EIM:+6
MR)KC2_H@D2N009T/7Z=%?8X0EFUM_\ ] -LSAWU8+R328"9HO0M79P@U8).*
MG<96U+E!1Z*RY%"%7SKC)ILU:"\=E^MLO]LN:GY)78EX=X.>-QG\-;231A=+
M1L#_#F,AF\&SV2C6RL@$L@QIM0-VL\&G(6S0D*H(VFC, ]IIY,I$/FUMO!K"
M4O^:+C>T=="';IGBEU+#,JUW6MHMQY2<3G*/V=P'LDV([WB*:O]T=5]GWW7S
MYK;6WG+JX0I31$9Q4R"^FLR;L!I;A9#&)-@)2&W3+!QE=AYV^L2V5\\E/N#X
M64N5B9=VI?WC%TH2+^83^S87R +8344D=WQ!F*2&U< DXRHSN5L#0^VWY866
M*L%W*_5T.#1&:*528JE>4/W,?B;9G"41R;FN*-3)KM\4,_"9LG!M(;A4&;NJ
M$9=YO#-R4P:[JC^62K@N%Q1*U3>R,:2VP;JVB7VG'G[NTI+KR-7:5=W*)88P
M-:V3JSBF3C&!I#8UYJA&SDFUX#L%-YH2I<M][+I>]4N$L-]?/F[;[$0C\DKM
M^-JE?M6-K-K'A*9+JS\#_2'5F]U8S2C;X>"04[Q*G7)=33;O?:=J6Z=&06L^
M"\/I#$@\-R>OL_A3T^>=24Y(_/*X"C<X&L+[!K]$]?R7U%.K=72F8E*QD6A]
MD;8?_>6CG36A[,LI",!W5G GK:4NN)-I ?3#JE?/;,?V_-%83]_J^5UN5>QM
MG+NW1_:MW?/ N*EDHU\!3X(/!G^T,%3GB(TG\TJL@BO; X$W(NDOD?I!3YO:
M18PX3/6?JR"'28YC2\K^<DGH-"$_7JM_&*7?L\F[+'M7,TYOJ9I8[3!WY7HD
M:_F(+UH4?K14Y.4N26+W^>:?: N"2;H[Y9PD;=:M(6MQLZUIL8@W:5758A]D
MPG.0)Z+4VI@KOLO,T?KTO^^P8>4H:XO>[-8)_*[-)$7TUA? 'U7U[-0K/.HQ
ML9(Y,&-NCE17-WNLQ]KI.R7NB X_=62I)GRHBT=Z>I(#LEHHJ@L?S:I*ZKDU
MQ/MD,4A:RWV0\[/2O#A95*EU+_SYO,X%BCKTI7[[)!"MN.V+ CMK@RAUL,P2
MIA0QA!M!G#6E)_+ULSAHH6C1]=8_._YE;Y -$# &:!T@B?XX7IR]CQY1/ZY=
M^8L9.M'Z?-6=_T>6W'(2T/$B!Q-\JW[\-\_>'[\\>2V<++#U%DFF V+&E,A8
MXE )!T%H62CBP][A_/UDW8__]*]G+QZMI)IT])HK5+]:MEUD$YA=S!MYNKWR
M  /]?*QS=G[M#TA_:KNC=6NT;A#J_0>X+Z.6%;O*= MH_] )1X2)-*,F)2**
M#X!.;=F1ET N,/ 1@%&NXIH[* -7^Q]W!V<3N_ZEG1W%6M2QPD&[?[M0SW*W
M-NI.-R02U6YMQR\IK'GG:&8;=HSK&"A,72\L#-TB1LA?#-PBB=LYXOM$GV28
M.Y].3H=FF&N#PC)K,%PJ<-5IN%I#8]Y>5N#OWGX?-:-Q@SK9(EMU0JN")"]@
MUR?V;5.TN<G$I?O)FY%FU5&W]BM[5;I]<\_IY'Q:3>S[8D-*4Y:PJBO8%3BK
MJ(#&HK.2Y'/%>M!K.5 =TWP36%J'OU<NFMR1+F9$P@+S%173_D!(PP7[SGR?
MXHW7^R)G1V%T9D1I;/>%L4\977,.7>YKJ1],1]MA50Y<#W+MT*8C\WJWJ?5B
M69]H+3@<1_-\S=:=UIM+ON-JR,^YSE9<8M$KNM])UHO>ARH=L2EA$)T"=53=
M<B/5-F6N<3XNE4I\F9CE4YO0=>HM]2]JG##1>3-=0BJC74PSC3)7'8N1@XV"
M3R;:U,QL5$?H[]<#M77%]KN5-F#\/$JUV[$JR&K24Y-,N)Y)&+UQ)Y&B]JL6
MZ"D)8#B+D1:+V.HQ)L16L917SXC=D *[W_B4!DUV[GRZ2*7P5]-C%[/<;*U%
M3I0#-JMO5I!7-42M7%_-\$UHXO>Q9<#,MMZQMFYGZJ\-Y[_?U!>(>VI'.6X4
M%M-.899.I$,741"&DXERZSPW7>W4>:NRD)I)+-K6=/M]H..G AWQC@<Z[G+@
M8M47HNU;N9]*Q:<LND6&+:!DP/31<HG'V"AXDO,/.]G;*UUT+L6_S"G)+=44
M1MC4Z3@F3'><=!MDC\](+#6>U,6&5_O,W@-Q8N_P4<P!V9A@6&5"=]H!=JZ5
M!LWV.ZVN1Q>M>[V-Q%XIVMIFL7:'2_V@XNLN":BL+>#Q6'^NRQ?,?&J+"+=!
MNBI3S'A\H",  &7,4WZ\B>'DLX6-EU58C&*$9I/AF0(\J^=RQE?=>5%OW)V<
M@Q!#2:>SZ+9S ( 7.4+R;.(Z39CJ1IWI@3C>, ;UMYEK5:CMAGW]JFC%92I.
MD?!M^M2DHNE.Z8V\R.&\%GON!^6^S/7 HFRXE%A@8I&0_*2/61*CV+(R%T:O
M4T)3.GT*,C87R_&Q30_[1+;=:@8Q^CJ'?M2YL)L+%&PZH4XF8E/(NLH ;>(M
M:\6F*<XQ!%$'9)%.4'&MB^7'Z]S(2UK'5/'.*1.KFC(\ 8KL:/BQSINL;5E+
M_9:S/)S#:&HJK27"\^C)S37_VZ"&$Y"BWS6ELBIO7E<N7$[ !L2U%U>5N]:>
MT@Y8/0VP79&L^6-M(TRM<D$NBZ^"I=LJ)S_MQJ4QRVW]E[9N3GVP3>@RH('/
M13>Z3:&N(A6.0(GHT$A3@*;JOQ0K>"Q<ZM"R^L%Y71*[_FI[^)VLV\[&+[6$
MJOT=S1*JSD1+AS"&U4S>K^Q\-MU87V]&CNH:)I_)6;PS0*$;PAO@!&9ZY&==
M:JXOA;J:0?>S=X!@,> \PF/D]!PCDPQ8]=9O7%8WU_>RND'?WPOX2TEI(Z_3
MLL9UTXHNJMAN<D<;Y5C7KAC.5JOJ;% ;*[#*Z;9M$VMMX-'Z[MSPM7B+GJ=<
MBWE[_W6GD=3?YC:L&S&..YF R\B5XX.:NWF_TM3?U=G=\1K.2GBR3>6Y7Y*;
M4<%H(K&4XI"I(>F'TZ9?]*49"PT,=\BQFS>VG)/3I'KO=],ULCS4)<:F!>52
M98[]NIU8Y3FI%>5VR_>3+!5#[2JU^S.U N*-USVPRMBPGVMDY6HB59)/^/JV
MR:ME**[;.WGYL<L[*>>HY$V=E.\#*W>E-0NO/XED-$ZU7:HKH.G"WB7>#0DH
M^^O"8+V5G026)!'F-NQ-BDP4,5>$S:HEUUHQLN[7FR#72,+M4)VLK$WL4N>Y
M_@C0_'VFO"KK"8C)-K4*QK"]74!KZ"M%'TZ:[B:1TGZ"H>JQYBFX&29S'@LW
M-J6:ED6:5"LVV<?7!ZN"K"\JQ,G9[9-4BC;)^--+;>;=\]GP>"73#7,RR+HY
M.IMOVLIPJX)B+1.V9672NNN%UWUUVBRR&C":^.=++:+))+BC"WQWZ?JZ4%8E
MMZTWBO=1_JQDD,8[L1YG"V^J7U3WL%]J=Q_UP9B$5TUBMYQWNU GNJJCN&EO
MVYS#JLIV-&96+0@3RE2;6QUKO[>7[6WN3*BC(+_2N&V)DF%'OWLW_ PUK[/3
M!G/:AGCT"*;IADA?O@T0.+B"C?K3#9USE(\6P3JO2FTIXX;H8(D*6C+-2>$=
M>UW&=O=K-9K/8Y6_\0D:^3#_D0@XL&[59A3_<N/F:;&1+-1-1U1\XNT_+6T+
M5@<\;4,.%SJ.+0:'=CGXRV$N:. %#2$PQ8@RA::P_5AR'22WL68+P57-%OBA
MC%%@RZ%=+[+)[Z_:^O&D<8^\A-?\/)K8MW<;T46.7E0176^>?7B5HKK^"]][
MQEZ]^>O-\3__#N'[\-YG_-]_GM'C)[^<O?KXE*Q&=!V]^668HKK^^9L?O3D=
M'O]ZA/\]^PWF^I:\>C,:O7ICBZ/X_I?_AJ,W1Q?'CUX+;PMG78$*:A1BMC!(
M>D61E,YP4P8MO%LM>N ILW .7%G%&"%.ZY(23'D@P3!F8/-!X=/GT1TS7<2L
MGKSY@V;WZ^"PZK0ODZ=W2MC>[$;Y_%8L;YWRS'!MX"$?& 4 *952@BEM %FH
MM.OIR)>&2596[+TM\,H71TSFJ,CGX7FM/51'/=N50,E;9ZOC)T]?,^DL*XE'
MJ@#&8C8()&T9D"P*7DA#9%G2O</YZ=3[]3#)5A&K#AA$TTU>C/VV7=V+3EWH
MF!VCAZ,??G_Y>"6SK&Y1[7]X7@E4:?@EHW\CKM?O;LH&P5] ;XZ:0*L^KGB1
MW4;!WYX.?>BL*M+:+)N1W\(LNCV!'C]_<M14;/#O]&B1RRM%:U,UG]JBN*ZN
M1A]@;:6*BF*J#9S>EF25T\G[I4JD\+7)8IHV+:6M=E]2V>NK&JF=H^@:C*M]
M@RFO3/4*$5+-BYK"34U!JW9AJ9:3WZ_DH.Q3S&5'9VM/#;[[]=&C/P9G7L<K
M[?LJNW6Y"V[R&IU% /[8*+/Q;,<GR;(2%[M< 7KNH_5IF'Q-^U7"JA_.<S_.
M6K=-*3'1A1%-LC&R:_99%7 P3EIS&%WFF,JQ21=Q^JT5H+OS+[RO_"(Q(GXX
M&K:JZ%)8V>>V*=<';)^_]!1BIU @H%P+:MHX)0%U.PU7TU;'36N3BY.]:6VP
M1)?9N9 *G5SVUF5_7 I-O'R&L6IGJL@/OP_/8YQ&7F4NZ[M&OOEY4'%/<__)
MC>ZG['W/VW1VGESC>C;O($!WP%P"M@JD7GI3].Z,]>CBH__<T684B=T!9@>#
MX\D8I?-JWU>M:6FZ=:A+LGHV/::O<JKP_&EREU9&J3HSK&YA4]5 C<>>=,W9
M @;(1>+V-TVJ*;7H<DOZ[/S)09_:QC)L[4;%A<4LCC6-Y M$H<MTEV\V^(;L
M>/#-9Z7 %:G1$J,D#DXRZQBLV6AAM2ME_%\PV-R\^A0#FQ<C_SRL*E+/6AG@
MYXOJPV]9I3IZ]-ICRPO.'.A0V" 6%/S$<(D"@Y/@\)-E9E5%NELG0M/ -47-
MKERKJ1#'.MA]3K2I9(/E,._)'+2,]2ZQGP*0>:K)T8#2%/ 9Q8KJ^GSF?ZQ_
M^"F&D([TQ8_#<5IA^M)/9SH6+T$5DD7N?>>CZT>/JI>D]^6/6\8^*#)SSZ?P
M_ZY^<_7Q0?KHA[E;_XP6!TS(2S\N#O"EGWUJ6'7 2/E%HW[Z,X"=K<]5'B@I
M[LU<@2G[N6Y]KI@<D.++AKV#R18'94&O-.P/"0\R)@#L1 3[__?HWHJM]T=R
M_F& :TMO1IEHYUQ%G@PZVY:/U&<=%6L&V>+3N2'/QMD5 +,8+;5:J;;K>CN1
M0?V6]^(3*]\[[%A6D@A76U>NL<XBKG+O2[?DD\1QF[+UU?:KMCEEJKC617X'
MLVT,8S?B[> 'DE]A&AMTKOGD_$=$#_ &D21:A#+K?8>_7U$H;IH6=X\]*V-F
M8LW?7SZ^-:[<O9UHK;=I,Y()MP>IS7OU++ZZ4D1V':*>CH9UC/$]A2G2P]3C
MCI*;V/-E4G27^/,S\J/1]NW)-)9#1]6DK?4^A)]V2[#\Y#:\C!ZMP1$\=SH;
M/(V9T5= J$L77NGZD0AAW8.TP8-Z#=>@I,_N[->,T4^RG^3]G^2UL2FD_]L-
M;/J\G3.!4RK52U.9"X*_")=6%OU%1]2/T8]QEV-L20H9Q/^* \%WG.G_RFU;
MJK(9,%$_':=R7U7:\"H.7&<;BL%]@+W_\U5+["YM&D?=J;5=&AJWF+F5L#A2
M:LU*;ZW%@07CM2P(#Z(4NJ24:USY0-DE87&H7(J*BQ%Q;C*O/N]V!/RCRMIZ
MJJ=C[X[]_-'8543X"Y#@XRIS])_A_/1Q181/ZUB=1RG<R+N7^D,3/E?>3Q?J
MZ:NS#Z/G;WX>'9-7^-^7QZ?'']_B?Y_\2?_]];?35V_^.SKZ]9>SHR?/R/$_
M?^*C)_]]6W\'WK7XE_Q='OWZ-_TW/D>>TN<O82Y/W-M79[\,C__Y^_VK?UZ]
M/WH#XS[Y^_WQ/W^%HXOBP^\OG\Z/7A3O7TO'N0O4(2J918PJBPQH*T@3Y:PR
M7C*M8J/!?5J*M>"[%:OF%W!,C8W7X)QMBHD]?CU0_-(8>TP!FBQCC/M24V$U
M#U(HX@3QNL>O>XU?'QO\HKQ4O @$8:("8J7A,6S8(XQQ((%;2K79.Z1\7S#>
MXU>/7_<$OVQ1,D-QT-:63#DGE19&L<+PP@3!1(]?]QJ_<(-?7!2*R-(@JBC@
M%[,<Z;)@B#I'J"]*;CC?.\3E/I8]?O7X=7_P2RNC#/4E5DP;*4'V"C!J887F
M/A17P*\>I.X8I&@+4L&$TI868<H-8IP"2/F@$2N$"X%)7A0L-ZON :H'J+M;
M6XJJ)C_U5-=3W6Y>BT)HS!T-TG'%/"4&,R*9*R4U5!-7]F+]O;XQ/\!MF4VK
MCUZ72AFN&4.:%G!3EH5$4I8E*J@2WF)>A +O'0JR3\DN&5:WY-J^+PZO;NA;
MJC2;O%^7NKO)]39B(S;?:P#3@I2N)%2%X)A@RC J@<AU()26$ILKR_5UIER/
M2C>+2L>/.\X>.*80)%>(<*D0PT0BC4L/8KWRFC!GJ8W.'ORU>/0)3+@IB>JJ
M@0#?/ =[YURI&'5  DP&JY73)16.*5U*C[<B@O3,?6O,W7I"7!E*HX&Y"\XX
M8BP8)(W42!F!M5#8>$> N?=YJ7K^?KC\71(2R@)3ZHO F "*T,K0TB@@#E]R
MU_/WO>+OUE-08.D\%C$^0U,$[,V0+*U % M=>,]IB<N]0[G/&>WY^Y[Q]Y<9
MKOICNN5C^NX:.,Q*PG4H@RN,9%HJY0RW'E-38,,5)5? X1DL&'[J 7F7 )FW
MH2=&6!)+EGBC' A<A0-9JQ#(2>X(\Y8:YO<.,=Z'RW@-D;_ON7Q7N?S.P?@;
M"SH_]G6-]*I<>JPU]D4FN*NZ1W:/YFXW-'NE**F?/VNV_UG:_?Y2N,ZE\*)C
M8N/:"D(H091:BYCE%"FL!+*,8%<$."=+X5*@NV3SWW;.W3?/HEN./O[HIQ.G
M9Z<]XVZ=<5OSF? .N-,(I#T'QL7,(T5U0$492F+@CZ+PC6S0,^_#9=XMA][V
MS'MCS-O:QCQ J^),(R4#,&_!"5)EX,@DYP;&6 ;3,^\WP;Q;BCOMV71K;-K&
MD1I< D,*@["T'#&N%9(!_L&^P-*#=%Q2!\(Q)SV+/EP6W8)AM+]?;X5Q6U,G
M)JHLE&*(XFCJ)!*T6L<*Q.'BQ2X(JH3L[]=O@'FW$,#:L^FVC4^=J%-3,.JI
M+9'UEB &!X0DM04J6' $<V6IAAN6R*\. =G1D--837G7[=VIV%T3;/HUL:97
MJESU0($H&$D\-L(;QRQGQBN'2T)T:4A9:GH#82ZS'IBN TS#CE4\%*R,MA/$
M3.$!ED*!#)P?HH%1;"SQBK%49823K\YRO2YOW"-GZC?,[Y@&;YGRS,$5QT'Z
MD%IRYDOC:5DP''I^OWM^;XWI1)38EU@C6I82L9C:;F*1#L]+1YGD)F"\=TCE
M/L6LY_>>WS=9"62P(12Z+!FPM]$.&Z6DC01%+.8]O]\]O[?V=V<MPUAJY'3@
MB!&JD<9&(RD#+K&%,RL]W.]L7Q#9\WO/[[=@N.^9^LN8NK76E[(P"G.,!(D9
MK 7PLU*&(2HLB.F%I):*O4,LO]I:WW/TO>'H^Q(!W;/]-=F^$]8L!5,!$\1#
M6: H?"')*+ ]D:(HG? ED]L+:^Z9?O>9?L<*7/2L_I5FN8Z_0%'J)&4">6)*
M!#*\0<9[C(R67%JG58%#JE)1XO*^7//?6/C\HTM;G'\WFLQF:XC<.S-ON\AY
M?4+/ZP/*?L[?X71Z[+H.=G4+EP<I')/.(B(-1<Q[A2)8(1Q OM24RL+%PID
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MG'E>%+Y'L/N-8)T@*^H\,UIRY# '&8QH N*7$:@0A:$%H25WL;1"C)7\ZK9
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MZ6N!%=F&!^8VR$LV19[+9WR9"R<LOP.B;?AW9!S?3MJ3#[^ ?(Q C68/PK
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MC=-BEM>GIF;A#(BS>GO1G%H*($#CH,;VIB$:^@8 UN<W@R6P[7W-6_#>YAT
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M>&CI[E_N@9OP;;4N>_V/5#A20E@7/TBO/[U_]\N//\@-RG9(K'9HHQ),/_&
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MSZ:@?:I:MVI($-7SY^)EPFB]9;$&'&Z^[@7N%[O:EH&PK"AWHD1HSYH&0U%
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MK:FU_;F6BQO-2NQ/>I=G#W7:)!=U99@WF;<:*%E>MB2[7F6I$>;;]Y(1AQW
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MF,]V>5IB.\_:].=^X[P;P&R*, :O,IMASXNJS=>B *RV",!O*X !TZ#>%06
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M4R$TM[UUB0&EF<@P;9TA5NV7PCR$=4^!!^N%M?5%FP#%_6!VC?&O8B.TF0\
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M]-+:JAD^C&%Z$S[QX7FDUO4Y?*Z'#9)8$._K/_R/J^OJ[:?/GYL'Q3?:[0]
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MPU"<4-12LZC.]#&)PS#AYZ&/EL,K#*O&Z3T6$/8I"+T88#9>EH!DXVD1) ^
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M+WKLD75]DNC*TO;KD22)P7_2]U(62>5^VW,O,_6BV93=I]S<+@+Q1EVK2(E
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MIQ#CJ\0=TSP+9T$)G"KN*TI\Y!XX'J\BA,H'#EP/_#D3$JF8)64%#CSD-D!
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MDSB-BS(788K62>9P+40%&-3NK;AY MYOPQC-K>N$2@@^'H)#OG %0&Y,6JZ
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MRJ+F'N!4H#0>2OZCN.%]-H'%/(J62,YM(7U(BQE>!E] >O?Y_7QKQC3/PED
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M@I<H[P&J<5I-:S%(SN=/(9'SYCU+KUE2,&)&E7I)LD( A$D)R^^XT!C!#%@
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M+EZO,6MO-V9QNG'X_U[%(7.B(.2>S0+#M'R=18'N1<PUF:6K/#1_<ZU79[2
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MXDGTY"P X?0O_@?QW"U]DFZ%F)T+T*V1A24'2WC+!9N96XLP\#Q=8[.Y%RQ
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M!;#?6.ZJN98">K6BQ$\P5<]3+5G^9/UK,D6/UFVZ>!HF@)-8*.>0N 6YPG>
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M'0G;>I>LYWE2IS\#Z+^&4\*\ZX"PB;P*TP_S9J-O@5X3_]R'DI]>W"""%M[
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M,1'O: $4- @C4ZFN]9!<E@&G&Q>^39;@!Z :RHNO5H6!:]>@!\IDJ.59&67
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MG':;//4Z.$\A@SH>,NP^Y'6W'B\I.5OUC9W.1UXEKUED('V@:(H<1O*)<0S
M$K/"Q"Q%FTSM6CA/T;X^'NWO/N25@]R32PA2QLB9R1"8+!5.!,-Y%1,:+B:=
M2#H[TZ8#^'<PGJ)M<SS:WGZ(6VF9.GR20'_$4#0RFB2PW''00C-GLY8FMTF?
M_D#+6VP\N?ZT-+S&?TIH]<5-2K#]8G[BNNX";>HJA6TE<UQS=+8,3B7!H\5
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M&K[O2H FPUV]G/@2RZ?.Q6M Q%&&HEE<>Z@'42KE3"8)DG=*$I9I;'1[]@]
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MQ/EB%M)BY+Q4BF4./*($%5V$J%P"7S)&$97643=9VSJ2FRN[XNB+V6J-%]O
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M'7XZ63*+9*:ST&50WENM,1OE6KTL]\ ZDA3QK=1]%W/V%GN+(NN;F%;9=!U
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M+%EE"$A8E"+KU-%Q"71>$A5C=$SI'4Z@0>J%^U=9/W(Z=&7PIE6<MY;R(L1
M9F_ANHHDDDALEF"%#BS5WNJFRU"939\]=*2[)TW=H_>M)=:S\[:.9]7CK0.B
MS6'K3KH\1-"Y'^G?H\H]1#>,4I7.M!T)5W/,D9!Q.O6-9W0V2L=RE-FFA[RS
MH95Y1]AW*%UN([&>=?@3QGI?^NJ_S\:+K^\QG<U(G#A_\87<Q+H#_3Q=!A\N
M@@0^1\R>5INU*'3B!U/'P4LHPF,2!GDI752[U4,/:S7MHJ'I$.+M.5?H'^2U
M?0P?\9=IF*QR*')DBFM=*LLY*&ET7;0'5U+47G&FUR=@;]3VAH]^U#K=5U0M
M"NEK(._:"B]0,>ZC6HX5"=5JY-Y"<-* SJ:&^FQAHLUDJ\UX'JW6>Q3S\*'3
MN@5=[3R]1$PW?V3/@=(.N-?BHYEY82Q3E@6E<LS!ZER\8EPKXTKVHP<_?<\
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MJW7]/)X0^\<U1C2GY]6//$_?KJ-+6%9 UJ2K=4*"OBH1M&>6!9$8+VTR3^\
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M%XD>O$)3T[184CX**W2'X$@O8)ZBQ7X831V=J;%N28VD\<&&K$%[1:LQS$+
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M!D#]:.JVVGL2\V <2(9.7DOGGDNF)F<("Z%$0_]PJZ06677K3G&,NK^CF<Z
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M*R$69D"$Z#!RD]"UMOI66 XUO6D8"MQI]NVDB@:%JC<1K:Z5_F>9J;8JE.R
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MV;EKK:A7'W@[A&[Q8=;AZ86%ZMW5]0B[+\W%Q<_-_$\_CQ-P5FBT;1*%Q*T
M7")E_"&124LEHR_O<Y?.\4'0C+]#O@I;O=.V/KY::^6Y[Q2@$/'%*I;D:C-O
M!;U<SJ>P6I: Y5OSL9F56!(UA]]X]@&CRGE:+"=<*P-9%5IV@9)4@1,;HB$N
M:<.\#3GQ.@F#8?"/9\Z'LIS'DIWCJKU"]/"DT%)NBDMU=]=8?$RX67SS?TW
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MS$7<-\L@,,L$<8'CYED<$&UY=+Y+"^(06([+E@ZBH1%[5Z.!'$*0!.T?PZ0
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M^O]\"KS;$S-5$4(5%W"[O4S(LEU7+UR6QG+=.QV.%QE8)7:E2#69*5O]Z1_
M)9/*A0DP08H3W=<EI4CBG-])_G  G.5?_M>/QR5XYD69YMF__L7]Q?D+X!G-
M69K=_^M?_OCZ$<9_^5__]M_^V[_\/Q#^GW=?/H'W.5T_\FP%K@J.5YR![^GJ
M ?R#\?)/((K\$?PC+_Y,GS&$_U;==)4_O13I_<,*>([G[OZU^"L77"0N19 D
M#H5(!#Z,N1O#R TQQR@1#N(7]W]%H7 #A!/HAO*/B,<(8I]A2!GR,.-.B(17
M/7299G_^5?U#<,F!5"XKJU__]2\/J]737W_]]?OW[[_\(,7RE[RX_]5S'/_7
M]NJ_-)?_V+O^NU]=[29)\FOUU\VE97KH0OE8]]?_\_NG._K 'S%,LW*%,ZH&
M*-._EM6'GW**5Q7F)^4"1Z]0O\'V,J@^@JX'??>7'R7[R[_]-P!J.(I\R;]P
M =1___AR?73(Y%=UQ:\9OU>6O>5%FK.[%2Y6GS#A2RE]];35RQ/_U[^4Z>/3
MDK>?/11<''[LLBA>/55)F2@IW5!)^4_'!OOU#/$MR;O:E]6"<)6ZGVW)V(?I
M9VOB?I7\P,<7N#/,V2+77Z@/&9OJN[L9ZFS1QY?8UM<B7^'E!%^+[3 =D9?J
M@T_RIV88]: >,JW&::B[(RK_L>(9XS5;OGHT2-F__D7^M%B7\![CI\7'-),D
MGN+EM:3SHIH$R\UGEV7)5^4[O%0\?_? ^>JW(E\_R5FTO"3R<DQ7"QQ2UW&0
MG.IBJ29RA0\3X3G0%5' G-!%":.+U>8=6/ ,_G'7BEO)9%>@OQ@@MSK"  4O
M\W5!MW/GX_+0A"CG0C5[QK]F^)&73[BY06JEW(Q:T7^K1?[KO_RZ57@"JRQG
MA_5R7)@W8H..+A=@^W&MS@5H% *51F"C$OC6*O7_'3553E^)OU3.3E[LXIM3
MZ_ANR::4T%3@"ER2"IUFK%^5(_HK7Z[*]A.H/H&.VWA._V1-J%_WOK^718L,
M+NB)+T-SQ:\TER,\K>"K[X7RM<>!<)6/\]6OOPI2J;^ O&"\D*N- P#MO>!W
MJYS^^84_R:__@_1R;XO\OL"/E^O50UZD_\79Y6.^SE;NPHL1#6(4R84$XU"N
M%^0*@2 ?\B2.'"? $7:%";MJCCLW$JW$!L5&;O!4"WX!\$9T@"O9S8A6UPYZ
M?#H"NB/39@WL5F1PVP*[E1I<]@-K3(N&,%EE/]VQ)R4Y0T!VN<ST]H&4M7Z2
M_J\B2KR\PN7#QV7^_3H3>?%8+?DWKD>0H"2((KEB1R%2E(5AX@H74NXA)V*N
M$^+$B++TQIT;97WAROCI,JVD!+D <J$-THSFCQRL\NHW*M515/:<2F<=D!>0
M/_%"7I_= ZE1^IRN4F[J.NJ:29/1[(,_-J-U) 9*9*!D!AVA1W'U#(&RRVF:
M8T_+:6: ['&:X>T#.8T^<+9>\AOQ$:?%W_%R+7^\XT]8OH7\DE+%F^6[E]_Q
M?^3%E?SH/B]>;L1U]LS+E9+MJUQIOY-:_[G@H<O<R$70=40$$48N3.) +HAY
MY"0QC@*$N!'KV9)L;KS8*J884:D&*MW4;ZUVH%5/,6*E(&@U5)=M=30D1FNV
MUJ3.M[#@V*OLC<$N]LS5,0SX]A43:6*E JATL,FTMG&UR\76I)N6K6V#NL?G
MU@<P8WSZ7"YN5@^\J-;V[S#]D[,[3M=%Y6/]SA\)+Q9!*/R !@%D3D D=;N^
M7&U[%#+7\T(<(B^( AT2UQEL;KQ<R0NP$AB22F)0;D368UHMC/O)TS9R(_-A
M#5HE*ZR%!5MIP;=:WN/<9XX>:PZJ*R=H,A1?C3JB:["%CN;+I62! B^K'0CI
M"&#PC(N4KRH?H/J:EJ!<TP?YL]H$RA]SDLHI9YGCK+P M. L50NL@H&"4YX^
MJPE)_N%!+;_X?ZY3^:#F6KZBOYP_/9E@7L\X\HYJ%G%"WZGF$*U'3#(MF"C3
M,KW1/</<]7?K,LUX65[ECR3-JF_C=2;GBJ+Z\0M77QEVE9>K<N$S!T>AAZ (
M,9;^. \A"4,&612RB+@.=UEDXH_K#STW8K^D\MM>IDI,6-1R@G0KNGS5I-!F
MKK2!'?1\Y7'0'9G\6Z%!1^H+T)$;-(*#JUZ(C3U@<[2LNK@&PT_JPYK#LNND
M#GC","+;^,"_<URN"UX?/[4?_BV5$U]!'U[>YX\XS198.,@/XA &@1- %"<8
M$A\YT/5<[#B4![[O&QVQFXP^-SKK[!EL) 4X8^#SY=_!MUIF38]KF#4TC];'
MPGBR%?X0>,U/R(? 9/<XW$B":<^^AX"S=] ]Z"'#:.TS7UU7!QR?\K)<T"0(
M210ET(TQARB@/HPCET#LA:&;"!+R(%ZL-F%0)U^I5T\WHJ4C$5TVWYO/V\,=
MO%H5*5FOJBVP50ZN_GX'_L;Q<O5@1DNOT=2CG<$8C4PK"IY:,/"3$NUG<+F#
MTBTN^K9TC9GE(!)6F>/U"),RPT'E=M_\PQ<->[._;-?0M_DRI2_;W7#Y8E/$
M5(B*0RE$S/=@C A7H8 X\3 FL8-,O)/C0\W-%=F<4VQ%-GO#>U#5>]WM8#7R
MN[\5$GRKI1SG8. T&%9?_Y[A)N6"TVKO$H/&'68LP7BZ^)"MTM7+AT=>W*?9
M_6]%_GWU(-=13SA[6<1>$),@26"4.$)21,!@@GTB5S%1X"1(N@)^K$,1)\:9
M&S_4HH)65E +"QII]:CB%+3]/&$1L)%)8B!6VB2AB<0!AB@Y_>4^?_Y5/J$F
M!_E#Q0D5&YQZ[B14H*E<RP.ZEP]S%7[/B]4]OI=>!\[*F^R+]'P_E"N\XI_Y
M]U=_6Q#?IP[!"21)@B$2+H:$QPQ&2'Y'6. 1&AD%MVJ//#>BD/*!QT; ^E3"
MS(_0AUS/K1@%R)$)Y.[#%6@/F2^ ZT$ON0!*<E"+WE!)J@Z!.I$*:09:C4"E
M$JCV;3>W70!EG%>7V/-8C'&VZL#HCSZI/V,,RJY[8_Z 841WTP9K?N*XY%]4
M.O"-^*/DU?G7(L!QA(1<%@G/=2%*: Q)% N5)H5\$B4^$MB$W'I'FQNA;80%
M2R4MJ'*E82[@6OY2']Z:,5P_UGJL9@W!D9EL"UXEJ&2Q%CTI;!UL8(^"M$"Q
M2CO](TY*-5K*[]*+WDW#*.56 LV+@K,JI/_N <OOU<UZI1+M5>V"!0Y9R)A+
M8<PPA8A[TG=R!9*_4LXCZ30Y'C,AE1/CS8U6-N*"4LE[ <I*8I!O108_R1F]
M_OAG,XHYA;T>R5A$=&2:V8)Y5X-9"PLZTMJC&4U8K!+-J3$GI1I- ';)1O>V
MH?LUEXS))Y;-?SZE&7>EYX)<-XD8=#SB0!3Y&"8T9) 3-W"X@QGRM$)G>D>9
M&[4T^P^-B!?M#T )"VXRS8W=?F!U]VK.A&N:G1ISI ;LU?0@<<9.S:&G3KQ/
MTZ/8_BY-W\7#_(Q/*2;I4C[Z8UY<+7'Z6%YFK/F!_<>Z7AM_^/'$,_GBR?&N
M5_RQ7 24QY%/ T@"#T$4$!>2)'!A3!/,<,C=B(<FWL<@*>9&'!LE@%")*I7T
M5<!$\^-6$]"H KY5KTJEC6&DRC"[Z7DNHUMC9%X:RQ#&OLY90%KU@(9),JE?
M=!98N][2>0\;F$+([]53O_"GO%"KPOI$;?<XE[BN'Q#)E51(2TF?*H:$.T0:
MCOG(]4CHAL0H/5!GU+E192,TV$AMF,"GA;0>V5G';^S=[5WH+D!SE#[JD;H1
M3';SZ+1&GC9'S@2,O?PWHYN'4=&'*JUEFW/Q\?ESNF"N[P0B3& L.('(80+&
M'A(PXB0*J(C"(#(*SSDTR-R(II;1.'^M%T<]7CD7G;'7;C4P6_DNP,>_P\_7
M%^!J7=B-O^M#PBI3'!QH4F+H4W67!WJO'?;:7^5950OA'^GJX4HZ.?ECDX,E
MG9^-1U0E9&]G2<4*% <QC&(W@(BHNE*A[T'JHSAA&#N>67K4 !GF1AK=P@2=
ME,%J"4$;]<"RT47E*%:%@=N_E'7)8-KH;L@X0TRH1T@C&V9DOFJEK\%MY9=L
MU7Y>J=+Y?:/2166W;NCAB"4)S@#9*A4.D6-2ICP#J%TB/>=10W?+/Z9+OJE.
ML/ \3E"$&)17AQ"A,(28^1&,$HJC1*[VXL PJO'5\^?&C\V^;R7CIB"+Z;;X
M:P1U-\0'XS+-5K@F) /VOP\J?L;.]^OG3;SG?5"9_=WNPY<-=8T>'_.L.CLK
MKS.Z7*M#LTO&JFQHO+S%*;O.KO!3NL++1<P2W_5=%WI>PN7['%"8X#B&PA$X
M#,. !I%1)6.3P>?VLM>RM\?L3[@ SU5.X']W?G'<OP+_0HK3GKYO2W#^,W O
M(N2U?TC+<JWJ<LJ)V+WPW?C0<3U>@?]WG?'_\4]NZ/RS[US4#17J6R+?/_(H
MY\BCWLOY7M49 +Y;/<FIO;<:8U"NBZ?EVM@U,_@*Z?IDXWPQ1G?&JN]$+;<*
MHFPD!UO1@9)=Q50VTMMTL<PQL^Q;&0@PL5-E#LV^-S7@&0/#)C<U0LK/4L%Z
MWV%!B"\BD80PQ"B"R.<!3%P709;$89@DW VH:Q0N>6B4N;%LI^:2:3SD01#U
MZ.=L:$;FF4Y1)4DS6Q$M!CWV(6 WV/'@2-,&.?8INQ?<V'OQT%KGTIE3F]]M
M>8UF+[R\_)&6"]_W6!PC ET4$_GBXQ#&./(@4CV4XB# <6!6+KAOM+D10"L;
M^*:D,PP&Z,=5\QS,%EK3G'^=!&I +7(- "Q7(.\;<>*ZXQK*[U<;U[G)O#IC
MM5?WM/HHI3Q0A^=V4]P\I7Q[F*]B(5/&;T2GND7=N6@14P='!'F01=2'R",Q
M3%# 8>@2*M=YOHN85M6<$62;&PTUZH&V/%BGS8+4".!MY$RUYXVW%<7T2QO:
M-F\_O[VQT49FP]9>E34.ER%KU0.5?IW@IPO0J*C..3I*@EK+MS.H?FG+-S3L
M1)4PW\+ 1I4N1S)!3V%,VR-.5D=S)*BZ93?'&L)\$G_/R6I[N'WYC-.E.H+Y
MF!=W>,DO59*SVBA4-?0^\]6"N=1+@AA#%#%5I5-@&+/0A7'L4QIY.$9<JT24
M^=!&4_ $]:,V\E7%(O59V!#PT[/F>#"./"DJP5]%MFQDAU)XJ*2_ *]A5LG=
MXV&M/Z&-A_E$\Y5U[(TFHV'P]<PUA@^<;"H9IFAWIACXA(&G;[A\4/]3,4_/
M\O%RC?B%ERLY#:DRJO(/EQE[_4'GRGHJNLYHH=)LW_/ZOYN]Z0\_Y)R6W?,O
M<L'R00A.5PLA4""$\"'EV(6(J$A'QU%SBYO(I:!(N. F]0:G%7]N$U)3T+ 2
M&_S$&@5^5H<[JFW51=V\BF\UKH[:B@T>U=\-C]JF_;YH'M;-]ELP]G%?9>6J
M@U9'(U5396/BZH]UG-7KSU[=4(, KC=?IA:'G[N'B"T60($!:C0L'A^^B17M
M'D!.J\*T1YAO8IZ]0]"WD<)\E=5&QT1-5Y $^YX7RZ],&+GJY,1U(":.!X/
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M/(I" F,/)Q!%R(<X0(%<$8C "1T1<.H9-6G2&G9N9*JDAG*@1\"DW(9-EO2
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M><&JEA^L>%9_8JM8F.4OP.F99*YF'7E:TBI,UNHH_]KJ#R0 H$9@\V>@,+@
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MAW[BSWSIU]W@%S0* A^Y,711Y$*$L( Q]@(8N83&/G$29':$UC/6W+9D*MF
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M0JDH=(M8+>R PH*GH--?7EN$<*(E]M<'^5539=PZZ7;-EW$?V@>^9"HP<O7
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MG/"(^) $B0,1<55=J4"H+F%RCG=<Y@MNMEX:(,7\UDFM$LJGWDG0ESXYN,S
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M6<93*$MC V&="\@RG4)2%#SAQ@9R+!\85:JI<52MF/71[H/I:]VJ$\Z.=E?
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MR=&),3SZ0WMW&PTLY%46B%7"\%9'#=#1 _Q1:3),$?4+T8SK;PB495SGP66
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M27& :)C,E+Z)WR9!Q0&*DWDJ+O?Z=^F[6:_DD]A^77]7ZQ]S40='9XE(N*T
MEV!EJ*>PH6RB2&&>E#Q!&4(\<8HR/S7!U BGD;&N;%V+Z15G?A+(?C*) <_
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M-U)NP"^R$73S%^M$6[[0#[0*>A23\%^?\^?I@Z(^,*5].8[H%:A7HI8?M J
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M6)*26N<@AV8#E<.R$&;O2(DA=*>C.,]YIT;(C;!7H!)W7T8TG(!=%\"-7@>
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M^(]#V*W]2>7 3:VCX4ZB:B?<;5D;G]=^U(1\WPQ"Z\S08^!_"7KPL1CI%O.
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M7AV/^H((@>+PK1#T;+]7P?:4[T?-W1'?4RT[(5]6;MG4UH_!-+-?-9<LE6.
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MG"UTSLWCC*"SGPR_AMP(L'\LUY+/'7E\6"C')[,"8I46.09$*>-..I&=XIB
MU%#"*$UE47A?13[7R=0F>6-G4AM:106)-;4*%_PO)9^%M'NRQP)JX.G>"Z.@
M*\J70.AU3?ELHZ-=5;[DUOYUY8N?O2*][W$YMT^LW:V.S>M/R\W>78Y=ZFS&
M)33*($ R* %"! -::/O/'#HY)$91'I[5Y]/SU"BA.F9M#/_7I#:]1YZ>%^A^
MP< @4 Y,&OLVMR@FSNR]&V')+X,D*0?#%3^]SJOW\;/J0D YF4P7U,"TMH==
M"G6YN%]H1ZZS%.>:%4H 8DG.J9@7@ F=@HRE!.N",IQY':^/:O74F/('O5[7
MN[_+A:YV?Z>Q2_=VJ-]WM[?W /ZAMG=K%!(+0Q4^3O%K,HW=V]Y?ES_D=JWO
MUV8RF[,GA^^==F/?VO*'V'X]">]8^ZVG.[\RW^:[U[V#]N_XNES?_E:N9SE&
M6*1& $40 JA0U*EQ,T 9$8)P(R'RVHKQ[&]J@<6>C4EE9/*+,S-P\_42R'Z+
MKXC0#?Q*#T:M?Y)--Q;#Y-><Z?-]4FNZ 3B;57/AL>MEZ?Z^>.:ENJ0[]&GA
M$GIT\^=L1E-1P)S9-1#3A<N.T8!+B0 S2'!*"$UE4'6]JRT*(J31*NR5C9')
MXZ%$6G\=M'X#YD==HP[#P.3V5C&M]L9+..TF:9UJ/C.,DMI5^ XFK];/JG?3
M7+L*Q"XAMNL:[D?+GQ;?=-U\G:Z]^W<K<<@H(H4N"D!RR[C(0 (8DAI(J%F.
MI=%YGK8UJOR(]V*?7C/Z;2VJ@:EU9V*B:QL#V?0RSGYL&0>[<=AP#[3:6,=R
MVU]%EXSTAB8JD5WN=52B\@;AD(C\'[RZU),3;_OH2OANRP<5 M%<(PQL>)<!
MA)$$/%4&9!@9K5A&!$][UG4ZZFQJR\BWI86<2F%E;HS23<= ^Q[EQ8%O\-.[
MWLA=4XKI+"1#U5TZ[O"]BBR==;VCHM+Y9\*/WJH5SHZ9ZAT2G.8FITJ" KI;
M$S0W@&5: J),AG/C,@*]3\E.=3 UPJB7>7M&!NT[G87Q\@G4M> ,3 ?!N 1M
MR'<YW[%W?O*QT;:YNXS>WY'N_%R_]_U/>N-F_N?5\ENIM/KN]>]KK3XMZD[>
MEMNB&>(%U@70A4OI$\A-8)H#@;&@FAFHI0K9V/'O>FH[..Y^<Z7Y_.+TG\J%
M_;_&YE:PJZL,U[7CX!<<#(/NP-S@@*TBA-9LI[7UI[_7*/\YV1H_2+6S<,2B
M1A(!W8\:5X3#<AAE]&BA[U4#YU,Y+ZN#ZWMS_ZQ7W/5@NS9U)5PGA/A%/U3T
M^75YMURLE_-2U66RVT0Z@@DNG'16"@T#2$,.F.00:(*S(DT%*DR0P'T<LZ86
MW[SURL7V6[^2#WSE2J^LD\VR$H.HUZJAUQVB#*8?6XX_1 ,S:=?HU#XU:AVU
M_FOKF!NP?=>27[ZZ,^^A!&!C@A[Y.D<4TT:^ A(3SN-K(U%;[UF3=[FJ<BLV
MVT/0$R4%&@6,@O(L1:@ 2N3:AJN%!-RD*1 R(YE@@J=YD.A10-]3H^K&](1O
M]JMI[!_Q7]30N'HX_'AX() ')ML(^(;7Y@U'*FY=WH#^QZW)&P[,43W>'DW$
ME<W;9IN9Y6K-YWHO#VU[T-C*-6VMW:Q*\;)Q3WU=?N;N!M LPR;-#$: 2TX!
M,D4*>,X%0)G,L%"<\E3&4'Z+9._4B-/%KB^[K--R=RSVP,O%NE:."U8D'7K0
M_:AV0D,Y,#U[*-;M,H^MU\"YO9>8O)<(LJ]M=Y.TO+_OOXN@:P2&U[Z+/%2C
MR.;%LGD2BGN1!\!7K"]VMU&WCK<+@]VVSO9<$Q8PIUP:( N: \3MUT90 0%E
M3'+.$<I($?(Z"C=A:F^8:K?35.>AU4)\N5VE[W:2_T>4K>2N<;EJ2SD2VN^[
MM;S;'=EY,<@)=7\0Q]AM[C)C"KO.'C!Y[C[[M!1^\ETQ]J>%71^X^E1MUJ!M
M^Z=EG0]HPS/,"!449D Y50RD%0<L+13(,&0,FR(OI%<6C6=_4V.\.AJ;+Q</
MP';W9&=?8WTRWYGO?TCN@_CE,_/(.(X2T&[-3?;LM0'JUN*X(/K?:8P,YDBW
M$:\%-2A-(0"BCJP%GU9&2V((<&D_IR'DL7 ^;LC]]=/B1QL'/_ '_<.2+UQ,
M;);S<ED=;NS.BIR>:T8A!@RE!B##%! ,V_]0&YIJ8K@R>O9-K\32AYN#^@Z9
M$/L6#)BV)Q^U>K$+6KO:;5UQN0ZM,XGS)MFZXT\V86-RF;L'PWE@%M\']:D%
M=>Y ?6YM#SE^NQ)G?WH?#.^1B+Z&=*7MJGJM%P=KK:[!4%7=K\025O)<%?_Z
M2YR702] .UX+8>V-]H+HY>;^JZ)? [T+BS>GE_:[>%@9EFM12)QC %T5%23M
M3Q1!#DBJ"<82:Y&'EA,_V]G4PO?/=@[(\MG5M7;IW/N6!U<,/X^PWX9$+-P&
M)OHW9KI=XZJF[J"U=7V0B5T._'R'8Q<!O^CZB=+?EY^9E@15I=C[L?RFOSZN
MEB\/C^>$Q$TND"JH!H1R"1 6"#")4B PD07$5!OE56AE(OY,C0YK$7#CCI2J
MB@4V.JC,GV0- X^OR^5P>P)63HC;WT-RW@&4- C]3LH<>'SSIJ&9-< W\ ^I
MIA7IFS@9L:W <7_/H@@>5OXA!+H"AV344@D!9EVGPV/-;]2<9Z*@!DEC0$H1
M 8CE%+#,Y""'$BN*J'(*#SV$=79=! 57HRGE-+O X<=#'5CZK2^O0VC@R./-
M^<1=K,.)RZX/HB^SU\V[",8<NWE. >;$)WOFLO/7IB!>Q1E?EU_Y;TX6T,DB
M6])Q7.7$P[_C:ZU<#I!>K.O0R$B.F=0<0 X90$@QP#0VH*"2$4T*1@UOE5Z^
M!N2W][3':TJ\58'Y.L8^5>-.)?&TX;_I=;)J2HULELE";^IJ\LE:;S;SK3R!
MKK7%^:]\I0)9IO=X^G'1H,,S4II\[<*-2YY,]FR_J0O/ ^%L3YI/);>KE7VX
M&IF(6?-7HA@WA;ZO,>/FTU\)V5%R_;7M]12VT<]\Y<(W*9<OB\WMVD[\]<Q2
MIL19;LE3T10@[NZTZPP#E;(T(R*E!)L@19M3O4QMSZHU,N&UE>N$5W8&"MB<
M!-2/S*Z&:6"FVB+4&)A4%D:4J>GR/ZX^S<F>QA6FZ7+V2)&F\\-]Q?.J655=
M3/PP+Y_*144HS<4T9#C$%!* E;$40'(.*&9N644%S:7.\CRH&%UG;U.C@GUC
MDSUK@V7SNA#VXX1HN W,#6<A&^"2GQ<FD77RNGH<62//P_EC?3R?A\*/\GYZ
M<0TLS3_X_)^?;'.JE'Q^9S]<RO7,,@04,M- TRQU!6 $X(PP)VU%<YH;CO+,
M]XRMJZ.IL4=MJULW_6JMK5)G:GL361OL?P+1B>_E0ZE8J W,'3O G*')IT72
MF)K<107,_RPE%G C'7+T!S#HI,$'E8XC@,['1]N;]W%B?]/<Z_-]=[,WY4/U
MU7"*@R_KIGRM5BR'N<H!9F[U18L,4)HQD%%FC*$0LLR+-[N[F1IK[JQ,:C-[
MU@,^ ZKOUO:U4 V^O1V,4H]-[BX0(F]TG^QJY,WN+G>/-[P[/QU&!.O59K:?
MM+F^7_RL^?S#V@F0MIGF50+G#*.<<(D9X,K5C\A(!IC.,4 "&P&EICP5/J3@
MW^74".)-AOTZL3/ &9[4EC<IX9Y<$8![-V\,@^;0VS@?[I+6MILDLVMZ=O,&
M2[>_R!?5"=J>Y/GA)8>C(=A>C;@T%MZ,% YO%SO9UO:8R?[KD)4"NAN%H<+=
M;]FJQY/]0IAF0VK]F;]6>>8K2T_M:7*6*FV4R"UED1R@HA" (@J!+%*A4BP0
M@UXYEAY]38VK6E.3Y]K6L!"F"U2_."825 ,3T1:EQLR;I#)T@'-[#SRBQC5=
M_8T:W'@X?ACA^#S2<[VS7*_K+*,'O9#V_5*_8@W,><:D 8@8"I"V%"&P)( R
MR9G*,#9^-[^[NYD:1539A6_,#(MA+H#JN=ZY&JJAUSOA*(6O=SI!B+O>.=W5
MN.N=3G>/UCO=GPXC J7+V0?;UN;U5BG[-7&YA1L^_S_E\]U2Z5F:<Y4I18%@
M$ +DJJGPW(8..(?0B"Q3=L7C0P3=W4R-"&I+D\94=Q'*&9M8:Q-GKA\;7$"V
MFPWBX34P&_2%RIL2_) X00EK+?_RL/SV;[:!F@WL#Q4)5-/_0K.C3'\_U]KI
M[_GI\!.C=O%Q;_;7)]7YU(+/[U9:E9N?*P6:]<%5;*TD$5(*P-Q_D&8,,"A2
M )F$&<4Y9ICYRQ#TMB-D.HPO2?!6AN#6W=FN[C+<V>&KBSA6GB7_\<*K2H^?
M%FX_VTX&_R.6_B-X^<!JE%$9>GNE'8[[P^%H_6@'H?'D*CF#_J/A?QHVRJB,
M=%2V'1VE-[R<.^4"68_&?S53HER8Y>JIWF/?RXTUY8+; ,A^?J6E+K\Y1]=.
M+>WH\69&5=/-_7W.U]6M\%,M1-)*N'J$.H[M^K<]VIG>U>[O'_A=W]CUI<'J
M-9S4% L)"=!5#A8GPE6/IH SRDF:06;_U;<VV"37Q">*8(4LB<\C>?G-<S4^
M []5PJ&YJD#8B26P5X6P$=>S%\WNJA%VS2K6M>?NMMV;^U7YT*12?:ZD;[[^
MNFSK+$ JF*$82.6JY5 %@9"%!KK0>2&Y@(6-5CWG[J7.IC:-[;<D]9^Q%Z&\
M/'EC C3P/':FNLAPSUB[CJW,3:R]@24GO/#S#_1BXCA2/'<UGD$TZ0M0!V->
M;&(T\O1U9I]'O9^)% /MJ1#J%*<D0R#'"@$D-02T4!1D4&-I,FXP#% A[.YL
MVFO\HU#@RN@H9($>#[=WBI?ZK;(OX.;/L/'P&TL6\+%<)^5&.T5B.7]1VA5#
M<]#NJGZL;Q*QW#QN;Z2[=>]6R#C2 M</M]! ]1V6JGZ.7 Q=KUUTNOW=1@KB
M-<O%UW)C5TEI05*2(@VXIL9=^T. $9,#7NC,P$*3S$\4ZU3C4XM1*Z,<FV;Y
MG\2?6X685__3EB/T+I^Q7(/)T'09"$?0B<HYOWN=HQPU-MKIR3DW]L],SG[F
MBD)8]6V_-@%(%52EBG  &<\!T@4!PMCIJI"$F:2*0>BU*72^BZE-U5J"?/MV
MZ7$I]P2,W;,U#C@#S]D:E]JZ 7*FSOL>OR+2VV[&+V)TTLV3=8=.?[+GY7N7
MC>G>Z?4F948-*U0.05ZXTIQ,<R @E( KI@C)!38%#;IU_Z;YJ<WJK77]TIX.
ML/.;SOT1&?K,T!N,\$OU)WV.>YO^;1?C7J,_Z=[1_?G3G[I.HNCC<O5#5>CP
M=E%IF^VJC'WXS>ESV!EM#*:$$X R9M_5BB/ ,YRZBUV28YIC"G&(-IEWST&3
M?3S)LCDOGUQ.=*GZB0A=1MR/!P;!<6"*:)6V7BOIIK\O'(K)78UHE=A1_[AS
M(6E\N&G_]+D+]]Z:0=X8#B(2=+GW=U$%\@;EG R0?P-]Q3_:_82Z=N)N+RO7
MN:"YP55%<+N^P!Q07DA@#.0T51JK%/KMLU[L:]K;K*XTWM[UI]KV4 &0<RC[
M\504Y ;FI2.(0C9:>TA_7$ DLNS'N=Y&EORXX/2QW,>E!_K6-OVUN1U2+AX^
MKY8+^Z.LXJIU71[@L& %(L3R!F: P%P ))0$(B\88 I!S(F0G**PRJ9A!DQM
MT6/M3W8.)&\]2'[6TO[OW"4X+Y]=VIE[K_^TW"3_VU)1\[O0HJ>! ^;'2T,.
MP\!TU3D"XU0AZ8M>Y$JG@4:,7.>T'T3'54Y[MM./'Z\3V,[R'^TG'M?W-O1;
M/.A5K3QR;]J_KV<<000+ @'-<@00%\C2J2$@-ZB !!)2%$&ZC /;.SGVW<KD
M[!<$^*OUS:GV;Q[Y(LGRY*ER*HQGAQYX/UJ>T' .S.(=51WLZABL_:LZV &O
MW;83/:D=OTEV7Y2M\_'H?Z11BOJV&-KF45\N(PW X;MHK&[[O;K.JD58^[2<
M+]<O=O[.)#*:%B8#F*48H,Q P(3]CR@*!K-,:\R#CBB\>IW::V1[J6=>J:"8
MQM30V-P/<3_FCX[CT.<=PTC0W"1[_L9C["!TH_*N7\^CLF<0&(<<&/9P>$K3
MW?*;7MV*]6;%Y69FB!"%XJXT#'1*6?8G;F1F*4L3FF$EE/9BJZ.6I\9(E7')
M+ZUYGD>IQX!UD\U5, Q,*-X(!"4NG?2V5];2VY9&2UDZZ<!^OM+I#X0G;_]-
M\]7&CHBR/\PWCY*O]!>]^E9*O6X%Q141.F<%X 1R@(P3=\#(_I220J,"4RF\
M!,6]>IO:!-T:G.PL3EJ3_=.0+Z/</8.C8S?PK.Z$K<=5F<OX^6=R1\5QI&3N
M*_$,RMCVQJ<C:?MR&Z/E;7N[LY^Z[?]0OT7;7Y=+]6LYG\^$%C1C! %6H (@
MS"6@U""09TP@R0W#:5#I];;AJ?%H:U?82FL+D]]BJH_S Q/A1;^#US2'3D9=
MMFP;'W5E<NC2X>+CZ.\]T[]62ZFU6G^T!E2J '9U>KM0WY??2J47:OUS)>Z@
MU8S+%$'#-< ,9P!)DP/*D ;$2)XA[2*>H$GIV_'4)FUK:W6<6>ZOYJMT@55C
M=F!*F.\H^,WY(; =F!-:DQ,W$Y(W(&_-3GZ^!&YXWE<@4G'3OGP['S?K*Q"2
MHZ2OT.=[;O&6BZ6[F])V,2NXC0V$9L!&778AIG($*-<08%H(F6:<<>2E*7ZN
M@ZD1T4]V.)>+C>UO[L[^R\;,P+.^(Q@]MVBO &?HW=C-4O[3%1JT8_"OR8>Z
MV.?M9K,JQ<NFRN7:+),#\%HW(NZRG@$H[H;J82?C[IV><?%HF_3<Y\(W9F[S
M-,,_ZV?[77GD:VVIYF'%GYK5;FHD(9ACD*/" %1P"!B4!!2Y3'7&,X5S;Y&2
MKHZF1@3.U&1G:](8Z[^1T(GJY3V86%@-S MG8.JQ\=*)E_^>2RS<1MINZ8U?
MT$:+#R@=>RR=CX^VO>+CQ/[.BM?GP]GRNY=UN=!.\?A)M (GVRY*J7=I^/<O
MF[6-SN[-CYJ[4ROWNUH+988$Y4;9B$H+E5I653E@1N= Z32'%A=)I JH1![+
M+J\),GY%\EMIXXTZAR'9SI1GYU3"=W=9EK5;+B7G:>=8\EQYYL]#4<;W,K^/
M-ESCO =:=Y(]?VZ2SSM:<X.U\^DFN=^-UIY?C2S3R*/E_W89>]1&>@N--'I!
M[ZR84'>\VZ)T,]H[,"8H^^_*J.V^1V+T#];XKX]\FP-W*^W$>:F4>=W'9B+/
M8,%8!DR&B5O&,$ AHD#@%%&B!=+2A%U9&]3>$(X8Y]K;07JLR[IR/KQC2O2E
M(??;<YG,, [\@HZ7#OUFV&NW;Y(]QZO/3R47VG. )I0)?<GBWU$>M"?X<;.@
M?3N]0FVIOA%4[X9^?%FH]0Q) CDK$(!<V_4<5 6@2""0:B@*CE6F8= YWNEN
MIK9'MF_@^K__-YIGY'\FQEG:0WOI&%0_ K\>JH&9M]9@VK<P^=B)43\9IK,0
MQ)=B.NYJ?#FFL^Z>E&0Z_^EHNMX?RV^Z%?86"&F8,T!4SFVPF>> 02HLG%PK
M!G.AN5=U;J_>ID8*>9J1JY6I]\"\O)42%:*!R:!+B]H9'$_<>P_"J]6]^T$Y
M 7EO/TACZ'L?0Q0N\+W7QGLK?!^[XR'Q?>*AGB6##V*^733H8L,?^:;YUS_*
MS6.YN%]H9]!'7J[^D\]?]"PG!:)0<*!S6@!DHR\@!,< ZPQI85!.<%"UT.O,
MF1I![]9ORX5.7JVI@:6'KQL<OZAN/,C?=]W]I5IW.\.3RO*;I/'MU7YR7C%1
M(_+QI5P\S/7VS\GWU66VFOP6$6^RQ4$^;JGDZTP:MYIR%/B."B[':;6G!NFV
MVM6A:-#/^GFYLE_0VZ>J'/1WKW?V2_FP7+W^4"[TIXU^6L\$S94L" ,0"^I6
MQAI0;13 @DDH.<T*':1'<8TQ4V/B?2FQ(XTL=]FU=BAI/+IQI>):IY)?G%M)
MY5>H+NHUX^E'WV.-TL#D?5+?S0_Y<!'6")#%E6R]QJ!Q!5XC0'<D!QNCS2E(
M!!T>BR"3I4AR!1BE#"""!1 F=W<N\RS/"Y()YE7!811KI\;8)T[!IJ<-]!X'
M81''\7=S$'92%VBJ!V&> S2A@[!+%O^.#L(\P1]6#BCN05BK0OQU^>7E^7E>
M6O*]7:@/3\_SY:O6-NY7%*9$8I!SDP'$E004,@DP@8JGE E-\X ,1\]N)YK
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M?_^7]C?V/X*O];__R_\'4$L#!!0    ( )DT!%-FER_249   (F7!@ 4
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M)<T# XETEPH YF/4S(%SD2/GWN$@@+BQ[$YP4/W#X7!9=@*&]TN8KZ95\%M
M>VFCUEFQF ))1*O(O'&<696<<P:3<6F8V^'6RCM!0O</B:,D.C(JGL_7T_6W
M%],9_G;V*>)RH@P&R8GBY-'7XXTNNQS)7"2.P!=.AO5QU\7M%7="@>D7!4=)
ML OMO\4/TRJ$^?HW^(23F"4O13F&AOPG'5*]X*QG19+'Q<D<HGMO  3<7'4G
M%-C>47"$)+M PDORZ9=TA&T$_X[DCT\79_/U\MO31<:)X6B4+HY!TB2;XCF#
MP V3&862AEMG80!@/$K$3CAQO>-D.#EW 9OW\/5E)O%-R_0\7+$]"9/+@1=
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MJ%C&>IQ*+^MUZADW3AOAG _\L0S_2YS0 M<P0G^[C8^'*!@7(<=H<S&@:/N
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MTVY8^F%BW0,)OP,876.BUCDI&R&2?[ I3[&&12L5"]S3GB@6);1Y(;E&Q&Y
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MAA[1=/V6]RD;KE SG@6Y*-YP%E$8YF*DLUCZF/F)(+6OY=6L5O_TN#I4(1V
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MDC%.!'08S=Z%R9%B'GL \]EG\CUK^X'G7VO359PG?%LK=R^XNPAUB.2C\,C
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MQ'6"Q]/"YFEW=109]@3+70NZK>T2HE*M'&!A2"QSM05J/3MC)3M/&M\JP!]
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M<D<EL";BD\\(@NM2EX(0$R.WQNIB1$P1=6,3>>85VOM 88\*[7WDTBG$MI7
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MZW7G#VP?_NVWQ?(_YE_"+%]<A=GG.ECX]IO\7]<W3L"O__R"\Q5>RDPKY;R
M%9[7:9H%G'<!F X4<>5@A&PS4>,8JL_&HNV#IZ<C@,9B/3/;=K'X_&4QK_>K
MBW+Q*<P_XFR^^R\/+TT>Z\TM+>:1?#B]<;6BN"1X!*$U Y6#H/V6.Y#)^43_
M]_IA)6\'QO5[W7M)ZVZB?F$QL4!N!3'7D,X'!3Y[ VA<SKX(%1^>W(UD4?<F
M]6S,Z#[(>6A&VPIPP@.3U7)]^6ZYR-=I_7;Y 9=?9^DF4XI[[6M/8@A8"[N%
M=/2=D% TADC*I&4:=/A'+_@.?/3I(?">HF#:XY'& E^,R/T^T%/Y<[N"[0@
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M'P,3CRH<1F'_B*?&K0W)P8T%GGA0&Z/2L)' DS!*RK"@N0(K<J8PG+:ND$P
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M,C R,65X,3 R+FAT;5!+ 0(4 Q0    ( )DT!%,D<**%HR8  "CB   2
M          "  ?3J 0!A,#8S,#(P,C%E>#$P,RYH=&U02P$"% ,4    " "9
M- 13_$O'B? 1  "U6P  $@              @ ''$0( 83 V,S R,#(Q97@Q
M,#0N:'1M4$L! A0#%     @ F30$4XV5T6.A+P  .1$! !(
M ( !YR," &$P-C,P,C R,65X,3 U+FAT;5!+ 0(4 Q0    ( )DT!%,8,,1
MBC<   .. 0 2              "  ;A3 @!A,#8S,#(P,C%E>#$P-BYH=&U0
M2P$"% ,4    " "9- 13'*]/XU<#   K"@  $@              @ %RBP(
M83 V,S R,#(Q97@Q-3$N:'1M4$L! A0#%     @ F30$4].P:9,0"   IB4
M !(              ( !^8X" &$P-C,P,C R,65X,S$Q+FAT;5!+ 0(4 Q0
M   ( )DT!%-2^K2G&P@  ,0E   2              "  3F7 @!A,#8S,#(P
M,C%E>#,Q,BYH=&U02P$"% ,4    " "9- 13#9&",=D$  #S$@  $@
M        @ &$GP( 83 V,S R,#(Q97@S,C$N:'1M4$L! A0#%     @ F30$
M4S8AD8CD!   6!,  !(              ( !C:0" &$P-C,P,C R,65X,S(R
M+FAT;5!+ 0(4 Q0    ( )DT!%.^#@H?)%@#  24,0 0              "
M :&I @!C=G,M,C R,3 V,S N:'1M4$L! A0#%     @ F30$4Q^+%H.T$@
M=<\  !               ( !\P$& &-V<RTR,#(Q,#8S,"YX<V102P$"% ,4
M    " "9- 139Y%I1^PF  "&CP$ %               @ '5% 8 8W9S+3(P
M,C$P-C,P7V-A;"YX;6Q02P$"% ,4    " "9- 13.K*,0*%>  "+.P0 %
M            @ 'S.P8 8W9S+3(P,C$P-C,P7V1E9BYX;6Q02P$"% ,4
M" "9- 131__R*<0.  !^#P  $P              @ '&F@8 8W9S+3(P,C$P
M-C,P7V<Q+FIP9U!+ 0(4 Q0    ( )DT!%-ZH(]>[.T  (3<"0 4
M      "  ;NI!@!C=G,M,C R,3 V,S!?;&%B+GAM;%!+ 0(4 Q0    ( )DT
M!%-FER_249   (F7!@ 4              "  =F7!P!C=G,M,C R,3 V,S!?
=<')E+GAM;%!+!08     $@ 2 (4$  !<* @    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
